Psyllid ID: psy15820

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230
Protein Sequence
MNDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMVSLSGEKL
Secondary Structure (PSIPRED)
ccccccccccccccccccccEEEccccccccccEEEEEEEEccccccccEEEEEEcccccccHHHHHHHHHHHHHHHHcccccccEEEEEEEEccccEEEEEEccccccHHHHHHHHcccccccccccccccccHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccEEEccccHHHEccHHHEEEEEEEEEccccEEEEEEEEEEEccEEEEEEEEEcccccccHHHHHHHHHHHHHHccccccccEccEEEEEccccccEEEEEcccccEHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHccccHHHcccHHHHHHHHHcEEEccccEEEEEccccccEEEEEEEccccc
Coil and Loop (DISEMBL)
mndpvlnqksddkwevprqHIKVFDIlgegcfgqvwkcealgidgregpCIVAVKTLKENAGERERLDLLQELTvmktldphpnvvrllgcctekepFFVIMEyvpygklqsFLRSSRAQRYynnmhgksnsltsrdLTSFCYQVARGMQFlssrgvrdgyrlekpdhcRRELYNIMYYcwdkepnerpnfTELCDLLEKLLLNetdyielerfpdhsyynmvslsgekl
Flexible Loop (DISEMBL)
mndpvlnqksddkwevprQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTlkenagereRLDLLQELTvmktldphpnVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNmhgksnsltsrDLTSFCYQVARGMQflssrgvrdgyrlekpdhcrrELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIElerfpdhsyynmvslsgekl
Low Complexity Region (SEG)
MNDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTelcdlleklllneTDYIELERFPDHSYYNMVSLSGEKL
Disordered region (IsUnstruct)
*************WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM******LTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMV*******
Disordered Region (DISOPRED)
**DPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS*******************RDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHS************
Disordered Region (DISEMBL)
************KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMVSLSGEKL
Disordered Region (DISPRO)
**DPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ****NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMVSLS****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMVSLSGEKL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	230	2.2.26 [Sep-21-2011]
Q9VBW3	773	Tyrosine kinase receptor	yes	N/A	0.634	0.188	0.678	8e-54
Q26614	972	Fibroblast growth factor	no	N/A	0.630	0.149	0.469	4e-31
Q04589	822	Fibroblast growth factor	yes	N/A	0.626	0.175	0.430	2e-28
P11362	822	Fibroblast growth factor	yes	N/A	0.626	0.175	0.430	2e-28
P16092	822	Fibroblast growth factor	yes	N/A	0.626	0.175	0.430	2e-28
Q91743	828	Fibroblast growth factor	N/A	N/A	0.630	0.175	0.433	6e-28
Q90330	713	Fibroblast growth factor	N/A	N/A	0.626	0.201	0.437	8e-28
P22607	806	Fibroblast growth factor	no	N/A	0.652	0.186	0.412	2e-27
Q91285	816	Fibroblast growth factor	N/A	N/A	0.626	0.176	0.430	2e-27
Q61851	801	Fibroblast growth factor	no	N/A	0.652	0.187	0.412	3e-27

>sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster GN=Cad96Ca PE=2 SV=2

 Score =  210 bits (534), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 99/146 (67%), Positives = 119/146 (81%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WE PR  +K F+ILGEG FGQVW+CEA  I+G EG   VAVKTLKE+A E +R DLL 
Sbjct: 461 DRWEFPRYRLKFFNILGEGAFGQVWRCEATNINGNEGITTVAVKTLKESATEVDRKDLLS 520

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           EL VMK+L+PH NVV LLGCCT+K+P FVI+EYV  GKLQ++LRSSRA+R+Y N HGKSN
Sbjct: 521 ELEVMKSLEPHINVVHLLGCCTDKDPTFVILEYVNRGKLQTYLRSSRAERHYGNTHGKSN 580

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
            LTS DLTSF YQVA+GM +L+SRG+
Sbjct: 581 VLTSCDLTSFMYQVAKGMDYLTSRGI 606

Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1

>sp|Q26614|FGFR_STRPU Fibroblast growth factor receptor OS=Strongylocentrotus purpuratus GN=FGFR PE=2 SV=1

 Score =  134 bits (338), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 69/147 (46%), Positives = 95/147 (64%), Gaps = 2/147 (1%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D +WE PR  + V   +GEG FG+V   EA+GI  +E    VAVK LK NA +RE  DL+
Sbjct: 629 DPEWEFPRDRLTVGKTIGEGAFGKVVIGEAVGIVCQEKTSTVAVKMLKANAMDREFSDLI 688

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN--MHG 128
            EL +MK +  +PN++ LLGCCT++ P +VI+E+  +G L+ FLRS R    Y    +  
Sbjct: 689 SELAMMKMIGKNPNIINLLGCCTQEGPPYVIVEFAHHGNLRDFLRSRRPPEEYEKSILLT 748

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSR 155
            S +LT++DL S  YQVARGM FL+S+
Sbjct: 749 TSQTLTNKDLMSMAYQVARGMDFLASK 775

Receptor for basic fibroblast growth factor.

Strongylocentrotus purpuratus (taxid: 7668)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus GN=Fgfr1 PE=1 SV=1

 Score =  125 bits (315), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/151 (43%), Positives = 96/151 (63%), Gaps = 7/151 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEGCFGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 468 DPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 526

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 527 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 586

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 587 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 617

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P11362|FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3

 Score =  125 bits (315), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/151 (43%), Positives = 96/151 (63%), Gaps = 7/151 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEGCFGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 468 DPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 526

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 527 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 586

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 587 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 617

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus GN=Fgfr1 PE=1 SV=2

 Score =  125 bits (315), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 65/151 (43%), Positives = 96/151 (63%), Gaps = 7/151 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEGCFGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 468 DPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 526

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 527 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 586

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 587 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 617

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q91743|FGFR4_XENLA Fibroblast growth factor receptor 4 OS=Xenopus laevis GN=fgfr4 PE=2 SV=1

 Score =  124 bits (311), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/150 (43%), Positives = 91/150 (60%), Gaps = 5/150 (3%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGI--DGREGPCIVAVKTLKENAGERERLD 68
           D KWE PR  + +   LGEGCFGQV + E  GI  D  E P  VAVK LK+N  +++  D
Sbjct: 480 DAKWEFPRDRLVLGKPLGEGCFGQVVRAEGYGIEKDRPEKPVTVAVKMLKDNGTDKDLSD 539

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR---AQRYYNN 125
           L+ E+ +MK +  H N++ LLG CT++ P FVI+EY   G L+ FLR+ R    +  ++ 
Sbjct: 540 LISEMELMKVIGKHKNIINLLGVCTQEGPLFVIVEYASKGNLREFLRARRPPTPEDAFDI 599

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                  L+ +DL S  YQVARGM++L S+
Sbjct: 600 TKVPEELLSFKDLVSCAYQVARGMEYLESK 629

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q90330|FGFR4_COTCO Fibroblast growth factor receptor 4 OS=Coturnix coturnix GN=FGFR4 PE=2 SV=1

 Score =  123 bits (309), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 66/151 (43%), Positives = 93/151 (61%), Gaps = 7/151 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D KWE PR+ + +   LGEGCFGQV + EA GID R+ P     VAVK LK+NA +++  
Sbjct: 369 DSKWEFPREKLVLGKPLGEGCFGQVVRAEAYGID-RQWPDRAVTVAVKMLKDNATDKDLA 427

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR---YYN 124
           DL+ E+ +MK +D H N++ LLG CT+  P +VI+E+   G L+ +LR+ R       ++
Sbjct: 428 DLISEMEMMKLMDKHKNIINLLGVCTQDGPLYVIVEFAAKGNLREYLRARRPPTPDYTFD 487

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   L  +DL S  YQVARGM++L SR
Sbjct: 488 ITELHEEQLCFKDLVSCVYQVARGMEYLESR 518

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation; MMP14 promotes internalization and degradation of FGFR4.

Coturnix coturnix (taxid: 9091)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P22607|FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1

 Score =  122 bits (307), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 64/155 (41%), Positives = 93/155 (60%), Gaps = 5/155 (3%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREG--PCIVAVKTLKENAGE 63
           L   +D KWE+ R  + +   LGEGCFGQV   EA+GID      P  VAVK LK++A +
Sbjct: 457 LELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATD 516

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY- 122
           ++  DL+ E+ +MK +  H N++ LLG CT+  P +V++EY   G L+ FLR+ R     
Sbjct: 517 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLD 576

Query: 123 --YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             ++        LT +DL S  YQVARGM++L+S+
Sbjct: 577 YSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQ 611

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of the inner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinase activation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Over-expressed or constitutively activated FGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A and STAT5B.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q91285|FGFR1_PLEWA Fibroblast growth factor receptor 1 OS=Pleurodeles waltl GN=FGFR1 PE=2 SV=1

 Score =  122 bits (306), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 65/151 (43%), Positives = 95/151 (62%), Gaps = 7/151 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE  R  + +   LGEGCFGQV   EA+G+D +E P     VAVK LK +A E++  
Sbjct: 464 DPRWEFSRDRLILGKPLGEGCFGQVVMGEAIGLD-KEKPNRVTKVAVKMLKSDATEKDLS 522

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R    +  YN
Sbjct: 523 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 582

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
            +H   + L+ +DL S  YQVARGM++L+S+
Sbjct: 583 PIHVSKDMLSFKDLVSCAYQVARGMEYLASK 613

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and normal skeletogenesis. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol-1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by ubiquitination, internalization and degradation.

Pleurodeles waltl (taxid: 8319)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q61851|FGFR3_MOUSE Fibroblast growth factor receptor 3 OS=Mus musculus GN=Fgfr3 PE=1 SV=1

 Score =  121 bits (304), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 64/155 (41%), Positives = 93/155 (60%), Gaps = 5/155 (3%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGE 63
           L   +D KWE+ R  + +   LGEGCFGQV   EA+GID      P  VAVK LK++A +
Sbjct: 451 LELPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDRTAKPVTVAVKMLKDDATD 510

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY- 122
           ++  DL+ E+ +MK +  H N++ LLG CT+  P +V++EY   G L+ FLR+ R     
Sbjct: 511 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGMD 570

Query: 123 --YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             ++        LT +DL S  YQVARGM++L+S+
Sbjct: 571 YSFDACRLPEEQLTCKDLVSCAYQVARGMEYLASQ 605

Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of the inner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinase activation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Over-expressed or constitutively activated FGFR3 promotes activation of STAT1, STAT5A and STAT5B. Plays a role in postnatal lung development.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	230
195151633	318	GL21933 [Drosophila persimilis] gi|19411	0.952	0.688	0.689	7e-88
242024461	630	tyrosine kinase receptor, putative [Pedi	0.647	0.236	0.744	3e-62
270002918	609	cadherin 96Ca [Tribolium castaneum]	0.647	0.244	0.718	7e-59
91076662	625	PREDICTED: similar to AGAP011648-PA [Tri	0.647	0.238	0.718	8e-59
332019653	606	Tyrosine kinase receptor Cad96Ca [Acromy	0.639	0.242	0.723	1e-58
158301106	706	AGAP011648-PA [Anopheles gambiae str. PE	0.634	0.206	0.698	8e-57
307206332	608	Tyrosine kinase receptor Cad96Ca [Harpeg	0.639	0.241	0.703	5e-56
307173288	913	Tyrosine kinase receptor Cad96Ca [Campon	0.639	0.161	0.703	1e-55
157110899	706	tyrosine kinase receptor [Aedes aegypti]	0.678	0.220	0.660	1e-55
328776753	634	PREDICTED: tyrosine kinase receptor Cad9	0.626	0.227	0.718	2e-55

>gi|195151633|ref|XP_002016743.1| GL21933 [Drosophila persimilis] gi|194111800|gb|EDW33843.1| GL21933 [Drosophila persimilis]

 Score =  328 bits (842), Expect = 7e-88,   Method: Compositional matrix adjust.
 Identities = 151/219 (68%), Positives = 186/219 (84%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WE PR  +K F+ILGEG FGQVW+CEA  I+G EG   VAVKTLKE+A E +R DLL 
Sbjct: 100 DRWEFPRYRLKFFNILGEGAFGQVWRCEATDINGFEGITTVAVKTLKESATEVDRKDLLS 159

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           EL VMK+L+PH NVV+L+GCCT+K+P FVI+EYV  GKLQS+LR+SRA+R+Y N HGKSN
Sbjct: 160 ELEVMKSLEPHVNVVQLIGCCTDKDPTFVIIEYVNRGKLQSYLRNSRAERHYGNTHGKSN 219

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
            LTS DLTSF YQ+A+GM +L++RGVRDGYRLEKP+HCRRELYNIMYYCW ++P+ERP F
Sbjct: 220 ILTSCDLTSFMYQIAKGMDYLTARGVRDGYRLEKPEHCRRELYNIMYYCWSQDPHERPLF 279

Query: 192 TELCDLLEKLLLNETDYIELERFPDHSYYNMVSLSGEKL 230
            E+ ++L+KLL  E DYI+LERFPDH+YYN+VS+SGEKL
Sbjct: 280 GEIINMLDKLLHTEMDYIQLERFPDHNYYNIVSISGEKL 318

Source: Drosophila persimilis

Species: Drosophila persimilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242024461|ref|XP_002432646.1| tyrosine kinase receptor, putative [Pediculus humanus corporis] gi|212518116|gb|EEB19908.1| tyrosine kinase receptor, putative [Pediculus humanus corporis]

 Score =  244 bits (622), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 111/149 (74%), Positives = 132/149 (88%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
           K  DKWE PR H+KVF+ILGEGCFGQVW+CEAL IDGREG  +VAVKTLKE+AGE+ER D
Sbjct: 315 KPGDKWEFPRHHLKVFNILGEGCFGQVWRCEALNIDGREGTTVVAVKTLKESAGEKERKD 374

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           LLQEL VMK+L+PHPN+VRLLGCCT+K+P FVIME+V  GKLQS+LR+SRA+R Y NMHG
Sbjct: 375 LLQELEVMKSLEPHPNIVRLLGCCTKKDPLFVIMEFVSLGKLQSYLRNSRAERCYGNMHG 434

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           +S +LTSRDLTSF YQ ARGM+FLS++G+
Sbjct: 435 ESKTLTSRDLTSFAYQCARGMEFLSNKGI 463

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270002918|gb|EEZ99365.1| cadherin 96Ca [Tribolium castaneum]

 Score =  232 bits (592), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 107/149 (71%), Positives = 125/149 (83%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
           K  D WE PR  +K F+ILGEG FGQVWKCEA  IDG+EG  +VAVKTLKENA E+E+ D
Sbjct: 294 KDSDHWEFPRHRLKFFNILGEGAFGQVWKCEASDIDGKEGVSVVAVKTLKENANEKEKSD 353

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           LL EL VMK L+ HPNVVRLLGCCT+KEP F+IMEY+  GKLQS+LR+SRA+RYYNNMHG
Sbjct: 354 LLSELRVMKMLETHPNVVRLLGCCTDKEPIFLIMEYISKGKLQSYLRNSRAERYYNNMHG 413

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           +S SLTSRDLTSF YQVA+GM+FLS+ G+
Sbjct: 414 QSKSLTSRDLTSFVYQVAKGMEFLSANGI 442

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91076662|ref|XP_971319.1| PREDICTED: similar to AGAP011648-PA [Tribolium castaneum]

 Score =  232 bits (592), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 107/149 (71%), Positives = 125/149 (83%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
           K  D WE PR  +K F+ILGEG FGQVWKCEA  IDG+EG  +VAVKTLKENA E+E+ D
Sbjct: 310 KDSDHWEFPRHRLKFFNILGEGAFGQVWKCEASDIDGKEGVSVVAVKTLKENANEKEKSD 369

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           LL EL VMK L+ HPNVVRLLGCCT+KEP F+IMEY+  GKLQS+LR+SRA+RYYNNMHG
Sbjct: 370 LLSELRVMKMLETHPNVVRLLGCCTDKEPIFLIMEYISKGKLQSYLRNSRAERYYNNMHG 429

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           +S SLTSRDLTSF YQVA+GM+FLS+ G+
Sbjct: 430 QSKSLTSRDLTSFVYQVAKGMEFLSANGI 458

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332019653|gb|EGI60127.1| Tyrosine kinase receptor Cad96Ca [Acromyrmex echinatior]

 Score =  232 bits (591), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 110/152 (72%), Positives = 126/152 (82%), Gaps = 5/152 (3%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
           +  K +DKWE PR  +KVF+ILGEGCFGQVWKCEALGIDG+ GP IVAVKTLKENA ERE
Sbjct: 293 IQSKQEDKWEFPRHRLKVFNILGEGCFGQVWKCEALGIDGKSGPTIVAVKTLKENAAERE 352

Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           RLDL QEL VMK LDPHPNVVRLLGCCTE+EP FVI+EYV  GKLQSFLR+SR +R    
Sbjct: 353 RLDLAQELRVMKNLDPHPNVVRLLGCCTEREPMFVILEYVSGGKLQSFLRASREERN--- 409

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
            HG S  LTSRDLT F YQ+A+GM++L+S+G+
Sbjct: 410 -HG-SAGLTSRDLTGFVYQIAKGMEYLASKGI 439

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158301106|ref|XP_320863.4| AGAP011648-PA [Anopheles gambiae str. PEST] gi|157013481|gb|EAA00411.4| AGAP011648-PA [Anopheles gambiae str. PEST]

 Score =  226 bits (575), Expect = 8e-57,   Method: Composition-based stats.
 Identities = 102/146 (69%), Positives = 119/146 (81%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WE PR  +KVF+ILGEG FGQVW+CEA  IDG EG  + AVKTLKENA E ER DLL 
Sbjct: 394 DRWEFPRHRLKVFNILGEGAFGQVWRCEATDIDGHEGVSVTAVKTLKENASEAERNDLLS 453

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           EL V+K+L+PH NVVRLLGCCTEK+P FVI+EYV  GKLQ+FLR+SR +++Y N HGKS 
Sbjct: 454 ELQVLKSLEPHINVVRLLGCCTEKDPIFVILEYVNMGKLQTFLRNSRVEKHYGNTHGKSK 513

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
            LTS DLTSF YQVARGM FL+SRG+
Sbjct: 514 ILTSGDLTSFMYQVARGMDFLTSRGI 539

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307206332|gb|EFN84389.1| Tyrosine kinase receptor Cad96Ca [Harpegnathos saltator]

 Score =  223 bits (568), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 107/152 (70%), Positives = 124/152 (81%), Gaps = 5/152 (3%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
           +  K +DKWE PR  +KVF+ILGEGCFGQVWKCEAL IDG+ G  IVAVKTLKENA ERE
Sbjct: 295 IQSKQEDKWEFPRHRLKVFNILGEGCFGQVWKCEALDIDGKAGATIVAVKTLKENATERE 354

Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           RLDL QEL VMK LDPHPNVVRLLGCCTE+EP FVI+EYV  GKLQSFLR+SR +R    
Sbjct: 355 RLDLAQELRVMKNLDPHPNVVRLLGCCTEREPMFVILEYVSGGKLQSFLRASREERN--- 411

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
            HG +  LTSRDLT F YQ+A+GM++L+S+G+
Sbjct: 412 -HGGA-GLTSRDLTGFVYQIAKGMEYLASKGI 441

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307173288|gb|EFN64322.1| Tyrosine kinase receptor Cad96Ca [Camponotus floridanus]

 Score =  221 bits (564), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 107/152 (70%), Positives = 124/152 (81%), Gaps = 5/152 (3%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
           +  K +DKWE PR  +KVF+ILGEGCFGQVWKCEAL IDG+ G  IVAVKTLKENA ERE
Sbjct: 299 IQNKQEDKWEFPRHRLKVFNILGEGCFGQVWKCEALDIDGKSGATIVAVKTLKENATERE 358

Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           RLDL QEL VMK LDPHPNVVRLLGCCTE+EP FVI+EYV  GKLQSFLR+SR +R    
Sbjct: 359 RLDLAQELRVMKNLDPHPNVVRLLGCCTEREPMFVILEYVSGGKLQSFLRASREERN--- 415

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
            HG +  LTSRDLT F YQ+A+GM++L+S+G+
Sbjct: 416 -HGGA-GLTSRDLTGFVYQIAKGMEYLASKGI 445

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157110899|ref|XP_001651299.1| tyrosine kinase receptor [Aedes aegypti] gi|108883900|gb|EAT48125.1| AAEL000850-PA, partial [Aedes aegypti]

 Score =  221 bits (564), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 103/156 (66%), Positives = 124/156 (79%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           N+  +N    D+WE PR  +KVF+ILGEG FGQVW+CEA  IDG++G  I AVKTLKENA
Sbjct: 384 NNSGMNGGPKDRWEFPRHRLKVFNILGEGAFGQVWRCEATDIDGKDGVSITAVKTLKENA 443

Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
            + ER DLL EL V+K+L+PH NVVRLLGCCTEK+P FVI+EYV  GKLQ+FLR+SR ++
Sbjct: 444 SDAERNDLLSELQVLKSLEPHINVVRLLGCCTEKDPIFVILEYVNMGKLQTFLRNSRVEK 503

Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           +Y N HGKS  LTS DLTSF YQVARGM FL+SRG+
Sbjct: 504 HYGNTHGKSKILTSGDLTSFMYQVARGMDFLTSRGI 539

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328776753|ref|XP_392586.4| PREDICTED: tyrosine kinase receptor Cad96Ca-like [Apis mellifera]

 Score =  221 bits (564), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 107/149 (71%), Positives = 122/149 (81%), Gaps = 5/149 (3%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
           K +DKWE PR  +KVF+ILGEGCFGQVWKCEAL IDG+ G  IVAVKTLKENA ERERLD
Sbjct: 324 KQEDKWEFPRHRLKVFNILGEGCFGQVWKCEALDIDGKSGAIIVAVKTLKENATERERLD 383

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           L QEL VMK LDPHPNVVRLLGCCTE+EP FVI+EYV  GKLQSFLR+SR +R     HG
Sbjct: 384 LAQELRVMKNLDPHPNVVRLLGCCTEREPMFVILEYVSGGKLQSFLRASREERN----HG 439

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
               LTSRDLT F YQ+A+GM++L+S+G+
Sbjct: 440 GP-GLTSRDLTGFVYQIAKGMEYLASKGI 467

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	230
FB|FBgn0022800	773	Cad96Ca "Cadherin 96Ca" [Droso	0.634	0.188	0.678	2.2e-78
UNIPROTKB|F1NL50	1046	RET "Uncharacterized protein"	0.617	0.135	0.441	1.8e-36
UNIPROTKB|F1NL49	1061	RET "Uncharacterized protein"	0.617	0.133	0.441	1.8e-36
UNIPROTKB|F1NL36	1091	RET "Uncharacterized protein"	0.617	0.130	0.441	2e-36
UNIPROTKB|F1NL37	1091	RET "Uncharacterized protein"	0.617	0.130	0.441	2e-36
UNIPROTKB|F1NI70	1116	RET "Uncharacterized protein"	0.617	0.127	0.441	2.2e-36
UNIPROTKB|K7GQJ1	731	FGFR1 "Fibroblast growth facto	0.626	0.196	0.437	5.6e-36
UNIPROTKB|E7EU09	733	FGFR1 "Fibroblast growth facto	0.626	0.196	0.437	5.6e-36
UNIPROTKB|K7GL40	733	FGFR1 "Fibroblast growth facto	0.626	0.196	0.437	5.6e-36
UNIPROTKB|K7GL48	733	FGFR1 "Fibroblast growth facto	0.626	0.196	0.437	5.6e-36

FB|FBgn0022800 Cad96Ca "Cadherin 96Ca" [Drosophila melanogaster (taxid:7227)]

 Score = 525 (189.9 bits), Expect = 2.2e-78, Sum P(2) = 2.2e-78
 Identities = 99/146 (67%), Positives = 119/146 (81%)

Query:    12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
             D+WE PR  +K F+ILGEG FGQVW+CEA  I+G EG   VAVKTLKE+A E +R DLL 
Sbjct:   461 DRWEFPRYRLKFFNILGEGAFGQVWRCEATNINGNEGITTVAVKTLKESATEVDRKDLLS 520

Query:    72 ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
             EL VMK+L+PH NVV LLGCCT+K+P FVI+EYV  GKLQ++LRSSRA+R+Y N HGKSN
Sbjct:   521 ELEVMKSLEPHINVVHLLGCCTDKDPTFVILEYVNRGKLQTYLRSSRAERHYGNTHGKSN 580

Query:   132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
              LTS DLTSF YQVA+GM +L+SRG+
Sbjct:   581 VLTSCDLTSFMYQVAKGMDYLTSRGI 606

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;NAS

GO:0004713 "protein tyrosine kinase activity" evidence=ISS;NAS

GO:0004714 "transmembrane receptor protein tyrosine kinase activity" evidence=ISS

GO:0005887 "integral to plasma membrane" evidence=ISS

GO:0004672 "protein kinase activity" evidence=ISS

GO:0016339 "calcium-dependent cell-cell adhesion" evidence=ISS

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0045792 "negative regulation of cell size" evidence=IMP

GO:0007030 "Golgi organization" evidence=IMP

UNIPROTKB|F1NL50 RET "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 301 (111.0 bits), Expect = 1.8e-36, Sum P(2) = 1.8e-36
 Identities = 68/154 (44%), Positives = 93/154 (60%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
             D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA + E  DLL
Sbjct:   688 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLL 747

Query:    71 QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRYYNNMHGK 129
              E  ++K ++ HP+V++L G C++  P ++I+EY  YG L+SFLR SR     Y    G 
Sbjct:   748 SEFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGPSYVGSDGN 806

Query:   130 SNS----------LTSRDLTSFCYQVARGMQFLS 153
              NS          LT  DL SF +Q++RGMQ+L+
Sbjct:   807 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 840

GO:0005509 "calcium ion binding" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1NL49 RET "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 301 (111.0 bits), Expect = 1.8e-36, Sum P(2) = 1.8e-36
 Identities = 68/154 (44%), Positives = 93/154 (60%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
             D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA + E  DLL
Sbjct:   703 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLL 762

Query:    71 QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRYYNNMHGK 129
              E  ++K ++ HP+V++L G C++  P ++I+EY  YG L+SFLR SR     Y    G 
Sbjct:   763 SEFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGPSYVGSDGN 821

Query:   130 SNS----------LTSRDLTSFCYQVARGMQFLS 153
              NS          LT  DL SF +Q++RGMQ+L+
Sbjct:   822 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 855

GO:0005509 "calcium ion binding" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1NL36 RET "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 301 (111.0 bits), Expect = 2.0e-36, Sum P(2) = 2.0e-36
 Identities = 68/154 (44%), Positives = 93/154 (60%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
             D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA + E  DLL
Sbjct:   690 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLL 749

Query:    71 QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRYYNNMHGK 129
              E  ++K ++ HP+V++L G C++  P ++I+EY  YG L+SFLR SR     Y    G 
Sbjct:   750 SEFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGPSYVGSDGN 808

Query:   130 SNS----------LTSRDLTSFCYQVARGMQFLS 153
              NS          LT  DL SF +Q++RGMQ+L+
Sbjct:   809 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 842

GO:0005509 "calcium ion binding" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1NL37 RET "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 301 (111.0 bits), Expect = 2.0e-36, Sum P(2) = 2.0e-36
 Identities = 68/154 (44%), Positives = 93/154 (60%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
             D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA + E  DLL
Sbjct:   705 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLL 764

Query:    71 QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRYYNNMHGK 129
              E  ++K ++ HP+V++L G C++  P ++I+EY  YG L+SFLR SR     Y    G 
Sbjct:   765 SEFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGPSYVGSDGN 823

Query:   130 SNS----------LTSRDLTSFCYQVARGMQFLS 153
              NS          LT  DL SF +Q++RGMQ+L+
Sbjct:   824 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 857

GO:0005509 "calcium ion binding" evidence=IEA

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|F1NI70 RET "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 301 (111.0 bits), Expect = 2.2e-36, Sum P(2) = 2.2e-36
 Identities = 68/154 (44%), Positives = 93/154 (60%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
             D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA + E  DLL
Sbjct:   716 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASQSELRDLL 775

Query:    71 QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRYYNNMHGK 129
              E  ++K ++ HP+V++L G C++  P ++I+EY  YG L+SFLR SR     Y    G 
Sbjct:   776 SEFNLLKQVN-HPHVIKLYGACSQDGPLYLIVEYAKYGSLRSFLRESRKVGPSYVGSDGN 834

Query:   130 SNS----------LTSRDLTSFCYQVARGMQFLS 153
              NS          LT  DL SF +Q++RGMQ+L+
Sbjct:   835 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 868

GO:0007156 "homophilic cell adhesion" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0001657 "ureteric bud development" evidence=IEA

GO:0001755 "neural crest cell migration" evidence=IEA

GO:0001838 "embryonic epithelial tube formation" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005887 "integral to plasma membrane" evidence=IEA

GO:0007158 "neuron cell-cell adhesion" evidence=IEA

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=IEA

GO:0010008 "endosome membrane" evidence=IEA

GO:0010976 "positive regulation of neuron projection development" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0033619 "membrane protein proteolysis" evidence=IEA

GO:0033630 "positive regulation of cell adhesion mediated by integrin" evidence=IEA

GO:0035799 "ureter maturation" evidence=IEA

GO:0042551 "neuron maturation" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0048265 "response to pain" evidence=IEA

GO:0048484 "enteric nervous system development" evidence=IEA

GO:0061146 "Peyer's patch morphogenesis" evidence=IEA

GO:0071300 "cellular response to retinoic acid" evidence=IEA

GO:0072300 "positive regulation of metanephric glomerulus development" evidence=IEA

UNIPROTKB|K7GQJ1 FGFR1 "Fibroblast growth factor receptor" [Sus scrofa (taxid:9823)]

 Score = 320 (117.7 bits), Expect = 5.6e-36, Sum P(2) = 5.6e-36
 Identities = 66/151 (43%), Positives = 96/151 (63%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
             D +WE+PR  + +   LGEGCFGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct:   377 DPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 435

Query:    68 DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ--RY-YN 124
             DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R     Y YN
Sbjct:   436 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 495

Query:   125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
               H     L+S+DL S  YQVARGM++L+S+
Sbjct:   496 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 526

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|E7EU09 FGFR1 "Fibroblast growth factor receptor" [Homo sapiens (taxid:9606)]

 Score = 320 (117.7 bits), Expect = 5.6e-36, Sum P(2) = 5.6e-36
 Identities = 66/151 (43%), Positives = 96/151 (63%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
             D +WE+PR  + +   LGEGCFGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct:   379 DPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 437

Query:    68 DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ--RY-YN 124
             DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R     Y YN
Sbjct:   438 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 497

Query:   125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
               H     L+S+DL S  YQVARGM++L+S+
Sbjct:   498 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 528

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

UNIPROTKB|K7GL40 FGFR1 "Fibroblast growth factor receptor" [Sus scrofa (taxid:9823)]

 Score = 320 (117.7 bits), Expect = 5.6e-36, Sum P(2) = 5.6e-36
 Identities = 66/151 (43%), Positives = 96/151 (63%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
             D +WE+PR  + +   LGEGCFGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct:   379 DPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 437

Query:    68 DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ--RY-YN 124
             DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R     Y YN
Sbjct:   438 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 497

Query:   125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
               H     L+S+DL S  YQVARGM++L+S+
Sbjct:   498 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 528

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

UNIPROTKB|K7GL48 FGFR1 "Fibroblast growth factor receptor" [Sus scrofa (taxid:9823)]

 Score = 320 (117.7 bits), Expect = 5.6e-36, Sum P(2) = 5.6e-36
 Identities = 66/151 (43%), Positives = 96/151 (63%)

Query:    11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
             D +WE+PR  + +   LGEGCFGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct:   379 DPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 437

Query:    68 DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ--RY-YN 124
             DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R     Y YN
Sbjct:   438 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 497

Query:   125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
               H     L+S+DL S  YQVARGM++L+S+
Sbjct:   498 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 528

GO:0016021 "integral to membrane" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0005007 "fibroblast growth factor-activated receptor activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9VBW3	CAD96_DROME	2, ., 7, ., 1, 0, ., 1	0.6780	0.6347	0.1888	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.10	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	230
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-44
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-37
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-35
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-34
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-33
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-33
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-31
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-29
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-26
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-26
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-25
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-24
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-24
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-23
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-23
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-23
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-22
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-21
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-21
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-21
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-20
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-20
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-18
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-16
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-14
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-14
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-13
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-12
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-12
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-12
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-08
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-08
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-08
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-07
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-07
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-07
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-06
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-06
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-05
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-05
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-05
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-05
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-05
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-05
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-04
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-04
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-04
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-04
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-04
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-04
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-04
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-04
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.001
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.001
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	0.002
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.002
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.002
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	0.002
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	0.003
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.004
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	0.004

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  174 bits (443), Expect = 7e-54
 Identities = 65/149 (43%), Positives = 94/149 (63%), Gaps = 3/149 (2%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
            D +WE+PR  + +   LGEG FGQV K EA+G+D       VAVK LK++A E++  DL
Sbjct: 3   LDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL 62

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           + E+ +MK +  H N++ LLG CT++ P +V++EY  +G L+ FLR+ R    Y +    
Sbjct: 63  VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP 122

Query: 130 SNS---LTSRDLTSFCYQVARGMQFLSSR 155
                 LT +DL SF YQVARGM+FL+S+
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFLASK 151

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 3e-52
 Identities = 65/137 (47%), Positives = 87/137 (63%), Gaps = 9/137 (6%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
             LGEG FG+V+K +  G DG      VAVKTLKE+A E ER D L+E  VMK L  HPN
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDG--KTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPN 57

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           VVRLLG CTE+EP ++++EY+  G L  +LR SR            ++L+ +DL SF  Q
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPE----KSTLSLKDLLSFAIQ 113

Query: 145 VARGMQFLSSRGV--RD 159
           +A+GM++L+S+    RD
Sbjct: 114 IAKGMEYLASKKFVHRD 130

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  153 bits (388), Expect = 6e-46
 Identities = 59/137 (43%), Positives = 81/137 (59%), Gaps = 15/137 (10%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
             LGEG FG+V+K    G         VAVKTLKE+A E++  + L+E  +M+ LD HPN
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGD-GKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPN 62

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V+LLG CTE+EP  ++MEY+P G L  +LR +R              L+  DL SF  Q
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-----------PKELSLSDLLSFALQ 111

Query: 145 VARGMQFLSSRGV--RD 159
           +ARGM++L S+    RD
Sbjct: 112 IARGMEYLESKNFIHRD 128

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (383), Expect = 3e-45
 Identities = 61/137 (44%), Positives = 85/137 (62%), Gaps = 16/137 (11%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
             LGEG FG+V+K +  G  G +    VAVKTLKE+A E++  + L+E  +M+ LD HPN
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGG-KKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPN 62

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           VV+LLG CTE+EP +++MEY+  G L S+LR +R              L+  DL SF  Q
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR------------PKLSLSDLLSFALQ 110

Query: 145 VARGMQFLSSRGV--RD 159
           +ARGM++L S+    RD
Sbjct: 111 IARGMEYLESKNFIHRD 127

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  149 bits (379), Expect = 1e-44
 Identities = 60/135 (44%), Positives = 78/135 (57%), Gaps = 16/135 (11%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LGEG FG+V+K    G DG      VAVKTLKE A E ER + L+E ++MK L  HPN+V
Sbjct: 7   LGEGAFGEVYKGTLKG-DGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-HPNIV 64

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           RLLG CT+ EP +++ EY+P G L  FLR                 LT +DL     Q+A
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG------------EKLTLKDLLQMALQIA 112

Query: 147 RGMQFLSSRGV--RD 159
           +GM++L S+    RD
Sbjct: 113 KGMEYLESKNFVHRD 127

Length = 258

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  130 bits (329), Expect = 8e-37
 Identities = 65/150 (43%), Positives = 91/150 (60%), Gaps = 5/150 (3%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGR--EGPCIVAVKTLKENAGERERLD 68
           D KWE PR  + +   LGEGCFGQV + EA GID    +    VAVK LK+NA +++  D
Sbjct: 4   DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD 63

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNN 125
           L+ E+ +MK +  H N++ LLG CT++ P +VI+EY   G L+ FLR+ R       ++ 
Sbjct: 64  LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                  L+ +DL S  YQVARGM++L SR
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESR 153

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  126 bits (317), Expect = 5e-35
 Identities = 67/151 (44%), Positives = 94/151 (62%), Gaps = 7/151 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WEVPR  + +   LGEGCFGQV   EA+G+D +E P     VAVK LK +A E++  
Sbjct: 10  DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLD-KEKPNRVTKVAVKMLKSDATEKDLS 68

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR--AQRY-YN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R     Y YN
Sbjct: 69  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   L+ +DL S  YQVARGM++L+S+
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASK 159

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  124 bits (312), Expect = 2e-34
 Identities = 63/146 (43%), Positives = 78/146 (53%), Gaps = 13/146 (8%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCI-VAVKTLKENAGERERLDL 69
           D KWE PR ++     LG G FG+V +  A G+  +    + VAVK LK  A   ER  L
Sbjct: 27  DLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGL-SKSDAVMKVAVKMLKPTAHSSEREAL 85

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           + EL +M  L  H N+V LLG CT   P  VI EY  YG L +FLR  R           
Sbjct: 86  MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR----------- 134

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            + LT  DL SF YQVA+GM FL+S+
Sbjct: 135 ESFLTLEDLLSFSYQVAKGMAFLASK 160

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  122 bits (308), Expect = 1e-33
 Identities = 64/151 (42%), Positives = 93/151 (61%), Gaps = 7/151 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE  R  + +   LGEGCFGQV   EALGID ++ P     VAVK LK++A E++  
Sbjct: 7   DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGID-KDKPKEAVTVAVKMLKDDATEKDLS 65

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R    +  Y+
Sbjct: 66  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   +T +DL S  YQVARGM++L+S+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQ 156

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  121 bits (304), Expect = 6e-33
 Identities = 62/151 (41%), Positives = 93/151 (61%), Gaps = 5/151 (3%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGRE--GPCIVAVKTLKENAGERERL 67
           +D KWE+ R  + +   LGEGCFGQV   EA+GID  +   P  VAVK LK++A +++  
Sbjct: 3   ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +V++EY   G L+ +LR+ R       ++
Sbjct: 63  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   LT +DL S  YQVARGM++L+S+
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQ 153

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  115 bits (288), Expect = 6e-31
 Identities = 62/139 (44%), Positives = 81/139 (58%), Gaps = 12/139 (8%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
            LGEG FG+V K  A  + GR G   VAVK LKENA   E  DLL E  ++K ++ HP+V
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHV 65

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRYYNNMHGKSNS----------LT 134
           ++L G C++  P  +I+EY  YG L+SFLR SR     Y    G  NS          LT
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 135 SRDLTSFCYQVARGMQFLS 153
             DL SF +Q++RGMQ+L+
Sbjct: 126 MGDLISFAWQISRGMQYLA 144

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 7e-29
 Identities = 53/144 (36%), Positives = 81/144 (56%), Gaps = 8/144 (5%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGI--DGREGPCIVAVKTLKENAGERERLDLLQ 71
           WE+PR+ I +   LG+G FG V++  A G+     E     A+KT+ ENA  RER++ L 
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRV--AIKTVNENASMRERIEFLN 58

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  +  +P  V+ME +  G L+S+LRS R +   N   G   
Sbjct: 59  EASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG--- 114

Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +       ++A GM +L+++
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAAK 138

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score =  106 bits (265), Expect = 3e-27
 Identities = 65/192 (33%), Positives = 87/192 (45%), Gaps = 49/192 (25%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FG+V +  A GI+       VAVK LKE A   E   L+ E
Sbjct: 1   KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTE 60

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKLQSFLRSSR------------- 118
           L ++  +  H NVV LLG CT+   P  VI+EY  +G L ++LRS R             
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRK 120

Query: 119 ---------AQRYYNNMHGKSNS--------------------------LTSRDLTSFCY 143
                     QR  +    +S++                          LT  DL S+ +
Sbjct: 121 REMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF 180

Query: 144 QVARGMQFLSSR 155
           QVARGM+FL+SR
Sbjct: 181 QVARGMEFLASR 192

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 2e-26
 Identities = 53/148 (35%), Positives = 71/148 (47%), Gaps = 22/148 (14%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+PR+ +K+   LG G FG+VW     G         VAVKTLK      E    LQE 
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGT------TKVAVKTLKPGTMSPE--AFLQEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +MK L  H  +V+L   C+E+EP +++ EY+  G L  FL+S           G+   L
Sbjct: 53  QIMKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS-----------GEGKKL 100

Query: 134 TSRDLTSFCYQVARGMQFLSSRGV--RD 159
               L     Q+A GM +L SR    RD
Sbjct: 101 RLPQLVDMAAQIAEGMAYLESRNYIHRD 128

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (256), Expect = 2e-26
 Identities = 55/145 (37%), Positives = 79/145 (54%), Gaps = 6/145 (4%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+P   ++  + LGEG FG+V+K E  G + R     VA+KTLKENA  + + +  QE  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS----SRAQRYYNNMHGKS 130
           +M  L  HPN+V LLG CT+++P  ++ EY+ +G L  FL      S       +   KS
Sbjct: 61  LMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
            SL   D      Q+A GM++LSS 
Sbjct: 120 -SLDCSDFLHIAIQIAAGMEYLSSH 143

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  101 bits (254), Expect = 4e-26
 Identities = 52/142 (36%), Positives = 76/142 (53%), Gaps = 7/142 (4%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           EVPR  I +   LG G FG+V++    G DG      VAVKTL E+  E++  D L E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   + H N+VRL+G   E+ P F+++E +  G L+SFLR +R          + +SLT
Sbjct: 62  IMSKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENR------PRPERPSSLT 114

Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
            +DL      VA+G ++L    
Sbjct: 115 MKDLLFCARDVAKGCKYLEENH 136

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  101 bits (252), Expect = 7e-26
 Identities = 49/138 (35%), Positives = 78/138 (56%), Gaps = 5/138 (3%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
            PR +++    LG G FG+V+  +A GI+   G  +V VK L++   E  + +  +EL +
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
            + L  H NVVRLLG C E EP ++I+EY   G L+ FLR+++++        K   L++
Sbjct: 62  FRKLS-HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKL----KPPPLST 116

Query: 136 RDLTSFCYQVARGMQFLS 153
           +   + C Q+A GM  LS
Sbjct: 117 KQKVALCTQIALGMDHLS 134

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  100 bits (250), Expect = 3e-25
 Identities = 55/152 (36%), Positives = 79/152 (51%), Gaps = 14/152 (9%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDG-----------REGPCIVAVKTLKENAGE 63
           E PRQ +   + LGEG FG+V  CEA G+              + P +VAVK L+ +A +
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
             R D L+E+ ++  L   PN+ RLLG CT   P  +IMEY+  G L  FL+   A+   
Sbjct: 61  NAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET-- 117

Query: 124 NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           + +   S SL+   L     Q+A GM++L S 
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESL 149

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 99.2 bits (247), Expect = 3e-25
 Identities = 50/128 (39%), Positives = 76/128 (59%), Gaps = 8/128 (6%)

Query: 26  ILGEGCFGQVWKCEALGIDGR-EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
            LG G FG+V++  A  I G   GP  VAVKTL++ A ++E+ + L+E  +M   + HPN
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPN 60

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V+LLG C   EP ++IME +  G L S+LR +R +R+   +      LT ++L   C  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL------LTLKELLDICLD 114

Query: 145 VARGMQFL 152
           VA+G  +L
Sbjct: 115 VAKGCVYL 122

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 99.4 bits (248), Expect = 3e-25
 Identities = 48/141 (34%), Positives = 69/141 (48%), Gaps = 2/141 (1%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
            V R  I +   LGEG FG+V+  E   ++      +VAVKTLKE A    R D  +E  
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS-SRAQRYYNNMHGKSNSL 133
           ++     H N+V+  G CTE +P  ++ EY+ +G L  FLRS      +  +       L
Sbjct: 61  LLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 134 TSRDLTSFCYQVARGMQFLSS 154
           T   L     Q+A GM +L+S
Sbjct: 120 TLSQLLQIAVQIASGMVYLAS 140

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 98.8 bits (246), Expect = 9e-25
 Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 10/150 (6%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E PR +I+    +G+G FG+V++  A G+   E   +VAVK LKE A    + D  +E  
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS-- 132
           +M   D HPN+V+LLG C   +P  ++ EY+ YG L  FLR    +   +  H  S++  
Sbjct: 61  LMAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119

Query: 133 -------LTSRDLTSFCYQVARGMQFLSSR 155
                  L+  +      QVA GM +LS R
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER 149

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 99.3 bits (247), Expect = 1e-24
 Identities = 62/193 (32%), Positives = 84/193 (43%), Gaps = 50/193 (25%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           +WE PR  +++  +LG G FG+V +  A GID +     VAVK LKE A   E   L+ E
Sbjct: 1   QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSE 60

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKLQSFLRSSR------------- 118
           L ++  +  H NVV LLG CT+   P  VI+E+  YG L +FLR+ R             
Sbjct: 61  LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120

Query: 119 --------------------AQRYYNNMHGKSNS----------------LTSRDLTSFC 142
                                     +    S S                LT  DL  + 
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180

Query: 143 YQVARGMQFLSSR 155
           +QVARGM+FL+SR
Sbjct: 181 FQVARGMEFLASR 193

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 99.1 bits (247), Expect = 2e-24
 Identities = 61/203 (30%), Positives = 84/203 (41%), Gaps = 59/203 (29%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 30  NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALM 89

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY-------- 122
            EL ++  L  H N+V LLG CT   P  VI EY  YG L +FLR  +A+ +        
Sbjct: 90  SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK-KAETFLNFVMALP 148

Query: 123 --------YNNMH---------------GKSNSLTSR----------------------- 136
                   Y N+                G    +  R                       
Sbjct: 149 EISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWP 208

Query: 137 ----DLTSFCYQVARGMQFLSSR 155
               DL  F  QVA+GM FL+S+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASK 231

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 97.0 bits (241), Expect = 5e-24
 Identities = 56/140 (40%), Positives = 78/140 (55%), Gaps = 6/140 (4%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           + IK  D++GEG FGQV +   +  DG +     A+K LKE A E +  D   EL V+  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRA-MIKKDGLKMN--AAIKMLKEFASENDHRDFAGELEVLCK 58

Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTS 135
           L  HPN++ LLG C  +   ++ +EY PYG L  FLR SR       +   HG +++LTS
Sbjct: 59  LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 136 RDLTSFCYQVARGMQFLSSR 155
           + L  F   VA GMQ+LS +
Sbjct: 119 QQLLQFASDVATGMQYLSEK 138

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 2e-23
 Identities = 46/130 (35%), Positives = 67/130 (51%), Gaps = 21/130 (16%)

Query: 27  LGEGCFGQVWKCEALGIDGR-EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +G+G FG V+K       G  +G   VAVKT +       +   LQE  ++K  D HPN+
Sbjct: 3   IGKGNFGDVYK-------GVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNI 54

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           V+L+G C +K+P +++ME VP G L +FLR             K N LT + L       
Sbjct: 55  VKLIGVCVQKQPIYIVMELVPGGSLLTFLR------------KKKNRLTVKKLLQMSLDA 102

Query: 146 ARGMQFLSSR 155
           A GM++L S+
Sbjct: 103 AAGMEYLESK 112

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 95.0 bits (236), Expect = 2e-23
 Identities = 54/142 (38%), Positives = 84/142 (59%), Gaps = 4/142 (2%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L E 
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 60

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+    
Sbjct: 61  SVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP- 116

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           T +++     ++A GM +L+++
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAK 138

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 95.3 bits (237), Expect = 4e-23
 Identities = 67/207 (32%), Positives = 82/207 (39%), Gaps = 62/207 (29%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 27  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALM 86

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR------------ 118
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R            
Sbjct: 87  SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHA 146

Query: 119 -AQRYYNNMHGKSNSLTSR----------------------------------------- 136
            A  Y N +H +  S  S                                          
Sbjct: 147 EAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEE 206

Query: 137 --------DLTSFCYQVARGMQFLSSR 155
                   DL SF YQVA+GM FL+S+
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASK 233

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 92.1 bits (228), Expect = 2e-22
 Identities = 49/134 (36%), Positives = 73/134 (54%), Gaps = 6/134 (4%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           D++GEG FGQV K   +  DG       A+K +KE A + +  D   EL V+  L  HPN
Sbjct: 1   DVIGEGNFGQVLKA-RIKKDGLR--MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSF 141
           ++ LLG C  +   ++ +EY P+G L  FLR SR       +   +  +++L+S+ L  F
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 142 CYQVARGMQFLSSR 155
              VARGM +LS +
Sbjct: 118 AADVARGMDYLSQK 131

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 90.8 bits (226), Expect = 2e-22
 Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 20/135 (14%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LGEG FG V+         ++    VA+K +K+        +LL+E+ ++K L+ HPN+V
Sbjct: 1   LGEGGFGTVYLARD-----KKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIV 54

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           +L G   ++   +++MEY   G L+  L+                 L+  ++     Q+ 
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLKDLLKE------------NEGKLSEDEILRILLQIL 102

Query: 147 RGMQFLSSRGV--RD 159
            G+++L S G+  RD
Sbjct: 103 EGLEYLHSNGIIHRD 117

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.1 bits (226), Expect = 4e-22
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 19/142 (13%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+ R  I +   LG G +G+V++    G+  +     VAVKTLKE+  E E  + L+E 
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYE----GVWKKYS-LTVAVKTLKEDTMEVE--EFLKEA 53

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q            +
Sbjct: 54  AVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-----------EV 101

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
            +  L     Q++  M++L  +
Sbjct: 102 NAVVLLYMATQISSAMEYLEKK 123

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 91.2 bits (226), Expect = 5e-22
 Identities = 55/154 (35%), Positives = 85/154 (55%), Gaps = 21/154 (13%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGI-----------DGREGPCIVAVKTLKENAGE 63
           E PRQ +++ + LGEG FG+V  CEA G+           DG+  P +VAVK L+ +  +
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQ--PVLVAVKMLRADVTK 58

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
             R D L+E+ +M  L  +PN++RLLG C   +P  +I EY+  G L  FL    +QR  
Sbjct: 59  TARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL----SQREI 113

Query: 124 NNMHGKSNSLTS---RDLTSFCYQVARGMQFLSS 154
            +    +N++ S    +L     Q+A GM++L+S
Sbjct: 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS 147

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 90.9 bits (225), Expect = 7e-22
 Identities = 52/141 (36%), Positives = 81/141 (57%), Gaps = 4/141 (2%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L E 
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   N +       
Sbjct: 61  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP--- 116

Query: 134 TSRDLTSFCYQVARGMQFLSS 154
           + + +     ++A GM +L++
Sbjct: 117 SLKKMIQMAGEIADGMAYLNA 137

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 2e-21
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 18/148 (12%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
             ++H+K    LGEG FG+V  C    +    G   VAVK+L  +  E+ R D  +E+ +
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGE-QVAVKSLNHSGEEQHRSDFEREIEI 59

Query: 76  MKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           ++TLD H N+V+  G C +       +IMEY+P G L+ +L+  R Q            +
Sbjct: 60  LRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ------------I 106

Query: 134 TSRDLTSFCYQVARGMQFLSSRGV--RD 159
             + L  F  Q+ +GM +L S+    RD
Sbjct: 107 NLKRLLLFSSQICKGMDYLGSQRYIHRD 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.0 bits (221), Expect = 2e-21
 Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 18/143 (12%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCI-VAVKTLKENAGERERLDLLQE 72
           +E+ R+ I +   +GEG FG V++   + +   E   I VAVKT K       R   LQE
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQ--GVYMS-PENEKIAVAVKTCKNCTSPSVREKFLQE 57

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             +M+  D HP++V+L+G  TE  P +++ME  P G+L+S+L+ ++             S
Sbjct: 58  AYIMRQFD-HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK------------YS 103

Query: 133 LTSRDLTSFCYQVARGMQFLSSR 155
           L    L  + YQ++  + +L S+
Sbjct: 104 LDLASLILYSYQLSTALAYLESK 126

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.7 bits (222), Expect = 2e-21
 Identities = 51/142 (35%), Positives = 76/142 (53%), Gaps = 14/142 (9%)

Query: 21  IKVFDILGEGCFGQVWKC----EALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           IK  D++GEG FGQV K     + L +D        A+K +KE A + +  D   EL V+
Sbjct: 9   IKFQDVIGEGNFGQVLKARIKKDGLRMDA-------AIKRMKEYASKDDHRDFAGELEVL 61

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSL 133
             L  HPN++ LLG C  +   ++ +EY P+G L  FLR SR       +   +  +++L
Sbjct: 62  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           +S+ L  F   VARGM +LS +
Sbjct: 122 SSQQLLHFAADVARGMDYLSQK 143

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 90.1 bits (223), Expect = 2e-21
 Identities = 48/109 (44%), Positives = 63/109 (57%), Gaps = 1/109 (0%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 1   KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 60

Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQ 120
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGE 109

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 89.2 bits (221), Expect = 3e-21
 Identities = 51/151 (33%), Positives = 74/151 (49%), Gaps = 14/151 (9%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGI-----------DGREGPCIVAVKTLKENAGE 63
           E PR+ +   + LGEG FG+V  CEA G+                P +VAVK L+E+A +
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
             R D L+E+ +M  L   PN++RLL  C   +P  +I EY+  G L  FL     Q   
Sbjct: 61  NARNDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE-- 117

Query: 124 NNMHGKSNSLTSRDLTSFCYQVARGMQFLSS 154
                   +++   L     Q+A GM++LSS
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSS 148

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 88.4 bits (220), Expect = 3e-21
 Identities = 36/137 (26%), Positives = 69/137 (50%), Gaps = 21/137 (15%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           + LGEG FG+V+        G+    +VA+K +K+   +++R  +L+E+ ++K L  HPN
Sbjct: 5   EKLGEGSFGKVYLARDKK-TGK----LVAIKVIKKKKIKKDRERILREIKILKKLK-HPN 58

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +VRL     +++  +++MEY   G L   L+                 L+  +   +  Q
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-------------RLSEDEARFYLRQ 105

Query: 145 VARGMQFLSSRGV--RD 159
           +   +++L S+G+  RD
Sbjct: 106 ILSALEYLHSKGIVHRD 122

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 5e-21
 Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 17/137 (12%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTL 79
           + +  ++G G FG+V     L + G+    I VA+KTLK  + +++RLD L E ++M   
Sbjct: 6   VTIEKVIGGGEFGEVC-RGRLKLPGK--KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
           D HPN++RL G  T+  P  +I EY+  G L  FLR +  +             T   L 
Sbjct: 63  D-HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK------------FTVGQLV 109

Query: 140 SFCYQVARGMQFLSSRG 156
                +A GM++LS   
Sbjct: 110 GMLRGIASGMKYLSEMN 126

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 86.5 bits (215), Expect = 2e-20
 Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 22/142 (15%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTL 79
            ++   LG G FG V+K +  G        IVAVK L K +   ++     +E+ +++ L
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGT-----GKIVAVKILKKRSEKSKKDQTARREIRILRRL 55

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
             HPN+VRL+    +K+  +++MEY   G L  +L              +   L+  +  
Sbjct: 56  S-HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-------------RGGPLSEDEAK 101

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
               Q+ RG+++L S G+  RD
Sbjct: 102 KIALQILRGLEYLHSNGIIHRD 123

Length = 260

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 88.5 bits (219), Expect = 2e-20
 Identities = 45/108 (41%), Positives = 62/108 (57%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D +WE PR  + +  ILG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 29  DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALM 88

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
            EL +M  L PH N+V LLG CT+  P ++I EY  YG L ++L  +R
Sbjct: 89  SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNR 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 88.5 bits (219), Expect = 2e-20
 Identities = 49/131 (37%), Positives = 70/131 (53%), Gaps = 2/131 (1%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D  WE+PR ++ +   LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 29  DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALM 88

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ--RYYNNMHG 128
            EL +M  L PH N+V LLG CT+  P ++I EY  YG L  +L  ++    +YY + + 
Sbjct: 89  SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNR 148

Query: 129 KSNSLTSRDLT 139
              SL S   T
Sbjct: 149 DDGSLISGGST 159

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 3e-20
 Identities = 48/142 (33%), Positives = 70/142 (49%), Gaps = 20/142 (14%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+ R  I++   LG G FG+VW+    G+     P  VAVKTLK   G  +  D L E 
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWE----GLWNNTTP--VAVKTLK--PGTMDPKDFLAEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +MK L  HP +++L   CT +EP +++ E + YG L  +L+            G   +L
Sbjct: 53  QIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ-----------GGAGRAL 100

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
               L     QVA GM +L ++
Sbjct: 101 KLPQLIDMAAQVASGMAYLEAQ 122

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 4e-20
 Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 25/149 (16%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  + +K+   +G+G FG V   +  G         VAVK LK+++   +    L E 
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQK-------VAVKCLKDDSTAAQAF--LAEA 51

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS-SRAQRYYNNMHGKSNS 132
           +VM TL  HPN+V+LLG   +  P +++ EY+  G L  +LRS  RA             
Sbjct: 52  SVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA------------V 98

Query: 133 LTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +T      F   V  GM++L  +    RD
Sbjct: 99  ITLAQQLGFALDVCEGMEYLEEKNFVHRD 127

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 85.2 bits (211), Expect = 6e-20
 Identities = 46/148 (31%), Positives = 68/148 (45%), Gaps = 21/148 (14%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE PR+   +   LG G FG+VW  E L  +       VA+K LK +   +++ D  +E+
Sbjct: 1   WERPREEFTLERKLGSGYFGEVW--EGLWKNRVR----VAIKILKSDDLLKQQ-DFQKEV 53

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             +K L  H +++ L   C+  EP ++I E +  G L +FLRS   Q            L
Sbjct: 54  QALKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-----------VL 101

Query: 134 TSRDLTSFCYQVARGMQFLSSRGV--RD 159
               L     QVA GM +L  +    RD
Sbjct: 102 PVASLIDMACQVAEGMAYLEEQNSIHRD 129

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 82.7 bits (204), Expect = 4e-19
 Identities = 47/131 (35%), Positives = 73/131 (55%), Gaps = 19/131 (14%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           ++LG+G FG+V+K    G    + P  VAVKT KE+  +  ++  L E  ++K  D HPN
Sbjct: 1   ELLGKGNFGEVFK----GTLKDKTP--VAVKTCKEDLPQELKIKFLSEARILKQYD-HPN 53

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V+L+G CT+++P +++ME VP G   SFLR             K + L ++ L  F   
Sbjct: 54  IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK------------KKDELKTKQLVKFALD 101

Query: 145 VARGMQFLSSR 155
            A GM +L S+
Sbjct: 102 AAAGMAYLESK 112

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.1 bits (203), Expect = 1e-18
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 19/148 (12%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCI-VAVKTLKENAGERERLDLLQEL 73
            +    ++   +LG G FG V+K   + I   E   I VA+K L+E    +   ++L E 
Sbjct: 3   ILKETELEKIKVLGSGAFGTVYK--GVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            VM ++D HP+VVRLLG C   +   +I + +P G L  ++R+ +              +
Sbjct: 61  YVMASVD-HPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDN------------I 106

Query: 134 TSRDLTSFCYQVARGMQFLSSRGV--RD 159
            S+ L ++C Q+A+GM +L  + +  RD
Sbjct: 107 GSQYLLNWCVQIAKGMSYLEEKRLVHRD 134

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 81.8 bits (202), Expect = 1e-18
 Identities = 49/137 (35%), Positives = 68/137 (49%), Gaps = 17/137 (12%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPN 84
           ILGEG FG V + +    DG +    VAVKT+K +     E  + L E   MK  D HPN
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK--VAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPN 62

Query: 85  VVRLLGCCTEKEPF------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           V++L+G C E           VI+ ++ +G L SFL  SR       + G    L  + L
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR-------LGGLPEKLPLQTL 115

Query: 139 TSFCYQVARGMQFLSSR 155
             F   +A GM++LS+R
Sbjct: 116 LKFMVDIALGMEYLSNR 132

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.4 bits (198), Expect = 6e-18
 Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 26/161 (16%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALG----------IDGREG-PCIVAVKTLKENAGE 63
           + PR H+   + LGEG FG+V  CE +            + R+G P +VAVK L+ +A +
Sbjct: 1   KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
             R D L+E+ ++  L   PN++RLLG C +++P  +I EY+  G L  FL S     + 
Sbjct: 61  NARNDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSS----HHL 115

Query: 124 NNMHGKSNSLTSRD----------LTSFCYQVARGMQFLSS 154
           ++     N                L     Q+A GM++LSS
Sbjct: 116 DDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 76.8 bits (190), Expect = 6e-17
 Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 24/139 (17%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLDPHPN 84
           +LG G FG V+    L +D   G  ++AVK+++ +    E L+ L +E+ ++ +L  HPN
Sbjct: 7   LLGRGSFGSVY----LALDKDTG-ELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPN 60

Query: 85  VVRLLGCCTEKEP--FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           +VR  G   ++E     + +EYV  G L S L+                 L    +  + 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-------------LPEPVIRKYT 107

Query: 143 YQVARGMQFLSSRGV--RD 159
            Q+  G+ +L S G+  RD
Sbjct: 108 RQILEGLAYLHSNGIVHRD 126

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 14/146 (9%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCI---VAVKTLKENAGERERLDLLQE 72
           + R  + + D+L EG FG+++     GI   E P     V VKT+K++A E +   LLQE
Sbjct: 3   ISRDRVTLSDLLQEGTFGRIFY----GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQE 58

Query: 73  LTVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
             ++  L  H N++ +L  C E  EP FV+  Y+ +G L+ FL+  R             
Sbjct: 59  SCLLYGL-SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCR-----LGEANNPQ 112

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
           +L+++ L     Q+A GM +L  RGV
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGV 138

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 75.4 bits (185), Expect = 3e-16
 Identities = 51/142 (35%), Positives = 71/142 (50%), Gaps = 9/142 (6%)

Query: 20  HIKVFDI-----LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           HIK  DI     LGEG FG+V+  E   +   +   +VAVK LKE A E  R D  +E  
Sbjct: 1   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAE 59

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS--SRAQRYYNNMHGKSNS 132
           ++  L  H ++VR  G CTE  P  ++ EY+ +G L  FLRS    A+            
Sbjct: 60  LLTVLQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ 118

Query: 133 LTSRDLTSFCYQVARGMQFLSS 154
           LT   + +   Q+A GM +L+S
Sbjct: 119 LTLGQMLAIASQIASGMVYLAS 140

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 74.5 bits (183), Expect = 5e-16
 Identities = 49/142 (34%), Positives = 69/142 (48%), Gaps = 21/142 (14%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WEVPR+ +K+   LG G FG+VW    +G     G   VA+K+LK+  G       L E 
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVW----MGY--YNGHTKVAIKSLKQ--GSMSPEAFLAEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +MK L  HP +VRL    T +EP ++I EY+  G L  FL++    +           L
Sbjct: 53  NLMKQLQ-HPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIK-----------L 99

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           T   L     Q+A GM F+  +
Sbjct: 100 TINKLIDMAAQIAEGMAFIERK 121

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 74.1 bits (183), Expect = 7e-16
 Identities = 22/43 (51%), Positives = 30/43 (69%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           +R GYRL KP++C  ELY +M  CW  +P +RP F+EL + LE
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 7e-16
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 17/137 (12%)

Query: 21  IKVFDILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
           IK+  ++G G FG+V  C   L + G+     VA+KTLK    E++R D L E ++M   
Sbjct: 6   IKIEKVIGAGEFGEV--CSGRLKLPGKREIP-VAIKTLKAGYTEKQRRDFLSEASIMGQF 62

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
           D HPN++ L G  T+ +P  ++ EY+  G L +FLR    Q             T   L 
Sbjct: 63  D-HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ------------FTVIQLV 109

Query: 140 SFCYQVARGMQFLSSRG 156
                +A GM++LS  G
Sbjct: 110 GMLRGIASGMKYLSDMG 126

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 73.8 bits (181), Expect = 1e-15
 Identities = 44/133 (33%), Positives = 68/133 (51%), Gaps = 15/133 (11%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           +K+ +++G G FG+V +   L + G+     VA+KTLK    E++R D L E ++M   D
Sbjct: 6   VKIEEVIGAGEFGEVCRGR-LKLPGKREIF-VAIKTLKSGYTEKQRRDFLSEASIMGQFD 63

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HPN++ L G  T+  P  +I E++  G L SFLR +  Q             T   L  
Sbjct: 64  -HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ------------FTVIQLVG 110

Query: 141 FCYQVARGMQFLS 153
               +A GM++LS
Sbjct: 111 MLRGIAAGMKYLS 123

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 1e-15
 Identities = 48/128 (37%), Positives = 64/128 (50%), Gaps = 17/128 (13%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G FG V K   L   G+E    VAVKTLK+      + + L+E +VM  LD HP +V
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVE--VAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIV 59

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           RL+G C + EP  ++ME  P G L  +L+  R              +   DL    +QVA
Sbjct: 60  RLIGVC-KGEPLMLVMELAPLGPLLKYLKKRR-------------EIPVSDLKELAHQVA 105

Query: 147 RGMQFLSS 154
            GM +L S
Sbjct: 106 MGMAYLES 113

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 73.1 bits (179), Expect = 1e-15
 Identities = 48/142 (33%), Positives = 68/142 (47%), Gaps = 20/142 (14%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+PR+ IK+   LG G FG+VW      +        VAVKTLK   G       L+E 
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVW------MGYYNNSTKVAVKTLK--PGTMSVQAFLEEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +MKTL  H  +VRL    T++EP ++I EY+  G L  FL+S    +           +
Sbjct: 53  NLMKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGK-----------V 100

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
               L  F  Q+A GM ++  +
Sbjct: 101 LLPKLIDFSAQIAEGMAYIERK 122

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.3 bits (177), Expect = 4e-15
 Identities = 47/144 (32%), Positives = 79/144 (54%), Gaps = 6/144 (4%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+P   ++  + LGE  FG+++K   L + G +   +VA+KTLK+    ++  +  QE +
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGH-LYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEAS 59

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL--RSSRAQRYYNNMHGKS-- 130
           +M  L  HPN+V LLG  T+++P  ++ EY+  G L  FL  RS  +    ++    +  
Sbjct: 60  LMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 131 NSLTSRDLTSFCYQVARGMQFLSS 154
           +SL   D      Q+A GM++LSS
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSS 142

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.3 bits (174), Expect = 1e-14
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 2/140 (1%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
           + R +I +   LGEG FG+V+  E   +   +   +VAVKTLK+ A +  R D  +E  +
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAEL 60

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           +  L  H ++V+  G C E +P  ++ EY+ +G L  FLR+            +   LT 
Sbjct: 61  LTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119

Query: 136 RDLTSFCYQVARGMQFLSSR 155
             +     Q+A GM +L+S+
Sbjct: 120 SQMLHIAQQIAAGMVYLASQ 139

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 70.6 bits (173), Expect = 1e-14
 Identities = 44/131 (33%), Positives = 72/131 (54%), Gaps = 16/131 (12%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           ++G+G FG V+    +  DG++  C  AVK+L       E    L+E  +MK    HPNV
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHC--AVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNV 58

Query: 86  VRLLGCCTEKEPF-FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           + LLG C   E    V++ Y+ +G L++F+RS            ++++ T +DL  F  Q
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS------------ETHNPTVKDLIGFGLQ 106

Query: 145 VARGMQFLSSR 155
           VA+GM++L+S+
Sbjct: 107 VAKGMEYLASK 117

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 68.0 bits (167), Expect = 8e-14
 Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 22/138 (15%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHP 83
           D++G G FG V+K    G++   G   VA+K +  E   E     ++QE+ ++K L  HP
Sbjct: 6   DLIGRGAFGVVYK----GLNLETGD-FVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HP 59

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 143
           N+V+ +G     +  ++I+EY   G L+  ++             K        +  + Y
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIK-------------KFGPFPESLVAVYVY 106

Query: 144 QVARGMQFLSSRGV--RD 159
           QV +G+ +L  +GV  RD
Sbjct: 107 QVLQGLAYLHEQGVIHRD 124

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 9e-14
 Identities = 44/135 (32%), Positives = 64/135 (47%), Gaps = 23/135 (17%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G FG V   +  G         VA+K ++E A   +  D ++E  VM  L  HPN+V
Sbjct: 12  LGSGQFGVVHLGKWRGKID------VAIKMIREGAMSED--DFIEEAKVMMKLS-HPNLV 62

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           +L G CT++ P F++ EY+  G L ++LR  +         GK  +     L   C  V 
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYLRERK---------GKLGTEW---LLDMCSDVC 110

Query: 147 RGMQFLSSRGV--RD 159
             M++L S G   RD
Sbjct: 111 EAMEYLESNGFIHRD 125

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.0 bits (166), Expect = 9e-14
 Identities = 45/143 (31%), Positives = 65/143 (45%), Gaps = 17/143 (11%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDG-REGPCIVAVKTLKENAGERERLDLLQEL 73
           E+  + IK+  ILG G FG++     L +   RE P  VA+ TL+    +++R   L E 
Sbjct: 1   ELDNKSIKIERILGTGRFGELC-RGCLKLPSKRELP--VAIHTLRAGCSDKQRRGFLAEA 57

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             +   D H N+VRL G  T      ++ EY+  G L SFLR    Q            L
Sbjct: 58  LTLGQFD-HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ------------L 104

Query: 134 TSRDLTSFCYQVARGMQFLSSRG 156
            +  L      +A GM++LS  G
Sbjct: 105 VAGQLMGMLPGLASGMKYLSEMG 127

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 67.9 bits (167), Expect = 1e-13
 Identities = 20/42 (47%), Positives = 29/42 (69%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           + DGYRL +P++C  ELY +M  CW  +P +RP F+EL + L
Sbjct: 217 LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 40/129 (31%), Positives = 63/129 (48%), Gaps = 18/129 (13%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG+V+         R     VAVK+ +E      +   LQE  ++K    HPN+V
Sbjct: 3   IGRGNFGEVFSGRL-----RADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIV 56

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           RL+G CT+K+P +++ME V  G   +FLR+   +            L  ++L       A
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR------------LKVKELIQMVENAA 104

Query: 147 RGMQFLSSR 155
            GM++L S+
Sbjct: 105 AGMEYLESK 113

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 67.0 bits (163), Expect = 3e-13
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 4/146 (2%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+    ++  + LGE  FG+V+K    G    E    VA+KTLK+ A    R +   E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE-A 59

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL--RSSRAQ-RYYNNMHGKSN 131
           +M++   HPN+V LLG  T+++P  +I  Y  +  L  FL  RS  +     ++     +
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
           +L   D      Q+A GM+FLSS  V
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHV 145

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 66.0 bits (162), Expect = 4e-13
 Identities = 19/42 (45%), Positives = 32/42 (76%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           +++GYRL +P +C  ELY++M  CW ++P +RP F+EL ++L
Sbjct: 216 LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.6 bits (162), Expect = 4e-13
 Identities = 48/136 (35%), Positives = 69/136 (50%), Gaps = 18/136 (13%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL-DLLQELTVMKTLDPHPNV 85
           LGEG FG V + +   ++  +    VAVKT+K     R  + D L E   MK  D HPNV
Sbjct: 7   LGEGEFGSVMEGQ---LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNV 62

Query: 86  VRLLGCC---TEKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
           +RL+G C    E E +    VI+ ++ +G L SFL  SR       +      L ++ L 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-------LGDCPQYLPTQMLV 115

Query: 140 SFCYQVARGMQFLSSR 155
            F   +A GM++LSS+
Sbjct: 116 KFMTDIASGMEYLSSK 131

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 65.6 bits (161), Expect = 6e-13
 Identities = 20/42 (47%), Positives = 30/42 (71%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           ++ GYRL KP +C  ELY +M  CW ++P +RP F+EL ++L
Sbjct: 217 LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.1 bits (161), Expect = 6e-13
 Identities = 47/141 (33%), Positives = 72/141 (51%), Gaps = 20/141 (14%)

Query: 18  RQHIKVFDILGEGCFGQV-WKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           ++++K   +LGEG FG+V   C     DG     +VAVKTLK   G++      +E+ ++
Sbjct: 3   KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGE--MVAVKTLKRECGQQNTSGWKKEINIL 60

Query: 77  KTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           KTL  H N+V+  GCC+E+  +   +IMEYVP G L+ +L                + L 
Sbjct: 61  KTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--------------PKHKLN 105

Query: 135 SRDLTSFCYQVARGMQFLSSR 155
              L  F  Q+  GM +L S+
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQ 126

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 65.5 bits (159), Expect = 8e-13
 Identities = 45/139 (32%), Positives = 64/139 (46%), Gaps = 21/139 (15%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+PR+ +++   LG+GCFG+VW           G   VA+KTLK      E    LQE 
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWM------GTWNGTTRVAIKTLKPGTMSPEA--FLQEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            VMK L  H  +V+L    +E EP +++ EY+  G L  FL+                 L
Sbjct: 53  QVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-----------MGKYL 99

Query: 134 TSRDLTSFCYQVARGMQFL 152
               L     Q+A GM ++
Sbjct: 100 RLPQLVDMAAQIASGMAYV 118

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.4 bits (159), Expect = 9e-13
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 15/139 (10%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   HI    ++G G FG+V++   L + GR+    VA+KTLK    E++R D L E +
Sbjct: 1   EIHPSHITKQKVIGAGEFGEVFR-GILKMPGRK-EVAVAIKTLKPGYTEKQRQDFLSEAS 58

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M     H N++RL G  T+ +P  +I EY+  G L  +LR                  +
Sbjct: 59  IMGQFS-HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD------------HDGEFS 105

Query: 135 SRDLTSFCYQVARGMQFLS 153
           S  L      +A GM++LS
Sbjct: 106 SYQLVGMLRGIAAGMKYLS 124

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 65.0 bits (158), Expect = 1e-12
 Identities = 42/131 (32%), Positives = 60/131 (45%), Gaps = 21/131 (16%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG VW    L          VA+KT++E A   E  D ++E  VM  L  HP +V
Sbjct: 12  IGSGQFGLVWLGYWLEKRK------VAIKTIREGAMSEE--DFIEEAQVMMKLS-HPKLV 62

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           +L G CTE+ P  ++ E++ +G L  +LR+ R               +   L   C  V 
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG------------KFSQETLLGMCLDVC 110

Query: 147 RGMQFLSSRGV 157
            GM +L S  V
Sbjct: 111 EGMAYLESSNV 121

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 21/139 (15%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+PR+ +++   LG G FG+VW      +    G   VAVKTLK      E    L+E 
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVW------MGTWNGNTKVAVKTLKPGTMSPE--SFLEEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +MK L  H  +V+L    +E EP +++ EY+  G L  FL+            G+  +L
Sbjct: 53  QIMKKLR-HDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKD-----------GEGRAL 99

Query: 134 TSRDLTSFCYQVARGMQFL 152
              +L     QVA GM ++
Sbjct: 100 KLPNLVDMAAQVAAGMAYI 118

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.1 bits (156), Expect = 2e-12
 Identities = 38/144 (26%), Positives = 59/144 (40%), Gaps = 29/144 (20%)

Query: 16  VPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           +  + +     LG G FG V    W+          G   VA+K +KE  G     + ++
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKE--GSMSEDEFIE 48

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VM  L  H  +V+L G CT++ P +++ EY+  G L ++LR                
Sbjct: 49  EAKVMMKLS-HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG------------K 95

Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
                 L   C  V  GM +L S+
Sbjct: 96  RFQPSQLLEMCKDVCEGMAYLESK 119

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 64.3 bits (156), Expect = 3e-12
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 21/138 (15%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCI---VAVKTLKENAGERERLDLLQELTVMK 77
           +K   +LG G FG V+K    GI   EG  +   VA+K L E  G +  ++ + E  +M 
Sbjct: 9   LKRVKVLGSGAFGTVYK----GIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           ++D HP++VRLLG C       ++ + +P+G L  ++            H   +++ S+ 
Sbjct: 65  SMD-HPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYV------------HEHKDNIGSQL 110

Query: 138 LTSFCYQVARGMQFLSSR 155
           L ++C Q+A+GM +L  R
Sbjct: 111 LLNWCVQIAKGMMYLEER 128

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 63.7 bits (156), Expect = 3e-12
 Identities = 33/136 (24%), Positives = 62/136 (45%), Gaps = 18/136 (13%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNV 85
           +G+G FG+V+       DG+    +  +K +   N  E+ER D L E+ ++K L+ HPN+
Sbjct: 8   IGKGSFGKVYLVRRK-SDGK----LYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNI 61

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           ++      EK    ++MEY   G L   ++  + +                 +  +  Q+
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP---------FPEEQILDWFVQL 112

Query: 146 ARGMQFLSSRGV--RD 159
              +++L SR +  RD
Sbjct: 113 CLALKYLHSRKILHRD 128

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.5 bits (154), Expect = 4e-12
 Identities = 48/142 (33%), Positives = 66/142 (46%), Gaps = 21/142 (14%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+PR+ +K+   LG G FG+VW      +        VAVKT+K   G       L E 
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVW------MATYNKHTKVAVKTMK--PGSMSVEAFLAEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            VMKTL  H  +V+L    T KEP ++I E++  G L  FL+S            + +  
Sbjct: 53  NVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-----------EGSKQ 99

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
               L  F  Q+A GM F+  R
Sbjct: 100 PLPKLIDFSAQIAEGMAFIEQR 121

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 64.4 bits (155), Expect = 4e-12
 Identities = 38/148 (25%), Positives = 72/148 (48%), Gaps = 22/148 (14%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL--KENAGERERLDLLQELTVMKTL 79
           ++   LGEG FG+V+    L  D +     VA+K L  K  +  +E    L+E+ ++ +L
Sbjct: 3   RILRKLGEGSFGEVY----LARDRKL----VALKVLAKKLESKSKEVERFLREIQILASL 54

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
           +  PN+V+L     ++   +++MEYV  G L+  L+            G+   L+  +  
Sbjct: 55  NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK----------IGRKGPLSESEAL 104

Query: 140 SFCYQVARGMQFLSSRGVRDGYRLEKPD 167
               Q+   +++L S+G+   +R  KP+
Sbjct: 105 FILAQILSALEYLHSKGII--HRDIKPE 130

Length = 384

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.8 bits (155), Expect = 5e-12
 Identities = 20/48 (41%), Positives = 36/48 (75%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN 204
           ++ GYR+E+P++C  E+YN+M  CW +EP++RP F ++   LEK+++ 
Sbjct: 242 LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 63.0 bits (154), Expect = 6e-12
 Identities = 27/96 (28%), Positives = 55/96 (57%), Gaps = 7/96 (7%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           ++ + +G+G FG+V+K        R G   VA+K +K  + E++   ++ E+ ++K    
Sbjct: 3   EILEKIGKGGFGEVYK----ARHKRTG-KEVAIKVIKLESKEKKE-KIINEIQILKKCK- 55

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS 117
           HPN+V+  G   +K+  +++ME+   G L+  L+S+
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST 91

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.1 bits (153), Expect = 6e-12
 Identities = 43/135 (31%), Positives = 68/135 (50%), Gaps = 21/135 (15%)

Query: 21  IKVFDILGEGCFGQVWKCEALGI---DGREGPCIVAVKTLKENAGERERLDLLQELTVMK 77
           +K   +LG G FG V+K    GI   DG      VA+K L+EN   +   ++L E  VM 
Sbjct: 9   LKKVKVLGSGAFGTVYK----GIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
            +   P V RLLG C       ++ + +PYG L  ++R ++            + + S+D
Sbjct: 65  GVGS-PYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENK------------DRIGSQD 110

Query: 138 LTSFCYQVARGMQFL 152
           L ++C Q+A+GM +L
Sbjct: 111 LLNWCVQIAKGMSYL 125

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.0 bits (153), Expect = 6e-12
 Identities = 37/95 (38%), Positives = 57/95 (60%), Gaps = 6/95 (6%)

Query: 25  DILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP 83
           D +G G FG+V   EA  G+        V VK L+ +A   E+L  LQE+   + L+ HP
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELN-HP 55

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
           NV++ LG C E  P+ +++E+ P G L+++LRS+R
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNR 90

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.8 bits (152), Expect = 8e-12
 Identities = 44/139 (31%), Positives = 65/139 (46%), Gaps = 21/139 (15%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    LQE 
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVW------MGTWNGTTKVAIKTLKPGTMMPEA--FLQEA 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +MK L  H  +V L    +E EP +++ E++  G L  FL+            G    L
Sbjct: 53  QIMKKLR-HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLK-----------EGDGKYL 99

Query: 134 TSRDLTSFCYQVARGMQFL 152
               L     Q+A GM ++
Sbjct: 100 KLPQLVDMAAQIADGMAYI 118

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.6 bits (152), Expect = 1e-11
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 4/93 (4%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG+V   E   ++    P  V VK L+ +A  +E++  L+E    ++L  H N++
Sbjct: 3   IGNGWFGKVILGE---VNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLL 58

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA 119
           + LG CTE  P+ ++ME+ P G L+ +LRS R 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRK 91

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 62.7 bits (152), Expect = 1e-11
 Identities = 43/135 (31%), Positives = 70/135 (51%), Gaps = 17/135 (12%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCI-VAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I   E   I VA+K L+E    +   ++L E  VM ++D
Sbjct: 10  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 68  -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 113

Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 114 WCVQIAKGMNYLEER 128

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 62.2 bits (152), Expect = 1e-11
 Identities = 36/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           PR+  K  + +GEG  G+V+K       G+E    VA+K ++     +E +  + E+ +M
Sbjct: 17  PRELYKNLEKIGEGASGEVYKATDRA-TGKE----VAIKKMRLRKQNKELI--INEILIM 69

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           K    HPN+V         +  +V+MEY+  G L   +                  +   
Sbjct: 70  KDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT------------QNFVRMNEP 116

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            +   C +V +G+++L S+ V  RD
Sbjct: 117 QIAYVCREVLQGLEYLHSQNVIHRD 141

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 61.0 bits (148), Expect = 3e-11
 Identities = 22/46 (47%), Positives = 34/46 (73%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +R G RL++P+ C  ELY++MY CW  +P +RP FT+L ++LE +L
Sbjct: 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 10/144 (6%)

Query: 20  HIKVFDI-----LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           HIK  DI     LGEG FG+V+  E   +   +   +VAVK LK+      R D  +E  
Sbjct: 1   HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAE 59

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS--SRAQRYYNNMHGKSN- 131
           ++  L  H ++V+  G C + +P  ++ EY+ +G L  FLR+    A    +    ++  
Sbjct: 60  LLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118

Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            L    +     Q+A GM +L+S+
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQ 142

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 60.5 bits (147), Expect = 4e-11
 Identities = 42/129 (32%), Positives = 59/129 (45%), Gaps = 15/129 (11%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG+G FG V + E     G+  P  VAVK LK +       D L+E  +M +LD H N++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIP--VAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLI 59

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           RL G      P  ++ E  P G L   LR               + L S  L  +  Q+A
Sbjct: 60  RLYGVVLTH-PLMMVTELAPLGSLLDRLRK----------DALGHFLIST-LCDYAVQIA 107

Query: 147 RGMQFLSSR 155
            GM++L S+
Sbjct: 108 NGMRYLESK 116

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 5e-11
 Identities = 19/46 (41%), Positives = 32/46 (69%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++GYR+ +P+H   E+Y+IM  CWD +P +RP F ++  L+ K L
Sbjct: 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.8 bits (147), Expect = 7e-11
 Identities = 23/46 (50%), Positives = 34/46 (73%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           ++ GYR+ KPDH  +E+Y+IM  CW+ EP +RP+F  L D++E LL
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.9 bits (145), Expect = 8e-11
 Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 16/131 (12%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LGEG FG+V  C         G   VAVK+LK  +G     DL +E+ +++ L  H N+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGE-QVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIV 69

Query: 87  RLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +  G CTE       +IME++P G L+ +L  ++            N +  +    +  Q
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK------------NKINLKQQLKYAVQ 117

Query: 145 VARGMQFLSSR 155
           + +GM +L SR
Sbjct: 118 ICKGMDYLGSR 128

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 20/46 (43%), Positives = 35/46 (76%)

Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL 203
           ++GYR+EKP +C +ELY++M  CW + P++RP F +L + L+++L 
Sbjct: 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 19/46 (41%), Positives = 32/46 (69%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           V+ GY++ +PD    E+Y+IM  CW+ EP ERP F+++  L+++ L
Sbjct: 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 44/141 (31%), Positives = 73/141 (51%), Gaps = 21/141 (14%)

Query: 19  QHIKVFDILGEGCFGQVWKC--EALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           +H+K    LG+G FG V  C  + L  +  E   +VAVK L+ +  E  R D  +E+ ++
Sbjct: 4   RHLKFIQQLGKGNFGSVELCRYDPLQDNTGE---VVAVKKLQHSTAEHLR-DFEREIEIL 59

Query: 77  KTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           K+L  H N+V+  G C    +    ++MEY+PYG L+ +L+  R +            L 
Sbjct: 60  KSLQ-HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------------LD 106

Query: 135 SRDLTSFCYQVARGMQFLSSR 155
            R L  +  Q+ +GM++L S+
Sbjct: 107 HRKLLLYASQICKGMEYLGSK 127

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 19/48 (39%), Positives = 31/48 (64%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           R +++G R+  P++   E+Y+IM  CW   P +RP F+EL ++L  LL
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 58.7 bits (142), Expect = 2e-10
 Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 29/144 (20%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-------ERERLDLLQ-ELTVMK 77
           ++G G FG V+    LG++   G  ++AVK ++  +        +R  LD L  E+ ++K
Sbjct: 7   LIGSGSFGSVY----LGMNASSGE-LMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
            L  H N+V+ LG   + +   + +EYVP G + + L          N +G   +     
Sbjct: 62  ELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALL----------NNYG---AFEETL 107

Query: 138 LTSFCYQVARGMQFLSSRGV--RD 159
           + +F  Q+ +G+ +L +RG+  RD
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRD 131

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.0 bits (140), Expect = 3e-10
 Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 25/133 (18%)

Query: 27  LGEGCFG----QVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH 82
           LG G FG     V+K     ID       VA+K LK    +  R ++++E  +M  LD +
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQID-------VAIKVLKNENEKSVRDEMMREAEIMHQLD-N 54

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           P +VR++G C E E   ++ME    G L  FL             GK + +T  ++    
Sbjct: 55  PYIVRMIGVC-EAEALMLVMEMASGGPLNKFLS------------GKKDEITVSNVVELM 101

Query: 143 YQVARGMQFLSSR 155
           +QV+ GM++L  +
Sbjct: 102 HQVSMGMKYLEGK 114

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 21/46 (45%), Positives = 29/46 (63%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           V DGYRL  P  C   LY +M  CW K+ NERP F+++   L+K++
Sbjct: 221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 21/142 (14%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCI---VAVKTLKENAGERERLDLLQELTV 75
             ++   +LG G FG V K    GI   EG  I   VA+KT+++ +G +   ++   +  
Sbjct: 7   TELRKLKLLGSGVFGTVHK----GIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M +LD H  +VRLLG C       ++ +  P G L   +R  R            +SL  
Sbjct: 63  MGSLD-HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHR------------DSLDP 108

Query: 136 RDLTSFCYQVARGMQFLSSRGV 157
           + L ++C Q+A+GM +L    +
Sbjct: 109 QRLLNWCVQIAKGMYYLEEHRM 130

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.2 bits (138), Expect = 6e-10
 Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 31/131 (23%)

Query: 27  LGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH 82
           LG G FG V    W+ +            VA+K + E A   E  D ++E  VM  L  H
Sbjct: 12  LGSGQFGVVHLGKWRAQIK----------VAIKAINEGAMSEE--DFIEEAKVMMKLS-H 58

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSF 141
           P +V+L G CT+++P +++ E++  G L ++LR  + +              S+D L S 
Sbjct: 59  PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-------------LSKDMLLSM 105

Query: 142 CYQVARGMQFL 152
           C  V  GM++L
Sbjct: 106 CQDVCEGMEYL 116

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.3 bits (139), Expect = 7e-10
 Identities = 22/43 (51%), Positives = 28/43 (65%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           V  GYR+ +P +C  ELY++M  CWDK+P ERP F  L   LE
Sbjct: 217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.0 bits (138), Expect = 9e-10
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           ++DGYRL +P +C  EL+ +M  CW  +P ERP+F++L   L
Sbjct: 232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.9 bits (137), Expect = 9e-10
 Identities = 19/48 (39%), Positives = 30/48 (62%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           + V DG+RL  P +C   L+ +M  CW KE  ERP F+++  +L K++
Sbjct: 219 KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 42/128 (32%), Positives = 68/128 (53%), Gaps = 21/128 (16%)

Query: 27  LGEGCFGQVWKCEALGI-DGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPN 84
           LG G FG V K    G+   ++    VAVK LK +N     + +LL+E  VM+ LD +P 
Sbjct: 3   LGSGNFGTVKK----GMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPY 57

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +VR++G C E E + ++ME    G L  FL+ ++              +T +++T   +Q
Sbjct: 58  IVRMIGIC-EAESWMLVMELAELGPLNKFLQKNK-------------HVTEKNITELVHQ 103

Query: 145 VARGMQFL 152
           V+ GM++L
Sbjct: 104 VSMGMKYL 111

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 56.4 bits (137), Expect = 1e-09
 Identities = 33/149 (22%), Positives = 61/149 (40%), Gaps = 36/149 (24%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL---------KENAGERERLDLLQE 72
           K   I+GEG F  V   +      +E     A+K L         K    + E+      
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKE-TNKE----YAIKILDKRQLIKEKKVKYVKIEK------ 52

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             V+  L+ HP +++L     ++E  + ++EY P G+L  ++R             K  S
Sbjct: 53  -EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-------------KYGS 98

Query: 133 LTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           L  +    +  ++   +++L S+G+  RD
Sbjct: 99  LDEKCTRFYAAEILLALEYLHSKGIIHRD 127

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 56.0 bits (136), Expect = 2e-09
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 26/141 (18%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--LQELTVMKTLDPH 82
             +GEG +GQV+K       G     +VA+K ++    E+E   +  ++E+ +++ L  H
Sbjct: 5   AQIGEGTYGQVYKARNK-KTGE----LVALKKIRME-NEKEGFPITAIREIKLLQKLR-H 57

Query: 83  PNVVRLLGCCTEKEP--FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
           PN+VRL    T K     +++ EY+ +  L   L S                 T   +  
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS------------PEVKFTESQIKC 104

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           +  Q+  G+Q+L S G+  RD
Sbjct: 105 YMKQLLEGLQYLHSNGILHRD 125

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 56.0 bits (136), Expect = 2e-09
 Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 36/145 (24%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGE-------RERLDLLQELTVM 76
           + LGEG +G V+K      D + G  IVA+K ++ +N  E       RE + LL+EL   
Sbjct: 5   EKLGEGTYGVVYKA----RDKKTGE-IVALKKIRLDNEEEGIPSTALRE-ISLLKELK-- 56

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
                HPN+V+LL     +   +++ EY     L+ +L              +   L+  
Sbjct: 57  -----HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK------------RPGPLSPN 98

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            + S  YQ+ RG+ +  S  +  RD
Sbjct: 99  LIKSIMYQLLRGLAYCHSHRILHRD 123

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 30/146 (20%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD---------LLQELTV 75
           +++G+G +G+V+    L +   E   ++AVK ++  A    R D         L  E+  
Sbjct: 7   ELIGKGTYGRVYLA--LNVTTGE---MMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           +K LD H N+V+ LG  T +E   + +EYVP G + S LR           +G+      
Sbjct: 62  LKDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR----------TYGRFEEQLV 110

Query: 136 RDLTSFCYQVARGMQFLSSRGV--RD 159
           R  T    QV  G+ +L S+G+  RD
Sbjct: 111 RFFTE---QVLEGLAYLHSKGILHRD 133

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 20/45 (44%), Positives = 29/45 (64%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           + +  GYR+ +PD+C  ELY +M  CW ++P ERP F  L  +LE
Sbjct: 214 QNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.4 bits (133), Expect = 4e-09
 Identities = 22/56 (39%), Positives = 38/56 (67%), Gaps = 1/56 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD-YIEL 211
           +R+G+R++KP +C  ELY +M  CW   P +RP F +L + L+K+L   ++ Y++L
Sbjct: 249 LREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDL 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 6e-09
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 7/91 (7%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLD 80
           +V  ++GEG +G V KC       +    IVA+K  KE+  + + +   L+E+ V++ L 
Sbjct: 4   EVLGVVGEGAYGVVLKCRN-----KATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 111
            H N+V L      K   +++ EYV    L+
Sbjct: 59  -HENIVNLKEAFRRKGRLYLVFEYVERTLLE 88

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 54.3 bits (131), Expect = 7e-09
 Identities = 17/41 (41%), Positives = 27/41 (65%)

Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           ++G RLE+P+ C +++YN+M  CW   P +RP F  L + L
Sbjct: 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.4 bits (128), Expect = 1e-08
 Identities = 19/48 (39%), Positives = 30/48 (62%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           + + +GYRL  P  C   L+ +M  CW K+ NERP F ++  +L+KL+
Sbjct: 220 KAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 53.4 bits (128), Expect = 1e-08
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 23/142 (16%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  Q + + +I+GEG FG V + E  G         VAVK +K +   +  L+   E 
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQK-------VAVKNIKCDVTAQAFLE---ET 50

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            VM  L  H N+VRLLG        +++ME +  G L +FLR+           G++  +
Sbjct: 51  AVMTKLH-HKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRT----------RGRA-LV 97

Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           +   L  F   VA GM++L S+
Sbjct: 98  SVIQLLQFSLDVAEGMEYLESK 119

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.3 bits (128), Expect = 1e-08
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 4/95 (4%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG+V   E   I    G   V VK LK NA  +E+ + LQ+    + L  HPN++
Sbjct: 3   IGNGWFGKVLLSE---IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNIL 58

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
           + LG C E  P+ ++ EY   G L+S+L   +  R
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHR 93

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 22/60 (36%), Positives = 34/60 (56%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSY 219
           GYR+EKP +C  E+Y +M  CW   P ERP F ++   L ++L     Y+ +  F + +Y
Sbjct: 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFENFTY 293

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 2e-08
 Identities = 18/46 (39%), Positives = 31/46 (67%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++GYR+  P+    E+Y+IM  CWD +P +RP F ++  L+E+ L
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 22/60 (36%), Positives = 36/60 (60%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSY 219
           GYRLEKP +C  E+Y++M  CW ++P ERP+F ++   L ++L     Y+    +   +Y
Sbjct: 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 298

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 19/50 (38%), Positives = 27/50 (54%), Gaps = 5/50 (10%)

Query: 149 MQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           +  L S     G RL +P+ C +E+Y+IM  CW   P +RP F+EL    
Sbjct: 208 IAMLES-----GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 35/146 (23%), Positives = 68/146 (46%), Gaps = 28/146 (19%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLD 80
           KV   LG+G +G V+K + L  D +      A+K +   +  ++ER D + E+ ++ +++
Sbjct: 3   KVLKKLGKGSYGSVYKVKRLS-DNQF----YALKEVDLGSMSQKEREDAVNEIRILASVN 57

Query: 81  PHPNVVR-----LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
            HPN++      L G         ++MEY P+G L   +   + +R           +  
Sbjct: 58  -HPNIISYKEAFLDGN-----KLCIVMEYAPFGDLSKAISKRKKKR---------KLIPE 102

Query: 136 RDLTSFCYQVARGMQFLSSRGV--RD 159
           +++     Q+ RG+Q L  + +  RD
Sbjct: 103 QEIWRIFIQLLRGLQALHEQKILHRD 128

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 19/48 (39%), Positives = 28/48 (58%), Gaps = 3/48 (6%)

Query: 154 SRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
              V  GYR+E P+ C  E+Y +M  CW+ +P +RP F +   L E+L
Sbjct: 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ---LREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 52.1 bits (125), Expect = 4e-08
 Identities = 19/42 (45%), Positives = 25/42 (59%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           V  GYRL +P     E+Y IMY CW ++P +RP F +L   L
Sbjct: 214 VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 51.9 bits (124), Expect = 4e-08
 Identities = 20/47 (42%), Positives = 30/47 (63%)

Query: 154 SRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK 200
              V  GYR+E P+ C  ++Y +M  CW+ EP +RP+F +L + LEK
Sbjct: 207 KECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 52.0 bits (125), Expect = 4e-08
 Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 25/139 (17%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK---ENAGERERL-DLLQELTVMKTLDPH 82
           LG G FG V+     G++  +G    AVK +    +    +E +  L QE+ ++  L  H
Sbjct: 8   LGSGSFGSVY----EGLNLDDGD-FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-H 61

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           PN+V+ LG   E++  ++ +E VP G L   L+             K  S     +  + 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-------------KYGSFPEPVIRLYT 108

Query: 143 YQVARGMQFLSSRGV--RD 159
            Q+  G+++L  R    RD
Sbjct: 109 RQILLGLEYLHDRNTVHRD 127

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 20/43 (46%), Positives = 27/43 (62%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           V  GYR+  P  C +ELY+IM  CW ++P++RP F  L   LE
Sbjct: 217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 19/46 (41%), Positives = 29/46 (63%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           ++DG R+  P++   E+Y IM  CW  +P ERP F+ L ++L  LL
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.7 bits (124), Expect = 6e-08
 Identities = 20/46 (43%), Positives = 27/46 (58%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           G RL  P +C   LY++M  CW  +P++RP FTEL   L  +L  E
Sbjct: 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 51.5 bits (124), Expect = 6e-08
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 26/143 (18%)

Query: 22  KVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           +VFDI   LGEG +G V+K        +E   +VA+K +       +  ++++E++++K 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIH-----KETGQVVAIKVVPVEE---DLQEIIKEISILKQ 54

Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
            D  P +V+  G   +    +++MEY   G +   ++ +              +LT  ++
Sbjct: 55  CD-SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN------------KTLTEEEI 101

Query: 139 TSFCYQVARGMQFLSSRGV--RD 159
            +  YQ  +G+++L S     RD
Sbjct: 102 AAILYQTLKGLEYLHSNKKIHRD 124

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 51.4 bits (123), Expect = 7e-08
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 7/91 (7%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G +G V+    L    R     +A+K + E    R    L +E+ +   L  H N+
Sbjct: 15  VLGKGTYGIVYAARDLSTQVR-----IAIKEIPER-DSRYVQPLHEEIALHSYLK-HRNI 67

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS 116
           V+ LG  +E   F + ME VP G L + LRS
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALLRS 98

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.6 bits (123), Expect = 8e-08
 Identities = 23/57 (40%), Positives = 40/57 (70%), Gaps = 2/57 (3%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL-LNETD-YIEL 211
           +++G+R++KP +C  ELY IM  CW   P++RP F +L + L+++L +  TD Y++L
Sbjct: 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDL 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.3 bits (123), Expect = 8e-08
 Identities = 17/44 (38%), Positives = 30/44 (68%)

Query: 159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +G RL +P  C  E+Y++M  CW+ EP +RP+F +L  ++++L 
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 51.4 bits (123), Expect = 9e-08
 Identities = 21/44 (47%), Positives = 30/44 (68%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK 200
           VRDG  L  PD+C  ELYN+M  CW K P++RP+F  +  +L++
Sbjct: 245 VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 50.9 bits (122), Expect = 9e-08
 Identities = 16/44 (36%), Positives = 26/44 (59%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK 200
           +  GYR+  P  C  E+Y +M  CW  +P  RP+F+E+ + L+ 
Sbjct: 208 IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 21/53 (39%), Positives = 34/53 (64%), Gaps = 2/53 (3%)

Query: 150 QFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           QF ++  ++ GYR+ KP H   E+Y IM  CW+++   RP+F++L  L+  LL
Sbjct: 350 QFYNA--IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 1e-07
 Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 25/134 (18%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVK---TLKENAGERERLDLL-QELTVMKTLDP 81
           +LG+G FG+V+ C  +   GRE    +AVK      ++   ++ ++ L  E+ ++K L  
Sbjct: 9   LLGQGAFGRVYLCYDVDT-GRE----LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ- 62

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-SNSLTSRDLTS 140
           H  +V+  GC  + E   + MEY+P G ++  L++          +G  + ++T +    
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA----------YGALTETVTRK---- 108

Query: 141 FCYQVARGMQFLSS 154
           +  Q+  G+++L S
Sbjct: 109 YTRQILEGVEYLHS 122

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 18/48 (37%), Positives = 29/48 (60%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           + + DG+RL  P  C   +Y +M  CW ++   RP F ++ +LL+KLL
Sbjct: 221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 20/45 (44%), Positives = 28/45 (62%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           R +  GYR+ +P++C  ELYNIM  CW   P ERP F  +  +L+
Sbjct: 214 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 17/45 (37%), Positives = 29/45 (64%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           +++  RL  P  C  E+Y IM  CW+ +P++RP+F+EL   +E +
Sbjct: 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 18/43 (41%), Positives = 25/43 (58%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           G RL++P  C  ++Y +M  CW  EP  RP+F  L D LE + 
Sbjct: 231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 23/142 (16%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  + +K+   +G+G FG V   +  G         VAVK +K +A  +     L E 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA---FLAEA 50

Query: 74  TVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
           +VM  L  H N+V+LLG   E K   +++ EY+  G L  +LRS           G+S  
Sbjct: 51  SVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS----------RGRS-V 98

Query: 133 LTSRDLTSFCYQVARGMQFLSS 154
           L    L  F   V   M++L +
Sbjct: 99  LGGDCLLKFSLDVCEAMEYLEA 120

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 49.9 bits (120), Expect = 2e-07
 Identities = 33/135 (24%), Positives = 55/135 (40%), Gaps = 23/135 (17%)

Query: 20  HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
            ++   +LG+G  G V+K          G  I A+K +  +  E  R  LL+EL   KTL
Sbjct: 2   DLERVKVLGQGSSGVVYKV----RHKPTG-KIYALKKIHVDGDEEFRKQLLREL---KTL 53

Query: 80  --DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
                P VV+  G   ++    +++EY+  G L   L+             K   +    
Sbjct: 54  RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK-------------KVGKIPEPV 100

Query: 138 LTSFCYQVARGMQFL 152
           L     Q+ +G+ +L
Sbjct: 101 LAYIARQILKGLDYL 115

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 17/38 (44%), Positives = 23/38 (60%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
           V  GYR+  P  C  ++Y +M  CWD +P  RP F+EL
Sbjct: 207 VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 49.7 bits (118), Expect = 3e-07
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 6/100 (6%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +     + +G+G FG+V+K    GID R    +VA+K +     E E  D+ QE+TV+
Sbjct: 2   PEELFTKLERIGKGSFGEVFK----GIDNRTQQ-VVAIKIIDLEEAEDEIEDIQQEITVL 56

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS 116
              D  P V +  G   +    ++IMEY+  G     LR+
Sbjct: 57  SQCDS-PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA 95

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 18/46 (39%), Positives = 33/46 (71%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++G+R++KP +C  ELY +M  CW   P++RP F +L + L+++L
Sbjct: 255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.1 bits (117), Expect = 4e-07
 Identities = 17/43 (39%), Positives = 30/43 (69%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           V  G RL+KP++C  ++Y +M  CW ++P+ERP F  + ++L+
Sbjct: 226 VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.6 bits (118), Expect = 4e-07
 Identities = 20/48 (41%), Positives = 30/48 (62%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+EL + L  LL
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 17/137 (12%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLDPHPN 84
           +LG+G FG V + +    DG      VAVK LK +      ++  L+E   MK  D HPN
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQK--VAVKMLKADIFSSSDIEEFLREAACMKEFD-HPN 62

Query: 85  VVRLLGCCTEKEPF------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           V++L+G               VI+ ++ +G L +FL  SR       +  +  +L  + L
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-------IGEEPFTLPLQTL 115

Query: 139 TSFCYQVARGMQFLSSR 155
             F   +A GM++LSS+
Sbjct: 116 VRFMIDIASGMEYLSSK 132

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 10/95 (10%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCI----VAVKTLKENAGERERLDLLQELTVMKTLD 80
           ++LG+G +G V+     G+   +G  I    V + T    A E+E   L +E+ ++K+L 
Sbjct: 6   EVLGKGAYGTVY----CGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLR 115
            H N+V+ LG C +     + ME+VP G + S L 
Sbjct: 61  -HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN 94

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 5e-07
 Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 21/145 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P++  ++   +G G +G V+K  A  I   E   +VA+K +K   G+ +   + QE++++
Sbjct: 1   PQEDYELIQRIGSGTYGDVYK--ARDIATGE---LVAIKVIKLEPGD-DFEIIQQEISML 54

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           K    HPN+V   G    ++  +++MEY   G LQ   + +R              L+  
Sbjct: 55  KECR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG------------PLSEL 101

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            +   C +  +G+ +L   G   RD
Sbjct: 102 QIAYVCRETLKGLAYLHETGKIHRD 126

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 48.7 bits (117), Expect = 6e-07
 Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 17/135 (12%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           KV   LG+G FG V+         +E   +VA+K +K+     E    L+E+  ++ L+ 
Sbjct: 2   KVIKQLGDGTFGSVYLARN-----KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE 56

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           HPN+V+L     E +  + + EY+     Q  L   R  +            +   + S 
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEGNLYQ--LMKDRKGKP----------FSESVIRSI 104

Query: 142 CYQVARGMQFLSSRG 156
            YQ+ +G+  +   G
Sbjct: 105 IYQILQGLAHIHKHG 119

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 19/51 (37%), Positives = 34/51 (66%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD 207
           +++G+R++KP +C  ELY +M  CW   P+ RP F +L + L+++L   T+
Sbjct: 252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 48.2 bits (115), Expect = 7e-07
 Identities = 18/39 (46%), Positives = 24/39 (61%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           GYR+  P  C +E+Y IM  CW  EP +RP+F  L + L
Sbjct: 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 48.2 bits (115), Expect = 7e-07
 Identities = 35/137 (25%), Positives = 66/137 (48%), Gaps = 19/137 (13%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK--ENAGERERLDLLQELTVMKTLDPHPN 84
           +G+G F  V+K   L +DGR    +VA+K ++  E    + R D L+E+ ++K LD HPN
Sbjct: 10  IGKGQFSVVYKAICL-LDGR----VVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPN 63

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           V++ L    E     +++E    G L   ++  + Q+           +  R +  +  Q
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK---------RLIPERTIWKYFVQ 114

Query: 145 VARGMQFLSSRGV--RD 159
           +   ++ + S+ +  RD
Sbjct: 115 LCSALEHMHSKRIMHRD 131

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 48.1 bits (114), Expect = 8e-07
 Identities = 17/43 (39%), Positives = 28/43 (65%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           ++ GYR+ + ++C  ELY+IM  CW ++  ERP F  L  +L+
Sbjct: 217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 8e-07
 Identities = 17/44 (38%), Positives = 26/44 (59%)

Query: 159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
            G RL +P++C   LY +M  CW  +P  RP F+EL   +E++ 
Sbjct: 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 48.1 bits (115), Expect = 8e-07
 Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 22/136 (16%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ-ELTVMKTLDPHPNV 85
           +G G FG+V+      ++   G  ++AVK ++    + + +  +  E+ V++ L  HPN+
Sbjct: 8   IGGGTFGKVY----TAVNLDTG-ELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNL 61

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           V+  G    +E  ++ MEY   G L+  L            HG+   L    +  +  Q+
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELLE-----------HGR--ILDEHVIRVYTLQL 108

Query: 146 ARGMQFLSSRGV--RD 159
             G+ +L S G+  RD
Sbjct: 109 LEGLAYLHSHGIVHRD 124

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 47.9 bits (114), Expect = 9e-07
 Identities = 34/136 (25%), Positives = 55/136 (40%), Gaps = 20/136 (14%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNV 85
           +G+G FG V+K      D R    + A+K +       RER + + E  V+  LD    +
Sbjct: 8   IGKGSFGVVFKV-VRKADKR----VYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYI 61

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           +R      +K    ++MEY   G L   L+  R +            L    +  F  Q+
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP-----------LPEDQVWRFFIQI 110

Query: 146 ARGMQFLSSRGV--RD 159
             G+  L S+ +  RD
Sbjct: 111 LLGLAHLHSKKILHRD 126

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 16/43 (37%), Positives = 23/43 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           V DG  L+ P++C  +L  +M  CW   P  RP F E+   L+
Sbjct: 234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 6/107 (5%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +     + +G+G FG+V+K    GID R    +VA+K +     E E  D+ QE+TV+
Sbjct: 2   PEELFTKLERIGKGSFGEVYK----GIDNRTKE-VVAIKIIDLEEAEDEIEDIQQEITVL 56

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
              D  P + R  G   +    ++IMEY+  G     L+    +  Y
Sbjct: 57  SQCDS-PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETY 102

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 18/46 (39%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           V DG  L++PD+C   + ++M  CW   P  RP F E+ +LL+  L
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 47.2 bits (112), Expect = 2e-06
 Identities = 16/43 (37%), Positives = 27/43 (62%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           GYR+E+P+ C  ++Y +M  CW   P++RP+F E+    E + 
Sbjct: 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 39/146 (26%), Positives = 63/146 (43%), Gaps = 25/146 (17%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGID-GREGPCIVAVKTLKENAGERERLDLLQELTV 75
           PR ++  F  +GEG  G V  C A     GR     VAVK +     +R  L L  E+ +
Sbjct: 17  PRSYLDNFVKIGEGSTGIV--CIATDKSTGR----QVAVKKMDLRKQQRREL-LFNEVVI 69

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M+    HPN+V +       +  +V+ME++  G L   +  +R              +  
Sbjct: 70  MRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--------------MNE 114

Query: 136 RDLTSFCYQVARGMQFLSSRGV--RD 159
             + + C  V + + FL ++GV  RD
Sbjct: 115 EQIATVCLAVLKALSFLHAQGVIHRD 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 30/143 (20%), Positives = 56/143 (39%), Gaps = 24/143 (16%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++GEG +G+V+K        + G  +VA+K +     E E  ++ +E  +++    HPN
Sbjct: 12  EVIGEGTYGKVYK----ARHKKTGQ-LVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPN 64

Query: 85  VVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           +    G   +K P       +++ME    G                 +  K   L    +
Sbjct: 65  IATFYGAFIKKNPPGNDDQLWLVMELCGGGS---------VTDLVKGLRKKGKRLKEEWI 115

Query: 139 TSFCYQVARGMQFLSSRGV--RD 159
                +  RG+ +L    V  RD
Sbjct: 116 AYILRETLRGLAYLHENKVIHRD 138

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 47.2 bits (113), Expect = 2e-06
 Identities = 29/105 (27%), Positives = 52/105 (49%), Gaps = 9/105 (8%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLD 80
           +V + +G+G FG V K      DG+    I+  K +   N  E+E+  L+ E+ +++ L 
Sbjct: 3   EVLETIGKGSFGTVRKVRRKS-DGK----ILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57

Query: 81  PHPNVVRLLG--CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
            HPN+VR          +  +++MEY   G L   ++  + +R Y
Sbjct: 58  -HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY 101

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (113), Expect = 2e-06
 Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 6/92 (6%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G+G FG+V+K     ID R    +VA+K +     E E  D+ QE+  +      P + 
Sbjct: 9   IGKGSFGEVYK----AIDKRTNQ-VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-PYIT 62

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
           +  G   +    ++IMEY   G     L+  +
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK 94

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 20/43 (46%), Positives = 31/43 (72%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           GYRLEKP +C  E+Y++M  CW ++P ERP+F ++   L ++L
Sbjct: 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 20/46 (43%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +R G RL++P  C   LY++M  CW   P +RP+F  L   LEK L
Sbjct: 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.5 bits (110), Expect = 3e-06
 Identities = 19/43 (44%), Positives = 23/43 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           V  GYR+  P  C   L+ +M  CW K+P ERP F  L   LE
Sbjct: 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 46.8 bits (111), Expect = 3e-06
 Identities = 31/141 (21%), Positives = 61/141 (43%), Gaps = 26/141 (18%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK---ENAGERERL--DLLQELTVMKTLD 80
            LG G F   ++      D + G  ++AVK +      + E+E +   L +E+ +M  L+
Sbjct: 7   QLGTGAFSSCYQAR----DVKTG-TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HP+++R+LG   E   F + +E++  G +   L         +       ++       
Sbjct: 62  -HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---------SKYGAFKEAVIIN---- 107

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           +  Q+ RG+ +L    +  RD
Sbjct: 108 YTEQLLRGLSYLHENQIIHRD 128

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 14/139 (10%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           + +GEG +G+V+K      D   G  +   KT  E   E      L+E+++++ L     
Sbjct: 7   EKIGEGTYGKVYKAR----DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS--LTSRDLTSFC 142
           +VRLL     +E       Y+ +  L S L+       + + +G+     L ++ + SF 
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKK------FMDSNGRGPGRPLPAKTIKSFM 116

Query: 143 YQVARGMQFLSSRGV--RD 159
           YQ+ +G+      GV  RD
Sbjct: 117 YQLLKGVAHCHKHGVMHRD 135

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 45.7 bits (108), Expect = 5e-06
 Identities = 16/45 (35%), Positives = 27/45 (60%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           V  GY+++ PD C   +Y++M  CW  +   RP+F +L + LE +
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 45.4 bits (107), Expect = 6e-06
 Identities = 20/43 (46%), Positives = 24/43 (55%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           V  GYR+  P  C   L+++M  CW KEP ERP F  L   LE
Sbjct: 216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 45.4 bits (107), Expect = 7e-06
 Identities = 18/43 (41%), Positives = 24/43 (55%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           V  GYR+  P  C   L+ +M  CW K+P+ERP F  +   LE
Sbjct: 216 VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 34/141 (24%), Positives = 63/141 (44%), Gaps = 19/141 (13%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +  ++   LG+G FG+V+K +      +E   + A K + E   E E  D + E+ ++
Sbjct: 10  PNEVWEIIGELGDGAFGKVYKAK-----NKETGALAAAKVI-ETKSEEELEDYMVEIEIL 63

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
            T + HP +V+LLG        ++++E+ P G + +             M      LT  
Sbjct: 64  ATCN-HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAI------------MLELDRGLTEP 110

Query: 137 DLTSFCYQVARGMQFLSSRGV 157
            +   C Q+   +Q+L S  +
Sbjct: 111 QIQVICRQMLEALQYLHSMKI 131

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 13/36 (36%), Positives = 22/36 (61%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           +  G RL  P+ C   +Y +M  CW+ +P +RP+F+
Sbjct: 209 IEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFS 244

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 16/42 (38%), Positives = 25/42 (59%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           G RL  P +C +E+Y +M  CW+ E   RP F  L  +L+++
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 11/101 (10%)

Query: 24  FDIL---GEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER--ERLDLLQELTVMKT 78
           F IL   G+G +GQV+   A   D  E   IVA+K +K++   +  E   +L E  ++ T
Sbjct: 3   FQILTQVGQGGYGQVFL--AKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDIL-T 56

Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA 119
                 +V+LL    + E  ++ MEYVP G  ++ L +   
Sbjct: 57  TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV 97

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 6/98 (6%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +     + +G+G FG+V+K    GID R    +VA+K +     E E  D+ QE+TV+
Sbjct: 2   PEELFTKLEKIGKGSFGEVFK----GIDNRTQK-VVAIKIIDLEEAEDEIEDIQQEITVL 56

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
              D  P V +  G   +    ++IMEY+  G     L
Sbjct: 57  SQCDS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL 93

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 19/53 (35%), Positives = 28/53 (52%), Gaps = 8/53 (15%)

Query: 149 MQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           M+F++      G RL+ P  C   +Y IM  CW   P +RPNF     +LE++
Sbjct: 231 MEFVTG-----GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFA---TILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 15/44 (34%), Positives = 27/44 (61%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK 200
           +  G  L++P  C  E+Y+IM  CW ++P +R N  ++ + L+K
Sbjct: 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 29/140 (20%), Positives = 62/140 (44%), Gaps = 20/140 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P++  ++   +G G +G V+K  A  ++  E   + A+K +K   GE     ++Q+  +M
Sbjct: 7   PQEDFELIQRIGSGTYGDVYK--ARNVNTGE---LAAIKVIKLEPGED--FAVVQQEIIM 59

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
                H N+V   G    ++  ++ ME+   G LQ             +++  +  L+  
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ-------------DIYHVTGPLSES 106

Query: 137 DLTSFCYQVARGMQFLSSRG 156
            +     +  +G+ +L S+G
Sbjct: 107 QIAYVSRETLQGLYYLHSKG 126

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 43.8 bits (104), Expect = 2e-05
 Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 6/102 (5%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
             ++    LG G  G V K       G+    I+AVKT++    E  +  +L+EL ++  
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRP-TGK----IMAVKTIRLEINEAIQKQILRELDILHK 55

Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 120
            +  P +V   G         + MEY+  G L   L+  + +
Sbjct: 56  CN-SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR 96

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 2e-05
 Identities = 32/145 (22%), Positives = 67/145 (46%), Gaps = 28/145 (19%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           K+   +GEG F +V K ++    G+      A+K +K++    E+++ L+E+  ++ L P
Sbjct: 2   KILGKIGEGTFSEVLKAQSRK-TGKY----YAIKCMKKHFKSLEQVNNLREIQALRRLSP 56

Query: 82  HPNVVRLLGCCTEKEP-----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           HPN++RL+    +++       F +M+                   Y  + G+   L  +
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMD----------------MNLYELIKGRKRPLPEK 100

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            + S+ YQ+ + +  +   G+  RD
Sbjct: 101 RVKSYMYQLLKSLDHMHRNGIFHRD 125

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 7/94 (7%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPN 84
           ++G G FG V  C       +    +V +K +  E   + ERL    E  V+K L  HPN
Sbjct: 7   VVGRGAFGIVHLCR-----RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPN 60

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
           ++       E +   ++MEY P G L  +++   
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC 94

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.8 bits (103), Expect = 3e-05
 Identities = 17/48 (35%), Positives = 29/48 (60%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           R + +G RL +P +C  E+Y +M  CW+ +P++R  F  L +  E +L
Sbjct: 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 43.6 bits (103), Expect = 3e-05
 Identities = 34/138 (24%), Positives = 56/138 (40%), Gaps = 19/138 (13%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
            LGEG  G V KC       +    I A+KT+  +     +  +L+EL + K+    P +
Sbjct: 8   RLGEGAGGSVTKCRL-----KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYI 61

Query: 86  VRLLGCCTEKEP--FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 143
           V+  G   ++      + MEY   G L S          Y  +  +   +  + L     
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSI---------YKKVKKRGGRIGEKVLGKIAE 112

Query: 144 QVARGMQFLSSRGV--RD 159
            V +G+ +L SR +  RD
Sbjct: 113 SVLKGLSYLHSRKIIHRD 130

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 43.0 bits (101), Expect = 4e-05
 Identities = 14/36 (38%), Positives = 20/36 (55%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           +  G R+E P  C  E+Y++M  CW    +ERP F 
Sbjct: 211 IESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFA 246

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 20/136 (14%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNV 85
           +GEG +G V+K    G + + G  IVA+K ++ E+  E      ++E++++K L  HPN+
Sbjct: 8   IGEGTYGVVYK----GRNKKTGQ-IVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNI 61

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           V L     ++   ++I E++    L+ +L S    +Y +    K          S+ YQ+
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVK----------SYLYQI 110

Query: 146 ARGMQFLSSRGV--RD 159
            +G+ F  SR V  RD
Sbjct: 111 LQGILFCHSRRVLHRD 126

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 26/138 (18%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK---ENAGERERLDLLQELTVMKTLDPHP 83
           +GEG +G V+K     + G     IVA+K +K   E+ G  +    L+E+ ++K L+ HP
Sbjct: 7   IGEGTYGVVYKARDK-LTGE----IVAIKKIKLRFESEGIPKTA--LREIKLLKELN-HP 58

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 143
           N+++LL     K   +++ E++                 Y  +  +   L    + S+ Y
Sbjct: 59  NIIKLLDVFRHKGDLYLVFEFM-------------DTDLYKLIKDRQRGLPESLIKSYLY 105

Query: 144 QVARGMQFLSSRGV--RD 159
           Q+ +G+ F  S G+  RD
Sbjct: 106 QLLQGLAFCHSHGILHRD 123

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 16/53 (30%), Positives = 28/53 (52%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE 212
           G RL +P  C  ++Y IM  CW  +   RP F EL D   ++  + + ++ ++
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFVVIQ 279

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 18/45 (40%), Positives = 27/45 (60%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           +  G  LE+P  C +E+Y+IM  CW +EP +R N  E+  +L  L
Sbjct: 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 5e-05
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 13/92 (14%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLD 80
           +    +GEG +G V+K   L   GR     VA+K ++   + E   L  L+E+ ++K L+
Sbjct: 2   EELAEIGEGAYGTVYKARDL-NTGR----FVALKKVRVPLSEEGIPLSTLREIALLKQLE 56

Query: 81  P--HPNVVRLLGCC----TEKE-PFFVIMEYV 105
              HPN+VRLL  C    T++E    ++ E+V
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV 88

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 42.5 bits (100), Expect = 6e-05
 Identities = 16/42 (38%), Positives = 24/42 (57%)

Query: 161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           YRL  P  C   L+ +M  CW K+ N RP F ++   L+K++
Sbjct: 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 42.6 bits (100), Expect = 6e-05
 Identities = 16/38 (42%), Positives = 22/38 (57%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
           V  G RL +P     ++Y IMY CW ++  ERP F +L
Sbjct: 214 VSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 42.3 bits (99), Expect = 9e-05
 Identities = 21/52 (40%), Positives = 28/52 (53%), Gaps = 2/52 (3%)

Query: 143 YQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
           YQ     Q L  R V +G  L+KPD+C   L+ +M  CW   P  RP+F E+
Sbjct: 222 YQGMSNEQVL--RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 33/141 (23%), Positives = 67/141 (47%), Gaps = 22/141 (15%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLD 80
           +   ++GEG +G V KC+      +E   IVA+K   E+  ++  +   ++E+ ++K L 
Sbjct: 4   ENLGLVGEGSYGMVMKCK-----HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            H N+V L+     K+  +++ E+V +  L             +++    N L    +  
Sbjct: 59  -HENLVNLIEVFRRKKRLYLVFEFVDHTVL-------------DDLEKYPNGLDESRVRK 104

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           + +Q+ RG++F  S  +  RD
Sbjct: 105 YLFQILRGIEFCHSHNIIHRD 125

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.8 bits (101), Expect = 9e-05
 Identities = 37/154 (24%), Positives = 72/154 (46%), Gaps = 18/154 (11%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGID---GREGPCIVAVKTLKENAGERERLD--LLQEL 73
           Q   +  ++G+G  G+V+    L  D    R     VA+K ++E+  E   L    L+E 
Sbjct: 2   QRYDIIRLIGKGGMGEVY----LAYDPVCSRR----VALKKIREDLSENPLLKKRFLREA 53

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +   L  HP +V +   C++ +P +  M Y+    L+S L+S   +   +    +  S+
Sbjct: 54  KIAADL-IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV 112

Query: 134 TSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPD 167
            +    S  +++   ++++ S+GV   +R  KPD
Sbjct: 113 GA--FLSIFHKICATIEYVHSKGVL--HRDLKPD 142

Length = 932

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 42.2 bits (100), Expect = 9e-05
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 29/141 (20%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD------LLQELTVMKTLD 80
           LGEG +  V+K      D   G  IVA+K +K   GER+          L+E+ +++ L 
Sbjct: 8   LGEGTYAVVYK----ARDKETGR-IVAIKKIK--LGERKEAKDGINFTALREIKLLQELK 60

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HPN++ LL     K    ++ E++    L+  ++             KS  LT  D+ S
Sbjct: 61  -HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKD------------KSIVLTPADIKS 106

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           +     RG+++L S  +  RD
Sbjct: 107 YMLMTLRGLEYLHSNWILHRD 127

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 15/39 (38%), Positives = 21/39 (53%)

Query: 162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK 200
            L  P+ C   LY +M  CW   P +RP+F+EL   L +
Sbjct: 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 14/35 (40%), Positives = 23/35 (65%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
           G+RL KP    + +Y +M +CW + P +RP+F+ L
Sbjct: 217 GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLL 251

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 42.1 bits (100), Expect = 1e-04
 Identities = 27/102 (26%), Positives = 46/102 (45%), Gaps = 8/102 (7%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQELTVM 76
              +    LG G FG+V           +     A+K L +    + +    +L E  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRH--KGSGK---YYALKILSKAKIVKLKQVEHVLNEKRIL 55

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
           +++  HP +V L G   +    +++MEYVP G+L S LR S 
Sbjct: 56  QSIR-HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG 96

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 26/70 (37%), Positives = 40/70 (57%), Gaps = 7/70 (10%)

Query: 27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDP--HP 83
          +GEG +G+V+K   L   GR     VA+K ++ +   E   L  ++E+ V++ L+   HP
Sbjct: 9  IGEGAYGKVFKARDLKNGGR----FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 84 NVVRLLGCCT 93
          NVVRL   CT
Sbjct: 65 NVVRLFDVCT 74

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 15/56 (26%), Positives = 28/56 (50%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE 212
           +  G RL +P  C  ++Y ++  CW  +   RP F EL +   K+  +   Y+ ++
Sbjct: 224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYLVIQ 279

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 32/147 (21%), Positives = 63/147 (42%), Gaps = 24/147 (16%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++ +++G G +GQV+K    G   + G  + A+K +     E E +   QE+ ++
Sbjct: 4   PAGIFELVELVGNGTYGQVYK----GRHVKTGQ-LAAIKVMDVTGDEEEEIK--QEINML 56

Query: 77  KTLDPHPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           K    H N+    G   +K P       +++ME+   G +   ++++           K 
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-----------KG 105

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV 157
           N+L    +   C ++ RG+  L    V
Sbjct: 106 NTLKEEWIAYICREILRGLSHLHQHKV 132

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 35/136 (25%), Positives = 64/136 (47%), Gaps = 22/136 (16%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNV 85
           +GEG +G V+K +      RE   IVA+K ++ ++  E      L+E+ ++K L  H N+
Sbjct: 8   IGEGTYGTVFKAK-----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNI 61

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           VRL       +   ++ EY               ++Y+++ +G  +    +   SF +Q+
Sbjct: 62  VRLYDVLHSDKKLTLVFEYC----------DQDLKKYFDSCNGDIDPEIVK---SFMFQL 108

Query: 146 ARGMQFLSSRGV--RD 159
            +G+ F  S  V  RD
Sbjct: 109 LKGLAFCHSHNVLHRD 124

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 24/134 (17%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--LQELTVMKTLDPHP 83
            +GEG +G V++      D   G  IVA+K ++ +  ER+ + +  L+E+T++  L  HP
Sbjct: 14  RIGEGTYGIVYR----ARDTTSGE-IVALKKVRMDN-ERDGIPISSLREITLLLNLR-HP 66

Query: 84  NVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           N+V L      K  +  F++MEY     L S L         +NM       +   +   
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL---------DNM---PTPFSESQVKCL 113

Query: 142 CYQVARGMQFLSSR 155
             Q+ RG+Q+L   
Sbjct: 114 MLQLLRGLQYLHEN 127

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 35/149 (23%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ------ELTVMKTLD 80
           +G G FG+V          R      A+K +       E + L Q      E  V+K + 
Sbjct: 9   VGTGTFGRVHLVRD-----RISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLKEVS 59

Query: 81  PHPNVVRLLGCCTEKEPFFV--IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
            HP ++RL    TE +  F+  +MEYVP G+L S+LR+S          G+ ++ T    
Sbjct: 60  -HPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNS----------GRFSNSTGLFY 106

Query: 139 TSFCYQVARGMQFLSSRGVRDGYRLEKPD 167
            S   ++   +++L S+ +   YR  KP+
Sbjct: 107 AS---EIVCALEYLHSKEI--VYRDLKPE 130

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 22/98 (22%), Positives = 45/98 (45%), Gaps = 6/98 (6%)

Query: 20  HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
             ++ +++G G    V+   A+ +   E    VA+K +     +    +L +E+  M   
Sbjct: 2   DYELIEVIGVGATAVVYA--AICLPNNE---KVAIKRIDLEKCQTSVDELRKEVQAMSQC 56

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS 117
           + HPNVV+        +  +++M Y+  G L   ++SS
Sbjct: 57  N-HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSS 93

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 37/135 (27%), Positives = 60/135 (44%), Gaps = 19/135 (14%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LGEG +  V+K        R    IVA+K +  +A E      ++E+++MK L  H N+V
Sbjct: 8   LGEGTYATVYKGRN-----RTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIV 61

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           RL      +    ++ EY+            +  + Y + HG   +L    + SF YQ+ 
Sbjct: 62  RLHDVIHTENKLMLVFEYM-----------DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 147 RGMQFLSSRGV--RD 159
           +G+ F     V  RD
Sbjct: 111 KGIAFCHENRVLHRD 125

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 40.6 bits (95), Expect = 3e-04
 Identities = 15/40 (37%), Positives = 22/40 (55%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
             +  G+RL +P      +Y +MY CW ++P  RP F EL
Sbjct: 212 EMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 40.6 bits (96), Expect = 3e-04
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 14/104 (13%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKTLDPHPN 84
           LG+G FG+V               + A+K L K+   +R+ ++  L E  ++  ++ HP 
Sbjct: 1   LGKGSFGKVLLVRKKDTGK-----LYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPF 54

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS------SRAQRY 122
           +V+L      +E  ++++EY P G+L S L         RA+ Y
Sbjct: 55  IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY 98

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 19/94 (20%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-------------LLQEL 73
           LGEG +G+V K     + G+    IVA+K +K      +                 L+EL
Sbjct: 17  LGEGTYGKVEKAYDT-LTGK----IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPY 107
            +M  +  H N++ L+    E +   ++M+ +  
Sbjct: 72  KIMNEIK-HENIMGLVDVYVEGDFINLVMDIMAS 104

Length = 335

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 20/140 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P+   ++   +G G +G V+K   L         + AVK +K   G+     L+Q+   M
Sbjct: 7   PQHDYELIQRVGSGTYGDVYKARNLHTGE-----LAAVKIIKLEPGDD--FSLIQQEIFM 59

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
                H N+V   G    +E  ++ MEY   G LQ             +++  +  L+  
Sbjct: 60  VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ-------------DIYHVTGPLSEL 106

Query: 137 DLTSFCYQVARGMQFLSSRG 156
            +   C +  +G+ +L S+G
Sbjct: 107 QIAYVCRETLQGLAYLHSKG 126

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 12/36 (33%), Positives = 22/36 (61%)

Query: 163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL 198
           L +P +C +++Y +M  CW ++  +RP F E+   L
Sbjct: 259 LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 36/149 (24%), Positives = 60/149 (40%), Gaps = 32/149 (21%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTL----KENAGERERLDLLQELTVMKTLDPH 82
           +GEG  G V+K +      RE    VA+K +     E     +    L+E+  ++    H
Sbjct: 8   IGEGAHGIVFKAKD-----RETGETVALKKVALRRLEGGIPNQ---ALREIKALQACQ-H 58

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           P VV+LL        F ++MEY+P   L   LR                 L    + S+ 
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEE------------RPLPEAQVKSYM 105

Query: 143 YQVARGMQFLSSRGV--RDGYRLEKPDHC 169
             + +G+ ++ + G+  RD     KP + 
Sbjct: 106 RMLLKGVAYMHANGIMHRD----LKPANL 130

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 40.0 bits (93), Expect = 4e-04
 Identities = 24/98 (24%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +  ++   LG+G FG+V+K +      +E   + A K + +   E E  D + E+ ++
Sbjct: 3   PEEFWEIIGELGDGAFGKVYKAQ-----NKETGVLAAAKVI-DTKSEEELEDYMVEIDIL 56

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            + D HPN+V+LL     +   ++++E+   G + + +
Sbjct: 57  ASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 39.7 bits (92), Expect = 7e-04
 Identities = 17/45 (37%), Positives = 28/45 (62%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           +  G  L++P  C +E+Y++M  CW +EP+ R N  E+  LL+ L
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 39.5 bits (92), Expect = 7e-04
 Identities = 33/145 (22%), Positives = 64/145 (44%), Gaps = 23/145 (15%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P++    F+ +G+G  G V+    +   G+E    VA+K +      ++ L ++ E+ VM
Sbjct: 17  PKKKYTRFEKIGQGASGTVYTAIDVAT-GQE----VAIKQMNLQQQPKKEL-IINEILVM 70

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           +  + HPN+V  L      +  +V+MEY+  G L   +  +               +   
Sbjct: 71  RE-NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--------------CMDEG 115

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            + + C +  + ++FL S  V  RD
Sbjct: 116 QIAAVCRECLQALEFLHSNQVIHRD 140

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 39.6 bits (92), Expect = 7e-04
 Identities = 31/147 (21%), Positives = 65/147 (44%), Gaps = 24/147 (16%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++ +++G G +GQV+K    G   + G  + A+K +  +  E E  ++  E+ ++
Sbjct: 14  PAGIFELVEVVGNGTYGQVYK----GRHVKTGQ-LAAIKVM--DVTEDEEEEIKLEINML 66

Query: 77  KTLDPHPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           K    H N+    G   +K P       +++ME+   G +   ++++           K 
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-----------KG 115

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV 157
           N+L    +   C ++ RG+  L +  V
Sbjct: 116 NALKEDWIAYICREILRGLAHLHAHKV 142

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 39.6 bits (92), Expect = 7e-04
 Identities = 38/142 (26%), Positives = 61/142 (42%), Gaps = 23/142 (16%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEAL-GIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
           PR  ++ +  +GEG  G V  C A     GR+    VAVK +     +R  L L  E+ +
Sbjct: 19  PRSLLENYIKIGEGSTGIV--CIAREKHSGRQ----VAVKMMDLRKQQRREL-LFNEVVI 71

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M+    H NVV +       E  +V+ME++  G L   +  +R              L  
Sbjct: 72  MRDYQ-HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--------------LNE 116

Query: 136 RDLTSFCYQVARGMQFLSSRGV 157
             + + C  V + + +L S+GV
Sbjct: 117 EQIATVCESVLQALCYLHSQGV 138

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 39.3 bits (92), Expect = 8e-04
 Identities = 35/145 (24%), Positives = 59/145 (40%), Gaps = 21/145 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++   LG+G FG+V+K +      +E     A K ++  + E E  D + E+ ++
Sbjct: 3   PNDIWEIIGELGDGAFGKVYKAQH-----KETGLFAAAKIIQIESEE-ELEDFMVEIDIL 56

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
                HPN+V L      +   ++++E+   G L S             M      LT  
Sbjct: 57  SECK-HPNIVGLYEAYFYENKLWILIEFCDGGALDSI------------MLELERGLTEP 103

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            +   C Q+   + FL S  V  RD
Sbjct: 104 QIRYVCRQMLEALNFLHSHKVIHRD 128

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 17/53 (32%), Positives = 27/53 (50%)

Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE 212
           G RL +P  C  ++Y IM  CW  + + RP F EL     K+  +   Y+ ++
Sbjct: 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 279

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 38.5 bits (89), Expect = 0.001
 Identities = 34/141 (24%), Positives = 60/141 (42%), Gaps = 21/141 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           PR+++  F  +GEG  G V     +  +   G   VAVK +     +R  L L  E+ +M
Sbjct: 20  PREYLDSFIKIGEGSTGIV----CIATEKHTGK-QVAVKKMDLRKQQRREL-LFNEVVIM 73

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           +    H NVV +       +  +V+ME++  G L   +  +R              +   
Sbjct: 74  RDYH-HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--------------MNEE 118

Query: 137 DLTSFCYQVARGMQFLSSRGV 157
            + + C  V R + +L ++GV
Sbjct: 119 QIATVCLSVLRALSYLHNQGV 139

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 7/91 (7%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE-RLDLLQELTVMKTLD 80
           +V  ++GEG +G V KC       +E   IVA+K  K++    E +   L+EL +++TL 
Sbjct: 4   EVLGVVGEGAYGVVLKCRH-----KETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 111
              N+V L      +   +++ EYV    L+
Sbjct: 59  -QENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 38.5 bits (89), Expect = 0.002
 Identities = 17/26 (65%), Positives = 21/26 (80%)

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
           S  LT+ DL SF YQVARGM+FL+S+
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASK 256

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 14/32 (43%), Positives = 19/32 (59%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNER 188
           +  G  LE+P  C  E+Y IM  CW +EP +R
Sbjct: 237 ITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 18/91 (19%), Positives = 37/91 (40%), Gaps = 13/91 (14%)

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E   + +   H ++V+L G C  ++   ++ EYV +G L  FL   +            
Sbjct: 49  FETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREK------------ 95

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGVRDGY 161
           N+++         Q+A  + +L  + +  G 
Sbjct: 96  NNVSLHWKLDVAKQLASALHYLEDKKLVHGN 126

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 26/153 (16%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLD-LLQELTVMKTLDPHP 83
           +LG+G FG+V   E  G D      + A+K LK++   + + +D  + E  ++     HP
Sbjct: 2   VLGKGSFGKVMLAELKGTDE-----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP 56

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 143
            +  L  C   K+  F +MEYV  G L   ++ SR          K +   SR    +  
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR----------KFDEPRSR---FYAA 103

Query: 144 QVARGMQFLSSRGV------RDGYRLEKPDHCR 170
           +V   + FL   GV       D   L+   HC+
Sbjct: 104 EVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK 136

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 37.8 bits (88), Expect = 0.002
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 20/109 (18%)

Query: 20  HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKT 78
              +   +GEG +GQV+K  A   D  E   +VA+K ++ +N  E   +  ++E+ +++ 
Sbjct: 8   KFDIIGQIGEGTYGQVYK--ARDKDTGE---LVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 79  LDPHPNVVRLLGCCT----------EKEPFFVIMEYVP---YGKLQSFL 114
           L+ H N+V L    T          +K  F+++ EY+     G L+S L
Sbjct: 63  LN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL 110

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 37.8 bits (87), Expect = 0.002
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P++    ++ +G+G  G V+    +   G+E    VA+K +      ++ L ++ E+ VM
Sbjct: 17  PKKKYTRYEKIGQGASGTVFTAIDVAT-GQE----VAIKQINLQKQPKKEL-IINEILVM 70

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 110
           K L  +PN+V  L      +  FV+MEY+  G L
Sbjct: 71  KELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSL 103

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 22/101 (21%), Positives = 52/101 (51%), Gaps = 8/101 (7%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL--DPH 82
           +++G G +G V++    G     G  +VA+K +  +  + +  D+ +E+ ++  L     
Sbjct: 7   ELIGRGAYGAVYR----GKHVPTGR-VVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRY 122
           PN+ +  G   +    ++IMEY   G +++ +++   A++Y
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY 102

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 37.4 bits (87), Expect = 0.004
 Identities = 20/91 (21%), Positives = 38/91 (41%), Gaps = 5/91 (5%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           K+      ++    +G G  GQV+K        ++   ++AVK ++    + E   +L +
Sbjct: 9   KYPADLNDLENLGEIGSGTCGQVYKMRF-----KKTGHVMAVKQMRRTGNKEENKRILMD 63

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIME 103
           L V+      P +V+  G        F+ ME
Sbjct: 64  LDVVLKSHDCPYIVKCYGYFITDSDVFICME 94

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 37.4 bits (87), Expect = 0.004
 Identities = 39/143 (27%), Positives = 61/143 (42%), Gaps = 32/143 (22%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQ-ELTVMKTLDPHP 83
           +LG+G FG+V   E  G D      + AVK LK++   + + ++    E  V+     HP
Sbjct: 2   VLGKGSFGKVLLAELKGTDE-----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHP 56

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA-----QRYYNNMHGKSNSLTSRDL 138
            + +L  C   K+  F +MEYV  G L   ++ S        R+Y               
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--------------- 101

Query: 139 TSFCYQVARGMQFLSSRGV--RD 159
                ++  G+QFL  RG+  RD
Sbjct: 102 ---AAEIVLGLQFLHERGIIYRD 121

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	230
KOG0197|consensus	468		100.0
KOG1026|consensus	774		99.98
KOG4257|consensus	974		99.97
KOG1095|consensus	1025		99.97
KOG0192|consensus	362		99.96
KOG0194|consensus	474		99.96
KOG0196|consensus	996		99.96
KOG4278|consensus	1157		99.96
KOG0581|consensus	364		99.96
KOG0193|consensus	678		99.95
KOG0575|consensus	592		99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
KOG0615|consensus	475		99.94
KOG0661|consensus	538		99.94
KOG1094|consensus	807		99.94
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.94
KOG0595|consensus	429		99.94
KOG0199|consensus	1039		99.94
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
KOG0200|consensus	609		99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.93
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.93
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.93
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.93
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.93
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.93
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.93
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.92
KOG1025|consensus	1177		99.92
KOG1989|consensus	738		99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.92
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.92
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.92
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.92
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.92
KOG0591|consensus	375		99.92
KOG0582|consensus	516		99.92
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.92
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.92
KOG0198|consensus	313		99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.92
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.92
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.92
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.91
KOG0589|consensus	426		99.91
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.91
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.91
KOG0580|consensus	281		99.91
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.91
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.91
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.91
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.91
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.91
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.91
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.91
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.91
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.91
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.91
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.91
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.91
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.91
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.91
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.91
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.91
KOG0593|consensus	396		99.9
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.9
KOG4721|consensus	904		99.9
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.9
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.9
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.9
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.9
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.9
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.9
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.9
KOG0611|consensus	668		99.9
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.9
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.9
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.9
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
KOG0583|consensus	370		99.89
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.89
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.89
KOG0201|consensus	467		99.89
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.89
KOG0598|consensus	357		99.89
KOG0659|consensus	318		99.89
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.89
KOG1187|consensus	361		99.89
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.89
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.89
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.89
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.89
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.89
PTZ00283	496	serine/threonine protein kinase; Provisional	99.89
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.89
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.89
KOG0600|consensus	560		99.89
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.89
KOG2345|consensus	302		99.89
KOG0578|consensus	550		99.89
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.88
KOG0588|consensus	786		99.88
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.88
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.88
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.88
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.88
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.88
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.88
PTZ00267	478	NIMA-related protein kinase; Provisional	99.88
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.88
KOG0597|consensus	808		99.88
KOG1024|consensus	563		99.88
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.88
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.88
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.88
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.88
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.88
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.88
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.88
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.88
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.88
KOG0592|consensus	604		99.88
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.87
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.87
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.87
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.87
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.87
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.87
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.87
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.87
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.87
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.87
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.87
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.87
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.87
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.87
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.87
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.87
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.87
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.87
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.87
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.87
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.87
KOG0579|consensus	1187		99.87
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.87
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.87
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.87
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.87
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.87
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.87
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.87
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.87
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.87
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.87
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.86
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.86
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.86
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.86
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.86
KOG0032|consensus	382		99.86
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.86
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.86
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.86
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.86
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.86
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.86
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.86
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.86
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.86
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.86
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.86
KOG0694|consensus	694		99.86
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.86
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.86
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.86
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.86
KOG0574|consensus	502		99.86
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.86
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.86
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.86
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.86
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.86
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.86
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.86
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.86
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.86
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.86
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.86
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.86
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.86
KOG4717|consensus	864		99.86
KOG0616|consensus	355		99.86
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.86
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.86
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.85
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.85
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.85
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.85
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.85
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.85
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.85
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.85
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.85
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.85
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.85
KOG0663|consensus	419		99.85
KOG0610|consensus	459		99.85
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.85
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.85
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.84
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.84
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.84
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.84
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.84
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.84
PHA03212	391	serine/threonine kinase US3; Provisional	99.84
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.84
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.84
PTZ00036	440	glycogen synthase kinase; Provisional	99.84
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.84
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.84
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.84
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.84
KOG0033|consensus	355		99.84
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.84
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.84
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.84
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.84
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.84
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.84
KOG4279|consensus	1226		99.83
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.83
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.83
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.83
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.83
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.83
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.83
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.83
KOG0605|consensus	550		99.83
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.83
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.83
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.83
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.83
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.83
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.83
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.83
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.83
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.83
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.83
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.83
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.82
KOG0586|consensus	596		99.82
KOG3653|consensus	534		99.82
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.82
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.82
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.82
KOG0584|consensus	632		99.82
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.82
KOG0585|consensus	576		99.82
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.82
KOG0660|consensus	359		99.82
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.82
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.82
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.82
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.82
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.82
PHA03209	357	serine/threonine kinase US3; Provisional	99.82
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.82
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.81
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.81
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.81
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.81
PHA03207	392	serine/threonine kinase US3; Provisional	99.81
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.81
KOG0577|consensus	948		99.81
KOG4645|consensus	1509		99.81
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.81
PLN00009	294	cyclin-dependent kinase A; Provisional	99.81
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.81
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.81
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.81
KOG2052|consensus	513		99.81
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.81
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.81
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.8
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.8
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.8
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.8
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.8
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.8
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.8
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.8
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.8
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.8
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.8
KOG0658|consensus	364		99.8
KOG4250|consensus	732		99.79
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.79
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.79
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.79
PHA03211	461	serine/threonine kinase US3; Provisional	99.79
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.79
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.79
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.79
KOG0667|consensus	586		99.79
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.79
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.78
KOG0596|consensus	677		99.78
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.78
KOG0594|consensus	323		99.78
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.77
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.77
KOG0599|consensus	411		99.77
KOG0587|consensus	953		99.77
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.77
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.77
PTZ00284	467	protein kinase; Provisional	99.77
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.77
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.77
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.77
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.76
KOG0607|consensus	463		99.76
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.76
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.76
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.76
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.75
KOG0690|consensus	516		99.75
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.75
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.74
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.74
KOG1035|consensus	1351		99.73
KOG0604|consensus	400		99.73
KOG0576|consensus	829		99.73
KOG0195|consensus	448		99.73
PHA03210	501	serine/threonine kinase US3; Provisional	99.72
KOG0668|consensus	338		99.71
KOG1151|consensus	775		99.7
KOG4236|consensus	888		99.7
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.7
PHA02882	294	putative serine/threonine kinase; Provisional	99.69
KOG0662|consensus	292		99.69
KOG0666|consensus	438		99.68
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.68
KOG1290|consensus	590		99.67
KOG0671|consensus	415		99.67
KOG0983|consensus	391		99.67
PRK09188	365	serine/threonine protein kinase; Provisional	99.65
KOG0695|consensus	593		99.63
KOG0612|consensus	1317		99.62
KOG0696|consensus	683		99.61
KOG1152|consensus	772		99.59
KOG0603|consensus	612		99.59
KOG0669|consensus	376		99.58
KOG1027|consensus	903		99.57
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.56
KOG1006|consensus	361		99.56
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.56
KOG0986|consensus	591		99.53
KOG0984|consensus	282		99.53
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.53
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.51
KOG1167|consensus	418		99.5
KOG0608|consensus	1034		99.5
PRK10345	210	hypothetical protein; Provisional	99.48
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.46
KOG1345|consensus	378		99.46
KOG0614|consensus	732		99.42
KOG1163|consensus	341		99.38
PRK14879	211	serine/threonine protein kinase; Provisional	99.37
KOG1165|consensus	449		99.34
KOG1164|consensus	322		99.33
smart00090	237	RIO RIO-like kinase.	99.3
KOG0670|consensus	752		99.29
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.29
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.26
KOG0664|consensus	449		99.24
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.22
PRK12274	218	serine/threonine protein kinase; Provisional	99.13
KOG4158|consensus	598		99.06
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.05
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.03
KOG1166|consensus	974		98.98
KOG0665|consensus	369		98.96
KOG1023|consensus	484		98.96
KOG0590|consensus	601		98.87
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.83
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.81
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.73
KOG1266|consensus	458		98.45
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.32
KOG1240|consensus	1431		98.15
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.08
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.03
PLN00181	793	protein SPA1-RELATED; Provisional	98.03
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.02
KOG3741|consensus	655		98.02
KOG1243|consensus	690		97.79
KOG0603|consensus	612		97.75
KOG0601|consensus	524		97.75
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	97.65
KOG0590|consensus	601		97.34
PLN02876	822	acyl-CoA dehydrogenase	97.3
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.24
KOG3087|consensus	229		97.22
KOG0601|consensus	524		97.17
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.06
PRK10593	297	hypothetical protein; Provisional	97.02
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	96.94
PF01636	239	APH: Phosphotransferase enzyme family This family	96.77
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.48
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.4
PRK09902	216	hypothetical protein; Provisional	96.21
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	95.7
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	94.85
PRK09550	401	mtnK methylthioribose kinase; Reviewed	94.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	94.74
KOG1033|consensus	516		94.7
KOG0606|consensus	1205		94.55
KOG1033|consensus	516		94.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.71
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	93.49
KOG1035|consensus	1351		93.45
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	92.87
KOG4720|consensus	391		92.21
COG0661	517	AarF Predicted unusual protein kinase [General fun	91.52
KOG1235|consensus	538		91.11
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	90.99
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	89.85
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	89.66
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	89.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	88.92
PLN02756	418	S-methyl-5-thioribose kinase	86.48
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	86.4
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	86.07
PLN02236	344	choline kinase	84.38
PLN00181	793	protein SPA1-RELATED; Provisional	84.24
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	82.51
KOG0606|consensus	1205		81.1
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	80.23

>KOG0197|consensus

Probab=100.00  E-value=6.8e-33  Score=226.38  Aligned_cols=176  Identities=39%  Similarity=0.808  Sum_probs=158.6

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+.|+|+++.+++.+.||+|.||.|+.|.+.+...      ||+|.++..  ....+.|.+|+.++.+++ |+|||+++
T Consensus       197 ~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~------vavk~ik~~--~m~~~~f~~Ea~iMk~L~-H~~lV~l~  267 (468)
T KOG0197|consen  197 ARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTK------VAVKTIKEG--SMSPEAFLREAQIMKKLR-HEKLVKLY  267 (468)
T ss_pred             ccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCc------ccceEEecc--ccChhHHHHHHHHHHhCc-ccCeEEEE
Confidence            378899999999999999999999999999976542      899998753  223356889999999999 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++.....++|||||++.|+|.++++..           ....+...+++.++.|||+||.||.+++             
T Consensus       268 gV~~~~~piyIVtE~m~~GsLl~yLr~~-----------~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV  336 (468)
T KOG0197|consen  268 GVCTKQEPIYIVTEYMPKGSLLDYLRTR-----------EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV  336 (468)
T ss_pred             EEEecCCceEEEEEecccCcHHHHhhhc-----------CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee
Confidence            9999988999999999999999999973           2345889999999999999999999999             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       337 ~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~  416 (468)
T KOG0197|consen  337 DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL  416 (468)
T ss_pred             ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                      +..|.|.+.|+.||+++.+++..||..+|++||||..+...+..+....
T Consensus       417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            8999999999999999999999999999999999999999998887654

>KOG1026|consensus

Probab=99.98  E-value=7.5e-32  Score=230.52  Aligned_cols=202  Identities=34%  Similarity=0.638  Sum_probs=175.4

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ......+|++.+..+.+.||+|+||+||+|...+.........||||.++.......+++|.+|++++..++ |+|||++
T Consensus       476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrL  554 (774)
T KOG1026|consen  476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRL  554 (774)
T ss_pred             CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEE
Confidence            345557899999999999999999999999987766455667899999998777778999999999999999 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhcc-ccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN-NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +|.|..++.+++|+|||..|+|.+|++......... ........++..+.+.|+.|||.||.||.++.           
T Consensus       555 lGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC  634 (774)
T KOG1026|consen  555 LGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC  634 (774)
T ss_pred             EEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence            999999999999999999999999999865443222 11111445889999999999999999999988           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence                                                                                            


Q ss_pred             ---CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccc
Q psy15820        157 ---VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIEL  211 (230)
Q Consensus       157 ---i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~  211 (230)
                         +..|....-|++||.+++.|+..||+.+|.+||+|.||-..|+...+..+.+..+
T Consensus       715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~~  772 (774)
T KOG1026|consen  715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSSL  772 (774)
T ss_pred             HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccccc
Confidence               7888888999999999999999999999999999999999999988877766543

>KOG4257|consensus

Probab=99.97  E-value=3e-31  Score=220.16  Aligned_cols=185  Identities=35%  Similarity=0.717  Sum_probs=166.3

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ++...+++.++.+...++||.|.||.||.|.+...+ +.....||||..+.+...+..+.|+.|..++.++. ||||+++
T Consensus       379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd-HphIikL  456 (974)
T KOG4257|consen  379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD-HPHIIKL  456 (974)
T ss_pred             CCCCcceeehhhccHHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC-Ccchhhe
Confidence            345578999999999999999999999999998765 34445699999998777888899999999999999 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      +|++.. ..+|+|||.++-|.|..++....            ..++...+..++.||+.||.|||+++            
T Consensus       457 IGv~~e-~P~WivmEL~~~GELr~yLq~nk------------~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiL  523 (974)
T KOG4257|consen  457 IGVCVE-QPMWIVMELAPLGELREYLQQNK------------DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNIL  523 (974)
T ss_pred             eeeeec-cceeEEEecccchhHHHHHHhcc------------ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhee
Confidence            999976 56999999999999999999853            35888999999999999999999998            


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       524 VsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~  603 (974)
T KOG4257|consen  524 VSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG  603 (974)
T ss_pred             ecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence                                                                                            


Q ss_pred             -CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        157 -VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       157 -i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                       +.+|.|++.|++||+.++.|+.+||+++|.+||+|.+|...|..+++.+...
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~  656 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN  656 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence             8999999999999999999999999999999999999999999998865443

>KOG1095|consensus

Probab=99.97  E-value=4.8e-30  Score=226.41  Aligned_cols=195  Identities=36%  Similarity=0.681  Sum_probs=172.8

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +++...++++.||+|+||.||.|...+.........||+|.++...+......|++|..+++.+. |||||+++|++...
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence            67889999999999999999999998877554466799999988778888899999999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      ...++++|||++|+|..||++.+...+.      ...++..+++.++.|||+|+.||+++.                   
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~------~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQ------PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCC------CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcE
Confidence            9999999999999999999997654332      456899999999999999999999998                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..|.
T Consensus       842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG  921 (1025)
T ss_pred             EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence                                                                                       45556


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCCCc
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDH  217 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~  217 (230)
                      |.++|..||+.++++|..||+.+|++||+|..|++.+..+..............+.
T Consensus       922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a~~  977 (1025)
T KOG1095|consen  922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPADY  977 (1025)
T ss_pred             ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccccccc
Confidence            99999999999999999999999999999999999999999887776665443333

>KOG0192|consensus

Probab=99.96  E-value=1.4e-28  Score=200.31  Aligned_cols=178  Identities=31%  Similarity=0.611  Sum_probs=156.5

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..|.|+...+.+.+.||+|+||+||+|.+.+..      .||+|++... .+......|.+|+.++.+++ |||||+++|
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~------~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G  106 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD------VVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYG  106 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeCCce------eEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEE
Confidence            558899999999999999999999999996644      2899999643 33444789999999999999 999999999


Q ss_pred             EEecCC-CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         91 CCTEKE-PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      ++..+. ..++||||+++|+|.+++...+           ...+++..++.++.|||.||.|||+++             
T Consensus       107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~~-----------~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiL  175 (362)
T KOG0192|consen  107 ACTSPPGSLCIVTEYMPGGSLSVLLHKKR-----------KRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNIL  175 (362)
T ss_pred             EEcCCCCceEEEEEeCCCCcHHHHHhhcc-----------cCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEE
Confidence            999877 7999999999999999998731           235899999999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       176 v~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~  255 (362)
T KOG0192|consen  176 VDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA  255 (362)
T ss_pred             EcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence                                                                                            


Q ss_pred             ---CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 ---VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 ---i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                         +..+.|++.|..|++.+..|+.+||..||..||+|.+|+..|..+......
T Consensus       256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence               457778889999999999999999999999999999999999988775443

>KOG0194|consensus

Probab=99.96  E-value=3.1e-28  Score=201.55  Aligned_cols=184  Identities=34%  Similarity=0.663  Sum_probs=162.8

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC--cCCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE--NAGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      .-..|.+.+++..+.++||+|+||.||+|............ ||+|..+.  .........+++|.+++.++. |+|||+
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~-VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr  225 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVP-VAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVR  225 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeee-eEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEE
Confidence            34569999999999999999999999999997543211222 89999874  356777889999999999999 999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +||+......+++|||+|+||+|.++++...            ..++..+...++.+.|.||+|||+++           
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~------------~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNc  293 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNK------------KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNC  293 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCC------------CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHh
Confidence            9999999999999999999999999999852            24899999999999999999999999           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       294 L~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~  373 (474)
T KOG0194|consen  294 LYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA  373 (474)
T ss_pred             eecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH
Confidence                                                                                            


Q ss_pred             -C-CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 -V-RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 -i-~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                       | ..+++.+.|...|.++..++..||..+|+.||||.++.+.++.+......
T Consensus       374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence             3 77888999999999999999999999999999999999999998877554

>KOG0196|consensus

Probab=99.96  E-value=2e-28  Score=207.56  Aligned_cols=192  Identities=33%  Similarity=0.596  Sum_probs=171.2

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .+|+.+..+|.++||.|.||.|++|..+...+  ....||||.++....+..+..|+.|..++.++. ||||+++-|+..
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgk--re~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVT  700 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGK--REITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVT  700 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCC--cceeEEEeeeccCccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEe
Confidence            47889999999999999999999999865442  234699999998888899999999999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ....++++.|||++|+|..|++.+            ...++..++.-+++.|+.||+||.+.+                 
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~------------DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL  768 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQN------------DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL  768 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhc------------CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce
Confidence            999999999999999999999985            334899999999999999999999998                 


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    |.
T Consensus       769 vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe  848 (996)
T KOG0196|consen  769 VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE  848 (996)
T ss_pred             EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH
Confidence                                                                                          88


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCCCccee
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYY  220 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~  220 (230)
                      .|.|.+.|-+||..+.+|+..||++|..+||+|.+|+..|.+++..-........+......
T Consensus       849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~  910 (996)
T KOG0196|consen  849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQ  910 (996)
T ss_pred             hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcc
Confidence            99999999999999999999999999999999999999999999876666655555444333

>KOG4278|consensus

Probab=99.96  E-value=1.9e-28  Score=203.83  Aligned_cols=178  Identities=35%  Similarity=0.719  Sum_probs=159.1

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .+-+.|++.+.++..-.+||.|.||.||.|.|+..     ...||||.++.+  ......|+.|..+++.+. |||+|++
T Consensus       257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky-----slTvAVKtLKED--tMeveEFLkEAAvMKeik-HpNLVqL  328 (1157)
T KOG4278|consen  257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQL  328 (1157)
T ss_pred             CCcchhhccchheeeeeccCCCcccceeeeeeecc-----ceeeehhhhhhc--chhHHHHHHHHHHHHhhc-CccHHHH
Confidence            35588999999999999999999999999999544     445999999854  456678999999999999 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      +|+|.....+|+|.|||..|+|.++++...           .+.++.-.++.++.||+.||.||..++            
T Consensus       329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecn-----------r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCL  397 (1157)
T KOG4278|consen  329 LGVCTHEPPFYIITEFMCYGNLLDYLRECN-----------RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL  397 (1157)
T ss_pred             hhhhccCCCeEEEEecccCccHHHHHHHhc-----------hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcc
Confidence            999999999999999999999999999852           334677788899999999999999887            


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       398 VgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~  477 (1157)
T KOG4278|consen  398 VGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG  477 (1157)
T ss_pred             ccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH
Confidence                                                                                            


Q ss_pred             -CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 -VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 -i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                       +.+|.|...|+.||+.++.|+..||+|+|.+||+|.+|-+.|+.++.+.
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence             7888999999999999999999999999999999999999988877553

>KOG0581|consensus

Probab=99.96  E-value=1.7e-27  Score=187.26  Aligned_cols=165  Identities=23%  Similarity=0.392  Sum_probs=146.2

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ..+..++++.+..||+|..|.||++.+     +.++..+|+|.+.....+....++.+|++++..+. ||+||.+||+|.
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~H-----k~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~  147 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRH-----KPTGKIYALKVILLNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFY  147 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEE-----cCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEE
Confidence            456777999999999999999999999     66777899999977777888899999999999998 999999999999


Q ss_pred             cCCC-eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC---------------
Q psy15820         94 EKEP-FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG---------------  156 (230)
Q Consensus        94 ~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~---------------  156 (230)
                      .++. ++++||||.+|+|..++...             +.+++..+..++.+|++||.|||. .+               
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~-------------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs  214 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRV-------------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS  214 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc
Confidence            9985 99999999999999998863             358999999999999999999997 44               


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     |
T Consensus       215 kGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I  294 (364)
T KOG0581|consen  215 KGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI  294 (364)
T ss_pred             CCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence                                                                                           4


Q ss_pred             CCCccCCCCCc-CcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        158 RDGYRLEKPDH-CRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       158 ~~~~~~~~p~~-~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      ..+..+..|.. |++++++++..||++||.+|||+.++++.
T Consensus       295 v~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  295 VDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             hcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            44445556665 99999999999999999999999999863

>KOG0193|consensus

Probab=99.95  E-value=5.1e-28  Score=200.24  Aligned_cols=180  Identities=25%  Similarity=0.493  Sum_probs=154.8

Q ss_pred             CCCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCc
Q psy15820          6 LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPN   84 (230)
Q Consensus         6 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~n   84 (230)
                      ..+.+...|+|..+.+.++..||+|.||+||+|.|++.        ||||.++.. ..++..+.|.+|+.++++.+ |.|
T Consensus       379 ~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~N  449 (678)
T KOG0193|consen  379 QASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HEN  449 (678)
T ss_pred             cCCccccccccCHHHhhccceeccccccceeecccccc--------eEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhh
Confidence            34456688999999999999999999999999999873        999999744 45678899999999999999 999


Q ss_pred             eeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------
Q psy15820         85 VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------  156 (230)
Q Consensus        85 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------  156 (230)
                      |+-+.|++..++. .+|+.||+|.+|+.+++..+            ..+...+++.|+.|||+||.|||.++        
T Consensus       450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e------------tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKS  516 (678)
T KOG0193|consen  450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE------------TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKS  516 (678)
T ss_pred             heeeehhhcCCce-eeeehhccCchhhhhccchh------------hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccc
Confidence            9999999987665 99999999999999998753            35888999999999999999999999        


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       517 nNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~  596 (678)
T KOG0193|consen  517 NNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ  596 (678)
T ss_pred             cceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence                                                                                            


Q ss_pred             --------CCCCccC----CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 --------VRDGYRL----EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 --------i~~~~~~----~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                              +-.|...    ..-.+|+.++.+|+..||.+++++||+|.+|+..|..+..+.+.
T Consensus       597 ~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  597 NRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             ChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence                    2223211    23358999999999999999999999999999998888876433

>KOG0575|consensus

Probab=99.95  E-value=1.2e-27  Score=198.15  Aligned_cols=159  Identities=24%  Similarity=0.464  Sum_probs=140.4

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .+|+.+++||+|+|+.+|.+..     ..++..||+|++...  .....+++..+|+++.+.++ |||||+++++|.+.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~-----~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARD-----LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEE-----cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCC
Confidence            7799999999999999999999     455667999999643  45667889999999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ++|+|+|+|++++|..+++..             ..+++.+++.+++||+.||.|||+++                    
T Consensus        92 nVYivLELC~~~sL~el~Krr-------------k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VK  158 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR-------------KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVK  158 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc-------------CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEE
Confidence            999999999999999999853             35999999999999999999999999                    


Q ss_pred             -----------------------------------------------------------------------CCCCccCCC
Q psy15820        157 -----------------------------------------------------------------------VRDGYRLEK  165 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~~~~~~  165 (230)
                                                                                             |.. -....
T Consensus       159 IgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-~~Y~~  237 (592)
T KOG0575|consen  159 IGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-NEYSM  237 (592)
T ss_pred             ecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-cCccc
Confidence                                                                                   110 12345


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      |...+.+..+||..+|+.||.+|||+.+|+..
T Consensus       238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            77899999999999999999999999999963

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=4.5e-27  Score=192.23  Aligned_cols=192  Identities=41%  Similarity=0.755  Sum_probs=150.0

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|.++.++|++++.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+..||||+++++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            37899999999999999999999999876544445566799999975555556678999999999994499999999988


Q ss_pred             ecC-CCeEEEEecCCCCCHHHHHHHhhhhhhc------------------------------------------------
Q psy15820         93 TEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYY------------------------------------------------  123 (230)
Q Consensus        93 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------------------------  123 (230)
                      ... +.++++|||+++|+|.+++...+.....                                                
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            754 4689999999999999999864210000                                                


Q ss_pred             -cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------------------------
Q psy15820        124 -NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------------------------  156 (230)
Q Consensus       124 -~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------------------------  156 (230)
                       .........+++..+..++.||+.||.|||+++                                              
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence             000001234778889999999999999999998                                              


Q ss_pred             -------------------------------------------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCC
Q psy15820        157 -------------------------------------------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNE  187 (230)
Q Consensus       157 -------------------------------------------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~  187 (230)
                                                                       +..+.....|..+++++.+++.+||+.||++
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence                                                             1111222335577889999999999999999


Q ss_pred             CCCHHHHHHHHHHHHhh
Q psy15820        188 RPNFTELCDLLEKLLLN  204 (230)
Q Consensus       188 Rpt~~~i~~~l~~~~~~  204 (230)
                      |||+.+|++.|+.++..
T Consensus       321 RPs~~el~~~l~~~~~~  337 (338)
T cd05102         321 RPTFSALVEILGDLLQE  337 (338)
T ss_pred             CcCHHHHHHHHHHHHhc
Confidence            99999999999987753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=8.5e-27  Score=183.87  Aligned_cols=164  Identities=36%  Similarity=0.770  Sum_probs=137.4

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      .+.+.||.|+||.||+|.+.. ........|++|.++........+.+.+|+..+..++ |+||++++|++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccc-cccccccccccccccccccc
Confidence            567899999999999999974 2245566799999976666666889999999999997 99999999999988889999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------------
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------------  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------------  156 (230)
                      +||+++|+|.+++....           ...+++..+..++.||+.||.|||+++                         
T Consensus        80 ~e~~~~g~L~~~L~~~~-----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKN-----------KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             EE--TTEBHHHHHHHTC-----------TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccccccc-----------cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999851           235899999999999999999999998                         


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           +..+.+...|.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  228 (259)
T PF07714_consen  149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPD  228 (259)
T ss_dssp             TGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceecc
Confidence                                                                                 44455667788


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      .++..+.+++..||+.||++|||+.+|++.|
T Consensus       229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            8999999999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=1.6e-26  Score=192.65  Aligned_cols=193  Identities=44%  Similarity=0.809  Sum_probs=154.0

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      +..|+++.++|.+++.||+|+||.||+|.+...........||+|+++........+.+.+|+.++..+..||||+++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            35799999999999999999999999999865543445567999999765556666789999999999966999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccc---------------------------------------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN---------------------------------------------  125 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~---------------------------------------------  125 (230)
                      ++...+..+++||||++|+|.+++...........                                             
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            99999999999999999999999876431100000                                             


Q ss_pred             --------------------------------------cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820        126 --------------------------------------MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus       126 --------------------------------------~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                                                            .......+++..++.++.|++.||.|||+.+           
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                  0001134788889999999999999999988           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence                                                                                            


Q ss_pred             ----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        157 ----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       157 ----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                          +..+.+...+..++.++.+++.+||+.||++|||+.+|.+.|..++.
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                11112334456788899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=1.8e-26  Score=182.56  Aligned_cols=171  Identities=34%  Similarity=0.618  Sum_probs=145.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |+..+|++.+.||+|+||.||+|.+....  ..+..+|+|.++..........+.+|+.++..+. ||||+++++++...
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   78 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPS--KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRG   78 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCC--CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecC
Confidence            67788999999999999999999875322  3455799999986655566678999999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..+++|||+++|+|.+++...            ...+++..++.++.|++.||.|||+++                   
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~------------~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~  146 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKH------------EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC  146 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcE
Confidence            9999999999999999998763            224789999999999999999999998                   


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                +..+.+
T Consensus       147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~  226 (266)
T cd05064         147 KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR  226 (266)
T ss_pred             EECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC
Confidence                                                                                      122334


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      .+.|..++..+.+++.+||+.+|++|||+.+|++.|..+
T Consensus       227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            456678899999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=2e-26  Score=192.10  Aligned_cols=114  Identities=39%  Similarity=0.722  Sum_probs=94.7

Q ss_pred             CCcCCCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC
Q psy15820          3 DPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH   82 (230)
Q Consensus         3 ~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h   82 (230)
                      ||-+.. ....|+++.++|.+++.||+|+||.||+|.+.+.........||+|+++..........+.+|+.++..+.+|
T Consensus        22 ~~~~~~-~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H  100 (401)
T cd05107          22 DPMQLP-YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH  100 (401)
T ss_pred             CCCCCC-CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCC
Confidence            344332 3445999999999999999999999999998754434556679999997654455556789999999999669


Q ss_pred             CceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHh
Q psy15820         83 PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS  117 (230)
Q Consensus        83 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  117 (230)
                      +||+++++++...+..++++||+++|+|.+++...
T Consensus       101 ~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~  135 (401)
T cd05107         101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRN  135 (401)
T ss_pred             CCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhc
Confidence            99999999999988999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=9.9e-27  Score=192.80  Aligned_cols=189  Identities=41%  Similarity=0.735  Sum_probs=147.8

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|.++.++|++++.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+..||||+++++++
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            47788889999999999999999999875443344566799999975544555678899999999994499999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhc-------------------------------------------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY-------------------------------------------------  123 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------------------------------------------------  123 (230)
                      ...+..+++||||++|+|.+++.........                                                 
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            9999999999999999999999763210000                                                 


Q ss_pred             -------------cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------------
Q psy15820        124 -------------NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------------  156 (230)
Q Consensus       124 -------------~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------------  156 (230)
                                   .........+++..+..++.||+.||.|||+++                                  
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                         000001124778889999999999999999998                                  


Q ss_pred             -------------------------------------------------------------CCCCccCCCCCcCcHHHHH
Q psy15820        157 -------------------------------------------------------------VRDGYRLEKPDHCRRELYN  175 (230)
Q Consensus       157 -------------------------------------------------------------i~~~~~~~~p~~~~~~~~~  175 (230)
                                                                                   +..+.+...|..++.++.+
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  348 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD  348 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence                                                                         1111222334567789999


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        176 IMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       176 li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      ++.+||+.||++|||+.+|++.|++.
T Consensus       349 li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         349 IMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHhh
Confidence            99999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=9.4e-26  Score=186.86  Aligned_cols=194  Identities=39%  Similarity=0.701  Sum_probs=152.0

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .....|.++.++|++++.||+|+||.||+|.+.......+...||+|.++..........+.+|+.++..+..|+||+++
T Consensus        28 ~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          28 PYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             cccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeE
Confidence            34567888999999999999999999999988655444555679999997655555667889999999999449999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhh-----------------------------------------------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR-----------------------------------------------  121 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------------------------------------  121 (230)
                      ++++...+..+++||||++|+|.+++.......                                               
T Consensus       108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            999999999999999999999999987532100                                               


Q ss_pred             ----------hccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------------------------
Q psy15820        122 ----------YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------------------------  156 (230)
Q Consensus       122 ----------~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------------------------  156 (230)
                                ...........+++..++.++.||+.||.|||+++                                   
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                      00000011234778889999999999999999998                                   


Q ss_pred             ---------------------------------------CC-CC--------------------ccCCCCCcCcHHHHHH
Q psy15820        157 ---------------------------------------VR-DG--------------------YRLEKPDHCRRELYNI  176 (230)
Q Consensus       157 ---------------------------------------i~-~~--------------------~~~~~p~~~~~~~~~l  176 (230)
                                                             +. .|                    .....|..+++++.++
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  347 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI  347 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence                                                   00 01                    1222334567899999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        177 MYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       177 i~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                      +.+||+.||++|||+.++++.|+.++
T Consensus       348 i~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         348 MKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            99999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0615|consensus

Probab=99.94  E-value=4.2e-26  Score=181.45  Aligned_cols=123  Identities=23%  Similarity=0.355  Sum_probs=105.4

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHH------HHHHHHHHHHHHhhcCCCCceeeE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER------ERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      +...+.|.+.+.||+|+||.|.+|..     +.++..||+|+++......      ......+|+++|.++. |||||++
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e-----~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~  241 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYE-----KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRI  241 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEE-----cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEE
Confidence            44667788899999999999999998     6677789999996542221      2234579999999999 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++......|+||||++||+|.+++-.+.             .+.+..-..+++|++.|+.|||++|
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-------------~l~ed~~K~~f~Qll~avkYLH~~G  296 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANK-------------YLREDLGKLLFKQLLTAVKYLHSQG  296 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhcc-------------ccccchhHHHHHHHHHHHHHHHHcC
Confidence            999999999999999999999999998743             4677777889999999999999999

>KOG0661|consensus

Probab=99.94  E-value=1.7e-27  Score=192.24  Aligned_cols=124  Identities=23%  Similarity=0.505  Sum_probs=107.7

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+..++|.+.++||.|.||.||+|+.     +.++..||||.++...-..+...-++|+..|.++..|||||++.+++.+
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~-----~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKS-----KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeee-----cCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            35667899999999999999999998     5666679999997553333445567899999999889999999999998


Q ss_pred             CC-CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KE-PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++ .+++|||||+. +|+++++.+            ...+++..+..|+.||++||+|+|.+|
T Consensus        81 ~~~~L~fVfE~Md~-NLYqLmK~R------------~r~fse~~irnim~QilqGL~hiHk~G  130 (538)
T KOG0661|consen   81 NDRILYFVFEFMDC-NLYQLMKDR------------NRLFSESDIRNIMYQILQGLAHIHKHG  130 (538)
T ss_pred             cCceEeeeHHhhhh-hHHHHHhhc------------CCcCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            88 89999999975 999999984            346999999999999999999999999

>KOG1094|consensus

Probab=99.94  E-value=3.9e-26  Score=188.55  Aligned_cols=170  Identities=38%  Similarity=0.733  Sum_probs=147.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      -+++++.+.++++||+|.||.|.+|...+      +..||+|.++.......+..|.+|+.+|.+++ ||||+.++|+|.
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~  605 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG------PLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCV  605 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecC------ceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeee
Confidence            37789999999999999999999998843      45699999998777888899999999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+.+++++||+++|+|.+|+..+...          . ......+.|+.||+.||+||.+.+                 
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheap----------t-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~  674 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELP----------T-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF  674 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCc----------c-cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc
Confidence            999999999999999999999986421          1 344566779999999999999988                 


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       675 ~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~  754 (807)
T KOG1094|consen  675 TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG  754 (807)
T ss_pred             cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence                                                                                            


Q ss_pred             --CCC---CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        157 --VRD---GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       157 --i~~---~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                        ..+   ...+..|..||.++.+++.+||..|.++||+|.++...|++.
T Consensus       755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence              111   123567889999999999999999999999999999888764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.94  E-value=6.7e-25  Score=176.87  Aligned_cols=140  Identities=35%  Similarity=0.627  Sum_probs=109.7

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCC-----------CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCc
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDG-----------REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN   84 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~n   84 (230)
                      ++..+|.+.+.||+|+||.||+|.+.....           ...+..||+|.+...........+.+|+.++..+. |+|
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCC
Confidence            567789999999999999999998743221           22345699999876555556678999999999998 999


Q ss_pred             eeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccc------cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         85 VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN------MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        85 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+++++++...+..+++|||+++|+|.+++...........      .......+++..+..++.||+.||.|||+.+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999998999999999999999999876321100000      0111234678889999999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0595|consensus

Probab=99.94  E-value=8.4e-26  Score=179.55  Aligned_cols=130  Identities=28%  Similarity=0.497  Sum_probs=117.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..+|.+.+.||+|+||.||+|.+     +.++..||||.+... ......+-+..|+.+|+.+. |+|||.+++++...+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h-----~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRH-----KKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEe-----ccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCC
Confidence            46788888999999999999999     445567999999644 36677788999999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      .+|||||||.||+|..+++...             .+++.....++.||+.||++||+++|.  ||+.+|+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~-------------~l~e~t~r~Fm~QLA~alq~L~~~~Ii--HRDLKPQN  139 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG-------------RLPEATARHFMQQLASALQFLHENNII--HRDLKPQN  139 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCee--eccCCcce
Confidence            9999999999999999999853             589999999999999999999999999  99998875

>KOG0199|consensus

Probab=99.94  E-value=5.1e-26  Score=191.24  Aligned_cols=174  Identities=33%  Similarity=0.618  Sum_probs=152.5

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      .+...-|..+.+++.+.||+|.||.|++|.|....  .+...||||+++..........|++|+.++.+++ |+|++++|
T Consensus       101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLy  177 (1039)
T KOG0199|consen  101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLY  177 (1039)
T ss_pred             CCcceeccHHHHHHHHHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEe
Confidence            45556789999999999999999999999997633  3344699999986655557789999999999999 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      |+..+ ..+.+|+|+++.|+|.+.++..           ....+....+..|+.|||.||.||.+++             
T Consensus       178 GvVl~-qp~mMV~ELaplGSLldrLrka-----------~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll  245 (1039)
T KOG0199|consen  178 GVVLD-QPAMMVFELAPLGSLLDRLRKA-----------KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL  245 (1039)
T ss_pred             eeecc-chhhHHhhhcccchHHHHHhhc-----------cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee
Confidence            99987 6688999999999999999872           1334778899999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       246 asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL  325 (1039)
T KOG0199|consen  246 ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL  325 (1039)
T ss_pred             cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH
Confidence                                                                                            


Q ss_pred             --CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        157 --VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       157 --i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                        |..+.+.+.|+.|+..+++++..||..+|++||||.+|.+.+
T Consensus       326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence              788899999999999999999999999999999999998543

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.94  E-value=1.2e-24  Score=174.42  Aligned_cols=192  Identities=44%  Similarity=0.876  Sum_probs=152.9

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      +..|.+..++|++.+.||+|+||.||++.............+++|.+...........+.+|+.++..+..|+||+++++
T Consensus         4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            45688999999999999999999999999876543445567999998755455556678999999999944999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccc---cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      .+...+..+++|||+++|+|..++...........   .......+++..++.++.|++.||.|||+.+           
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            99998999999999999999999976421110000   0112345889999999999999999999987           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence                                                                                            


Q ss_pred             ---CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        157 ---VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       157 ---i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                         +..+.....|..++.++.+|+.+||..||++|||+.++++.|+.++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               1112223445567889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=4.5e-25  Score=180.86  Aligned_cols=192  Identities=42%  Similarity=0.723  Sum_probs=148.2

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|..+.++|++.+.||+|+||.||+|.+.+.....++..||+|.++..........+.+|+.++..+.+|+||+++++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (343)
T cd05103           1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   80 (343)
T ss_pred             CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence            37888999999999999999999999987655556677899999976544555667889999999996589999999987


Q ss_pred             ec-CCCeEEEEecCCCCCHHHHHHHhhhhhhc-c----------------------------------------------
Q psy15820         93 TE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYY-N----------------------------------------------  124 (230)
Q Consensus        93 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~----------------------------------------------  124 (230)
                      .. ...++++||||++|+|.+++......... .                                              
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (343)
T cd05103          81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD  160 (343)
T ss_pred             ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence            64 45689999999999999999763210000 0                                              


Q ss_pred             -------ccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC----------------------------------------
Q psy15820        125 -------NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV----------------------------------------  157 (230)
Q Consensus       125 -------~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i----------------------------------------  157 (230)
                             ........+++..+..++.|++.||.|||++++                                        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                   000001236788889999999999999999980                                        


Q ss_pred             -------------------------------------------------------CCCccCCCCCcCcHHHHHHHHHhcC
Q psy15820        158 -------------------------------------------------------RDGYRLEKPDHCRRELYNIMYYCWD  182 (230)
Q Consensus       158 -------------------------------------------------------~~~~~~~~p~~~~~~~~~li~~cl~  182 (230)
                                                                             ..+.+...|..+++++.+++..||+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence                                                                   0111122233456789999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHHHhh
Q psy15820        183 KEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       183 ~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      .||++|||+.+|++.|+.+++.
T Consensus       321 ~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         321 GEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0200|consensus

Probab=99.93  E-value=8.5e-25  Score=190.50  Aligned_cols=202  Identities=44%  Similarity=0.811  Sum_probs=169.6

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCC--CceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGRE--GPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      .|+++.+++++.+.||+|.||.|++|...+.....  ....||||.++........+.+..|+.++..+..|+||+.+.|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            79999999999999999999999999987655332  2557999999877666788899999999999988999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhh-hhccccCCCC--CCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ-RYYNNMHGKS--NSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      ++...+..+++.||+..|+|.++++..+.. ..........  ..++..+++.++.|||.||.||+++.           
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence            999999999999999999999999997611 1111000111  23899999999999999999999998           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence                                                                                            


Q ss_pred             -----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCC
Q psy15820        157 -----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFP  215 (230)
Q Consensus       157 -----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~  215 (230)
                           +..|.|..+|.+|++++++++..||+.+|++||+|.++.+.|...+.. ..+.+...+.
T Consensus       530 ~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~-~~~~~~~~~~  592 (609)
T KOG0200|consen  530 ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD-ELYLDVEAFE  592 (609)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH-hhhhhhhccc
Confidence                 678899999999999999999999999999999999999999997654 4444444433

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=1.5e-24  Score=171.54  Aligned_cols=171  Identities=36%  Similarity=0.696  Sum_probs=143.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |..++|++.+.||+|+||.||+|.+....  .+...+++|.++..........+.+|+.++..+. |+||+++++.+...
T Consensus         1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   77 (266)
T cd05033           1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKS   77 (266)
T ss_pred             CChHHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecC
Confidence            35678999999999999999999885431  2344699999876555666778999999999998 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..++++||+++++|.+++...            ...+++..+..++.|++.||.|||+.+                   
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~  145 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLREN------------DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVC  145 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCE
Confidence            9999999999999999998763            224789999999999999999999988                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~  225 (266)
T cd05033         146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY  225 (266)
T ss_pred             EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence                                                                                       11122


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      +.+.+..+++.+.+++.+||+.+|++||++.++++.|+.+
T Consensus       226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            3344567889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.93  E-value=3.6e-24  Score=172.88  Aligned_cols=196  Identities=42%  Similarity=0.805  Sum_probs=154.4

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      ..+.|.+..++|.+++.||+|+||.||.+.+.+...  ......+|+|.++..........+.+|+.++..+.+|+||++
T Consensus         9 ~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (307)
T cd05098           9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN   88 (307)
T ss_pred             CCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEee
Confidence            355689999999999999999999999998754331  123346999998755445556678899999999944999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhh---hccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR---YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------  156 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------  156 (230)
                      +++.+...+..++++||+++|+|.+++......+   .++........+++..++.++.|++.||.|||+.+        
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence            9999999999999999999999999998743211   00000111234788899999999999999999988        


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence                                                                                            


Q ss_pred             ------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 ------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 ------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                            +..+.+...|..++.++.+++.+||..+|.+|||+.++++.|..++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         249 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                  1122233455678889999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.93  E-value=1.1e-24  Score=173.58  Aligned_cols=184  Identities=35%  Similarity=0.638  Sum_probs=147.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||+|.............+++|.++..........+.+|+.++..+. |+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCC
Confidence            45678999999999999999999987654445556799999976555666678999999999998 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccc---cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...++++||+++++|.+++...........   .......+++..+..++.|++.||.|||+++                
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            899999999999999999986421100000   0011245788899999999999999999998                


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence                                                                                          12


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      .+.....|..+++++.+|+.+||+.||.+|||+.+|++.|..
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            223344566789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=3.4e-24  Score=171.51  Aligned_cols=185  Identities=37%  Similarity=0.652  Sum_probs=145.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |++..++|++.+.||+|+||.||+|..........+..+|+|.++..........+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence            7889999999999999999999999876433334455799999875544555567889999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..+++|||+++|+|.+++........   ........+...+..++.|++.||.|||+++                 
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAE---NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC
Confidence            88999999999999999999976321100   0001223466788899999999999999988                 


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence                                                                                         011


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                      +.....+..+++.+.+++.+||+.||++|||+.++++.|....
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1122334567889999999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.93  E-value=4.1e-24  Score=171.02  Aligned_cols=192  Identities=31%  Similarity=0.622  Sum_probs=150.8

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .|+.++|.+.+.||+|+||.||++.........+...+++|.+... .......+.+|+.++..+. |+||+++++++..
T Consensus         1 ~~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   78 (288)
T cd05093           1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVE   78 (288)
T ss_pred             CCchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            3678899999999999999999998644322344556899988643 3445567999999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+..++++||+++++|.+++..................+++..+..++.|++.||.|||+++                  
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            99999999999999999999764211000000112234899999999999999999999999                  


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        1111


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      .....+..++.++.+++.+||+.||.+|||+.++++.|+.+......|
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~  286 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY  286 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence            223344568889999999999999999999999999999998776554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.93  E-value=1.7e-24  Score=170.92  Aligned_cols=169  Identities=36%  Similarity=0.752  Sum_probs=142.7

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |++...+|.+.+.||+|+||.||+|.+.     ..+..+++|.+...  ......+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   72 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT   72 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEe-----cCCceEEEEEecCC--chHHHHHHHHHHHHHhCC-CCChhheEEEEc
Confidence            6788899999999999999999999984     34455999988643  333467889999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..++++||+++++|.+++....           ...+++..+..++.|++.||.|||+++                 
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~  141 (263)
T cd05052          73 REPPFYIITEFMTYGNLLDYLRECN-----------RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH  141 (263)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC
Confidence            8899999999999999999987632           234788899999999999999999998                 


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       142 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  221 (263)
T cd05052         142 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG  221 (263)
T ss_pred             cEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence                                                                                        1112


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      .+...|..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            23345567889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.93  E-value=3.9e-24  Score=172.40  Aligned_cols=202  Identities=35%  Similarity=0.640  Sum_probs=157.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||+|.+...   .....+++|.++..........+.+|+.++..+.+|+||+++++++...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccC---CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            6678999999999999999999988431   1122467887765444556677889999999994499999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      +..++++||+++++|.+++........   ..........+++..++.++.|++.|++|||+++                
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            999999999999999999986431100   0000111235789999999999999999999998                


Q ss_pred             -------------------------------------------------------CCC-Cc-------------------
Q psy15820        157 -------------------------------------------------------VRD-GY-------------------  161 (230)
Q Consensus       157 -------------------------------------------------------i~~-~~-------------------  161 (230)
                                                                             +.. |.                   
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence                                                                   110 11                   


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCCCccee
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYY  220 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~  220 (230)
                      +...+..+++++.+++.+||+.+|+.||++.+++..+..++.....+.+...+....|.
T Consensus       241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~~~~~~~~~  299 (303)
T cd05088         241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA  299 (303)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhhhhccCccC
Confidence            12233457788999999999999999999999999999999999999998887766664

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.93  E-value=3.7e-24  Score=172.47  Aligned_cols=179  Identities=44%  Similarity=0.768  Sum_probs=146.6

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..|.+..++|.+.+.||+|+||.||++.+.......+...+|+|.++..........+.+|+.++..+..|+||+++++.
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            45788889999999999999999999987544334456679999987554555667899999999999449999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +...+..++++||+++|+|.+++....           ...+++..+..++.|++.||.|||+++               
T Consensus       108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~  176 (302)
T cd05055         108 CTIGGPILVITEYCCYGDLLNFLRRKR-----------ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH  176 (302)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC
Confidence            999999999999999999999987632           223789999999999999999999998               


Q ss_pred             -----------------------------------------------------------CC-CCc---------------
Q psy15820        157 -----------------------------------------------------------VR-DGY---------------  161 (230)
Q Consensus       157 -----------------------------------------------------------i~-~~~---------------  161 (230)
                                                                                 +. .|.               
T Consensus       177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~  256 (302)
T cd05055         177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL  256 (302)
T ss_pred             CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence                                                                       01 111               


Q ss_pred             -----cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        162 -----RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       162 -----~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                           +...+...+.++.+++.+||..+|++|||+.++++.|.++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 1122335678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=1.7e-24  Score=177.00  Aligned_cols=192  Identities=42%  Similarity=0.714  Sum_probs=147.8

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|.++.++|++.+.||+|+||.||+|...+.....+++.||+|+++..........+.+|+.++..+..|+||+++++++
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            38889999999999999999999999876655455667899999875544555567889999999994499999999988


Q ss_pred             ec-CCCeEEEEecCCCCCHHHHHHHhhhhhhc-cc---------------------------------------------
Q psy15820         93 TE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYY-NN---------------------------------------------  125 (230)
Q Consensus        93 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~---------------------------------------------  125 (230)
                      .. ...+++++||+++++|.+++......... ..                                             
T Consensus        81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence            65 45689999999999999998753211000 00                                             


Q ss_pred             --cCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC----------------------------------------------
Q psy15820        126 --MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV----------------------------------------------  157 (230)
Q Consensus       126 --~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i----------------------------------------------  157 (230)
                        .......+++..+..++.||+.||.|||++++                                              
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence              00001257889999999999999999999980                                              


Q ss_pred             ----------------------------C-CCc--------------------cCCCCCcCcHHHHHHHHHhcCCCCCCC
Q psy15820        158 ----------------------------R-DGY--------------------RLEKPDHCRRELYNIMYYCWDKEPNER  188 (230)
Q Consensus       158 ----------------------------~-~~~--------------------~~~~p~~~~~~~~~li~~cl~~dp~~R  188 (230)
                                                  . .|.                    +...|..+++++.+++.+||+.+|++|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence                                        0 011                    111233456788999999999999999


Q ss_pred             CCHHHHHHHHHHHHhh
Q psy15820        189 PNFTELCDLLEKLLLN  204 (230)
Q Consensus       189 pt~~~i~~~l~~~~~~  204 (230)
                      ||+.+|++.|+.++..
T Consensus       321 Ps~~ell~~l~~~~~~  336 (337)
T cd05054         321 PTFSELVEILGDLLQE  336 (337)
T ss_pred             cCHHHHHHHHHHHHhc
Confidence            9999999999988763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=5.1e-24  Score=168.56  Aligned_cols=171  Identities=36%  Similarity=0.671  Sum_probs=141.7

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |...+|++.+.||+|+||.||+|......  .....+++|.++..........+.+|+.++..+. ||||+++++++...
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   77 (267)
T cd05066           1 IDASCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKS   77 (267)
T ss_pred             CCHHHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence            34578899999999999999999874322  2233589999875555566678999999999998 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..+++|||+++++|.+++...            ...+++..+..++.|++.||.|||+++                   
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  145 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKH------------DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC  145 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeE
Confidence            9999999999999999998763            234788999999999999999999998                   


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~  225 (267)
T cd05066         146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG  225 (267)
T ss_pred             EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC
Confidence                                                                                        1122


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      .+.+.+..+++.+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            23344556788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=6.2e-24  Score=168.78  Aligned_cols=182  Identities=36%  Similarity=0.662  Sum_probs=146.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |++..++|++.+.||+|+||.||+|.............+++|.+...........+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEc
Confidence            6789999999999999999999999986544334556799999875544555667889999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      .....++++||+++++|.+++........   .......+++..+..++.|++.||.|||+.+                 
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAE---NNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchh---hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC
Confidence            99999999999999999999976421100   0001234678889999999999999999988                 


Q ss_pred             ---------------------------------------------------------C--------------------CC
Q psy15820        157 ---------------------------------------------------------V--------------------RD  159 (230)
Q Consensus       157 ---------------------------------------------------------i--------------------~~  159 (230)
                                                                               +                    ..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence                                                                     1                    11


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      +.....|..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1123456678899999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.93  E-value=6e-24  Score=169.04  Aligned_cols=182  Identities=36%  Similarity=0.643  Sum_probs=144.5

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |.+..++|++.+.||+|+||.||.|.+.+......+..+|+|.+...........+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence            6778899999999999999999999886544344566799999865444455667899999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..++++||+++++|.+++...+....   .......+++..+..++.|++.||.|||+.+                 
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~  156 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEME---NNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  156 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCcccc---ccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC
Confidence            88999999999999999999876321100   0001223577888999999999999999988                 


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence                                                                                         011


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      +.....+..+++.+.+++.+||+.||++|||+.++++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1122345567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.93  E-value=7.2e-24  Score=170.84  Aligned_cols=196  Identities=41%  Similarity=0.775  Sum_probs=153.7

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccC--CCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGID--GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ...|.+...+|.+++.||+|+||.||.+.+....  ....+..+++|.+...........+.+|+.++..+.+|+||+++
T Consensus         7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhe
Confidence            3458899999999999999999999999875432  12334568999887544455567899999999999449999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhc---cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------  156 (230)
                      ++++......+++|||+++++|.+++...+.....   .........+++..+..++.|++.||.|||+++         
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence            99999999999999999999999999874321100   000011234788889999999999999999998         


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence                                                                                            


Q ss_pred             -----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 -----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 -----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                           +..+.+...+..++.++.+++.+||+.+|.+|||+.++++.|..+.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence                 12223334556788899999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.93  E-value=6.5e-24  Score=170.61  Aligned_cols=200  Identities=38%  Similarity=0.692  Sum_probs=156.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +++|++.+.||+|+||.||+|......   ....+++|.++..........+.+|+.++.++..||||+++++++...+.
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDG---LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCC---CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            468999999999999999999874321   11236888877444455566789999999999449999999999998899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhc---cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .++++||+++++|.+++.........   .........+++..++.++.|++.||.|||+.+                  
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            99999999999999999764311000   000011234788999999999999999999988                  


Q ss_pred             -----------------------------------------------------CC-CC-------------------ccC
Q psy15820        157 -----------------------------------------------------VR-DG-------------------YRL  163 (230)
Q Consensus       157 -----------------------------------------------------i~-~~-------------------~~~  163 (230)
                                                                           +. .|                   ...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~  237 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM  237 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence                                                                 11 01                   122


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCCCccee
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYY  220 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~  220 (230)
                      ..|..++.++.+++.+||+.+|.+|||+.++++.|..+.+....+.....|..+.|.
T Consensus       238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~  294 (297)
T cd05089         238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFENFTYA  294 (297)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccccchhhhhhccc
Confidence            344568899999999999999999999999999999999999999988888777775

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.92  E-value=6.5e-24  Score=172.09  Aligned_cols=178  Identities=31%  Similarity=0.620  Sum_probs=145.7

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +...+|++.+.||+|+||.||+|.+.... ......+|+|.++..........+.+|+.++..+. |+||+++++++.. 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~-   80 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT-   80 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCC-CccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcC-
Confidence            56788999999999999999999985432 22334589999875555666678999999999998 9999999999876 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..++++||+++|+|.+++....            ..+++..+..++.||+.||.|||+++                   
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHK------------DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcE
Confidence            45789999999999999988632            24788899999999999999999998                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  228 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC
Confidence                                                                                       11122


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      +.+.|..++.++.+++.+||..+|+.|||+.+++..+..+......+
T Consensus       229 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~  275 (316)
T cd05108         229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY  275 (316)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence            33445667889999999999999999999999999999887665443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1025|consensus

Probab=99.92  E-value=1.9e-25  Score=190.62  Aligned_cols=181  Identities=32%  Similarity=0.660  Sum_probs=161.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ....++..++||+|+||+||+|.|... .+.-...||+|++...........++.|+-++..+. |||++++++++....
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~  771 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST  771 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch
Confidence            445556678999999999999999766 355556799999987767777788999999999999 999999999997644


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                       +.||++|++.|+|.++++.++            ..+.....+.|+.|||+||.|||.++                    
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr------------~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvk  838 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHR------------DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVK  838 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhh------------ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEE
Confidence             889999999999999999865            34888999999999999999999998                    


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                +..|.|
T Consensus       839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR  918 (1177)
T KOG1025|consen  839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER  918 (1177)
T ss_pred             EEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence                                                                                      788899


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccccccc
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE  212 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~  212 (230)
                      ...|+.|+.+++.++.+||..|+..||+|+++...+..+....+.|+.+.
T Consensus       919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~  968 (1177)
T KOG1025|consen  919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ  968 (1177)
T ss_pred             CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence            99999999999999999999999999999999999999999888888776

>KOG1989|consensus

Probab=99.92  E-value=2.8e-24  Score=184.82  Aligned_cols=186  Identities=20%  Similarity=0.298  Sum_probs=153.9

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .....+.|...++++.+.|.+|+|+.||+++..+.     +..+|+|++-.. +........+|+++++.+.+|+|||.+
T Consensus        27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~-----~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~y  100 (738)
T KOG1989|consen   27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKG-----GKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSY  100 (738)
T ss_pred             CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCC-----CceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence            34556789999999999999999999999999543     255999998654 677788999999999999999999999


Q ss_pred             eeEE-ec---C---CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----
Q psy15820         89 LGCC-TE---K---EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----  156 (230)
Q Consensus        89 ~~~~-~~---~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----  156 (230)
                      ++.. ..   .   -.++|+||||.||.|-+++..+.           ...+++.++++|+.|+|+|+.+||...     
T Consensus       101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl-----------q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIH  169 (738)
T KOG1989|consen  101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL-----------QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIH  169 (738)
T ss_pred             eccccccccCCCceeEEEeehhhccCCcHHHHHHHHH-----------hccCChHHHHHHHHHHHHHHHHHhcCCCccch
Confidence            9932 21   1   23799999999999999999864           345999999999999999999999998     


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       170 RDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY  249 (738)
T KOG1989|consen  170 RDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY  249 (738)
T ss_pred             hhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence                                                                                            


Q ss_pred             ----------------CCCCccC-CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccc
Q psy15820        157 ----------------VRDGYRL-EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIEL  211 (230)
Q Consensus       157 ----------------i~~~~~~-~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~  211 (230)
                                      |.+|..- +..+..++.+.+||..||+.||++||++-+++..+..+....+...+.
T Consensus       250 kLCy~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~  321 (738)
T KOG1989|consen  250 KLCYFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI  321 (738)
T ss_pred             HHHHhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence                            3333333 333689999999999999999999999999999888887766554443

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=1.5e-23  Score=167.86  Aligned_cols=184  Identities=42%  Similarity=0.814  Sum_probs=145.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      +|++.+.||+|+||.||+|.............+++|.+...........+.+|+.++..+. ||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCCcE
Confidence            4778899999999999999886544444456789998875555556678999999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhcc-----------ccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYN-----------NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      +++||+++++|.+++...+......           ........+++..++.++.|++.||.|||+.+            
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999987642110000           00011235788999999999999999999998            


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence                                                                                            


Q ss_pred             --CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 --VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 --i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                        +..+.+.+.|..++.++.+++.+||+.+|++||++.++++.|++++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence              011122334566788999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.92  E-value=5.4e-24  Score=167.37  Aligned_cols=162  Identities=32%  Similarity=0.675  Sum_probs=132.8

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ++.++|++.+.||+|+||.||++.+..      +..+|+|.+....  .....+.+|+.++..+. |+||+++++++...
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   71 (256)
T cd05114           1 INPSELTFMKELGSGQFGVVHLGKWRA------QIKVAIKAINEGA--MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQ   71 (256)
T ss_pred             CCHHHcEEeeEecCCcCceEEEEEecc------CceEEEEecccCC--ccHHHHHHHHHHHHHCC-CCCceeEEEEEccC
Confidence            355789999999999999999998742      2348999876432  22356888999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..+++|||+++|+|.+++...            ...+++..+..++.|++.||.|||+++                   
T Consensus        72 ~~~~iv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~  139 (256)
T cd05114          72 KPLYIVTEFMENGCLLNYLRQR------------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV  139 (256)
T ss_pred             CCEEEEEEcCCCCcHHHHHHhC------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeE
Confidence            9999999999999999988753            124788999999999999999999998                   


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                +..+.+
T Consensus       140 kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~  219 (256)
T cd05114         140 KVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR  219 (256)
T ss_pred             EECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC
Confidence                                                                                      111222


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      ...|...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            333455677899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.92  E-value=7.2e-24  Score=167.07  Aligned_cols=167  Identities=38%  Similarity=0.737  Sum_probs=138.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |.|..++|++.++||+|+||.||+|....      +..+++|.+...  ....+.+.+|+.++..+. |+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   71 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNN------STKVAVKTLKPG--TMSVQAFLEEANLMKTLQ-HDKLVRLYAVVT   71 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecC------CceEEEEEccCC--chhHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence            67899999999999999999999998632      234899987643  223567899999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..++++||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                 
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~  140 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDE-----------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL  140 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC
Confidence            9899999999999999999987632           234788889999999999999999998                 


Q ss_pred             --------------------------------------------------------C--------------------CCC
Q psy15820        157 --------------------------------------------------------V--------------------RDG  160 (230)
Q Consensus       157 --------------------------------------------------------i--------------------~~~  160 (230)
                                                                              +                    ..+
T Consensus       141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05072         141 MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG  220 (261)
T ss_pred             cEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence                                                                    1                    111


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      .+.+.+..++.++.+++.+||..+|++|||+.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         221 YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2223344678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.92  E-value=2.2e-23  Score=168.86  Aligned_cols=194  Identities=44%  Similarity=0.830  Sum_probs=151.6

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      +..|.+...+|.+++.||+|+||.||++...+...  ......+|+|.++..........+.+|+.++..+..|+||+++
T Consensus         4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            45588999999999999999999999998754321  1234468999987555555667789999999999559999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------  156 (230)
                      ++++...+..++++||+++|+|.+++........   ..........+++..+..++.|++.||.|||+++         
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  163 (314)
T cd05099          84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR  163 (314)
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence            9999988899999999999999999987431100   0000111235788899999999999999999998         


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence                                                                                            


Q ss_pred             -----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 -----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 -----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                           +..+.....|..++.++.+++.+||..+|++|||+.++++.|..+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                 111112234566788999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.92  E-value=1.7e-23  Score=170.84  Aligned_cols=196  Identities=41%  Similarity=0.808  Sum_probs=154.6

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCC--CCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGR--EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      .+..|++...+|++++.||+|+||.||.+.+.+....  .....+|+|.++..........+.+|+.++..+..|+||++
T Consensus         3 ~~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~   82 (334)
T cd05100           3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN   82 (334)
T ss_pred             CCcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            3467999999999999999999999999987543321  22346899988765555666789999999999944999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------  156 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------  156 (230)
                      +++++...+..++++||+++|+|.+++......+.   ..........+++..+..++.|++.||.|||+++        
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            99999998899999999999999999986431110   0000012234788889999999999999999988        


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence                                                                                            


Q ss_pred             ------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 ------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 ------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                            +..+.....|..++.++.+++.+||+.+|++|||+.+++..|..+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                  2222334455677889999999999999999999999999999888554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.92  E-value=1.1e-23  Score=168.37  Aligned_cols=183  Identities=38%  Similarity=0.688  Sum_probs=142.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ++.++|++.+.||+|+||.||++...+.....+...+++|.+...........+.+|+.++..+. |+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence            56788999999999999999999875422223456799999876555556677999999999998 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccc---------cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNN---------MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------  156 (230)
                      ...++++||+++++|.+++...........         .......+++..++.++.|++.||.|||+++          
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            899999999999999999986321100000         0011234788889999999999999999988          


Q ss_pred             ----------------------------------------------------------------C---------------
Q psy15820        157 ----------------------------------------------------------------V---------------  157 (230)
Q Consensus       157 ----------------------------------------------------------------i---------------  157 (230)
                                                                                      +               
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence                                                                            0               


Q ss_pred             -----CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        158 -----RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       158 -----~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                           ..+.....|..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                 001111224567889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0591|consensus

Probab=99.92  E-value=8.6e-26  Score=172.00  Aligned_cols=176  Identities=20%  Similarity=0.398  Sum_probs=146.8

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC-CcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ...+-.-...+|++.++||.|+||.||++..     ..++..+|.|.++ ...+...++....|+.+|+++. |||||++
T Consensus        10 ~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~-----~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqY   83 (375)
T KOG0591|consen   10 DFSPPQKTLADYQILKKIGRGSFGEVYKVQC-----LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQY   83 (375)
T ss_pred             CCCCCcccHHHHHHHHHHcCCcchheEEeee-----ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHH
Confidence            3344456778899999999999999999999     5667779999987 3356778889999999999999 9999999


Q ss_pred             eeEEe-cCC-CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------
Q psy15820         89 LGCCT-EKE-PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------  156 (230)
Q Consensus        89 ~~~~~-~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------  156 (230)
                      |++.. ..+ .++++||||.+|+|.+.++..+..         ...+++..+++++.|++.||.++|++-          
T Consensus        84 y~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~q---------kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDI  154 (375)
T KOG0591|consen   84 YAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQ---------KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDI  154 (375)
T ss_pred             HHHhhhccchhhHHHHHhhcccCHHHHHHHHHhc---------cccCchHHHHHHHHHHHHHHHHHhccccccceeeccC
Confidence            99543 333 389999999999999999876532         346899999999999999999999932          


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       155 KPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~  234 (375)
T KOG0591|consen  155 KPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL  234 (375)
T ss_pred             cchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH
Confidence                                                                                            


Q ss_pred             -----CCCCccCCCC-CcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        157 -----VRDGYRLEKP-DHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       157 -----i~~~~~~~~p-~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                           |.+|..++.| +..+.++..||..|+..||+.||+...++..+..
T Consensus       235 ~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  235 SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                 7888788778 7899999999999999999999986555554444

>KOG0582|consensus

Probab=99.92  E-value=5.7e-24  Score=170.88  Aligned_cols=133  Identities=17%  Similarity=0.376  Sum_probs=119.0

Q ss_pred             CCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820          7 NQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus         7 ~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      ...+...|.++.++|++...||.|..+.||+|...     ..+..||||++.........+.+.+|+..+..+. ||||+
T Consensus        14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~-----p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~-HPNIv   87 (516)
T KOG0582|consen   14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCI-----PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID-HPNIV   87 (516)
T ss_pred             cccccccCCCCccceeEEEEEeccceeEeeeeeec-----ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC-CCCcc
Confidence            34456678999999999999999999999999994     4445699999986666666889999999999999 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++..|.....+|+||.||.+|++.++++..-           ...+.+..+..|+++++.||.|||.+|
T Consensus        88 ~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~-----------~~Gl~E~~Ia~iLre~LkaL~YLH~~G  146 (516)
T KOG0582|consen   88 TYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY-----------PDGLEEASIATILREVLKALDYLHQNG  146 (516)
T ss_pred             eEEEEEEecceeEEeehhhcCCcHHHHHHHHc-----------cccccHHHHHHHHHHHHHHHHHHHhcC
Confidence            99999999999999999999999999999864           234899999999999999999999999

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.8e-23  Score=165.32  Aligned_cols=178  Identities=30%  Similarity=0.625  Sum_probs=146.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +...+|++.+.||+|+||.||+|.+.... ......+++|.++..........+.+|+.++..+. |+||+++++++.. 
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEG-EKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS-   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCC-CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-
Confidence            46788999999999999999999875433 22234589998876555556678999999999998 9999999999877 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      ...++++||+++|+|.+++...            ...+++..+..++.|++.||.|||+.+                   
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~  148 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH------------KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV  148 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeE
Confidence            7899999999999999998763            224889999999999999999999998                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  228 (279)
T cd05057         149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE  228 (279)
T ss_pred             EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Confidence                                                                                       11222


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      ..+.|..++.++.+++.+||..+|..|||+.++++.|..+....+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~  275 (279)
T cd05057         229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY  275 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence            33445567888999999999999999999999999999987755443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.92  E-value=2.7e-23  Score=166.48  Aligned_cols=191  Identities=30%  Similarity=0.591  Sum_probs=150.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +...+|.+.+.||+|+||.||++...+.....+...+++|.+... .......+.+|+.++..+. |+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDG   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccC
Confidence            566789999999999999999998765444455566889988643 3444567899999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      +..+++|||+++++|.+++........   ..........+++..++.++.|++.||.|||+++                
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            999999999999999999986421100   0000112234788999999999999999999999                


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence                                                                                          11


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      .+..+..+..++..+.+++.+||+.+|++|||+.++++.|..+....+.|
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~  289 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIY  289 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCcc
Confidence            12222344567889999999999999999999999999999998765544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0198|consensus

Probab=99.92  E-value=6.8e-24  Score=168.44  Aligned_cols=162  Identities=25%  Similarity=0.485  Sum_probs=137.0

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC-
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~-   96 (230)
                      ..++..++.||+|+||.||++...     .++...|+|.+....... .+.+.+|+.+|.++. |||||+++|...... 
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~-----~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNK-----KTGELMAVKSVELEDSPT-SESLEREIRILSRLN-HPNIVQYYGSSSSREN   88 (313)
T ss_pred             cchhhhhccccCccceEEEEEEec-----CCCcceeeeeeecccchh-HHHHHHHHHHHHhCC-CCCEEeeCCccccccC
Confidence            566888999999999999999994     346679999986543333 677899999999999 999999999855544 


Q ss_pred             -CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         97 -PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        97 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                       .++++|||+++|+|.+++....           . .+++..++.+.+||++||.|||++|                   
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g-----------~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~  156 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYG-----------G-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD  156 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcC-----------C-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe
Confidence             5999999999999999998852           2 5899999999999999999999999                   


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     .
T Consensus       157 ~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig  236 (313)
T KOG0198|consen  157 VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG  236 (313)
T ss_pred             EEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh
Confidence                                                                                           1


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      ..+..+..|..++++..+++.+|+..||+.|||+.++++..
T Consensus       237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            11223567788999999999999999999999999999854

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.3e-23  Score=165.19  Aligned_cols=166  Identities=35%  Similarity=0.693  Sum_probs=139.3

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |.+..++|++.+.||.|+||.||+|...       +..+++|.++....  ...++.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~-------~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   70 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYR-------GQKVAVKCLKDDST--AAQAFLAEASVMTTLR-HPNLVQLLGVVL   70 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEec-------CcEEEEEEeccchh--HHHHHHHHHHHHHhcC-CcceeeeEEEEc
Confidence            5677889999999999999999999874       33499999975432  4577899999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..++++||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                 
T Consensus        71 ~~~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~  139 (256)
T cd05039          71 QGNPLYIVTEYMAKGSLVDYLRSRG-----------RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL  139 (256)
T ss_pred             CCCCeEEEEEecCCCcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC
Confidence            8889999999999999999987632           224789999999999999999999999                 


Q ss_pred             ------------------------------------------------------------------------CCCCccCC
Q psy15820        157 ------------------------------------------------------------------------VRDGYRLE  164 (230)
Q Consensus       157 ------------------------------------------------------------------------i~~~~~~~  164 (230)
                                                                                              +..+.+..
T Consensus       140 ~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd05039         140 VAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME  219 (256)
T ss_pred             CEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence                                                                                    01111222


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      .|..+++++.+++.+||..+|++|||+.++++.|+.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            344578899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.92  E-value=3.2e-23  Score=165.36  Aligned_cols=182  Identities=30%  Similarity=0.543  Sum_probs=141.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||+|...... ...+..+++|.+...........+.+|+.++..+. |+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecC
Confidence            45688999999999999999999864332 33456799999975544555577889999999998 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhcc---c-cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYN---N-MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~---~-~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      ...+++|||+++++|.+++..........   . .......+++..+..++.|++.||.|||+++               
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            99999999999999999986532110000   0 0001234788889999999999999999999               


Q ss_pred             -----------------------------------------------------------CCC-Cc---------------
Q psy15820        157 -----------------------------------------------------------VRD-GY---------------  161 (230)
Q Consensus       157 -----------------------------------------------------------i~~-~~---------------  161 (230)
                                                                                 +.. |.               
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence                                                                       000 11               


Q ss_pred             ----cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        162 ----RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       162 ----~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                          ..+.+..+++++.+++.+||+.||++||++.+|++.|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence                12234567889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=2e-23  Score=166.78  Aligned_cols=168  Identities=18%  Similarity=0.245  Sum_probs=137.0

Q ss_pred             ccccCCCeeEe--eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         14 WEVPRQHIKVF--DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        14 ~~i~~~~~~~~--~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..|+.++++..  ..||+|++|.||+|.+.       +..||+|.++...  .......+.+|+.++..+. ||||++++
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~   84 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIFN-------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIY   84 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEEC-------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEe
Confidence            45666666665  67999999999999883       3459999996432  2233567889999999999 99999999


Q ss_pred             eEEec----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C--------
Q psy15820         90 GCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G--------  156 (230)
Q Consensus        90 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~--------  156 (230)
                      +++..    ....+++|||+++|+|.+++...             ..+++.....++.|++.||.|||+. +        
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp  151 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-------------KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS  151 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhC-------------CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCCh
Confidence            99866    45789999999999999999763             2478889999999999999999975 3        


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       152 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~  231 (283)
T PHA02988        152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY  231 (283)
T ss_pred             hhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence                                                                                            


Q ss_pred             ---CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        157 ---VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       157 ---i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                         +..+.++..|..+++++.+++.+||+.||++|||+.+++..|+++.
T Consensus       232 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        232 DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence               1223344556678999999999999999999999999999998764

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.92  E-value=3.4e-23  Score=164.06  Aligned_cols=176  Identities=36%  Similarity=0.684  Sum_probs=144.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +++..++|.+.+.||+|+||.||+|.+....  .....+++|...........+.+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~   77 (270)
T cd05056           1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVIT   77 (270)
T ss_pred             CeechhhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEc
Confidence            3567788999999999999999999885431  2233589998875554566678999999999998 999999999886


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      . +..+++|||+++++|.+++...            ...+++..+..++.|++.||.|||+.+                 
T Consensus        78 ~-~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~  144 (270)
T cd05056          78 E-NPVWIVMELAPLGELRSYLQVN------------KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD  144 (270)
T ss_pred             C-CCcEEEEEcCCCCcHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC
Confidence            5 5578999999999999999763            224788999999999999999999998                 


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       145 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~  224 (270)
T cd05056         145 CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG  224 (270)
T ss_pred             CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        1122


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                      .+.+.|..++..+.+++.+||..+|.+|||+.++++.|..+...+
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            233456678899999999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.92  E-value=3e-23  Score=164.13  Aligned_cols=171  Identities=33%  Similarity=0.651  Sum_probs=142.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |..++|+..+.||+|+||.||+|......  .....+++|.++..........+..|+.++..+. |+|++++.+++...
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   78 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPG--RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKF   78 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCC--CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccC
Confidence            56678899999999999999999885322  1233589999875545556678999999999998 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..+++|||+++++|.+++...            ...+++..+..++.|++.|+.|||+.+                   
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~  146 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDH------------DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLEC  146 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcE
Confidence            9999999999999999998763            234788999999999999999999998                   


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~  226 (268)
T cd05063         147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG  226 (268)
T ss_pred             EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC
Confidence                                                                                        1112


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      .+.+.+..++.++.+++.+||+.+|+.||++.++++.|..+
T Consensus       227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            23344556788999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.92  E-value=2.1e-23  Score=163.60  Aligned_cols=157  Identities=34%  Similarity=0.699  Sum_probs=131.0

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||+|+||.||+|...     .++..+|+|.+...........+.+|+.++..+. |+||+++++++......++++||
T Consensus         1 ~~lg~g~~g~vy~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLR-----ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEe-----cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEee
Confidence            36899999999999983     4455699998865555666678999999999998 99999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------  156 (230)
                      +++++|.+++...            ...+++..+..++.|++.||.|||+++                            
T Consensus        75 ~~~~~L~~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  142 (252)
T cd05084          75 VQGGDFLTFLRTE------------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR  142 (252)
T ss_pred             ccCCcHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCc
Confidence            9999999998753            234788999999999999999999988                            


Q ss_pred             ------------------------------------------------------------------CCCCccCCCCCcCc
Q psy15820        157 ------------------------------------------------------------------VRDGYRLEKPDHCR  170 (230)
Q Consensus       157 ------------------------------------------------------------------i~~~~~~~~p~~~~  170 (230)
                                                                                        +..+.+...+..++
T Consensus       143 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (252)
T cd05084         143 EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCP  222 (252)
T ss_pred             ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCC
Confidence                                                                              11111223344567


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        171 RELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       171 ~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      ..+.+++.+||+.+|++|||+.++++.|+
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            88999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=2.4e-23  Score=164.87  Aligned_cols=170  Identities=34%  Similarity=0.631  Sum_probs=140.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ...+|++.+.||+|+||.||+|......  .....+++|.+...........+..|+.++..+. ||||+++++++....
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~   78 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPG--KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSR   78 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCC--CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCC
Confidence            4567899999999999999999985432  1234599999876555666778999999999998 999999999999888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..++++||+++++|.+++...            ...+++..+..++.|++.||.|||+++                    
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN------------DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEE
Confidence            999999999999999998763            234788999999999999999999998                    


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~  226 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ  226 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence                                                                                         011


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      ..+.+.+..++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            112234456788999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=2.5e-23  Score=163.41  Aligned_cols=161  Identities=20%  Similarity=0.375  Sum_probs=134.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      +|++.+.||+|+||.||++.+     ..++..+++|.++..........+..|+.++..+. |+||+++++.+...+..+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQH-----VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEE-----cCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence            578899999999999999988     44556699999864444555677889999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------------
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------------  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------------  156 (230)
                      +++||+++++|.+++....           ...+++..+..++.|++.||.|||+++                       
T Consensus        75 lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~d  143 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQR-----------GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGD  143 (255)
T ss_pred             EEEeeCCCCcHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcc
Confidence            9999999999999887532           234788899999999999999999998                       


Q ss_pred             --------------------------------------------------------------------CCCCccCCCCCc
Q psy15820        157 --------------------------------------------------------------------VRDGYRLEKPDH  168 (230)
Q Consensus       157 --------------------------------------------------------------------i~~~~~~~~p~~  168 (230)
                                                                                          +..+...+.|..
T Consensus       144 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  223 (255)
T cd08219         144 FGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSH  223 (255)
T ss_pred             cCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence                                                                                122223334556


Q ss_pred             CcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        169 CRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       169 ~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      ++..+.+++.+||+.||++|||+.+|+..
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            78889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.92  E-value=3e-23  Score=165.36  Aligned_cols=178  Identities=29%  Similarity=0.588  Sum_probs=141.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +...+|++.+.||+|+||.||+|.+.... ......+++|.+...........+..|+..+..+. |+||+++++++.. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~-   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEG-DSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG-   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCC-CceeeEEEEeecccccchHHHHHHHHHHHHHhcCC-CCCcceEEEEECC-
Confidence            45678999999999999999999984322 11122478888764434444567788888889998 9999999998754 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      ...++++||+++|+|.+++...            ...+++..+..++.|++.||.|||+++                   
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQH------------RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcE
Confidence            5678999999999999999763            224789999999999999999999998                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE  228 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence                                                                                       12223


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      ++..+..|+.++.+++.+||..||+.|||+.++++.|..+....+.|
T Consensus       229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~  275 (279)
T cd05111         229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY  275 (279)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence            33445567888999999999999999999999999999888766554

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=3.1e-23  Score=164.64  Aligned_cols=136  Identities=36%  Similarity=0.672  Sum_probs=111.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ++.++|++.+.||+|+||.||+|.............+++|.+...........+.+|+.++..+. |+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   80 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLCREA   80 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEECCC
Confidence            45688999999999999999999986554445556799998865444445678999999999998 99999999999888


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++++||+++++|.+++.......    .......+++..+..++.|++.||.|||+.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~----~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~  137 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLSTKQKVALCTQIALGMDHLSNAR  137 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhccccc----ccccccCCCHHHHHHHHHHHHHHHHHhhhcC
Confidence            89999999999999999998643110    0001124889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.92  E-value=5.1e-23  Score=162.68  Aligned_cols=168  Identities=18%  Similarity=0.385  Sum_probs=136.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||+|..     ..++..+|+|.++..  ........+.+|+.++..+. |+||+++++.+...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATC-----LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEE-----eCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECC
Confidence            5799999999999999999998     344556999987532  33455667899999999998 999999999999889


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..++++||+++++|.+++.....         ....+++..+..++.|++.||.|||+++                    
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~  146 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKK---------QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhh---------ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEE
Confidence            99999999999999998875321         1234788899999999999999999998                    


Q ss_pred             ----------------------------------------------------CCCCc---------------------cC
Q psy15820        157 ----------------------------------------------------VRDGY---------------------RL  163 (230)
Q Consensus       157 ----------------------------------------------------i~~~~---------------------~~  163 (230)
                                                                          +..|.                     .+
T Consensus       147 l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (267)
T cd08228         147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP  226 (267)
T ss_pred             ECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC
Confidence                                                                01111                     11


Q ss_pred             CC-CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        164 EK-PDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       164 ~~-p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      +. +..++..+.+++.+||..+|++|||+.++++.+.++
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11 235667899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.91  E-value=2.5e-23  Score=163.78  Aligned_cols=162  Identities=32%  Similarity=0.647  Sum_probs=133.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |+.++|++.+.||+|+||.||.+.+.+      ...+|+|.+....  .....+.+|+.++..+. ||||+++++++...
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   71 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQ   71 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCC-CCCeeeEEEEEccC
Confidence            356789999999999999999998743      2238999886432  22356889999999999 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..+++|||+++++|.+++....            ..+++..+..++.|++.||.|||+.+                   
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~  139 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHG------------KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCV  139 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCE
Confidence            88999999999999999987631            24789999999999999999999998                   


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                +..+.+
T Consensus       140 kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~  219 (256)
T cd05113         140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR  219 (256)
T ss_pred             EECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC
Confidence                                                                                      111122


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      ...+...+..+.+++.+||+.+|++|||+.+|+..+
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            333455678899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0589|consensus

Probab=99.91  E-value=3.5e-24  Score=174.65  Aligned_cols=163  Identities=21%  Similarity=0.364  Sum_probs=143.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|..++.+|+|+||.+++..++.     ....+++|.++.. .....+....+|+.+++++. |||||.+.+.|...+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~-----~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKS-----DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDG   76 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhcc-----CCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCC
Confidence            4678999999999999999998854     3446999999743 45566678899999999999 999999999999888


Q ss_pred             C-eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         97 P-FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        97 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      . ++++|+||+||++.+.+...+           +..+++..+..|+.|++.|+.|||+++                   
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k-----------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~V  145 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQK-----------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKV  145 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHh-----------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCce
Confidence            7 999999999999999999864           235899999999999999999999776                   


Q ss_pred             ------------------------------------------------------------------------CCCCccCC
Q psy15820        157 ------------------------------------------------------------------------VRDGYRLE  164 (230)
Q Consensus       157 ------------------------------------------------------------------------i~~~~~~~  164 (230)
                                                                                              +..+...+
T Consensus       146 kLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P  225 (426)
T KOG0589|consen  146 KLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP  225 (426)
T ss_pred             eecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC
Confidence                                                                                    56666788


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .|...+.++..|+..|++.+|+.||++.+++..
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            899999999999999999999999999999986

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=3e-23  Score=166.54  Aligned_cols=139  Identities=35%  Similarity=0.676  Sum_probs=108.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCC---------CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDG---------REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      ++.++|++.+.||+|+||.||+|...+...         ......+|+|.++..........+.+|++++..+. |+|++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcC
Confidence            566789999999999999999988753211         12234589999976555666678999999999999 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++++...+..+++|||+++++|.+++........... ......+++..++.++.|++.||.|||+++
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  149 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH-ANNIPSVSIANLLYMAVQIASGMKYLASLN  149 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccc-cccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence            999999999999999999999999999865321000000 001123678889999999999999999999

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.91  E-value=6.1e-23  Score=163.77  Aligned_cols=125  Identities=32%  Similarity=0.632  Sum_probs=103.0

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      ...+|++.+.||+|+||.||.+...... ...+..+++|.+... .......+.+|+.++..+. |+||+++++++..  
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   78 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCC
Confidence            3468899999999999999999864332 345667999998643 3445567899999999998 9999999998754  


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....++++||+++++|.+++...+            ..+++..+..++.|++.||.|||+++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~------------~~l~~~~~~~~~~~l~~aL~~LH~~~  128 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR------------ERLDHRKLLLYASQICKGMEYLGSKR  128 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC------------cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            346899999999999999987532            24788999999999999999999999

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0580|consensus

Probab=99.91  E-value=1.2e-24  Score=162.13  Aligned_cols=167  Identities=23%  Similarity=0.369  Sum_probs=141.2

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .....++|++++.||+|.||.||+|..     +.+...||+|++....  .......+.+|+++.+.++ ||||+++|++
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlare-----kks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~   90 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLARE-----KKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGY   90 (281)
T ss_pred             cccchhhccccccccCCccccEeEeee-----ccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhh
Confidence            455778999999999999999999999     4556679999985331  2233457889999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      |-+...+||++||.++|+++..+...+           ...+++.....++.|+|.|+.|+|.++               
T Consensus        91 fhd~~riyLilEya~~gel~k~L~~~~-----------~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~  159 (281)
T KOG0580|consen   91 FHDSKRIYLILEYAPRGELYKDLQEGR-----------MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS  159 (281)
T ss_pred             eeccceeEEEEEecCCchHHHHHHhcc-----------cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC
Confidence            999999999999999999999998643           345888999999999999999999998               


Q ss_pred             -------------------------------------------------------------------------CCCCccC
Q psy15820        157 -------------------------------------------------------------------------VRDGYRL  163 (230)
Q Consensus       157 -------------------------------------------------------------------------i~~~~~~  163 (230)
                                                                                               -....+.
T Consensus       160 ~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~  239 (281)
T KOG0580|consen  160 AGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL  239 (281)
T ss_pred             CCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc
Confidence                                                                                     0001234


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      ..|++++.+..++|.+|+..+|.+|.+..++++.
T Consensus       240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            5678999999999999999999999999998864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=4.1e-23  Score=164.85  Aligned_cols=124  Identities=33%  Similarity=0.565  Sum_probs=103.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--C
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--E   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--~   96 (230)
                      +-|++.+.||+|+||.||++.+.... ..++..+++|.++..........+.+|+.++..+. |+||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            45788999999999999999864322 34566799999875544555678999999999998 99999999988764  5


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~i~~~i~~aL~~lH~~g  129 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN------------KNKINLKQQLKYAVQICKGMDYLGSRQ  129 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            689999999999999998653            124788999999999999999999999

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=5.7e-23  Score=163.92  Aligned_cols=120  Identities=37%  Similarity=0.612  Sum_probs=100.4

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--CCe
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPF   98 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--~~~   98 (230)
                      |++.+.||+|+||.||++.+.... ..++..+|+|.++..........+.+|+.++..+. |+||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCceE
Confidence            488899999999999988764332 34566799999875544455677889999999998 99999999987653  358


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++|||+++++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        84 ~lv~e~~~~~~l~~~~~~~--------------~l~~~~~~~i~~~l~~~l~~lH~~~  127 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH--------------KLNLAQLLLFAQQICEGMAYLHSQH  127 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999998653              3899999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.91  E-value=6.5e-23  Score=163.27  Aligned_cols=177  Identities=31%  Similarity=0.604  Sum_probs=144.7

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||+|.+.... ......||+|.++..........+.+|+.++..+. |+||+++++++.. 
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-   80 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDG-ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-   80 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCC-CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-
Confidence            56788999999999999999999985433 22233589999876556666678899999999998 9999999999865 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      ...++++||+++|+|.+++...            ...+++..++.++.|++.||.|||+++                   
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~  148 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVREN------------KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHV  148 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcE
Confidence            4578999999999999998763            234889999999999999999999999                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (279)
T cd05109         149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE  228 (279)
T ss_pred             EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence                                                                                       12222


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                      .++.+..++.++.+++.+||..||+.||++.+++..|..+......
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05109         229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR  274 (279)
T ss_pred             cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence            3444567888999999999999999999999999998877655533

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.91  E-value=9e-23  Score=162.48  Aligned_cols=182  Identities=34%  Similarity=0.647  Sum_probs=145.6

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+..++|++.+.||+|+||.||.|.+.... ...+..+++|.+...........+.+|+.++..+. |+||+++++++..
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~   79 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS-HQNILPILHVCIE   79 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence            467889999999999999999999986422 12345689999876656666788999999999998 9999999998765


Q ss_pred             -CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         95 -KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                       +...++++||+++++|.+++.......     ......+++..+..++.|++.||.|||+.+                 
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~  154 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGE-----ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL  154 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccc-----cccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC
Confidence             567899999999999999987642100     001245889999999999999999999998                 


Q ss_pred             ---------------------------------------------------------C--------------------CC
Q psy15820        157 ---------------------------------------------------------V--------------------RD  159 (230)
Q Consensus       157 ---------------------------------------------------------i--------------------~~  159 (230)
                                                                               +                    ..
T Consensus       155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  234 (280)
T cd05043         155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD  234 (280)
T ss_pred             cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence                                                                     0                    11


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                      +.+...+..+++++.+++.+||..||+.|||+.+++..|..+..
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11223334678899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.91  E-value=7.3e-24  Score=166.96  Aligned_cols=168  Identities=35%  Similarity=0.706  Sum_probs=139.1

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |+.+..+|++++.||.|+||.||+|.+..      +..+++|.+.... ......+..|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   72 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKN------RVRVAIKILKSDD-LLKQQDFQKEVQALKRLR-HKHLISLFAVCS   72 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecC------CCcEEEEeccccc-hhhHHHHHHHHHHHhcCC-CcchhheeeeEe
Confidence            45567789999999999999999999843      3458999986432 334567889999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      .....+++|||+++++|.+++....           ...+++..+..++.|++.||.|||+++                 
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~  141 (261)
T cd05148          73 VGEPVYIITELMEKGSLLAFLRSPE-----------GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL  141 (261)
T ss_pred             cCCCeEEEEeecccCCHHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc
Confidence            9999999999999999999997632           234788899999999999999999998                 


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       142 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~  221 (261)
T cd05148         142 VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY  221 (261)
T ss_pred             eEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC
Confidence                                                                                       11111


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      +.+.+..+++++.+++.+||+.||.+|||+.+|++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            223345678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=2.4e-23  Score=164.16  Aligned_cols=167  Identities=38%  Similarity=0.750  Sum_probs=139.1

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |++..++|++.+.||+|++|.||+|.+..      +..+|+|.++...  .....+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   71 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN------TTPVAVKTLKPGT--MDPKDFLAEAQIMKKLR-HPKLIQLYAVCT   71 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecC------CeEEEEEeeCCCc--ccHHHHHHHHHHHHHCC-CCCccceeEEEe
Confidence            67889999999999999999999998732      2459999986432  22456889999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..++++||+++++|.+++....           ...+++..+..++.|++.|+.|||+++                 
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~  140 (261)
T cd05068          72 LEEPIYIVTELMKYGSLLEYLQGGA-----------GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN  140 (261)
T ss_pred             cCCCeeeeeecccCCcHHHHHhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC
Confidence            9899999999999999999987631           234789999999999999999999988                 


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05068         141 ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG  220 (261)
T ss_pred             CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        1111


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      ...+.+..++..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1233455678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.91  E-value=2.2e-23  Score=165.86  Aligned_cols=183  Identities=34%  Similarity=0.628  Sum_probs=144.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|.+.+.||+|+||.||+|.............+|+|.++.....+....+.+|+.++..+. |+||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence            45678899999999999999999875443234456799999876555556678999999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhcc-ccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYN-NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      ...+++|||+++++|.+++.......... ........+++..+..++.|++.|+.|||+++                  
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999998742110000 00112345788899999999999999999988                  


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        1111


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      .....+..++..+.+++.+||+.||++|||+.++++.|.
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            222334567889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.91  E-value=5.8e-23  Score=167.61  Aligned_cols=122  Identities=21%  Similarity=0.322  Sum_probs=107.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||++.+     ..++..+|+|.+...........+.+|+.++..+. |+||+++++++...
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   75 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQH-----KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSD   75 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEE-----CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEEC
Confidence            5678999999999999999999998     44556699999875545566678999999999999 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~  123 (331)
T cd06649          76 GEISICMEHMDGGSLDQVLKEA-------------KRIPEEILGKVSIAVLRGLAYLREKH  123 (331)
T ss_pred             CEEEEEeecCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            9999999999999999998763             24788999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=1e-22  Score=160.74  Aligned_cols=168  Identities=21%  Similarity=0.435  Sum_probs=137.8

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC--cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE--NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .+|++.+.||+|+||.||+|..     ..++..+++|.++.  .........+.+|+.++..+. |+|++++++.+...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAIC-----LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEE-----cCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCC
Confidence            5799999999999999999998     34556799998863  233444678999999999998 999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..++++||+++++|.+++.....         ....+++..+..++.+++.||.|||+.+                    
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~  146 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKK---------QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcc---------cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEE
Confidence            99999999999999999875321         1234788999999999999999999988                    


Q ss_pred             -------------------------------------------------------------------------CCCCccC
Q psy15820        157 -------------------------------------------------------------------------VRDGYRL  163 (230)
Q Consensus       157 -------------------------------------------------------------------------i~~~~~~  163 (230)
                                                                                               +..+...
T Consensus       147 l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (267)
T cd08224         147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP  226 (267)
T ss_pred             EeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC
Confidence                                                                                     0111112


Q ss_pred             CCCC-cCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        164 EKPD-HCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       164 ~~p~-~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      +.|. .++.++.+++.+||..+|..|||+.+|++.++++
T Consensus       227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            2233 5677899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.91  E-value=2.7e-23  Score=165.69  Aligned_cols=183  Identities=31%  Similarity=0.549  Sum_probs=144.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |+..+|++.+.||+|+||.||+|...+......+..+|+|.++..........+..|+.++..+. |+||+++++++...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCC
Confidence            55677888999999999999999886654344566799999975555555677889999999999 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhc---cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      +..++++||+++++|.+++.........   .........+++..+..++.|++.||.|||+++                
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998643211000   000111234788889999999999999999988                


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence                                                                                          12


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      .+...+.|..++..+.+++..||+.+|++||++.+|+..|.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            22233446678999999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.91  E-value=1.2e-22  Score=161.52  Aligned_cols=134  Identities=38%  Similarity=0.626  Sum_probs=110.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||+|.+...........+++|.++..........+.+|+.++..+. |+||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence            45678999999999999999999986533223556799998875555555667999999999998 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..+++|||+++++|.+++...+..      ......+++..++.++.||+.||.|||+++
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~------~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  136 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPR------PERPSSLTMKDLLFCARDVAKGCKYLEENH  136 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            8999999999999999999875311      011234788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.91  E-value=8.6e-23  Score=160.80  Aligned_cols=160  Identities=31%  Similarity=0.575  Sum_probs=131.5

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecC
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV  105 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~  105 (230)
                      .||+|+||.||+|.+...   ..+..+|+|++...........+.+|+.++..+. |+||+++++++. ....++++||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~---~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecC---CCceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeC
Confidence            389999999999987532   2344589999875545555677999999999998 999999999875 45789999999


Q ss_pred             CCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------------------
Q psy15820        106 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------------------  156 (230)
Q Consensus       106 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------------------  156 (230)
                      ++++|.+++...            ...+++..++.++.|++.||.|||+++                             
T Consensus        77 ~~~~L~~~l~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~  144 (257)
T cd05115          77 SGGPLNKFLSGK------------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKA  144 (257)
T ss_pred             CCCCHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCcccc
Confidence            999999998753            234889999999999999999999998                             


Q ss_pred             ------------------------------------------------------------------CCCCccCCCCCcCc
Q psy15820        157 ------------------------------------------------------------------VRDGYRLEKPDHCR  170 (230)
Q Consensus       157 ------------------------------------------------------------------i~~~~~~~~p~~~~  170 (230)
                                                                                        +..+.+...|..++
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (257)
T cd05115         145 LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECP  224 (257)
T ss_pred             ccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCC
Confidence                                                                              11222334456678


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        171 RELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       171 ~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                      +++.+++.+||+.+|++||++.+|.+.|..++
T Consensus       225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.91  E-value=8.5e-23  Score=163.82  Aligned_cols=138  Identities=39%  Similarity=0.668  Sum_probs=110.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCC-----------CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCc
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDG-----------REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN   84 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~n   84 (230)
                      +...+|++++.||+|+||.||++.......           ...+..+|+|.+...........+.+|+.++..+. |+|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~   80 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPN   80 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCC
Confidence            456789999999999999999998764321           12345689999876655666778999999999999 999


Q ss_pred             eeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         85 VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        85 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+++++++...+..++++||+++++|.+++..........  ......+++..+..++.|++.||.|||+.+
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~al~~LH~~~  150 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL--ACNSKSLSFSTLLYMATQIASGMRYLESLN  150 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc--cccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            9999999998899999999999999999997643110000  011235789999999999999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.91  E-value=1.1e-22  Score=163.29  Aligned_cols=138  Identities=36%  Similarity=0.658  Sum_probs=108.7

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccC-----------CCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCc
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGID-----------GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN   84 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~n   84 (230)
                      .+.++|++.+.||+|+||.||++.+....           ....+..+|+|.++..........+.+|+.++..+. |+|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCC
Confidence            35678999999999999999998654321           122344689999876555566678999999999998 999


Q ss_pred             eeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         85 VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        85 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+++++++...+..++++||+++++|.+++........  ........+++..+..++.|++.||.|||+++
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  150 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA--AEKADVVTISYSTLIFMATQIASGMKYLSSLN  150 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccc--cccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999999987431100  00112234778889999999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.91  E-value=4.8e-23  Score=162.35  Aligned_cols=166  Identities=40%  Similarity=0.789  Sum_probs=135.5

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |+|..++|++.++||+|+||.||+|...      ++..+|+|.+.....  ....+.+|+.++..+. |+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   71 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQ-HPRLVRLYAVVT   71 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCCC--cHHHHHHHHHHHHhcC-CcCeeeEEEEEc
Confidence            6789999999999999999999999763      234599998864322  2356889999999998 999999998864


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                       .+..++++||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                 
T Consensus        72 -~~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~  139 (260)
T cd05067          72 -QEPIYIITEYMENGSLVDFLKTPE-----------GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL  139 (260)
T ss_pred             -cCCcEEEEEcCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC
Confidence             467899999999999999887532           234788899999999999999999988                 


Q ss_pred             --------------------------------------------------------CC--------------------CC
Q psy15820        157 --------------------------------------------------------VR--------------------DG  160 (230)
Q Consensus       157 --------------------------------------------------------i~--------------------~~  160 (230)
                                                                              +.                    .+
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05067         140 CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG  219 (260)
T ss_pred             CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence                                                                    01                    11


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      .+.+.+..++.++.+++.+||..+|++|||+.+++..|+.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1223345577899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.91  E-value=1.2e-22  Score=161.82  Aligned_cols=183  Identities=33%  Similarity=0.597  Sum_probs=143.4

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      +|+.++|.+.+.||+|+||.||++.........++..+++|.++.. .......+.+|+.++..+. |+||+++++++..
T Consensus         1 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   78 (280)
T cd05092           1 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQ-HQHIVRFYGVCTE   78 (280)
T ss_pred             CCChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEec
Confidence            3678899999999999999999997654332344556899988643 3455668999999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhh--hccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQR--YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      .+..++++||+++++|.+++.......  ...........+++..+..++.|++.|+.|||+.+                
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            899999999999999999998643110  00000111234788999999999999999999998                


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence                                                                                          11


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      .+.....|..+++.+.+++.+||+.||.+||++.+|++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            12223445678899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.91  E-value=9.1e-23  Score=166.58  Aligned_cols=122  Identities=21%  Similarity=0.350  Sum_probs=106.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ++..++|++.+.||+|+||.||++.+     ..++..+|+|.+...........+.+|+.++..+. |+||+++++++..
T Consensus         1 ~l~~~~y~~~~~lg~g~~g~V~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   74 (333)
T cd06650           1 ELKDDDFEKISELGAGNGGVVFKVSH-----KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS   74 (333)
T ss_pred             CcchhhhheeccccCCCCEEEEEEEE-----CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEE
Confidence            35678999999999999999999988     44556689998875545556678999999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      .+..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||++
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~l~~~l~~lH~~  122 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKA-------------GRIPEQILGKVSIAVIKGLTYLREK  122 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            99999999999999999998763             2478889999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.1e-22  Score=160.28  Aligned_cols=167  Identities=43%  Similarity=0.812  Sum_probs=138.7

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |++..++|++.+.||+|+||.||++...+      ...+++|.+....  .....+.+|+.++..+. |+||+++++.+.
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~------~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   71 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNG------TTKVAVKTLKPGT--MSPEAFLQEAQIMKKLR-HDKLVQLYAVCS   71 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcC------CceEEEEEecCCc--cCHHHHHHHHHHHhhCC-CCCEeeeeeeee
Confidence            67899999999999999999999998732      2348999886432  23356889999999999 999999999998


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      .....++++||+++++|.+++....           ...+++..+..++.|++.|+.|||+++                 
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~i~~~~-----------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~  140 (261)
T cd05034          72 EEEPIYIVTEYMSKGSLLDFLKSGE-----------GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL  140 (261)
T ss_pred             cCCceEEEEeccCCCCHHHHHhccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC
Confidence            8889999999999999999987631           234788999999999999999999999                 


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       141 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05034         141 VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG  220 (261)
T ss_pred             CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        0111


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      .+.+.|..++.++.+++.+||..+|.+|||+.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1223455678899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.91  E-value=9.6e-23  Score=160.26  Aligned_cols=165  Identities=34%  Similarity=0.666  Sum_probs=135.3

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |.++.++|++.+.||+|+||.||++...+       ..+++|.++...   ....+.+|+.++..+. |+|++++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~k~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   69 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLLGVIV   69 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcC-------CcEEEEEeCCCc---hHHHHHHHHHHHHhCC-CCCeeeEEEEEE
Confidence            67888999999999999999999997643       338999886432   3456889999999998 999999999764


Q ss_pred             -cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         94 -EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        94 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                       ..+..++++||+++++|.+++....           ...+++..+..++.|++.||.|||+++                
T Consensus        70 ~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~  138 (256)
T cd05082          70 EEKGGLYIVTEYMAKGSLVDYLRSRG-----------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED  138 (256)
T ss_pred             cCCCceEEEEECCCCCcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC
Confidence             4567899999999999999987632           224788899999999999999999998                


Q ss_pred             -------------------------------------------------------------------------CCCCccC
Q psy15820        157 -------------------------------------------------------------------------VRDGYRL  163 (230)
Q Consensus       157 -------------------------------------------------------------------------i~~~~~~  163 (230)
                                                                                               +..+...
T Consensus       139 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~  218 (256)
T cd05082         139 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  218 (256)
T ss_pred             CcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Confidence                                                                                     1111122


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      ..+..+++.+.+++.+||+.+|++|||+.++++.|..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            3345678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0593|consensus

Probab=99.90  E-value=1.1e-23  Score=161.95  Aligned_cols=119  Identities=24%  Similarity=0.440  Sum_probs=103.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +.|+.+.++|+|+||.|++|..     +.+++.||||.+..+ .++...+-.++|+++|.+++ |+|+|.+.++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrn-----k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRN-----KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEecc-----CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcce
Confidence            4678888999999999999999     678888999999644 44666677899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++||+|||+. ++.+.+...            ..+++...+..+++|++.|+.|+|+++
T Consensus        76 lhLVFE~~dh-TvL~eLe~~------------p~G~~~~~vk~~l~Q~l~ai~~cHk~n  121 (396)
T KOG0593|consen   76 LHLVFEYCDH-TVLHELERY------------PNGVPSELVKKYLYQLLKAIHFCHKNN  121 (396)
T ss_pred             eEEEeeecch-HHHHHHHhc------------cCCCCHHHHHHHHHHHHHHhhhhhhcC
Confidence            9999999987 454555543            345899999999999999999999999

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.90  E-value=1.7e-22  Score=160.94  Aligned_cols=125  Identities=34%  Similarity=0.646  Sum_probs=104.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--C
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--K   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--~   95 (230)
                      .++|++.+.||+|+||.||++.+.... ..++..+|+|.++..........+.+|+.++..+. |+||+++++++..  .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            457888899999999999999875432 33466799999975544345678999999999998 9999999999876  5


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...++++||+++++|.+++....            ..+++..+..++.|++.||.|||+++
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~------------~~~~~~~~~~~~~~l~~aL~~lH~~~  129 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR------------DQINLKRLLLFSSQICKGMDYLGSQR  129 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc------------cccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            57899999999999999997632            24889999999999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4721|consensus

Probab=99.90  E-value=8.6e-24  Score=174.59  Aligned_cols=160  Identities=28%  Similarity=0.594  Sum_probs=138.8

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      .++.|+|+.+.+.-++.||+|+-|-||+|+.++..       ||||.++.-+        .-+|.-|..++ |+||+.+.
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~net-------VAVKKV~elk--------ETdIKHLRkLk-H~NII~Fk  178 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNET-------VAVKKVRELK--------ETDIKHLRKLK-HPNIITFK  178 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeeccCce-------ehhHHHhhhh--------hhhHHHHHhcc-CcceeeEe
Confidence            46779999999999999999999999999986543       9999876321        13567788898 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      |+|....-+++|||||+.|.|+..++..+             .++...++.|..+||.||+|||.+.             
T Consensus       179 GVCtqsPcyCIiMEfCa~GqL~~VLka~~-------------~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI  245 (904)
T KOG4721|consen  179 GVCTQSPCYCIIMEFCAQGQLYEVLKAGR-------------PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI  245 (904)
T ss_pred             eeecCCceeEEeeeccccccHHHHHhccC-------------ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence            99999999999999999999999999743             4888999999999999999999988             


Q ss_pred             -----------------------------------------------------------------------------C-C
Q psy15820        157 -----------------------------------------------------------------------------V-R  158 (230)
Q Consensus       157 -----------------------------------------------------------------------------i-~  158 (230)
                                                                                                   | .
T Consensus       246 s~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs  325 (904)
T KOG4721|consen  246 SYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS  325 (904)
T ss_pred             eccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC
Confidence                                                                                         1 1


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      +....+.|..||+.+.=|+..||+..|..||+|++|+..|
T Consensus       326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            1224678899999999999999999999999999999876

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.90  E-value=8.2e-23  Score=160.71  Aligned_cols=162  Identities=37%  Similarity=0.707  Sum_probs=132.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |+..+|++.+.||+|+||.||++.+..      ...+++|.+.....  ....+.+|+.++..+. |+||+++++++...
T Consensus         1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~------~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   71 (256)
T cd05059           1 IDPSELTFLKELGSGQFGVVHLGKWRG------KIDVAIKMIREGAM--SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQ   71 (256)
T ss_pred             CChHHcchhhhhccCCCceEEEeEecC------CccEEEEEeccCCC--CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCC
Confidence            356678999999999999999998742      22489998863321  2245788999999998 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..++++||+++++|.+++...            ...+++..+..++.|++.||.|||+++                   
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~  139 (256)
T cd05059          72 RPIFIVTEYMANGCLLNYLRER------------KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVV  139 (256)
T ss_pred             CceEEEEecCCCCCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcE
Confidence            9999999999999999998763            224789999999999999999999988                   


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                +..+.+
T Consensus       140 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~  219 (256)
T cd05059         140 KVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR  219 (256)
T ss_pred             EECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc
Confidence                                                                                      111112


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      ...|..++.++.+++.+||..+|++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            233456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.90  E-value=2.1e-22  Score=158.97  Aligned_cols=168  Identities=36%  Similarity=0.693  Sum_probs=135.3

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |.|+..+|++.++||+|+||.||+|.+...      ..+++|.++....  ....+.+|+.++..+. |+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~------~~valK~~~~~~~--~~~~~~~E~~~l~~l~-~~~i~~~~~~~~   71 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTM--SPEAFLQEAQVMKKLR-HEKLVQLYAVVS   71 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCC------ceEEEEecccCcc--CHHHHHHHHHHHHhCC-CCCcceEEEEEC
Confidence            678889999999999999999999987322      2389999874322  2346889999999998 999999999874


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                       ....+++|||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                 
T Consensus        72 -~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~  139 (262)
T cd05071          72 -EEPIYIVTEYMSKGSLLDFLKGEM-----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL  139 (262)
T ss_pred             -CCCcEEEEEcCCCCcHHHHHhhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC
Confidence             456899999999999999997631           224788899999999999999999998                 


Q ss_pred             --------------------------------------------------------CCC-Cc------------------
Q psy15820        157 --------------------------------------------------------VRD-GY------------------  161 (230)
Q Consensus       157 --------------------------------------------------------i~~-~~------------------  161 (230)
                                                                              +.. |.                  
T Consensus       140 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~  219 (262)
T cd05071         140 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG  219 (262)
T ss_pred             cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence                                                                    011 11                  


Q ss_pred             -cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        162 -RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       162 -~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                       ..+.+..++..+.+++.+||+.+|++|||+.++++.|+..+
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence             11223456788999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.90  E-value=1.6e-22  Score=159.81  Aligned_cols=168  Identities=20%  Similarity=0.417  Sum_probs=135.8

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+++|.+...  ........+.+|+.++..+. |+||+++++++...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATC-----LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEee-----cCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCC
Confidence            5788889999999999999998     344566999987532  23344568899999999998 999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..++++||+++++|.+++.....         ....+++..+..++.|++.||.|||+++                    
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~  146 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKK---------QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999998875321         1234789999999999999999999988                    


Q ss_pred             ----------------------------------------------------CCCC---------------------ccC
Q psy15820        157 ----------------------------------------------------VRDG---------------------YRL  163 (230)
Q Consensus       157 ----------------------------------------------------i~~~---------------------~~~  163 (230)
                                                                          +..|                     ..+
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  226 (267)
T cd08229         147 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP  226 (267)
T ss_pred             ECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC
Confidence                                                                0000                     001


Q ss_pred             -CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        164 -EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       164 -~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                       ..+..++.++.+++.+||..||++|||+.+|++.++++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence             12235778999999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.90  E-value=1.7e-22  Score=159.21  Aligned_cols=166  Identities=37%  Similarity=0.717  Sum_probs=134.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |.+..++|++.+.||+|+||.||+|....      +..+++|.+.....  ....+.+|+.++..+. |+|++++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~-~~~i~~~~~~~~   71 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNG------NTKVAVKTLKPGTM--SPESFLEEAQIMKKLR-HDKLVQLYAVVS   71 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecC------CceeEEEEecCCCC--CHHHHHHHHHHHHhcC-CCceEEEEeEEC
Confidence            67888999999999999999999997732      23489998864322  2356889999999998 999999999875


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                       .+..+++|||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                 
T Consensus        72 -~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~  139 (260)
T cd05070          72 -EEPIYIVTEYMSKGSLLDFLKDGE-----------GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL  139 (260)
T ss_pred             -CCCcEEEEEecCCCcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc
Confidence             456899999999999999987631           234788999999999999999999998                 


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05070         140 VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG  219 (260)
T ss_pred             eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        1111


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      .+.+.+..++.++.+++.+||..+|.+|||+.++.+.|++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1223345677899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=2.3e-22  Score=158.26  Aligned_cols=158  Identities=34%  Similarity=0.627  Sum_probs=130.6

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      .||+|+||.||+|.+..   ..++..+|+|+++.. ........+..|+.++..+. |+||+++++++. ....++++||
T Consensus         2 ~lg~G~~g~v~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM---KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEec---CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEec
Confidence            58999999999998743   234556999998643 33445678899999999998 999999999875 4567899999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------  156 (230)
                      +++++|.+++...             ..+++..+..++.|++.||.|||+++                            
T Consensus        77 ~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~  143 (257)
T cd05116          77 AELGPLNKFLQKN-------------KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK  143 (257)
T ss_pred             CCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCcccc
Confidence            9999999998753             24788999999999999999999999                            


Q ss_pred             -------------------------------------------------------------------CCCCccCCCCCcC
Q psy15820        157 -------------------------------------------------------------------VRDGYRLEKPDHC  169 (230)
Q Consensus       157 -------------------------------------------------------------------i~~~~~~~~p~~~  169 (230)
                                                                                         +..+.+.+.|..+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  223 (257)
T cd05116         144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRC  223 (257)
T ss_pred             ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence                                                                               2222334566778


Q ss_pred             cHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        170 RRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       170 ~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      ++++.+++.+||+.||++||++.+|...|+..
T Consensus       224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            99999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.90  E-value=2.7e-22  Score=157.40  Aligned_cols=160  Identities=23%  Similarity=0.428  Sum_probs=134.1

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|.+.+.||+|++|.||++..     ..++..+++|.+... ........+.+|+.++..+. |+||+++++.+...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVR-----KADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEE-----cCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEE
Confidence            578889999999999999998     444566999988632 34556778999999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------  156 (230)
                      ++++||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                      
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~  143 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQR-----------GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIG  143 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEc
Confidence            99999999999999988642           235788999999999999999999998                      


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           +..+..+..+.
T Consensus       144 df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd08529         144 DLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ  223 (256)
T ss_pred             ccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence                                                                                 11122333444


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .++.++.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            67789999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.90  E-value=6.2e-23  Score=168.83  Aligned_cols=120  Identities=21%  Similarity=0.345  Sum_probs=101.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .....++|+..+.||+|+||.||++.+     ..++..||+|++...........+.+|+.++..+. |+||+++++++.
T Consensus        69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  142 (353)
T PLN00034         69 AAKSLSELERVNRIGSGAGGTVYKVIH-----RPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFD  142 (353)
T ss_pred             CCCCHHHHhhhhhccCCCCeEEEEEEE-----CCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEec
Confidence            344567889999999999999999988     44556799999865545556678999999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+.+++++||+++++|....                 ...+..+..++.||+.||.|||+++
T Consensus       143 ~~~~~~lv~e~~~~~~L~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~~  188 (353)
T PLN00034        143 HNGEIQVLLEFMDGGSLEGTH-----------------IADEQFLADVARQILSGIAYLHRRH  188 (353)
T ss_pred             cCCeEEEEEecCCCCcccccc-----------------cCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999885421                 2466778899999999999999998

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.90  E-value=1.4e-22  Score=165.21  Aligned_cols=124  Identities=19%  Similarity=0.345  Sum_probs=106.2

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .....++|++.+.||+|+||.||+|.+     ..++..+|+|+++..  ........+.+|+.++..+. ||||+++++.
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~   86 (329)
T PTZ00263         13 SSWKLSDFEMGETLGTGSFGRVRIAKH-----KGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCS   86 (329)
T ss_pred             CCCCchheEEEEEEEecCCeEEEEEEE-----CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEE
Confidence            345668999999999999999999998     445567999998633  12234567889999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..+++|||+++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        87 ~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~  138 (329)
T PTZ00263         87 FQDENRVYFLLEFVVGGELFTHLRKA-------------GRFPNDVAKFYHAELVLAFEYLHSKD  138 (329)
T ss_pred             EEcCCEEEEEEcCCCCChHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999998763             24788899999999999999999998

>KOG0611|consensus

Probab=99.90  E-value=1.2e-23  Score=167.74  Aligned_cols=121  Identities=21%  Similarity=0.492  Sum_probs=108.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ...+|++.+.||+|.||+|.+|..     ...++.||+|.++.+  .+......+.+|+++++.+. ||||+.+|.+|..
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e-----~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN  124 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYE-----HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN  124 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhh-----ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC
Confidence            456899999999999999999988     456678999999754  34556678899999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+.+.+||||..+|.|++++...+             .+++....++++||..|+.|+|.++
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer~-------------~LsErEaRhfFRQIvSAVhYCHknr  173 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISERG-------------SLSEREARHFFRQIVSAVHYCHKNR  173 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHhc-------------cccHHHHHHHHHHHHHHHHHHhhcc
Confidence            999999999999999999999854             4999999999999999999999998

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.90  E-value=4.8e-22  Score=156.68  Aligned_cols=166  Identities=39%  Similarity=0.751  Sum_probs=135.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |++..++|++.+.||+|+||.||++....      +..+++|.+...  ......+.+|+.++..+. |+||+++++.+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   71 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNK------HTKVAVKTMKPG--SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT   71 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecC------CccEEEEecCCC--hhHHHHHHHHHHHHHhcC-CCCcceEEEEEc
Confidence            78899999999999999999999997632      223899987643  334567899999999998 999999999987


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      . ...++++||+++++|.+++....           ....++..+..++.|++.||.|||+.+                 
T Consensus        72 ~-~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~  139 (260)
T cd05073          72 K-EPIYIITEFMAKGSLLDFLKSDE-----------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL  139 (260)
T ss_pred             C-CCeEEEEEeCCCCcHHHHHHhCC-----------ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC
Confidence            7 77899999999999999987632           234678889999999999999999998                 


Q ss_pred             --------------------------------------------------------CC--------------------CC
Q psy15820        157 --------------------------------------------------------VR--------------------DG  160 (230)
Q Consensus       157 --------------------------------------------------------i~--------------------~~  160 (230)
                                                                              +.                    .+
T Consensus       140 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05073         140 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG  219 (260)
T ss_pred             cEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence                                                                    01                    11


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      ...+.+...+.++.+++.+||..+|++||++.++.+.|+.
T Consensus       220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1122334566789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.90  E-value=4.5e-22  Score=157.60  Aligned_cols=171  Identities=41%  Similarity=0.718  Sum_probs=135.4

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC--
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--   97 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~--   97 (230)
                      |++++.||+|+||.||.|......  .....+|+|.++.. ........+.+|+..+..+. |+||+++++.+.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDD--GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCC--CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccc
Confidence            567899999999999999874321  23356999998743 33445567899999999998 9999999998865443  


Q ss_pred             ----eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         98 ----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        98 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                          .++++||+++++|..++...+..       .....+++..+..++.|++.||.|||+++                 
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~  150 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLG-------GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM  150 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhcc-------CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC
Confidence                79999999999999998664311       01235888999999999999999999988                 


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05035         151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH  230 (273)
T ss_pred             eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence                                                                                         111


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      +.....|..++.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222334556788999999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.90  E-value=7.8e-22  Score=155.46  Aligned_cols=164  Identities=35%  Similarity=0.673  Sum_probs=130.7

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe-cCCCeEEEEe
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EKEPFFVIME  103 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~-~~~~~~lv~e  103 (230)
                      +.||+|+||.||+|......  .....+|+|.+...........+.+|+.++..+. |+||+++++++. ..+..++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCC--CceEEEEEEecCccCCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            36899999999999875322  2345699998865444556678899999999998 999999999765 4556899999


Q ss_pred             cCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------------
Q psy15820        104 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------------  156 (230)
Q Consensus       104 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------------  156 (230)
                      |+++++|.+++....            ...++..+..++.|++.||.|||+.+                           
T Consensus        78 ~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~  145 (262)
T cd05058          78 YMKHGDLRNFIRSET------------HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLA  145 (262)
T ss_pred             cCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccc
Confidence            999999999987631            23567788899999999999999988                           


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           +..+.....+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (262)
T cd05058         146 RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPE  225 (262)
T ss_pred             ccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence                                                                                 01111223345


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                      .+++.+.+++.+||..+|++||++.++++.|+.++.
T Consensus       226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            578899999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.90  E-value=4.6e-22  Score=156.81  Aligned_cols=166  Identities=35%  Similarity=0.700  Sum_probs=133.7

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |++..++|.+.+.||+|++|.||++.+.+.      ..+++|.+....  .....+.+|+.++..+. |+|++++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   71 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT------TKVAIKTLKPGT--MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS   71 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCC------ceEEEEEcccCC--ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence            567888899999999999999999987432      238999876432  22356888999999999 999999999875


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                       .+..+++|||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                 
T Consensus        72 -~~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~  139 (260)
T cd05069          72 -EEPIYIVTEFMGKGSLLDFLKEGD-----------GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL  139 (260)
T ss_pred             -CCCcEEEEEcCCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC
Confidence             456899999999999999987632           234788899999999999999999998                 


Q ss_pred             --------------------------------------------------------CCC-C-------------------
Q psy15820        157 --------------------------------------------------------VRD-G-------------------  160 (230)
Q Consensus       157 --------------------------------------------------------i~~-~-------------------  160 (230)
                                                                              +.. |                   
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05069         140 VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG  219 (260)
T ss_pred             eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence                                                                    000 1                   


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      ...+.+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1222345577889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=6.1e-22  Score=155.58  Aligned_cols=160  Identities=19%  Similarity=0.391  Sum_probs=133.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|+||.+|.+..     ..++..+++|.+... ........+.+|+.+++.+. |+||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKS-----KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEE-----cCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeE
Confidence            588999999999999999988     445567999988632 23445567899999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------  156 (230)
                      ++++||+++++|.+++....           ...+++..+..++.|++.||.|||+++                      
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~  143 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQR-----------GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLG  143 (256)
T ss_pred             EEEEecCCCCcHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEe
Confidence            99999999999999887632           224788899999999999999999988                      


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           +..+..+..+.
T Consensus       144 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd08218         144 DFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSS  223 (256)
T ss_pred             eccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcc
Confidence                                                                                 11122223455


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .++.++.+++.+||+.+|.+||++.++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            67889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0583|consensus

Probab=99.89  E-value=3.4e-22  Score=164.06  Aligned_cols=164  Identities=20%  Similarity=0.356  Sum_probs=138.4

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC----CHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ......|.+++.||+|+||.|+.|.+     ..++..||+|++....    .......+.+|+.++..+..||||++++.
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~-----~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKH-----RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeee-----ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            45677999999999999999999998     4455679999775431    11234456689999999988999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++.....+++|||||.||+|.+++...             .++.+.....++.|++.|++|||++|              
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~~-------------g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld  154 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVNK-------------GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD  154 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHHc-------------CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec
Confidence            999999999999999999999999882             35888999999999999999999998              


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     .
T Consensus       155 ~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k  234 (370)
T KOG0583|consen  155 GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK  234 (370)
T ss_pred             CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence                                                                                           0


Q ss_pred             CCCccCCCCCcC-cHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        158 RDGYRLEKPDHC-RRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       158 ~~~~~~~~p~~~-~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ........|..+ ++++..|+.+|+..||..|+|+.+|+.
T Consensus       235 i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  235 IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            111234567778 999999999999999999999999993

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.89  E-value=7.9e-22  Score=156.28  Aligned_cols=170  Identities=39%  Similarity=0.614  Sum_probs=131.8

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC----
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK----   95 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~----   95 (230)
                      +.+++.||+|+||.||+|.+....   ....+|+|.++.. ........+.+|+.++..+. |+||+++++.+...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC---CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCccc
Confidence            356789999999999999884321   1235899988643 34555678899999999998 99999999976432    


Q ss_pred             --CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         96 --EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        96 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                        ...++++||+++|+|.+++...+..       .....+++..+..++.|++.||.|||+++                 
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~  149 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLG-------DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM  149 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhccc-------CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC
Confidence              2468999999999999988643210       01234788999999999999999999998                 


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  229 (272)
T cd05075         150 NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ  229 (272)
T ss_pred             CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence                                                                                         111


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      +.+...+..+++.+.+++.+||+.||++|||+.+|++.|..+
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            122234556788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=6.3e-22  Score=155.70  Aligned_cols=160  Identities=39%  Similarity=0.715  Sum_probs=132.1

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||+|+||.||+|.+.....  ....+++|.+...........+.+|+.++..+. |+||+++++++. .+..++++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCC--CcceEEEEecccccchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence            468999999999998854331  235699999975544455678899999999998 999999999875 4568999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------  156 (230)
                      +++++|.+++...             ..+++..+..++.|++.||.|||+.+                            
T Consensus        77 ~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~  143 (257)
T cd05060          77 APLGPLLKYLKKR-------------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSR  143 (257)
T ss_pred             CCCCcHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccc
Confidence            9999999999763             24789999999999999999999998                            


Q ss_pred             -------------------------------------------------------------------CCCCccCCCCCcC
Q psy15820        157 -------------------------------------------------------------------VRDGYRLEKPDHC  169 (230)
Q Consensus       157 -------------------------------------------------------------------i~~~~~~~~p~~~  169 (230)
                                                                                         +..+...+.|..+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  223 (257)
T cd05060         144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEEC  223 (257)
T ss_pred             eeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCC
Confidence                                                                               1122233456678


Q ss_pred             cHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        170 RRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       170 ~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      +..+.+++.+||..+|++|||+.++++.|..+
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            89999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0201|consensus

Probab=99.89  E-value=6e-24  Score=170.37  Aligned_cols=161  Identities=25%  Similarity=0.453  Sum_probs=138.0

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ....|...++||+|+||.||+|.+     ..+++.||+|++...........+.+|+.++..+. ++||.++|+.+..+.
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d-----~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAID-----NKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGT   84 (467)
T ss_pred             cccccccchhccccccceeeeeee-----ccccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheeecc
Confidence            455667779999999999999999     45566699999987777778889999999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      .+|++||||.||++.++++..             ..+.+..+.-++++++.|+.|||.++                    
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~-------------~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vk  151 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSG-------------NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVK  151 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccC-------------CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEE
Confidence            999999999999999999863             23478888899999999999999998                    


Q ss_pred             -----------------------------------------------------------------------CCCCccCCC
Q psy15820        157 -----------------------------------------------------------------------VRDGYRLEK  165 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~~~~~~  165 (230)
                                                                                             |.+...|..
T Consensus       152 l~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L  231 (467)
T KOG0201|consen  152 LADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL  231 (467)
T ss_pred             EEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc
Confidence                                                                                   221112222


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ...+++.+++++..||.+||+.||++.++++
T Consensus       232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2478899999999999999999999999997

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.89  E-value=9.6e-22  Score=153.91  Aligned_cols=156  Identities=40%  Similarity=0.822  Sum_probs=129.0

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||+|+||.||+|...      .+..+|+|.++..........+.+|+.++..+. |+||+++++++...+..+++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEEC
Confidence            36899999999999762      234589999876555555667899999999998 99999999999998999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------  156 (230)
                      +++++|.+++...            ...+++..+..++.|++.||.|||+.+                            
T Consensus        74 ~~~~~L~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~  141 (250)
T cd05085          74 VPGGDFLSFLRKK------------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR  141 (250)
T ss_pred             CCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccce
Confidence            9999999988653            224788999999999999999999988                            


Q ss_pred             -----------------------------------------------------------------CCCCccCCCCCcCcH
Q psy15820        157 -----------------------------------------------------------------VRDGYRLEKPDHCRR  171 (230)
Q Consensus       157 -----------------------------------------------------------------i~~~~~~~~p~~~~~  171 (230)
                                                                                       +..+.+...+..++.
T Consensus       142 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (250)
T cd05085         142 QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD  221 (250)
T ss_pred             eccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence                                                                             011112233456788


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        172 ELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       172 ~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      .+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            9999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0598|consensus

Probab=99.89  E-value=2.1e-22  Score=158.57  Aligned_cols=123  Identities=20%  Similarity=0.458  Sum_probs=109.6

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+..++|++.+.||+|+||+|++++.     +.+++.+|+|+++..  ...........|..+|..+. ||.||+++-.|
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk-----~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysF   94 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRK-----KDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSF   94 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEE-----cccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEec
Confidence            57899999999999999999999988     466777999999644  22335677889999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+...+|+|+||+.||.|.-.+...             ..+++.++..++..|+.||.|||+++
T Consensus        95 Qt~~kLylVld~~~GGeLf~hL~~e-------------g~F~E~~arfYlaEi~lAL~~LH~~g  145 (357)
T KOG0598|consen   95 QTEEKLYLVLDYLNGGELFYHLQRE-------------GRFSEDRARFYLAEIVLALGYLHSKG  145 (357)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhc-------------CCcchhHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999988863             35899999999999999999999999

>KOG0659|consensus

Probab=99.89  E-value=8.2e-23  Score=154.50  Aligned_cols=119  Identities=24%  Similarity=0.481  Sum_probs=104.0

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+|...++||+|.||.||+|.+     ..+++.||+|.++.. ..+......++|+..|+.++ |+||+.+.++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d-----~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARD-----TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEe-----cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCc
Confidence            4678889999999999999998     556777999999743 33333457889999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.||+||++. +|+..++..            .-.++..++..|+.+++.|++|||++.
T Consensus        76 l~lVfEfm~t-dLe~vIkd~------------~i~l~pa~iK~y~~m~LkGl~y~H~~~  121 (318)
T KOG0659|consen   76 LSLVFEFMPT-DLEVVIKDK------------NIILSPADIKSYMLMTLKGLAYCHSKW  121 (318)
T ss_pred             eEEEEEeccc-cHHHHhccc------------ccccCHHHHHHHHHHHHHHHHHHHhhh
Confidence            9999999985 999999874            345899999999999999999999998

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.89  E-value=1.1e-21  Score=155.43  Aligned_cols=174  Identities=38%  Similarity=0.712  Sum_probs=133.9

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecC
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV  105 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~  105 (230)
                      .||+|+||.||+|......   ....+++|.++..........+.+|+.++..+..||||+++++++...+..+++|||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             cCCCCCCceEEEEEEcCCC---CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            5899999999999884311   1224788888754445566788999999999955999999999999989999999999


Q ss_pred             CCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------------
Q psy15820        106 PYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------------  156 (230)
Q Consensus       106 ~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------------  156 (230)
                      ++|+|.+++........   ..........+++..+..++.|++.||.|||+.+                          
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            99999999976431100   0000111234788999999999999999999988                          


Q ss_pred             -----------------------------------------------------------------CCCCccCCCCCcCcH
Q psy15820        157 -----------------------------------------------------------------VRDGYRLEKPDHCRR  171 (230)
Q Consensus       157 -----------------------------------------------------------------i~~~~~~~~p~~~~~  171 (230)
                                                                                       +..+.+...+..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD  238 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence                                                                             011112233445778


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        172 ELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       172 ~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                      ++.+++.+||+.+|.+|||+.+++..|..++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         239 EVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            9999999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1187|consensus

Probab=99.89  E-value=2e-22  Score=164.99  Aligned_cols=126  Identities=30%  Similarity=0.556  Sum_probs=104.7

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.+.-..++|.-...||+|+||.||+|...+      +..||||++....... ...|.+|+.++..++ |+|+|+++|+
T Consensus        68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~------~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~-H~Nlv~LlGy  139 (361)
T KOG1187|consen   68 DELRKATNNFSESNLIGEGGFGTVYKGVLSD------GTVVAVKRLSSNSGQG-EREFLNEVEILSRLR-HPNLVKLLGY  139 (361)
T ss_pred             HHHHHHHhCCchhcceecCCCeEEEEEEECC------CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCC-CcCcccEEEE
Confidence            3344455677777899999999999998843      2559999887544332 345999999999999 9999999999


Q ss_pred             EecCCC-eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEP-FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |...+. .+||+||+++|+|.+.+.....          . .++|..+.+|+.++|+||.|||...
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~----------~-~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG----------E-PLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCC----------C-CCCHHHHHHHHHHHHHHHHHHccCC
Confidence            998884 9999999999999999876421          1 6899999999999999999999965

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.9e-22  Score=161.66  Aligned_cols=119  Identities=24%  Similarity=0.437  Sum_probs=102.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||+|..     ..++..+|+|++....  .......+.+|+.++..+. ||||+++++.+.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRD-----RISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCC
Confidence            4788999999999999999998     4456679999986321  2234556889999999999 999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  121 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNS-------------GRFSNSTGLFYASEIVCALEYLHSKE  121 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998763             24788999999999999999999999

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.89  E-value=1e-21  Score=154.33  Aligned_cols=120  Identities=22%  Similarity=0.432  Sum_probs=103.1

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|+..+.||.|+||.||.+..     ..++..+++|.+... ........+.+|+.++..+. |+||+++++++...+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRR-----TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEE-----cCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeE
Confidence            588999999999999999887     345566999988533 34555677899999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++....           ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~  121 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQK-----------GQLFEEEMVLWYLFQIVSAVSYIHKAG  121 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999987631           234788999999999999999999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.89  E-value=1e-21  Score=158.35  Aligned_cols=179  Identities=29%  Similarity=0.623  Sum_probs=142.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +...+|+..+.||+|+||.||++.+.... ......+++|.+...........+.+|+.++..+. |+||+++++++.. 
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~-   80 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEG-ETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLS-   80 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCC-CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcC-
Confidence            46778899999999999999999885433 11223578998875544555567889999999998 9999999999865 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      ...++++||+++|+|.+++...            ...+++..+..++.|++.||.|||+++                   
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEH------------KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCce
Confidence            4567999999999999998763            224788899999999999999999998                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (303)
T cd05110         149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE  228 (303)
T ss_pred             EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence                                                                                       11122


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccc
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYI  209 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~  209 (230)
                      +.+.+..++..+.+++..||..+|++||++.++++.|..+......+.
T Consensus       229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~  276 (303)
T cd05110         229 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYL  276 (303)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhhe
Confidence            233445678889999999999999999999999999998876655443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.89  E-value=6e-22  Score=157.57  Aligned_cols=118  Identities=25%  Similarity=0.479  Sum_probs=102.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ..|+..+.||.|+||.||.|.+     ..++..+|+|.+...........+.+|+.++..+. |+||+++++++...+..
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGID-----NRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEE-----ccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEE
Confidence            4577788999999999999988     34556699999875544556678999999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++...              .+++..+..++.|++.||.|||+.+
T Consensus        78 ~lv~e~~~~~~L~~~i~~~--------------~l~~~~~~~~~~~l~~~l~~lh~~~  121 (277)
T cd06640          78 WIIMEYLGGGSALDLLRAG--------------PFDEFQIATMLKEILKGLDYLHSEK  121 (277)
T ss_pred             EEEEecCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999988642              3788889999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.89  E-value=1.1e-21  Score=158.44  Aligned_cols=118  Identities=23%  Similarity=0.332  Sum_probs=103.0

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||++.+     ..++..+++|.+...........+.+|+.++..++ |+||+++++++...+..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLH-----RPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEE-----cCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEE
Confidence            4689999999999999999988     34455689998875545556677899999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      ++++||+++++|.+++...             ..+++..+..++.|++.||.|||++
T Consensus        75 ~lv~ey~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~  118 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA-------------GRIPENILGKISIAVLRGLTYLREK  118 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhh
Confidence            9999999999999998763             2478899999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=1.1e-21  Score=154.01  Aligned_cols=160  Identities=21%  Similarity=0.434  Sum_probs=133.3

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|+||.||++...     .++..+++|.+... ........+.+|+.++..+. |+|++++++.+...+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK-----ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc-----CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEE
Confidence            5888999999999999999884     34556999998543 33445678999999999998 99999999999888899


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------  156 (230)
                      ++++||+++++|.+++....           ...+++..+..++.+++.||.|||+++                      
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l  143 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRC-----------NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKI  143 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEE
Confidence            99999999999999997642           234788999999999999999999988                      


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           +..+...+.+.
T Consensus       144 ~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (256)
T cd08220         144 GDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD  223 (256)
T ss_pred             ccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCC
Confidence                                                                                 11111233455


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .++.++.+++.+||+.+|.+|||+.++++
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            67889999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.89  E-value=5.5e-22  Score=155.75  Aligned_cols=163  Identities=37%  Similarity=0.692  Sum_probs=132.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |-+..++|++.+.||+|+||.||++...       +..+++|.++...   ....+.+|+.++..+. |+|++++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~-~~~i~~~~~~~~   69 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYT-------GQKVAVKNIKCDV---TAQAFLEETAVMTKLH-HKNLVRLLGVIL   69 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccC-------CCceEEEeecCcc---hHHHHHHHHHHHHhCC-CCCcCeEEEEEc
Confidence            4456788999999999999999998653       2348999886432   3357889999999998 999999999986


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      .. ..++++||+++++|.+++....           ...+++..+..++.|++.||.|||+.+                 
T Consensus        70 ~~-~~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~  137 (254)
T cd05083          70 HN-GLYIVMELMSKGNLVNFLRTRG-----------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG  137 (254)
T ss_pred             CC-CcEEEEECCCCCCHHHHHHhcC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC
Confidence            54 5799999999999999987632           224788899999999999999999998                 


Q ss_pred             ------------------------------------------------------------------------CCCCccCC
Q psy15820        157 ------------------------------------------------------------------------VRDGYRLE  164 (230)
Q Consensus       157 ------------------------------------------------------------------------i~~~~~~~  164 (230)
                                                                                              +..+.+..
T Consensus       138 ~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  217 (254)
T cd05083         138 VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME  217 (254)
T ss_pred             cEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC
Confidence                                                                                    11122233


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      .+..+++.+.+++.+||+.+|+.|||+.+++..|.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            44567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=8.3e-22  Score=155.81  Aligned_cols=121  Identities=25%  Similarity=0.469  Sum_probs=103.0

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ....+|++.+.||+|+||.||+|..     ..++..+++|++.... ......+.+|+.++..+. |+||+++++.+...
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~   78 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARN-----LHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSR   78 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEE-----CCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Confidence            3567899999999999999999988     4455679999886432 223346788999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        79 ~~~~iv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  126 (267)
T cd06646          79 EKLWICMEYCGGGSLQDIYHVT-------------GPLSELQIAYVCRETLQGLAYLHSKG  126 (267)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999988652             24788999999999999999999988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.89  E-value=9.1e-22  Score=156.44  Aligned_cols=117  Identities=18%  Similarity=0.293  Sum_probs=94.1

Q ss_pred             eecceeceeEEEeEEeccCC-------------------CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820         26 ILGEGCFGQVWKCEALGIDG-------------------REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~-------------------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      .||+|+||.||+|.......                   ......+++|.+.... ......+.+|+.++..+. |+||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~-h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVS-HIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCC-CCCee
Confidence            58999999999998643210                   1112358888886432 233457888999999998 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++++...+..++||||+++|+|..++...            ...+++..+..++.|++.||.|||+++
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~  137 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE------------KGRVPVAWKITVAQQLASALSYLEDKN  137 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999888653            234788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=2.3e-21  Score=165.87  Aligned_cols=172  Identities=16%  Similarity=0.230  Sum_probs=138.7

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+......+|++.+.||+|+||.||+|..     ..++..||+|++... ........+.+|+.++..+. |+|+++++
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~   97 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKR-----VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCH   97 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEE-----cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEee
Confidence            344566778999999999999999999988     445667999998643 34555677889999999998 99999998


Q ss_pred             eEEecCC--------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----
Q psy15820         90 GCCTEKE--------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----  156 (230)
Q Consensus        90 ~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----  156 (230)
                      ..+....        .++++|||+++|+|.+++.....         ....+++..+..++.|++.||.|||+++     
T Consensus        98 ~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~---------~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrD  168 (496)
T PTZ00283         98 EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK---------TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD  168 (496)
T ss_pred             cceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhc---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence            8765432        26899999999999999876421         1235889999999999999999999988     


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       169 LKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~  248 (496)
T PTZ00283        169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE  248 (496)
T ss_pred             CCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                                                                                            


Q ss_pred             --------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        157 --------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       157 --------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                              +..+...+.|..+++++.+++.+||+.||.+||++.+++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        249 NMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                    11122334567788999999999999999999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.89  E-value=1.4e-21  Score=153.51  Aligned_cols=161  Identities=34%  Similarity=0.688  Sum_probs=131.4

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +..+|++.+.||+|+||.||++.+..      +..+++|.+.....  ....+..|+.++..+. |+|++++++.+....
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   72 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLE------KRKVAIKTIREGAM--SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERS   72 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeC------CCeEEEEECCCCCC--CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCC
Confidence            45689999999999999999998742      23489998864322  1246888999999998 999999999999888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..++++||+++++|.+++...            ...+++..+..++.|++.|+.|||+.+                    
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~  140 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQ------------RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVK  140 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhC------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEE
Confidence            999999999999999988753            224788899999999999999999888                    


Q ss_pred             -------------------------------------------------------------------------CCCCccC
Q psy15820        157 -------------------------------------------------------------------------VRDGYRL  163 (230)
Q Consensus       157 -------------------------------------------------------------------------i~~~~~~  163 (230)
                                                                                               +..+++.
T Consensus       141 l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05112         141 VSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL  220 (256)
T ss_pred             ECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC
Confidence                                                                                     1111122


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      ..|...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            23445678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.89  E-value=1.2e-21  Score=156.83  Aligned_cols=121  Identities=23%  Similarity=0.444  Sum_probs=101.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..++|++.+.||+|+||.||+|..     ..++..||+|+++..........+.+|+.++..+. |+||+++++++...+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   76 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRS-----KLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTER   76 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEE-----CCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCC
Confidence            457899999999999999999988     44556799999864433333456788999999998 999999999999888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++ +|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus        77 ~~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~~  123 (288)
T cd07871          77 CLTLVFEYLDS-DLKQYLDNC------------GNLMSMHNVKIFMFQLLRGLSYCHKRK  123 (288)
T ss_pred             eEEEEEeCCCc-CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999985 898888653            224688899999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0600|consensus

Probab=99.89  E-value=1.4e-22  Score=165.09  Aligned_cols=121  Identities=27%  Similarity=0.532  Sum_probs=105.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..+.|+.+++||+|.||.||+|.+     ..++..||+|.++-. ..+.......+||.+|.++. ||||+++.+.....
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~-----~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~  188 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARD-----LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSK  188 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeee-----cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEec
Confidence            456788889999999999999999     667778999999743 34555667889999999999 99999999998876


Q ss_pred             --CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 --EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        +.+|||+|||++ +|..++...            .-.+++.++..|+.|++.||.|||++|
T Consensus       189 ~~~siYlVFeYMdh-DL~GLl~~p------------~vkft~~qIKc~mkQLl~Gl~~cH~~g  238 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDH-DLSGLLSSP------------GVKFTEPQIKCYMKQLLEGLEYCHSRG  238 (560)
T ss_pred             CCceEEEEEecccc-hhhhhhcCC------------CcccChHHHHHHHHHHHHHHHHHhhcC
Confidence              689999999986 898888774            335899999999999999999999999

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.89  E-value=1.4e-21  Score=155.40  Aligned_cols=118  Identities=25%  Similarity=0.483  Sum_probs=101.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +-|+..+.||+|+||.||+|..     ..++..+|+|.+...........+.+|+.++..+. |+||+++++.+...+..
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   77 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGID-----NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL   77 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEE-----CCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeE
Confidence            3467788999999999999987     34456799998865444555677889999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++...              .+++..+..++.|++.|+.|||+.+
T Consensus        78 ~lv~e~~~~~~l~~~i~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~~  121 (277)
T cd06641          78 WIIMEYLGGGSALDLLEPG--------------PLDETQIATILREILKGLDYLHSEK  121 (277)
T ss_pred             EEEEEeCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHccCC
Confidence            9999999999999888642              3788999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG2345|consensus

Probab=99.89  E-value=3e-22  Score=150.14  Aligned_cols=130  Identities=17%  Similarity=0.305  Sum_probs=111.4

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..+..|+.++|.+.+.||+|+|+.||+++.     -.++..+|+|.+.... .+..+..++|++..+++. |||++++++
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~-----~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~-s~~vl~l~d   85 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKG-----LSTGHLYALKKILCHS-QEDIEEALREIDNHRKFN-SPNVLRLVD   85 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecc-----cCcccchhhheeeccc-hHHHHHHHHHHHHHHhhC-CcchHHHHH
Confidence            455679999999999999999999999986     4556679999987543 566788999999999999 999999988


Q ss_pred             EEecC-----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEK-----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +....     ...|+++.|...|+|.+.+.....+         +..+++.+++.|+.+|+.||.+||+..
T Consensus        86 h~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~k---------g~~~sE~~iL~if~gic~gL~~lH~~~  147 (302)
T KOG2345|consen   86 HQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIK---------GNFVSEAQILWIFLGICRGLEALHEKE  147 (302)
T ss_pred             HHHHhhccCceeEEEEeehhccccHHHHHHHHhhc---------CCccCHHHHHHHHHHHHHHHHHHhccC
Confidence            76543     3489999999999999999886542         346899999999999999999999988

>KOG0578|consensus

Probab=99.89  E-value=6.3e-23  Score=169.10  Aligned_cols=160  Identities=26%  Similarity=0.517  Sum_probs=134.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +...|....+||+|+.|.||.+...     .++..||+|++.... ....+-+++|+.++...+ |+|||.+++.+...+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~-----~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKI-----STKQEVAIKRMDLRK-QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeec-----cCCceEEEEEEEecc-CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccc
Confidence            3456777789999999999999984     445569999996442 223356889999999999 999999999998889


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      .+|+||||++||+|.+.+...              .+++.++..|++++++||.|||.++                    
T Consensus       344 eLWVVMEym~ggsLTDvVt~~--------------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vK  409 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT--------------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVK  409 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc--------------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEE
Confidence            999999999999999998764              3899999999999999999999999                    


Q ss_pred             -----------------------------------------------------------------------CCCCc--cC
Q psy15820        157 -----------------------------------------------------------------------VRDGY--RL  163 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~~--~~  163 (230)
                                                                                             +....  ..
T Consensus       410 ltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l  489 (550)
T KOG0578|consen  410 LTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL  489 (550)
T ss_pred             EeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc
Confidence                                                                                   11111  22


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      ..|+.+++++.+++.+||..|+++||++.+||+.
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            3457899999999999999999999999999973

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.88  E-value=3.6e-22  Score=158.82  Aligned_cols=118  Identities=25%  Similarity=0.478  Sum_probs=101.6

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +.|+..+.||+|+||.||+|.+     ..++..+|+|.++..........+.+|+.++..+. |+||+++++++...+..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGID-----NRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEE-----cCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence            3466778899999999999988     44556799999875544556678999999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++...              .+++..+..++.|++.|+.|||+++
T Consensus        78 ~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~  121 (277)
T cd06642          78 WIIMEYLGGGSALDLLKPG--------------PLEETYIATILREILKGLDYLHSER  121 (277)
T ss_pred             EEEEEccCCCcHHHHhhcC--------------CCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            9999999999999887542              3788899999999999999999988

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0588|consensus

Probab=99.88  E-value=2e-22  Score=168.85  Aligned_cols=158  Identities=25%  Similarity=0.443  Sum_probs=138.8

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      |++++.||.|+.|.|-+|++     ..+|+.+|||++...  ........+.+|+.+++.+. ||||+++|+++.++..+
T Consensus        14 wkLgkTLG~Gstg~vrlakh-----~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~l   87 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKH-----AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHL   87 (786)
T ss_pred             eeccccccCCCCceehhhhc-----ccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceE
Confidence            46788899999999999999     678888999999643  34445667889999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------  156 (230)
                      |+|+||+++|.|.+++...             +++++.+..++++||+.|+.|+|..+                      
T Consensus        88 ylvlEyv~gGELFdylv~k-------------G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIA  154 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRK-------------GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIA  154 (786)
T ss_pred             EEEEEecCCchhHHHHHhh-------------CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeee
Confidence            9999999999999999874             35999999999999999999999998                      


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           |..|. ...|.
T Consensus       155 DFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f~MPs  233 (786)
T KOG0588|consen  155 DFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-FEMPS  233 (786)
T ss_pred             ccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-ccCCC
Confidence                                                                                 33222 34678


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      +++.++.+||.+|+.-||++|.|+.+|++..
T Consensus       234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  234 NISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            9999999999999999999999999998753

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.6e-21  Score=159.21  Aligned_cols=119  Identities=24%  Similarity=0.415  Sum_probs=102.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .+|++.+.||+|+||.||+|.+     ..++..||+|+++...  .......+.+|+.++..+. |+||+++++.+...+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKK-----KDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEE-----CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCC
Confidence            4689999999999999999998     4455679999986431  2234567889999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~  121 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL-------------GVLSEDHARFYMAEMFEAVDALHELG  121 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998763             24788999999999999999999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.88  E-value=1.7e-21  Score=159.53  Aligned_cols=127  Identities=20%  Similarity=0.343  Sum_probs=107.7

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ....+..++|++.+.||+|+||.||+|.+...    ....+|+|.+...  ........+.+|+.++..+. ||||++++
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~   97 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNE----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLY   97 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECC----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceE
Confidence            34678889999999999999999999987432    2346999988532  12334567889999999999 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++...+..+++|||+++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~  151 (340)
T PTZ00426         98 GSFKDESYLYLVLEFVIGGEFFTFLRRN-------------KRFPNDVGCFYAAQIVLIFEYLQSLN  151 (340)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999998763             24788999999999999999999998

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=6.6e-22  Score=157.95  Aligned_cols=121  Identities=23%  Similarity=0.441  Sum_probs=102.9

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||++.+.     ..+..+|+|.++..........+.+|+.++..+. |+||+++++.+...+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLELDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc-----CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeE
Confidence            46889999999999999999883     4455699998875444555678899999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      ++++||+++++|.+++....          ....+++..+..++.|++.||.|||++
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~  121 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGV----------ATEGIPEDVLRRITYAVVKGLKFLKEE  121 (286)
T ss_pred             EEEEeecCCCCHHHHHHhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            99999999999998887631          123488999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.88  E-value=8.4e-22  Score=160.24  Aligned_cols=113  Identities=22%  Similarity=0.329  Sum_probs=97.2

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++..     ..++..+|+|+++..  ........+.+|+.++..+. ||||+++++.+...+..+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVRE-----KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEE
Confidence            3689999999999988     455667999998643  12334557889999999999 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        75 e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~~  115 (323)
T cd05571          75 EYANGGELFFHLSRE-------------RVFSEDRARFYGAEIVSALGYLHSCD  115 (323)
T ss_pred             eCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999888763             24789999999999999999999999

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.2e-21  Score=156.49  Aligned_cols=120  Identities=18%  Similarity=0.334  Sum_probs=100.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .|++.+.||+|+||.||++..     ..++..||+|.+....  .......+.+|+.++..+. |+||+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEE-----cCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCe
Confidence            478889999999999999988     4456679999986431  1223345788999999998 9999999999998889


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++|+|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~  122 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMG-----------NPGFDEERAVFYAAEITCGLEDLHRER  122 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcC-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999998876521           234789999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=2.7e-21  Score=152.38  Aligned_cols=119  Identities=27%  Similarity=0.489  Sum_probs=101.3

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC----CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ++|++.+.||+|++|.||.+..     ..++..+++|.+....    .......+.+|+.++..+. |+||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~-----~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYD-----VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEE-----cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEcc
Confidence            5788999999999999999987     3445569999885331    1223457889999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lH~~~  124 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAY-------------GALTETVTRKYTRQILEGVEYLHSNM  124 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999998763             24788899999999999999999988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.88  E-value=4.5e-21  Score=163.67  Aligned_cols=164  Identities=18%  Similarity=0.187  Sum_probs=132.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ...|.+.+.||+|+||.||.|.....    .+..+++|.+... .......+.+|+.++..+. ||||+++++++...+.
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~----~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSD----PKEKVVAKFVMLN-DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDK  139 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCC----CCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCE
Confidence            44599999999999999999987432    1445888876433 3344456788999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      .++||||+++|+|.+++.....         ....+++..+..++.|++.||.|||+++                     
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL  210 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLK---------EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL  210 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEE
Confidence            9999999999999998875321         1235788899999999999999999998                     


Q ss_pred             ------------------------------------------------------------------------CCCCccCC
Q psy15820        157 ------------------------------------------------------------------------VRDGYRLE  164 (230)
Q Consensus       157 ------------------------------------------------------------------------i~~~~~~~  164 (230)
                                                                                              +..+...+
T Consensus       211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  290 (478)
T PTZ00267        211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP  290 (478)
T ss_pred             EeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence                                                                                    11122334


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .|..+++++.+++.+||..||+.||++.+++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            55678899999999999999999999999875

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.88  E-value=1.9e-21  Score=152.77  Aligned_cols=167  Identities=50%  Similarity=0.885  Sum_probs=134.1

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||+|+||.||.|......  ..+..+++|.++..........+.+|+..+..+. |+||+++++++......++++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            46899999999999995431  2245699999975544445678999999999999 99999999999998999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------  156 (230)
                      +++++|.+++.......    .......+++..+..++.|++.||.|||+++                            
T Consensus        78 ~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          78 MEGGDLLDYLRKSRPVF----PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             ccCCcHHHHHhhccccc----cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence            99999999988741000    0001245899999999999999999999998                            


Q ss_pred             ------------------------------------------------------------------CCCCccCCCCCcCc
Q psy15820        157 ------------------------------------------------------------------VRDGYRLEKPDHCR  170 (230)
Q Consensus       157 ------------------------------------------------------------------i~~~~~~~~p~~~~  170 (230)
                                                                                        +..+.+...|..++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP  233 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence                                                                              11122334556788


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        171 RELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       171 ~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      .++.+++.+||..+|.+|||+.++++.|
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         234 DELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             hHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            9999999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0597|consensus

Probab=99.88  E-value=1.4e-22  Score=167.30  Aligned_cols=158  Identities=24%  Similarity=0.454  Sum_probs=138.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC-CcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|.+.+.||+|+||.||+|..     +++...||+|.+. ......+...+.+|++++..++ ||||+.++++|.....
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrr-----K~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRR-----KYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccc-----ccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccce
Confidence            5788889999999999999998     6778889999995 4455667888999999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      +|+|+|||.| +|..++..             ...+++..+..++.+++.||.|||+.+                     
T Consensus        76 ~~vVte~a~g-~L~~il~~-------------d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~Kl  141 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQ-------------DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKL  141 (808)
T ss_pred             EEEEehhhhh-hHHHHHHh-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceee
Confidence            9999999987 99999987             345999999999999999999999998                     


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           .........|.
T Consensus       142 cdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~  221 (808)
T KOG0597|consen  142 CDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS  221 (808)
T ss_pred             chhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc
Confidence                                                                                 11112334566


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ..+..+.++++..|.+||..|.|..+++.
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            88899999999999999999999999986

>KOG1024|consensus

Probab=99.88  E-value=2.7e-22  Score=159.27  Aligned_cols=189  Identities=31%  Similarity=0.502  Sum_probs=158.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +.+...+++....+-+|.||.||.|.|...+.-.+.+.|.+|.++...++.....++.|...+..+. |+|+..+.+++.
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~i  357 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeEEEe
Confidence            3456667777888999999999999887665445556688999988888888889999999999999 999999999876


Q ss_pred             -cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         94 -EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        94 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                       +....++++.+..-|+|..|+...+..     .......++..++..++.|++.||.|||+.+                
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~-----~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGD-----DPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccC-----CCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence             456788999999999999999864411     0112344778889999999999999999999                


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence                                                                                          88


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      +|.|..+|-|||+++..++..||+.+|++||+|.|+..+|..+...-..|
T Consensus       513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~Y  562 (563)
T KOG1024|consen  513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRY  562 (563)
T ss_pred             ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhc
Confidence            99999999999999999999999999999999999999998776544433

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.6e-21  Score=154.76  Aligned_cols=118  Identities=23%  Similarity=0.458  Sum_probs=103.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||.|++|.||+|..     ..++..+++|.+...........+.+|+.++..+. |+||+++++.+......
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAID-----KRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEE-----CCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeE
Confidence            4688889999999999999988     44566799999865444445567889999999999 99999999999988999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lh~~~  118 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG--------------KLDETYIAFILREVLLGLEYLHEEG  118 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999998752              4789999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.88  E-value=4.3e-21  Score=153.20  Aligned_cols=131  Identities=19%  Similarity=0.367  Sum_probs=104.2

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+.+....++|++.+.||+|+||.||++..     ..++..+++|+++...  .....+.+|+.++..+..|+||++++
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~-----~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~   81 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLN-----KKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFY   81 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEE-----CCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeee
Confidence            3455667889999999999999999999988     3445569999876432  22345778999999984499999999


Q ss_pred             eEEe-----cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCT-----EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++.     ..+..+++|||+++++|.+++.....         ....+++..+..++.|++.||.|||+++
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~  144 (286)
T cd06638          82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK---------RGERMEEPIIAYILHEALMGLQHLHVNK  144 (286)
T ss_pred             eeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhc---------cCccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            9874     34568999999999999998875321         1234788889999999999999999987

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.5e-21  Score=155.50  Aligned_cols=121  Identities=26%  Similarity=0.484  Sum_probs=104.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.++|++.+.||.|+||.||++...     .++..+++|.+... .......+..|+.++..+. |+||+++++.+....
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   75 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKIIQIE-SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYEN   75 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEc-----CCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCC
Confidence            4567999999999999999999884     34556999998643 3445577889999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~------------~~~l~~~~~~~~~~ql~~~l~~lh~~~  123 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLEL------------ERGLTEPQIRYVCRQMLEALNFLHSHK  123 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998763            234889999999999999999999988

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.88  E-value=2.4e-21  Score=154.88  Aligned_cols=120  Identities=18%  Similarity=0.330  Sum_probs=100.3

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .|+..+.||+|+||.||++..     ..++..+|+|.+....  .......+.+|+.++..+. |+||+++++.+...+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEE-----ecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCe
Confidence            377889999999999999998     4455679999886331  2223346788999999998 9999999999999899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+++|+|.+.+....           ...+++..+..++.|++.||.|||+++
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~  122 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMG-----------NPGFDEQRAIFYAAELCCGLEDLQRER  122 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999988876431           224788999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.88  E-value=2.4e-21  Score=152.03  Aligned_cols=123  Identities=46%  Similarity=0.803  Sum_probs=103.6

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV  100 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~l  100 (230)
                      +++.+.||.|+||.||++.+.... ......+|+|.++..........+..|+.++..+. |+||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLS-GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCC-CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEE
Confidence            356788999999999999996433 12346699999976555546678999999999997 9999999999999899999


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++||+++++|.+++....           ...+++..+..++.|++.|+.|||+.+
T Consensus        79 i~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lh~~~  123 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNR-----------PKELSLSDLLSFALQIARGMEYLESKN  123 (258)
T ss_pred             EEeccCCCCHHHHHHhhh-----------hccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            999999999999987642           112789999999999999999999998

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.88  E-value=3.7e-21  Score=153.25  Aligned_cols=115  Identities=23%  Similarity=0.342  Sum_probs=99.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..+|+|.+...........+.+|+.++..+. |+||+++++.+...+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   74 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYH-----LLTRRILAVKVIPLDITVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRI   74 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEE-----cCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEE
Confidence            4688899999999999999988     34556699999865444555667999999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|..+.                 .+++..+..++.|++.||.|||+.+
T Consensus        75 ~lv~e~~~~~~l~~~~-----------------~~~~~~~~~~~~qi~~~l~~lH~~~  115 (279)
T cd06619          75 SICTEFMDGGSLDVYR-----------------KIPEHVLGRIAVAVVKGLTYLWSLK  115 (279)
T ss_pred             EEEEecCCCCChHHhh-----------------cCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999985431                 2678889999999999999999999

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.88  E-value=7.7e-21  Score=150.41  Aligned_cols=124  Identities=27%  Similarity=0.430  Sum_probs=102.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +++..+.+.....||+|+||.||+|.+     ..++..+++|.+.... ......+.+|+.++..++ |+||+++++++.
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   75 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARD-----LSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLK-HRNIVQYLGSDS   75 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEe-----cCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcC-CCCeeeeeeeec
Confidence            455666666667899999999999987     3445669999886432 334567889999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCC--ChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL--TSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..++++||+++++|.+++....            ..+  ++..+..++.|++.||.|||+++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~qi~~al~~lH~~~  128 (268)
T cd06624          76 ENGFFKIFMEQVPGGSLSALLRSKW------------GPLKDNEQTIIFYTKQILEGLKYLHDNQ  128 (268)
T ss_pred             cCCEEEEEEecCCCCCHHHHHHHhc------------ccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999987632            123  77888899999999999999998

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=1.5e-21  Score=155.91  Aligned_cols=121  Identities=21%  Similarity=0.349  Sum_probs=104.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||++.+     ..++..+|+|++...........+.+|+.++..+. |+||+++++.+...
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~-----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   75 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKH-----IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFLNE   75 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEE-----cCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEecC
Confidence            4567899999999999999999988     44556699998865444555678899999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      +..++++||+++++|.+++...             ..+++..+..++.+++.||.|||+.
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~LH~~  122 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKG-------------GPIPVEILGKIAVAVVEGLTYLYNV  122 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999888653             2478899999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.88  E-value=2.5e-21  Score=154.67  Aligned_cols=119  Identities=26%  Similarity=0.533  Sum_probs=99.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..+|+|+++.. ........+.+|+.++..+. |+||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRH-----KETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEE-----CCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEecCCE
Confidence            4689999999999999999998     445667999998643 22334567889999999999 9999999999999899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||++++.+..+...             ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~lH~~~  120 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM-------------PNGVPPEKVRSYIYQLIKAIHWCHKND  120 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999998766544322             234888999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0592|consensus

Probab=99.88  E-value=6.1e-22  Score=162.62  Aligned_cols=124  Identities=22%  Similarity=0.390  Sum_probs=106.6

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .-...+|.+++.||+|+|++|++|..     ..+++.+|+|++....  ......-...|-.+|..+.+||.|+++|--|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~-----~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLARE-----KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeee-----cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            34678999999999999999999999     4566679999986432  1222344667888899996699999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+...+|+|+||+++|+|.++|....             .+.+...+.++.+|+.||.|||++|
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~G-------------sfde~caR~YAAeIldAleylH~~G  194 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYG-------------SFDETCARFYAAEILDALEYLHSNG  194 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhC-------------cchHHHHHHHHHHHHHHHHHHHhcC
Confidence            99999999999999999999999853             4899999999999999999999999

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=6e-21  Score=150.81  Aligned_cols=118  Identities=25%  Similarity=0.452  Sum_probs=98.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--------HHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--------ERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +|.++..||+|++|.||.|...     .++..+++|.+.....        ......+.+|+.++..+. |+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA-----SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEec-----CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEE
Confidence            3667889999999999999873     3445699998853211        122356889999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~~l~~~l~~lH~~~  126 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNY-------------GAFEETLVRNFVRQILKGLNYLHNRG  126 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhc-------------cCccHHHHHHHHHHHHHHHHHHHhcC
Confidence            99999999999999999999999763             24788889999999999999999888

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.87  E-value=7.8e-21  Score=148.83  Aligned_cols=156  Identities=38%  Similarity=0.790  Sum_probs=129.4

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||.|+||.||++....      +..+++|.+...........+.+|+.++..+. |+||+++++++......++++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEc
Confidence            368999999999998843      34599999876544556678999999999999 99999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------------
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------------  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------------  156 (230)
                      +++++|.+++...            ...++...+..++.+++.|+.|||+++                            
T Consensus        74 ~~~~~l~~~l~~~------------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~  141 (251)
T cd05041          74 VPGGSLLTFLRKK------------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR  141 (251)
T ss_pred             CCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccc
Confidence            9999999998763            224788899999999999999999988                            


Q ss_pred             ------------------------------------------------------------------CCCCccCCCCCcCc
Q psy15820        157 ------------------------------------------------------------------VRDGYRLEKPDHCR  170 (230)
Q Consensus       157 ------------------------------------------------------------------i~~~~~~~~p~~~~  170 (230)
                                                                                        +..+.+.+.|..++
T Consensus       142 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (251)
T cd05041         142 EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCP  221 (251)
T ss_pred             cccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence                                                                              11111223345677


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        171 RELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       171 ~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      .++.+++.+||..+|.+|||+.++++.|.
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            89999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.87  E-value=9.8e-21  Score=149.94  Aligned_cols=120  Identities=31%  Similarity=0.564  Sum_probs=96.9

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||+|+||.||+|...+   ..+...+++|.++..........+.+|+.++..++ |+||+++++++......+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcC---CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence            358999999999998743   23345689998875544555567899999999999 99999999999988889999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++|+|.+++......        .....++..+..++.|++.||.|||+.+
T Consensus        77 ~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (269)
T cd05087          77 CPLGDLKGYLRSCRKA--------ELMTPDPTTLQRMACEIALGLLHLHKNN  120 (269)
T ss_pred             CCCCcHHHHHHHhhhc--------ccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999764310        1123566778889999999999999888

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.87  E-value=6.8e-21  Score=150.42  Aligned_cols=117  Identities=26%  Similarity=0.488  Sum_probs=98.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-----CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      +|++++.||+|+||.||+|...      ++..+|+|.++...     .......+.+|+.++..+. |+||+++++++..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeec
Confidence            4778899999999999999752      34458999886331     1223456889999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  122 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRF-------------GPLPEPVFCKYTKQILDGVAYLHNNC  122 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999998763             24788899999999999999999987

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.87  E-value=8.5e-21  Score=149.40  Aligned_cols=163  Identities=22%  Similarity=0.428  Sum_probs=132.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC-cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--CC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KE   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--~~   96 (230)
                      +|++.+.||.|+||.||++..     ..++..+++|.++. .........+..|+.++..+. |+||+++++.+..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRR-----KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeee-----cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCC
Confidence            578889999999999999988     44556699998863 334556678899999999999 9999999998754  44


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhh-----hcC---------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS-----SRG---------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH-----~~~---------------  156 (230)
                      ..++++||+++++|.+++.....         ....+++..++.++.|++.||.|||     +.+               
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~  145 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKK---------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA  145 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec
Confidence            58999999999999999976421         1345889999999999999999999     555               


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       146 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  225 (265)
T cd08217         146 NNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG  225 (265)
T ss_pred             CCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC
Confidence                                                                                        1222


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .....+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            2234556778899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.87  E-value=9.7e-21  Score=152.18  Aligned_cols=119  Identities=21%  Similarity=0.453  Sum_probs=101.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ...+|++.+.||+|+||.||++..     ..++..+++|.+...... ....+.+|+.++..+. |+||+++++.+....
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~   90 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMD-----VATGQEVAIRQMNLQQQP-KKELIINEILVMRENK-NPNIVNYLDSYLVGD   90 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEE-----CCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCC
Confidence            456899999999999999999987     344556999988643322 3466889999999998 999999999999888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++|+||+++++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~i~~ql~~aL~~LH~~g  136 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQ  136 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999988652              3788899999999999999999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.87  E-value=3.8e-21  Score=150.99  Aligned_cols=120  Identities=21%  Similarity=0.456  Sum_probs=101.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|+||.||++..     ..++..+++|.+... ........+.+|+.++..++ |+||+++++.+...+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKA-----KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEE-----cCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeE
Confidence            578899999999999999998     444556899998532 22334567889999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++....           ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~~  121 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQR-----------GVLFSEDQILSWFVQISLGLKHIHDRK  121 (257)
T ss_pred             EEEEecCCCCcHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999887531           224788999999999999999999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.87  E-value=8.7e-21  Score=149.00  Aligned_cols=160  Identities=21%  Similarity=0.356  Sum_probs=130.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec-CCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~-~~~   97 (230)
                      +|++.+.||+|++|.||.+...     .++..+++|.+... ........+.+|+.++..++ |+|++++++.+.. .+.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR-----TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc-----CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCE
Confidence            4889999999999999999983     44556999998633 23445567889999999998 9999999988764 345


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      .++++||+++++|.+++....           ...+++.++..++.|++.|+.|||+.+                     
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~-----------~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l  143 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQK-----------GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKV  143 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEE
Confidence            799999999999999987632           234789999999999999999999998                     


Q ss_pred             ----------------------------------------------------------------------CCCCccCCCC
Q psy15820        157 ----------------------------------------------------------------------VRDGYRLEKP  166 (230)
Q Consensus       157 ----------------------------------------------------------------------i~~~~~~~~p  166 (230)
                                                                                            +..+..+..+
T Consensus       144 ~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  223 (257)
T cd08223         144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP  223 (257)
T ss_pred             ecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence                                                                                  1111222344


Q ss_pred             CcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        167 DHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       167 ~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ...++++.+++.+||+.+|++|||+.+++.
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            567789999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=2.5e-21  Score=156.74  Aligned_cols=111  Identities=21%  Similarity=0.355  Sum_probs=95.6

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      ||+|+||.||++..     ..++..+|+|.++..  ........+.+|+.++..+. ||||+++++++...+..+++|||
T Consensus         1 lg~G~~g~Vy~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRK-----RDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcC
Confidence            69999999999998     445567999998632  23344567889999999998 99999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  113 (312)
T cd05585          75 INGGELFHHLQRE-------------GRFDLSRARFYTAELLCALENLHKFN  113 (312)
T ss_pred             CCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999998763             24788999999999999999999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.87  E-value=3e-21  Score=152.32  Aligned_cols=120  Identities=25%  Similarity=0.404  Sum_probs=104.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||++..     ..++..+++|.+...........+.+|+.++..+. |+||+++++.+...+..
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   74 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLH-----RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDI   74 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEE-----cCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEE
Confidence            3678889999999999999988     44556699999876545566678999999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      ++++||+++++|.+++....            ..+++..+..++.|++.||.|||+ .+
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~~  121 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ------------GRIPERILGKIAVAVLKGLTYLHEKHK  121 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc------------CCCCHHHHHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999987631            357889999999999999999999 66

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.87  E-value=5.2e-21  Score=151.34  Aligned_cols=124  Identities=40%  Similarity=0.739  Sum_probs=98.7

Q ss_pred             eecceeceeEEEeEEeccCC-CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         26 ILGEGCFGQVWKCEALGIDG-REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      .||+|+||.||+|....... ...+..+++|.+...........+.+|+.++..+. |+||+++++++...+..++++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEEEec
Confidence            58999999999998854321 12334689998865443455667899999999998 99999999999988899999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++|.+++........      ....+++..+..++.|++.||.|||+++
T Consensus        81 ~~~~~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (269)
T cd05044          81 MEGGDLLSYLRDARVERF------GPPLLTLKELLDICLDVAKGCVYLEQMH  126 (269)
T ss_pred             cCCCcHHHHHHHhhhccc------CCccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999976421100      1223688899999999999999999987

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.87  E-value=6.4e-21  Score=150.66  Aligned_cols=118  Identities=22%  Similarity=0.408  Sum_probs=100.9

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-----HHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-----ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      +|+.++.||+|++|.||.+..     ..++..+++|.++....     ......+.+|+.++..++ |+||+++++.+..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARD-----VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEE-----cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceecc
Confidence            477889999999999999987     34456699999863221     224567899999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~ql~~al~~LH~~~  123 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKY-------------GAFKEAVIINYTEQLLRGLSYLHENQ  123 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999998763             24788999999999999999999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=9.6e-21  Score=151.77  Aligned_cols=124  Identities=26%  Similarity=0.509  Sum_probs=105.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +-.+.+.|++.+.||.|+||.||+|..     ..++..+++|.+... .......+.+|+.++..+. |+||+++++.+.
T Consensus         7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~-----~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   79 (292)
T cd06644           7 DLDPNEVWEIIGELGDGAFGKVYKAKN-----KETGALAAAKVIETK-SEEELEDYMVEIEILATCN-HPYIVKLLGAFY   79 (292)
T ss_pred             ccCcchhhhhhheecCCCCeEEEEEEE-----CCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEE
Confidence            334567899999999999999999988     444556999998643 3555677889999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..+++|||+++++|..++...            ...+++..+..++.|++.||.|||+.+
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~~~~~------------~~~l~~~~~~~~~~ql~~~l~~lH~~~  130 (292)
T cd06644          80 WDGKLWIMIEFCPGGAVDAIMLEL------------DRGLTEPQIQVICRQMLEALQYLHSMK  130 (292)
T ss_pred             eCCeEEEEEecCCCCcHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999998887653            234789999999999999999999988

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=1.8e-20  Score=149.85  Aligned_cols=123  Identities=26%  Similarity=0.433  Sum_probs=102.4

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--CC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--~~   96 (230)
                      ++|...+.||.|++|.||++...     .++..+++|.+...........+.+|++++..+. |+||+++++++..  .+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLK-----NTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEEC-----CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCC
Confidence            46888999999999999999983     4556799999875544455678999999999998 9999999998864  34


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++|||+++++|.+++.....         ....+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~lH~~~  125 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKK---------RGGRIGEKVLGKIAESVLKGLSYLHSRK  125 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            68999999999999998765321         1234788899999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.87  E-value=4.7e-21  Score=150.40  Aligned_cols=118  Identities=24%  Similarity=0.561  Sum_probs=102.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||++...     .++..+++|.++...   ....+.+|++++..+. |+||+++++.+.....
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~   72 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEE---DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTD   72 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEc-----CCCcEEEEEEeecHH---HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCc
Confidence            578899999999999999999884     345569999886432   2578999999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+++++|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~------------~~~l~~~~~~~~~~~l~~~l~~lh~~~  119 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKIT------------NKTLTEEEIAAILYQTLKGLEYLHSNK  119 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhC------------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999998753            235789999999999999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.87  E-value=9.9e-21  Score=150.82  Aligned_cols=123  Identities=21%  Similarity=0.363  Sum_probs=98.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||++.+     ..++..||+|+++..........+..|+..+.+...|+||+++++++...+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRH-----VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEE-----cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence            4789999999999999999998     45566799999875433333455666777644444499999999999998999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      ++++||++ |+|.+++.....         ....+++..+..++.|++.||.|||++ +
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~  124 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYD---------KGLTIPEDILGKIAVSIVKALEYLHSKLS  124 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence            99999997 589888876321         123589999999999999999999987 5

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.87  E-value=5.1e-21  Score=155.85  Aligned_cols=117  Identities=17%  Similarity=0.315  Sum_probs=99.0

Q ss_pred             Eeeeecce--eceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         23 VFDILGEG--CFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        23 ~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      +++.||+|  +||.||++..     +.++..||+|+++... .......+.+|+.++..+. ||||+++++++...+..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARY-----KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEee-----cccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEE
Confidence            46789999  7789999988     4566679999997442 3444556778999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||+++|+|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        76 lv~e~~~~~~l~~~~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~  121 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHF-----------MDGMSELAIAYILQGVLKALDYIHHMG  121 (327)
T ss_pred             EEEeccCCCcHHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999987642           224788999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.87  E-value=3e-21  Score=157.05  Aligned_cols=113  Identities=22%  Similarity=0.358  Sum_probs=96.4

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++..     ..++..||+|+++..  ........+.+|+.++..+. ||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVRE-----KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEE
Confidence            3689999999999988     445667999998643  12334556788999999998 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.||+.||.|||+++
T Consensus        75 E~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~  115 (323)
T cd05595          75 EYANGGELFFHLSRE-------------RVFTEERARFYGAEIVSALEYLHSRD  115 (323)
T ss_pred             eCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999998887653             24789999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.87  E-value=8.5e-22  Score=155.14  Aligned_cols=118  Identities=22%  Similarity=0.410  Sum_probs=95.0

Q ss_pred             eeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||+|.......  ......+++|.+... .......+..|+.++..+. |+||+++++++......+++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEEEE
Confidence            368999999999998753221  112334777877532 2334567888999999998 999999999999888999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|.+++....            ..+++..++.++.||+.||.|||+++
T Consensus        79 e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (258)
T cd05078          79 EYVKFGSLDTYLKKNK------------NLINISWKLEVAKQLAWALHFLEDKG  120 (258)
T ss_pred             ecCCCCcHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999987632            24788899999999999999999999

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.87  E-value=1.9e-20  Score=147.44  Aligned_cols=119  Identities=24%  Similarity=0.451  Sum_probs=104.4

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|++|.||++...     .++..+++|++...........+.+|+..+..+. |+|++++++.+...+..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK-----PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeE
Confidence            46889999999999999999984     4556699999875544355678999999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      ++++||+++++|.+++...             ..+++..+..++.|++.|+.|||+ .+
T Consensus        75 ~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~~l~~~l~~lh~~~~  120 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV-------------GKIPEPVLAYIARQILKGLDYLHTKRH  120 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            9999999999999998763             248899999999999999999999 77

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.87  E-value=8.2e-21  Score=153.02  Aligned_cols=120  Identities=24%  Similarity=0.467  Sum_probs=101.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||+|..     ..++..+|+|+++..........+.+|+.++..+. |+||+++++++.....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKS-----KVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEE-----CCCCCEEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCe
Confidence            47899999999999999999998     44556799999864433333346778999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||++ ++|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~lH~~~  123 (303)
T cd07869          78 LTLVFEYVH-TDLCQYMDKH------------PGGLHPENVKLFLFQLLRGLSYIHQRY  123 (303)
T ss_pred             EEEEEECCC-cCHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999996 5888887653            234788899999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.87  E-value=9.7e-21  Score=150.96  Aligned_cols=117  Identities=24%  Similarity=0.521  Sum_probs=100.2

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV  100 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~l  100 (230)
                      |++.+.||+|+||.||++..     ..++..+++|.+... .......+.+|+.++..+. |+||+++++.+...+..++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~-----~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~   79 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQN-----KETGVLAAAKVIDTK-SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI   79 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEE-----CCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEE
Confidence            57788999999999999988     445556888888543 3445667889999999998 9999999999999899999


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++||+++++|..++...            ...+++..+..++.|++.||.|||+.+
T Consensus        80 v~e~~~~~~l~~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~  123 (282)
T cd06643          80 LIEFCAGGAVDAVMLEL------------ERPLTEPQIRVVCKQTLEALNYLHENK  123 (282)
T ss_pred             EEEecCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999998887652            234889999999999999999999988

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.87  E-value=3.6e-21  Score=156.22  Aligned_cols=114  Identities=29%  Similarity=0.481  Sum_probs=95.5

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++.+.     .++..+|+|+++..  ........+..|..++..+..|+||+++++++...+.++++|
T Consensus         1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELK-----GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            36899999999999983     44556999998643  123345567788888887755999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~~  116 (318)
T cd05570          76 EYVNGGDLMFHIQRS-------------GRFDEPRARFYAAEIVLGLQFLHERG  116 (318)
T ss_pred             cCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999888753             24889999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.87  E-value=5.8e-21  Score=155.64  Aligned_cols=113  Identities=25%  Similarity=0.363  Sum_probs=96.9

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++..     ..++..+|+|++...  ........+.+|+.++..+. ||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVRE-----KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEE
Confidence            3689999999999998     455667999998643  22344567889999999999 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|...+...             ..+++..+..++.||+.||.|||+++
T Consensus        75 Ey~~~g~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~  115 (328)
T cd05593          75 EYVNGGELFFHLSRE-------------RVFSEDRTRFYGAEIVSALDYLHSGK  115 (328)
T ss_pred             eCCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999998887653             24889999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0579|consensus

Probab=99.87  E-value=7.4e-23  Score=171.07  Aligned_cols=160  Identities=27%  Similarity=0.533  Sum_probs=135.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+.+.|+..||.|+||+||+|..     +.++...|.|+|.. .+.+....|+-|+++|..+. ||+||++++.|...+.
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~n-----ket~~lAAaKvIet-kseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enk  103 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVN-----KETKLLAAAKVIET-KSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENK  103 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhc-----ccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCc
Confidence            34456778899999999999988     44455577787753 45778899999999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      +|++.|||.||-....+-..            +..+++.++.-+++|++.||.|||+++                     
T Consensus       104 LwiliEFC~GGAVDaimlEL------------~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirL  171 (1187)
T KOG0579|consen  104 LWILIEFCGGGAVDAIMLEL------------GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRL  171 (1187)
T ss_pred             eEEEEeecCCchHhHHHHHh------------ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEee
Confidence            99999999999998877763            456999999999999999999999998                     


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 |....
T Consensus       172 ADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe  251 (1187)
T KOG0579|consen  172 ADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE  251 (1187)
T ss_pred             ecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC
Confidence                                                                                       11111


Q ss_pred             --cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        162 --RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       162 --~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                        -...|..++..+.+++.+||..||..||++.+|++
T Consensus       252 PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  252 PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence              22467889999999999999999999999999986

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.87  E-value=4.2e-21  Score=155.79  Aligned_cols=116  Identities=23%  Similarity=0.421  Sum_probs=96.8

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEe
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME  103 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e  103 (230)
                      +.||+|+||.||++.....  ..++..+|+|+++... .......+.+|+.++..+. |+||+++++.+...+..++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG--PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEc
Confidence            5799999999999876321  2456679999986432 2233456778999999998 9999999999999999999999


Q ss_pred             cCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        104 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       104 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+++|+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        79 ~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~  118 (318)
T cd05582          79 FLRGGDLFTRLSKE-------------VMFTEEDVKFYLAELALALDHLHSLG  118 (318)
T ss_pred             CCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999988653             24789999999999999999999999

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.87  E-value=9.9e-21  Score=152.96  Aligned_cols=121  Identities=22%  Similarity=0.454  Sum_probs=101.1

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..++|.+.+.||+|+||.||+|.+     ..++..+|+|.++..........+.+|+.++..+. |+||+++++++...+
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   77 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRS-----KLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDK   77 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEe-----cCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCC
Confidence            347799999999999999999988     34455699999864433333446778999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++ +|.+++...            ...++...+..++.|++.||.|||+++
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~lH~~~  124 (309)
T cd07872          78 SLTLVFEYLDK-DLKQYMDDC------------GNIMSMHNVKIFLYQILRGLAYCHRRK  124 (309)
T ss_pred             eEEEEEeCCCC-CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999985 888877653            224788889999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.87  E-value=1.4e-20  Score=151.26  Aligned_cols=118  Identities=21%  Similarity=0.430  Sum_probs=101.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ..+|++.+.||+|+||.||++..     ..++..+++|.+..... .....+.+|+.++..+. |+||+++++.+...+.
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~   90 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAID-----IATGQEVAIKQMNLQQQ-PKKELIINEILVMRENK-NPNIVNYLDSYLVGDE   90 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEE-----CCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCE
Confidence            47889999999999999999987     44556799999864322 23456888999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+++++|.+++...              .+++..+..++.|++.||.|||+.+
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~~l~~~L~~LH~~~  135 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALDFLHSNQ  135 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999988652              3788899999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.87  E-value=7e-21  Score=150.38  Aligned_cols=118  Identities=23%  Similarity=0.367  Sum_probs=94.4

Q ss_pred             eeecceeceeEEEeEEeccCC-------CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         25 DILGEGCFGQVWKCEALGIDG-------REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +.||+|+||.||.|.......       ......+++|.+.... ......+..|+.++..+. ||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVS-HKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCC
Confidence            358999999999998643210       1123358888875432 334457888999999998 9999999999998888


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+++++|..++...            ...+++..+..++.||+.||.|||+++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~  125 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRK------------SDVLTTPWKFKVAKQLASALSYLEDKD  125 (262)
T ss_pred             CEEEEecccCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence            99999999999998887653            234788999999999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.87  E-value=1.3e-20  Score=147.99  Aligned_cols=118  Identities=27%  Similarity=0.506  Sum_probs=100.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC----CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +|+..+.||+|++|.||+|..     ..++..+++|.+....    .......+.+|+.++..+. |+||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLN-----LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEE-----cCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecC
Confidence            467778999999999999988     3345569999885321    2345567899999999998 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~  122 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKY-------------GSFPEPVIRLYTRQILLGLEYLHDRN  122 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999998763             23788899999999999999999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.87  E-value=1e-20  Score=152.28  Aligned_cols=121  Identities=24%  Similarity=0.463  Sum_probs=102.0

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..++|++.+.||+|+||.||+|.+     ..++..+|+|.++..........+.+|+.++..+. |+||+++++++...+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~   77 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRS-----KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEK   77 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEE-----cCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEecCC
Confidence            457899999999999999999988     34455699999864433333456778999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||++ ++|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~~~~qi~~aL~~lH~~~  124 (301)
T cd07873          78 SLTLVFEYLD-KDLKQYLDDC------------GNSINMHNVKLFLFQLLRGLNYCHRRK  124 (301)
T ss_pred             eEEEEEeccc-cCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999997 5898888653            224788899999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.87  E-value=6.3e-21  Score=155.50  Aligned_cols=114  Identities=23%  Similarity=0.431  Sum_probs=96.7

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++..     ..++..+|+|+++..  ........+..|..++..+..||||+++++++...+..+++|
T Consensus         1 ~~lG~G~~g~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVEL-----KKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence            3689999999999998     445567999999643  223345568889999998855999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 e~~~~g~L~~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~  116 (329)
T cd05588          76 EFVSGGDLMFHMQRQ-------------RKLPEEHARFYSAEISLALNFLHERG  116 (329)
T ss_pred             eCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999998887653             24899999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.87  E-value=5.2e-21  Score=155.65  Aligned_cols=116  Identities=24%  Similarity=0.449  Sum_probs=95.7

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHh---hcCCCCceeeEeeEEecC
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMK---TLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~---~~~~h~niv~l~~~~~~~   95 (230)
                      |++.+.||+|+||.||++.+     ..++..+|+|+++..  ........+.+|.+++.   .+. ||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEY-----KKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcC
Confidence            67889999999999999988     445567999998633  12233456777776654   555 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++||||+++++|...+..              ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~--------------~~l~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT--------------DVFSEPRAVFYAACVVLGLQYLHENK  121 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999887754              24889999999999999999999999

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.87  E-value=1.8e-20  Score=150.60  Aligned_cols=119  Identities=23%  Similarity=0.477  Sum_probs=102.2

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ...+|++.+.||.|++|.||++..     ..++..+++|.+..... .....+.+|+.++..+. |+|++++++.+...+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   89 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAID-----VATGQEVAIKQINLQKQ-PKKELIINEILVMKELK-NPNIVNFLDSFLVGD   89 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEE-----cCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcC-CCceeeeeeeEecCc
Confidence            346799999999999999999987     44566799998864322 23456889999999998 999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|..++...              .+++..+..++.|++.||.|||+.+
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~--------------~l~~~~~~~i~~~l~~al~~LH~~~  135 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET--------------CMDEAQIAAVCRECLQALEFLHANQ  135 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999988652              3789999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.87  E-value=1.2e-20  Score=153.81  Aligned_cols=120  Identities=19%  Similarity=0.332  Sum_probs=102.8

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+|+|+++...  .......+..|+.++..+. |+||+++++++...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVRE-----KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCC
Confidence            4789999999999999999988     4456679999986431  2334556788999999988 999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++||||+++|+|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~------------~~~l~~~~~~~~~~qi~~aL~~lH~~~  122 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRY------------EDQFDEDMAQFYLAELVLAIHSVHQMG  122 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999764            134889999999999999999999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.86  E-value=2.5e-20  Score=147.51  Aligned_cols=119  Identities=34%  Similarity=0.571  Sum_probs=96.1

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecC
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV  105 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~  105 (230)
                      .||+|+||.||+|.....   .....+++|.+...........+.+|+.++..+. |+||+++++.+...+..+++|||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG---MSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecC---CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence            589999999999976332   2234588888765444555567889999999998 999999999999989999999999


Q ss_pred             CCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        106 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       106 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|+|.+++......        .....++..+..++.|++.||.|||+++
T Consensus        78 ~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (269)
T cd05042          78 PLGDLKNYLRSNRGM--------VAQMAQKDVLQRMACEVASGLLWLHQAD  120 (269)
T ss_pred             CCCcHHHHHHhcccc--------ccccccHHHHHHHHHHHHHHHHHHHhcC
Confidence            999999999874311        1122456778899999999999999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.86  E-value=2e-20  Score=146.97  Aligned_cols=117  Identities=32%  Similarity=0.488  Sum_probs=98.3

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||+|++|.||+|.+...  ......+|+|.+...........+.+|+.++..+. |+||+++++.+.. ...++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            3689999999999998542  12233589999976544366678999999999999 9999999999988 889999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        77 ~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH~~~  117 (257)
T cd05040          77 APLGSLLDRLRKDA-----------LGHFLISTLCDYAVQIANGMRYLESKR  117 (257)
T ss_pred             cCCCcHHHHHHhcc-----------cccCcHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999988742           134789999999999999999999999

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.86  E-value=1.4e-20  Score=153.59  Aligned_cols=122  Identities=16%  Similarity=0.339  Sum_probs=101.8

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc---CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN---AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +|++.+.||+|+||.||++.....  ..++..+|+|++...   ........+..|+.++..+..|+||+++++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            588999999999999999877432  245667999998532   122334567889999999966999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++|+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  125 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQR-------------DNFSEDEVRFYSGEIILALEHLHKLG  125 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998763             24889999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.86  E-value=1e-20  Score=156.62  Aligned_cols=124  Identities=19%  Similarity=0.341  Sum_probs=105.4

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      .+.+..++|++.+.||+|+||.||++..     ..++..+|+|+++..  ........+.+|+.++..+. |+||+++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~  110 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRH-----KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHY  110 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEE
Confidence            4567788999999999999999999988     445667999998532  12223345778999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+..++||||+++|+|.+++...              .+++..+..++.|++.||.|||+++
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~~  162 (370)
T cd05596         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY--------------DIPEKWARFYTAEVVLALDAIHSMG  162 (370)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999988653              3788889999999999999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.86  E-value=1.3e-20  Score=150.19  Aligned_cols=120  Identities=27%  Similarity=0.500  Sum_probs=99.6

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|++|.||+|..     ..++..+++|.++... .......+.+|+.++..+. |+||+++++.+...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRN-----KKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEE-----CCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeE
Confidence            578899999999999999988     4445679999986432 2223456788999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||++ ++|.+++....          ....+++..+..++.|++.||.|||+++
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~~~qi~~~L~~lH~~~  121 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLP----------KGQYMDAELVKSYLYQILQGILFCHSRR  121 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCC----------CCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999998 58888876532          1235889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0032|consensus

Probab=99.86  E-value=1.3e-20  Score=154.87  Aligned_cols=121  Identities=24%  Similarity=0.437  Sum_probs=106.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ....|++++.||.|.||.||.|..     +.++..+|+|.++....  ......+.+|+.+|..+.+|||||.+++.+.+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~-----~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCRE-----KSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEe-----cCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence            455789999999999999999999     45577799999964422  23456889999999999889999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+++|||+|.||.|.+.+...              .+++.+...++.|++.|+.|||+.|
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~--------------~~sE~da~~~~~~il~av~~lH~~g  155 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK--------------HYSERDAAGIIRQILEAVKYLHSLG  155 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc--------------cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999998872              2899999999999999999999999

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.86  E-value=3.9e-20  Score=145.97  Aligned_cols=122  Identities=22%  Similarity=0.409  Sum_probs=104.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++++.||.|+||.||++...     .++..+++|++...........+.+|+.++..+. |+|++++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICL-----PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEc-----CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEE
Confidence            47899999999999999999873     3455699999865443446678999999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++|++++++|.+++.....          ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~~ql~~al~~lh~~~  122 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYP----------RGGLDEAIIATVLKEVLKGLEYLHSNG  122 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999976321          134788999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.86  E-value=1.1e-20  Score=149.66  Aligned_cols=121  Identities=21%  Similarity=0.490  Sum_probs=98.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      ...|++.+.||+|+||.||+|..     ..++..+|+|.+....  .....+.+|+.++..+..|+||+++++.+...  
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRH-----VKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEE-----cCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            45678888999999999999988     4455679999986432  22356788999999885599999999998653  


Q ss_pred             ----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                          ...++++||+++++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~~~~qi~~~l~~LH~~~  131 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTK-----------GNTLKEEWIAYICREILRGLSHLHQHK  131 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                35899999999999999987632           234788999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2e-20  Score=148.68  Aligned_cols=118  Identities=17%  Similarity=0.454  Sum_probs=100.8

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC--CCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~~~~~   97 (230)
                      .|++.+.||+|+||.||+|.+     ..++..+++|.++..........+.+|+.++..+.  .|+|++++++.+...+.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKH-----VPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEE-----cCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence            467788999999999999998     34556799999865444555567888999988885  59999999999998889


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+++++|.+++...              .+++..+..++.|++.||.|||+.+
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~lh~~~  121 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG--------------PIAEKYISVIIREVLVALKYIHKVG  121 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999887642              4788999999999999999999988

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.86  E-value=1.5e-20  Score=150.21  Aligned_cols=120  Identities=18%  Similarity=0.326  Sum_probs=100.1

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .|++.+.||+|+||.||++.+     ..++..+|+|.+...  ........+.+|+.++..+. |++++.+++.+...+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEE-----cCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCE
Confidence            367888999999999999999     445567999988532  12233456778999999998 9999999999998899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++++|.+++....           ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~-----------~~~l~~~~~~~~~~qi~~~l~~lH~~~  122 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMG-----------EAGFEEGRAVFYAAEICCGLEDLHQER  122 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999886532           234788999999999999999999988

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.86  E-value=2.3e-20  Score=152.45  Aligned_cols=117  Identities=20%  Similarity=0.451  Sum_probs=97.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      +|++.+.||+|+||.||+|..     ..++..||+|.++.. ........+.+|+.++..+. ||||+++++++...+  
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEE-----CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCC
Confidence            588999999999999999998     445667999998632 22334457889999999999 999999999885432  


Q ss_pred             ---CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ---PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ..+++|||+. ++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~~~~lv~e~~~-~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~  123 (338)
T cd07859          75 EFKDIYVVFELME-SDLHQVIKAN-------------DDLTPEHHQFFLYQLLRALKYIHTAN  123 (338)
T ss_pred             CCceEEEEEecCC-CCHHHHHHhc-------------ccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence               4799999996 6898888653             24889999999999999999999999

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.86  E-value=3.3e-20  Score=145.40  Aligned_cols=122  Identities=23%  Similarity=0.496  Sum_probs=104.3

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||.|+||.||++.+.     .++..+++|++... ........+.+|++++..+. |+|++++.+.+...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK-----SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc-----CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEE
Confidence            5788999999999999999984     34556999998643 33456677899999999999 99999999999988999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++.....         ....+++..+..++.+++.||.|||+++
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lh~~~  123 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKK---------EGKPFPEEQILDWFVQLCLALKYLHSRK  123 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhc---------cCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999887421         1245899999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.86  E-value=1.1e-20  Score=153.69  Aligned_cols=119  Identities=24%  Similarity=0.406  Sum_probs=99.8

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +|++.+.||+|+||.||+|...     .++..+|+|+++..  ........+..|..++..+..|++|+.+++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence            5889999999999999999983     44556999998643  1233456788899999988745678899999998899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV-------------GKFKEPHAVFYAAEIAIGLFFLHSKG  121 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999888763             24788999999999999999999999

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.86  E-value=7.8e-21  Score=151.63  Aligned_cols=119  Identities=26%  Similarity=0.520  Sum_probs=100.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..+|+|.+... ........+.+|+.++..+. |+||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKH-----KETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEE-----CCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCe
Confidence            4688999999999999999998     344556999988533 22234556889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||++++.|..+....             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~LH~~~  120 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP-------------NGLDESRVRKYLFQILRGIEFCHSHN  120 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999998887766532             23789999999999999999999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.86  E-value=2.8e-20  Score=146.64  Aligned_cols=118  Identities=25%  Similarity=0.491  Sum_probs=102.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|+||.||.+..     ..++..+++|.++... .......+..|+.++..+. |+||+++++.+...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVN-----LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEE-----CCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEE
Confidence            578899999999999999988     3445669999986442 2346678999999999998 99999999999988999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~  119 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHG-------------RILDEHVIRVYTLQLLEGLAYLHSHG  119 (264)
T ss_pred             EEEEecCCCCcHHHHHhhc-------------CCCChHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999998763             23778889999999999999999988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.4e-20  Score=146.82  Aligned_cols=120  Identities=25%  Similarity=0.560  Sum_probs=103.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||++...     .++..+++|.+..... .....+.+|+.++..+. |+||+++++.+...+.
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDI-----ATGELVAIKVIKLEPG-DDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDK   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEec-----CCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCE
Confidence            578999999999999999999884     3445699999864432 25578899999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++++|.+++....            ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~------------~~l~~~~~~~~~~ql~~~l~~lh~~~  121 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTR------------GPLSELQIAYVCRETLKGLAYLHETG  121 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999887631            34889999999999999999999988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.86  E-value=3.2e-20  Score=146.99  Aligned_cols=118  Identities=30%  Similarity=0.520  Sum_probs=95.1

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecC
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV  105 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~  105 (230)
                      .||+|+||.||++.....   .....+++|.++..........+.+|+.++..+. ||||+++++.+......+++|||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD---TGVARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcC---CCcceEEEEEecCCCChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecC
Confidence            589999999999976432   1223467777765544556678999999999998 999999999999988999999999


Q ss_pred             CCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        106 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       106 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|+|.+++.....         .....+...+..++.||+.||.|||+++
T Consensus        78 ~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~~i~~al~~lH~~~  119 (268)
T cd05086          78 ELGDLKSYLSQEQW---------HRRNSQLLLLQRMACEIAAGVTHMHKHN  119 (268)
T ss_pred             CCCcHHHHHHhhhc---------ccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999976321         1123566778899999999999999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0694|consensus

Probab=99.86  E-value=3e-21  Score=162.40  Aligned_cols=124  Identities=27%  Similarity=0.472  Sum_probs=107.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      -.+..++|.+.++||+|+||+|+++..+     .++..+|||.++..  ...+..+..+.|-+++..+.+||.+++++.+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k-----~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELK-----GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEc-----CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            4678899999999999999999999994     45557999999754  3455667788899999888789999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |.+...+|+||||+.||++....+.              ..+++.++..|+..|+.||+|||+++
T Consensus       438 fQT~~~l~fvmey~~Ggdm~~~~~~--------------~~F~e~rarfyaAev~l~L~fLH~~~  488 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDLMHHIHT--------------DVFSEPRARFYAAEVVLGLQFLHENG  488 (694)
T ss_pred             cccCCeEEEEEEecCCCcEEEEEec--------------ccccHHHHHHHHHHHHHHHHHHHhcC
Confidence            9999999999999999996554433              24899999999999999999999999

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.86  E-value=7.8e-21  Score=149.51  Aligned_cols=118  Identities=19%  Similarity=0.464  Sum_probs=102.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +|++.+.||.|+||.||++.+     ..++..+++|.+...  ........+.+|+.++..+. ||||+++++.+.....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQK-----RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEE-----ccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCe
Confidence            588999999999999999988     445566999998632  22345678999999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+.+++|.+++...             ..+++..+..++.|+++||.|||+++
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~~i~~~l~~lh~~~  120 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK-------------VKFSEEQVKFWICEIVLALEYLHSKG  120 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc-------------CCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999998763             24788999999999999999999988

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.86  E-value=1.9e-20  Score=149.96  Aligned_cols=119  Identities=26%  Similarity=0.438  Sum_probs=103.0

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||.+.+.     .++..+|+|.++...  .......+.+|+.++..+. |+||+++++.+...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEc-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCC
Confidence            47899999999999999999984     455679999986431  2334567889999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~qil~~l~~lH~~~  121 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS-------------GRFPEPVARFYAAQVVLALEYLHSLD  121 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998763             24889999999999999999999988

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.86  E-value=1e-20  Score=153.39  Aligned_cols=114  Identities=27%  Similarity=0.440  Sum_probs=93.5

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||+|..     ..++..||+|+++...  .......+..|..++.....|+||+++++.+...+.++++|
T Consensus         1 ~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAEL-----KGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            3689999999999998     3445569999986431  22334456667777776545999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 e~~~gg~L~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~LH~~~  116 (316)
T cd05592          76 EYLNGGDLMFHIQSS-------------GRFDEARARFYAAEIICGLQFLHKKG  116 (316)
T ss_pred             cCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999888763             24888999999999999999999999

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.86  E-value=2.6e-20  Score=148.89  Aligned_cols=120  Identities=18%  Similarity=0.328  Sum_probs=100.3

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .|+..+.||+|+||.||.+.+     ..++..+|+|.+....  .......+.+|+.++..+. |+||+.+.+.+...+.
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~   74 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQV-----RATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEE-----CCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCE
Confidence            367788999999999999998     4456679999885431  2223456788999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+++++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH~~~  122 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMG-----------NPGFEEERALFYAAEILCGLEDLHREN  122 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999988876531           224899999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0574|consensus

Probab=99.86  E-value=1.8e-22  Score=155.65  Aligned_cols=159  Identities=23%  Similarity=0.502  Sum_probs=136.1

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.+-|.++.+||+|+||.||++.+     +..|..+|+|.+..   ....+.+..|+.+++++. .+++|++||.+..+.
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH-----~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~s  101 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIH-----RESGHVLAIKKVPV---DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHS  101 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHH-----hccCcEEEEEecCc---cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCC
Confidence            344567889999999999999998     56777899999874   345577899999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      .+|+|||||-.|+..+.++..            ...+++..+..+++..+.||.|||...                    
T Consensus       102 DLWIVMEYCGAGSiSDI~R~R------------~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AK  169 (502)
T KOG0574|consen  102 DLWIVMEYCGAGSISDIMRAR------------RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAK  169 (502)
T ss_pred             ceEeehhhcCCCcHHHHHHHh------------cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhh
Confidence            999999999999999999885            346999999999999999999999887                    


Q ss_pred             -----------------------------------------------------------------------CCCCccC--
Q psy15820        157 -----------------------------------------------------------------------VRDGYRL--  163 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~~~~--  163 (230)
                                                                                             +.....+  
T Consensus       170 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF  249 (502)
T KOG0574|consen  170 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF  249 (502)
T ss_pred             hhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC
Confidence                                                                                   1211111  


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .+|+.+++++.+++..||...|+.|-|+-++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            256778999999999999999999999999886

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.86  E-value=2.5e-20  Score=166.64  Aligned_cols=127  Identities=20%  Similarity=0.373  Sum_probs=105.8

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +..+...+|++++.||+|+||.||++.+     ..++..+|+|.+... ........+..|+.++..+. ||||++++++
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkd-----k~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~   80 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKH-----KRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDR   80 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEE-----CCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEE
Confidence            4456678999999999999999999998     445567999988633 34455678999999999999 9999999998


Q ss_pred             Eec--CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh
Q psy15820         92 CTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS  154 (230)
Q Consensus        92 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~  154 (230)
                      |..  ...+|+||||+++++|.+++.....         ....+++..++.|+.||+.||.|||+
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~---------~~g~L~E~~Il~Ia~QIL~ALaYLHs  136 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYK---------MFGKIEEHAIVDITRQLLHALAYCHN  136 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            854  3468999999999999999976421         12358999999999999999999997

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.86  E-value=7.6e-21  Score=154.47  Aligned_cols=114  Identities=24%  Similarity=0.452  Sum_probs=95.6

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||+|..     +.++..+|+|+++..  ........+..|..++..+..|+||+++++++...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARL-----KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEE-----cCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence            3689999999999988     445567999998643  122344567788888887755999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 Ey~~~g~L~~~i~~~-------------~~l~~~~~~~~~~ql~~~L~~lH~~~  116 (320)
T cd05590          76 EFVNGGDLMFHIQKS-------------RRFDEARARFYAAEITSALMFLHDKG  116 (320)
T ss_pred             cCCCCchHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999888763             24889999999999999999999999

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.86  E-value=1.3e-20  Score=149.94  Aligned_cols=113  Identities=20%  Similarity=0.319  Sum_probs=92.9

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      ||+|+||.||++..     ..++..+|+|.+....  .......+..|+.++..+. ||||+++++.+......+++|||
T Consensus         1 lg~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQV-----KNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEE-----ccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEec
Confidence            69999999999988     4456679999885321  1122334567999999998 99999999999998999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++|..++....           ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~g~~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~~  115 (277)
T cd05607          75 MNGGDLKYHIYNVG-----------ERGLEMERVIHYSAQITCGILHLHSMD  115 (277)
T ss_pred             CCCCCHHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999988876532           224788889999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.86  E-value=1.1e-20  Score=153.85  Aligned_cols=113  Identities=22%  Similarity=0.352  Sum_probs=95.4

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++..     ..++..+|+|+++..  ........+..|+.++..+. |+||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKE-----KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEE
Confidence            3689999999999988     445667999998643  22334556788999999998 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.||+.||.|||+ ++
T Consensus        75 E~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~lH~~~~  116 (325)
T cd05594          75 EYANGGELFFHLSRE-------------RVFSEDRARFYGAEIVSALDYLHSEKN  116 (325)
T ss_pred             eCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence            999999998887653             248899999999999999999997 56

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=2.2e-20  Score=147.99  Aligned_cols=118  Identities=30%  Similarity=0.448  Sum_probs=98.8

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC---------HHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG---------ERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      +|.+.+.||+|+||.||+|..     ..++..+|+|.++....         ....+.+.+|+.++..+. |+|++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALN-----VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEee-----cCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEE
Confidence            467889999999999999987     34455699998753211         112346788999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+...+..++++||+++++|.++++..             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~  128 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY-------------GRFEEQLVRFFTEQVLEGLAYLHSKG  128 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            999999999999999999999998763             24788899999999999999999988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.86  E-value=2.3e-20  Score=148.73  Aligned_cols=124  Identities=20%  Similarity=0.488  Sum_probs=101.0

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .-+...|++.+.||.|+||.||+|...     .++..+++|.+...  ......+..|+.++..+..|+||+++++++..
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEc-----CCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            346678899999999999999999983     44556999988543  33445678899999988559999999999853


Q ss_pred             ------CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 ------KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            ....+++|||+++|+|.+++....           ...+++..+..++.|++.||.|||+.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~LH~~~  141 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-----------GNALKEDWIAYICREILRGLAHLHAHK  141 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                  356899999999999999987642           234778888999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.86  E-value=4.5e-20  Score=146.28  Aligned_cols=171  Identities=34%  Similarity=0.601  Sum_probs=132.0

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC---
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE---   96 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~---   96 (230)
                      |++.+.||+|+||.||+|.+...  ..++..+|+|+++.. ......+.+.+|+.++..+. ||||+++++.+....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCC
Confidence            56788999999999999987532  234567999998643 34455677899999999998 999999999876432   


Q ss_pred             ---CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         97 ---PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        97 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                         ..+++++|+++|+|.+++...+..       .....++...+..++.|++.||.|||+++                 
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~-------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~  150 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIG-------EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM  150 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC
Confidence               247889999999999887643210       01224788889999999999999999998                 


Q ss_pred             ---------------------------------------------------------CC--------------------C
Q psy15820        157 ---------------------------------------------------------VR--------------------D  159 (230)
Q Consensus       157 ---------------------------------------------------------i~--------------------~  159 (230)
                                                                               +.                    .
T Consensus       151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05074         151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK  230 (273)
T ss_pred             CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence                                                                     01                    1


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      +.....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111223345778999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.86  E-value=1.4e-20  Score=148.79  Aligned_cols=121  Identities=22%  Similarity=0.478  Sum_probs=103.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ...++|++.+.||+|+||.||.|...     .++..+++|.++... ......+.+|+.++..+. |+||+++++.+...
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~   78 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNV-----NTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRR   78 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEc-----CCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Confidence            34568889999999999999999883     445569999986442 233356788999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~  126 (267)
T cd06645          79 DKLWICMEFCGGGSLQDIYHVT-------------GPLSESQIAYVSRETLQGLYYLHSKG  126 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999998753             24889999999999999999999988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.86  E-value=3.5e-20  Score=146.68  Aligned_cols=123  Identities=24%  Similarity=0.465  Sum_probs=97.9

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc---------CCHHHHHHHHHHHHHHhh-cCCCCceeeEe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN---------AGERERLDLLQELTVMKT-LDPHPNVVRLL   89 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~-~~~h~niv~l~   89 (230)
                      +|++.+.||+|+||.||.+.+...    .+..+++|.+...         ........+..|+.++.. +. |+||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR-HPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCC-CCCeeeEE
Confidence            477889999999999999998531    3446899987422         123344567788888876 55 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      +++...+..++++||+++++|.+++.....         ....+++..++.++.|++.||.|||+ .+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~  134 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKE---------KKQRFTEERIWNIFVQMVLALRYLHKEKR  134 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHhccCCc
Confidence            999999999999999999999998865321         13358889999999999999999996 44

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.86  E-value=1.6e-20  Score=153.14  Aligned_cols=114  Identities=21%  Similarity=0.411  Sum_probs=96.0

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++..     ..++..+|+|+++..  ........+..|+.++..+..||||+++++++...+..+++|
T Consensus         1 ~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRL-----KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEE-----CCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            3689999999999998     445567999998643  233445667889988887745999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 E~~~~~~L~~~~~~~-------------~~l~~~~~~~i~~qi~~~l~~lH~~~  116 (329)
T cd05618          76 EYVNGGDLMFHMQRQ-------------RKLPEEHARFYSAEISLALNYLHERG  116 (329)
T ss_pred             eCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999998887653             24889999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=3.9e-20  Score=146.50  Aligned_cols=124  Identities=21%  Similarity=0.462  Sum_probs=102.0

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..++|++.+.||+|++|.||+|...     .++..+++|++....  .....+.+|+.++..+..|+||+++++++....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEEC-----CCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            4578999999999999999999883     445569999886432  234678899999999845999999999997644


Q ss_pred             ------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            ..++++||+++++|.+++.....         ....+++..+..++.|++.||.|||+.+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lH~~~  133 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRK---------KGKRLKEEWIAYILRETLRGLAYLHENK  133 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence                  38999999999999999876321         1235789999999999999999999998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.86  E-value=1.4e-20  Score=152.97  Aligned_cols=114  Identities=25%  Similarity=0.427  Sum_probs=95.4

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||+|..     ..++..+|+|+++..  ........+..|..++..+..||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAEL-----KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEE-----CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence            3689999999999998     345556999998643  123345567788888887755999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++++|...+...             ..+++..+..++.|++.||.|||+++
T Consensus        76 E~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~  116 (321)
T cd05591          76 EYVNGGDLMFQIQRS-------------RKFDEPRSRFYAAEVTLALMFLHRHG  116 (321)
T ss_pred             eCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999888763             24788999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.86  E-value=6e-20  Score=163.40  Aligned_cols=130  Identities=20%  Similarity=0.385  Sum_probs=104.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .+|++.+.||+|+||.||+|.+     ..++..||+|+++..  .......++.+|+.++..+. ||||+++++++...+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d-----~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYD-----PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEE-----CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCC
Confidence            5799999999999999999988     445667999998643  22344567999999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||++|++|.+++........  .........+...++.++.||+.||.|||+++
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~--l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G  133 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKES--LSKELAEKTSVGAFLSIFHKICATIEYVHSKG  133 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccc--cchhhhcccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999876321100  00011223566788899999999999999998

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=1.8e-20  Score=153.84  Aligned_cols=119  Identities=20%  Similarity=0.454  Sum_probs=103.0

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||+|..     ..++..+|+|+++...  .......+..|+.++..+. |+||+++++.+...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRD-----KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEE-----CCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCC
Confidence            4789999999999999999998     4456679999986331  2234557888999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++||||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~g  121 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK-------------DVFPEETARFYIAELVLALDSVHKLG  121 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998763             24889999999999999999999988

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.86  E-value=2.7e-20  Score=150.10  Aligned_cols=119  Identities=17%  Similarity=0.349  Sum_probs=101.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..|++|.+....  .......+.+|+.++..+. |+||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRH-----KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEE-----CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCC
Confidence            4688999999999999999988     4445569999886432  2334567889999999998 999999999999988


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~  121 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNI-------------GALPVDMARMYFAETVLALEYLHNYG  121 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999998763             24788899999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4717|consensus

Probab=99.86  E-value=2.5e-21  Score=158.67  Aligned_cols=157  Identities=20%  Similarity=0.331  Sum_probs=136.1

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      |.+.+.||+|.|..|.+|.+     -.+|..||||++... .+.-....+.+|++.++.++ |||||++|++......+|
T Consensus        20 YDLekTlG~GHFAVVKLArH-----VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             ehhhhhhcCCceehhhhhhh-----hcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceEE
Confidence            56678899999999999988     456677999999644 34445667899999999999 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------------
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------------  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------------  156 (230)
                      ||+|+=.+|+|+++|..+            ...+.+....+|+.||+.|+.|+|...                       
T Consensus        94 LiLELGD~GDl~DyImKH------------e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKH------------EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             EEEEecCCchHHHHHHhh------------hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEee
Confidence            999999999999999986            346899999999999999999999887                       


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           |+ .-+...|.
T Consensus       162 DFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-DCKYtvPs  240 (864)
T KOG4717|consen  162 DFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-DCKYTVPS  240 (864)
T ss_pred             eccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-cccccCch
Confidence                                                                                 11 12345678


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      +++.++.+||+.||..||.+|.+..+|..
T Consensus       241 hvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  241 HVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            89999999999999999999999999875

>KOG0616|consensus

Probab=99.86  E-value=5.7e-21  Score=146.59  Aligned_cols=122  Identities=25%  Similarity=0.452  Sum_probs=109.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ...++|++.+.||.|+||+|.+.+.     +.++..+|+|+++..  ..-...+...+|..+|+.+. ||.++++++.+.
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~-----k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~  114 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVRE-----KHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFK  114 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEE-----ccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeec
Confidence            6788999999999999999999998     556778999999643  22344567889999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.+.+|+||||.+||.|..+++..+             ++++...+.++.||+.|+.|||+++
T Consensus       115 d~~~lymvmeyv~GGElFS~Lrk~~-------------rF~e~~arFYAAeivlAleylH~~~  164 (355)
T KOG0616|consen  115 DNSNLYMVMEYVPGGELFSYLRKSG-------------RFSEPHARFYAAEIVLALEYLHSLD  164 (355)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcC-------------CCCchhHHHHHHHHHHHHHHHHhcC
Confidence            9999999999999999999999843             5999999999999999999999999

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.86  E-value=9.1e-21  Score=174.37  Aligned_cols=109  Identities=25%  Similarity=0.441  Sum_probs=91.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      .+.....||+|+||.||+|..     ..++..||+|.++.....     ...|+..+..++ ||||+++++++...+..+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKS-----IKNGMQFVVKEINDVNSI-----PSSEIADMGKLQ-HPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEE-----CCCCcEEEEEEccCCccc-----cHHHHHHHhhCC-CCCcceEEEEEEcCCCCE
Confidence            455567899999999999988     445567999988643221     124577888998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      +||||+++|+|.++++.                +++..+..++.|++.||+|||..
T Consensus       760 lv~Ey~~~g~L~~~l~~----------------l~~~~~~~i~~~ia~~L~yLH~~  799 (968)
T PLN00113        760 LIHEYIEGKNLSEVLRN----------------LSWERRRKIAIGIAKALRFLHCR  799 (968)
T ss_pred             EEEeCCCCCcHHHHHhc----------------CCHHHHHHHHHHHHHHHHHhccC
Confidence            99999999999999864                78889999999999999999943

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.86  E-value=3.4e-20  Score=148.79  Aligned_cols=119  Identities=23%  Similarity=0.482  Sum_probs=101.5

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ...+|++.+.||+|+||.||++...     .++..+++|.+.... ......+.+|+.++..+. ||||+++++.+...+
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~   89 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDV-----ATGQEVAIKQMNLQQ-QPKKELIINEILVMRENK-HPNIVNYLDSYLVGD   89 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEc-----CCCCEEEEEEecccc-chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCC
Confidence            3478999999999999999999873     344569999885332 233467889999999998 999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~--------------~l~~~~~~~i~~~l~~al~~LH~~g  135 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQ  135 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999988653              3678899999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.85  E-value=2.8e-20  Score=148.31  Aligned_cols=115  Identities=19%  Similarity=0.312  Sum_probs=94.6

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      ||+|+||.||++.+     ..++..+|+|.+....  .......+..|+.++..+. |+||+++.+++...+..+++|||
T Consensus         1 lg~G~~g~Vy~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQM-----RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEE-----ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeC
Confidence            69999999999988     4455679999986321  1223356788999999998 99999999999988899999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++|+|...+.....         ....+++..++.++.|++.||.|||+++
T Consensus        75 ~~~g~L~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~~l~~lH~~~  117 (280)
T cd05608          75 MNGGDLRYHIYNVDE---------ENPGFPEPRACFYTAQIISGLEHLHQRR  117 (280)
T ss_pred             CCCCCHHHHHHhccc---------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999888754211         1235889999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.85  E-value=1.3e-20  Score=152.76  Aligned_cols=114  Identities=28%  Similarity=0.446  Sum_probs=94.0

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||+|.+     ..++..+|+|+++...  .......+..|..++.....||||+++++++...+.++++|
T Consensus         1 ~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAEL-----KGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence            3689999999999998     4455669999986431  12334456778888876544999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ey~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~LH~~~  116 (316)
T cd05619          76 EYLNGGDLMFHIQSC-------------HKFDLPRATFYAAEIICGLQFLHSKG  116 (316)
T ss_pred             eCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999998763             24788899999999999999999999

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.85  E-value=2.7e-20  Score=145.98  Aligned_cols=122  Identities=25%  Similarity=0.524  Sum_probs=102.8

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|+||.||++...     .++..+++|.+... ........+.+|+.++..+. |+||+++++.+......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL-----SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC-----CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEE
Confidence            5788999999999999999873     44556999988643 23455667889999999999 99999999999988999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++.....         ....+++..+..++.|++.||.|||+.+
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~al~~lh~~~  123 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKK---------KRKLIPEQEIWRIFIQLLRGLQALHEQK  123 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            999999999999999876321         1235788899999999999999999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.85  E-value=7.3e-20  Score=144.70  Aligned_cols=119  Identities=26%  Similarity=0.490  Sum_probs=98.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc----CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+|+..+.||+|+||.||++...     .++..+++|.+...    ........+.+|+.++..++ |+||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV-----DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc-----CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEc
Confidence            46888999999999999999883     44556999987532    12234567889999999998 9999999998865


Q ss_pred             --CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 --KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        ....++++||+++++|.+++...             ..+++...+.++.|++.||.|||+.+
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~~  126 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAY-------------GALTESVTRKYTRQILEGMSYLHSNM  126 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence              35688999999999999998763             23788889999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.85  E-value=3.2e-20  Score=150.97  Aligned_cols=116  Identities=20%  Similarity=0.407  Sum_probs=96.1

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      +.||+|+||.||++.....  ...+..+|+|+++...   .......+..|+.++..+. ||||+++++++...+..+++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTG--ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEccc--CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEE
Confidence            5799999999999976422  2456679999986421   2233456788999999999 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |||+++++|.+++...             ..+.+..+..++.|++.||.|||+++
T Consensus        79 ~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (323)
T cd05584          79 LEYLSGGELFMHLERE-------------GIFMEDTACFYLSEISLALEHLHQQG  120 (323)
T ss_pred             EeCCCCchHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999988763             24778888999999999999999999

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.85  E-value=1.5e-20  Score=148.09  Aligned_cols=122  Identities=24%  Similarity=0.413  Sum_probs=96.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC----cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE----NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +|.+.+.||+|+||.||++.+...     +..+++|.++.    .........+..|+.++..+. ||||+++++.+...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKA-----VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCC-----CCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcC
Confidence            578899999999999999988533     22244444432    112233445677899999998 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...++++||+++++|.+++.....         ....+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKH---------TGKTLSENQVCEWFIQLLLGVHYMHQRR  126 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhh---------cccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence            899999999999999998876321         1335889999999999999999999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=8.9e-20  Score=142.80  Aligned_cols=118  Identities=27%  Similarity=0.574  Sum_probs=102.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|++|.||++..     ...+..+++|.+... ........+.+|+.++..+. |+|++++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLN-----LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEE-----cCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEE
Confidence            478899999999999999988     344556999998643 22345678999999999998 99999999999988999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++...             ..+++..+..++.|++.|+.|||+.+
T Consensus        75 ~~v~e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~~i~~~l~~lH~~~  119 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF-------------GPFPESLVAVYVYQVLQGLAYLHEQG  119 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            9999999999999998763             24889999999999999999999999

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.85  E-value=1.2e-19  Score=143.41  Aligned_cols=120  Identities=26%  Similarity=0.449  Sum_probs=99.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc----CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +++|++++.||+|+||.||.+..     ..++..+++|.+...    ........+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~-----~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   74 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYD-----ADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLR   74 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEE-----cCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEec
Confidence            36789999999999999999988     445567999987522    12334567889999999998 999999999886


Q ss_pred             cC--CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..  ..+++++||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~~~~~~~v~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (265)
T cd06652          75 DPMERTLSIFMEHMPGGSIKDQLKSY-------------GALTENVTRKYTRQILEGVSYLHSNM  126 (265)
T ss_pred             cCCCceEEEEEEecCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            53  4678999999999999988753             23678889999999999999999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.85  E-value=2e-20  Score=151.76  Aligned_cols=114  Identities=26%  Similarity=0.392  Sum_probs=94.2

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||+|.+     +.++..+|+|.++...  ..........|..++.....|+||+++++++...+.+++||
T Consensus         1 ~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAEL-----KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            4689999999999998     4455679999986431  12234556778888876644999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 E~~~~g~L~~~i~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  116 (316)
T cd05620          76 EFLNGGDLMFHIQDK-------------GRFDLYRATFYAAEIVCGLQFLHSKG  116 (316)
T ss_pred             CCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999888763             24788899999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.85  E-value=5e-20  Score=148.72  Aligned_cols=122  Identities=22%  Similarity=0.499  Sum_probs=101.0

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ...+.|.+.+.||+|+||.||++...     .++..+++|.+...  ........+.+|+.++..+. |+||+++++++.
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~   85 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDV-----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYL   85 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEc-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEE
Confidence            34466889999999999999999883     44556999988532  23444567889999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..++++||++ |++.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        86 ~~~~~~lv~e~~~-g~l~~~~~~~------------~~~l~~~~~~~~~~ql~~~L~~LH~~~  135 (307)
T cd06607          86 REHTAWLVMEYCL-GSASDILEVH------------KKPLQEVEIAAICHGALQGLAYLHSHE  135 (307)
T ss_pred             eCCeEEEEHHhhC-CCHHHHHHHc------------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999997 5777776542            224789999999999999999999988

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.85  E-value=2.1e-19  Score=140.81  Aligned_cols=118  Identities=28%  Similarity=0.505  Sum_probs=102.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--C
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--E   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--~   96 (230)
                      +|++.+.||+|++|.||+|...     .++..+++|++.... .......+.+|+.++..+. |+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDK-----DTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEEC-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCC
Confidence            4778899999999999999883     455569999986432 2345678899999999999 99999999999887  7


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~  121 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKF-------------GKLPEPVIRKYTRQILEGLAYLHSNG  121 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            899999999999999998763             14889999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.85  E-value=8.1e-20  Score=145.70  Aligned_cols=118  Identities=26%  Similarity=0.471  Sum_probs=101.8

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|+||.||+|.+     ..++..+++|++.... .......+.+|+.++..+. |+||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKD-----RETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEE-----CCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCee
Confidence            588999999999999999998     3445669999986432 2344567899999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+ +++|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~v~e~~-~~~L~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~  119 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDE------------ERPLPEAQVKSYMRMLLKGVAYMHANG  119 (286)
T ss_pred             EEEeccc-CCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999 99999998763            234889999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0663|consensus

Probab=99.85  E-value=6.2e-21  Score=148.64  Aligned_cols=120  Identities=23%  Similarity=0.448  Sum_probs=101.8

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-HHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      .++|+.+..|++|+||.||+|++     +.+...||+|+++-... ....-..++|+.+|..++ |||||.+-.+...  
T Consensus        75 v~efe~lnrI~EGtyGiVYRakd-----k~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKD-----KKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSN  148 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEecc-----CCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccc
Confidence            46788889999999999999999     66677899999975432 222345789999999999 9999999888765  


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      -+.+|+|||||+. +|..++..            ..+++....+..++.|++.|+.|||+..
T Consensus       149 ~d~iy~VMe~~Eh-DLksl~d~------------m~q~F~~~evK~L~~QlL~glk~lH~~w  197 (419)
T KOG0663|consen  149 MDKIYIVMEYVEH-DLKSLMET------------MKQPFLPGEVKTLMLQLLRGLKHLHDNW  197 (419)
T ss_pred             cceeeeeHHHHHh-hHHHHHHh------------ccCCCchHHHHHHHHHHHHHHHHHhhce
Confidence            3569999999986 89999987            3457899999999999999999999998

>KOG0610|consensus

Probab=99.85  E-value=4.4e-21  Score=153.07  Aligned_cols=139  Identities=23%  Similarity=0.408  Sum_probs=120.0

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..-.+..++|++++.||.|..|.||++...+     +...+|+|++...  .......+..-|-++|..+. ||.++.+|
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLY  143 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLY  143 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhh
Confidence            3356788899999999999999999999954     3456999999643  23445567788999999999 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      ..+......|++||||+||+|..+.+..           ....+++..++.|+..++.||.|||-.||.  .|+.+|+|+
T Consensus       144 a~fet~~~~cl~meyCpGGdL~~LrqkQ-----------p~~~fse~~aRFYaAEvl~ALEYLHmlGiv--YRDLKPENI  210 (459)
T KOG0610|consen  144 ASFETDKYSCLVMEYCPGGDLHSLRQKQ-----------PGKRFSESAARFYAAEVLLALEYLHMLGIV--YRDLKPENI  210 (459)
T ss_pred             heeeccceeEEEEecCCCccHHHHHhhC-----------CCCccchhhHHHHHHHHHHHHHHHHhhcee--eccCCccee
Confidence            9999999999999999999998887764           245689999999999999999999999999  999999875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.85  E-value=7.9e-20  Score=148.64  Aligned_cols=119  Identities=24%  Similarity=0.402  Sum_probs=99.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +|.+.+.||+|+||.||+|...     .++..+|+|+++...  .......+..|..++..+..|++|+.+++++...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence            5788999999999999999883     445569999986432  223344567788888877658999999999999899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++||||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~  121 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV-------------GRFKEPHAVFYAAEIAIGLFFLHSKG  121 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999888753             24788999999999999999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.85  E-value=2.8e-20  Score=148.31  Aligned_cols=118  Identities=27%  Similarity=0.513  Sum_probs=98.3

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||+|+||.||+|.+     ..++..+++|.++... .......+.+|+.++..+. |+||+++++.+...+..
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~-----~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKN-----RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEE-----CCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCce
Confidence            478899999999999999998     4455679999986432 2223346778999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++ +|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus        75 ~lv~e~~~~-~l~~~~~~~------------~~~~~~~~~~~~~~qi~~al~~LH~~~  119 (284)
T cd07839          75 TLVFEYCDQ-DLKKYFDSC------------NGDIDPEIVKSFMFQLLKGLAFCHSHN  119 (284)
T ss_pred             EEEEecCCC-CHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999974 788877653            234899999999999999999999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.84  E-value=8.9e-20  Score=145.38  Aligned_cols=120  Identities=28%  Similarity=0.509  Sum_probs=101.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      +|++.+.||.|++|.||+|..     ..++..+++|.++..........+.+|+.++..+. |+||+++++.+...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRN-----RTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEE-----CCCCeEEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence            588999999999999999998     44566799999875433334456778999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||+++ +|.+++....          ....+++..+..++.|++.||.|||+++
T Consensus        75 lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (284)
T cd07836          75 LVFEYMDK-DLKKYMDTHG----------VRGALDPNTVKSFTYQLLKGIAFCHENR  120 (284)
T ss_pred             EEEecCCc-cHHHHHHhcC----------CCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999985 8888876532          1234889999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.84  E-value=7.4e-20  Score=145.93  Aligned_cols=119  Identities=24%  Similarity=0.460  Sum_probs=99.8

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|+||.||+|..     ..++..+++|++.... .......+.+|+.++..+. |+|++++++.+.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRN-----RETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEE-----CCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCE
Confidence            4789999999999999999988     4455679999885332 2233456789999999999 9999999999999889


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||++++.|..++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~LH~~~  120 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNP-------------RGVPEHLIKKIIWQTLQAVNFCHKHN  120 (286)
T ss_pred             EEEEEeccCccHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999998887765432             24889999999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.84  E-value=5.6e-20  Score=149.80  Aligned_cols=114  Identities=21%  Similarity=0.408  Sum_probs=96.9

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||++..     ..++..+|+|+++...  .......+..|..++..+..|+||+.+++++...+.+++||
T Consensus         1 ~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRL-----KKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            3699999999999988     4455679999996432  23445668889999988866999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~~  116 (327)
T cd05617          76 EYVNGGDLMFHMQRQ-------------RKLPEEHARFYAAEICIALNFLHERG  116 (327)
T ss_pred             eCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999888653             24899999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.84  E-value=4.9e-20  Score=152.71  Aligned_cols=117  Identities=25%  Similarity=0.430  Sum_probs=97.9

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      +|++.+.||+|+||.||++.+     ..++..||+|.+... ........+.+|+.++..++ |+||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTD-----PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEE-----CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCcc
Confidence            478889999999999999988     445667999998643 23344567889999999998 999999999998766  


Q ss_pred             ---CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ---PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ..++++||+. ++|.+.+...             ..+++..+..++.||+.||.|||+++
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~  123 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSP-------------QPLSSDHVKVFLYQILRGLKYLHSAG  123 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence               6899999997 5787777542             34889999999999999999999999

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.84  E-value=2.9e-20  Score=146.11  Aligned_cols=117  Identities=30%  Similarity=0.645  Sum_probs=100.8

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHH-HHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER-ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      |++++.||+|+||.||++..     ..++..+|+|++....... ......+|+.++..+. |+||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKN-----KKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEE-----TTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEE-----CCCCeEEEEEEeccccccccccchhhhhhhcccccc-cccccccccccccccccc
Confidence            78899999999999999999     5566679999997543222 2334566999999997 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||+++++|.+++...             ..+++..+..++.|++.||.+||+++
T Consensus        75 ~v~~~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~L~~Lh~~~  118 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN-------------KPLSEEEILKIAYQILEALAYLHSKG  118 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH-------------SSBBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccc-------------cccccccccccccccccccccccccc
Confidence            999999999999999842             24899999999999999999999999

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.84  E-value=7.8e-20  Score=148.70  Aligned_cols=119  Identities=24%  Similarity=0.434  Sum_probs=99.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +|++.+.||+|+||.||+|..     ..++..||+|+++...  .......+..|..++..+.+|++|+++++++...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAER-----KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence            477889999999999999998     4556679999986431  223345677888888888757888899999998899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||||+++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~-------------~~l~~~~~~~i~~qi~~al~~lH~~~  121 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV-------------GKFKEPQAVFYAAEISVGLFFLHRRG  121 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999988763             24889999999999999999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.84  E-value=7.5e-20  Score=152.40  Aligned_cols=114  Identities=17%  Similarity=0.313  Sum_probs=98.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +...+|++.+.||+|+||.||+|.+     ..++..||+|....       ..+.+|+.++..+. ||||+++++++...
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d-----~~~~~~vaiK~~~~-------~~~~~E~~il~~l~-HpnIv~~~~~~~~~  155 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACID-----NKTCEHVVIKAGQR-------GGTATEAHILRAIN-HPSIIQLKGTFTYN  155 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEE-----CCCCCEEEEechhh-------hhhHHHHHHHHhCC-CCCCCCEeEEEEEC
Confidence            4557899999999999999999998     45566799996532       34678999999999 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...++++|++. ++|..++...             ..+++..++.++.|++.||.|||+++
T Consensus       156 ~~~~lv~e~~~-~~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~ylH~~~  202 (391)
T PHA03212        156 KFTCLILPRYK-TDLYCYLAAK-------------RNIAICDILAIERSVLRAIQYLHENR  202 (391)
T ss_pred             CeeEEEEecCC-CCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            89999999996 6888887653             24788999999999999999999998

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.84  E-value=1.1e-19  Score=146.06  Aligned_cols=118  Identities=26%  Similarity=0.463  Sum_probs=99.7

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC----HHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG----ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +|++.+.||+|+||.||+|..     ..++..+++|.++....    ......+..|+.++..+. |+||+++++++...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARD-----KETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEE-----CCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecC
Confidence            478889999999999999998     34456799999864322    223456778999999999 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++|+||+ +++|.+++....            ..+++..+..++.||+.||.|||+++
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~  122 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS------------IVLTPADIKSYMLMTLRGLEYLHSNW  122 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            8999999999 889999987531            24889999999999999999999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.84  E-value=1.6e-19  Score=145.00  Aligned_cols=129  Identities=19%  Similarity=0.396  Sum_probs=105.5

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ....|.+..++|++.+.||+|+||.||+|.+     ..++..+|+|.++..........+..|+.++....+|+||++++
T Consensus         6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~   80 (296)
T cd06618           6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRF-----KKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY   80 (296)
T ss_pred             cceeccCCcchheeeeEeeccCCeEEEEEEE-----CCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhh
Confidence            4566788999999999999999999999998     44456799999875444445566777887777766699999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      +++......++++||+. +++..++...            ...+++..+..++.|++.||.|||+. +
T Consensus        81 ~~~~~~~~~~~v~e~~~-~~l~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~  135 (296)
T cd06618          81 GYFITDSDVFICMELMS-TCLDKLLKRI------------QGPIPEDILGKMTVAIVKALHYLKEKHG  135 (296)
T ss_pred             eeeecCCeEEEEeeccC-cCHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence            99999999999999986 4777776552            23588889999999999999999974 5

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.84  E-value=9.3e-20  Score=154.05  Aligned_cols=120  Identities=23%  Similarity=0.418  Sum_probs=94.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ....+|++++.||+|+||.||+|..     ..++..||+|.+.....     ...+|+.++..+. |+||+++++++...
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~-h~niv~l~~~~~~~  131 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAIC-----IDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLN-HINIIFLKDYYYTE  131 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEE-----CCCCCEEEEEEEecCcc-----hHHHHHHHHHhcC-CCCCcceeeeEeec
Confidence            4556899999999999999999998     34556699998853321     2346999999999 99999998876432


Q ss_pred             --------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 --------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                              ..++++|||+++ +|.+++.....         ....+++..+..++.||+.||.|||+++
T Consensus       132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~gL~yLH~~~  190 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYAR---------NNHALPLFLVKLYSYQLCRALAYIHSKF  190 (440)
T ss_pred             ccccCCCceEEEEEEecCCc-cHHHHHHHHhh---------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                    236799999985 78787765321         1345889999999999999999999999

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.84  E-value=4e-19  Score=142.27  Aligned_cols=128  Identities=20%  Similarity=0.396  Sum_probs=102.1

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+.-..++|++.+.||+|+||.||++..     ..++..+++|.+...  ......+.+|+.++..+..|+|++++++++
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~-----~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTN-----KKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEE-----CCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            3334568899999999999999999988     445566999988643  122345678899999884499999999988


Q ss_pred             ecC-----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEK-----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...     +..++++||+++++|.+++.....         ....+++..+..++.|++.||.|||+.+
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~~  148 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLI---------CGQRLDEAMISYILYGALLGLQHLHNNR  148 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhh---------cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            643     358999999999999998875321         1235788999999999999999999988

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.84  E-value=1.2e-19  Score=145.20  Aligned_cols=122  Identities=30%  Similarity=0.577  Sum_probs=93.6

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcC--CCCceeeEeeEEe--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLD--PHPNVVRLLGCCT--   93 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~--   93 (230)
                      ++|++.+.||+|+||.||+|.+..    .++..+|+|.++... .......+.+|+.++..+.  .||||+++++++.  
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC----CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            478899999999999999998742    234569999886432 2222344566777776552  3999999999875  


Q ss_pred             ---cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 ---EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ....+++++||+. ++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~i~~qi~~aL~~lH~~~  130 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVP-----------EPGVPTETIKDMMFQLLRGLDFLHSHR  130 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence               2456899999997 58988887532           234788999999999999999999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2e-19  Score=145.75  Aligned_cols=121  Identities=23%  Similarity=0.385  Sum_probs=103.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH--HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE--RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|++|.||+|...     .++..+|+|.+......  .....+..|+.++..+. |+||+++++.+....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLK-----GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEc-----CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCC
Confidence            47899999999999999999884     34556999998644222  35567899999999999 999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+.+++|.+++....           ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~-----------~~~l~~~~~~~~~~qi~~~l~~lH~~~  123 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQP-----------GKCLSEEVARFYAAEVLLALEYLHLLG  123 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCC-----------CCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999987531           235888999999999999999999998

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.84  E-value=1.4e-19  Score=142.22  Aligned_cols=116  Identities=23%  Similarity=0.451  Sum_probs=93.7

Q ss_pred             eeecceeceeEEEeEEeccCC-----CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         25 DILGEGCFGQVWKCEALGIDG-----REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      +.||+|+||.||+|.......     ......+++|.+......  ...+.+|+.++..+. |+||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLS-HKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCC-CcchhheeeEEec-CCcE
Confidence            368999999999999965331     111234777876543222  577889999999998 9999999999887 7789


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||+++|+|.+++....            ..+++..+..++.|++.||.|||+++
T Consensus        77 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~  121 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREK------------NNVSLHWKLDVAKQLASALHYLEDKK  121 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            9999999999999988642            24788899999999999999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0033|consensus

Probab=99.84  E-value=5e-22  Score=149.00  Aligned_cols=162  Identities=20%  Similarity=0.292  Sum_probs=136.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ...+.|++.+.||+|+|+.|++|..     ..+++.+|+|+++.. .....-+.+.+|+++...++ ||||+++.+....
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~-----~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~   81 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVH-----KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQE   81 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHh-----ccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhhcc
Confidence            4567888999999999999999988     566677899988633 23345678899999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+..|+|+|++.|++|..-|-...             ..++..+.++++||+.||+|+|+++                  
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R~-------------~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~  148 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVARE-------------FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAK  148 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHHH-------------HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccC
Confidence            999999999999999987766542             3789999999999999999999999                  


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 |..|.
T Consensus       149 ~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~  228 (355)
T KOG0033|consen  149 GAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA  228 (355)
T ss_pred             CCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence                                                                                       33333


Q ss_pred             cCC---CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        162 RLE---KPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       162 ~~~---~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .+-   ..++++++.++|+.+||..||.+|.|+.+.+.
T Consensus       229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            322   33578999999999999999999999999875

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.84  E-value=1.5e-19  Score=144.35  Aligned_cols=120  Identities=25%  Similarity=0.482  Sum_probs=102.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..+.|++...||+|++|.||.+.+.     .++..+++|++.....  ....+.+|+.++..+. |+|++++++.+...+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   88 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDR-----ATGKEVAIKKMRLRKQ--NKELIINEILIMKDCK-HPNIVDYYDSYLVGD   88 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEc-----cCCcEEEEEEEecCch--hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECC
Confidence            3456788899999999999999884     3455699999864322  4567889999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|.+++....            ..+++..+..++.|++.||.|||+.+
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~lH~~g  136 (286)
T cd06614          89 ELWVVMEYMDGGSLTDIITQNF------------VRMNEPQIAYVCREVLQGLEYLHSQN  136 (286)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999998742            24889999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.84  E-value=9.8e-20  Score=145.37  Aligned_cols=119  Identities=28%  Similarity=0.509  Sum_probs=99.8

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+|++.+.||+|+||.||+|.+     ..++..+++|.++.. ........+.+|+.++..+. |+||+++++++...+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRN-----KATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEe-----CCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCE
Confidence            3689999999999999999988     444567999988643 23344567899999999999 9999999999999889


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||++++.+..+...             ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~iv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~LH~~~  120 (288)
T cd07833          75 LYLVFEYVERTLLELLEAS-------------PGGLPPDAVRSYIWQLLQAIAYCHSHN  120 (288)
T ss_pred             EEEEEecCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999998766555443             224788999999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.84  E-value=1.9e-19  Score=141.87  Aligned_cols=111  Identities=23%  Similarity=0.393  Sum_probs=95.6

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      ||.|++|.||++...     .++..+++|++....  .......+.+|+.++..+. |+||+++++.+...+..++++||
T Consensus         1 lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVK-----SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEEC-----CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEec
Confidence            689999999999984     345569999986432  2345567999999999998 99999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        75 ~~~~~L~~~l~~~~-------------~l~~~~~~~~~~~i~~~l~~lH~~~  113 (262)
T cd05572          75 CLGGELWTILRDRG-------------LFDEYTARFYIACVVLAFEYLHNRG  113 (262)
T ss_pred             CCCCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            99999999997632             3788899999999999999999998

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.84  E-value=1.9e-19  Score=144.07  Aligned_cols=120  Identities=24%  Similarity=0.471  Sum_probs=100.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|++|.||+|..     +.++..+++|.+...........+.+|+.++..+. |+||+++++++...+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   77 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRS-----KLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKT   77 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEE-----cCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCe
Confidence            47899999999999999999987     34456799999864332222345678999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++|+||+++ +|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        78 ~~lv~e~~~~-~L~~~~~~~------------~~~~~~~~~~~~~~ql~~al~~lH~~~  123 (291)
T cd07844          78 LTLVFEYLDT-DLKQYMDDC------------GGGLSMHNVRLFLFQLLRGLAYCHQRR  123 (291)
T ss_pred             EEEEEecCCC-CHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999985 898888753            224788999999999999999999988

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.84  E-value=1.2e-19  Score=144.77  Aligned_cols=119  Identities=24%  Similarity=0.514  Sum_probs=99.5

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++.+.||.|++|.||+|..     ..++..+++|.++... .......+.+|++++..+. |+||+++++++...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARN-----KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEE-----CCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcE
Confidence            478899999999999999988     3455579999886432 2233457889999999999 99999999999998999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+. ++|.+++....           ...+++..+..++.|++.||+|||+.+
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lh~~~  120 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASP-----------LSGIPLPLIKSYLFQLLQGLAFCHSHR  120 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999996 58888876532           235789999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=3e-19  Score=145.77  Aligned_cols=120  Identities=17%  Similarity=0.283  Sum_probs=102.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+|+|++...  ........+.+|..++..+. |+||+++++++...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKM-----KNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEE-----CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence            4789999999999999999988     445566999998632  12234456788999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++||||+++|+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~  122 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF------------EDRLPEDMARFYLAEMVLAIDSVHQLG  122 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999998763            234889999999999999999999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4279|consensus

Probab=99.83  E-value=2.1e-20  Score=157.94  Aligned_cols=153  Identities=29%  Similarity=0.507  Sum_probs=130.8

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      -+||+|.||.||.|.++.     +...+|+|.+.... ....+.+..|+.+.+.++ |.|||++.|.+..++.+-+.||-
T Consensus       581 vVLGKGTYG~VYA~RD~~-----tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEq  653 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMD-----TQVRIAIKEIPEKD-SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQ  653 (1226)
T ss_pred             EEeecCceeEEEeecccc-----ceeEEEeeeccccc-chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeec
Confidence            469999999999999954     44459999997543 445577899999999999 99999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCC--ChHHHHHHHHHHHhhhhhhhhcC--------------------------
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSL--TSRDLTSFCYQVARGMQFLSSRG--------------------------  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~i~~qi~~gl~~LH~~~--------------------------  156 (230)
                      .+||+|.+++++.=            +++  .+..+-.+..||++||.|||++.                          
T Consensus       654 VPGGSLSsLLrskW------------GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFG  721 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKW------------GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFG  721 (1226)
T ss_pred             CCCCcHHHHHHhcc------------CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccc
Confidence            99999999999841            234  67788999999999999999988                          


Q ss_pred             ----------------------------------------------------------------------CCCCccCCCC
Q psy15820        157 ----------------------------------------------------------------------VRDGYRLEKP  166 (230)
Q Consensus       157 ----------------------------------------------------------------------i~~~~~~~~p  166 (230)
                                                                                            =+-...+++|
T Consensus       722 TsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP  801 (1226)
T KOG4279|consen  722 TSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP  801 (1226)
T ss_pred             cchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence                                                                                  0111347788


Q ss_pred             CcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        167 DHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       167 ~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      +..+.+..++|.+|+..||.+||++.+++.
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            889999999999999999999999999986

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.83  E-value=9.8e-20  Score=145.59  Aligned_cols=122  Identities=20%  Similarity=0.370  Sum_probs=100.4

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +|++.+.||+|++|.||++...+..  .++..+|+|.++...   .......+.+|+.++..+.+|+||+++++.+....
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence            4788999999999999999865332  345569999886321   12334568889999999966999999999999888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~~  125 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQR-------------EHFTESEVRVYIAEIVLALDHLHQLG  125 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhc-------------CCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999988753             24788899999999999999999987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.83  E-value=1.2e-19  Score=147.58  Aligned_cols=113  Identities=23%  Similarity=0.437  Sum_probs=91.8

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHH-HHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELT-VMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      +.||+|+||.||+|.+     ..++..+|+|++....  .......+..|.. ++..+. ||||+++++.+...+..+++
T Consensus         1 ~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKH-----KADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEE
Confidence            3689999999999998     4556679999986321  1223344555555 456677 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |||+++|+|..++...             ..+++..+..++.||+.||.|||+++
T Consensus        75 ~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~g  116 (323)
T cd05575          75 LDYVNGGELFFHLQRE-------------RSFPEPRARFYAAEIASALGYLHSLN  116 (323)
T ss_pred             EcCCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999888753             24788999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.83  E-value=2.7e-19  Score=147.53  Aligned_cols=118  Identities=23%  Similarity=0.349  Sum_probs=97.1

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..++|++.+.||+|+||.||++.+     ..++..+|+|.+... ........+.+|+.++..+. |+||+++++++...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~   92 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFD-----TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQ   92 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEE-----cCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccC
Confidence            458899999999999999999988     445667999998643 33444567889999999999 99999999998654


Q ss_pred             C------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 E------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .      ..+++|||+++ +|.+.+..               .+++..+..++.|++.||.|||+++
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~qi~~~L~~LH~~~  143 (359)
T cd07876          93 KSLEEFQDVYLVMELMDA-NLCQVIHM---------------ELDHERMSYLLYQMLCGIKHLHSAG  143 (359)
T ss_pred             CCccccceeEEEEeCCCc-CHHHHHhc---------------cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3      47999999975 56666543               2778889999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.83  E-value=2.7e-19  Score=148.13  Aligned_cols=123  Identities=20%  Similarity=0.363  Sum_probs=104.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..+..++|++.+.||+|+||.||++.+     ..++..+|+|++...  ........+.+|+.++..+. ||||++++++
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~  111 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRH-----KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCA  111 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence            456678999999999999999999998     445667999998532  12223445778999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+.+++||||+++|+|.+++...              .+++..+..++.||+.||.|||+++
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~--------------~~~~~~~~~~~~qil~aL~~LH~~~  162 (370)
T cd05621         112 FQDDKYLYMVMEYMPGGDLVNLMSNY--------------DVPEKWAKFYTAEVVLALDAIHSMG  162 (370)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999998653              3788899999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.83  E-value=3.3e-19  Score=144.66  Aligned_cols=120  Identities=19%  Similarity=0.424  Sum_probs=99.2

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ...|...+.||+|+||.||++..     ..++..+++|.+...  ........+.+|+.++..+. |+|++++++++...
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~   97 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARD-----VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLRE   97 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEE-----cCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeC
Confidence            34577888999999999999988     344566999988532  23344567889999999998 99999999999998


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...++++||+++ ++.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        98 ~~~~lv~e~~~g-~l~~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~  145 (317)
T cd06635          98 HTAWLVMEYCLG-SASDLLEVH------------KKPLQEVEIAAITHGALQGLAYLHSHN  145 (317)
T ss_pred             CeEEEEEeCCCC-CHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            899999999975 777776543            234788999999999999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=2.8e-19  Score=140.81  Aligned_cols=114  Identities=22%  Similarity=0.365  Sum_probs=90.6

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      +.||+|+||.||+|...     .++..+|+|.++...  .......+..|..++.....|+|++++++.+...+..++++
T Consensus         2 ~~l~~g~~~~v~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKR-----STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEec-----CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence            56899999999999883     445569999986432  12222344556555544434999999999999989999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        77 e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~  117 (260)
T cd05611          77 EYLNGGDCASLIKTL-------------GGLPEDWAKQYIAEVVLGVEDLHQRG  117 (260)
T ss_pred             eccCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999998763             24788999999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=5.6e-20  Score=151.83  Aligned_cols=129  Identities=22%  Similarity=0.410  Sum_probs=110.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||+|..     ..++..+|+|+++..  ........+.+|+.++..+. |+||+++++++...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQK-----KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCC
Confidence            4789999999999999999998     445667999999643  12234456788999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      ..+++|||+++|+|.+++...             ..+++..+..++.|++.||.|||++++.  |++.+|+|
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~lH~~~iv--H~Dlkp~N  131 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKK-------------DTFTEEETRFYIAETILAIDSIHKLGYI--HRDIKPDN  131 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eccCCHHH
Confidence            999999999999999998763             2488999999999999999999999988  77777754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0605|consensus

Probab=99.83  E-value=5.9e-20  Score=150.84  Aligned_cols=134  Identities=24%  Similarity=0.384  Sum_probs=119.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .++..++|++++.||+|+||.||+|+-     +.++..+|+|+++..  ...........|-.+|.... +++||++|-.
T Consensus       136 ~r~~~~DFe~Lk~IgkGAfGeVrLarK-----k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYs  209 (550)
T KOG0605|consen  136 TRLSLDDFELLKVIGKGAFGEVRLARK-----KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYS  209 (550)
T ss_pred             ccCCcccchhheeeccccceeEEEEEE-----ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEE
Confidence            477899999999999999999999998     667778999999754  22334567788999999987 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      |.+..++||||||++||++..+|....             .+++..+..++.+++.|+.-||..|+.  ||+.+|+|
T Consensus       210 FQD~~~LYLiMEylPGGD~mTLL~~~~-------------~L~e~~arfYiaE~vlAI~~iH~~gyI--HRDIKPdN  271 (550)
T KOG0605|consen  210 FQDKEYLYLIMEYLPGGDMMTLLMRKD-------------TLTEDWARFYIAETVLAIESIHQLGYI--HRDIKPDN  271 (550)
T ss_pred             ecCCCeeEEEEEecCCccHHHHHHhcC-------------cCchHHHHHHHHHHHHHHHHHHHcCcc--cccCChhh
Confidence            999999999999999999999998743             489999999999999999999999999  99999975

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.83  E-value=3.1e-19  Score=147.84  Aligned_cols=125  Identities=19%  Similarity=0.342  Sum_probs=106.0

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+.+..++|++.+.||+|+||.||++.+     ..++..+|+|++...  ........+.+|+.++..+. ||||++++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~  109 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRH-----KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLF  109 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEE-----CCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEE
Confidence            34677889999999999999999999998     455667999998532  12223445778999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++...+..+++|||+++|+|.+++...              .+++..+..++.||+.||.|||+++
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~~  162 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSNY--------------DVPEKWARFYTAEVVLALDAIHSMG  162 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999998653              3788889999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.83  E-value=3.5e-19  Score=141.72  Aligned_cols=118  Identities=24%  Similarity=0.516  Sum_probs=95.8

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--CCe
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPF   98 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--~~~   98 (230)
                      |++.+.||+|+||.||++..     ..++..+|+|.++............+|+.++..+..|+|++++++++...  +..
T Consensus         1 y~~~~~lg~g~~~~v~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   75 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQS-----RKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL   75 (282)
T ss_pred             CceEeeccccccceEEEEEE-----cCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence            57789999999999999998     34556699999864422223334567888888886699999999999877  889


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||++ +++.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        76 ~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~~~~qi~~~L~~LH~~~  120 (282)
T cd07831          76 ALVFELMD-MNLYELIKGR------------KRPLPEKRVKSYMYQLLKSLDHMHRNG  120 (282)
T ss_pred             EEEEecCC-ccHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999997 4888887653            124789999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=8.1e-20  Score=151.63  Aligned_cols=130  Identities=22%  Similarity=0.353  Sum_probs=111.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+|+|++...  ........+.+|+.++..+. |+||+++++++...+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQK-----KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEE-----CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCC
Confidence            4789999999999999999988     455667999998532  12334567888999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .+|+||||+++|+|.+++...             ..+++..+..++.|++.||.|||++++.  |++.+|.|+
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~giv--HrDlkp~NI  132 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY-------------DTFSEDVTRFYMAECVLAIEAVHKLGFI--HRDIKPDNI  132 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHE
Confidence            999999999999999998763             2478889999999999999999999999  888887653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.83  E-value=3.3e-19  Score=142.89  Aligned_cols=124  Identities=24%  Similarity=0.473  Sum_probs=99.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-HHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|.++.... ......+.+|+.++..+..|+||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~-----~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   75 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARD-----KNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK   75 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEE-----CCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence            4688999999999999999998     44556799998864322 22335678899999999757999999999876655


Q ss_pred             -----eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 -----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                           .++++||+++ +|.+++......        ....+++..++.++.||+.||.|||+++
T Consensus        76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~LH~~~  130 (295)
T cd07837          76 NGKPSLYLVFEYLDS-DLKKFMDSNGRG--------PGRPLPAKTIKSFMYQLLKGVAHCHKHG  130 (295)
T ss_pred             CCCceEEEEeeccCc-CHHHHHHHhccc--------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                 8999999986 898888753210        1235789999999999999999999999

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.83  E-value=1.1e-19  Score=150.97  Aligned_cols=130  Identities=21%  Similarity=0.321  Sum_probs=111.4

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.|++++.||+|+||.||+|..     ..++..+|+|+++..  ........+.+|+.++..+. |+||+++++++...+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~   74 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACK-----VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKD   74 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCC
Confidence            3688999999999999999988     445667999998643  22334567889999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      ..+++|||+++|+|.+++...             ..+++..+..++.|++.||.|||++++.  |++.+|+|+
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~-------------~~~~e~~~~~~~~qi~~aL~~LH~~giv--HrDlKp~Ni  132 (381)
T cd05626          75 NLYFVMDYIPGGDMMSLLIRM-------------EVFPEVLARFYIAELTLAIESVHKMGFI--HRDIKPDNI  132 (381)
T ss_pred             EEEEEEecCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCee--ecCCcHHHE
Confidence            999999999999999998763             2478889999999999999999999998  888887653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=1.1e-18  Score=137.89  Aligned_cols=120  Identities=25%  Similarity=0.465  Sum_probs=100.0

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc----CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +.+|++++.||+|+||.||++..     ..++..+++|.+...    ........+.+|+.++..+. |+||+++++++.
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~   74 (264)
T cd06653           1 PVNWRLGKLLGRGAFGEVYLCYD-----ADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLR   74 (264)
T ss_pred             CCceeeeeeEccCCCeEEEEEEE-----cCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEE
Confidence            35789999999999999999988     345567999987421    22345568889999999998 999999999987


Q ss_pred             cC--CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..  ...++++||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        75 ~~~~~~~~~v~e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~~i~~al~~LH~~~  126 (264)
T cd06653          75 DPEEKKLSIFVEYMPGGSIKDQLKAY-------------GALTENVTRRYTRQILQGVSYLHSNM  126 (264)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            64  4588999999999999988752             23788889999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.83  E-value=3.6e-19  Score=145.10  Aligned_cols=115  Identities=19%  Similarity=0.349  Sum_probs=96.2

Q ss_pred             eeecce--eceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         25 DILGEG--CFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        25 ~~lg~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      ..||+|  +||.||.+.+     ..++..||+|++... ......+.+.+|+.++..+. |+||+++++++..++..+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARH-----TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEE-----cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEE
Confidence            346666  9999999988     445667999998643 34445578889999999898 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +||+.+++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        78 ~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~~qi~~aL~~lH~~~  121 (328)
T cd08226          78 SPFMAYGSANSLLKTYF-----------PEGMSEALIGNILFGALRGLNYLHQNG  121 (328)
T ss_pred             EecccCCCHHHHHHhhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999988642           224788899999999999999999988

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.83  E-value=1e-18  Score=136.34  Aligned_cols=118  Identities=26%  Similarity=0.612  Sum_probs=102.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      +|.+.+.||+|++|.||++...     .++..+++|++..... .....+.+|+.++..+. |+|++++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHK-----RTGKEVAIKVIKLESK-EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEEC-----CCCcEEEEEEecccch-hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence            4788899999999999999983     3455699999865432 45578899999999999 999999999999889999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||+++++|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        74 l~~e~~~~~~L~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~  118 (253)
T cd05122          74 IVMEFCSGGSLKDLLKST------------NQTLTESQIAYVCKELLKGLEYLHSNG  118 (253)
T ss_pred             EEEecCCCCcHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence            999999999999998763            134899999999999999999999988

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.83  E-value=2.3e-19  Score=143.82  Aligned_cols=119  Identities=23%  Similarity=0.445  Sum_probs=98.9

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      ++|++.+.||.|+||.||+|.+     ..++..+++|.++... .......+.+|+.++..+. |+||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARD-----KKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEE-----CCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCC
Confidence            5788899999999999999998     3445569999986432 2223345678999999999 99999999998776  


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++++||+++ +|.+++....            ..+++..+..++.|++.||.|||+++
T Consensus        79 ~~~~lv~e~~~~-~L~~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~  126 (293)
T cd07843          79 DKIYMVMEYVEH-DLKSLMETMK------------QPFLQSEVKCLMLQLLSGVAHLHDNW  126 (293)
T ss_pred             CcEEEEehhcCc-CHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            889999999985 8988887632            24889999999999999999999999

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.83  E-value=5.1e-19  Score=140.71  Aligned_cols=113  Identities=19%  Similarity=0.336  Sum_probs=94.6

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      ||+|+||.||+|..     ..++..+++|.+....  .......+..|+.++..+. |+||+++++.+...+..++++||
T Consensus         1 lg~g~~g~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQV-----KATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEE-----cCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEec
Confidence            68999999999987     4456679999885321  2223456778999999999 99999999999988999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++|.+++....           ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~ql~~~l~~lH~~~  115 (277)
T cd05577          75 MNGGDLKYHIYNVG-----------EPGFPEARAIFYAAQIICGLEHLHQRR  115 (277)
T ss_pred             CCCCcHHHHHHHcC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999987642           124789999999999999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=2.9e-19  Score=145.77  Aligned_cols=112  Identities=18%  Similarity=0.335  Sum_probs=90.8

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcC--CCCceeeEeeEEecCCCeEEEE
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      ||+|+||.||+|..     ..++..+|+|++....  ..........|..++....  .||||+++++.+...+..+++|
T Consensus         1 lG~G~~g~Vy~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRK-----KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEE-----CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            69999999999988     4556679999985321  1223344556666666552  5999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++|+|..++...             ..+++..+..++.||+.||.|||+++
T Consensus        76 e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~qil~al~~LH~~~  116 (330)
T cd05586          76 DYMSGGELFWHLQKE-------------GRFSEDRAKFYIAELVLALEHLHKYD  116 (330)
T ss_pred             cCCCCChHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999888753             24889999999999999999999999

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.82  E-value=2.3e-19  Score=142.51  Aligned_cols=120  Identities=25%  Similarity=0.447  Sum_probs=102.8

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++...     .++..+++|++...  ........+.+|..++..+..|+||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEc-----CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence            47899999999999999999983     45567999988642  223344677889999988866999999999999989


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~ql~~~l~~Lh~~~  122 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKY-------------GSLDEKCTRFYAAEILLALEYLHSKG  122 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999763             24899999999999999999999999

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0586|consensus

Probab=99.82  E-value=2.8e-19  Score=148.94  Aligned_cols=121  Identities=21%  Similarity=0.418  Sum_probs=105.6

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ....|.+.+.||+|.|+.|.++.+.     -++..||+|.+... .....+..+.+|++++..+. |||||+++.+....
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~-----~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHI-----LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETE  127 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEec-----CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeeeeeeec
Confidence            4456888999999999999999994     45666999999644 44556677999999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+|+||||+.+|.+++++....             ...+.....++.|+..|++|||++.
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~g-------------r~~e~~ar~~F~q~vsaveYcH~k~  175 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHG-------------RMKEKEARAKFRQIVSAVEYCHSKN  175 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcc-------------cchhhhhhhhhHHHHHHHHHHhhcc
Confidence            99999999999999999998742             3566888899999999999999998

>KOG3653|consensus

Probab=99.82  E-value=1.3e-19  Score=146.89  Aligned_cols=116  Identities=23%  Similarity=0.509  Sum_probs=99.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC-CCCceeeEeeEEec
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTE   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-~h~niv~l~~~~~~   94 (230)
                      .+...+++.+.||+|.||.||+|+..+       +.||||+++    ....+.|..|-+++.... .|+||+++++.-..
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~~-------~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr  275 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLDN-------RLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKR  275 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhccC-------ceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence            456777888999999999999998854       459999986    556677888888887543 49999999998866


Q ss_pred             CC----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..    .++||+||.+.|+|.+++..+              .++|....+++..+++||+|||+..
T Consensus       276 ~t~~~~eywLVt~fh~kGsL~dyL~~n--------------tisw~~~cria~SmarGLa~LHee~  327 (534)
T KOG3653|consen  276 GTADRMEYWLVTEFHPKGSLCDYLKAN--------------TISWNSLCRIAESMARGLAHLHEEL  327 (534)
T ss_pred             CCccccceeEEeeeccCCcHHHHHHhc--------------cccHHHHHHHHHHHHHHHHHhcccC
Confidence            55    799999999999999999875              3899999999999999999999876

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.82  E-value=1.2e-19  Score=149.81  Aligned_cols=130  Identities=20%  Similarity=0.373  Sum_probs=111.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+|+|+++...  .......+..|+.++..+. |+||+++++.+....
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQK-----KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            4789999999999999999988     4455679999986431  2233456788999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .+++||||+++|+|.+++...             ..+++..+..++.|++.||.|||++++.  |++.+|+|+
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~lH~~giv--HrDlKp~NI  132 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK-------------DTLTEEETQFYIAETVLAIDSIHQLGFI--HRDIKPDNL  132 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeE--ecCCCHHHe
Confidence            999999999999999998763             2488999999999999999999999998  888877653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.82  E-value=2.9e-19  Score=145.47  Aligned_cols=113  Identities=23%  Similarity=0.415  Sum_probs=92.2

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHH-HhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTV-MKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~-l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      +.||+|+||.||+|..     ..++..+|+|++...  ........+..|..+ +..+. |+||+++++.+...+..+++
T Consensus         1 ~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKR-----KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEE
Confidence            3689999999999988     455667999998533  122333455666554 56677 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |||+++|+|...+...             ..+++..+..++.||+.||.|||+++
T Consensus        75 ~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~g  116 (325)
T cd05604          75 LDFVNGGELFFHLQRE-------------RSFPEPRARFYAAEIASALGYLHSIN  116 (325)
T ss_pred             EcCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999998887653             24889999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.82  E-value=1.5e-19  Score=149.99  Aligned_cols=130  Identities=20%  Similarity=0.318  Sum_probs=111.0

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+|+|++....  .......+.+|+.++..+. |+||+++++.+...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRK-----VDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEE-----CCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCC
Confidence            4789999999999999999998     4456679999986321  1223456788999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .++++|||+++|+|.+++...             ..+++..+..++.||+.||.|||++++.  |++.+|.|+
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~iv--HrDlkp~Ni  132 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL-------------GIFEEDLARFYIAELTCAIESVHKMGFI--HRDIKPDNI  132 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eCCCCHHHE
Confidence            999999999999999998763             2478888999999999999999999999  888888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0584|consensus

Probab=99.82  E-value=5.1e-20  Score=153.69  Aligned_cols=117  Identities=26%  Similarity=0.497  Sum_probs=100.5

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC---CcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK---ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~---~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++...||+|+|-+||+|.+     ..++.+||--.++   ...++...++|..|+++|+.+. |+||+++|..|.+..+
T Consensus        42 ~k~~evLGrGafKtVYka~D-----e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFD-----EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDN  115 (632)
T ss_pred             eehhhhcccccceeeeeccc-----cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCC
Confidence            35678899999999999999     5666667754443   2356777899999999999999 9999999999987554


Q ss_pred             --eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 --FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        +-+|+|.+..|+|..+.+..+             .+....+.+|++||+.||.|||++.
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~-------------~vn~kaik~W~RQILkGL~yLHs~~  163 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHR-------------RVNIKAIKSWCRQILKGLVYLHSQD  163 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhc-------------cCCHHHHHHHHHHHHHHhhhhhcCC
Confidence              899999999999999999865             4788899999999999999999998

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.82  E-value=5.9e-19  Score=141.04  Aligned_cols=116  Identities=24%  Similarity=0.483  Sum_probs=98.1

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      .|...+.||+|++|.||++..     ..++..+++|.+... .......+.+|+.++..+. |+||+++++.+...+..+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~   92 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATD-----KSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELW   92 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEE-----CCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEE
Confidence            455567899999999999987     344556999988533 2334456889999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||+++++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        93 ~v~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lH~~~  135 (285)
T cd06648          93 VVMEFLEGGALTDIVTHT--------------RMNEEQIATVCLAVLKALSFLHAQG  135 (285)
T ss_pred             EEEeccCCCCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999988652              3788899999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0585|consensus

Probab=99.82  E-value=1e-19  Score=147.64  Aligned_cols=123  Identities=20%  Similarity=0.396  Sum_probs=99.8

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-------------CHHHHHHHHHHHHHHhhcCC
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-------------GERERLDLLQELTVMKTLDP   81 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~~e~~~l~~~~~   81 (230)
                      ....++|++.+.||+|.||.|.+|..     ..++..||+|++....             .....++..+|+.+++++. 
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~-----~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-  166 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARD-----EVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-  166 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEee-----cCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-
Confidence            45678899999999999999999998     5667789999995321             0112357889999999999 


Q ss_pred             CCceeeEeeEEecC--CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         82 HPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        82 h~niv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+|||+++++..++  +.+|||+|||..|.+...-.             ....+.+.+.++|++++..||.|||.+|
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-------------d~~els~~~Ar~ylrDvv~GLEYLH~Qg  230 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-------------DKPELSEQQARKYLRDVVLGLEYLHYQG  230 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcC
Confidence            99999999999875  46999999999887732211             1112889999999999999999999999

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.82  E-value=2.1e-19  Score=146.30  Aligned_cols=113  Identities=21%  Similarity=0.421  Sum_probs=90.2

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHH-HHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELT-VMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      +.||+|+||.||+|.+     ..++..+|+|++....  .......+..|.. ++..+. |+||+++++.+...+..+++
T Consensus         1 ~~lg~G~fg~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARH-----KAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEE-----CCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEE
Confidence            3689999999999988     4455669999986321  1122234444544 456677 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |||+++++|.+++...             ..+.+..+..++.||+.||.|||+++
T Consensus        75 ~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~g  116 (325)
T cd05602          75 LDYINGGELFYHLQRE-------------RCFLEPRARFYAAEIASALGYLHSLN  116 (325)
T ss_pred             EeCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999988763             24778888999999999999999999

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0660|consensus

Probab=99.82  E-value=2.2e-19  Score=141.24  Aligned_cols=118  Identities=22%  Similarity=0.433  Sum_probs=100.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC-CcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec---
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE---   94 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~---   94 (230)
                      ..|...+.||+|+||.|..+.+     +.++..||+|.+. ........++.++|+.+|..++ |+||+.+.+++..   
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~-----~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKD-----KRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR   95 (359)
T ss_pred             ceecccccccCcceeeEEEEEE-----cCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence            3444478999999999999999     4555679999986 3455667788999999999999 9999999999865   


Q ss_pred             --CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 --KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        -+.+|+|+|+++ .+|.+.++..             ..++......+++|++.||.|+|+-+
T Consensus        96 ~~f~DvYiV~elMe-tDL~~iik~~-------------~~L~d~H~q~f~YQiLrgLKyiHSAn  145 (359)
T KOG0660|consen   96 DKFNDVYLVFELME-TDLHQIIKSQ-------------QDLTDDHAQYFLYQILRGLKYIHSAN  145 (359)
T ss_pred             cccceeEEehhHHh-hHHHHHHHcC-------------ccccHHHHHHHHHHHHHhcchhhccc
Confidence              346999999995 5899999874             24889999999999999999999998

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.82  E-value=4.8e-19  Score=141.54  Aligned_cols=126  Identities=21%  Similarity=0.360  Sum_probs=99.5

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.++|+..+.||+|+||.||++.+     ..++..+|+|.+...........+.+|+.++.++..|+||+++++++...+
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~   76 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLH-----KPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG   76 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEE-----CCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence            346777888999999999999988     445567999998754444556778999999998866999999999999888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      ..++++||+.. ++.++.......        ....+++..+..++.|++.||.|||+. +
T Consensus        77 ~~~~~~e~~~~-~l~~l~~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~  128 (288)
T cd06616          77 DCWICMELMDI-SLDKFYKYVYEV--------LKSVIPEEILGKIAVATVKALNYLKEELK  128 (288)
T ss_pred             cEEEEEecccC-CHHHHHHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence            99999999864 666554321100        123588999999999999999999975 5

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.82  E-value=3.1e-19  Score=143.51  Aligned_cols=117  Identities=25%  Similarity=0.443  Sum_probs=97.4

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ..|.....||+|+||.||++..     ..++..+++|.+.... ......+.+|+.++..+. |+||+++++.+...+..
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIARE-----KHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEE-----cCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeE
Confidence            3444556799999999999988     3445569999985432 223456889999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|..++...              .+++..+..++.|++.||.|||+++
T Consensus        94 ~iv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~  137 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQT--------------RLNEEQIATVCESVLQALCYLHSQG  137 (297)
T ss_pred             EEEEecCCCCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999998877542              3788999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.82  E-value=2e-19  Score=144.32  Aligned_cols=117  Identities=24%  Similarity=0.459  Sum_probs=98.4

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +.|.....||+|+||.||++..     ..++..+++|.+... .......+.+|+.++..+. |+||+++++.+...+..
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATE-----KHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDEL   94 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEE-----CCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeE
Confidence            4455567899999999999987     344556999988643 2344567889999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++...              .+++..+..++.||+.||.|||+++
T Consensus        95 ~lv~e~~~~~~L~~~~~~~--------------~l~~~~~~~~~~qi~~~l~~LH~~~  138 (292)
T cd06658          95 WVVMEFLEGGALTDIVTHT--------------RMNEEQIATVCLSVLRALSYLHNQG  138 (292)
T ss_pred             EEEEeCCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999887532              3788899999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.82  E-value=7.1e-19  Score=144.83  Aligned_cols=119  Identities=23%  Similarity=0.353  Sum_probs=97.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ...++|++.+.||+|+||.||++.+     ...+..+|+|.+... ........+.+|+.++..+. |+||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYD-----AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEe-----cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeec
Confidence            3568999999999999999999987     344566999998643 33445567889999999998 9999999998864


Q ss_pred             C------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 K------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .      ...+++|||+++ ++.+.+..               .+++..+..++.|++.||.|||+++
T Consensus        88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~l~~~~~~~~~~qi~~aL~~LH~~g  139 (355)
T cd07874          88 QKSLEEFQDVYLVMELMDA-NLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAG  139 (355)
T ss_pred             cccccccceeEEEhhhhcc-cHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3      247999999975 67666643               2788889999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.82  E-value=3.6e-19  Score=144.62  Aligned_cols=113  Identities=24%  Similarity=0.438  Sum_probs=91.5

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHH-HHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELT-VMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      +.||+|+||.||+|.+     ..++..+|+|++....  .......+..|.. ++..+. |+||+++++.+...+..+++
T Consensus         1 ~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKR-----KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEE
Confidence            3689999999999998     4556679999985321  2223345555655 566777 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |||+++++|...+...             ..+++..+..++.||+.||.|||+++
T Consensus        75 ~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~~  116 (321)
T cd05603          75 LDYVNGGELFFHLQRE-------------RCFLEPRARFYAAEVASAIGYLHSLN  116 (321)
T ss_pred             EcCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999998887652             24788899999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.82  E-value=5.7e-19  Score=145.58  Aligned_cols=114  Identities=18%  Similarity=0.283  Sum_probs=95.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ...+|++.+.||+|+||.||+|...     .++..||+|+....       ....|+.++..+. |+||+++++++...+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~valK~~~~~-------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  130 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKP-----GQPDPVVLKIGQKG-------TTLIEAMLLQNVN-HPSVIRMKDTLVSGA  130 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEEC-----CCCceEEEEeCCcc-------ccHHHHHHHHhCC-CCCCcChhheEEeCC
Confidence            4457999999999999999999984     34456899975432       1346888999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++|++. ++|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus       131 ~~~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~  177 (357)
T PHA03209        131 ITCMVLPHYS-SDLYTYLTKR------------SRPLPIDQALIIEKQILEGLRYLHAQR  177 (357)
T ss_pred             eeEEEEEccC-CcHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999996 5888888653            235889999999999999999999998

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.82  E-value=2.6e-19  Score=148.82  Aligned_cols=130  Identities=22%  Similarity=0.325  Sum_probs=111.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.|++++.||+|+||.||+|..     ..++..+|+|++....  .......+.+|+.++..+. |+||+++++.+...+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~   74 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARK-----VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKD   74 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEE-----CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCC
Confidence            3688999999999999999988     4455679999986431  2334567889999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .+++|||||++|+|.+++...             ..+++..+..++.||+.||.|||++++.  |++.+|+|+
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~-------------~~~~e~~~~~~~~qi~~al~~lH~~~iv--HrDlKp~NI  132 (382)
T cd05625          75 NLYFVMDYIPGGDMMSLLIRM-------------GIFPEDLARFYIAELTCAVESVHKMGFI--HRDIKPDNI  132 (382)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHE
Confidence            999999999999999988763             2478889999999999999999999999  888888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.81  E-value=5.9e-19  Score=141.93  Aligned_cols=123  Identities=24%  Similarity=0.493  Sum_probs=99.4

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +...++|++.+.||+|+||.||+|..     +.++..+++|.++... .......+.+|+.++..++ ||||+++++++.
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~   76 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARD-----KDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEE-----CCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheec
Confidence            34567899999999999999999998     3445669999986332 2223346778999999998 999999999887


Q ss_pred             cCC----------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKE----------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...          ..++++||+++ ++..++...            ...+++..+..++.|++.||.|||+.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~  136 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG------------LVHFSEDHIKSFMKQLLEGLNYCHKKN  136 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            644          78999999986 777776542            234889999999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.81  E-value=1.4e-18  Score=139.17  Aligned_cols=120  Identities=23%  Similarity=0.404  Sum_probs=98.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|.+.+.||+|+||.||+|...     .++..+++|.+...........+.+|+.++..+. |+||+++++++...+.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISR-----INGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEc-----CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCe
Confidence            368999999999999999999883     4445699999864433333345678999999998 9999999999999889


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+. +++.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~  123 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQH------------PGGLHPYNVRLFMFQLLRGLAYIHGQH  123 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999996 6787776542            224677888899999999999999999

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.81  E-value=8.7e-19  Score=141.61  Aligned_cols=121  Identities=21%  Similarity=0.482  Sum_probs=99.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ....|+..+.||+|+||.||+|..     ..++..+++|.+...  ........+.+|+.++..+. |+|++++++++..
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   86 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARD-----VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR   86 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEE-----cCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEc
Confidence            445577788999999999999998     344556999988532  23444567889999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....++++||+. |++.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        87 ~~~~~lv~e~~~-~~l~~~~~~~------------~~~l~~~~~~~~~~~l~~~l~~LH~~~  135 (308)
T cd06634          87 EHTAWLVMEYCL-GSASDLLEVH------------KKPLQEVEIAAVTHGALQGLAYLHSHN  135 (308)
T ss_pred             CCeeEEEEEccC-CCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            899999999997 5787776542            234788899999999999999999988

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=5.2e-19  Score=140.90  Aligned_cols=119  Identities=27%  Similarity=0.531  Sum_probs=98.1

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV  100 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~l  100 (230)
                      |++.+.||+|++|.||+|...     .++..+++|.+.............+|+..+..+.+|+|++++++++...+..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEEC-----CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence            578899999999999999983     345569999986443323334456788888888779999999999999999999


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +|||+ +++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        76 v~e~~-~~~l~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~Lh~~~  119 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRK-----------GKPFSESVIRSIIYQILQGLAHIHKHG  119 (283)
T ss_pred             EEecC-CCCHHHHHHhcc-----------cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999 779998887632           134789999999999999999999999

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.81  E-value=1.4e-18  Score=144.92  Aligned_cols=118  Identities=21%  Similarity=0.350  Sum_probs=98.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+...+|++++.||+|+||.||+|...+   ...+..+++|.+...      ....+|+.++..+. |+||+++++++..
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~---~~~~~~v~vK~~~~~------~~~~~E~~il~~l~-h~~iv~~~~~~~~  157 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHG---DEQRKKVIVKAVTGG------KTPGREIDILKTIS-HRAIINLIHAYRW  157 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcC---CccceeEEEEecccc------ccHHHHHHHHHhcC-CCCccceeeeEee
Confidence            4456679999999999999999997643   234556899987643      12457999999999 9999999999998


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....+++||++. ++|.+++..             ...+++..++.++.||+.||.|||+++
T Consensus       158 ~~~~~lv~e~~~-~~l~~~l~~-------------~~~l~~~~~~~i~~ql~~aL~~LH~~g  205 (392)
T PHA03207        158 KSTVCMVMPKYK-CDLFTYVDR-------------SGPLPLEQAITIQRRLLEALAYLHGRG  205 (392)
T ss_pred             CCEEEEEehhcC-CCHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            889999999996 588888843             234899999999999999999999998

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.81  E-value=1.1e-18  Score=139.48  Aligned_cols=120  Identities=24%  Similarity=0.491  Sum_probs=92.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcC--CCCceeeEeeEEec--
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLD--PHPNVVRLLGCCTE--   94 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~~--   94 (230)
                      +|++.+.||+|+||.||+|.+     ..++..+|+|.++... .......+.+|+.++..+.  .|+||+++++++..  
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~   75 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARD-----PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR   75 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence            588899999999999999998     4556679999886432 1112234556777666552  39999999998754  


Q ss_pred             ---CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 ---KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ....++++||+++ +|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        76 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~~  128 (288)
T cd07863          76 TDRETKVTLVFEHVDQ-DLRTYLDKVP-----------PPGLPAETIKDLMRQFLRGLDFLHANC  128 (288)
T ss_pred             CCCCceEEEEEccccc-CHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence               2347999999985 8888886531           234789999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0577|consensus

Probab=99.81  E-value=5.2e-20  Score=153.02  Aligned_cols=158  Identities=22%  Similarity=0.447  Sum_probs=130.6

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .|.-++.||.|+||-||.+.+     ..+...||||.+.=.  .+.+.-..++.|+..|..+. |||+|.+-||+.....
T Consensus        27 lf~dLrEIGHGSFGAVYfArd-----~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARD-----VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEeec-----cCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccch
Confidence            355567899999999999999     455667999998622  34445567899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      .|||||||- |+..+++.-.+            .++.+-.+..|+.+.+.||+|||+.+                     
T Consensus       101 aWLVMEYCl-GSAsDlleVhk------------KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKL  167 (948)
T KOG0577|consen  101 AWLVMEYCL-GSASDLLEVHK------------KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKL  167 (948)
T ss_pred             HHHHHHHHh-ccHHHHHHHHh------------ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeee
Confidence            999999996 58888888753            35888899999999999999999998                     


Q ss_pred             ---------------------------------------------------------------------CCCCccCC-CC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLE-KP  166 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~-~p  166 (230)
                                                                                           |.....+. ..
T Consensus       168 aDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs  247 (948)
T KOG0577|consen  168 ADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS  247 (948)
T ss_pred             ccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC
Confidence                                                                                 22222222 22


Q ss_pred             CcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        167 DHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       167 ~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ..+++.+.+++..||+.-|.+|||..+++.
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            458899999999999999999999999886

>KOG4645|consensus

Probab=99.81  E-value=9.7e-21  Score=168.59  Aligned_cols=158  Identities=25%  Similarity=0.440  Sum_probs=137.6

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +++.+.+||.|.||+||.|..     ..+|...|+|.++-. ..........+|..++..+. |||+|++||+-.....+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN-----~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVN-----LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             eeccccccCCcceeeeEEeec-----CCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeecHHHH
Confidence            345678899999999999998     566777999998632 22333446788999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------  156 (230)
                      ++.||||++|+|.+++...+             ..++.....+..|++.|++|||.+|                      
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gr-------------i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR-------------IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcc-------------hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEee
Confidence            99999999999999998643             3677788889999999999999999                      


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   |.-
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence                                                                                         677


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ||.|..|+..+.+-.++|..||..||+.|.++.||++
T Consensus      1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            8899999999999999999999999999999998886

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.81  E-value=3.3e-18  Score=139.69  Aligned_cols=120  Identities=16%  Similarity=0.259  Sum_probs=101.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++...     .++..+|+|++...  ........+..|+.++..+. |++|+++++++...+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCC
Confidence            47899999999999999999983     44556999998532  12233445788899999988 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++||||+++|+|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~------------~~~l~~~~~~~~~~qi~~al~~lH~~~  122 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF------------EDRLPEDMARFYLAEMVIAIDSVHQLH  122 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999763            224788899999999999999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.81  E-value=1.9e-18  Score=138.55  Aligned_cols=120  Identities=23%  Similarity=0.467  Sum_probs=98.6

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|++|.||+|..     ..++..+++|.+.... .......+.+|+.++..+. |+||+++++++...+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARD-----RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEe-----cCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCe
Confidence            5799999999999999999998     4455679999885432 2233456788999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||++ ++|.+++....           ...+++..+..++.||+.||.|||+++
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~~qi~~aL~~LH~~~  122 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSP-----------DFAKNPRLIKTYLYQILRGIAYCHSHR  122 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCC-----------CCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999996 47888775431           123577888899999999999999998

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.81  E-value=3.3e-19  Score=140.36  Aligned_cols=111  Identities=24%  Similarity=0.463  Sum_probs=95.4

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      ||.|+||.||++.+     ..++..+++|.+....  .......+.+|+.++..+. |+||+++++.+......++++||
T Consensus         1 lg~g~~~~vy~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKK-----KSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEE-----CCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEec
Confidence            68999999999998     3445679999986432  2245567889999999999 99999999999988899999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~L~~lH~~~  113 (265)
T cd05579          75 LPGGDLASLLENV-------------GSLDEDVARIYIAEIVLALEYLHSNG  113 (265)
T ss_pred             CCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            9999999998763             24789999999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.81  E-value=7e-19  Score=140.21  Aligned_cols=118  Identities=26%  Similarity=0.522  Sum_probs=98.2

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      |++.+.||.|++|.||+|.+     ..++..+++|++.... .......+.+|+.++..+. |+|++++++++...+..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARD-----KLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEE-----cCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEE
Confidence            56778999999999999998     4456679999886432 2223356788999999999 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||++ ++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        75 iv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~L~~lH~~~  119 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSP-----------LTGLDPPLIKSYLYQLLQGIAYCHSHR  119 (283)
T ss_pred             EEEeccC-cCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999996 68998887632           134789999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.81  E-value=6.6e-19  Score=143.98  Aligned_cols=117  Identities=19%  Similarity=0.427  Sum_probs=97.0

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|.++..........+.+|+.++..+. |+||+++++++....  
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   78 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATH-----KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFE   78 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEE-----cCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccc
Confidence            6799999999999999999988     44556799999864333445567888999999999 999999998875433  


Q ss_pred             ---CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ---PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ..++++||+++ +|.+.+...              .+++..+..++.|++.||.|||+.+
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~~~~~--------------~l~~~~~~~i~~ql~~aL~~LH~~~  126 (336)
T cd07849          79 SFNDVYIVQELMET-DLYKLIKTQ--------------HLSNDHIQYFLYQILRGLKYIHSAN  126 (336)
T ss_pred             ccceEEEEehhccc-CHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence               47999999975 787776542              4889999999999999999999999

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG2052|consensus

Probab=99.81  E-value=3.6e-19  Score=143.40  Aligned_cols=124  Identities=23%  Similarity=0.456  Sum_probs=100.1

Q ss_pred             CCCCCCCcccc---cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhh--cC
Q psy15820          6 LNQKSDDKWEV---PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT--LD   80 (230)
Q Consensus         6 ~~~~~~~~~~i---~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~   80 (230)
                      |-+++..|+.+   -.+++.+.+.||+|.||.||+|.|++..       ||||++...    +...+.+|.++++.  ++
T Consensus       195 SGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~-------VAVKiF~sr----dE~SWfrEtEIYqTvmLR  263 (513)
T KOG2052|consen  195 SGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGED-------VAVKIFSSR----DERSWFRETEIYQTVMLR  263 (513)
T ss_pred             CCCCCCchhHhHHhhhheeEEEEEecCccccceeeccccCCc-------eEEEEeccc----chhhhhhHHHHHHHHHhc
Confidence            34445555544   4567889999999999999999998765       999999643    22457788888885  46


Q ss_pred             CCCceeeEeeEEecCC----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         81 PHPNVVRLLGCCTEKE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        81 ~h~niv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                       |+||+.+++.-...+    .+|||++|.+.|+|++++...              .++....++++..+|.||+|||..
T Consensus       264 -HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--------------tv~~~~ml~LalS~AsGLaHLH~e  327 (513)
T KOG2052|consen  264 -HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--------------TVTTEGMLKLALSIASGLAHLHME  327 (513)
T ss_pred             -cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc--------------cCCHHHHHHHHHHHhhhHHHHHHH
Confidence             999999988765332    489999999999999999874              488899999999999999999965

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.81  E-value=2.8e-18  Score=138.96  Aligned_cols=117  Identities=22%  Similarity=0.470  Sum_probs=97.0

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      |...+.||+|+||.||+|..     ..++..+++|.+...  ........+.+|+.++..++ |+|++++++++......
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~-----~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATN-----SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEE-----CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence            55567899999999999987     445667999988532  23344467889999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+. +++.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        97 ~lv~e~~~-~~l~~~l~~~------------~~~l~~~~~~~~~~qi~~al~~LH~~g  141 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH------------KKPLQEVEIAAITHGALQGLAYLHSHN  141 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999997 5787777652            234788999999999999999999999

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.81  E-value=2.2e-18  Score=142.45  Aligned_cols=118  Identities=23%  Similarity=0.356  Sum_probs=96.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..++|++.+.||+|+||.||.+.+     ...+..+|+|++... ........+.+|+.++..+. |+||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYD-----AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEE-----CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeeccc
Confidence            357899999999999999999988     344556999998643 23444567889999999998 99999999987543


Q ss_pred             ------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            ..+++||||+++ +|.+.+..               .+++..+..++.|++.||.|||+++
T Consensus        96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~qi~~aL~~LH~~~  146 (364)
T cd07875          96 KSLEEFQDVYIVMELMDA-NLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAG  146 (364)
T ss_pred             ccccccCeEEEEEeCCCC-CHHHHHHh---------------cCCHHHHHHHHHHHHHHHHHHhhCC
Confidence                  347999999975 77777643               2778889999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.80  E-value=4.9e-19  Score=145.09  Aligned_cols=121  Identities=24%  Similarity=0.440  Sum_probs=97.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      |++ .++|++.+.||+|+||.||+|..     ..++..||+|.+... ........+.+|+.++..+. |+||+++++++
T Consensus        11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   83 (343)
T cd07878          11 WEV-PERYQNLTPVGSGAYGSVCSAYD-----TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVF   83 (343)
T ss_pred             hhh-hhhhhhheecccCCCeEEEEEEE-----CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhh
Confidence            444 47899999999999999999988     345566999998643 22234456789999999999 99999999887


Q ss_pred             ecC------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEK------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...      ...+++++++ +++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~  138 (343)
T cd07878          84 TPATSIENFNEVYLVTNLM-GADLNNIVKCQ--------------KLSDEHVQFLIYQLLRGLKYIHSAG  138 (343)
T ss_pred             cccccccccCcEEEEeecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            532      3478999988 67898877532              4889999999999999999999999

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.80  E-value=2.6e-18  Score=140.07  Aligned_cols=119  Identities=24%  Similarity=0.355  Sum_probs=97.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec-
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~-   94 (230)
                      ..++|++.+.||.|+||.||++..     ..++..+|+|.+... ........+.+|+.++..+. ||||+++++++.. 
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   81 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARD-----QLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFISP   81 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEE-----CCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecC
Confidence            345699999999999999999988     445667999987532 22334566788999999999 9999999998865 


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....++++||+ +++|..++...              .+++..+..++.|++.||.|||+++
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~aL~~LH~~~  128 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTSR--------------PLEKQFIQYFLYQILRGLKYVHSAG  128 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            56789999998 46888877542              3678888899999999999999999

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.80  E-value=1.4e-18  Score=139.36  Aligned_cols=113  Identities=24%  Similarity=0.463  Sum_probs=96.5

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      ....||+|+||.||++..     ..++..+++|.+... .......+.+|+.++..+. |+|++++++.+...+..++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~-----~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          24 NFIKIGEGSTGIVCIATV-----KSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hHHHcCCCCCeEEEEEEE-----cCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEE
Confidence            346799999999999988     445667999988543 2345567899999999998 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++++|.+++...              .+++..+..++.|++.||.|||+.+
T Consensus        97 e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~ql~~~l~~lH~~g  136 (292)
T cd06657          97 EFLEGGALTDIVTHT--------------RMNEEQIAAVCLAVLKALSVLHAQG  136 (292)
T ss_pred             ecCCCCcHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999998876532              3788899999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.80  E-value=1.8e-18  Score=139.78  Aligned_cols=121  Identities=26%  Similarity=0.485  Sum_probs=98.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +.++|++.+.||+|+||.||+|.+     ..++..||+|.++... .......+.+|+.++..+. |+||+++++++...
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   78 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARD-----TTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGK   78 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEE-----CCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecC
Confidence            567899999999999999999998     4456679999986332 1222234567999999999 99999999998754


Q ss_pred             --CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 --EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        +..++++||+.+ +|.+++....            ..+++..+..++.|++.||.|||+.+
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~l~~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~  128 (309)
T cd07845          79 HLDSIFLVMEYCEQ-DLASLLDNMP------------TPFSESQVKCLMLQLLRGLQYLHENF  128 (309)
T ss_pred             CCCeEEEEEecCCC-CHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence              468999999975 8888887531            34889999999999999999999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.80  E-value=1.6e-18  Score=141.74  Aligned_cols=118  Identities=23%  Similarity=0.439  Sum_probs=96.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      .+|++.+.||+|+||.||++..     ..++..|++|.+... ........+.+|+.++..+. |+||+++++++...  
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~   78 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKN-----SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHR   78 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEe-----cCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccc
Confidence            4689999999999999999988     445567999988643 22333456778999999998 99999999987643  


Q ss_pred             ---CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ---EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ...++++||+. ++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~  128 (337)
T cd07858          79 EAFNDVYIVYELMD-TDLHQIIRSS-------------QTLSDDHCQYFLYQLLRGLKYIHSAN  128 (337)
T ss_pred             cccCcEEEEEeCCC-CCHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence               34899999996 6888887652             24889999999999999999999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.80  E-value=2.4e-18  Score=137.72  Aligned_cols=122  Identities=17%  Similarity=0.362  Sum_probs=100.8

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +|++.+.||+|+||.||.+.....  ..++..+|+|+++...   .....+.+.+|+.++..+.+|+||+++++++....
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~--~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG--HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC--CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence            478899999999999999987432  1345679999986431   12334567889999999966999999999999888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++++||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~~  125 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQR-------------ERFKEQEVQIYSGEIVLALEHLHKLG  125 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            899999999999999998763             24788899999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.80  E-value=8e-19  Score=144.84  Aligned_cols=130  Identities=20%  Similarity=0.382  Sum_probs=110.9

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+|+|+++..  ........+..|+.++..+. |+||+++++.+...+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQK-----KDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence            4789999999999999999998     445567999998632  12334567788999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .+++||||+++|+|.+++...             ..+++..+..++.|++.||.|||++++.  |++.+|+|+
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~L~~lH~~giv--HrDLkp~NI  132 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKK-------------DTLSEEATQFYIAETVLAIDAIHQLGFI--HRDIKPDNL  132 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCeE--ccCCCHHHE
Confidence            999999999999999998763             2478999999999999999999999998  888777653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.80  E-value=3.2e-18  Score=136.43  Aligned_cols=117  Identities=28%  Similarity=0.541  Sum_probs=98.2

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--CC
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EP   97 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--~~   97 (230)
                      |++.+.||+|+||.||+|..     ..++..+++|.+.... .......+.+|+.++..+. |+|++++++++...  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARN-----KKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEE-----CCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCc
Confidence            57889999999999999998     3445679999997442 2334456888999999999 99999999999887  78


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++||+++ +|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~------------~~~~~~~~~~~i~~~i~~al~~LH~~~  120 (287)
T cd07840          75 IYMVFEYMDH-DLTGLLDSP------------EVKFTESQIKCYMKQLLEGLQYLHSNG  120 (287)
T ss_pred             EEEEeccccc-cHHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999975 888887653            135889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.80  E-value=2.9e-18  Score=140.64  Aligned_cols=123  Identities=24%  Similarity=0.476  Sum_probs=99.6

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..|.+ .++|++.+.||+|+||.||++..     ..++..||+|++... ........+.+|+.++..+. |+||+++++
T Consensus         9 ~~~~~-~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~   81 (343)
T cd07880           9 TIWEV-PDRYRDLKQVGSGAYGTVCSALD-----RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLD   81 (343)
T ss_pred             hhhcc-ccceEEEEEeeecCCeEEEEEEE-----CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceee
Confidence            33544 56699999999999999999987     445566999998532 23444567889999999998 999999999


Q ss_pred             EEecCC------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKE------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++....      ..++++||+ +++|..++...              .+++..+..++.|++.||.|||+.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--------------~l~~~~~~~i~~qi~~al~~LH~~g  138 (343)
T cd07880          82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE--------------KLSEDRIQFLVYQMLKGLKYIHAAG  138 (343)
T ss_pred             eecCCccccccceEEEEEecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            886543      358999999 67888777542              3789999999999999999999988

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.80  E-value=1.2e-18  Score=142.19  Aligned_cols=128  Identities=18%  Similarity=0.251  Sum_probs=106.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++|++.+.||+|+||.||++..     ..++..+|+|++...  ........+.+|..++..+. |+||+.+++++...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKM-----KHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence            4789999999999999999988     445566999998632  12233445778888998888 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKP  166 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p  166 (230)
                      ..|++|||+++|+|.+++...            ...+++..+..++.|++.||.|||++++.  |++.+|
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~------------~~~l~~~~~~~~~~qi~~~L~~lH~~~ii--HrDlkp  130 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKF------------EDRLPEDMARFYIAEMVLAIHSIHQLHYV--HRDIKP  130 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCee--eccCch
Confidence            999999999999999999763            23478889999999999999999999976  555444

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.80  E-value=4.3e-18  Score=137.24  Aligned_cols=124  Identities=22%  Similarity=0.435  Sum_probs=98.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      +.-..++|++.+.||+|+||.||+|..     ..++..+|+|.+.... .......+.+|+.++..+. ||||+++++++
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~   80 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARH-----KKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEIC   80 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEE-----CCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEE
Confidence            334567899999999999999999988     4456679999885332 2222345678999999998 99999999988


Q ss_pred             ecCC--------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKE--------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+        ..++++||+.+ +|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~  139 (310)
T cd07865          81 RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK------------NVKFTLSEIKKVMKMLLNGLYYIHRNK  139 (310)
T ss_pred             ecccccccCCCceEEEEEcCCCc-CHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            6543        35999999975 788877652            224889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0658|consensus

Probab=99.80  E-value=5.4e-19  Score=139.27  Aligned_cols=115  Identities=28%  Similarity=0.538  Sum_probs=91.1

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--C--
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--E--   96 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--~--   96 (230)
                      |.-.+.+|.|+||.||+|....     +...+|+|.+-.+.....     +|+.++..+. |||||++.-+|...  +  
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~r~kn-----rEl~im~~l~-HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDKRYKN-----RELQIMRKLD-HPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCCCcCc-----HHHHHHHhcC-CcCeeeEEEEEEecCCCch
Confidence            5556889999999999999954     355699998854433322     6888999998 99999998877542  2  


Q ss_pred             -CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 -PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                       ...+||||+|. +|++.++....         .+..++...+.-+.+||.+||.|||+.+
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~---------~~~~mp~~~iKLYt~Qlfrgl~yLh~~~  145 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTR---------ANQRMPLLEIKLYTYQLFRGLAYLHSHG  145 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhh---------cCCCCceeeeHHHHHHHHHHHHHHHhcC
Confidence             35789999996 99999986421         2446888899999999999999999998

>KOG4250|consensus

Probab=99.79  E-value=1.9e-19  Score=152.13  Aligned_cols=130  Identities=28%  Similarity=0.466  Sum_probs=113.7

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC-----
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-----   96 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~-----   96 (230)
                      ..-+.||+|+||.||+|..     +.+|+.||+|.++.......++...+|+++++++. |+|||+++++-....     
T Consensus        16 ~~~e~LG~Ga~g~V~rgrn-----ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRN-----KETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             eehhhhcCCccceeeeecc-----cccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence            3456799999999999988     67788899999987666677888999999999999 999999999875433     


Q ss_pred             -CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 -PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                       ...++||||+||+|...+.+..          ...++++..++.++.+++.||.|||.++|.  ||+.+|.|+
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PE----------N~~GLpE~e~l~lL~d~~~al~~LrEn~Iv--HRDlKP~NI  151 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPE----------NAYGLPESEFLDLLSDLVSALRHLRENGIV--HRDLKPGNI  151 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcc----------cccCCCHHHHHHHHHHHHHHHHHHHHcCce--eccCCCCcE
Confidence             4689999999999999998754          245699999999999999999999999999  999999875

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.79  E-value=5.3e-18  Score=135.18  Aligned_cols=113  Identities=18%  Similarity=0.351  Sum_probs=88.0

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhc--CCCCceeeEeeEEecCCCeEEE
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTL--DPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~--~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      .||+|+||.||++..     ..++..+|+|.+.....  ......+.+|..++..+  ..|+||+.+++.+...+..+++
T Consensus         1 ~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEE-----CCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence            489999999999988     44556799998854321  12223344454444433  2399999999999988899999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~e~~~~~~L~~~i~~~-------------~~l~~~~~~~i~~qi~~al~~lH~~~  117 (279)
T cd05633          76 LDLMNGGDLHYHLSQH-------------GVFSEKEMRFYATEIILGLEHMHNRF  117 (279)
T ss_pred             EecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999888753             24899999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.79  E-value=6.5e-18  Score=139.06  Aligned_cols=118  Identities=23%  Similarity=0.350  Sum_probs=97.1

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      -..+|++.+.||+|+||.||+|..     ..++..+|+|.+... ........+.+|+.++..+. |+||+++++++...
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   87 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYD-----TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQ   87 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEE-----CCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccC
Confidence            457799999999999999999988     445567999998632 33444567788999999998 99999999988643


Q ss_pred             ------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            ...++++||+.+ +|.+.+..               .++...+..++.|++.||.|||+++
T Consensus        88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~l~~~~~~~~~~ql~~aL~~LH~~g  138 (353)
T cd07850          88 KSLEEFQDVYLVMELMDA-NLCQVIQM---------------DLDHERMSYLLYQMLCGIKHLHSAG  138 (353)
T ss_pred             CCccccCcEEEEEeccCC-CHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                  347999999974 88877654               2788889999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.79  E-value=3.1e-18  Score=135.62  Aligned_cols=114  Identities=19%  Similarity=0.308  Sum_probs=88.3

Q ss_pred             CCeeEeeee--cceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDIL--GEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~l--g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.|.+.+.+  |+|+||.||++..     +.++..+++|.+.......      .|+.....+..|+||+++++.+...+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKH-----KPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEE-----cCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            345555554  9999999999988     4456669999885321111      12222222324999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lH~~~  129 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE-------------GKLSEAEVKKIIRQLVEALNDLHKHN  129 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999763             24899999999999999999999999

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.79  E-value=3.6e-18  Score=144.56  Aligned_cols=113  Identities=19%  Similarity=0.257  Sum_probs=95.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ...|.+.+.||+|+||.||+|.+.     ..+..||+|....       ..+.+|+.++..+. |+||+++++++...+.
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-----~~~~~vavK~~~~-------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP-----DYPQRVVVKAGWY-------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC-----CCCCEEEEecccc-------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence            457999999999999999999983     4455699995431       23568999999999 9999999999998899


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++|++. ++|.+++...            ...+++..++.++.|++.||.|||+++
T Consensus       235 ~~lv~e~~~-~~L~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~g  280 (461)
T PHA03211        235 TCLVLPKYR-SDLYTYLGAR------------LRPLGLAQVTAVARQLLSAIDYIHGEG  280 (461)
T ss_pred             EEEEEEccC-CCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999995 6888887653            224899999999999999999999998

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.79  E-value=1.9e-18  Score=139.77  Aligned_cols=115  Identities=17%  Similarity=0.330  Sum_probs=92.1

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      +++.+|.|++  ||.+..     ..++..+|+|+++.. ........+.+|+.++..++ |+||+++++++...+..+++
T Consensus         6 i~~~~~~~~~--v~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~   77 (314)
T cd08216           6 IGKCFEDLMI--VHLAKH-----KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVV   77 (314)
T ss_pred             hhHhhcCCce--EEEEEe-----cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEE
Confidence            4444444444  455545     234556999998644 34556678999999999999 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +||+++++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        78 ~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~~~l~~~L~~LH~~~  121 (314)
T cd08216          78 SPLMAYGSCEDLLKTHF-----------PEGLPELAIAFILKDVLNALDYIHSKG  121 (314)
T ss_pred             EeccCCCCHHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999998642           234788899999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.79  E-value=7.4e-18  Score=134.38  Aligned_cols=119  Identities=29%  Similarity=0.530  Sum_probs=94.2

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-HHHHHHHHHHHHHHhhcC--CCCceeeEeeEEecCCC
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~~~~~   97 (230)
                      |++.+.||+|+||.||++.+.     .++..+|+|.++.... ......+.+|+.++..+.  .|+|++++++++.....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   75 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDL-----NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT   75 (287)
T ss_pred             CeEEEEecccCceEEEEEEEC-----CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence            678899999999999999984     3455699999864322 223345667877776553  39999999999987776


Q ss_pred             -----eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 -----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                           .++++||+.+ +|.+++....           ...+++..+..++.|++.||.|||+.+
T Consensus        76 ~~~~~~~l~~e~~~~-~l~~~l~~~~-----------~~~l~~~~~~~~~~~i~~al~~LH~~~  127 (287)
T cd07838          76 DRELKLTLVFEHVDQ-DLATYLSKCP-----------KPGLPPETIKDLMRQLLRGVDFLHSHR  127 (287)
T ss_pred             CCCceeEEEehhccc-CHHHHHHHcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                 9999999975 7888876531           224789999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.79  E-value=3.4e-18  Score=136.03  Aligned_cols=117  Identities=27%  Similarity=0.533  Sum_probs=98.7

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      |++.+.||+|++|.||+|..     ..++..+++|.++... .......+.+|+.++..+. |+||+++++.+..++..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARD-----KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEc-----CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEE
Confidence            56778999999999999988     4456679999986432 2244567888999999999 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||+++ ++.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        75 ~v~e~~~~-~l~~~l~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~  118 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDR------------QRGLPESLIKSYLYQLLQGLAFCHSHG  118 (283)
T ss_pred             EEEeccCC-CHHHHHHhh------------cccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999985 888887763            234889999999999999999999998

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0667|consensus

Probab=99.79  E-value=3.9e-18  Score=143.18  Aligned_cols=118  Identities=25%  Similarity=0.423  Sum_probs=102.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC-----CCCceeeEeeEEec
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLLGCCTE   94 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~niv~l~~~~~~   94 (230)
                      +|.+.+.||+|+||+|.+|.+     ..++..||||++++.  .........|+.+|..+.     ..-|+|+++++|..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d-----~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYD-----HKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEecccccceeEEEEe-----cCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            778999999999999999999     455667999999865  444556778999998876     34579999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++.+|||+|.+.. +|+++++.++.           .+++...++.++.||+.||.+||..+
T Consensus       260 r~HlciVfELL~~-NLYellK~n~f-----------~Glsl~~ir~~~~Qil~~L~~L~~l~  309 (586)
T KOG0667|consen  260 RNHLCIVFELLST-NLYELLKNNKF-----------RGLSLPLVRKFAQQILTALLFLHELG  309 (586)
T ss_pred             ccceeeeehhhhh-hHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999964 99999998753           35899999999999999999999998

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.79  E-value=3.4e-18  Score=133.64  Aligned_cols=111  Identities=25%  Similarity=0.472  Sum_probs=94.9

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      ||.|+||.||.+...     ..+..+++|.++...  .......+..|+.++..+. |+||+++++.+...+..++++||
T Consensus         1 lg~G~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEEC-----CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEec
Confidence            689999999999883     345569999986432  2334567889999999999 99999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++|.+++...             ..+++..+..++.|++.|+.|||+.+
T Consensus        75 ~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~~l~~lh~~~  113 (250)
T cd05123          75 APGGELFSHLSKE-------------GRFSEERARFYAAEIVLALEYLHSLG  113 (250)
T ss_pred             CCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999998763             24789999999999999999999988

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.78  E-value=4.3e-18  Score=139.51  Aligned_cols=117  Identities=23%  Similarity=0.402  Sum_probs=96.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      ..+|.+.+.||.|+||.||+|..     ..++..+++|.+..... .....+.+|+.++..+. |+||+++++.+...  
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~-----~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~   76 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVD-----SDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEE-----CCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcC-CCcchhhHhhhccccc
Confidence            37899999999999999999988     44556799998864322 34466888999999998 99999999876543  


Q ss_pred             ------------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                                  ...++++||++ ++|.+++...              .+++..+..++.||+.||.|||+.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~g  134 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--------------PLSEEHARLFMYQLLRGLKYIHSAN  134 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                        34789999997 4888777542              3788999999999999999999999

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0596|consensus

Probab=99.78  E-value=1.9e-18  Score=142.57  Aligned_cols=127  Identities=16%  Similarity=0.232  Sum_probs=106.2

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC-CcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ...+.|+.+.|++.+.||+|+-+.||++...+.      ..+|+|.+. ...+....+.|.+|+..|.++++|.+||+++
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~------~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~  426 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDK------QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY  426 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecCCC------cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence            344688999999999999999999999877332      236666654 4567788899999999999999999999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++-...+.+|+||||=+ .+|..+++...            ...+...+..|..|++.|+.++|..|
T Consensus       427 DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~------------~~~~~~~lk~ywkqML~aV~~IH~~g  480 (677)
T KOG0596|consen  427 DYEVTDGYLYMVMECGD-IDLNKILKKKK------------SIDPDWFLKFYWKQMLLAVKTIHQHG  480 (677)
T ss_pred             eeeccCceEEEEeeccc-ccHHHHHHhcc------------CCCchHHHHHHHHHHHHHHHHHHHhc
Confidence            99999999999999764 59999998852            12343488899999999999999999

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.78  E-value=3.3e-18  Score=139.73  Aligned_cols=118  Identities=21%  Similarity=0.407  Sum_probs=97.3

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec---
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE---   94 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~---   94 (230)
                      ++|++.+.||+|+||.||+|..     ..++..+++|++... ........+.+|+.++..+. |+||+++++++..   
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   78 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAID-----TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA   78 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEE-----cCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence            7899999999999999999988     445567999998643 22334566788999999999 9999999988753   


Q ss_pred             -CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 -KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                       ....++++||+. ++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        79 ~~~~~~lv~e~~~-~~l~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~  127 (334)
T cd07855          79 DFKDVYVVMDLME-SDLHHIIHSD-------------QPLTEEHIRYFLYQLLRGLKYIHSAN  127 (334)
T ss_pred             CCceEEEEEehhh-hhHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence             346899999996 5888887642             24889999999999999999999999

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0594|consensus

Probab=99.78  E-value=9.2e-19  Score=137.70  Aligned_cols=134  Identities=28%  Similarity=0.476  Sum_probs=111.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-HHHHHHHHHHHHHHhhcCCCCc-eeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTLDPHPN-VVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~~h~n-iv~l~~~~~~~   95 (230)
                      ...|+.+++||+|+||.||+|..     +.++..||+|.++.... +.......+|+.++..++ |+| |+.+++++...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~-----~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~   83 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARS-----KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTS   83 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEE-----ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeec
Confidence            56678888899999999999999     45566799999975433 233456789999999999 999 99999999876


Q ss_pred             C------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         96 E------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        96 ~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      +      .+++|+||++. +|..++.....         ....++...+..+++||+.||+|||+++|.  ||+.+|+|+
T Consensus        84 ~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~---------~~~g~~~~~ik~~m~Qll~gl~~~H~~~Il--HRDLKPQNl  151 (323)
T KOG0594|consen   84 NNHRGIGKLYLVFEFLDR-DLKKYMDSLPK---------KPQGLPPRLIKSFMRQLLRGLAFLHSHGIL--HRDLKPQNL  151 (323)
T ss_pred             ccccccceEEEEEEeecc-cHHHHHHhccc---------cccCCCHHHHHHHHHHHHHHHHHHHhCCee--cccCCcceE
Confidence            6      78999999975 89999987431         113577789999999999999999999999  999999763

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.77  E-value=1.2e-17  Score=136.50  Aligned_cols=121  Identities=23%  Similarity=0.324  Sum_probs=97.4

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHH-------------HHHHHHHHHHHHhhcCCC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER-------------ERLDLLQELTVMKTLDPH   82 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~~~~h   82 (230)
                      +..+...+.+.||.|+||.||+|.+     ...+..+|+|.++......             ....+.+|+.++..+. |
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h   79 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYD-----TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-H   79 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEE-----CCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-C
Confidence            4444445678899999999999988     3455669999885332111             0124778999999999 9


Q ss_pred             CceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         83 PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        83 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +||+++++++...+..+++|||+. ++|.+++...             ..+++.....++.|++.||.|||+.+
T Consensus        80 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~~  139 (335)
T PTZ00024         80 ENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-------------IRLTESQVKCILLQILNGLNVLHKWY  139 (335)
T ss_pred             cceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999997 5898888652             24788999999999999999999999

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.77  E-value=5.3e-18  Score=139.05  Aligned_cols=123  Identities=24%  Similarity=0.465  Sum_probs=99.8

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..|.+ .++|++.+.||+|++|.||+|..     ..++..+|+|.+... ........+.+|+.++..+. |+|++++.+
T Consensus         9 ~~~~~-~~~y~~~~~ig~g~~g~vy~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~   81 (343)
T cd07851           9 TVWEV-PDRYQNLSPVGSGAYGQVCSAFD-----TKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLD   81 (343)
T ss_pred             ceecc-cCceEEEEEeccCCceEEEEEEE-----CCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHH
Confidence            34444 55799999999999999999998     345566999988643 23334466788999999998 999999998


Q ss_pred             EEecCCC------eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+.      .++++||+ +++|.+++...              .+++..+..++.|++.||.|||+.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~g  138 (343)
T cd07851          82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ--------------KLSDDHIQFLVYQILRGLKYIHSAG  138 (343)
T ss_pred             HhhccccccccccEEEEEecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            7765544      89999998 56998887642              4889999999999999999999998

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0599|consensus

Probab=99.77  E-value=6.3e-19  Score=134.38  Aligned_cols=171  Identities=18%  Similarity=0.303  Sum_probs=140.0

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-------CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-------AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...|.--+.||.|..+.|..|.+     +.++.++|+|++...       ...+.++.-.+|+.+|.++.+||+|+.+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~-----k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIH-----KETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhh-----cccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            44566667899999999999988     556666899988422       122345667889999999999999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      .+..+..+++|+|.|+.|.|.+++.+..             .+++.....+++|+..|+.|||.++              
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~V-------------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld  157 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSKV-------------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD  157 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhhe-------------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec
Confidence            9999999999999999999999998742             4899999999999999999999998              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       158 dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML  237 (411)
T KOG0599|consen  158 DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML  237 (411)
T ss_pred             cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH
Confidence                                                                                            


Q ss_pred             --CCCCcc---CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHHHHhhcc
Q psy15820        157 --VRDGYR---LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL--LEKLLLNET  206 (230)
Q Consensus       157 --i~~~~~---~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~--l~~~~~~~~  206 (230)
                        |+.|..   .+...+.+...++||.+||+-||.+|.|+.++++.  +.++....-
T Consensus       238 R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~  294 (411)
T KOG0599|consen  238 RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA  294 (411)
T ss_pred             HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence              444443   33445788899999999999999999999999963  455554433

>KOG0587|consensus

Probab=99.77  E-value=1.2e-17  Score=144.20  Aligned_cols=127  Identities=19%  Similarity=0.450  Sum_probs=103.4

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.+.-+.+-+++.+.||.|.+|.||+++.+     .+++.+|+|+.....  +.-+....|..++.....|||++.+||+
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~-----~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHV-----KTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeee-----ecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEE
Confidence            334456677899999999999999999984     455568888875432  2223456788899988889999999999


Q ss_pred             Eec-----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTE-----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..     ++.+|||||||.+|+..++++...           +..+.|..+..|++.++.|+.+||...
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-----------g~rl~E~~IaYI~re~lrgl~HLH~nk  143 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-----------GNRLKEEWIAYILREILRGLAHLHNNK  143 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhc-----------ccchhhHHHHHHHHHHHHHHHHHhhcc
Confidence            853     457999999999999999998743           456899999999999999999999987

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.77  E-value=2.4e-17  Score=133.28  Aligned_cols=124  Identities=21%  Similarity=0.371  Sum_probs=98.6

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      .|++.+.||+|+||.||+|.....   ..+..+|+|.+....  .......+.+|+.++..+. ||||+++++++...  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCC
Confidence            478889999999999999998431   145679999986532  1223356788999999999 99999999999887  


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...++|+||+++ ++.+++......        ....+++..+..++.|++.||.|||+++
T Consensus        77 ~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH~~~  128 (316)
T cd07842          77 KSVYLLFDYAEH-DLWQIIKFHRQA--------KRVSIPPSMVKSLLWQILNGVHYLHSNW  128 (316)
T ss_pred             ceEEEEEeCCCc-CHHHHHHhhccC--------CCcCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            779999999975 777777653211        1235788999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.77  E-value=9.7e-18  Score=136.64  Aligned_cols=117  Identities=22%  Similarity=0.436  Sum_probs=98.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      +|++.+.||.|++|.||+|...     .++..+++|.+.... .......+.+|+.++..+. |+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK-----RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC-----CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcc
Confidence            5889999999999999999983     345569999886432 2445567899999999999 999999999987764  


Q ss_pred             ---CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ---PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ..++++||+++ +|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 ~~~~~~lv~e~~~~-~l~~~l~~~-------------~~l~~~~~~~i~~~l~~~l~~LH~~g  123 (330)
T cd07834          75 DFNDVYIVTELMET-DLHKVIKSP-------------QPLTDDHIQYFLYQILRGLKYLHSAN  123 (330)
T ss_pred             cccceEEEecchhh-hHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence               78999999984 788887652             25889999999999999999999999

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00284 protein kinase; Provisional

Probab=99.77  E-value=3e-17  Score=139.97  Aligned_cols=121  Identities=18%  Similarity=0.323  Sum_probs=92.0

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC-----CCCceeeEe
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLL   89 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~niv~l~   89 (230)
                      .+...+|++.+.||+|+||.||+|.+     ...+..||+|+++..  .........|+.++..+.     .|.++++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~-----~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWD-----RKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEE-----cCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            34467899999999999999999988     445567999998642  222234455666666554     245688898


Q ss_pred             eEEecC-CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         90 GCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        90 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      +++... +.+++++|++ +++|.+++...             ..+++..+..++.||+.||.|||++ +
T Consensus       198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~g  252 (467)
T PTZ00284        198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH-------------GPFSHRHLAQIIFQTGVALDYFHTELH  252 (467)
T ss_pred             EEEEcCCceEEEEEecc-CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence            888754 4688999988 67898888763             2488999999999999999999974 5

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.77  E-value=9.7e-18  Score=137.11  Aligned_cols=118  Identities=24%  Similarity=0.535  Sum_probs=95.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhc-CCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTL-DPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~-~~h~niv~l~~~~~~~   95 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..+++|.+... ........+.+|+.++..+ . |+||+++++++...
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~ni~~~~~~~~~~   79 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAID-----RRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD-HPNIVKLLNVIKAE   79 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEE-----cCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcC-CCCccceeeeeccC
Confidence            46788899999999999999988     344566999988532 2233445677899999999 6 99999999988643


Q ss_pred             --CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 --EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        ...++++||++ ++|.+++...              .+++..+..++.|++.||.|||+.+
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~  127 (337)
T cd07852          80 NDKDIYLVFEYME-TDLHAVIRAN--------------ILEDVHKRYIMYQLLKALKYIHSGN  127 (337)
T ss_pred             CCceEEEEecccc-cCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence              35899999997 4888887642              3778888899999999999999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.77  E-value=2.7e-17  Score=130.97  Aligned_cols=112  Identities=20%  Similarity=0.350  Sum_probs=86.5

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-C-HHHHHHHHHHHHH---HhhcCCCCceeeEeeEEecCCCeEE
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-G-ERERLDLLQELTV---MKTLDPHPNVVRLLGCCTEKEPFFV  100 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~-~~~~~~~~~e~~~---l~~~~~h~niv~l~~~~~~~~~~~l  100 (230)
                      .||+|+||.||++..     ..++..||+|.+.... . ......+..|..+   +.... |++|+.+++.+...+..++
T Consensus         1 ~ig~g~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEE-----ecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCEEEE
Confidence            379999999999988     3445569999885321 1 1111223344433   33345 9999999999999999999


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++||++|++|.+++...             ..+++..+..++.|++.||.|||+.+
T Consensus        75 v~e~~~g~~L~~~l~~~-------------~~l~~~~~~~~~~ql~~~l~~lH~~~  117 (278)
T cd05606          75 ILDLMNGGDLHYHLSQH-------------GVFSEAEMRFYAAEIILGLEHMHNRF  117 (278)
T ss_pred             EEecCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999998887652             24899999999999999999999888

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.77  E-value=2.8e-17  Score=133.21  Aligned_cols=121  Identities=21%  Similarity=0.381  Sum_probs=91.7

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--CCCeEEE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVI  101 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--~~~~~lv  101 (230)
                      +.+||+|+||.||+|....   ..++..+|+|.+.....   ...+.+|+.++..+. ||||+++++++..  ...++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~---~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD---GKDDRDYALKQIEGTGI---SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEcc---CCCCceEEEEEECCCCC---cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence            4689999999999998743   23345699998864322   234678999999999 9999999998864  3458999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +||+.+ +|.+++.......    .......+++..+..++.|++.||.|||+++
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~  128 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASK----ANKKPVQLPRGMVKSLLYQILDGIHYLHANW  128 (317)
T ss_pred             EeccCC-CHHHHHHhccccc----ccCCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999964 8888877532110    0011234788999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.76  E-value=3.3e-17  Score=134.44  Aligned_cols=120  Identities=22%  Similarity=0.367  Sum_probs=97.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ...++|++.+.||+|+||.||++..     ..++..||+|++... ........+.+|+.++..++ |+||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~   87 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFD-----TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTP   87 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEE-----cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeee
Confidence            3458899999999999999999987     345667999998643 23334566888999999999 9999999998754


Q ss_pred             C------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 K------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .      ...+++++++ +++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~~  140 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--------------KLTDDHVQFLIYQILRGLKYIHSAD  140 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            2      3467888876 77898877542              3788999999999999999999999

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0607|consensus

Probab=99.76  E-value=7.4e-19  Score=136.62  Aligned_cols=124  Identities=22%  Similarity=0.438  Sum_probs=112.1

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEe
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME  103 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e  103 (230)
                      .+.||+|+|+.|-.|..     ..++.++|||++... ..+.+.+..+|++++...++|+||+.++++|.+...+|||+|
T Consensus        83 ~e~LGeGAyasVqtcv~-----i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE  156 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVS-----IQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE  156 (463)
T ss_pred             HHHhcCccceeeeeeee-----eccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence            46799999999999988     455667999999654 567788999999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820        104 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus       104 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      -+.||.|.+.|....             .+++.....+..+|+.||+|||.+||.  ||+.+|+|
T Consensus       157 Km~GGplLshI~~~~-------------~F~E~EAs~vvkdia~aLdFlH~kgIA--HRDlKPEN  206 (463)
T KOG0607|consen  157 KMRGGPLLSHIQKRK-------------HFNEREASRVVKDIASALDFLHTKGIA--HRDLKPEN  206 (463)
T ss_pred             cccCchHHHHHHHhh-------------hccHHHHHHHHHHHHHHHHHHhhcCcc--cccCCccc
Confidence            999999999998864             389999999999999999999999999  99999876

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.76  E-value=1.2e-17  Score=132.94  Aligned_cols=117  Identities=28%  Similarity=0.538  Sum_probs=98.6

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      |++.+.||+|.+|.||+|..     ..++..+++|.+.... .......+..|+.++..+. |+|++++++++...+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~-----~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARD-----KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeee-----cCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceE
Confidence            56678899999999999998     4445679999986432 2333456788999999999 999999999999889999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||++ ++|.+++....            ..+++..+..++.|++.||.|||+++
T Consensus        75 ~v~e~~~-~~l~~~i~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~  118 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP------------GPLSPNLIKSIMYQLLRGLAYCHSHR  118 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999998 48999988641            24889999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.76  E-value=1.8e-17  Score=135.84  Aligned_cols=121  Identities=26%  Similarity=0.491  Sum_probs=95.9

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .|.+ ..+|.+.+.||+|+||.||+|..     ..++..+|+|.+... ........+.+|+.++..+. |+||++++++
T Consensus        10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~   82 (342)
T cd07879          10 VWEL-PERYTSLKQVGSGAYGSVCSAID-----KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDV   82 (342)
T ss_pred             hhcc-ccceEEEEEeeecCCeEEEEEEe-----CCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhhe
Confidence            3555 35799999999999999999988     345567999988643 22333456789999999998 9999999998


Q ss_pred             EecCC------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKE------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +....      ..++++||+.. +|..+..               ..+++..+..++.|++.||.|||+.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~  137 (342)
T cd07879          83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---------------HPLSEDKVQYLVYQMLCGLKYIHSAG  137 (342)
T ss_pred             ecccccCCCCceEEEEeccccc-CHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            86542      36999999964 6655432               23788999999999999999999998

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.76  E-value=1.7e-17  Score=146.82  Aligned_cols=131  Identities=20%  Similarity=0.326  Sum_probs=112.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++..  ........+..|+.++..+. |+||+++++.+...
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~   76 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRK-----KNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSA   76 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEE-----CCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEEC
Confidence            47899999999999999999998     445567999998632  23444567889999999998 99999999999988


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      +.+++||||+++++|.+++...             ..+++..++.++.||+.||.|||++++.  |++.+|.|+
T Consensus        77 ~~~~lVmEy~~g~~L~~li~~~-------------~~l~~~~~~~i~~qil~aL~yLH~~gIi--HrDLKP~NI  135 (669)
T cd05610          77 NNVYLVMEYLIGGDVKSLLHIY-------------GYFDEEMAVKYISEVALALDYLHRHGII--HRDLKPDNM  135 (669)
T ss_pred             CEEEEEEeCCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEE--eCCccHHHE
Confidence            9999999999999999998763             2378888999999999999999999999  888888764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.75  E-value=7.7e-17  Score=130.52  Aligned_cols=121  Identities=21%  Similarity=0.384  Sum_probs=91.4

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--CCCeEEE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVI  101 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--~~~~~lv  101 (230)
                      +.+||+|+||.||+|....   ..++..+|+|.+.....   ...+.+|+.++..+. |+||+++++++..  ....+++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~---~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKD---GKDEKEYALKQIEGTGI---SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecC---CCccceEEEEEecCCCC---cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence            4679999999999998743   22345699998864322   234678999999999 9999999998854  4568999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +||+.+ +|.+++.......    .......+++..+..++.|++.||.|||+++
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~----~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~  128 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASK----ANKKPMQLPRSMVKSLLYQILDGIHYLHANW  128 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccc----cCCCCccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999875 7888876432110    0011234788899999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0690|consensus

Probab=99.75  E-value=9.2e-19  Score=136.49  Aligned_cols=124  Identities=23%  Similarity=0.390  Sum_probs=108.1

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      -++..++|..+++||+|.||+|.+|..     +.+++.+|+|+++..  ....+...-+-|.++|.+.. ||.+..+--.
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rE-----Kat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYs  236 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCRE-----KATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYS  236 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEee-----cccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhh
Confidence            456778999999999999999999998     677788999999754  34455566788999999999 9999999888


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |..++.+|+||||..||.|.-.+...+             .+++.+.+.+...|..||.|||+++
T Consensus       237 FQt~drlCFVMeyanGGeLf~HLsrer-------------~FsE~RtRFYGaEIvsAL~YLHs~~  288 (516)
T KOG0690|consen  237 FQTQDRLCFVMEYANGGELFFHLSRER-------------VFSEDRTRFYGAEIVSALGYLHSRN  288 (516)
T ss_pred             hccCceEEEEEEEccCceEeeehhhhh-------------cccchhhhhhhHHHHHHhhhhhhCC
Confidence            899999999999999999987776643             3899999999999999999999998

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.75  E-value=9.7e-17  Score=130.98  Aligned_cols=120  Identities=22%  Similarity=0.375  Sum_probs=94.7

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC---
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK---   95 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~---   95 (230)
                      +|++.+.||+|+||.||++.....   ..+..+|+|.+... ........+.+|+.++..+..|+||+++++.+...   
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET---SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC---CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            478899999999999999998543   11456999988643 22334567888999999985599999999875432   


Q ss_pred             -CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 -EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                       ..+++++||+. ++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~g  125 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSG-------------QPLTDAHFQSFIYQILCGLKYIHSAN  125 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence             45789999886 5888887642             34889999999999999999999999

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.74  E-value=4.6e-17  Score=126.70  Aligned_cols=102  Identities=16%  Similarity=0.230  Sum_probs=84.0

Q ss_pred             eeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecCCCCC
Q psy15820         30 GCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGK  109 (230)
Q Consensus        30 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~  109 (230)
                      |.+|.||++.+     ..++..+|+|.++...      .+.+|...+.... ||||+++++.+...+..+++|||+++|+
T Consensus         4 g~~~~v~~~~~-----~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMD-----TRTQQTFILKGLRKSS------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEE-----ccCCcEEEEEeecchh------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCC
Confidence            89999999998     5556679999986431      1223444444555 9999999999999999999999999999


Q ss_pred             HHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        110 LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       110 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |.+++....             .+++..+..++.|++.||.|||+++
T Consensus        72 L~~~l~~~~-------------~l~~~~~~~~~~ql~~~l~~lH~~~  105 (237)
T cd05576          72 LWSHISKFL-------------NIPEECVKRWAAEMVVALDALHREG  105 (237)
T ss_pred             HHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999987632             3789999999999999999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.74  E-value=6.1e-17  Score=130.60  Aligned_cols=120  Identities=26%  Similarity=0.504  Sum_probs=95.4

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||++.+     ..++..+++|.+.... .......+.+|+.++..++ |+||+++++.+....
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQ-----IKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEE-----CCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheeccc
Confidence            58999999999999999999998     4455569999885322 2222345678999999998 999999999875432


Q ss_pred             --------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 --------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 --------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                              .+++++||+.+ ++...+...            ...+++..+..++.|++.||.|||+++
T Consensus        81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~------------~~~~~~~~~~~i~~~l~~al~~lH~~~  135 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMDH-DLSGLLENP------------SVKLTESQIKCYMLQLLEGINYLHENH  135 (311)
T ss_pred             ccccccCceEEEEEecCCc-CHHHHHhcc------------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                    46999999975 676666542            234899999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1035|consensus

Probab=99.73  E-value=7.9e-18  Score=149.52  Aligned_cols=69  Identities=28%  Similarity=0.470  Sum_probs=59.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      ..+|+..+.||+|+||.||+++.     +-+|+.||+|+|+...+.....+..+|+.++.++. |||||++|..|
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRN-----KlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn-HpNVVRYysAW  546 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRN-----KLDGREYAIKKIPLKASDKLYSKILREVKLLARLN-HPNVVRYYSAW  546 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEee-----cccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC-Ccceeeeehhh
Confidence            34567778999999999999998     67888899999986556777788999999999999 99999887764

>KOG0604|consensus

Probab=99.73  E-value=5.9e-18  Score=130.50  Aligned_cols=116  Identities=20%  Similarity=0.388  Sum_probs=97.1

Q ss_pred             CCeeE-eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec---
Q psy15820         19 QHIKV-FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE---   94 (230)
Q Consensus        19 ~~~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~---   94 (230)
                      ++|.+ -++||-|-.|+|-.|..     +.++..+|+|++...      .+..+|+++.-...+|+|||++++++.+   
T Consensus        61 edY~is~qvLG~GinGkV~~C~~-----k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVH-----KRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hhheehhhhhccccCCceEEEEe-----ccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            44544 36799999999999999     555666999988643      3456899988888889999999998854   


Q ss_pred             -CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 -KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                       ...+.+|||+++||.|.+.+....           ...+++.++..|+.||+.|++|||+.+
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g-----------~~afTErea~eI~~qI~~Av~~lH~~n  181 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRG-----------DQAFTEREASEIMKQIGLAVRYLHSMN  181 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcc-----------cccchHHHHHHHHHHHHHHHHHHHhcc
Confidence             345889999999999999998863           456999999999999999999999998

>KOG0576|consensus

Probab=99.73  E-value=1.2e-18  Score=146.49  Aligned_cols=121  Identities=25%  Similarity=0.559  Sum_probs=104.8

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      -+.++|+....+|+|.||.||++.+     +..+...|+|+++..... .......|+-++...+ |+||+.++|.+...
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd-----~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~-h~nivay~gsylr~   84 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARD-----KRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR   84 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcc-----cccCchhhheeeeccCCc-cccccccceeeeecCC-CcChHHHHhhhhhh
Confidence            5678999999999999999999999     455667999999855333 3355778899999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...|+.||||-+|+|++...-             -..+++.++..+++..++|+.|||+++
T Consensus        85 dklwicMEycgggslQdiy~~-------------TgplselqiayvcRetl~gl~ylhs~g  132 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHV-------------TGPLSELQIAYVCRETLQGLKYLHSQG  132 (829)
T ss_pred             cCcEEEEEecCCCcccceeee-------------cccchhHHHHHHHhhhhccchhhhcCC
Confidence            999999999999999887654             345899999999999999999999999

>KOG0195|consensus

Probab=99.73  E-value=1.9e-18  Score=131.83  Aligned_cols=168  Identities=27%  Similarity=0.565  Sum_probs=141.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .|+..++.+..+|.+...|..|+|.|.+.+       ++.|+++.. ........|-.|.-.|.-+. ||||+.+++.|.
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwqgnd-------ivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgacn  257 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQGND-------IVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGACN  257 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccccCcc-------hhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhcc
Confidence            456666777788999999999999996654       677877532 33444456888888888888 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      .+....++..|++.|+|+..+....           ...+...+..+++.+++.||+|||+..                 
T Consensus       258 sppnlv~isq~mp~gslynvlhe~t-----------~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide  326 (448)
T KOG0195|consen  258 SPPNLVIISQYMPFGSLYNVLHEQT-----------SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE  326 (448)
T ss_pred             CCCCceEeeeeccchHHHHHHhcCc-----------cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc
Confidence            9999999999999999999998742           223577789999999999999999987                 


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 -.+|.
T Consensus       327 dltarismad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl  406 (448)
T KOG0195|consen  327 DLTARISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL  406 (448)
T ss_pred             hhhhheecccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc
Confidence                                                                                       45677


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                      |+.+|+.++.-+..|+.-|...||.+||.|+.|+-.|+.+
T Consensus       407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            8899999999999999999999999999999998777654

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.72  E-value=8.9e-17  Score=137.99  Aligned_cols=127  Identities=18%  Similarity=0.306  Sum_probs=90.4

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCC----------ceE----EEEEecCCcCCHHHHHHHHHHHHHHhhcCCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREG----------PCI----VAVKTLKENAGERERLDLLQELTVMKTLDPHP   83 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~----------~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~   83 (230)
                      ..+|++++.||+|+||.||+|..+.......          +..    ++.|.+.  ........+.+|+.++..+. |+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~Ei~il~~l~-Hp  223 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK--AGSRAAIQLENEILALGRLN-HE  223 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh--cchHHHHHHHHHHHHHHhCC-CC
Confidence            4679999999999999999987643221100          000    0111111  12234456889999999999 99


Q ss_pred             ceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         84 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        84 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++++++...+..++++|++. ++|.+++......        .........+..++.|++.||.|||+++
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--------~~~~~~~~~~~~i~~ql~~aL~yLH~~g  287 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD--------WKDRPLLKQTRAIMKQLLCAVEYIHDKK  287 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc--------ccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999986 5777776543210        1112345667889999999999999999

>KOG0668|consensus

Probab=99.71  E-value=1.2e-17  Score=124.44  Aligned_cols=115  Identities=20%  Similarity=0.417  Sum_probs=98.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..++|++.+++|+|.|+.|+.|.....     ...+++|+++.    -...++.+|+.+|.++++||||++++++..++.
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~-----~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITN-----NEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCC-----CceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            678899999999999999999987433     33488998873    344678899999999999999999999998754


Q ss_pred             --CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 --PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        ...|++||+.+.+...+..+                ++..++..++.+++.||.|+|++|
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~t----------------l~d~dIryY~~elLkALdyCHS~G  152 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYPT----------------LTDYDIRYYIYELLKALDYCHSMG  152 (338)
T ss_pred             ccCchhHhhhhccccHHHHhhh----------------hchhhHHHHHHHHHHHHhHHHhcC
Confidence              57899999999888777654                788899999999999999999999

>KOG1151|consensus

Probab=99.70  E-value=2e-17  Score=133.87  Aligned_cols=122  Identities=22%  Similarity=0.414  Sum_probs=101.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CH----HHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GE----RERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~----~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      .-.++|.++..||+|+|+.||++.+     ....+.||+|+-..+.  .+    .......+|.++...+. ||.||++|
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFD-----l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlY  533 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFD-----LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLY  533 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcc-----cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeee
Confidence            4457788899999999999999998     4455679999754322  12    22345678999999999 99999999


Q ss_pred             eEEe-cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCT-EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++. +...+|.|+|||+|.+|.-++..++             .+++.....|+.||+.||.||....
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQhk-------------lmSEKEARSIiMQiVnAL~YLNEik  588 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-------------LMSEKEARSIIMQIVNALKYLNEIK  588 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhhh-------------hhhHHHHHHHHHHHHHHHHHHhccC
Confidence            9986 6778999999999999999998865             3799999999999999999999887

>KOG4236|consensus

Probab=99.70  E-value=1.2e-16  Score=131.87  Aligned_cols=126  Identities=25%  Similarity=0.368  Sum_probs=105.5

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCC-cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      .+.||+|.||.||-|.+     +.+|+.||||++.. .........+.+|+.+|+++. ||.||.+-..|.+++.+++||
T Consensus       569 devLGSGQFG~VYgg~h-----RktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKH-----RKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeeccee-----cccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEe
Confidence            37899999999999999     66777899999953 333334467889999999999 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      |-+.|.-|+=.+.+.            .+++++.....++.||+.||.|||.++|.  |.+.+|+|+
T Consensus       643 EKl~GDMLEMILSsE------------kgRL~er~TkFlvtQIL~ALr~LH~knIv--HCDLKPENV  695 (888)
T KOG4236|consen  643 EKLHGDMLEMILSSE------------KGRLPERITKFLVTQILVALRYLHFKNIV--HCDLKPENV  695 (888)
T ss_pred             hhhcchHHHHHHHhh------------cccchHHHHHHHHHHHHHHHHHhhhccee--eccCCchhe
Confidence            999765554444442            34689999999999999999999999999  888888764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.70  E-value=8.1e-16  Score=119.07  Aligned_cols=107  Identities=27%  Similarity=0.567  Sum_probs=90.5

Q ss_pred             eceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecCCCCCH
Q psy15820         31 CFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL  110 (230)
Q Consensus        31 ~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  110 (230)
                      +||.||+|...     .++..+++|++...........+.+|+..+..+. |+|++++++++......++++||+++++|
T Consensus         1 ~~g~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDK-----KTGKLVAIKVIKKEKIKKKRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            58999999984     3455699999865433332578899999999998 99999999999988899999999999999


Q ss_pred             HHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        111 QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       111 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++....             .++...+..++.+++.|+.|||+.+
T Consensus        75 ~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh~~~  107 (244)
T smart00220       75 FDLLKKRG-------------RLSEDEARFYARQILSALEYLHSNG  107 (244)
T ss_pred             HHHHHhcc-------------CCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            99987631             2788899999999999999999998

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.69  E-value=1.5e-15  Score=121.97  Aligned_cols=125  Identities=13%  Similarity=0.241  Sum_probs=83.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHH----------HHHHHHHHHHhhcCCCCc
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER----------LDLLQELTVMKTLDPHPN   84 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~e~~~l~~~~~h~n   84 (230)
                      .+...+|++.+.||+|+||.||+|......  .....+++|...........          .....+...+..+. |++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~   84 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLG   84 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCC
Confidence            466788999999999999999999885431  11334666654322111100          11222333445666 999


Q ss_pred             eeeEeeEEecCC----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         85 VVRLLGCCTEKE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        85 iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++++++....    ..++++|++.. ++.+++...             ...++..+..++.|++.||.|||+++
T Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~  146 (294)
T PHA02882         85 IPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-------------KCKNKKLIKNIMKDMLTTLEYIHEHG  146 (294)
T ss_pred             CCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-------------ccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999765433    34678887743 666665542             12567888999999999999999998

>KOG0662|consensus

Probab=99.69  E-value=3.2e-17  Score=118.11  Aligned_cols=128  Identities=29%  Similarity=0.469  Sum_probs=108.0

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      .|...++||+|.||+|++|..     +.+...||+|.++.. .++......++|+.++..+. |.|||++++..-....+
T Consensus         3 ~ydkmekigegtygtvfkarn-----~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARN-----RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEeccc-----CCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCcee
Confidence            455668899999999999988     566667999999744 33444567899999999999 99999999999888889


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      -+|+|||.. +|..+..+.            ++.+.......++.|++.||.|+|++++.  +|+.+|++
T Consensus        77 tlvfe~cdq-dlkkyfdsl------------ng~~d~~~~rsfmlqllrgl~fchshnvl--hrdlkpqn  131 (292)
T KOG0662|consen   77 TLVFEFCDQ-DLKKYFDSL------------NGDLDPEIVRSFMLQLLRGLGFCHSHNVL--HRDLKPQN  131 (292)
T ss_pred             EEeHHHhhH-HHHHHHHhc------------CCcCCHHHHHHHHHHHHhhhhhhhhhhhh--hccCCcce
Confidence            999999974 788887763            45688899999999999999999999988  88877764

>KOG0666|consensus

Probab=99.68  E-value=2.5e-17  Score=127.75  Aligned_cols=140  Identities=21%  Similarity=0.371  Sum_probs=112.6

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-HHHHHHHHHHHHHhhcCCCCceeeEeeEEec-
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-RERLDLLQELTVMKTLDPHPNVVRLLGCCTE-   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~-   94 (230)
                      ....|+....||+|.||.||+|...++..+. ...+|+|.++...+. ......-+|+.++..++ |+||+.+..++.. 
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhcc
Confidence            4567889999999999999999776543222 336899999755322 22345678999999999 9999999999887 


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      ...+++++||.+. +|++.|+-++..        ....++..-+..+++||+.|+.|||++.|.  ||+.+|.|+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~--------~~~~lp~~mvKsilwQil~Gv~YLH~NWvl--HRDLKPaNI  163 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRAS--------KAKQLPRSMVKSILWQILDGVHYLHSNWVL--HRDLKPANI  163 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccc--------hhccCCHHHHHHHHHHHHhhhHHHhhhhee--eccCCcceE
Confidence            6789999999986 899999876532        123578889999999999999999999999  999888753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.68  E-value=3.4e-15  Score=112.86  Aligned_cols=153  Identities=27%  Similarity=0.529  Sum_probs=121.4

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecCC
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP  106 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~~  106 (230)
                      ||+|.+|.||++...     .++..+++|.+...........+.+|+..+..+. |++++++++++......++++|+++
T Consensus         1 l~~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDK-----KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEec-----CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence            689999999999884     3455699999875433324567899999999999 9999999999998889999999999


Q ss_pred             CCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccC-----------------------
Q psy15820        107 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRL-----------------------  163 (230)
Q Consensus       107 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~-----------------------  163 (230)
                      +++|.+++....            ..++...+..++.+++.++.+||+.++.++..-                       
T Consensus        75 ~~~l~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~  142 (215)
T cd00180          75 GGSLKDLLKENE------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKL  142 (215)
T ss_pred             CCcHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence            999999987631            247889999999999999999999993322100                       


Q ss_pred             -----------------CCCC-------------cCc--------HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        164 -----------------EKPD-------------HCR--------RELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       164 -----------------~~p~-------------~~~--------~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                                       ..|+             .+.        ..+.+++..|++.+|..|||+.++++.
T Consensus       143 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         143 LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHHHHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                             0000             001        467789999999999999999998863

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290|consensus

Probab=99.67  E-value=1.1e-15  Score=124.88  Aligned_cols=132  Identities=22%  Similarity=0.329  Sum_probs=110.1

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCC-------CCceeeEe
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP-------HPNVVRLL   89 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~-------h~niv~l~   89 (230)
                      +..+|.+.++||-|.|++||+|.+     ....+.||+|+.+..  ....++.+.||.+|++++.       ..+||+++
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawD-----tq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWD-----TQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             cCceEEEEEeccccccceeEEEee-----ccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            347899999999999999999999     556677999999853  6667788999999998762       34699999


Q ss_pred             eEEecCC----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-CCCCCccCC
Q psy15820         90 GCCTEKE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-GVRDGYRLE  164 (230)
Q Consensus        90 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~i~~~~~~~  164 (230)
                      +.|...+    -+++|+|++ |.+|..+|..+.           ...++..-+..|++||+.||.|||++ |+.  |-+.
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-----------YrGlpl~~VK~I~~qvL~GLdYLH~ecgII--HTDl  214 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-----------YRGLPLSCVKEICRQVLTGLDYLHRECGII--HTDL  214 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHhC-----------CCCCcHHHHHHHHHHHHHHHHHHHHhcCcc--ccCC
Confidence            9997533    489999999 679999998763           34589999999999999999999988 677  7888


Q ss_pred             CCCcC
Q psy15820        165 KPDHC  169 (230)
Q Consensus       165 ~p~~~  169 (230)
                      +|+|+
T Consensus       215 KPENv  219 (590)
T KOG1290|consen  215 KPENV  219 (590)
T ss_pred             Cccee
Confidence            88863

>KOG0671|consensus

Probab=99.67  E-value=3.1e-16  Score=124.40  Aligned_cols=121  Identities=21%  Similarity=0.334  Sum_probs=101.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCC-----ceeeEeeE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP-----NVVRLLGC   91 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~-----niv~l~~~   91 (230)
                      ...+|.+...+|+|.||.|..|.+..     .+..||+|+++.-  ...+++.+-|++++.++..+.     -++.+.+|
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~-----~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRE-----TKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecC-----CCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            36789999999999999999999953     3567999999853  566778889999999984222     37788899


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |...+..++|+|.+ |-++++++..+.           ..+++...+..+++|++.+|.|||+.+
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~-----------y~~fpi~~ir~m~~QL~~sv~fLh~~k  212 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENN-----------YIPFPIDHIRHMGYQLLESVAFLHDLK  212 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCC-----------ccccchHHHHHHHHHHHHHHHHHHhcc
Confidence            99999999999988 559999998742           345899999999999999999999999

>KOG0983|consensus

Probab=99.67  E-value=2.3e-16  Score=120.53  Aligned_cols=128  Identities=21%  Similarity=0.410  Sum_probs=107.8

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...+..+.++++++..||.|..|.|+++.+     +.++..+|||.+......++.+++++.+++......+|.||+.+|
T Consensus        84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~-----rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~G  158 (391)
T KOG0983|consen   84 GQRYQADINDLENLGDLGSGTCGQVWKMRF-----RSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFG  158 (391)
T ss_pred             CcccccChHHhhhHHhhcCCCccceEEEEE-----cccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence            445666777888889999999999999999     566677999999877778888999999998888777899999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +|..+..+++.||.+.. -+..+++.-            ..++++.-+-++...+..||.||-.+.
T Consensus       159 yFi~n~dV~IcMelMs~-C~ekLlkri------------k~piPE~ilGk~tva~v~AL~YLKeKH  211 (391)
T KOG0983|consen  159 YFITNTDVFICMELMST-CAEKLLKRI------------KGPIPERILGKMTVAIVKALYYLKEKH  211 (391)
T ss_pred             EEeeCchHHHHHHHHHH-HHHHHHHHh------------cCCchHHhhhhhHHHHHHHHHHHHHhc
Confidence            99999999999998843 345555542            346888889999999999999999886

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=3.1e-15  Score=122.33  Aligned_cols=128  Identities=17%  Similarity=0.116  Sum_probs=97.8

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc----CCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      .++...-..+|.+.+.||+|+||.||+|.+..    .++..+|+|++...    ........+.+|+.++..+. |+|++
T Consensus        10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv   84 (365)
T PRK09188         10 GDQIPALSARFVETAVLKRDVFSTVERGYFAG----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVV   84 (365)
T ss_pred             ccccccccCCceEccEEeecCcEEEEEEEEcC----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCC
Confidence            44566778899999999999999999998742    23445799986432    12334567999999999999 99988


Q ss_pred             e-EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCC-
Q psy15820         87 R-LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLE-  164 (230)
Q Consensus        87 ~-l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~-  164 (230)
                      . ++++    +..+++|||++|++|.. +..                ..   ...++.|++.||.|||++|+.  |++. 
T Consensus        85 ~~l~~~----~~~~LVmE~~~G~~L~~-~~~----------------~~---~~~~~~~i~~aL~~lH~~gIi--HrDL~  138 (365)
T PRK09188         85 PQLLAT----GKDGLVRGWTEGVPLHL-ARP----------------HG---DPAWFRSAHRALRDLHRAGIT--HNDLA  138 (365)
T ss_pred             cEEEEc----CCcEEEEEccCCCCHHH-hCc----------------cc---hHHHHHHHHHHHHHHHHCCCe--eCCCC
Confidence            5 5442    45899999999999952 110                11   146788999999999999999  9998 


Q ss_pred             CCCcC
Q psy15820        165 KPDHC  169 (230)
Q Consensus       165 ~p~~~  169 (230)
                      +|.|+
T Consensus       139 KP~NI  143 (365)
T PRK09188        139 KPQNW  143 (365)
T ss_pred             CcceE
Confidence            88874

>KOG0695|consensus

Probab=99.63  E-value=4.3e-16  Score=122.26  Aligned_cols=127  Identities=20%  Similarity=0.369  Sum_probs=112.2

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..|.+...+|.++++||+|+|.+|.++..     +.+.+.+|+|+++..  ...+..+....|-.+......||.+|-+.
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~-----~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh  317 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRL-----KKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH  317 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheeh-----cccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence            55889999999999999999999999988     556667999999754  44566778888999999888899999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+|.+.+.+++|.||.+||+|.-.+...+             .+++.....+...|+-||.|||++|
T Consensus       318 scfqtesrlffvieyv~ggdlmfhmqrqr-------------klpeeharfys~ei~lal~flh~rg  371 (593)
T KOG0695|consen  318 SCFQTESRLFFVIEYVNGGDLMFHMQRQR-------------KLPEEHARFYSAEICLALNFLHERG  371 (593)
T ss_pred             hhhcccceEEEEEEEecCcceeeehhhhh-------------cCcHHHhhhhhHHHHHHHHHHhhcC
Confidence            99999999999999999999977776643             4999999999999999999999999

>KOG0612|consensus

Probab=99.62  E-value=1.5e-16  Score=140.65  Aligned_cols=136  Identities=20%  Similarity=0.297  Sum_probs=116.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .++..++|.+++.||+|+||.|.+..+     +.++..||+|+++..  .......-|..|-.++.... .+.|+.++-.
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~-----k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyA  143 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRH-----KSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYA  143 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEe-----eccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHH
Confidence            567899999999999999999999999     555667999998742  11122345777888888887 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcCc
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCR  170 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~~  170 (230)
                      |.+..++|+||||++||+|-.++....             .+++.-++.|+..|+-||+-||+.|..  ||+.+|.|+-
T Consensus       144 FQD~~~LYlVMdY~pGGDlltLlSk~~-------------~~pE~~ArFY~aEiVlAldslH~mgyV--HRDiKPDNvL  207 (1317)
T KOG0612|consen  144 FQDERYLYLVMDYMPGGDLLTLLSKFD-------------RLPEDWARFYTAEIVLALDSLHSMGYV--HRDIKPDNVL  207 (1317)
T ss_pred             hcCccceEEEEecccCchHHHHHhhcC-------------CChHHHHHHHHHHHHHHHHHHHhccce--eccCCcceeE
Confidence            999999999999999999999998742             589999999999999999999999999  9999888753

>KOG0696|consensus

Probab=99.61  E-value=6.8e-16  Score=124.06  Aligned_cols=124  Identities=25%  Similarity=0.435  Sum_probs=104.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|...+|.++.+||+|+||+|-++..++++     ..+|+|+++.+.  .....+--+.|-++|....+-|.++++..+|
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtd-----ELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF  419 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF  419 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcc-----hhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence            788899999999999999999999996554     459999997542  2223334556778888877688999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+-+.+|+||||+.||+|.-.+++.             ..+.+...+.++..|+.||-|||++|
T Consensus       420 QTmDRLyFVMEyvnGGDLMyhiQQ~-------------GkFKEp~AvFYAaEiaigLFFLh~kg  470 (683)
T KOG0696|consen  420 QTMDRLYFVMEYVNGGDLMYHIQQV-------------GKFKEPVAVFYAAEIAIGLFFLHSKG  470 (683)
T ss_pred             hhhhheeeEEEEecCchhhhHHHHh-------------cccCCchhhhhhHHHHHHhhhhhcCC
Confidence            9999999999999999998888773             34888899999999999999999999

>KOG1152|consensus

Probab=99.59  E-value=2.6e-15  Score=124.92  Aligned_cols=134  Identities=20%  Similarity=0.308  Sum_probs=110.2

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-------CHHHHHHHHHHHHHHhhcC--CCCceee
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLD--PHPNVVR   87 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~~~--~h~niv~   87 (230)
                      +..+|...+.+|+|+||+|++|.+     +.....|++|.+....       .....-..-.|+.+|..+.  .|+||++
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~-----K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK  633 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIH-----KENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK  633 (772)
T ss_pred             ccccceeeeeccccccceEEEeee-----cccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence            456688999999999999999999     4445679999986431       1112224567999999875  6999999


Q ss_pred             EeeEEecCCCeEEEEec-CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCC
Q psy15820         88 LLGCCTEKEPFFVIMEY-VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKP  166 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p  166 (230)
                      ++++|.+.+++||++|- =+|-+|.++|...             ..+.+.....|++||+-|+.+||+++|.  ||+.+.
T Consensus       634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~k-------------p~m~E~eAk~IFkQV~agi~hlh~~~iv--hrdikd  698 (772)
T KOG1152|consen  634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-------------PRMDEPEAKLIFKQVVAGIKHLHDQGIV--HRDIKD  698 (772)
T ss_pred             hhheeecCCeeEEEecCCCCCcchhhhhhcc-------------CccchHHHHHHHHHHHhccccccccCce--eccccc
Confidence            99999999999999997 4678899998763             3589999999999999999999999999  999888


Q ss_pred             CcCc
Q psy15820        167 DHCR  170 (230)
Q Consensus       167 ~~~~  170 (230)
                      +|+-
T Consensus       699 envi  702 (772)
T KOG1152|consen  699 ENVI  702 (772)
T ss_pred             ccEE
Confidence            7643

>KOG0603|consensus

Probab=99.59  E-value=3.3e-15  Score=125.50  Aligned_cols=157  Identities=21%  Similarity=0.331  Sum_probs=124.6

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..+.|.+...+|.|+|+.|..|...     .+....++|++....     ....+|+.++.....|+||+++.+.+.+..
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~-----~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESS-----PTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cchhhccccccCCCCccceeeeecc-----ccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCc
Confidence            3677888888999999999999884     444558999986442     223357767777767999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..|+|||.+.|+.+.+.+....              .....+..|+++|+.|+.|||++|                    
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~--------------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~l  455 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKP--------------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHL  455 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcc--------------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcE
Confidence            9999999999998888776532              223677789999999999999999                    


Q ss_pred             --------------------------------------------------CCCC--------------ccCCCC---CcC
Q psy15820        157 --------------------------------------------------VRDG--------------YRLEKP---DHC  169 (230)
Q Consensus       157 --------------------------------------------------i~~~--------------~~~~~p---~~~  169 (230)
                                                                        ...|              .+...|   .++
T Consensus       456 rltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~v  535 (612)
T KOG0603|consen  456 RLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECV  535 (612)
T ss_pred             EEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcccccc
Confidence                                                              0000              111223   688


Q ss_pred             cHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        170 RRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       170 ~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      |++.++|++.||+.||.+||++.++...
T Consensus       536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  536 SDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             CHHHHHHHHHhccCChhhCcChhhhccC
Confidence            9999999999999999999999999863

>KOG0669|consensus

Probab=99.58  E-value=2.7e-16  Score=118.90  Aligned_cols=194  Identities=19%  Similarity=0.284  Sum_probs=147.5

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC-CcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..|+-.....|+...+||+|.||.||+|..     +.+++.||+|++- .+.........++|+.+|..+. |+|++.++
T Consensus         9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~-----~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nli   82 (376)
T KOG0669|consen    9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARS-----KNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLI   82 (376)
T ss_pred             cCCceecchHHHHHHhcCCchHHHHHHHhh-----cCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHH
Confidence            445666778888889999999999999988     4455558887663 1222333456789999999999 99999999


Q ss_pred             eEEecC--------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC---
Q psy15820         90 GCCTEK--------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR---  158 (230)
Q Consensus        90 ~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~---  158 (230)
                      +.|...        ..+|+|+.+|+. +|..++...            ...++...+.+++.+++.||.|+|+..+.   
T Consensus        83 Eic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~------------~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRD  149 (376)
T KOG0669|consen   83 EICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNR------------KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRD  149 (376)
T ss_pred             HHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCc------------cccccHHHHHHHHHHHHHHHHHHHHhhHHhhc
Confidence            887542        348999999986 888888763            34589999999999999999999998811   


Q ss_pred             ---------------------------------------------------CCccCCCCCcCcHHHHHHHHHhcCCCCC-
Q psy15820        159 ---------------------------------------------------DGYRLEKPDHCRRELYNIMYYCWDKEPN-  186 (230)
Q Consensus       159 ---------------------------------------------------~~~~~~~p~~~~~~~~~li~~cl~~dp~-  186 (230)
                                                                         -|.+.--|+.--+....++..||...|- 
T Consensus       150 mKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim  229 (376)
T KOG0669|consen  150 MKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM  229 (376)
T ss_pred             ccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence                                                               1112222222234566799999999998 


Q ss_pred             CCCCHHHHHHHHHHHHhhccccccccCCCCcceeeec
Q psy15820        187 ERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMV  223 (230)
Q Consensus       187 ~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  223 (230)
                      .--|-.+-+..+..++.+-..-+|+....-.-|.-++
T Consensus       230 qgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie  266 (376)
T KOG0669|consen  230 QGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIE  266 (376)
T ss_pred             cCChHHHHHHHHHHHhccCCcccCCCcccchHHHhcc
Confidence            5578888889999999999999999876666666553

>KOG1027|consensus

Probab=99.57  E-value=1e-14  Score=125.69  Aligned_cols=112  Identities=29%  Similarity=0.338  Sum_probs=88.1

Q ss_pred             eeeecceecee-EEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         24 FDILGEGCFGQ-VWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        24 ~~~lg~G~~g~-V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      -+.+|.|+-|+ ||+|.+.+.       .||||++-    .+...-..+|+..|.....|||||++|+.-.+....|+.+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye~R-------~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYEGR-------EVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             HHHcccCCCCcEEEEEeeCCc-------eehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            35688898876 899988543       49999874    3334457799999999988999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |.|. .+|.+++......         .........+.++.|++.||+|||+.+
T Consensus       583 ELC~-~sL~dlie~~~~d---------~~~~~~i~~~~~l~q~~~GlaHLHsl~  626 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLD---------VEMQSDIDPISVLSQIASGLAHLHSLK  626 (903)
T ss_pred             hHhh-hhHHHHHhccccc---------hhhcccccHHHHHHHHHHHHHHHHhcc
Confidence            9997 4999999874100         001122456788999999999999988

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.56  E-value=2.2e-13  Score=116.08  Aligned_cols=140  Identities=16%  Similarity=0.212  Sum_probs=93.0

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccC-----------CCCCceEEEEEecCCcCCHHHHH--------------HH
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGID-----------GREGPCIVAVKTLKENAGERERL--------------DL   69 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~--------------~~   69 (230)
                      ++..++|.+.++||+|+||.||+|......           ....++.||+|.++... .....              ..
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchh
Confidence            457889999999999999999999753221           12334569999986432 11122              23


Q ss_pred             HHHHHHHhhcCCCCce-----eeEeeEEec--------CCCeEEEEecCCCCCHHHHHHHhhhh------hhcc--c---
Q psy15820         70 LQELTVMKTLDPHPNV-----VRLLGCCTE--------KEPFFVIMEYVPYGKLQSFLRSSRAQ------RYYN--N---  125 (230)
Q Consensus        70 ~~e~~~l~~~~~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~--~---  125 (230)
                      ..|+.++..+. |.++     +++++++..        .+..++|+||+++++|.+++......      ....  .   
T Consensus       220 ~vE~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        220 MVEAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             HHHHHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            34666677776 5543     566666542        35689999999999999998753110      0000  0   


Q ss_pred             cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       126 ~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .......+++..+..++.|++.||.|||+++
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~  329 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIG  329 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            0001123567788899999999999999998

>KOG1006|consensus

Probab=99.56  E-value=2e-15  Score=114.94  Aligned_cols=129  Identities=19%  Similarity=0.300  Sum_probs=106.1

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|....++++-...||.|+||.|++-.+     +..+..+|||+++......+..+++.|.++..+....||||++||..
T Consensus        58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~h-----k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~  132 (361)
T KOG1006|consen   58 LHTFTSDNLQDLGEIGNGAFGTVNKMLH-----KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL  132 (361)
T ss_pred             ccccccchHHHHHHhcCCcchhhhhhhc-----CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence            3677888888889999999999999888     56677899999987766778889999999888887799999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHH-hhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRS-SRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..|+-||.+. .+|..+.+. +..         ....+++.-+-+|......||.||-..-
T Consensus       133 F~EGdcWiCMELMd-~SlDklYk~vy~v---------q~~~ipE~Ilg~ItvatV~AL~yLK~~l  187 (361)
T KOG1006|consen  133 FSEGDCWICMELMD-ISLDKLYKRVYSV---------QKSRIPENILGHITVATVDALDYLKEEL  187 (361)
T ss_pred             hcCCceeeeHHHHh-hhHHHHHHHHHHH---------HhccCcHhhhhheeeeehhHHHHHHHHh
Confidence            99999999999996 477665543 111         1345888888888888889999987665

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.56  E-value=4.3e-14  Score=122.69  Aligned_cols=136  Identities=15%  Similarity=0.209  Sum_probs=81.0

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE--
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC--   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~--   91 (230)
                      .....++|.+.+.||+|+||.||+|.+..... ..+..+|+|.+......+   ....+  .+.... +.++..+...  
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~~e---~~~~e--~l~~~~-~~~~~~~~~~~~  199 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGAVE---IWMNE--RVRRAC-PNSCADFVYGFL  199 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccchhH---HHHHH--HHHhhc-hhhHHHHHHhhh
Confidence            34577899999999999999999999954321 225569999876432111   11111  111111 2222211111  


Q ss_pred             ----EecCCCeEEEEecCCCCCHHHHHHHhhhhh----h-cccc--CCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 ----CTEKEPFFVIMEYVPYGKLQSFLRSSRAQR----Y-YNNM--HGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~-~~~~--~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                          .......++++||+.+++|.+++......-    . ....  ...........+..++.|++.||.|||+++
T Consensus       200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g  275 (566)
T PLN03225        200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG  275 (566)
T ss_pred             cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence                234567899999999999999987532100    0 0000  000011123446689999999999999999

>KOG0986|consensus

Probab=99.53  E-value=1.2e-14  Score=117.88  Aligned_cols=126  Identities=19%  Similarity=0.380  Sum_probs=105.0

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC-c-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE-N-AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.+..+.|..-++||+|+||.|+-|+.     +.+|..+|+|.+.. . +........++|-.+|..+. .+.||.+--.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqv-----raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYA  253 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQV-----RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYA  253 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEE-----ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeee
Confidence            345667788889999999999999998     66777799998832 1 22333456788999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.+.+.+++||..|.||+|.-.|...           ....+++.+.+.++.+|+.||.+||+.+
T Consensus       254 feTkd~LClVLtlMNGGDLkfHiyn~-----------g~~gF~e~ra~FYAAEi~cGLehlH~~~  307 (591)
T KOG0986|consen  254 FETKDALCLVLTLMNGGDLKFHIYNH-----------GNPGFDEQRARFYAAEIICGLEHLHRRR  307 (591)
T ss_pred             ecCCCceEEEEEeecCCceeEEeecc-----------CCCCCchHHHHHHHHHHHhhHHHHHhcc
Confidence            99999999999999999997666553           2346899999999999999999999999

>KOG0984|consensus

Probab=99.53  E-value=3.9e-14  Score=104.33  Aligned_cols=143  Identities=25%  Similarity=0.386  Sum_probs=120.1

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .....++++.+++.-+..||+|++|.|-+-++     .+.+...|+|.+..........+.++|+.+..+...+|.+|++
T Consensus        36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh-----~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~F  110 (282)
T KOG0984|consen   36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRH-----IQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHF  110 (282)
T ss_pred             EecCccccchhhhhhhhhhcCCccchhhheee-----ccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEe
Confidence            34455888999999999999999999988777     5677789999998776777788999999998887779999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-CCCCccCCCCC
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-VRDGYRLEKPD  167 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-i~~~~~~~~p~  167 (230)
                      ||.....+.+|+.||.+. .+|..|.+.--.         .+..+++..+-+|+..+..||.|||++- +.  ||+.+|.
T Consensus       111 yGa~~regdvwIcME~M~-tSldkfy~~v~~---------~g~~ipE~vlGkIa~Svv~al~~L~~kL~vI--HRDvKPs  178 (282)
T KOG0984|consen  111 YGALFREGDVWICMELMD-TSLDKFYRKVLK---------KGGTIPEDVLGKIAVSVVHALEFLHSKLSVI--HRDVKPS  178 (282)
T ss_pred             ehhhhccccEEEeHHHhh-hhHHHHHHHHHh---------cCCcCchHHhhHhHHHHHHHHHHHHHHhhhh--hccCCcc
Confidence            999999999999999996 478777766322         3456899999999999999999999983 55  8888886


Q ss_pred             c
Q psy15820        168 H  168 (230)
Q Consensus       168 ~  168 (230)
                      |
T Consensus       179 N  179 (282)
T KOG0984|consen  179 N  179 (282)
T ss_pred             e
Confidence            5

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.53  E-value=3.3e-14  Score=106.90  Aligned_cols=122  Identities=13%  Similarity=0.055  Sum_probs=87.7

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-HH------------------------HHHHHHHHHHHhh
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-RE------------------------RLDLLQELTVMKT   78 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~e~~~l~~   78 (230)
                      ...||+|+||.||+|..     . ++..||+|+++..... ..                        ......|+..+..
T Consensus         2 ~~~ig~G~~~~Vy~a~~-----~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05147           2 NGCISTGKEANVYHATT-----A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR   75 (190)
T ss_pred             CCccccccceEEEEEEC-----C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            46799999999999988     2 4566999999643211 00                        1123458899998


Q ss_pred             cCCCCceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhh-hhcCC
Q psy15820         79 LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGV  157 (230)
Q Consensus        79 ~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L-H~~~i  157 (230)
                      +. ++++........  ...++||||++++++......             ...++...+..++.|++.+|.++ |+.++
T Consensus        76 l~-~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~l~H~~gi  139 (190)
T cd05147          76 LV-TAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-------------DAPLSESKARELYLQVIQIMRILYQDCRL  139 (190)
T ss_pred             HH-HCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-------------cCCCCHHHHHHHHHHHHHHHHHHHHhCCc
Confidence            87 766543322222  224899999998777544322             12478889999999999999999 79999


Q ss_pred             CCCccCCCCCcC
Q psy15820        158 RDGYRLEKPDHC  169 (230)
Q Consensus       158 ~~~~~~~~p~~~  169 (230)
                      .  |++++|.|+
T Consensus       140 i--HrDlkP~NI  149 (190)
T cd05147         140 V--HADLSEYNL  149 (190)
T ss_pred             c--cCCCCHHHE
Confidence            9  999999875

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.51  E-value=4.1e-13  Score=102.93  Aligned_cols=120  Identities=33%  Similarity=0.634  Sum_probs=101.1

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEE
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV  100 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~l  100 (230)
                      |.+.+.||+|++|.||++....     ++..+++|.+...........+.+|+..+..+. |+|++++++.+......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG-----TGELVAVKVLKKEKTEKQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC-----CCcEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEE
Confidence            5677899999999999998843     345699999875433335678889999999998 9999999999998889999


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      ++|++++++|.+++....            ..+++..+..++.+++.++.+||+.++.
T Consensus        75 v~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~  120 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKG------------GKLSEEEARFYLRQILEALEYLHSLGIV  120 (225)
T ss_pred             EEeccCCCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            999999999999987632            1168889999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167|consensus

Probab=99.50  E-value=4.2e-14  Score=113.62  Aligned_cols=130  Identities=22%  Similarity=0.416  Sum_probs=112.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ...|.+..+||+|.|+.||++.....  ....+.||+|.+.....+   .++..|+++|..+.++.||+++.+++..++.
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            35677889999999999999998653  234567999998643323   4588999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcCc
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCR  170 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~~  170 (230)
                      +.+|+||++..+..++.+.                ++...+..+++.++.||.++|.+||.  ||+.+|.|+-
T Consensus       110 v~ivlp~~~H~~f~~l~~~----------------l~~~~i~~Yl~~ll~Al~~~h~~GIv--HRDiKpsNFL  164 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS----------------LSLAEIRWYLRNLLKALAHLHKNGIV--HRDIKPSNFL  164 (418)
T ss_pred             eEEEecccCccCHHHHHhc----------------CCHHHHHHHHHHHHHHhhhhhccCcc--ccCCCccccc
Confidence            9999999999999998876                67889999999999999999999999  9999998753

>KOG0608|consensus

Probab=99.50  E-value=9.6e-14  Score=117.06  Aligned_cols=137  Identities=20%  Similarity=0.320  Sum_probs=113.5

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..-+++.+-|..++.||-|+||.|.++.-..     +...+|+|.++...  ..........|-++|.... ++.||++|
T Consensus       622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvD-----T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLy  695 (1034)
T KOG0608|consen  622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVD-----TRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLY  695 (1034)
T ss_pred             HHhhccccceEEEeeecccccceeEEEeecc-----hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEE
Confidence            3446778889999999999999999987633     34458999886331  1223345667888999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      -.|.+.+.+|+||+|++||++..++...             +.+++...+.++..+..|+.+.|..|..  ||+.+|.|+
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIrm-------------gIFeE~LARFYIAEltcAiesVHkmGFI--HRDiKPDNI  760 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIRM-------------GIFEEDLARFYIAELTCAIESVHKMGFI--HRDIKPDNI  760 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHHh-------------ccCHHHHHHHHHHHHHHHHHHHHhccce--ecccCccce
Confidence            9999999999999999999999998873             3488999999999999999999999988  888888764

>PRK10345 hypothetical protein; Provisional

Probab=99.48  E-value=3.2e-13  Score=102.70  Aligned_cols=119  Identities=16%  Similarity=0.230  Sum_probs=88.2

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC----CCCceeeEeeEEecCC---
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----PHPNVVRLLGCCTEKE---   96 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~----~h~niv~l~~~~~~~~---   96 (230)
                      .+.||+|+||.||.  +.     .+.. .++|++.... ......+.+|+.++..+.    .||||++++|++.+..   
T Consensus         7 ~~~LG~G~~~~Vy~--hp-----~~~~-k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HP-----EDAQ-RCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             cceecCCCceEEEE--CC-----CCcC-eEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            46799999999995  31     1222 3688875432 223457899999999993    2799999999998763   


Q ss_pred             CeE-EEEec--CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhh-hhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFF-VIMEY--VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGM-QFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl-~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .++ +|+||  +++++|.+++...              .+++.  ..++.+++.++ .|||+++|.  +++.+|+|+
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~--------------~~~e~--~~~~~~~L~~l~~yLh~~~Iv--hrDlKp~NI  136 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC--------------RYEED--VAQLRQLLKKLKRYLLDNRIV--TMELKPQNI  136 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc--------------cccHh--HHHHHHHHHHHHHHHHHCCEe--ecCCCHHHE
Confidence            333 78999  6689999999652              24444  35678888877 899999999  888888753

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.46  E-value=8.2e-13  Score=99.43  Aligned_cols=122  Identities=16%  Similarity=0.045  Sum_probs=89.0

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-------------------------HHHHHHHHHHHHHhh
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-------------------------RERLDLLQELTVMKT   78 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~   78 (230)
                      .+.||+|++|.||+|..     . ++..||+|+++.....                         .....+..|...+..
T Consensus         2 ~~~ig~G~~~~Vy~a~~-----~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   75 (190)
T cd05145           2 NGCISTGKEANVYHART-----G-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR   75 (190)
T ss_pred             CceeecCCCcEEEEEEc-----C-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999987     2 4567999998643210                         002234578889999


Q ss_pred             cCCCCceeeEeeEEecCCCeEEEEecCCCCCHHHH-HHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         79 LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF-LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        79 ~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      +. ++++.....+...  ..+++|||++|+++... +..              ..++......++.|++.++.++|+ .|
T Consensus        76 l~-~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~g  138 (190)
T cd05145          76 LY-EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--------------VPLEEEEAEELYEQVVEQMRRLYQEAG  138 (190)
T ss_pred             HH-hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--------------ccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            98 8876443333322  24899999998755333 322              236778899999999999999999 99


Q ss_pred             CCCCccCCCCCcCc
Q psy15820        157 VRDGYRLEKPDHCR  170 (230)
Q Consensus       157 i~~~~~~~~p~~~~  170 (230)
                      +.  |++.+|.|+-
T Consensus       139 iv--HrDlkP~NIl  150 (190)
T cd05145         139 LV--HGDLSEYNIL  150 (190)
T ss_pred             Ee--cCCCChhhEE
Confidence            99  9999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1345|consensus

Probab=99.46  E-value=4.1e-13  Score=102.80  Aligned_cols=118  Identities=18%  Similarity=0.366  Sum_probs=96.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE-EecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC-CTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~-~~~~~   96 (230)
                      .+.|.+.+.||+|.||.|.++.++++     ...+++|.+...  ......|.+|..--..+..|.||+.-|+. |...+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s-----~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQS-----KTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCC-----ceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            46688889999999999999999543     445999988753  44557899999877777779999998775 55667


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+.+++||++.|+|.+-+..              .++-+.-...++.|+++|+.|||+++
T Consensus        96 ~YvF~qE~aP~gdL~snv~~--------------~GigE~~~K~v~~ql~SAi~fMHskn  141 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEA--------------AGIGEANTKKVFAQLLSAIEFMHSKN  141 (378)
T ss_pred             eEEEeeccCccchhhhhcCc--------------ccccHHHHHHHHHHHHHHHHHhhccc
Confidence            78899999999999776543              34677788899999999999999998

>KOG0614|consensus

Probab=99.42  E-value=1.4e-14  Score=119.17  Aligned_cols=134  Identities=23%  Similarity=0.355  Sum_probs=113.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+..++++++..||-|+||.|-+....+...     .+|+|+++..  .+....+....|-.++..++ .+.||++|.-|
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~-----~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTf  489 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKA-----TFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTF  489 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccch-----HHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHh
Confidence            3567888999999999999999988854332     3788988643  34445567888999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .+..++|++||-|-||.++..++..             +.+.......++.-+++|+.|||++++.  .|+.+|+|+
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdR-------------g~Fdd~tarF~~acv~EAfeYLH~k~iI--YRDLKPENl  551 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDR-------------GSFDDYTARFYVACVLEAFEYLHRKGII--YRDLKPENL  551 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhc-------------CCcccchhhhhHHHHHHHHHHHHhcCce--eccCChhhe
Confidence            9999999999999999999999874             3488889999999999999999999988  888888654

>KOG1163|consensus

Probab=99.38  E-value=5.9e-12  Score=95.02  Aligned_cols=133  Identities=20%  Similarity=0.243  Sum_probs=109.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      -.|....|+++++||+|+||++|+|...     ..+..||+|.=+.....   ..+..|..++..+++...|+.+..+..
T Consensus        10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i-----~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   10 ELIVGGKYKLVRKIGSGSFGDIYLGISI-----TSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             hheeccceEEEEeecCCchhheeeeeec-----cCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhcc
Confidence            3477889999999999999999999984     44556999976533211   246778999999986788888888888


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      ....-.+||+.+ |.+|++++.-..            ..++..+++..+-|++.-+.|+|.++..  ||+.+|+|+
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~------------R~ftmkTvLMLaDQml~RiEyvH~r~fi--HRDIKPdNF  142 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCS------------RRFTMKTVLMLADQMLSRIEYVHLRNFI--HRDIKPDNF  142 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHh------------hhhhHHhHHHHHHHHHHHHHHHHhhccc--cccCCccce
Confidence            888889999988 789999887532            2488899999999999999999999999  999999764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.37  E-value=1.1e-11  Score=94.64  Aligned_cols=117  Identities=17%  Similarity=0.206  Sum_probs=89.6

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CH-----HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GE-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      +.||+|++|.||+|.+.+.       .+++|......  ..     .....+.+|+.++..+. |++++....++...+.
T Consensus         2 ~~l~~G~~~~vy~~~~~~~-------~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGI-------KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEeeCCC-------ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCC
Confidence            5689999999999987322       38888764321  11     12346788999999998 8888776666666678


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      .+++|||++|++|.+++...                .. ....++.+++.+|.++|+.++.  |++..|.|
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~----------------~~-~~~~i~~~i~~~l~~lH~~~i~--H~Dl~p~N  125 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSN----------------GM-EELELSREIGRLVGKLHSAGII--HGDLTTSN  125 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhc----------------cH-HHHHHHHHHHHHHHHHHhCCcc--cCCCCccc
Confidence            89999999999999887642                22 7788999999999999999988  66666544

>KOG1165|consensus

Probab=99.34  E-value=7.3e-12  Score=98.54  Aligned_cols=134  Identities=17%  Similarity=0.232  Sum_probs=110.6

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .-.|..-+|+++++||+|+||.++.|+.     -.++..||||.=...   ...-.+.-|.+.++.+.+.++|...|-+.
T Consensus        22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~N-----l~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFG   93 (449)
T KOG1165|consen   22 GVLMVGPHYRVGKKIGEGSFGVLFLGKN-----LYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFG   93 (449)
T ss_pred             CceEecccceeccccccCcceeeecccc-----cccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeec
Confidence            4457888999999999999999999988     566778999975422   12234667888888888789999998887


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      ..+-.-.||+|.+ |.+|++++.-.            +..++..+++.++.|++.-+.|+|++.+.  .|+.+|+|+
T Consensus        94 qeG~~NiLVidLL-GPSLEDLFD~C------------gR~FSvKTV~miA~Qmi~rie~vH~k~LI--YRDIKPdNF  155 (449)
T KOG1165|consen   94 QEGKYNILVIDLL-GPSLEDLFDLC------------GRRFSVKTVAMIAKQMITRIEYVHEKDLI--YRDIKPDNF  155 (449)
T ss_pred             cccchhhhhhhhh-CcCHHHHHHHh------------cCcccHHhHHHHHHHHHHHHHHHHhccee--ecccCccce
Confidence            7777778999988 78999998764            33589999999999999999999999988  888888764

>KOG1164|consensus

Probab=99.33  E-value=1.2e-11  Score=100.70  Aligned_cols=133  Identities=21%  Similarity=0.271  Sum_probs=103.6

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC---CCCceeeEeeEE-ecC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD---PHPNVVRLLGCC-TEK   95 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---~h~niv~l~~~~-~~~   95 (230)
                      +|++.+.||+|+||.||.+......    ...+|+|........... .+..|..++..+.   +.+++..+++.. ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            8999999999999999999985432    345888877543222211 5667888887776   246888999888 466


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcCcH
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRR  171 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~~~  171 (230)
                      ..-++||+.+ |.+|.++.....           ...++..+++.++.|++.+|.+||+.|..  ||+.+|.|+.-
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~-----------~~~fs~~T~l~ia~q~l~~l~~lH~~G~i--HRDiKp~N~~~  155 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNP-----------PGRFSRKTVLRIAIQNLNALEDLHSKGFI--HRDIKPENFVV  155 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCC-----------CCCcCHhHHHHHHHHHHHHHHHHHhcCcc--cCCcCHHHeee
Confidence            7789999977 789999876531           34689999999999999999999999999  99998877543

>smart00090 RIO RIO-like kinase

Probab=99.30  E-value=1.4e-11  Score=95.78  Aligned_cols=126  Identities=13%  Similarity=0.042  Sum_probs=90.6

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----------------------HHHHHHHHHHHHH
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----------------------RERLDLLQELTVM   76 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~e~~~l   76 (230)
                      .|.+.+.||+|+||.||+|.+.    ..++..||+|+++.....                       .....+..|+..+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~----~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDF----DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEec----CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            5788899999999999999821    234567999998643110                       0112456899999


Q ss_pred             hhcCCC--CceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh
Q psy15820         77 KTLDPH--PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS  154 (230)
Q Consensus        77 ~~~~~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~  154 (230)
                      ..+. +  ..++++++.    ...++||||++|++|......             ...........++.|++.++.+||+
T Consensus       105 ~~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~  166 (237)
T smart00090      105 QRLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-------------DVEPEEEEEFELYDDILEEMRKLYK  166 (237)
T ss_pred             HHHH-hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-------------cCCcchHHHHHHHHHHHHHHHHHHh
Confidence            9987 4  334444543    235899999999887654322             1124555678899999999999999


Q ss_pred             cC-CCCCccCCCCCcC
Q psy15820        155 RG-VRDGYRLEKPDHC  169 (230)
Q Consensus       155 ~~-i~~~~~~~~p~~~  169 (230)
                      .+ +.  |++.+|.|+
T Consensus       167 ~g~ii--H~Dikp~NI  180 (237)
T smart00090      167 EGELV--HGDLSEYNI  180 (237)
T ss_pred             cCCEE--eCCCChhhE
Confidence            99 99  889888875

>KOG0670|consensus

Probab=99.29  E-value=1.3e-11  Score=102.21  Aligned_cols=122  Identities=21%  Similarity=0.321  Sum_probs=100.0

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC-----CCCceeeEeeE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLLGC   91 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~niv~l~~~   91 (230)
                      --.+|.+....|+|-|+.|..|.+     ...+..||||+|.++  ......=+.|+++|..+.     .--|+++++..
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D-----~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARD-----QARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccc-----cCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            346788888899999999999998     444557999999754  334455678999999875     34578999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |...+.+|||+|.+. -+|.+.+....          ...++....+..|+.|+.-||..|-..+
T Consensus       503 F~hknHLClVFE~Ls-lNLRevLKKyG----------~nvGL~ikaVRsYaqQLflALklLK~c~  556 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPLS-LNLREVLKKYG----------RNVGLHIKAVRSYAQQLFLALKLLKKCG  556 (752)
T ss_pred             hhhcceeEEEehhhh-chHHHHHHHhC----------cccceeehHHHHHHHHHHHHHHHHHhcC
Confidence            999999999999986 48999999853          2445888899999999999999999888

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.29  E-value=5e-11  Score=91.36  Aligned_cols=123  Identities=10%  Similarity=0.064  Sum_probs=93.4

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHH------HHHHHHHHhhcCCCCceee
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLD------LLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~------~~~e~~~l~~~~~h~niv~   87 (230)
                      +-..+|+..+.+|.|+||.||+....       +..+++|.+....  .+.....      +.+|+..+..+. |++|..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~~-------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~   99 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDTD-------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLAS   99 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEecC-------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCc
Confidence            45678999999999999999986552       2239999996432  2222223      578999999998 999999


Q ss_pred             EeeEEecC--------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCC
Q psy15820         88 LLGCCTEK--------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRD  159 (230)
Q Consensus        88 l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~  159 (230)
                      +..++...        +..+++|||++|.+|.++..                 +++    ....+++.++..+|+.|+. 
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------------~~~----~~~~~i~~~l~~lH~~gi~-  157 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----------------ISE----DVKAKIKASIESLHQHGMV-  157 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----------------ccH----HHHHHHHHHHHHHHHcCCc-
Confidence            88875533        35899999999999977631                 222    2355899999999999999 


Q ss_pred             CccCCCCCcC
Q psy15820        160 GYRLEKPDHC  169 (230)
Q Consensus       160 ~~~~~~p~~~  169 (230)
                       |+++.|.|+
T Consensus       158 -H~Dikp~Ni  166 (232)
T PRK10359        158 -SGDPHKGNF  166 (232)
T ss_pred             -cCCCChHHE
Confidence             888888764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.26  E-value=3.9e-11  Score=90.84  Aligned_cols=114  Identities=12%  Similarity=0.148  Sum_probs=82.6

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CH-----HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GE-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      .||+|+||.||++.+.+       ..+++|......  ..     ....++.+|+.++..+. |+++.....++...+..
T Consensus         1 ~ig~G~~~~vy~~~~~~-------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG-------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeecCC-------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCC
Confidence            37999999999998633       238888754221  11     12356778999999998 77654444444455667


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      +++|||++|++|.+++...                ..    .++.+++.+|.+||+.++.  |++..|.|+
T Consensus        73 ~lv~e~~~g~~l~~~~~~~----------------~~----~~~~~i~~~l~~lH~~gi~--H~Dl~~~Ni  121 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEG----------------ND----ELLREIGRLVGKLHKAGIV--HGDLTTSNI  121 (199)
T ss_pred             EEEEEEECCccHHHHHhhc----------------HH----HHHHHHHHHHHHHHHCCee--cCCCCcceE
Confidence            9999999999998876541                01    7889999999999999998  666666553

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0664|consensus

Probab=99.24  E-value=7.5e-13  Score=101.58  Aligned_cols=127  Identities=24%  Similarity=0.435  Sum_probs=99.7

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      +++-.+.||-|+||.||..++     ..+++.+++|.+.+- ..-....++.+|+.+|..++ |.|++...++..-..  
T Consensus        54 Di~PDRPIGYGAFGVVWsVTD-----PRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTD-----PRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEeccC-----CCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCch
Confidence            344457899999999999888     456666999988543 23345568899999999999 999999988875433  


Q ss_pred             ---CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         97 ---PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        97 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                         .+|++.|.++. +|-..+-+             .+.++...+.-+++||++||.|||+.+|.  ||+.+|.|
T Consensus       128 fFqEiYV~TELmQS-DLHKIIVS-------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~IL--HRDIKPGN  186 (449)
T KOG0664|consen  128 FFQELYVLTELMQS-DLHKIIVS-------------PQALTPDHVKVFVYQILRGLKYLHTANIL--HRDIKPGN  186 (449)
T ss_pred             HHHHHHHHHHHHHh-hhhheecc-------------CCCCCcchhhhhHHHHHhhhHHHhhcchh--hccCCCcc
Confidence               36777777753 66666554             34588889999999999999999999999  99999864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.22  E-value=2e-10  Score=99.71  Aligned_cols=116  Identities=17%  Similarity=0.141  Sum_probs=88.1

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEEEec--CCcCC-----HHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL--KENAG-----ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~--~~~~~-----~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ...+.||+|+||.||++.+.+..       +++|..  +....     ......+.+|+.++..+. |++++....+...
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~-------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~  407 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRD-------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVD  407 (535)
T ss_pred             CccceeccCCcEEEEEEeecCcc-------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEe
Confidence            34788999999999998874432       333322  11111     122356889999999999 9998887777777


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      ....+++|||++|++|.+++..                     ...++.+++.+|.+||+.++.  |++.+|.|
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~~---------------------~~~~~~~i~~~L~~lH~~gii--HrDlkp~N  458 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLEG---------------------NPELVRKVGEIVAKLHKAGIV--HGDLTTSN  458 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHHH---------------------HHHHHHHHHHHHHHHHhCCCc--cCCCChHH
Confidence            7778999999999999887642                     346788999999999999999  88888765

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.13  E-value=9e-10  Score=83.03  Aligned_cols=141  Identities=16%  Similarity=0.109  Sum_probs=92.7

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC---HHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG---ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      .....|++|.||.|+++..       .+..++.+.+....-   ......+.+|++++..+.+++++++++++    +..
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence            3567899999999996544       223366665543311   11223578999999999757889999886    457


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCC-CCCcCcH---HHH
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLE-KPDHCRR---ELY  174 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~-~p~~~~~---~~~  174 (230)
                      +++|||+.|.+|.+.+..                    ....++.|++.+|.++|++|+.  |++. +|.|+--   .-.
T Consensus        74 ~lvmeyI~G~~L~~~~~~--------------------~~~~~~~qi~~~L~~lH~~GIv--HrDL~kp~NILv~~~g~i  131 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR--------------------GDLAYFRAARRLLQQLHRCGVA--HNDLAKEANWLVQEDGSP  131 (218)
T ss_pred             EEEEeeecCccHHhhhhh--------------------hhHHHHHHHHHHHHHHHHCcCc--cCCCCCcceEEEcCCCCE
Confidence            999999999888643211                    1135678999999999999999  8888 5666331   112


Q ss_pred             HHHHHhcCCCCCCCCCHHHHH
Q psy15820        175 NIMYYCWDKEPNERPNFTELC  195 (230)
Q Consensus       175 ~li~~cl~~dp~~Rpt~~~i~  195 (230)
                      .||.-.++.....|.....++
T Consensus       132 ~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274        132 AVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             EEEECCCceecCCcchHHHHH
Confidence            244444444333455433333

>KOG4158|consensus

Probab=99.06  E-value=4.7e-10  Score=90.59  Aligned_cols=177  Identities=15%  Similarity=0.232  Sum_probs=123.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccC--CCCC----------------------------ceEEEEEecCCc----
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGID--GREG----------------------------PCIVAVKTLKEN----   60 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~----------------------------~~~vavK~~~~~----   60 (230)
                      +...++|+++..||+|.-..||.+......  -..+                            ....|+|.+-+.    
T Consensus       153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s  232 (598)
T KOG4158|consen  153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS  232 (598)
T ss_pred             ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence            456788999999999999999998765411  0000                            013466665221    


Q ss_pred             CCHHHHHHHHHHHHHH-----------------h----hcCCCCceeeEeeEEecC------------------------
Q psy15820         61 AGERERLDLLQELTVM-----------------K----TLDPHPNVVRLLGCCTEK------------------------   95 (230)
Q Consensus        61 ~~~~~~~~~~~e~~~l-----------------~----~~~~h~niv~l~~~~~~~------------------------   95 (230)
                      .+........+|..-.                 .    .+.+|||||++.++|.+.                        
T Consensus       233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~  312 (598)
T KOG4158|consen  233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA  312 (598)
T ss_pred             chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence            1222233333333211                 0    123599999999988442                        


Q ss_pred             ---CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         96 ---EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                         ..+|+||.-++. +|.+++...              ..+.....-++.|+++|+.|||.+|                
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~--------------~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~Eld  377 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTR--------------HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELD  377 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcC--------------CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEec
Confidence               348999998864 898888763              2566777888999999999999999                


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       378 dD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPF  457 (598)
T KOG4158|consen  378 DDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPF  457 (598)
T ss_pred             CCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcc
Confidence                                                                                            


Q ss_pred             ------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 ------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 ------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                                  ..+.+.+..|+.|++.+.+|+...|+.||.+|++..-....+.-.+..+.
T Consensus       458 Y~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~  519 (598)
T KOG4158|consen  458 YKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMG  519 (598)
T ss_pred             cccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCc
Confidence                        33445567889999999999999999999999998877776654444443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.05  E-value=1.5e-09  Score=82.25  Aligned_cols=117  Identities=16%  Similarity=0.079  Sum_probs=84.3

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH---------------------HHHHHHHHHHHHHhhc
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE---------------------RERLDLLQELTVMKTL   79 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~~   79 (230)
                      |.+.+.||+|+||.||++...      ++..+|+|+++.....                     .....+..|..++..+
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            677889999999999999762      4556999987532100                     1112356788888888


Q ss_pred             CCCC--ceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820         80 DPHP--NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus        80 ~~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      . ++  .++..++.    ...+++|||++|++|.....                   ......++.+++.++.++|..++
T Consensus        91 ~-~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-------------------~~~~~~~~~~i~~~l~~lh~~gi  146 (198)
T cd05144          91 Y-EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV-------------------LEDPEEVLDEILEEIVKAYKHGI  146 (198)
T ss_pred             H-HcCCCCCceeec----CCceEEEEEeCCcchhhccc-------------------cccHHHHHHHHHHHHHHHHHCCC
Confidence            7 66  44444432    45689999999998865421                   12345788899999999999999


Q ss_pred             CCCccCCCCCcC
Q psy15820        158 RDGYRLEKPDHC  169 (230)
Q Consensus       158 ~~~~~~~~p~~~  169 (230)
                      .  |++..|.|+
T Consensus       147 ~--H~Dl~p~Ni  156 (198)
T cd05144         147 I--HGDLSEFNI  156 (198)
T ss_pred             C--cCCCCcccE
Confidence            9  888888775

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.03  E-value=6e-09  Score=83.58  Aligned_cols=127  Identities=28%  Similarity=0.544  Sum_probs=104.2

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHH--HHHHHHHHHHHHhhcCCCC-ceeeEeeEEecCCC
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER--ERLDLLQELTVMKTLDPHP-NVVRLLGCCTEKEP   97 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~~h~-niv~l~~~~~~~~~   97 (230)
                      |.+.+.||.|+||.||.+.+.        ..+++|.+.......  ....+.+|+.++..+. |+ +++++.+.+.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCE
Confidence            678889999999999999885        347889886443332  4678999999999999 66 79999999977777


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      .+++++++.++++.+++.....          ...++......++.|++.++.|+|+.++.  |++.+|.+
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~~H~~~~~--hrd~kp~n  131 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGR----------KGPLSESEALFILAQILSALEYLHSKGII--HRDIKPEN  131 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhccc----------ccCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHH
Confidence            8999999999999977665310          02488899999999999999999999988  88887654

>KOG1166|consensus

Probab=98.98  E-value=1.1e-09  Score=98.30  Aligned_cols=135  Identities=21%  Similarity=0.346  Sum_probs=101.7

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHH--HHHHHHHHHHHhhcCCCCceee
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE--RLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      -...+++....|.|-+.||+|+||.||+|....      +..+|+|+=+.....+.  ..+++..+.  ..+  -+.|..
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~------~~~~alK~e~P~~~WEfYI~~q~~~RLk--~~~--~~~~~~  758 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN------GKLVALKVEKPPNPWEFYICLQVMERLK--PQM--LPSIMH  758 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCC------CcEEEEEeecCCCceeeeehHHHHHhhc--hhh--hcchHH
Confidence            344568889999999999999999999999843      66799998764432221  112222222  111  345666


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCC
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPD  167 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~  167 (230)
                      +..+....+.-+|++||.+.|+|.+++...             ...++..+..++.|++.-+.+||..+|.  |.+.+|.
T Consensus       759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~-------------~~m~e~lv~~~~~qml~ive~lH~~~II--HgDiKPD  823 (974)
T KOG1166|consen  759 ISSAHVFQNASVLVSEYSPYGTLLDLINTN-------------KVMDEYLVMFFSCQMLRIVEHLHAMGII--HGDIKPD  823 (974)
T ss_pred             HHHHHccCCcceeeeeccccccHHHhhccC-------------CCCCchhhhHHHHHHHHHHHHHHhccee--cccCCcc
Confidence            677777778889999999999999999853             3488999999999999999999999999  7677776


Q ss_pred             cC
Q psy15820        168 HC  169 (230)
Q Consensus       168 ~~  169 (230)
                      |+
T Consensus       824 Nf  825 (974)
T KOG1166|consen  824 NF  825 (974)
T ss_pred             ee
Confidence            53

>KOG0665|consensus

Probab=98.96  E-value=7.9e-10  Score=86.63  Aligned_cols=130  Identities=22%  Similarity=0.296  Sum_probs=101.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC-CcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .....+|.-+..+|.|+- .|..+.+     .-.++.|++|.+. .........+..+|..++..+. |+||++++.++.
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D-----~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ft   85 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFD-----QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFT   85 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecch-----hhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccC
Confidence            345667777888888887 6666666     3344558888774 2222334466789999999999 999999999996


Q ss_pred             cCC------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCC
Q psy15820         94 EKE------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPD  167 (230)
Q Consensus        94 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~  167 (230)
                      -..      .+|+|||++. .+|.+.+..               .+.-.++..+++|++.|++|||+.||.  ||+.+|+
T Consensus        86 P~~~l~~~~e~y~v~e~m~-~nl~~vi~~---------------elDH~tis~i~yq~~~~ik~lhs~~Ii--hRdLkPs  147 (369)
T KOG0665|consen   86 PQKTLEEFQEVYLVMELMD-ANLCQVILM---------------ELDHETISYILYQMLCGIKHLHSAGII--HRDLKPS  147 (369)
T ss_pred             ccccHHHHHhHHHHHHhhh-hHHHHHHHH---------------hcchHHHHHHHHHHHHHHHHHHhccee--ecccCcc
Confidence            543      4899999997 489988874               267789999999999999999999999  8988887


Q ss_pred             cC
Q psy15820        168 HC  169 (230)
Q Consensus       168 ~~  169 (230)
                      ++
T Consensus       148 ni  149 (369)
T KOG0665|consen  148 NI  149 (369)
T ss_pred             cc
Confidence            53

>KOG1023|consensus

Probab=98.96  E-value=3.1e-09  Score=89.38  Aligned_cols=67  Identities=25%  Similarity=0.473  Sum_probs=59.9

Q ss_pred             hhcCCCCceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         77 KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        77 ~~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+. |.|+.+++|.+.+++..+.|.+||+.|+|.+.+...            ...+++.....++++|+.||.|||...
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~------------~~~~d~~F~~s~~rdi~~Gl~ylh~s~   68 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE------------DIKLDYFFILSFIRDISKGLAYLHNSP   68 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc------------ccCccHHHHHHHHHHHHHHHHHHhcCc
Confidence            3456 999999999999999999999999999999999873            345888899999999999999999876

>KOG0590|consensus

Probab=98.87  E-value=1.9e-09  Score=94.07  Aligned_cols=119  Identities=26%  Similarity=0.403  Sum_probs=83.6

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEEEec-CCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEE
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFV  100 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~l  100 (230)
                      .....+|.|++|.|+........+......++++ . ...........+..|..+-..+. |+|++..............
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcccchh
Confidence            3567899999997777766543333222233333 2 11111122223666777777888 9999888777776666666


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .||||++ +|+.++...             ..+...++..++.|++.|++|||+.|
T Consensus       399 ~mE~~~~-Dlf~~~~~~-------------~~~~~~e~~c~fKqL~~Gv~y~h~~G  440 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSN-------------GKLTPLEADCFFKQLLRGVKYLHSMG  440 (601)
T ss_pred             hhhcccH-HHHHHHhcc-------------cccchhhhhHHHHHHHHHHHHHHhcC
Confidence            6999999 999998763             24788899999999999999999999

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.83  E-value=1.6e-08  Score=75.72  Aligned_cols=118  Identities=17%  Similarity=0.113  Sum_probs=76.9

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-HHHHH----------------------HHHHHHHHhhcC
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-RERLD----------------------LLQELTVMKTLD   80 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~----------------------~~~e~~~l~~~~   80 (230)
                      ++.||+|+||.||.|...      ++..||+|+++..... .....                      ...|...+..+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~   75 (187)
T cd05119           2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY   75 (187)
T ss_pred             CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence            467999999999999773      3556999988643211 11111                      134555555554


Q ss_pred             CCC--ceeeEeeEEecCCCeEEEEecCCCCCHHH-HHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         81 PHP--NVVRLLGCCTEKEPFFVIMEYVPYGKLQS-FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        81 ~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                       +.  .+.+.++.    ...+++|||++++.+.. .+...               ........++.+++.++.++|. .+
T Consensus        76 -~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---------------~~~~~~~~~~~~~~~~l~~lh~~~~  135 (187)
T cd05119          76 -EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---------------RLLEDPEELYDQILELMRKLYREAG  135 (187)
T ss_pred             -HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh---------------hhcccHHHHHHHHHHHHHHHhhccC
Confidence             22  24444443    23589999999855421 12111               1115677889999999999999 99


Q ss_pred             CCCCccCCCCCcC
Q psy15820        157 VRDGYRLEKPDHC  169 (230)
Q Consensus       157 i~~~~~~~~p~~~  169 (230)
                      +.  |++..|.|+
T Consensus       136 iv--H~Dl~p~Ni  146 (187)
T cd05119         136 LV--HGDLSEYNI  146 (187)
T ss_pred             cC--cCCCChhhE
Confidence            99  888888875

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.81  E-value=2.4e-08  Score=73.85  Aligned_cols=33  Identities=15%  Similarity=0.250  Sum_probs=29.2

Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        172 ELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       172 ~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      ++.+++.+||..+|++|||+.++++.+..+...
T Consensus       140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      140 SFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             hHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            589999999999999999999999988766543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.76  E-value=7.1e-08  Score=69.00  Aligned_cols=114  Identities=14%  Similarity=0.127  Sum_probs=86.6

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC-CceeeEeeEEecCCCeEEE
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH-PNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h-~niv~l~~~~~~~~~~~lv  101 (230)
                      +.+.||+|.++.||++...+       ..+++|..+....   ...+..|+.++..+..+ .+++++++.....+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEecC-------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            35679999999999998743       2389998865432   45688899999999723 5889999888877889999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc---CCCCCccCCCCCc
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR---GVRDGYRLEKPDH  168 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~i~~~~~~~~p~~  168 (230)
                      +||++++.+..+                    +......++.+++.++.+||..   ++.  |.+..|.|
T Consensus        72 ~e~~~g~~~~~~--------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~--H~Dl~~~N  119 (155)
T cd05120          72 MEWIEGETLDEV--------------------SEEEKEDIAEQLAELLAKLHQLPLLVLC--HGDLHPGN  119 (155)
T ss_pred             EEecCCeecccC--------------------CHHHHHHHHHHHHHHHHHHhCCCceEEE--ecCCCcce
Confidence            999998766432                    3445667788999999999985   466  55555544

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.73  E-value=1.5e-07  Score=73.41  Aligned_cols=117  Identities=12%  Similarity=0.165  Sum_probs=80.1

Q ss_pred             eeec-ceeceeEEEeEEeccCCCCCceEEEEEecCCcC------------CHHHHHHHHHHHHHHhhcCCCCce--eeEe
Q psy15820         25 DILG-EGCFGQVWKCEALGIDGREGPCIVAVKTLKENA------------GERERLDLLQELTVMKTLDPHPNV--VRLL   89 (230)
Q Consensus        25 ~~lg-~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~~~~h~ni--v~l~   89 (230)
                      ..|| .|+.|.||.....       +..+++|.+....            .......+.+|+.++..+. |+++  +..+
T Consensus        37 ~~lg~~~g~gtv~~v~~~-------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl  108 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPI  108 (239)
T ss_pred             ceeecCCCCccEEEEEeC-------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeE
Confidence            4566 6777777776553       2237888774211            1123456888999999998 7764  6666


Q ss_pred             eEEecC-CC---eEEEEecCCC-CCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCC
Q psy15820         90 GCCTEK-EP---FFVIMEYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLE  164 (230)
Q Consensus        90 ~~~~~~-~~---~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~  164 (230)
                      +..... ..   .++++|+++| .+|.+++...              .++..    .+.+++.+|.+||+.|+.  |++.
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--------------~l~~~----~~~~i~~~l~~lH~~GI~--HrDl  168 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQEA--------------PLSEE----QWQAIGQLIARFHDAGVY--HADL  168 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--------------CCCHH----HHHHHHHHHHHHHHCCCC--CCCC
Confidence            654332 22   3599999997 6888887541              23433    356899999999999999  8899


Q ss_pred             CCCcC
Q psy15820        165 KPDHC  169 (230)
Q Consensus       165 ~p~~~  169 (230)
                      +|.|+
T Consensus       169 kp~NI  173 (239)
T PRK01723        169 NAHNI  173 (239)
T ss_pred             CchhE
Confidence            99876

>KOG1266|consensus

Probab=98.45  E-value=1.3e-07  Score=74.93  Aligned_cols=71  Identities=25%  Similarity=0.504  Sum_probs=57.8

Q ss_pred             HhhcCCCCceeeEeeEEecC-----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhh
Q psy15820         76 MKTLDPHPNVVRLLGCCTEK-----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQ  150 (230)
Q Consensus        76 l~~~~~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~  150 (230)
                      +-.+- |.||+++..++.+.     ....++.||++.|++.++++.-+.         ....+......+|+.||+.||.
T Consensus       121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~---------~~~a~~~~~wkkw~tqIlsal~  190 (458)
T KOG1266|consen  121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK---------NQKALFQKAWKKWCTQILSALS  190 (458)
T ss_pred             HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH---------hhhhhhHHHHHHHHHHHHhhhh
Confidence            33455 99999999888653     458899999999999999997432         2345778888899999999999


Q ss_pred             hhhhcC
Q psy15820        151 FLSSRG  156 (230)
Q Consensus       151 ~LH~~~  156 (230)
                      |||+..
T Consensus       191 yLhs~~  196 (458)
T KOG1266|consen  191 YLHSCD  196 (458)
T ss_pred             hhhccC
Confidence            999987

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.38  E-value=2.7e-06  Score=65.09  Aligned_cols=114  Identities=19%  Similarity=0.175  Sum_probs=82.2

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCC-CCceeeEeeEEecC---CCeEE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEK---EPFFV  100 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~-h~niv~l~~~~~~~---~~~~l  100 (230)
                      +.|+.|..+.+|++....      +..+++|.............+..|..++..+.. +.++++++.+....   +..++
T Consensus         4 ~~l~~G~~n~~~~v~~~~------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~   77 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY   77 (223)
T ss_pred             eecCCCccceEEEEEecC------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence            568999999999987632      234889987643221234567889999998872 23467777776553   35789


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      +|||++|.++...+..              ..++......++.+++.+|..||+....
T Consensus        78 v~e~i~G~~l~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~  121 (223)
T cd05154          78 VMERVDGRVLRDRLLR--------------PELSPEERRALARALADTLAALHSVDPA  121 (223)
T ss_pred             EEEEeCCEecCCCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhCCChh
Confidence            9999999888654321              1367778889999999999999997643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.32  E-value=3.4e-06  Score=71.48  Aligned_cols=121  Identities=19%  Similarity=0.146  Sum_probs=73.5

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHH--------------------------------------
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER--------------------------------------   66 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--------------------------------------   66 (230)
                      +.||+|++|+||+|..+      +|..||||+.+........                                      
T Consensus       123 ~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             cceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            56999999999999873      3556999998643211100                                      


Q ss_pred             -HHHHHHHHHHhhcC---CCCceeeEeeEEe-cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHH
Q psy15820         67 -LDLLQELTVMKTLD---PHPNVVRLLGCCT-EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF  141 (230)
Q Consensus        67 -~~~~~e~~~l~~~~---~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i  141 (230)
                       -.|.+|...+..+.   .+.+-+.+...+. ..+..+++|||++|++|.++.....            ...   ....+
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~------------~~~---~~~~i  261 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE------------AGL---DRKAL  261 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh------------cCC---CHHHH
Confidence             02344554444432   1333333333332 2345789999999999988765421            012   23345


Q ss_pred             HHHHHh-hhhhhhhcCCCCCccCCCCCc
Q psy15820        142 CYQVAR-GMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus       142 ~~qi~~-gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      +..++. .+..+|..|+.  |+++.|.|
T Consensus       262 a~~~~~~~l~ql~~~g~~--H~D~hPgN  287 (437)
T TIGR01982       262 AENLARSFLNQVLRDGFF--HADLHPGN  287 (437)
T ss_pred             HHHHHHHHHHHHHhCCce--eCCCCccc
Confidence            555555 46788999988  77777764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1240|consensus

Probab=98.15  E-value=6.6e-07  Score=80.88  Aligned_cols=114  Identities=17%  Similarity=0.230  Sum_probs=84.9

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH---HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE---RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ++...+.||++.|=+|.+|++..      | .|++|++-.....   ..-.+.+.|+. ....+ +||++.+.-+.....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~-~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMK-APNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhc-CCcccchHHHHHhhH
Confidence            67888999999999999988732      2 2888988433222   22223344444 44445 999999877776666


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..|||-+|..+ +|++.+..+-             .+...+...|+.|++.||.-+|..|
T Consensus        95 AAylvRqyvkh-nLyDRlSTRP-------------FL~~iEKkWiaFQLL~al~qcH~~g  140 (1431)
T KOG1240|consen   95 AAYLVRQYVKH-NLYDRLSTRP-------------FLVLIEKKWIAFQLLKALSQCHKLG  140 (1431)
T ss_pred             HHHHHHHHHhh-hhhhhhccch-------------HHHHHHHHHHHHHHHHHHHHHHHcC
Confidence            77888888864 8999888742             3677888899999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.08  E-value=2.1e-05  Score=57.69  Aligned_cols=111  Identities=14%  Similarity=0.019  Sum_probs=73.5

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEe
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME  103 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e  103 (230)
                      .+.|+.|.++.||++...       +..+++|.......  ....+..|+.++..+.+...+++++....  ...+++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~-------~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e   71 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-------NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE   71 (170)
T ss_pred             eeecCCcccCceEEEEEC-------CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence            356889999999998763       23489998754321  12245678888888762333455665543  33579999


Q ss_pred             cCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC-----CCCccCCCCCc
Q psy15820        104 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV-----RDGYRLEKPDH  168 (230)
Q Consensus       104 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i-----~~~~~~~~p~~  168 (230)
                      |++|.++...  .                .   ....++.+++.+|..||..++     .  |.+..|.|
T Consensus        72 ~i~G~~l~~~--~----------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~--HgD~~~~N  118 (170)
T cd05151          72 FIEGSELLTE--D----------------F---SDPENLEKIAKLLKKLHSSPLPDLVPC--HNDLLPGN  118 (170)
T ss_pred             ecCCCccccc--c----------------c---cCHHHHHHHHHHHHHHhCCCCCCceee--cCCCCcCc
Confidence            9999877432  0                1   112346789999999999875     5  56666654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.03  E-value=5e-06  Score=71.74  Aligned_cols=90  Identities=14%  Similarity=0.103  Sum_probs=55.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH---------------------------------H
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE---------------------------------R   64 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------~   64 (230)
                      ..+|.. +.||+|++|+||.|..+     .+|+.||||+.+.....                                 +
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~-----~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e  192 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLK-----DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE  192 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEEC-----CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence            445665 68999999999999983     34667999999643110                                 1


Q ss_pred             HHH------HHHHHHHHHhhcC---CCCceeeEeeEEec-CCCeEEEEecCCCCCHHHH
Q psy15820         65 ERL------DLLQELTVMKTLD---PHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSF  113 (230)
Q Consensus        65 ~~~------~~~~e~~~l~~~~---~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~  113 (230)
                      ...      .+.+|...+.++.   .+.+.+.+...+.+ .+...|+|||++|+.+.++
T Consensus       193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~  251 (537)
T PRK04750        193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDV  251 (537)
T ss_pred             HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhH
Confidence            111      1344444443332   13333444343322 3457899999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=98.03  E-value=2.2e-06  Score=78.11  Aligned_cols=72  Identities=17%  Similarity=0.197  Sum_probs=56.5

Q ss_pred             CceeeEeeEE-------ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         83 PNVVRLLGCC-------TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        83 ~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      .||.++++.+       .....+..++||+ +++|.+++...            ...+++..++.++.||+.||.|||++
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~   99 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP------------DRSVDAFECFHVFRQIVEIVNAAHSQ   99 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc------------cccccHHHHHHHHHHHHHHHHHHHhC
Confidence            4666666665       2224577888887 46999999752            23489999999999999999999999


Q ss_pred             CCCCCccCCCCCcC
Q psy15820        156 GVRDGYRLEKPDHC  169 (230)
Q Consensus       156 ~i~~~~~~~~p~~~  169 (230)
                      +|.  |++.+|+|+
T Consensus       100 gIv--HrDlKP~Ni  111 (793)
T PLN00181        100 GIV--VHNVRPSCF  111 (793)
T ss_pred             Cee--eccCCchhE
Confidence            999  999998764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.02  E-value=0.00021  Score=56.84  Aligned_cols=125  Identities=22%  Similarity=0.212  Sum_probs=73.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecC--CcCCHHHHHHHHHHHHHHhhcCC---------CCceeeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK--ENAGERERLDLLQELTVMKTLDP---------HPNVVRL   88 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~~~~---------h~niv~l   88 (230)
                      .+..++.||.|+++.||.+++     ..++..+++|++.  ........+.+.+|.-....+.+         |-.++-.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d-----~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTD-----VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE-----TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEEccccccCCceEEEEEEE-----ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            556789999999999999999     6677789999884  22223345666666655544321         2122222


Q ss_pred             eeEEe---------cC---C-----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhh
Q psy15820         89 LGCCT---------EK---E-----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF  151 (230)
Q Consensus        89 ~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~  151 (230)
                      ++...         ..   +     +.+++|+-++ ++|.+++..-.....      ....+.....+.+..|+++.+++
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~------~~~~l~~~arl~lT~Q~I~lvA~  160 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQ------THSPLAFAARLSLTVQMIRLVAN  160 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTT------TSHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhccc------ccchhHHHHHHHHHHHHHHHHHH
Confidence            22221         11   1     3467777775 599888775221100      01112233344566899999999


Q ss_pred             hhhcC
Q psy15820        152 LSSRG  156 (230)
Q Consensus       152 LH~~~  156 (230)
                      ||+.|
T Consensus       161 Lh~~G  165 (288)
T PF14531_consen  161 LHSYG  165 (288)
T ss_dssp             HHHTT
T ss_pred             Hhhcc
Confidence            99999

>KOG3741|consensus

Probab=98.02  E-value=6.8e-05  Score=63.36  Aligned_cols=117  Identities=15%  Similarity=0.129  Sum_probs=78.4

Q ss_pred             eeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec----CCCeEEEEecCCC-
Q psy15820         33 GQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEYVPY-  107 (230)
Q Consensus        33 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~----~~~~~lv~e~~~~-  107 (230)
                      ...|++..     ..+|..+++|++...... ..-....-++.++++. |+|+|.+.+++..    ...+.+|++|.++ 
T Consensus       290 ~Ttyk~~s-----~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  290 ITTYKATS-----NVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ceeEeeee-----ccCCceeeeeeecccccc-CcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            45677776     567777999999422111 1111224467888999 9999999998863    3458999999874 


Q ss_pred             CCHHHHHHHhhhhh--hccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        108 GKLQSFLRSSRAQR--YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       108 g~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|+++.-......  ...-....+...++..++.++.|+..||.++|+.|
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG  413 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG  413 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC
Confidence            57777654422111  00001112345788999999999999999999999

>KOG1243|consensus

Probab=97.79  E-value=9.4e-05  Score=64.10  Aligned_cols=91  Identities=22%  Similarity=0.344  Sum_probs=72.2

Q ss_pred             CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccc
Q psy15820         46 REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN  125 (230)
Q Consensus        46 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  125 (230)
                      +.++.++.+...+.... .......+.+..++.++ ||||+++++.+...+..|+|+|.+.  .|..++.+         
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------  100 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------
Confidence            34455577777765544 44455677888899999 9999999999999999999999984  68888876         


Q ss_pred             cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       126 ~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                             +....+..-++||+.||.|||+.+
T Consensus       101 -------l~~~~v~~Gl~qIl~AL~FL~~d~  124 (690)
T KOG1243|consen  101 -------LGKEEVCLGLFQILAALSFLNDDC  124 (690)
T ss_pred             -------hHHHHHHHHHHHHHHHHHHHhccC
Confidence                   446677778899999999999665

>KOG0603|consensus

Probab=97.75  E-value=3.8e-06  Score=71.72  Aligned_cols=124  Identities=23%  Similarity=0.370  Sum_probs=91.5

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      .+|+|+||.|+++.-.+.  ...+..+++|+++.. ...........|..++..++.||.++++.-++...+..++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g--~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGG--ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhcc--ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            368999999998644322  344556888887533 11122224556777888887799999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKP  166 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p  166 (230)
                      ..||.+...+...             ..+.+.....+...++-|+.++|..++.  ++..++
T Consensus        79 ~rgg~lft~l~~~-------------~~f~~~~~~~~~aelaLald~lh~l~ii--yrd~k~  125 (612)
T KOG0603|consen   79 LRGGDLFTRLSKE-------------VMFDELDVAFYLAELALALDHLHKLGIA--YRDYKL  125 (612)
T ss_pred             cccchhhhccccC-------------CchHHHHHHHHHHHHHHHHhhcchhHHH--Hhcccc
Confidence            9999887665543             2367788888999999999999999955  444433

>KOG0601|consensus

Probab=97.75  E-value=6.3e-05  Score=64.08  Aligned_cols=137  Identities=18%  Similarity=0.181  Sum_probs=102.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .....+|..+..||.|.|+.++.....    ..++..+++|.+.+. ........-+.|+-+...+..|.+++..+..|.
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r----~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKR----PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeec----CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence            346678888999999999999987742    134445888887543 223232334566666776766999999888777


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcCc
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCR  170 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~~  170 (230)
                      .....++-.|||+++++...+...+             -+.+..++.+..|++.++.++|++...  +.+.+|.++.
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~~~~~-------------~~d~~~~~~~~~q~~~~l~~i~s~~~~--~~d~~psni~  398 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRSVTSQ-------------MLDEDPRLRLTAQILTALNVIHSKLFV--HLDVKPSNIL  398 (524)
T ss_pred             ccccccCchhhhcCcchhhhhHHHH-------------hcCcchhhhhHHHHHhccccccchhhh--ccccccccee
Confidence            7777889999999999877764432             378888999999999999999999988  7777776643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=97.65  E-value=0.00036  Score=52.52  Aligned_cols=125  Identities=14%  Similarity=0.116  Sum_probs=79.2

Q ss_pred             eeeecceeceeEEEeEEeccC-CCCCceEEEEEecCCcC------------CH---------HHHH----HHHHHHHHHh
Q psy15820         24 FDILGEGCFGQVWKCEALGID-GREGPCIVAVKTLKENA------------GE---------RERL----DLLQELTVMK   77 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~-~~~~~~~vavK~~~~~~------------~~---------~~~~----~~~~e~~~l~   77 (230)
                      ...||.|.=+.||.|...... ....+..+|+|+.+...            ..         ..+.    +..+|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357899999999999753210 01124568999875321            00         0011    2348999998


Q ss_pred             hcC-CCCceeeEeeEEecCCCeEEEEecCCCCCHHH-HHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhh-hh
Q psy15820         78 TLD-PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS-FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SS  154 (230)
Q Consensus        78 ~~~-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L-H~  154 (230)
                      ++. ..-+++..+.+    ..-+++|||+.++.+.. .++.              ..++......+..+++.+|..| |.
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--------------~~~~~~~~~~i~~~i~~~l~~l~H~  143 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--------------AKLNDEEMKNAYYQVLSMMKQLYKE  143 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--------------cccCHHHHHHHHHHHHHHHHHHHHh
Confidence            886 23567777765    45689999997654321 1221              1244556677889999999998 89


Q ss_pred             cCCCCCccCCCCCc
Q psy15820        155 RGVRDGYRLEKPDH  168 (230)
Q Consensus       155 ~~i~~~~~~~~p~~  168 (230)
                      .++.  |.+..+.|
T Consensus       144 ~glV--HGDLs~~N  155 (197)
T cd05146         144 CNLV--HADLSEYN  155 (197)
T ss_pred             CCee--cCCCCHHH
Confidence            9999  55555544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0590|consensus

Probab=97.34  E-value=4.7e-05  Score=66.93  Aligned_cols=134  Identities=21%  Similarity=0.302  Sum_probs=98.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ....|.+.+.||+|+|+.+-.......    ....++.|.+... ...........|..+-..+.+|.|++++++.....
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~----~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~   93 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRD----PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP   93 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCC----CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC
Confidence            456777788899999999887665322    2224666766533 23333344455666666666699999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHH-HHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhh-hcCCCCCccCCCCCc
Q psy15820         96 EPFFVIMEYVPYGKLQSFL-RSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS-SRGVRDGYRLEKPDH  168 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH-~~~i~~~~~~~~p~~  168 (230)
                      ...++.++|..++++...+ ...            ....+....-.+..|+..|+.|+| ..++.  +++.+|++
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~------------~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~--h~~ikP~n  154 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPD------------STGTSSSSASRYLPQLNSGLSYLHPENGVT--HRDIKPSN  154 (601)
T ss_pred             cccccccCcccccccccccccCC------------ccCCCCcchhhhhhhhccCccccCcccccc--cCCCCCcc
Confidence            9999999999999998777 321            113566777889999999999999 77777  77777764

>PLN02876 acyl-CoA dehydrogenase

Probab=97.30  E-value=0.0015  Score=60.02  Aligned_cols=116  Identities=17%  Similarity=0.175  Sum_probs=77.1

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCc--eeeEeeEEecC---CCe
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN--VVRLLGCCTEK---EPF   98 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~n--iv~l~~~~~~~---~~~   98 (230)
                      .+.++.|.++.+|+.......   ....+++|+............+.+|.+++..+..|.+  +++++.++.+.   +..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~---~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG---SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC---cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            467899999999987663211   1123667765432222223467899999998853444  47888877654   467


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      |+||||++|..+.+.               ....++......+..+++.+|..||+...
T Consensus       120 flVME~v~G~~~~~~---------------~~~~~~~~~r~~l~~~l~~~La~LH~vd~  163 (822)
T PLN02876        120 FYIMEYLEGRIFVDP---------------KLPGVAPERRRAIYRATAKVLAALHSADV  163 (822)
T ss_pred             eEEEEecCCcccCCc---------------cCCCCCHHHHHHHHHHHHHHHHHHhCCCc
Confidence            899999998544210               01124566777899999999999998753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.24  E-value=0.011  Score=46.82  Aligned_cols=89  Identities=15%  Similarity=0.092  Sum_probs=59.5

Q ss_pred             HHHHHHHHHhhcC-CCCceeeEeeEEec-----CCCeEEEEecCCCC-CHHHHHHHhhhhhhccccCCCCCCCChHHHHH
Q psy15820         68 DLLQELTVMKTLD-PHPNVVRLLGCCTE-----KEPFFVIMEYVPYG-KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS  140 (230)
Q Consensus        68 ~~~~e~~~l~~~~-~h~niv~l~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (230)
                      .+.+|...+..+. ..-.++....+...     ...-++|+|++++. +|.+++....           ....+......
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-----------~~~~~~~~~~~  142 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA-----------TNPPDPRLKRM  142 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc-----------ccCCCHHHHHH
Confidence            3678888887764 12233344444322     22478999999886 7888876421           11245566778


Q ss_pred             HHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820        141 FCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus       141 i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      ++.+++..+.-||..|+.  |.+..+.|+
T Consensus       143 ll~~la~~i~~LH~~Gi~--HgDL~~~Ni  169 (268)
T PRK15123        143 LIKRVATMVRDMHAAGIN--HRDCYICHF  169 (268)
T ss_pred             HHHHHHHHHHHHHHCcCc--cCCCChhhE
Confidence            999999999999999999  555555543

>KOG3087|consensus

Probab=97.22  E-value=0.0073  Score=44.87  Aligned_cols=121  Identities=12%  Similarity=0.115  Sum_probs=81.9

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEec-CCc------CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KEN------AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~-~~~------~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ....+.+|+=+.|+.+.+.+..       ..+|.- ...      ...-.+.+..+|++.+.++. --.|.--.-++.+.
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~-------~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEA-------AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccCCce-------eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEec
Confidence            4566788999999999885532       445542 211      11234567788999999876 44444444455566


Q ss_pred             CCeEEEEecCCC-CCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCcc
Q psy15820         96 EPFFVIMEYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYR  162 (230)
Q Consensus        96 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~  162 (230)
                      ..-.+.|||++| .++.+++...-           ...........++.+|-+.+.-||..++.+|..
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~-----------~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDL  139 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTM-----------EDESEDEGLAELARRIGELIGKLHDNDIIHGDL  139 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHc-----------cCcccchhHHHHHHHHHHHHHHhhhCCeecccc
Confidence            667899999986 47888887642           122333444788999999999999999875553

>KOG0601|consensus

Probab=97.17  E-value=0.0005  Score=58.71  Aligned_cols=132  Identities=22%  Similarity=0.193  Sum_probs=97.6

Q ss_pred             CCcccccCCCeeEeeeecc--eeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820         11 DDKWEVPRQHIKVFDILGE--GCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      ..........+.+...+|.  |.+|.+|.+....   ..++..+|+|.-+.. ..+.....-.+|+.....+..|+|.++
T Consensus       106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~  182 (524)
T KOG0601|consen  106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVR  182 (524)
T ss_pred             CCccchhhhhcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCCCccccccccchhhcccccCccccccc
Confidence            3344566667777888999  9999999877632   334455888874322 222333344567777788878999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHh----hhhhhhhcCCC
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR----GMQFLSSRGVR  158 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~----gl~~LH~~~i~  158 (230)
                      .+..+...+..++-+|+|. .+|..+....            ...++...++.+..+...    ||.++|+..+.
T Consensus       183 ~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~------------~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~  244 (524)
T KOG0601|consen  183 DSPAWEGSGILFIQTELCG-ESLQSYCHTP------------CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIV  244 (524)
T ss_pred             cCcccccCCcceeeecccc-chhHHhhhcc------------cccCCchhhhhHHhhhhhcccccccccCCCccc
Confidence            9999999999999999995 5777766552            233788888899999988    99999999965

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.06  E-value=0.0012  Score=48.52  Aligned_cols=82  Identities=22%  Similarity=0.229  Sum_probs=57.7

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      ..+..+.|++|.+|.||+|.+.+.       .+|+|+-+.+   ..+..+..|..+|..+.+-.--.++|.+..+    +
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~~~-------~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~   88 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWRGG-------EVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYGED----F   88 (201)
T ss_pred             hhhhhhhhhcccccEEEEeeccCc-------eEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEechh----h
Confidence            334567899999999999999654       3888876643   3345688899988888733333456666433    3


Q ss_pred             EEEecCCCCCHHHHHH
Q psy15820        100 VIMEYVPYGKLQSFLR  115 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~  115 (230)
                      +.|||+.|..|.+.-.
T Consensus        89 i~me~i~G~~L~~~~~  104 (201)
T COG2112          89 IRMEYIDGRPLGKLEI  104 (201)
T ss_pred             hhhhhhcCcchhhhhh
Confidence            5599999988876543

>PRK10593 hypothetical protein; Provisional

Probab=97.02  E-value=0.013  Score=47.26  Aligned_cols=109  Identities=11%  Similarity=0.068  Sum_probs=73.7

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC--CceeeEeeEEec---
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH--PNVVRLLGCCTE---   94 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h--~niv~l~~~~~~---   94 (230)
                      ...-.+.||.|..+.||.....+      + .+.+|..+...   ....+..|...+..+..+  ..++++++++..   
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~------~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~   84 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQ------G-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS   84 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCC------C-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence            34445779999999999975421      1 16667644311   124678899988888633  468888887754   


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+..++|||+++++++.+.                  .........+..+++.+|.-||...
T Consensus        85 ~g~~~LVmE~i~G~~~~~~------------------~~~~~~~~~l~~~l~~~La~LH~~~  128 (297)
T PRK10593         85 PGPDVLLLERLRGVSVEAP------------------ARTPERWEQLKDQIVEGLLAWHRID  128 (297)
T ss_pred             CCCeEEEEeccCCEecCCC------------------CCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            3668999999999877541                  0223344566678889999999853

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=96.94  E-value=0.01  Score=44.01  Aligned_cols=108  Identities=17%  Similarity=0.214  Sum_probs=73.1

Q ss_pred             eecceeceeEEEeEEeccCCCCCceEEEEEec-CCcCC-H-----HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         26 ILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAG-E-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        26 ~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~-~~~~~-~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      .+++|+=+.|+.+.+.+..       +++|.= +.... +     -...+-.+|++++..+. --.|..-+=+..+++..
T Consensus         3 ~i~~GAEa~i~~~~~~g~~-------av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLP-------AVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             hhhCCcceeEEeeeccCcc-------eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCC
Confidence            5678888999998774422       555542 22211 1     12346678999999886 44444444444566778


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCc
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGY  161 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~  161 (230)
                      .++|||++|..|.+.+...                    ...++..+-.-+.-||..|+.+|.
T Consensus        75 ~I~me~I~G~~lkd~l~~~--------------------~~~~~r~vG~~vg~lH~~givHGD  117 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA--------------------RPDLLREVGRLVGKLHKAGIVHGD  117 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc--------------------chHHHHHHHHHHHHHHhcCeecCC
Confidence            8999999998888887652                    245667777778899999988554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.77  E-value=0.012  Score=45.10  Aligned_cols=104  Identities=21%  Similarity=0.269  Sum_probs=74.2

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC-CceeeEeeEEec---CCCeE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH-PNVVRLLGCCTE---KEPFF   99 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h-~niv~l~~~~~~---~~~~~   99 (230)
                      ++.++.|..+.||.....+       ..+++|.....   .....+.+|..++..+..+ ..+++++.....   ....+
T Consensus         2 i~~l~~G~~n~~~~v~~~~-------~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~   71 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-------GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY   71 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-------SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred             CccCCCCCeeeEEEEEECC-------cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence            4678999999999987733       14888987542   4455677888888777523 245667664322   33478


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|++++|..+..   .                .+......++.+++..+..||+..
T Consensus        72 ~~~~~i~g~~~~~---~----------------~~~~~~~~~~~~~~~~l~~lh~~~  109 (239)
T PF01636_consen   72 LLMEYIPGRPLDD---E----------------LSPEQRPELLRQLGRALAQLHQVP  109 (239)
T ss_dssp             EEEEEESSEEHHH---T----------------STHHHHHHHHHHHHHHHHHHHHSH
T ss_pred             EEEEEeccccccc---c----------------ccccccccccccchhhhhhccccc
Confidence            9999999988866   1                566777888899999999999985

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.54  E-value=0.021  Score=44.47  Aligned_cols=101  Identities=12%  Similarity=0.121  Sum_probs=68.2

Q ss_pred             eecceec-eeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         26 ILGEGCF-GQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        26 ~lg~G~~-g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      .|..|.. ..||.....+       ..+.+|......    ...+.+|++++..+..+-.+++++++....+..+++||+
T Consensus         5 ~~~~g~~~~~v~~~~~~~-------~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   73 (244)
T cd05150           5 RVTEGQSGATVYRLDGKN-------PGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSA   73 (244)
T ss_pred             ecCCCCCcCeEEEEcCCC-------CcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEe
Confidence            3455555 6788875522       237888775432    234667888888886455677888887766678999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|.++.....                   ......++.++++.+.-||+..
T Consensus        74 i~G~~l~~~~~-------------------~~~~~~~~~~l~~~l~~lH~i~  106 (244)
T cd05150          74 VPGVPAAALWE-------------------ELEPERLVDALAEALRRLHALP  106 (244)
T ss_pred             eCCccHhHhhc-------------------ccCHHHHHHHHHHHHHHHhcCC
Confidence            99987753321                   1123356788999999999864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.48  E-value=0.036  Score=42.82  Aligned_cols=103  Identities=12%  Similarity=0.069  Sum_probs=69.8

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC-CceeeEeeEEecCCCeEEEEe
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH-PNVVRLLGCCTEKEPFFVIME  103 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h-~niv~l~~~~~~~~~~~lv~e  103 (230)
                      ..||+|..+.||+..  +       ..+++|........   ....+|.+++..+... -.+++.+++....+...++||
T Consensus         7 ~~i~~G~t~~~y~~~--~-------~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTHK--T-------GKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEec--C-------CCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            468999999999732  1       12678877643322   3357788888877522 335677888777777889999


Q ss_pred             cCCCCC-HHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        104 YVPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       104 ~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++|.+ +...+.                 .+......++.++++.+.-||+..
T Consensus        75 ~i~G~~~~~~~~~-----------------~~~~~~~~l~~~la~~l~~lH~~~  111 (226)
T TIGR02172        75 LIVGKRSFSRIIS-----------------DNPSRLEEIAKIFAEMAKKLHSTK  111 (226)
T ss_pred             ecCCccchhhhhc-----------------CCHHHHHHHHHHHHHHHHHHhCCC
Confidence            999863 322221                 234455677888999999999753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.40  E-value=0.11  Score=39.44  Aligned_cols=116  Identities=22%  Similarity=0.262  Sum_probs=74.8

Q ss_pred             CCCeeEeeeecceec-eeEEEeEEeccCCCCCceEEEEEecCC----c-------CCH---------HHHHHHHHHHHHH
Q psy15820         18 RQHIKVFDILGEGCF-GQVWKCEALGIDGREGPCIVAVKTLKE----N-------AGE---------RERLDLLQELTVM   76 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~-g~V~~~~~~~~~~~~~~~~vavK~~~~----~-------~~~---------~~~~~~~~e~~~l   76 (230)
                      ..+++.++.||.|.. |.|++....+.       .+|+|.++.    .       ...         .....|..|++++
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I~g~-------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEIDGR-------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEECCe-------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            379999999999999 99999988543       499999321    0       000         2334688999999


Q ss_pred             hhcC--CCCce--eeEeeEEecC------------------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCC
Q psy15820         77 KTLD--PHPNV--VRLLGCCTEK------------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT  134 (230)
Q Consensus        77 ~~~~--~h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~  134 (230)
                      .+++  ++.++  ++++||..-.                  ....+|-||.+...                      .++
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------------~~~  166 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------------PLQ  166 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------------ccc
Confidence            9886  34455  8899987322                  11345555554322                      022


Q ss_pred             hHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820        135 SRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus       135 ~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      .    .-+.++.+-|..+|..|+.  .++..+.+
T Consensus       167 ~----~~~~~~~~dl~~~~k~gI~--~~Dv~~~n  194 (207)
T PF13095_consen  167 I----RDIPQMLRDLKILHKLGIV--PRDVKPRN  194 (207)
T ss_pred             h----hHHHHHHHHHHHHHHCCee--eccCcccc
Confidence            2    2245677778889999977  55544443

>PRK09902 hypothetical protein; Provisional

Probab=96.21  E-value=0.13  Score=39.29  Aligned_cols=121  Identities=13%  Similarity=0.067  Sum_probs=77.3

Q ss_pred             cceeceeEEEeEEeccCCCCCceEEEEEecCCc--CC---HHHHHHHHHHHHHHhhcC-CCCceeeEeeEEec--C--CC
Q psy15820         28 GEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AG---ERERLDLLQELTVMKTLD-PHPNVVRLLGCCTE--K--EP   97 (230)
Q Consensus        28 g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~---~~~~~~~~~e~~~l~~~~-~h~niv~l~~~~~~--~--~~   97 (230)
                      |+|+-+.|+.-...+.       .+-+|+..+.  .+   +.....|.+|...+..+. ..-++++..-....  +  -.
T Consensus        27 ~rgG~SgV~r~~~~g~-------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~r   99 (216)
T PRK09902         27 RRNGMSGVQCVERNGK-------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWR   99 (216)
T ss_pred             CCCCcceEEEEEeCCc-------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceE
Confidence            5678888888665332       3777876421  11   335568999999999875 12334444422111  1  12


Q ss_pred             eEEEEecCCC-CCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820         98 FFVIMEYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus        98 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      -+||+|-+.+ .+|.+++....           ....+......+..+++..+.-||+.|+.  |..+-+.+
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~-----------~~~~~~~~k~~il~~va~~ia~LH~~Gv~--Hgdly~kh  158 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHA-----------VSPYSDEVRQAMLKAVALAFKKMHSVNRQ--HGCCYVRH  158 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCC-----------cCCcchHHHHHHHHHHHHHHHHHHHCCCc--CCCCCHhh
Confidence            6889997653 57877775521           12356677789999999999999999999  54444433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=95.70  E-value=0.18  Score=38.33  Aligned_cols=88  Identities=16%  Similarity=0.178  Sum_probs=60.3

Q ss_pred             HHHHHHHHHHHhhcC-CCCceeeEeeEEecCC----CeEEEEecCCCC-CHHHHHHHhhhhhhccccCCCCCCCChHHHH
Q psy15820         66 RLDLLQELTVMKTLD-PHPNVVRLLGCCTEKE----PFFVIMEYVPYG-KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT  139 (230)
Q Consensus        66 ~~~~~~e~~~l~~~~-~h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  139 (230)
                      ..+..+|...+..+. ..-.++..+++.....    ..++++|++++. +|.+++....             ..+.....
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-------------~~~~~~~~  121 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-------------QLDPSQRR  121 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-------------ccchhhHH
Confidence            345677777766654 1233445555554322    358999999874 7888887621             14556678


Q ss_pred             HHHHHHHhhhhhhhhcCCCCCccCCCCCc
Q psy15820        140 SFCYQVARGMQFLSSRGVRDGYRLEKPDH  168 (230)
Q Consensus       140 ~i~~qi~~gl~~LH~~~i~~~~~~~~p~~  168 (230)
                      .++.+++..+.-||..|+.  |.+..+.|
T Consensus       122 ~ll~~l~~~i~~lH~~gi~--H~Dl~~~N  148 (206)
T PF06293_consen  122 ELLRALARLIAKLHDAGIY--HGDLNPSN  148 (206)
T ss_pred             HHHHHHHHHHHHHHHCcCC--CCCCCccc
Confidence            8999999999999999999  66655544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=94.85  E-value=0.24  Score=37.09  Aligned_cols=79  Identities=16%  Similarity=0.135  Sum_probs=47.8

Q ss_pred             HHHHHHHHHHHhhcCCC-CceeeEeeEEecCCCeEEEEecCC--CCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHH
Q psy15820         66 RLDLLQELTVMKTLDPH-PNVVRLLGCCTEKEPFFVIMEYVP--YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC  142 (230)
Q Consensus        66 ~~~~~~e~~~l~~~~~h-~niv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~  142 (230)
                      ..+..+|.+.|..+... -++++.+.+.    .-.+||||++  |..+..+....               ++......++
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~---------------~~~~~~~~~~  112 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD---------------LSPEEPKELL  112 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG---------------GGGSTHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc---------------ccchhHHHHH
Confidence            34678899999998723 3677777663    3479999998  65554433221               2244566777


Q ss_pred             HHHHhhhhh-hhhcCCCCCccC
Q psy15820        143 YQVARGMQF-LSSRGVRDGYRL  163 (230)
Q Consensus       143 ~qi~~gl~~-LH~~~i~~~~~~  163 (230)
                      .+++..+.. +|..|+.+|...
T Consensus       113 ~~il~~~~~~~~~~givHGDLs  134 (188)
T PF01163_consen  113 EEILEEIIKMLHKAGIVHGDLS  134 (188)
T ss_dssp             HHHHHHHHHHHHCTTEEESS-S
T ss_pred             HHHHHHHHHHHHhcCceecCCC
Confidence            788885555 579998855443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=94.76  E-value=0.44  Score=40.12  Aligned_cols=79  Identities=19%  Similarity=0.111  Sum_probs=52.5

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-----CC-HHHHHHHHHHHHHHhhcCC--CCceeeEeeEEecC
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-----AG-ERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEK   95 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-----~~-~~~~~~~~~e~~~l~~~~~--h~niv~l~~~~~~~   95 (230)
                      .+.||.|.+..||+....     .++..++||.-...     .. +....+...|.+.|..+..  ..++++++.+.  .
T Consensus        31 ~~elggGn~N~VyrV~~~-----~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDT-----EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeC-----CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C
Confidence            467899999999998873     22234899985311     10 1234566778888876542  34577777773  3


Q ss_pred             CCeEEEEecCCCCC
Q psy15820         96 EPFFVIMEYVPYGK  109 (230)
Q Consensus        96 ~~~~lv~e~~~~g~  109 (230)
                      ...++||||+++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            55789999998644

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=94.74  E-value=0.32  Score=38.61  Aligned_cols=113  Identities=19%  Similarity=0.192  Sum_probs=72.7

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-------------------C--HHHHHHHHHHHHHHhhcC
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-------------------G--ERERLDLLQELTVMKTLD   80 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------------------~--~~~~~~~~~e~~~l~~~~   80 (230)
                      .++..||-|.=+.||.|...      .+.++++|.=+...                   +  ...+....+|.++|..+.
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~  167 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY  167 (304)
T ss_pred             hhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence            46788999999999999873      34458888632110                   0  123445688999999997


Q ss_pred             CC-CceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCC
Q psy15820         81 PH-PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRD  159 (230)
Q Consensus        81 ~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~  159 (230)
                      .. -.|++.+++    +...++||+++|..|...                  ++.......++..|+.-+.-+-..|+.+
T Consensus       168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~------------------r~~~en~~~il~~il~~~~~~~~~GiVH  225 (304)
T COG0478         168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRL------------------RLDVENPDEILDKILEEVRKAYRRGIVH  225 (304)
T ss_pred             hcCCCCCCcccc----ccceeeeehcccceeecc------------------cCcccCHHHHHHHHHHHHHHHHHcCccc
Confidence            33 356666655    567899999998766432                  1223344455555666555555777765


Q ss_pred             Ccc
Q psy15820        160 GYR  162 (230)
Q Consensus       160 ~~~  162 (230)
                      |..
T Consensus       226 GDl  228 (304)
T COG0478         226 GDL  228 (304)
T ss_pred             cCC
Confidence            553

>KOG1033|consensus

Probab=94.70  E-value=0.029  Score=47.75  Aligned_cols=45  Identities=16%  Similarity=0.304  Sum_probs=36.7

Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhh
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQF  151 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~  151 (230)
                      .+++.|++|.-.+|.+++...+          .....+....+.++.|++.|+.|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~----------~~e~~s~s~~~~~~~q~~~~~~y  374 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR----------TGEERSLSLMLDIFKQIAPAVEY  374 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC----------cccccchhHHHHHHHhhccchhh
Confidence            4889999999999999997543          23346777888999999999986

>KOG0606|consensus

Probab=94.55  E-value=0.068  Score=49.49  Aligned_cols=38  Identities=16%  Similarity=0.293  Sum_probs=28.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKT   56 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~   56 (230)
                      ..--..+|..++.|..|+||.||...++     .+...+|+|+
T Consensus        78 ~~p~e~df~~IklisngAygavylvrh~-----~trqrfa~ki  115 (1205)
T KOG0606|consen   78 RAPSESDFNTIKLISNGAYGAVYLVRHK-----ETRQRFAMKI  115 (1205)
T ss_pred             cCCCccccceeEeeccCCCCceeeeecc-----ccccchhhcc
Confidence            3446678899999999999999999884     3344477743

>KOG1033|consensus

Probab=94.04  E-value=0.012  Score=49.88  Aligned_cols=73  Identities=23%  Similarity=0.406  Sum_probs=59.4

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ...+++.+..+|.|+||.|+.+..     +.+...+|||.|..........+..++...+..+. |+++++++..|...
T Consensus        47 ~a~~~e~~~~~~~~g~~~~~~~~n-----~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~fe-h~g~~~~~ha~~~~  119 (516)
T KOG1033|consen   47 EANDFEPGQCLGRGGFGVVFSAQN-----KADENKYAVKRITLKNREESRSRVLREVSSLAEFE-HPGIKRYFHAWYER  119 (516)
T ss_pred             hhccccccccccccCccccCCccc-----cccchhhHHHHhcccchhhhhhhhhccccchhhhc-ccchhhheeceecC
Confidence            456788899999999999999887     44444589999865556677788899999999999 99999988777543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.71  E-value=0.89  Score=35.00  Aligned_cols=103  Identities=19%  Similarity=0.146  Sum_probs=61.7

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.|..|-...+|+......    .+..+++|+...... . .....+|..++..+..+.-.+++++....    .+++||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~----~~~~~vlR~~~~~~~-~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED----NQDAVLVRVYGNKTE-L-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCC----CCCeEEEEEccCCcc-c-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEe
Confidence            5677888889998765210    122478887653211 1 11233678788877534444556554321    389999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      ++|.++....                  +.   ...++.++++.|.-||.....
T Consensus        74 i~G~~l~~~~------------------~~---~~~~~~~la~~l~~lH~~~~~  106 (235)
T cd05157          74 IPGRTLEPED------------------LR---NPKIYRLIARELAKLHSIKPP  106 (235)
T ss_pred             eCCCcCCHHH------------------cc---ChHHHHHHHHHHHHHhccccc
Confidence            9987663211                  11   123567789999999988654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=93.49  E-value=1.6  Score=33.63  Aligned_cols=122  Identities=11%  Similarity=0.120  Sum_probs=66.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHH--H------HHHHHHHHHhhcC--CCCcee
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER--L------DLLQELTVMKTLD--PHPNVV   86 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~------~~~~e~~~l~~~~--~h~niv   86 (230)
                      --.+|+..+.+.......|.+-...       +..+.+|..+.......+  .      ...+.+..+..+.  +.....
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~  101 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA  101 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence            3456666666666666666655442       234888887643211110  0      1122233233332  133333


Q ss_pred             eEeeEEe-----cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCc
Q psy15820         87 RLLGCCT-----EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGY  161 (230)
Q Consensus        87 ~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~  161 (230)
                      .++-+..     .....+++|||++|..|.+...                 +++    .+...+.+++.-||..|+.  |
T Consensus       102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----------------i~e----~~~~ki~~~ikqlH~~G~~--H  158 (229)
T PF06176_consen  102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----------------IDE----DLAEKIVEAIKQLHKHGFY--H  158 (229)
T ss_pred             cceeeeeeeeccceeEEEEEEEEecCeecccchh-----------------cCH----HHHHHHHHHHHHHHHcCCc--c
Confidence            3333222     1234678999999988755421                 222    2345677889999999999  6


Q ss_pred             cCCCCCc
Q psy15820        162 RLEKPDH  168 (230)
Q Consensus       162 ~~~~p~~  168 (230)
                      .++-|.|
T Consensus       159 GD~hpgN  165 (229)
T PF06176_consen  159 GDPHPGN  165 (229)
T ss_pred             CCCCcCc
Confidence            6666655

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035|consensus

Probab=93.45  E-value=0.35  Score=45.64  Aligned_cols=79  Identities=22%  Similarity=0.227  Sum_probs=59.8

Q ss_pred             HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC----eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHH
Q psy15820         64 RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT  139 (230)
Q Consensus        64 ~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  139 (230)
                      .......-|...+..+. |+|++.++.+....-.    ..+..++|...++...+...             ..++....+
T Consensus       224 ~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-------------~~i~~~~~r  289 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-------------GSIPLETLR  289 (1351)
T ss_pred             HHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-------------cccCHHHHH
Confidence            34444556677778888 9999999888765432    33556678888887777763             347888899


Q ss_pred             HHHHHHHhhhhhhhhcC
Q psy15820        140 SFCYQVARGMQFLSSRG  156 (230)
Q Consensus       140 ~i~~qi~~gl~~LH~~~  156 (230)
                      .+..+...|+.|+|+..
T Consensus       290 ~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  290 ILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHhhhHHHHHHhc
Confidence            99999999999999987

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=92.87  E-value=2.8  Score=31.72  Aligned_cols=84  Identities=14%  Similarity=0.252  Sum_probs=53.8

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---------------CHHHHHHHHHHHHHHhhc-----CCCCc
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---------------GERERLDLLQELTVMKTL-----DPHPN   84 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~~-----~~h~n   84 (230)
                      ..||+|+.-.||.--        .....+||++....               .........+|+.-+..+     ..+.+
T Consensus         7 ~~i~~G~~R~cy~HP--------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~   78 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP--------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH   78 (199)
T ss_pred             cccccCCCceEEECC--------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence            468999998888721        22237888886443               011123344455433322     14889


Q ss_pred             eeeEeeEEecCCCeEEEEecCC------CCCHHHHHHH
Q psy15820         85 VVRLLGCCTEKEPFFVIMEYVP------YGKLQSFLRS  116 (230)
Q Consensus        85 iv~l~~~~~~~~~~~lv~e~~~------~g~L~~~l~~  116 (230)
                      |.+++|+..++-...+|+|.+.      ..+|.+++..
T Consensus        79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~  116 (199)
T PF10707_consen   79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE  116 (199)
T ss_pred             cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc
Confidence            9999999999888999999853      2456777654

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG4720|consensus

Probab=92.21  E-value=0.37  Score=38.66  Aligned_cols=117  Identities=19%  Similarity=0.207  Sum_probs=72.4

Q ss_pred             HHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhh
Q psy15820         71 QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQ  150 (230)
Q Consensus        71 ~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~  150 (230)
                      +|+.....++.|..-.++|+-|..+    |++||++|.+|.---                  +   +--+|.++||.-|+
T Consensus       127 ~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~p~~------------------m---r~pki~~lIAr~ma  181 (391)
T KOG4720|consen  127 NEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLEPEH------------------M---REPKIFRLIARRMA  181 (391)
T ss_pred             HHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccChhh------------------c---cChHHHHHHHHHHH
Confidence            4555555665577778999998765    999999998873211                  1   11256778999999


Q ss_pred             hhhhcCCCCCccCCCCCcCc--HHHHHHHHHhcCCCCCC-----CCCHHHHHHHHHHHHhhccccccccCC
Q psy15820        151 FLSSRGVRDGYRLEKPDHCR--RELYNIMYYCWDKEPNE-----RPNFTELCDLLEKLLLNETDYIELERF  214 (230)
Q Consensus       151 ~LH~~~i~~~~~~~~p~~~~--~~~~~li~~cl~~dp~~-----Rpt~~~i~~~l~~~~~~~~~~~~~~~~  214 (230)
                      -+|+.-.. | ..++|.-+-  ..+.+++..-+...+.+     -|++.++-+++..+.+...-...+..|
T Consensus       182 k~H~~~~~-g-~~pkp~lw~km~~f~~lv~~~f~de~~kq~~~~~~~~~~L~~Ei~~l~E~l~~L~sPVVF  250 (391)
T KOG4720|consen  182 KIHSIVAT-G-GNPKPPLWEKMRKFLQLVPTSFEDEINKQNLFDEPSPEDLGEEISKLKEMLSMLKSPVVF  250 (391)
T ss_pred             HhheeccC-C-CCCCCcHHHHHHHHHHhcCchhhcccchhhcccCCCHHHHHHHHHHHHHHHHhhCCCeEE
Confidence            99998544 2 223332221  23334443334334343     478888888888777665555555544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=91.52  E-value=1.4  Score=38.51  Aligned_cols=85  Identities=18%  Similarity=0.152  Sum_probs=51.8

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHH---------------------------------HH----
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE---------------------------------RL----   67 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------------~~----   67 (230)
                      ..|+.++-|+||.|+.+.      |+.||||+.+.......                                 .+    
T Consensus       131 ~PiAsASIaQVH~A~L~s------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         131 EPIASASIAQVHRAVLKS------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             CchhhhhHhhheeEEecC------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            568899999999999943      56699999865321110                                 00    


Q ss_pred             --HHHHHHHHHhh----cCCCCceeeEeeEE-ecCCCeEEEEecCCCCCHHHHHHH
Q psy15820         68 --DLLQELTVMKT----LDPHPNVVRLLGCC-TEKEPFFVIMEYVPYGKLQSFLRS  116 (230)
Q Consensus        68 --~~~~e~~~l~~----~~~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~  116 (230)
                        .+.+|...+..    +...++ +.+..++ ...+.-.|+|||++|-.+.++...
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l  259 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL  259 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHH
Confidence              12334443333    232333 3333333 223556799999999999888544

>KOG1235|consensus

Probab=91.11  E-value=2  Score=37.67  Aligned_cols=30  Identities=20%  Similarity=0.173  Sum_probs=24.0

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN   60 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~   60 (230)
                      +.|+.-+.|+||+|+.++      |..||||+-+..
T Consensus       167 ~piaaASlaQVhrA~L~~------G~~VaVKVQ~P~  196 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN------GEDVAVKVQHPG  196 (538)
T ss_pred             chhhhcchhheEEEEecC------CCEEEEEecCcC
Confidence            568889999999999854      556999987643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=90.99  E-value=0.53  Score=35.27  Aligned_cols=69  Identities=22%  Similarity=0.299  Sum_probs=50.9

Q ss_pred             HHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecCCCCCHHHH---HHHhhhhhhccccCCCCCCCChHHHHHHHHHHHh
Q psy15820         71 QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF---LRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR  147 (230)
Q Consensus        71 ~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  147 (230)
                      .|..++..+...+++++++|.|-.    +++.||...+++...   +..             -...+|..+.+++.+++.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-------------~~~~~w~~R~~iA~~lL~   70 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-------------FLQSPWEQRAKIALQLLE   70 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-------------ccccCHHHHHHHHHHHHH
Confidence            467778888745799999999832    578899987655421   111             012589999999999999


Q ss_pred             hhhhhhhcC
Q psy15820        148 GMQFLSSRG  156 (230)
Q Consensus       148 gl~~LH~~~  156 (230)
                      .+.+++..-
T Consensus        71 ~l~~l~~~~   79 (188)
T PF12260_consen   71 LLEELDHGP   79 (188)
T ss_pred             HHHHHhcCC
Confidence            999998854

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=89.85  E-value=1.6  Score=33.71  Aligned_cols=101  Identities=14%  Similarity=0.105  Sum_probs=61.2

Q ss_pred             eeecceece-eEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC--CceeeEeeEEecC---CCe
Q psy15820         25 DILGEGCFG-QVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH--PNVVRLLGCCTEK---EPF   98 (230)
Q Consensus        25 ~~lg~G~~g-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h--~niv~l~~~~~~~---~~~   98 (230)
                      +.|+.|+.. .||....          .+++|..+...   ....+.+|..++..+..+  -.+..+++.....   +..
T Consensus         3 ~~~~~gG~~n~vy~~~~----------~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~   69 (235)
T cd05155           3 EPVDSGGTDNATFRLGD----------DMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP   69 (235)
T ss_pred             eeccCCCcccceEEcCC----------ceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence            456666665 5887421          16777655321   234678899988877622  1344444443322   235


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      +++|++++|.++....                  ..  ....+..++++.+.-||+....
T Consensus        70 ~~l~~~i~G~~l~~~~------------------~~--~~~~l~~~la~~l~~LH~i~~~  109 (235)
T cd05155          70 WSVYRWLEGETATAAA------------------LS--DPSEFAEDLADFLAALRQIDPS  109 (235)
T ss_pred             eEEEEeecCCCCCccc------------------cC--CHHHHHHHHHHHHHHHhCCCcc
Confidence            8899999998874321                  11  1236778899999999987543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=89.66  E-value=0.33  Score=43.88  Aligned_cols=32  Identities=16%  Similarity=0.199  Sum_probs=28.8

Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      ...++..+.+++..||..||++|||+.+++..
T Consensus       603 ~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h  634 (669)
T cd05610         603 EEKLSVNAQNAIEILLTMDPTKRAGLKELKQH  634 (669)
T ss_pred             cccCCHHHHHHHHHHcccChhHCcCHHHHHhC
Confidence            34678899999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=89.16  E-value=0.3  Score=33.67  Aligned_cols=44  Identities=18%  Similarity=0.223  Sum_probs=30.1

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhh
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT   78 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~   78 (230)
                      ..|+.|+.|+||+|..+.      |..||||+.+..    ....+...+.++..
T Consensus        17 ~PlasASiaQVh~a~l~~------g~~VaVKV~rP~----i~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKD------GEEVAVKVQRPG----IEEQIEADLRILRR   60 (119)
T ss_pred             chhhheehhhheeeeecc------cchhhhhhcchH----HHHHHHHHHHHHHH
Confidence            568999999999999843      455999988643    33344444444443

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=88.92  E-value=1.5  Score=34.28  Aligned_cols=98  Identities=11%  Similarity=0.126  Sum_probs=56.8

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecCC
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVP  106 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~~  106 (230)
                      +..|-.+.+|+....       +..+++|.......... ....+|..++..+..+.-.++++....    -++|+||++
T Consensus         4 ~~~G~tn~~y~~~~~-------~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEHP-------GISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEeC-------CccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence            456777888877532       22377786543211110 124568888887763322344554432    368999999


Q ss_pred             CCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820        107 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus       107 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      |..+...                  .+.   ....+.+++..|.-||+...
T Consensus        72 G~~~~~~------------------~~~---~~~~~~~la~~l~~lH~~~~  101 (256)
T TIGR02721        72 GEVITLD------------------QFV---ALDLLLELAALLHQLHSQPR  101 (256)
T ss_pred             Ccccccc------------------ccc---CchhHHHHHHHHHHHhCCCC
Confidence            8665321                  000   11345788999999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PLN02756 S-methyl-5-thioribose kinase

Probab=86.48  E-value=6.6  Score=33.35  Aligned_cols=109  Identities=15%  Similarity=0.064  Sum_probs=63.2

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc---CCH---HHHHHHHHHHHHHhhcCC--CCceeeEeeEEec
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN---AGE---RERLDLLQELTVMKTLDP--HPNVVRLLGCCTE   94 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~---~~~~~~~~e~~~l~~~~~--h~niv~l~~~~~~   94 (230)
                      ..+.||.|....||+....+       ..++||+-...   .+.   ....+-..|...|.....  ..++++++.++. 
T Consensus        36 ~~~eiggGn~N~VyrV~~~~-------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSS-------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCC-------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            35678999999999976521       12888886511   111   123344455666665431  257788888876 


Q ss_pred             CCCeEEEEecCCC--CCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh
Q psy15820         95 KEPFFVIMEYVPY--GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS  154 (230)
Q Consensus        95 ~~~~~lv~e~~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~  154 (230)
                       +...++||++++  ..+.+-+..              ....+.....+..-++..|-|=.+
T Consensus       108 -d~~vlvME~L~~~~~ilr~~Ll~--------------G~~~p~~a~~ig~~la~tLf~tSd  154 (418)
T PLN02756        108 -TMALIGMRYLEPPHIILRKGLIA--------------GIEYPLLAEHMSDYMAKTLFFTSL  154 (418)
T ss_pred             -CCCEEEEeecCCcceehhhhhcc--------------CCCCHHHHHHHHHHHHHHHhhcch
Confidence             446788999976  234433322              112345555666666666544333

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=86.40  E-value=6.4  Score=31.04  Aligned_cols=116  Identities=19%  Similarity=0.166  Sum_probs=66.9

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHH-----------------------HHHHHHHHHHHHhhc
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER-----------------------ERLDLLQELTVMKTL   79 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~   79 (230)
                      +...|++|.-+.||+|..      .++..+|+|+.+......                       ...+...|...|.++
T Consensus        52 ~~g~istGKEA~Vy~a~~------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~  125 (268)
T COG1718          52 LVGCISTGKEANVYLAET------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRA  125 (268)
T ss_pred             eEeeecCCcceEEEeecc------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345788899999999865      234459999986542211                       112345677777766


Q ss_pred             C-CCCceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cCC
Q psy15820         80 D-PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RGV  157 (230)
Q Consensus        80 ~-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~i  157 (230)
                      . .+-.+++-+.+..    -.|+|||+.....    ...+-         ....+.......+..++++.|.-|-. .++
T Consensus       126 ~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~----pAP~L---------kDv~~e~~e~~~~~~~~v~~~~~l~~~a~L  188 (268)
T COG1718         126 YEAGVRVPEPIAFRN----NVLVMEFIGDDGL----PAPRL---------KDVPLELEEAEGLYEDVVEYMRRLYKEAGL  188 (268)
T ss_pred             HHcCCCCCCceeecC----CeEEEEeccCCCC----CCCCc---------ccCCcCchhHHHHHHHHHHHHHHHHHhcCc
Confidence            4 3455555555542    3599999854311    00000         11123333566667777777777776 566


Q ss_pred             CCCc
Q psy15820        158 RDGY  161 (230)
Q Consensus       158 ~~~~  161 (230)
                      .+|.
T Consensus       189 VHgD  192 (268)
T COG1718         189 VHGD  192 (268)
T ss_pred             cccc
Confidence            6444

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=86.07  E-value=3.2  Score=32.41  Aligned_cols=76  Identities=16%  Similarity=0.273  Sum_probs=48.9

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC--CCCceeeEeeEEecCCCeEEE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~~~~~~~lv  101 (230)
                      .+.+..|..-..|...+.       ...+.+|+-.    ......|..|+.-|..+.  ..-.+.+++.+...++..|+|
T Consensus        21 r~~v~gG~inea~~v~dg-------~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylV   89 (286)
T COG3001          21 REEVSGGDINEAWRLRDG-------TDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLV   89 (286)
T ss_pred             ccccCCccccceeEeecC-------CcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEE
Confidence            344555555555544332       2237777543    344566777777666554  135677888888888999999


Q ss_pred             EecCCCCCH
Q psy15820        102 MEYVPYGKL  110 (230)
Q Consensus       102 ~e~~~~g~L  110 (230)
                      |||++-+.+
T Consensus        90 le~L~~~~~   98 (286)
T COG3001          90 LEYLPTGPL   98 (286)
T ss_pred             EeeccCCCC
Confidence            999987654

>PLN02236 choline kinase

Probab=84.38  E-value=12  Score=30.96  Aligned_cols=113  Identities=17%  Similarity=0.108  Sum_probs=65.2

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..+.+.+ ..+..|-...+|+....+.. ...+..+++++..... .... ...+|..++..+..+.--+++++.+..+ 
T Consensus        35 ~~~~~~i-~~l~gGlTN~~y~v~~~~~~-~~~~~~~v~Ri~g~~t-~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g-  109 (344)
T PLN02236         35 DDEALQV-IPLKGAMTNEVFQIKWPTKE-GNLGRKVLVRIYGEGV-ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG-  109 (344)
T ss_pred             CcCcEEE-EEcCCcccceeEEEEeCCCC-CCCCCeEEEEEccCCC-Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc-
Confidence            3444554 45556888899997653211 1123457888775332 2221 2256777777776333334566666332 


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                         .+.+|+++.++...-                  +.   -..+..+++..|.-+|+..+.
T Consensus       110 ---~v~efi~g~~l~~~~------------------l~---~~~~~~~ia~~L~~lH~~~~~  147 (344)
T PLN02236        110 ---RVEEFIHARTLSAAD------------------LR---DPEISALIAAKLREFHSLDMP  147 (344)
T ss_pred             ---eEEEeeCCCCCCHHH------------------cC---ChHHHHHHHHHHHHHhCCCCC
Confidence               689999776552110                  11   123567899999999997543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=84.24  E-value=0.86  Score=42.08  Aligned_cols=28  Identities=21%  Similarity=0.319  Sum_probs=24.5

Q ss_pred             cHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        170 RRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       170 ~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .+...+++.+||+.+|.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            4567789999999999999999999863

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=82.51  E-value=5.2  Score=32.22  Aligned_cols=77  Identities=17%  Similarity=0.235  Sum_probs=43.5

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC--CCCceeeEeeEEecCCCe
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD--PHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~~~~~~   98 (230)
                      .+-.+.++.|....+|....       ++..+.+|.-..    .....|..|.+-|..+.  ..-.+++.+++....+..
T Consensus        19 i~~~~~v~GG~i~~a~~~~~-------~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~   87 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDT-------DGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA   87 (288)
T ss_dssp             --EEEEE--SSSSEEEEEET-------TS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred             eeeeEecCCCChhheEEEEC-------CCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence            34456788888898888653       223488887642    22234666777666663  256678889888777778


Q ss_pred             EEEEecCCCC
Q psy15820         99 FVIMEYVPYG  108 (230)
Q Consensus        99 ~lv~e~~~~g  108 (230)
                      +|+|||++.+
T Consensus        88 fLlle~l~~~   97 (288)
T PF03881_consen   88 FLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-----
T ss_pred             eEEEEeecCC
Confidence            9999999754

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG0606|consensus

Probab=81.10  E-value=0.47  Score=44.30  Aligned_cols=126  Identities=15%  Similarity=0.157  Sum_probs=77.5

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ++...+.+.+.+-+.+|+++.++.+.-.+..+.     .+.+......  .........++-.++.... +|-++...--
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~-----~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s  872 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHT-----RPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPS  872 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccc-----cchhhhccchhhccccccccCCccCccccCC-CCceecccCC
Confidence            778889999999999999999998776543322     2222221110  0000111122222233333 5666654444


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      +......+|+++|+.+++|...++...             ..+..-...+...+.+++.+||+..+.
T Consensus       873 ~~~rsP~~L~~~~~~~~~~~Skl~~~~-------------~~saepaRs~i~~~vqs~e~L~s~~r~  926 (1205)
T KOG0606|consen  873 FPCRSPLPLVGHYLNGGDLPSKLHNSG-------------CLSAEPARSPILERVQSLESLHSSLRK  926 (1205)
T ss_pred             CCCCCCcchhhHHhccCCchhhhhcCC-------------CcccccccchhHHHHhhhhccccchhh
Confidence            555678999999999999999888642             233344455666788999999998533

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=80.23  E-value=27  Score=28.15  Aligned_cols=102  Identities=12%  Similarity=0.073  Sum_probs=57.0

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCC-CCceeeEeeEE------e
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCC------T   93 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~-h~niv~l~~~~------~   93 (230)
                      ....+.++.|....+|+....      ++ .+++|+........   ....|..++..+.. .-++++++...      .
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~------~~-~~vLK~~~~~~~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~   93 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD------VG-RYILTLYEKRVKAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLST   93 (307)
T ss_pred             ceeccccCCccccceEEEEeC------CC-cEEEEEecCCCCHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence            334566777877889987542      11 27778765332222   23345555555531 11234443321      1


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..+++++|++|..+..                    ...    ..+.++..+|..||...
T Consensus        94 ~~g~~~~l~e~i~G~~~~~--------------------~~~----~~~~~~G~~LA~lH~~~  132 (307)
T TIGR00938        94 LAGKPACLVEFLQGLSVGR--------------------PTA----MHCRPVGEVLAWMHLAG  132 (307)
T ss_pred             cCCeEEEEEEeCCCCCCCC--------------------CCH----HHHHHHHHHHHHHHhhh
Confidence            2355789999999865420                    111    13567888899999865

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	230
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-29
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-29
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-29
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-29
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-29
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-29
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-28
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-28
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-28
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-28
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-28
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-28
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-28
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-27
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-27
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-27
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-27
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-27
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-27
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-27
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-27
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-27
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-27
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-27
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-27
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-26
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-25
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-25
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-24
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-23
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-23
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-23
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-23
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-23
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-23
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-23
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-23
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-23
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-23
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-22
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-22
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-22
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-22
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-22
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-22
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-22
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-22
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-22
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-22
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-22
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-20
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-20
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-20
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-20
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-20
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-20
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-19
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-18
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-18
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-18
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-18
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-18
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-18
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-04
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-04
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-04
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-05
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-04
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-05
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		8e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-04
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-04
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-04
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-04
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-04

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 12  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 70
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 71  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 130
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 161

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 257 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 291

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  124 bits (310), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 61  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 119
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 210

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 306 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 9   DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 67
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 68  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 127
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 158

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 254 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 288

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  124 bits (310), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 13  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 71
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 72  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 131
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 162

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 258 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 292

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  124 bits (310), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 20  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 138
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 169

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 265 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  123 bits (308), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 20  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 138
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 169

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 265 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 5   DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 123
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 154

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  122 bits (306), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 63/151 (41%), Positives = 95/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 20  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  +N
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFN 138
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 169

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 265 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 63/151 (41%), Positives = 94/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D +WE+PR  + +   LGEG FGQV   EA+G+D ++ P     VAVK LK +A E++  
Sbjct: 20  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLD-KDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++      +  YN
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYN 138
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
             H     L+S+DL S  YQVARGM++L+S+
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK 169

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 265 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 94/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D KWE PR  + +   LGEGCFGQV   EA+GID ++ P     VAVK LK++A E++  
Sbjct: 73  DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID-KDKPKEAVTVAVKMLKDDATEKDLS 131
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R    +  Y+
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   +T +DL S  YQ+ARGM++L+S+
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ 222

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 352

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 68/167 (40%), Positives = 100/167 (59%), Gaps = 13/167 (7%)
Query: 1   MNDPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CI 51
           M+ P+L   S      D KWE PR  + +   LGEGCFGQV   EA+GID ++ P     
Sbjct: 3   MDTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID-KDKPKEAVT 61
Query: 52  VAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQ 111
           VAVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 112 SFLRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
            +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 168

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 264 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 298

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 94/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D KWE PR  + +   LGEGCFGQV   EA+GID ++ P     VAVK LK++A E++  
Sbjct: 14  DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID-KDKPKEAVTVAVKMLKDDATEKDLS 72
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR---AQRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R    +  Y+
Sbjct: 73  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 132
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   +T +DL S  YQ+ARGM++L+S+
Sbjct: 133 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ 163

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 259 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 293

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  121 bits (303), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 64/151 (42%), Positives = 94/151 (62%), Gaps = 7/151 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVAVKTLKENAGERERL 67
           D KWE PR  + +   LGEGCFGQV   EA+GID ++ P     VAVK LK++A E++  
Sbjct: 16  DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID-KDKPKEAVTVAVKMLKDDATEKDLS 74
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R    +  Y+
Sbjct: 75  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 134
Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   +T +DL S  YQ+ARGM++L+S+
Sbjct: 135 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ 165

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 261 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 295

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 67/165 (40%), Positives = 98/165 (59%), Gaps = 13/165 (7%)
Query: 3   DPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVA 53
           DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     VA
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVA 71
Query: 54  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
           VK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 114 LRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 132 LRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 65/154 (42%), Positives = 90/154 (58%), Gaps = 12/154 (7%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA   E  DLL
Sbjct: 15  DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR--AQRYYNNM-- 126
            E  V+K ++ HP+V++L G C++  P  +I+EY  YG L+ FLR SR     Y  +   
Sbjct: 75  SEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 127 -------HGKSNSLTSRDLTSFCYQVARGMQFLS 153
                  H    +LT  DL SF +Q+++GMQ+L+
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 16/36 (44%), Positives = 27/36 (75%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++ G+R+E+PD+C  E+Y +M  CW +EP++RP F 
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 65/154 (42%), Positives = 90/154 (58%), Gaps = 12/154 (7%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA   E  DLL
Sbjct: 15  DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR--AQRYYNNM-- 126
            E  V+K ++ HP+V++L G C++  P  +I+EY  YG L+ FLR SR     Y  +   
Sbjct: 75  SEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 127 -------HGKSNSLTSRDLTSFCYQVARGMQFLS 153
                  H    +LT  DL SF +Q+++GMQ+L+
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 16/36 (44%), Positives = 27/36 (75%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++ G+R+E+PD+C  E+Y +M  CW +EP++RP F 
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 65/154 (42%), Positives = 90/154 (58%), Gaps = 12/154 (7%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA   E  DLL
Sbjct: 15  DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR--AQRYYNNM-- 126
            E  V+K ++ HP+V++L G C++  P  +I+EY  YG L+ FLR SR     Y  +   
Sbjct: 75  SEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 127 -------HGKSNSLTSRDLTSFCYQVARGMQFLS 153
                  H    +LT  DL SF +Q+++GMQ+L+
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 16/36 (44%), Positives = 27/36 (75%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++ G+R+E+PD+C  E+Y +M  CW +EP++RP F 
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/166 (40%), Positives = 98/166 (59%), Gaps = 13/166 (7%)
Query: 2   NDPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIV 52
            DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     V
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTV 70
Query: 53  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 112
           AVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ 
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 113 FLRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/165 (40%), Positives = 98/165 (59%), Gaps = 13/165 (7%)
Query: 3   DPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVA 53
           DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     VA
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVA 71
Query: 54  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
           VK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 114 LRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/165 (40%), Positives = 98/165 (59%), Gaps = 13/165 (7%)
Query: 3   DPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVA 53
           DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     VA
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVA 71
Query: 54  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
           VK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 114 LRSSR---AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/166 (40%), Positives = 98/166 (59%), Gaps = 13/166 (7%)
Query: 2   NDPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIV 52
            DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     V
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTV 70
Query: 53  AVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQS 112
           AVK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ 
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 113 FLRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           +LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 67/165 (40%), Positives = 98/165 (59%), Gaps = 13/165 (7%)
Query: 3   DPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVA 53
           DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     VA
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVA 71
Query: 54  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
           VK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 114 LRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  117 bits (294), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 67/165 (40%), Positives = 97/165 (58%), Gaps = 13/165 (7%)
Query: 3   DPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVA 53
           DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     VA
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVA 71
Query: 54  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
           VK LK++A E +  DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +
Sbjct: 72  VKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 114 LRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 63/148 (42%), Positives = 82/148 (55%), Gaps = 3/148 (2%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMH 127
            EL +M  L  H N+V LLG CT   P  VI EY  YG L +FLR  R    +  YN  H
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                L+SRDL  F  QVA+GM FL+S+
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASK 185

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 22/35 (62%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V+DGY++ +P    + +Y+IM  CW  EP  RP F
Sbjct: 282 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 316

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 66/165 (40%), Positives = 97/165 (58%), Gaps = 13/165 (7%)
Query: 3   DPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVA 53
           DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     VA
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVA 71
Query: 54  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
           VK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+ Y   G L+ +
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREY 131
Query: 114 LRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 66/165 (40%), Positives = 97/165 (58%), Gaps = 13/165 (7%)
Query: 3   DPVLNQKS------DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGP---CIVA 53
           DP+L   S      D KWE PR  + +   LGEG FGQV   EA+GID ++ P     VA
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGID-KDKPKEAVTVA 71
Query: 54  VKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
           VK LK++A E++  DL+ E+ +MK +  H N++ LLG CT+  P +VI+ Y   G L+ +
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREY 131
Query: 114 LRSSRA---QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           LR+ R    +  Y+        +T +DL S  YQ+ARGM++L+S+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 25/35 (71%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           +++G+R++KP +C  ELY +M  CW   P++RP F
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/152 (41%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR++++   +LG G FG+V    A GI        VAVK LKE A   ER  L+
Sbjct: 37  DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 96
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            EL +M  L  H N+V LLG CT   P ++I EY  YG L ++LRS R +   + +  ++
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 131 ----------NSLTSRDLTSFCYQVARGMQFL 152
                     N LT  DL  F YQVA+GM+FL
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  110 bits (275), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 60/146 (41%), Positives = 82/146 (56%), Gaps = 1/146 (0%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL-RSSRAQRYYNNMHGK 129
            EL +M  L  H N+V LLG CT   P  VI EY  YG L +FL R SR           
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
           +++L++RDL  F  QVA+GM FL+S+
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFLASK 183

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 22/35 (62%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V+DGY++ +P    + +Y+IM  CW  EP  RP F
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 314

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 59/146 (40%), Positives = 81/146 (55%), Gaps = 1/146 (0%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL-RSSRAQRYYNNMHGK 129
            EL +M  L  H N+V LLG CT   P  VI EY  YG L +FL R SR           
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
           +++ ++RDL  F  QVA+GM FL+S+
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASK 183

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 22/35 (62%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V+DGY++ +P    + +Y+IM  CW  EP  RP F
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 314

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/145 (42%), Positives = 82/145 (56%), Gaps = 2/145 (1%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 82
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRY-YNNMHGKS 130
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +   Y       
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
           + LT   L  + +QVA+GM+FL+SR
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFLASR 167

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 84/145 (57%), Gaps = 4/145 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  + +   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRY-YNNMHGKS 130
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +   Y +++   
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY--K 138
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
           + LT   L  + +QVA+GM+FL+SR
Sbjct: 139 DFLTLEHLIXYSFQVAKGMEFLASR 163

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 258 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 295

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 81/145 (55%), Gaps = 3/145 (2%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            EL +M  L  H N+V LLG CT   P  VI EY  YG L +FLR  +A+   +   G+ 
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKAEADLDKEDGR- 155
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             L  RDL  F  QVA+GM FL+S+
Sbjct: 156 -PLELRDLLHFSSQVAQGMAFLASK 179

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 22/35 (62%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V+DGY++ +P    + +Y+IM  CW  EP  RP F
Sbjct: 276 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 310

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 81/145 (55%), Gaps = 3/145 (2%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 30  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 89
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            EL +M  L  H N+V LLG CT   P  VI EY  YG L +FLR  +A+   +   G+ 
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKAEADLDKEDGR- 147
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             L  RDL  F  QVA+GM FL+S+
Sbjct: 148 -PLELRDLLHFSSQVAQGMAFLASK 171

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 22/35 (62%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V+DGY++ +P    + +Y+IM  CW  EP  RP F
Sbjct: 268 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 302

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 84/145 (57%), Gaps = 4/145 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  + +   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRY-YNNMHGKS 130
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +   Y +++   
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY--K 138
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
           + LT   L  + +QVA+GM+FL+SR
Sbjct: 139 DFLTLEHLICYSFQVAKGMEFLASR 163

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 258 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 295

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 83/147 (56%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 58  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 117
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +     +  +  
Sbjct: 118 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFLASR 204

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 336

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 83/147 (56%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +     +  +  
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASR 167

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 83/147 (56%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +     +  +  
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASR 158

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 290

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  103 bits (257), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 83/147 (56%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +     +  +  
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASR 167

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 83/147 (56%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +     +  +  
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASR 167

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 82/147 (55%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI E+  +G L ++LRS R +     +  +  
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASR 158

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 290

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/146 (41%), Positives = 81/146 (55%), Gaps = 3/146 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  + +   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 22  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 81
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQ--RYYNNMHGK 129
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +   Y       
Sbjct: 82  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLY 141
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            + LT   L  + +QVA+GM+FL+SR
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASR 167

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 299

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 82/147 (55%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI E+  +G L ++LRS R +     +  +  
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASR 158

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 290

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 82/147 (55%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI E+  +G L ++LRS R +     +  +  
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASR 158

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 253 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 290

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 60/147 (40%), Positives = 82/147 (55%), Gaps = 4/147 (2%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 82
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK-- 129
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +        +  
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL 142
Query: 130 -SNSLTSRDLTSFCYQVARGMQFLSSR 155
             + LT   L  + +QVA+GM+FL+SR
Sbjct: 143 YKDFLTLEHLICYSFQVAKGMEFLASR 169

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 264 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 301

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/160 (38%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 23  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 82
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            EL +M  L  H N+V LLG CT   P  VI EY  YG L +FLR     R    M G S
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-----RKAEAMLGPS 137
Query: 131 NS---------------LTSRDLTSFCYQVARGMQFLSSR 155
            +               L  RDL  F  QVA+GM FL+S+
Sbjct: 138 LAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK 177

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/35 (42%), Positives = 22/35 (62%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V+DGY++ +P    + +Y+IM  CW  EP  RP F
Sbjct: 274 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 308

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/150 (42%), Positives = 79/150 (52%), Gaps = 5/150 (3%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 38  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 97
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-----AQRYYNN 125
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R     ++     
Sbjct: 98  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           M     +L   DL SF YQVA+GM FL+S+
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASK 187

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 29/53 (54%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTXXXXXXXXXXXXXTDYI 209
           +++G+R+  P+H   E+Y+IM  CWD +P +RP F              T++I
Sbjct: 284 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 336

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/150 (42%), Positives = 79/150 (52%), Gaps = 5/150 (3%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 38  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 97
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-----AQRYYNN 125
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R     ++     
Sbjct: 98  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           M     +L   DL SF YQVA+GM FL+S+
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASK 187

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 29/53 (54%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTXXXXXXXXXXXXXTDYI 209
           +++G+R+  P+H   E+Y+IM  CWD +P +RP F              T++I
Sbjct: 284 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 336

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/150 (42%), Positives = 79/150 (52%), Gaps = 5/150 (3%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 33  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 92
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-----AQRYYNN 125
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R     ++     
Sbjct: 93  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 152
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           M     +L   DL SF YQVA+GM FL+S+
Sbjct: 153 MEDDELALDLEDLLSFSYQVAKGMAFLASK 182

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 29/53 (54%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTXXXXXXXXXXXXXTDYI 209
           +++G+R+  P+H   E+Y+IM  CWD +P +RP F              T++I
Sbjct: 279 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 331

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/150 (42%), Positives = 79/150 (52%), Gaps = 5/150 (3%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-----AQRYYNN 125
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R     ++     
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           M     +L   DL SF YQVA+GM FL+S+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASK 164

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 29/53 (54%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTXXXXXXXXXXXXXTDYI 209
           +++G+R+  P+H   E+Y+IM  CWD +P +RP F              T++I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 313

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/150 (42%), Positives = 79/150 (52%), Gaps = 5/150 (3%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 31  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 90
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-----AQRYYNN 125
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R     ++     
Sbjct: 91  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 150
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           M     +L   DL SF YQVA+GM FL+S+
Sbjct: 151 MEDDELALDLEDLLSFSYQVAKGMAFLASK 180

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/53 (32%), Positives = 29/53 (54%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTXXXXXXXXXXXXXTDYI 209
           +++G+R+  P+H   E+Y+IM  CWD +P +RP F              T++I
Sbjct: 277 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 329

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 4/144 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+  
Sbjct: 70  EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPP 126
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +++     ++A GM +L+++
Sbjct: 127 P-TLQEMIQMAAEIADGMAYLNAK 149

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 4/144 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L 
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 70
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+  
Sbjct: 71  EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPP 127
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +++     ++A GM +L+++
Sbjct: 128 P-TLQEMIQMAAEIADGMAYLNAK 150

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 4/144 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+  
Sbjct: 70  EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPP 126
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +++     ++A GM +L+++
Sbjct: 127 P-TLQEMIQMAAEIADGMAYLNAK 149

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 4/144 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+  
Sbjct: 70  EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE--AENNPGRPP 126
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +++     ++A GM +L+++
Sbjct: 127 P-TLQEMIQMAAEIADGMAYLNAK 149

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 4/144 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+  
Sbjct: 70  EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPP 126
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +++     ++A GM +L+++
Sbjct: 127 P-TLQEMIQMAAEIADGMAYLNAK 149

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 4/144 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L 
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 66
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+  
Sbjct: 67  EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE--AENNPGRPP 123
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +++     ++A GM +L+++
Sbjct: 124 P-TLQEMIQMAAEIADGMAYLNAK 146

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 4/144 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L 
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+  
Sbjct: 70  EASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPE--AENNPGRPP 126
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
             T +++     ++A GM +L+++
Sbjct: 127 P-TLQEMIQMAAEIADGMAYLNAK 149

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 71  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 128
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 129 SLSK--MIQMAGEIADGMAYLNA 149

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 63  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 120
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 121 SLSK--MIQMAGEIADGMAYLNA 141

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 71  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 128
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 129 SLSK--MIQMAGEIADGMAYLNA 149

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 65  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 122
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 123 SLSK--MIQMAGEIADGMAYLNA 143

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 78  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 135
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 136 SLSK--MIQMAGEIADGMAYLNA 156

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 72  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 129
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 130 SLSK--MIQMAGEIADGMAYLNA 150

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 72  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 129
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 130 SLSK--MIQMAGEIADGMAYLNA 150

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 100 EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 157
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 158 SLSK--MIQMAGEIADGMAYLNA 178

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 69  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 126
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 127 SLSK--MIQMAGEIADGMAYLNA 147

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R +   NN      
Sbjct: 65  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE-MENNPVLAPP 122
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 123 SLSK--MIQMAGEIADGMAYLNA 143

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 83/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R     NN      
Sbjct: 78  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA-MANNPVLAPP 135
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 136 SLSK--MIQMAGEIADGMAYLNA 156

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 83/143 (58%), Gaps = 4/143 (2%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  + H +VVRLLG  ++ +P  VIME +  G L+S+LRS R     NN      
Sbjct: 68  EASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA-MANNPVLAPP 125
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
           SL+   +     ++A GM +L++
Sbjct: 126 SLSK--MIQMAGEIADGMAYLNA 146

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 89/198 (44%), Gaps = 55/198 (27%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE  R+ +K+   LG G FG+V +  A GI        VAVK LKE A   E   L+ E
Sbjct: 21  KWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTE 80
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNN---MH- 127
           L ++  +  H NVV LLG CT++  P  VI+EY  YG L ++L+S R   + N    +H 
Sbjct: 81  LKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHM 140
Query: 128 -------------GKS---NSLTS----------------------------------RD 137
                        GK    +S+TS                                   D
Sbjct: 141 EPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMED 200
Query: 138 LTSFCYQVARGMQFLSSR 155
           L S+ +QVARGM+FLSSR
Sbjct: 201 LISYSFQVARGMEFLSSR 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 23/36 (63%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           +R+G R+  P++   E+Y IM  CW ++P ERP F 
Sbjct: 315 LREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFA 350

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/107 (44%), Positives = 62/107 (57%), Gaps = 1/107 (0%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 14  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 73
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSR 118
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R
Sbjct: 74  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 120

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 305 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 342

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/107 (44%), Positives = 62/107 (57%), Gaps = 1/107 (0%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 16  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 75
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSR 118
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R
Sbjct: 76  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 344

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/141 (37%), Positives = 83/141 (58%), Gaps = 4/141 (2%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           EV R+ I +   LG+G FG V++  A  I   E    VAVKT+ E+A  RER++ L E +
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           VMK    H +VVRLLG  ++ +P  V+ME + +G L+S+LRS R +    N  G+    T
Sbjct: 72  VMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-T 127
Query: 135 SRDLTSFCYQVARGMQFLSSR 155
            +++     ++A GM +L+++
Sbjct: 128 LQEMIQMAAEIADGMAYLNAK 148

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/107 (44%), Positives = 62/107 (57%), Gaps = 1/107 (0%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 82
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSR 118
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 129

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 314 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 351

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/107 (44%), Positives = 62/107 (57%), Gaps = 1/107 (0%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ E
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 73  LTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSR 118
           L ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           R +++G R+  PD+   E+Y  M  CW  EP++RP F+
Sbjct: 312 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 349

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/142 (35%), Positives = 76/142 (53%), Gaps = 14/142 (9%)
Query: 21  IKVFDILGEGCFGQVWKC----EALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           IK  D++GEG FGQV K     + L +D        A+K +KE A + +  D   EL V+
Sbjct: 27  IKFQDVIGEGNFGQVLKARIKKDGLRMDA-------AIKRMKEYASKDDHRDFAGELEVL 79
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR---YYNNMHGKSNSL 133
             L  HPN++ LLG C  +   ++ +EY P+G L  FLR SR       +   +  +++L
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           +S+ L  F   VARGM +LS +
Sbjct: 140 SSQQLLHFAADVARGMDYLSQK 161

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 18/33 (54%), Positives = 25/33 (75%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           GYRLEKP +C  E+Y++M  CW ++P ERP+F 
Sbjct: 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 289

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/142 (35%), Positives = 76/142 (53%), Gaps = 14/142 (9%)
Query: 21  IKVFDILGEGCFGQVWKC----EALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           IK  D++GEG FGQV K     + L +D        A+K +KE A + +  D   EL V+
Sbjct: 24  IKFQDVIGEGNFGQVLKARIKKDGLRMDA-------AIKRMKEYASKDDHRDFAGELEVL 76
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR---YYNNMHGKSNSL 133
             L  HPN++ LLG C  +   ++ +EY P+G L  FLR SR       +   +  +++L
Sbjct: 77  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 136
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           +S+ L  F   VARGM +LS +
Sbjct: 137 SSQQLLHFAADVARGMDYLSQK 158

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 18/33 (54%), Positives = 25/33 (75%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           GYRLEKP +C  E+Y++M  CW ++P ERP+F 
Sbjct: 254 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 286

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/142 (35%), Positives = 76/142 (53%), Gaps = 14/142 (9%)
Query: 21  IKVFDILGEGCFGQVWKC----EALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           IK  D++GEG FGQV K     + L +D        A+K +KE A + +  D   EL V+
Sbjct: 17  IKFQDVIGEGNFGQVLKARIKKDGLRMDA-------AIKRMKEYASKDDHRDFAGELEVL 69
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR---YYNNMHGKSNSL 133
             L  HPN++ LLG C  +   ++ +EY P+G L  FLR SR       +   +  +++L
Sbjct: 70  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 129
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           +S+ L  F   VARGM +LS +
Sbjct: 130 SSQQLLHFAADVARGMDYLSQK 151

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 18/33 (54%), Positives = 25/33 (75%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           GYRLEKP +C  E+Y++M  CW ++P ERP+F 
Sbjct: 247 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 279

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 77/142 (54%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++  L+ H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 83  MEALIISKLN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 135
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 136 SSLAMLDLLHVARDIACGCQYL 157

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 259 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 294

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 77/142 (54%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 96
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++  L+ H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 97  MEALIISKLN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 149
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 150 SSLAMLDLLHVARDIACGCQYL 171

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 273 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 96
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F++ME +  G L+SFLR +R +        + 
Sbjct: 97  MEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR------PSQP 149
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 150 SSLAMLDLLHVARDIACGCQYL 171

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 273 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F++ME +  G L+SFLR +R +        + 
Sbjct: 82  MEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR------PSQP 134
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 135 SSLAMLDLLHVARDIACGCQYL 156

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 49  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 108
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 109 MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 161
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 162 SSLAMLDLLHVARDIACGCQYL 183

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 285 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 320

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 83  MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 135
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 136 SSLAMLDLLHVARDIACGCQYL 157

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 259 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 294

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 63  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 122
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 123 MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 175
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 176 SSLAMLDLLHVARDIACGCQYL 197

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 334

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 23  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 83  MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 135
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 136 SSLAMLDLLHVARDIACGCQYL 157

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 259 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 294

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 39  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 98
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 99  MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 151
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 152 SSLAMLDLLHVARDIACGCQYL 173

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 275 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 310

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 29  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 88
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 89  MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 141
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 142 SSLAMLDLLHVARDIACGCQYL 163

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 265 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 300

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 40  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 99
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 100 MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 152
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 153 SSLAMLDLLHVARDIACGCQYL 174

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 276 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 311

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 82  MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 134
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 135 SSLAMLDLLHVARDIACGCQYL 156

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 14  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 73
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 74  MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 126
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 127 SSLAMLDLLHVARDIACGCQYL 148

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 250 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 285

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E PR +I+    +GEG FG+V++  A G+   E   +VAVK LKE A    + D  +E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS-- 132
           +M   D +PN+V+LLG C   +P  ++ EY+ YG L  FLRS       +  H   ++  
Sbjct: 103 LMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 133 ---------LTSRDLTSFCYQVARGMQFLSSR 155
                    L+  +      QVA GM +LS R
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 19/35 (54%), Positives = 24/35 (68%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           VRDG  L  P++C  ELYN+M  CW K P +RP+F
Sbjct: 289 VRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 323

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 37  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFL 96
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +        + 
Sbjct: 97  MEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR------PSQP 149
Query: 131 NSLTSRDLTSFCYQVARGMQFL 152
           +SL   DL      +A G Q+L
Sbjct: 150 SSLAMLDLLHVARDIACGCQYL 171

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 21/36 (58%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           V  G R++ P +C   +Y IM  CW  +P +RPNF 
Sbjct: 273 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 308

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 82/147 (55%), Gaps = 19/147 (12%)
Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
           +S DKWE+ R  I +   LG G +G+V+    +G+  ++    VAVKTLKE+  E E  +
Sbjct: 22  QSMDKWEMERTDITMKHKLGGGQYGEVY----VGV-WKKYSLTVAVKTLKEDTMEVE--E 74
Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            L+E  VMK +  HPN+V+LLG CT + PF+++ EY+PYG L  +LR    +        
Sbjct: 75  FLKEAAVMKEIK-HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREE------- 126
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSR 155
               +T+  L     Q++  M++L  +
Sbjct: 127 ----VTAVVLLYMATQISSAMEYLEKK 149

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 80/146 (54%), Gaps = 19/146 (13%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S DKWE+ R  I +   LG G FG+V++    G+  ++    VAVKTLKE+  E E  + 
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQFGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EF 54
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q         
Sbjct: 55  LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------- 105
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +++  L     Q++  M++L  +
Sbjct: 106 ---VSAVVLLYMATQISSAMEYLEKK 128

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 81/146 (55%), Gaps = 19/146 (13%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + 
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EF 54
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L  +LR    Q         
Sbjct: 55  LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-------- 105
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +++  L     Q++  M++L  +
Sbjct: 106 ---VSAVVLLYMATQISSAMEYLEKK 128

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 80/144 (55%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 58
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L  +LR    Q           
Sbjct: 59  EAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE---------- 107
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            +++  L     Q++  M++L  +
Sbjct: 108 -VSAVVLLYMATQISSAMEYLEKK 130

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 80/144 (55%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 58
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L  +LR    Q           
Sbjct: 59  EAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE---------- 107
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            +++  L     Q++  M++L  +
Sbjct: 108 -VSAVVLLYMATQISSAMEYLEKK 130

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 27/148 (18%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERL 67
           DKWE+ R  I +   LG G +G+V    WK  +L          VAVKTLKE+  E E  
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEVE-- 261
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
           + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q       
Sbjct: 262 EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE------ 314
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                +++  L     Q++  M++L  +
Sbjct: 315 -----VSAVVLLYMATQISSAMEYLEKK 337

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 63
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L  +LR    Q           
Sbjct: 64  EAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE---------- 112
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 113 -VNAVVLLYMATQISSAMEYLEKK 135

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 59
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I+E++ YG L  +LR    Q           
Sbjct: 60  EAAVMKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE---------- 108
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 109 -VNAVVLLYMATQISSAMEYLEKK 131

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 58
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 59  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 107
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            +++  L     Q++  M++L  +
Sbjct: 108 -VSAVVLLYMATQISSAMEYLEKK 130

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 63
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 64  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 112
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            +++  L     Q++  M++L  +
Sbjct: 113 -VSAVVLLYMATQISSAMEYLEKK 135

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 80/146 (54%), Gaps = 19/146 (13%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + 
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EF 54
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q         
Sbjct: 55  LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------- 105
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +++  L     Q++  M++L  +
Sbjct: 106 ---VSAVVLLYMATQISSAMEYLEKK 128

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 58
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 59  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 107
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            +++  L     Q++  M++L  +
Sbjct: 108 -VSAVVLLYMATQISSAMEYLEKK 130

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 76/148 (51%), Gaps = 27/148 (18%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERL 67
           DKWE+ R  I +   LG G +G+V    WK  +L          VAVKTLKE+  E E  
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEVE-- 300
Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
           + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q       
Sbjct: 301 EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE------ 353
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                + +  L     Q++  M++L  +
Sbjct: 354 -----VNAVVLLYMATQISSAMEYLEKK 376

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 63
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 64  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 112
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 113 -VNAVVLLYMATQISSAMEYLEKK 135

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 19  DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 71
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 72  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 120
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 121 -VNAVVLLYMATQISSAMEYLEKK 143

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 60
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 61  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 109
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 110 -VNAVVLLYMATQISSAMEYLEKK 132

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 60
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 61  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 109
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 110 -VNAVVLLYMATQISSAMEYLEKK 132

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 62
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 63  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 111
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 112 -VNAVVLLYMATQISSAMEYLEKK 134

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 60
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 61  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 109
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 110 -VNAVVLLYMATQISSAMEYLEKK 132

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 63
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 64  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 112
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 113 -VNAVVLLYMATQISSAMEYLEKK 135

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 58
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 59  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 107
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 108 -VNAVVLLYMATQISSAMEYLEKK 130

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 59
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 60  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 108
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 109 -VNAVVLLYMATQISSAMEYLEKK 131

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 11  DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 63
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 64  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 112
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 113 -VNAVVLLYMATQISSAMEYLEKK 135

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 19/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKWE+ R  I +   LG G +G+V++    G+  ++    VAVKTLKE+  E E  + L+
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYE----GV-WKKYSLTVAVKTLKEDTMEVE--EFLK 58
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q           
Sbjct: 59  EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---------- 107
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            + +  L     Q++  M++L  +
Sbjct: 108 -VNAVVLLYMATQISSAMEYLEKK 130

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/144 (34%), Positives = 68/144 (47%), Gaps = 20/144 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ IK+   LG G FG+VW      +        VAVKTLK   G       L+
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVW------MGYYNNSTKVAVKTLK--PGTMSVQAFLE 57
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  +MKTL  H  +VRL    T +EP ++I EY+  G L  FL+S    +          
Sbjct: 58  EANLMKTLQ-HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGK---------- 106
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            +    L  F  Q+A GM ++  +
Sbjct: 107 -VLLPKLIDFSAQIAEGMAYIERK 129

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 7/142 (4%)
Query: 19  QHIKVFDI-----LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           QHIK  +I     LGEG FG+V+  E   +   +   +VAVKTLK+ A +  R D  +E 
Sbjct: 8   QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREA 66
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            ++  L  H ++V+  G C E +P  ++ EY+ +G L  FLR+                L
Sbjct: 67  ELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTEL 125
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
           T   +     Q+A GM +L+S+
Sbjct: 126 TQSQMLHIAQQIAAGMVYLASQ 147

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 39  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 96
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 97  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 143
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 144 VIQLVGMLRGIASGMKYLSDMG 165

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 259 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 295

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 20/145 (13%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D  WE+PR+ IK+   LG G FG+VW      +        VAVKTLK   G       L
Sbjct: 4   DPAWEIPRESIKLVKKLGAGQFGEVW------MGYYNNSTKVAVKTLK--PGTMSVQAFL 55
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           +E  +MKTL  H  +VRL    T++EP ++I E++  G L  FL+S    +         
Sbjct: 56  EEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGK--------- 105
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             +    L  F  Q+A GM ++  +
Sbjct: 106 --VLLPKLIDFSAQIAEGMAYIERK 128

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 15/36 (41%), Positives = 23/36 (63%)
Query: 156 GVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
            +  GYR+ + ++C  ELY+IM  CW ++  ERP F
Sbjct: 222 ALSQGYRMPRMENCPDELYDIMKMCWKEKAEERPTF 257

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 12  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 69
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 70  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 116
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMG 138

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 232 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 268

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 29  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 86
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ             T
Sbjct: 87  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------------FT 133
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMG 155

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 249 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 285

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 7   EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 58
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 59  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 107
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 108 --LTINKLLDMAAQIAEGMAFIEER 130

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 228 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 259

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 56
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 57  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 105
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 106 --LTINKLLDMAAQIAEGMAFIEER 128

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 10  EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 61
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 62  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 110
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 111 --LTINKLLDMAAQIAEGMAFIEER 133

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 231 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 11  EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 62
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 63  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 111
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 112 --LTINKLLDMAAQIAEGMAFIEER 134

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 232 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 263

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 15  EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 66
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 67  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 115
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 116 --LTINKLLDMAAQIAEGMAFIEER 138

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 236 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 267

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 56
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 57  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 105
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 106 --LTINKLLDMAAQIAEGMAFIEER 128

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 11  EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 62
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 63  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 111
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 112 --LTINKLLDMAAQIAEGMAFIEER 134

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 232 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 263

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 13  EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 64
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 65  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 113
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 114 --LTINKLLDMAAQIAEGMAFIEER 136

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 234 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 265

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 56
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 57  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 105
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 106 --LTINKLLDMAAQIAEGMAFIEER 128

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 6   EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 57
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 58  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 106
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 107 --LTINKLLDMAAQIAEGMAFIEER 129

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 227 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 258

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 71/145 (48%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L
Sbjct: 14  EDEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 65
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 66  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 114
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 115 --LTINKLLDMAAQIAEGMAFIEER 137

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 235 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 70/144 (48%), Gaps = 21/144 (14%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L 
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFLA 52
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +          
Sbjct: 53  EANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK---------- 100
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            LT   L     Q+A GM F+  R
Sbjct: 101 -LTINKLLDMAAQIAEGMAFIEER 123

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 221 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 252

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 72/139 (51%), Gaps = 15/139 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   ++K+ +++G G FG+V +   L   G++  C VA+KTLK    ER+R + L E +
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGR-LKAPGKKESC-VAIKTLKGGYTERQRREFLSEAS 69
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   + HPN++RL G  T   P  ++ E++  G L SFLR +  Q             T
Sbjct: 70  IMGQFE-HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ------------FT 116
Query: 135 SRDLTSFCYQVARGMQFLS 153
              L      +A GM++L+
Sbjct: 117 VIQLVGMLRGIASGMRYLA 135

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKW +  + + + + +G G FG+V+         R    +VAVK+ +E      +   LQ
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRL-----RADNTLVAVKSCRETLPPDLKAKFLQ 161
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  ++K    HPN+VRL+G CT+K+P +++ME V  G   +FLR+  A+           
Sbjct: 162 EARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR----------- 209
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            L  + L       A GM++L S+
Sbjct: 210 -LRVKTLLQMVGDAAAGMEYLESK 232

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           DKW +  + + + + +G G FG+V+         R    +VAVK+ +E      +   LQ
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRL-----RADNTLVAVKSCRETLPPDLKAKFLQ 161
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  ++K    HPN+VRL+G CT+K+P +++ME V  G   +FLR+  A+           
Sbjct: 162 EARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR----------- 209
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            L  + L       A GM++L S+
Sbjct: 210 -LRVKTLLQMVGDAAAGMEYLESK 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/143 (35%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 19  QHIKVFDI-----LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
            HIK  DI     LGEG FG+V+  E   +   +   +VAVK LKE A E  R D  +E 
Sbjct: 36  HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREA 94
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR--AQRYYNNMHGKSN 131
            ++  L  H ++VR  G CTE  P  ++ EY+ +G L  FLRS    A+           
Sbjct: 95  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
            L    L +   QVA GM +L+ 
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAG 176

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 72/139 (51%), Gaps = 15/139 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   ++K+ +++G G FG+V +   L   G++  C VA+KTLK    ER+R + L E +
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGR-LKAPGKKESC-VAIKTLKGGYTERQRREFLSEAS 67
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   + HPN++RL G  T   P  ++ E++  G L SFLR +  Q             T
Sbjct: 68  IMGQFE-HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ------------FT 114
Query: 135 SRDLTSFCYQVARGMQFLS 153
              L      +A GM++L+
Sbjct: 115 VIQLVGMLRGIASGMRYLA 133

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/143 (35%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 19  QHIKVFDI-----LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
            HIK  DI     LGEG FG+V+  E   +   +   +VAVK LKE A E  R D  +E 
Sbjct: 13  HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREA 71
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS--RAQRYYNNMHGKSN 131
            ++  L  H ++VR  G CTE  P  ++ EY+ +G L  FLRS    A+           
Sbjct: 72  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 130
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
            L    L +   QVA GM +L+ 
Sbjct: 131 PLGLGQLLAVASQVAAGMVYLAG 153

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/143 (35%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 19  QHIKVFDI-----LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
            HIK  DI     LGEG FG+V+  E   +   +   +VAVK LKE A E  R D  +E 
Sbjct: 7   HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREA 65
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS--RAQRYYNNMHGKSN 131
            ++  L  H ++VR  G CTE  P  ++ EY+ +G L  FLRS    A+           
Sbjct: 66  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 124
Query: 132 SLTSRDLTSFCYQVARGMQFLSS 154
            L    L +   QVA GM +L+ 
Sbjct: 125 PLGLGQLLAVASQVAAGMVYLAG 147

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 67/134 (50%), Gaps = 17/134 (12%)
Query: 21  IKVFDILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
           +K+  ++G G FG+V  C   L + G+     VA+KTLK    E++R D L E ++M   
Sbjct: 35  VKIEQVIGAGEFGEV--CSGHLKLPGKR-EIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 91
Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
           D HPNV+ L G  T+  P  +I E++  G L SFLR +  Q             T   L 
Sbjct: 92  D-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ------------FTVIQLV 138
Query: 140 SFCYQVARGMQFLS 153
                +A GM++L+
Sbjct: 139 GMLRGIAAGMKYLA 152

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ E +  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG 167

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 68/144 (47%), Gaps = 21/144 (14%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ +K+   LG G FG+VW      +        VAVKT+K  +   E    L 
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVW------MATYNKHTKVAVKTMKPGSMSVEA--FLA 59
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMKTL  H  +V+L    T KEP ++I E++  G L  FL+S           G   
Sbjct: 60  EANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD---------EGSKQ 108
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            L    L  F  Q+A GM F+  R
Sbjct: 109 PLPK--LIDFSAQIAEGMAFIEQR 130

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 19/37 (51%), Positives = 24/37 (64%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           R +  GYR+ +P++C  ELYNIM  CW   P ERP F
Sbjct: 223 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 259

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 68/144 (47%), Gaps = 21/144 (14%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ +K+   LG G FG+VW      +        VAVKT+K  +   E    L 
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVW------MATYNKHTKVAVKTMKPGSMSVEA--FLA 226
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMKTL  H  +V+L    T KEP ++I E++  G L  FL+S           G   
Sbjct: 227 EANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD---------EGSKQ 275
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            L    L  F  Q+A GM F+  R
Sbjct: 276 PLPK--LIDFSAQIAEGMAFIEQR 297

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 19/37 (51%), Positives = 24/37 (64%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           R +  GYR+ +P++C  ELYNIM  CW   P ERP F
Sbjct: 380 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 416

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 69/140 (49%), Gaps = 17/140 (12%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           E+    +K+  ++G G FG+V  C   L + G+     VA+KTLK    E++R D L E 
Sbjct: 3   EIDISCVKIEQVIGAGEFGEV--CSGHLKLPGKR-EIFVAIKTLKSGYTEKQRRDFLSEA 59
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           ++M   D HPNV+ L G  T+  P  +I E++  G L SFLR +  Q             
Sbjct: 60  SIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ------------F 106
Query: 134 TSRDLTSFCYQVARGMQFLS 153
           T   L      +A GM++L+
Sbjct: 107 TVIQLVGMLRGIAAGMKYLA 126

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 15/143 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ E +  G L SFLR   AQ             T
Sbjct: 99  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ------------FT 145
Query: 135 SRDLTSFCYQVARGMQFLSSRGV 157
              L      +A GM++LS  G 
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGA 168

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 297

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 68/144 (47%), Gaps = 21/144 (14%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ +K+   LG G FG+VW      +        VAVKT+K  +   E    L 
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVW------MATYNKHTKVAVKTMKPGSMSVEA--FLA 232
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMKTL  H  +V+L    T KEP ++I E++  G L  FL+S           G   
Sbjct: 233 EANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD---------EGSKQ 281
Query: 132 SLTSRDLTSFCYQVARGMQFLSSR 155
            L    L  F  Q+A GM F+  R
Sbjct: 282 PLPK--LIDFSAQIAEGMAFIEQR 303

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 19/37 (51%), Positives = 24/37 (64%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           R +  GYR+ +P++C  ELYNIM  CW   P ERP F
Sbjct: 396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 432

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 77/161 (47%), Gaps = 5/161 (3%)
Query: 1   MNDPVLNQKSDDKW-EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE 59
           M  P++NQ    K  E+    ++  + LGE  FG+V+K    G    E    VA+KTLK+
Sbjct: 7   MEMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 60  NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL--RSS 117
            A    R +   E  +   L  HPNVV LLG  T+ +P  +I  Y  +G L  FL  RS 
Sbjct: 67  KAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 118 RAQR-YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
            +     ++     ++L   D      Q+A GM++LSS  V
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV 166

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+   +I +  ++G G FG+V  C        +    VA+KTLK    E++R D L E +
Sbjct: 12  ELDATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 69
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T+ +P  ++ E +  G L SFLR   AQ             T
Sbjct: 70  IMGQFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ------------FT 116
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      +A GM++LS  G
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMG 138

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/37 (45%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW K+ N RP F
Sbjct: 232 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKF 268

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 69/143 (48%), Gaps = 21/143 (14%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           +WEVPR+ +K+ + LG G FG+VW      +    G   VAVK+LK+  G       L E
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFLAE 54
Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +           
Sbjct: 55  ANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----------- 101
Query: 133 LTSRDLTSFCYQVARGMQFLSSR 155
           LT   L     Q+A GM F+  R
Sbjct: 102 LTINKLLDMAAQIAEGMAFIEER 124

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 222 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 253

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 16/149 (10%)
Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
           L  +   ++ + R+ + +  ILGEG FG+V+  E +  + +     VAVKT K++     
Sbjct: 11  LVPRGSPQYGIAREDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDN 68
Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           +   + E  +MK LD HP++V+L+G   E+EP ++IME  PYG+L  +L  ++       
Sbjct: 69  KEKFMSEAVIMKNLD-HPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNK------- 119
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSS 154
                NSL    L  +  Q+ + M +L S
Sbjct: 120 -----NSLKVLTLVLYSLQICKAMAYLES 143

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/33 (54%), Positives = 22/33 (66%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           G RL KPD C   LY +M  CWD +P++RP FT
Sbjct: 242 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFT 274

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 76/142 (53%), Gaps = 16/142 (11%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           ++ + R+ + +  ILGEG FG+V+  E +  + +     VAVKT K++     +   + E
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 59
Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             +MK LD HP++V+L+G   E+EP ++IME  PYG+L  +L  ++            NS
Sbjct: 60  AVIMKNLD-HPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNK------------NS 105
Query: 133 LTSRDLTSFCYQVARGMQFLSS 154
           L    L  +  Q+ + M +L S
Sbjct: 106 LKVLTLVLYSLQICKAMAYLES 127

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/33 (54%), Positives = 22/33 (66%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           G RL KPD C   LY +M  CWD +P++RP FT
Sbjct: 226 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFT 258

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 76/142 (53%), Gaps = 16/142 (11%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           ++ + R+ + +  ILGEG FG+V+  E +  + +     VAVKT K++     +   + E
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             +MK LD HP++V+L+G   E+EP ++IME  PYG+L  +L  ++            NS
Sbjct: 64  AVIMKNLD-HPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNK------------NS 109
Query: 133 LTSRDLTSFCYQVARGMQFLSS 154
           L    L  +  Q+ + M +L S
Sbjct: 110 LKVLTLVLYSLQICKAMAYLES 131

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 18/33 (54%), Positives = 22/33 (66%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           G RL KPD C   LY +M  CWD +P++RP FT
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFT 262

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 17/140 (12%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           E+    IK+  ++G G FG+V  C   L + G+   C VA+KTLK    +++R D L E 
Sbjct: 10  EIDASCIKIEKVIGVGEFGEV--CSGRLKVPGKREIC-VAIKTLKAGYTDKQRRDFLSEA 66
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           ++M   D HPN++ L G  T+ +P  +I EY+  G L +FLR +  +             
Sbjct: 67  SIMGQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR------------F 113
Query: 134 TSRDLTSFCYQVARGMQFLS 153
           T   L      +  GM++LS
Sbjct: 114 TVIQLVGMLRGIGSGMKYLS 133

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 17/140 (12%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           E+    IK+  ++G G FG+V  C   L + G+   C VA+KTLK    +++R D L E 
Sbjct: 4   EIDASCIKIEKVIGVGEFGEV--CSGRLKVPGKREIC-VAIKTLKAGYTDKQRRDFLSEA 60
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           ++M   D HPN++ L G  T+ +P  +I EY+  G L +FLR +  +             
Sbjct: 61  SIMGQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR------------F 107
Query: 134 TSRDLTSFCYQVARGMQFLS 153
           T   L      +  GM++LS
Sbjct: 108 TVIQLVGMLRGIGSGMKYLS 127

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 69/145 (47%), Gaps = 21/145 (14%)
Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D WEVPR+ +K+ + LG G  G+VW      +    G   VAVK+LK+  G       L
Sbjct: 5   EDAWEVPRETLKLVERLGAGQAGEVW------MGYYNGHTKVAVKSLKQ--GSMSPDAFL 56
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 57  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 105
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             LT   L     Q+A GM F+  R
Sbjct: 106 --LTINKLLDMAAQIAEGMAFIEER 128

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 16/32 (50%), Positives = 22/32 (68%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           GYR+ +PD+C  ELY +M  CW + P +RP F
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 17/140 (12%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           E+    IK+  ++G G FG+V  C   L + G+   C VA+KTLK    +++R D L E 
Sbjct: 25  EIDASCIKIEKVIGVGEFGEV--CSGRLKVPGKREIC-VAIKTLKAGYTDKQRRDFLSEA 81
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           ++M   D HPN++ L G  T+ +P  +I EY+  G L +FLR +  +             
Sbjct: 82  SIMGQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR------------F 128
Query: 134 TSRDLTSFCYQVARGMQFLS 153
           T   L      +  GM++LS
Sbjct: 129 TVIQLVGMLRGIGSGMKYLS 148

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           + P     + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK   
Sbjct: 250 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGT 303
Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
              E    LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    + 
Sbjct: 304 MSPEA--FLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY 359
Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 152
                      L    L     Q+A GM ++
Sbjct: 360 -----------LRLPQLVDMAAQIASGMAYV 379

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 511

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 90
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 91  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 137
Query: 143 YQVARGMQFLSSR 155
            QVA+GM+FL+S+
Sbjct: 138 LQVAKGMKFLASK 150

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           + P     + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK   
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGT 220
Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
              E    LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    + 
Sbjct: 221 MSPE--AFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY 276
Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 152
                      L    L     Q+A GM ++
Sbjct: 277 -----------LRLPQLVDMAAQIASGMAYV 296

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 428

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 97
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 98  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 144
Query: 143 YQVARGMQFLSSR 155
            QVA+GM+FL+S+
Sbjct: 145 LQVAKGMKFLASK 157

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++MEY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           + P     + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK   
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGT 220
Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
              E    LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    + 
Sbjct: 221 MSPE--AFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY 276
Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 152
                      L    L     Q+A GM ++
Sbjct: 277 -----------LRLPQLVDMAAQIASGMAYV 296

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 428

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 93
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 94  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 140
Query: 143 YQVARGMQFLSSR 155
            QVA+GM+FL+S+
Sbjct: 141 LQVAKGMKFLASK 153

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 92
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 93  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 139
Query: 143 YQVARGMQFLSSR 155
            QVA+GM+FL+S+
Sbjct: 140 LQVAKGMKFLASK 152

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP ++++EY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 92
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 93  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 139
Query: 143 YQVARGMQFLSSR 155
            QVA+GM+FL+S+
Sbjct: 140 LQVAKGMKFLASK 152

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP ++++EY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+    I +  ++G G FG+V          RE P  VA+KTLK    E++R D L E +
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELP--VAIKTLKVGYTEKQRRDFLGEAS 75
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++ L G  T+ +P  ++ EY+  G L +FL+ +  Q             T
Sbjct: 76  IMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ------------FT 122
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      ++ GM++LS  G
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMG 144

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 18/37 (48%), Positives = 21/37 (56%)
Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           + V +GYRL  P  C   LY +M  CW KE N RP F
Sbjct: 238 KAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKF 274

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 93
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 94  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 140
Query: 143 YQVARGMQFLSSR 155
            QVA+GM+FL+S+
Sbjct: 141 LQVAKGMKFLASK 153

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 151
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 152 VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 198
Query: 143 YQVARGMQFLSSR 155
            QVA+GM+FL+S+
Sbjct: 199 LQVAKGMKFLASK 211

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 17/137 (12%)
Query: 21  IKVFDILGEGCFGQVWKCEA-LGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
           IK+  ++G G FG+V  C   L + G+     VA+KTLK    E++R D L E ++M   
Sbjct: 45  IKIERVIGAGEFGEV--CSGRLKLPGKRD-VAVAIKTLKVGYTEKQRRDFLCEASIMGQF 101
Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
           D HPNVV L G  T  +P  +++E++  G L +FLR    Q             T   L 
Sbjct: 102 D-HPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ------------FTVIQLV 148
Query: 140 SFCYQVARGMQFLSSRG 156
                +A GM++L+  G
Sbjct: 149 GMLRGIAAGMRYLADMG 165

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           + P     + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK   
Sbjct: 168 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLK--P 219
Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
           G       LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    + 
Sbjct: 220 GNMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY 277
Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 152
                      L    L     Q+A GM ++
Sbjct: 278 -----------LRLPQLVDMAAQIASGMAYV 297

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           + P     + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK   
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGT 220
Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
              E    LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    + 
Sbjct: 221 MSPE--AFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKY 276
Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 152
                      L    L     Q+A GM ++
Sbjct: 277 -----------LRLPQLVDMAAQIASGMAYV 296

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 428

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 2   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 53
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 54  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK--------- 102
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 103 --YLRLPQLVDMAAQIASGMAYV 123

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 221 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 255

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPEA--F 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 21/138 (15%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCI---VAVKTLKENAGERERLDLLQELTVMK 77
           +K   +LG G FG V+K    GI   EG  +   VA+K L E  G +  ++ + E  +M 
Sbjct: 17  LKRVKVLGSGAFGTVYK----GIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 72
Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           ++D HP++VRLLG C       ++ + +P+G L  ++            H   +++ S+ 
Sbjct: 73  SMD-HPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYV------------HEHKDNIGSQL 118
Query: 138 LTSFCYQVARGMQFLSSR 155
           L ++C Q+A+GM +L  R
Sbjct: 119 LLNWCVQIAKGMMYLEER 136

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 21/138 (15%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCI---VAVKTLKENAGERERLDLLQELTVMK 77
           +K   +LG G FG V+K    GI   EG  +   VA+K L E  G +  ++ + E  +M 
Sbjct: 40  LKRVKVLGSGAFGTVYK----GIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 95
Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           ++D HP++VRLLG C       ++ + +P+G L  ++            H   +++ S+ 
Sbjct: 96  SMD-HPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYV------------HEHKDNIGSQL 141
Query: 138 LTSFCYQVARGMQFLSSR 155
           L ++C Q+A+GM +L  R
Sbjct: 142 LLNWCVQIAKGMMYLEER 159

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 21/141 (14%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    LQ
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AFLQ 53
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +           
Sbjct: 54  EAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK----------- 100
Query: 132 SLTSRDLTSFCYQVARGMQFL 152
            L    L     Q+A GM ++
Sbjct: 101 YLRLPQLVDMAAQIASGMAYV 121

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 219 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 253

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 21/141 (14%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ +++   LG G FG+VW      +    G   VA+KTLK      E    L+
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVW------MGTWNGNTKVAIKTLKPGTMSPE--SFLE 53
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  +MK L  H  +V+L    +E EP +++ EY+  G L  FL+            G+  
Sbjct: 54  EAQIMKKLK-HDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKD-----------GEGR 100
Query: 132 SLTSRDLTSFCYQVARGMQFL 152
           +L   +L     QVA GM ++
Sbjct: 101 ALKLPNLVDMAAQVAAGMAYI 121

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+ +M +CW K+P ERP F
Sbjct: 219 VERGYRMPCPQDCPISLHELMIHCWKKDPEERPTF 253

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK +  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKIR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 87
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 88  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 134
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 135 LQVAKGMKYLASK 147

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 91
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 92  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 138
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 139 LQVAKGMKYLASK 151

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 6   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 57
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 58  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGK--------- 106
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 107 --YLRLPQLVDMSAQIASGMAYV 127

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 225 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 259

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 92
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 93  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 139
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 140 LQVAKGMKYLASK 152

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 92
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 93  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 139
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 140 LQVAKGMKYLASK 152

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 6   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 57
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 58  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGK--------- 106
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 107 --YLRLPQLVDMSAQIASGMAYV 127

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 225 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 259

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 110
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 111 VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 157
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 158 LQVAKGMKYLASK 170

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 90
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 91  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 137
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 138 LQVAKGMKYLASK 150

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 111
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 112 VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 158
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 159 LQVAKGMKYLASK 171

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 91
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 92  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 138
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 139 LQVAKGMKYLASK 151

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 89
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 90  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 136
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 137 LQVAKGMKYLASK 149

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELT 74
           + R  + +  ILGEG FG V +      DG      VAVKT+K +N+ +RE  + L E  
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTS--LKVAVKTMKLDNSSQREIEEFLSEAA 88
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPF-----FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
            MK    HPNV+RLLG C E          VI+ ++ YG L ++L        Y+ +   
Sbjct: 89  CMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-------LYSRLETG 140
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +  + L  F   +A GM++LS+R
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNR 166

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/33 (51%), Positives = 24/33 (72%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           G+RL++P+ C  ELY IMY CW  +P +RP F+
Sbjct: 265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 18/133 (13%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +++G G FG V+    L  DG++  C  AVK+L       E    L E  +MK    HPN
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHC--AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 84
Query: 85  VVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           V+ LLG C  +E  P  V++ Y+ +G L++F+R+            ++++ T +DL  F 
Sbjct: 85  VLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN------------ETHNPTVKDLIGFG 131
Query: 143 YQVARGMQFLSSR 155
            QVA+GM++L+S+
Sbjct: 132 LQVAKGMKYLASK 144

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    
Sbjct: 9   AKDAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +         
Sbjct: 61  LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGK--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFL 152
              L    L     Q+A GM ++
Sbjct: 110 --YLRLPQLVDMAAQIASGMAYV 130

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 228 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 262

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 70/146 (47%), Gaps = 4/146 (2%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+    ++  + LGE  FG+V+K    G    E    VA+KTLK+ A    R +   E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL--RSSRAQ-RYYNNMHGKSN 131
           +   L  HPNVV LLG  T+ +P  +I  Y  +G L  FL  RS  +     ++     +
Sbjct: 65  LRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
           +L   D      Q+A GM++LSS  V
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV 149

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 21/141 (14%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    LQ
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AFLQ 52
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK L  H  +V+L    +E EP  ++ EY+  G L  FL+    +           
Sbjct: 53  EAQVMKKLR-HEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGK----------- 99
Query: 132 SLTSRDLTSFCYQVARGMQFL 152
            L    L     Q+A GM ++
Sbjct: 100 YLRLPQLVDMAAQIASGMAYV 120

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW KEP ERP F
Sbjct: 218 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 252

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LL 70
           D  ++P   + + + +G G FG V + E  G D       VAVK L E     ER++  L
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD-------VAVKILMEQDFHAERVNEFL 82
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           +E+ +MK L  HPN+V  +G  T+     ++ EY+  G L   L  S          G  
Sbjct: 83  REVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS----------GAR 131
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             L  R   S  Y VA+GM +L +R
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHNR 156

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LL 70
           D  ++P   + + + +G G FG V + E  G D       VAVK L E     ER++  L
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD-------VAVKILMEQDFHAERVNEFL 82
Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           +E+ +MK L  HPN+V  +G  T+     ++ EY+  G L   L  S          G  
Sbjct: 83  REVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS----------GAR 131
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             L  R   S  Y VA+GM +L +R
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHNR 156

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 21/139 (15%)
Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           WE+PR+ +++   LG+GCFG+VW      +    G   VA+KTLK      E    LQE 
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVW------MGTWNGTTRVAIKTLKPGTMSPE--AFLQEA 53
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +            L
Sbjct: 54  QVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGK-----------YL 100
Query: 134 TSRDLTSFCYQVARGMQFL 152
               L     Q+A GM ++
Sbjct: 101 RLPQLVDMAAQIASGMAYV 119

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 16/35 (45%), Positives = 21/35 (60%)
Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNF 191
           V  GYR+  P  C   L+++M  CW K+P ERP F
Sbjct: 217 VERGYRMPCPPECPESLHDLMCQCWRKDPEERPTF 251

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 19  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 77  -NPHVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHK------------DNIGSQYLLN 122
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 123 WCVQIAKGMNYLEDR 137

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 65/141 (46%), Gaps = 21/141 (14%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+ R+ I +   LG G FG V       +   +G   VAVK +KE  G     +  QE  
Sbjct: 4   ELKREEITLLKELGSGQFGVV------KLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQ 55
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
            M  L  HP +V+  G C+++ P +++ EY+  G L ++LRS          HGK   L 
Sbjct: 56  TMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS----------HGK--GLE 102
Query: 135 SRDLTSFCYQVARGMQFLSSR 155
              L   CY V  GM FL S 
Sbjct: 103 PSQLLEMCYDVCEGMAFLESH 123

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 63/142 (44%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+    I +  I+G G  G+V          R+ P  VA+K LK    ER+R D L E +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP--VAIKALKAGYTERQRRDFLSEAS 102
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T      ++ EY+  G L +FLR+   Q             T
Sbjct: 103 IMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ------------FT 149
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      V  GM++LS  G
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLG 171

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 63/142 (44%), Gaps = 15/142 (10%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+    I +  I+G G  G+V          R+ P  VA+K LK    ER+R D L E +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP--VAIKALKAGYTERQRRDFLSEAS 102
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +M   D HPN++RL G  T      ++ EY+  G L +FLR+   Q             T
Sbjct: 103 IMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ------------FT 149
Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
              L      V  GM++LS  G
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLG 171

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKF 86
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL   + ++Y       
Sbjct: 87  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKY------- 134
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 135 --SLDLASLILYAYQLSTALAYLESK 158

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKF 60
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL   + ++Y       
Sbjct: 61  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKY------- 108
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 109 --SLDLASLILYAYQLSTALAYLESK 132

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKF 61
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL   + ++Y       
Sbjct: 62  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKY------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 110 --SLDLASLILYAYQLSTALAYLESK 133

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL+  +           
Sbjct: 439 LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKF---------- 486
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 487 --SLDLASLILYAYQLSTALAYLESK 510

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL+  +           
Sbjct: 439 LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKF---------- 486
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 487 --SLDLASLILYAYQLSTALAYLESK 510

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKF 58
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL   + ++Y       
Sbjct: 59  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKY------- 106
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 107 --SLDLASLILYAYQLSTALAYLESK 130

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKF 63
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL   + ++Y       
Sbjct: 64  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKY------- 111
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 112 --SLDLASLILYAYQLSTALAYLESK 135

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKF 58
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL   + ++Y       
Sbjct: 59  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKY------- 106
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 107 --SLDLASLILYAYQLSTALAYLESK 130

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 73/142 (51%), Gaps = 16/142 (11%)
Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   LQE 
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             M+  D HP++V+L+G  TE  P ++IME    G+L+SFL   + ++Y         SL
Sbjct: 60  LTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKY---------SL 105
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
               L  + YQ++  + +L S+
Sbjct: 106 DLASLILYAYQLSTALAYLESK 127

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 22  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 80  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 125
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 126 WCVQIAKGMNYLEDR 140

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 20  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 78  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 123
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 124 WCVQIAKGMNYLEDR 138

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 22  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 80  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 125
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 126 WCVQIAKGMNYLEDR 140

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 20  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 78  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 123
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 124 WCVQIAKGMNYLEDR 138

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 18  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 76  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 121
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 122 WCVQIAKGMNYLEDR 136

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 21  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 79  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 124
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 125 WCVQIAKGMNYLEDR 139

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 19  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 77  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 122
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 123 WCVQIAKGMNYLEDR 137

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 72/135 (53%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 20  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 78  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 123
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 124 WCVQIAKGMNYLEDR 138

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKF 58
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL+             +
Sbjct: 59  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV------------R 104
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 105 KFSLDLASLILYAYQLSTALAYLESK 130

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 16/146 (10%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V   + + +        VA+KT K    +  R   
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVH--QGIYMSPENPAMAVAIKTCKNCTSDSVREKF 58
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  TE  P ++IME    G+L+SFL+             +
Sbjct: 59  LQEALTMRQFD-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV------------R 104
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
             SL    L  + YQ++  + +L S+
Sbjct: 105 KFSLDLASLILYAYQLSTALAYLESK 130

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 14/129 (10%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           ++G G FG+V+K       G++    VA+KTLK    E++R+D L E  +M     H N+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKK-EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH-NI 108
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           +RL G  ++ +P  +I EY+  G L  FLR             K    +   L      +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE------------KDGEFSVLQLVGMLRGI 156
Query: 146 ARGMQFLSS 154
           A GM++L++
Sbjct: 157 AAGMKYLAN 165

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 65/130 (50%), Gaps = 21/130 (16%)
Query: 26  ILGEGCFGQVWKCEALGI---DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH 82
           +LG G FG V+K    GI   DG      VA+K L+EN   +   ++L E  VM  +   
Sbjct: 24  VLGSGAFGTVYK----GIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-S 78
Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           P V RLLG C       ++ + +PYG L   +R +R +            L S+DL ++C
Sbjct: 79  PYVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGR------------LGSQDLLNWC 125
Query: 143 YQVARGMQFL 152
            Q+A+GM +L
Sbjct: 126 MQIAKGMSYL 135

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 18  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGXLLDYVREHK------------DNIGSQYLLN 121
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 122 WCVQIAKGMNYLEDR 136

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 19  QHIKVFDI-----LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           QHIK  DI     LGEG FG+V+  E   +   +   +VAVK LK+      R D  +E 
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREA 68
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKS 130
            ++  L  H ++V+  G C + +P  ++ EY+ +G L  FLR+                 
Sbjct: 69  ELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSR 155
             L    +     Q+A GM +L+S+
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQ 152

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 17/148 (11%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D 
Sbjct: 2   SRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DF 59
Query: 70  LQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
            +E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +       
Sbjct: 60  EREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------- 111
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                +    L  +  Q+ +GM++L ++
Sbjct: 112 -----IDHIKLLQYTSQICKGMEYLGTK 134

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 28  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 86  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 131
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 132 WCVQIAKGMNYLEDR 146

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 43  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 101 -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 146
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 147 WCVQIAKGMNYLEDR 161

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 24  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 82  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 127
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 128 WCVQIAKGMNYLEDR 142

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 20  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 78  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 123
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 124 WCVQIAKGMNYLEDR 138

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 18  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 121
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 122 WCVQIAKGMNYLEDR 136

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 20  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 78  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 123
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 124 WCVQIAKGMNYLEDR 138

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +L  G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 25  KKIKVLSSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +IM+ +P+G L  ++R  +            +++ S+ L +
Sbjct: 83  -NPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHK------------DNIGSQYLLN 128
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 129 WCVQIAKGMNYLEDR 143

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 21  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 79  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 124
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 125 WCVQIAKGMNYLEDR 139

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 12  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 70  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 115
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 116 WCVQIAKGMNYLEDR 130

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 21  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 79  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 124
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 125 WCVQIAKGMNYLEDR 139

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 25  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 83  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 128
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 129 WCVQIAKGMNYLEDR 143

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 21  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 79  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 124
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 125 WCVQIAKGMNYLEDR 139

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 25  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 83  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 128
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 129 WCVQIAKGMNYLEDR 143

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 18  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 121
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 122 WCVQIAKGMNYLEDR 136

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 63
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+ + A+R        
Sbjct: 64  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-AHAER-------- 113
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 114 ---IDHIKLLQYTSQICKGMEYLGTK 136

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 18  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 121
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 122 WCVQIAKGMNYLEDR 136

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 2   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 59
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 60  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 109
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 110 ---IDHIKLLQYTSQICKGMEYLGTK 132

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 6   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 63
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 64  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 113
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 114 ---IDHIKLLQYTSQICKGMEYLGTK 136

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 8   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 65
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 66  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 115
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 116 ---IDHIKLLQYTSQICKGMEYLGTK 138

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 10  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 67
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 68  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 117
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 118 ---IDHIKLLQYTSQICKGMEYLGTK 140

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 60
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 61  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 110
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 111 ---IDHIKLLQYTSQICKGMEYLGTK 133

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 9   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 66
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 67  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 116
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 117 ---IDHIKLLQYTSQICKGMEYLGTK 139

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 60
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 61  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 110
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 111 ---IDHIKLLQYTSQICKGMEYLGTK 133

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 60
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 61  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 110
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 111 ---IDHIKLLQYTSQICKGMEYLGTK 133

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 7   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 64
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 65  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 114
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 115 ---IDHIKLLQYTSQICKGMEYLGTK 137

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 1   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 58
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 59  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 108
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 109 ---IDHIKLLQYTSQICKGMEYLGTK 131

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 34  DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 91
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 92  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 141
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 142 ---IDHIKLLQYTSQICKGMEYLGTK 164

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 17/148 (11%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S +  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D 
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DF 76
Query: 70  LQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
            +E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +       
Sbjct: 77  EREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------- 128
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                +    L  +  Q+ +GM++L ++
Sbjct: 129 -----IDHIKLLQYTSQICKGMEYLGTK 151

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 15  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 73  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 118
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A GM +L  R
Sbjct: 119 WCVQIAEGMNYLEDR 133

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 17/148 (11%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S +  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D 
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DF 76
Query: 70  LQELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
            +E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +       
Sbjct: 77  EREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------- 128
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                +    L  +  Q+ +GM++L ++
Sbjct: 129 -----IDHIKLLQYTSQICKGMEYLGTK 151

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 5   VLNQKSDDKWEVPRQHIKVFDILGEGCFGQV-WKCEALGIDGREGPCIVAVKTLKENAGE 63
           VL Q   D     ++++K    LGEG FG+V   C     DG     +VAVK LK +AG 
Sbjct: 17  VLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE--MVAVKALKADAGP 74
Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQR 121
           + R    QE+ +++TL  H ++++  GCC +       ++MEYVP G L+ +L       
Sbjct: 75  QHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL------- 126
Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                    +S+    L  F  Q+  GM +L ++
Sbjct: 127 -------PRHSIGLAQLLLFAQQICEGMAYLHAQ 153

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +L  G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 18  KKIKVLSSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 121
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 122 WCVQIAKGMNYLEDR 136

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +L  G FG V+K   L I +G +    VA+K L+E    +   ++L E  VM ++D
Sbjct: 25  KKIKVLSSGAFGTVYK--GLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 83  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 128
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 129 WCVQIAKGMNYLEDR 143

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 22  KVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           K   +LG G FG V+K   L I +G +    VA+  L+E    +   ++L E  VM ++D
Sbjct: 52  KKIKVLGSGAFGTVYK--GLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            +P+V RLLG C       +I + +P+G L  ++R  +            +++ S+ L +
Sbjct: 110 -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK------------DNIGSQYLLN 155
Query: 141 FCYQVARGMQFLSSR 155
           +C Q+A+GM +L  R
Sbjct: 156 WCVQIAKGMNYLEDR 170

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 17/146 (11%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E  R D  +
Sbjct: 6   DPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGE-VVAVKKLQHSTEEHLR-DFER 63
Query: 72  ELTVMKTLDPHPNVVRLLGCC--TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IME++PYG L+ +L+  + +         
Sbjct: 64  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--------- 113
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
              +    L  +  Q+ +GM++L ++
Sbjct: 114 ---IDHIKLLQYTSQICKGMEYLGTK 136

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D     ++ +K    LGEG FG+V  C     +G      VAVK+LK  +G     DL +
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKK 72
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ +++ L  H N+V+  G CTE       +IME++P G L+ +L  ++           
Sbjct: 73  EIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK----------- 120
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            N +  +    +  Q+ +GM +L SR
Sbjct: 121 -NKINLKQQLKYAVQICKGMDYLGSR 145

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D     ++ +K    LGEG FG+V  C     +G      VAVK+LK  +G     DL +
Sbjct: 2   DPTHFEKRFLKRIRDLGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIADLKK 60
Query: 72  ELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ +++ L  H N+V+  G CTE       +IME++P G L+ +L  ++           
Sbjct: 61  EIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK----------- 108
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            N +  +    +  Q+ +GM +L SR
Sbjct: 109 -NKINLKQQLKYAVQICKGMDYLGSR 133

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 21/140 (15%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KW +    +     +G G FG V     L  D       VA+KT++E A   E  D ++E
Sbjct: 4   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE--DFIEE 55
Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             VM  L  HP +V+L G C E+ P  ++ E++ +G L  +LR+ R              
Sbjct: 56  AEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL------------ 102
Query: 133 LTSRDLTSFCYQVARGMQFL 152
             +  L   C  V  GM +L
Sbjct: 103 FAAETLLGMCLDVCEGMAYL 122

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQV-WKCEALGIDGREGPCIVAVKTLKENAGER 64
           +   + D     ++++K    LGEG FG+V   C     DG     +VAVK LK + G +
Sbjct: 1   MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE--MVAVKALKADCGPQ 58
Query: 65  ERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRY 122
            R    QE+ +++TL  H ++++  GCC ++  +   ++MEYVP G L+ +L        
Sbjct: 59  HRSGWKQEIDILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-------- 109
Query: 123 YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   +S+    L  F  Q+  GM +L S+
Sbjct: 110 ------PRHSIGLAQLLLFAQQICEGMAYLHSQ 136

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 21/140 (15%)
Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KW +    +     +G G FG V     L  D       VA+KT++E A   E  D ++E
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE--DFIEE 53
Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             VM  L  HP +V+L G C E+ P  ++ E++ +G L  +LR+ R              
Sbjct: 54  AEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL------------ 100
Query: 133 LTSRDLTSFCYQVARGMQFL 152
             +  L   C  V  GM +L
Sbjct: 101 FAAETLLGMCLDVCEGMAYL 120

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 29/146 (19%)
Query: 14  WEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           WE+  + +     LG G FG V    W+          G   VA+K +KE  G     + 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKE--GSMSEDEF 51
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L ++LR  R           
Sbjct: 52  IEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----------- 99
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            +   ++ L   C  V   M++L S+
Sbjct: 100 -HRFQTQQLLEMCKDVCEAMEYLESK 124

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 29/158 (18%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTL 57
           N P         WE+  + +     LG G FG V    W+          G   VA+K +
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMI 56
Query: 58  KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS 117
           KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L ++LR  
Sbjct: 57  KE--GSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 118 RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           R            +   ++ L   C  V   M++L S+
Sbjct: 114 R------------HRFQTQQLLEMCKDVCEAMEYLESK 139

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 29/158 (18%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTL 57
           N P         WE+  + +     LG G FG V    W+          G   VA+K +
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMI 56
Query: 58  KENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS 117
           KE  G     + ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L ++LR  
Sbjct: 57  KE--GSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 118 RAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
           R            +   ++ L   C  V   M++L S+
Sbjct: 114 R------------HRFQTQQLLEMCKDVCEAMEYLESK 139

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 29/146 (19%)
Query: 14  WEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           WE+  + +     LG G FG V    W+          G   VA+K +KE  G     + 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKE--GSMSEDEF 50
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L ++LR  R           
Sbjct: 51  IEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----------- 98
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            +   ++ L   C  V   M++L S+
Sbjct: 99  -HRFQTQQLLEMCKDVCEAMEYLESK 123

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 29/146 (19%)
Query: 14  WEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           WE+  + +     LG G FG V    W+          G   VA+K +KE  G     + 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKE--GSMSEDEF 57
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L ++LR  R           
Sbjct: 58  IEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----------- 105
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            +   ++ L   C  V   M++L S+
Sbjct: 106 -HRFQTQQLLEMCKDVCEAMEYLESK 130

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 29/146 (19%)
Query: 14  WEVPRQHIKVFDILGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           WE+  + +     LG G FG V    W+          G   VA+K +KE  G     + 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKE--GSMSEDEF 51
Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L ++LR  R           
Sbjct: 52  IEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----------- 99
Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSR 155
            +   ++ L   C  V   M++L S+
Sbjct: 100 -HRFQTQQLLEMCKDVCEAMEYLESK 124

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQV-WKCEALGIDGREGPCIVAVKTLKENAGER 64
           +   + D     ++++K    LGEG FG+V   C     DG     +VAVK LK + G +
Sbjct: 1   MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE--MVAVKALKADCGPQ 58
Query: 65  ERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRY 122
            R    QE+ +++TL  H ++++  GCC ++  +   ++MEYVP G L+ +L        
Sbjct: 59  HRSGWKQEIDILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-------- 109
Query: 123 YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                   +S+    L  F  Q+  GM +L ++
Sbjct: 110 ------PRHSIGLAQLLLFAQQICEGMAYLHAQ 136

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 58/131 (44%), Gaps = 21/131 (16%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG V     L  D       VA+KT++E A   E  D ++E  VM  L  HP +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLV 65
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           +L G C E+ P  ++ E++ +G L  +LR+ R                +  L   C  V 
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL------------FAAETLLGMCLDVC 113
Query: 147 RGMQFLSSRGV 157
            GM +L    V
Sbjct: 114 EGMAYLEEASV 124

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 16/131 (12%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           ++G+G FG V+  E   ID  +     A+K+L      ++    L+E  +M+ L+ HPNV
Sbjct: 28  VIGKGHFGVVYHGEY--IDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNV 84
Query: 86  VRLLGCCTEKEPF-FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           + L+G     E    V++ Y+ +G L  F+RS +             + T +DL SF  Q
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------------RNPTVKDLISFGLQ 132
Query: 145 VARGMQFLSSR 155
           VARGM++L+ +
Sbjct: 133 VARGMEYLAEQ 143

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 23/136 (16%)
Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           + I+V +++G G FG V K +    D       VA+K ++    E ER   + EL  +  
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIES---ESERKAFIVELRQLSR 57
Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           ++ HPN+V+L G C    P  ++MEY   G L + L  +    YY   H           
Sbjct: 58  VN-HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA---------- 104
Query: 139 TSFCYQVARGMQFLSS 154
            S+C Q ++G+ +L S
Sbjct: 105 MSWCLQCSQGVAYLHS 120

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 23/136 (16%)
Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           + I+V +++G G FG V K +    D       VA+K ++    E ER   + EL  +  
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIES---ESERKAFIVELRQLSR 58
Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           ++ HPN+V+L G C    P  ++MEY   G L + L  +    YY   H           
Sbjct: 59  VN-HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA---------- 105
Query: 139 TSFCYQVARGMQFLSS 154
            S+C Q ++G+ +L S
Sbjct: 106 MSWCLQCSQGVAYLHS 121

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 19/133 (14%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           ++LG+GCFGQ     A+ +  RE   ++ +K L     E +R   L+E+ VM+ L+ HPN
Sbjct: 16  EVLGKGCFGQ-----AIKVTHRETGEVMVMKELIRFDEETQR-TFLKEVKVMRCLE-HPN 68
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           V++ +G   + +    I EY+  G L+  ++S  +Q  ++               SF   
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR------------VSFAKD 116
Query: 145 VARGMQFLSSRGV 157
           +A GM +L S  +
Sbjct: 117 IASGMAYLHSMNI 129

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 57/126 (45%), Gaps = 21/126 (16%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG V     L  D       VA+KT++E A   E  D ++E  VM  L  HP +V
Sbjct: 15  IGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLV 65
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           +L G C E+ P  ++ E++ +G L  +LR+ R                +  L   C  V 
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL------------FAAETLLGMCLDVC 113
Query: 147 RGMQFL 152
            GM +L
Sbjct: 114 EGMAYL 119

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 57/126 (45%), Gaps = 21/126 (16%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG V     L  D       VA+KT++E A   E  D ++E  VM  L  HP +V
Sbjct: 13  IGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE--DFIEEAEVMMKLS-HPKLV 63
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           +L G C E+ P  ++ E++ +G L  +LR+ R                +  L   C  V 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL------------FAAETLLGMCLDVC 111
Query: 147 RGMQFL 152
            GM +L
Sbjct: 112 EGMAYL 117

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 56/126 (44%), Gaps = 21/126 (16%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG V     L  D       VA+KT+KE  G     D ++E  VM  L  HP +V
Sbjct: 35  IGSGQFGLVHLGYWLNKDK------VAIKTIKE--GSMSEDDFIEEAEVMMKLS-HPKLV 85
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
           +L G C E+ P  ++ E++ +G L  +LR+ R                +  L   C  V 
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL------------FAAETLLGMCLDVC 133
Query: 147 RGMQFL 152
            GM +L
Sbjct: 134 EGMAYL 139

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 19/140 (13%)
Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           +H+K    LG+G FG V  C    +    G  +VAVK L+ +  +++R D  +E+ ++K 
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTG-ALVAVKQLQHSGPDQQR-DFQREIQILKA 67
Query: 79  LDPHPNVV---RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           L  H + +   R +     ++   ++MEY+P G L+ FL+  RA+            L +
Sbjct: 68  L--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR------------LDA 113
Query: 136 RDLTSFCYQVARGMQFLSSR 155
             L  +  Q+ +GM++L SR
Sbjct: 114 SRLLLYSSQICKGMEYLGSR 133

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 19/140 (13%)
Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           +H+K    LG+G FG V  C    +    G  +VAVK L+ +  +++R D  +E+ ++K 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTG-ALVAVKQLQHSGPDQQR-DFQREIQILKA 80
Query: 79  LDPHPNVV---RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           L  H + +   R +     ++   ++MEY+P G L+ FL+  RA+            L +
Sbjct: 81  L--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR------------LDA 126
Query: 136 RDLTSFCYQVARGMQFLSSR 155
             L  +  Q+ +GM++L SR
Sbjct: 127 SRLLLYSSQICKGMEYLGSR 146

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 60/133 (45%), Gaps = 29/133 (21%)
Query: 27  LGEGCFGQV----WKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH 82
           LG G FG V    W+          G   VA+K +KE  G     + ++E  VM  L  H
Sbjct: 12  LGTGQFGVVKYGKWR----------GQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLS-H 58
Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
             +V+L G CT++ P F+I EY+  G L ++LR  R            +   ++ L   C
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMC 106
Query: 143 YQVARGMQFLSSR 155
             V   M++L S+
Sbjct: 107 KDVCEAMEYLESK 119

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 71/140 (50%), Gaps = 19/140 (13%)
Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           +H+K    LG+G FG V  C    +    G  +VAVK L+ +  +++R D  +E+ ++K 
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYDPLGDNTG-ALVAVKQLQHSGPDQQR-DFQREIQILKA 68
Query: 79  LDPHPNVV---RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           L  H + +   R +     ++   ++MEY+P G L+ FL+  RA+            L +
Sbjct: 69  L--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR------------LDA 114
Query: 136 RDLTSFCYQVARGMQFLSSR 155
             L  +  Q+ +GM++L SR
Sbjct: 115 SRLLLYSSQICKGMEYLGSR 134

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
           L +K +D   +P Q   +  +LG+G FG V + +    DG      VAVK LK +     
Sbjct: 11  LKEKLEDVL-IPEQQFTLGRMLGKGEFGSVREAQLKQEDG--SFVKVAVKMLKADIIASS 67
Query: 66  RLD-LLQELTVMKTLDPHPNVVRLLGCCTEKE-----PF-FVIMEYVPYGKLQSFLRSSR 118
            ++  L+E   MK  D HP+V +L+G           P   VI+ ++ +G L +FL +SR
Sbjct: 68  DIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 119 AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR 155
                 N       L  + L  F   +A GM++LSSR
Sbjct: 127 IGENPFN-------LPLQTLVRFMVDIACGMEYLSSR 156

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 16/33 (48%), Positives = 24/33 (72%)
Query: 160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           G RL++P  C  E+Y++MY CW  +P +RP+FT
Sbjct: 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT 287

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 20/141 (14%)
Query: 18  RQHIKVFDILGEGCFGQV-WKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           ++++K    LGEG FG+V   C     DG     +VAVK LKE  G + R    +E+ ++
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE--MVAVKALKEGCGPQLRSGWQREIEIL 64
Query: 77  KTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +TL  H ++V+  GCC ++  +   ++MEYVP G L+ +L                + + 
Sbjct: 65  RTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--------------PRHCVG 109
Query: 135 SRDLTSFCYQVARGMQFLSSR 155
              L  F  Q+  GM +L ++
Sbjct: 110 LAQLLLFAQQICEGMAYLHAQ 130

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 20/147 (13%)
Query: 11  DDKWEVPRQHIKVFDI-LGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLD 68
           D K  + R ++ + DI LG G FG V +    G+   R+    VA+K LK+   + +  +
Sbjct: 1   DKKLFLKRDNLLIADIELGCGNFGSVRQ----GVYRMRKKQIDVAIKVLKQGTEKADTEE 56
Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           +++E  +M  LD +P +VRL+G C + E   ++ME    G L  FL             G
Sbjct: 57  MMREAQIMHQLD-NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV------------G 102
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSR 155
           K   +   ++    +QV+ GM++L  +
Sbjct: 103 KREEIPVSNVAELLHQVSMGMKYLEEK 129

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 20/141 (14%)
Query: 18  RQHIKVFDILGEGCFGQV-WKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           ++++K    LGEG FG+V   C     DG     +VAVK LKE  G + R    +E+ ++
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE--MVAVKALKEGCGPQLRSGWQREIEIL 65
Query: 77  KTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +TL  H ++V+  GCC ++  +   ++MEYVP G L+ +L                + + 
Sbjct: 66  RTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--------------PRHCVG 110
Query: 135 SRDLTSFCYQVARGMQFLSSR 155
              L  F  Q+  GM +L ++
Sbjct: 111 LAQLLLFAQQICEGMAYLHAQ 131

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 20/147 (13%)
Query: 11  DDKWEVPRQHIKVFDI-LGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLD 68
           D K  + R ++ + DI LG G FG V +    G+   R+    VA+K LK+   + +  +
Sbjct: 327 DKKLFLKRDNLLIADIELGCGNFGSVRQ----GVYRMRKKQIDVAIKVLKQGTEKADTEE 382
Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           +++E  +M  LD +P +VRL+G C + E   ++ME    G L  FL             G
Sbjct: 383 MMREAQIMHQLD-NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV------------G 428
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSR 155
           K   +   ++    +QV+ GM++L  +
Sbjct: 429 KREEIPVSNVAELLHQVSMGMKYLEEK 455

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 19/128 (14%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +ILG G FGQV KCE      +    I+  +      G +++ ++  E++VM  LD H N
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTR------GMKDKEEVKNEISVMNQLD-HAN 147
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +++L      K    ++MEYV  G+L            ++ +  +S +LT  D   F  Q
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGEL------------FDRIIDESYNLTELDTILFMKQ 195
Query: 145 VARGMQFL 152
           +  G++ +
Sbjct: 196 ICEGIRHM 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           +H+K    LG+G FG V  C    +    G  +VAVK L+ +  +++R D  +E+ ++K 
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTG-ALVAVKQLQHSGPDQQR-DFQREIQILKA 64
Query: 79  LDPHPNVV---RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           L  H + +   R +     +    ++MEY+P G L+ FL+  RA+            L +
Sbjct: 65  L--HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR------------LDA 110
Query: 136 RDLTSFCYQVARGMQFLSSR 155
             L  +  Q+ +GM++L SR
Sbjct: 111 SRLLLYSSQICKGMEYLGSR 130

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 19/141 (13%)
Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +  ++   LG+G FG+V+K +      +E   + A K + E   E E  D + E+ ++
Sbjct: 17  PNEVWEIVGELGDGAFGKVYKAK-----NKETGALAAAKVI-ETKSEEELEDYIVEIEIL 70
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
            T D HP +V+LLG        ++++E+ P G + +             M      LT  
Sbjct: 71  ATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI------------MLELDRGLTEP 117
Query: 137 DLTSFCYQVARGMQFLSSRGV 157
            +   C Q+   + FL S+ +
Sbjct: 118 QIQVVCRQMLEALNFLHSKRI 138

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 19/141 (13%)
Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +  ++   LG+G FG+V+K +      +E   + A K + E   E E  D + E+ ++
Sbjct: 9   PNEVWEIVGELGDGAFGKVYKAK-----NKETGALAAAKVI-ETKSEEELEDYIVEIEIL 62
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
            T D HP +V+LLG        ++++E+ P G + +             M      LT  
Sbjct: 63  ATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI------------MLELDRGLTEP 109
Query: 137 DLTSFCYQVARGMQFLSSRGV 157
            +   C Q+   + FL S+ +
Sbjct: 110 QIQVVCRQMLEALNFLHSKRI 130

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 66/140 (47%), Gaps = 21/140 (15%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCI---VAVKTLKENAGERERLDLLQELTVMK 77
           ++   +LG G FG V K    G+   EG  I   V +K +++ +G +    +   +  + 
Sbjct: 33  LRKLKVLGSGVFGTVHK----GVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 88
Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           +LD H ++VRLLG C       ++ +Y+P G L   +R  R             +L  + 
Sbjct: 89  SLD-HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRG------------ALGPQL 134
Query: 138 LTSFCYQVARGMQFLSSRGV 157
           L ++  Q+A+GM +L   G+
Sbjct: 135 LLNWGVQIAKGMYYLEEHGM 154

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 66/140 (47%), Gaps = 21/140 (15%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCI---VAVKTLKENAGERERLDLLQELTVMK 77
           ++   +LG G FG V K    G+   EG  I   V +K +++ +G +    +   +  + 
Sbjct: 15  LRKLKVLGSGVFGTVHK----GVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           +LD H ++VRLLG C       ++ +Y+P G L   +R  R             +L  + 
Sbjct: 71  SLD-HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHR------------GALGPQL 116
Query: 138 LTSFCYQVARGMQFLSSRGV 157
           L ++  Q+A+GM +L   G+
Sbjct: 117 LLNWGVQIAKGMYYLEEHGM 136

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 23/152 (15%)
Query: 7   NQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER 66
           ++ S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++
Sbjct: 12  SRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQ 63
Query: 67  LDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           L   + E+ V++    H N++  +G  T K    ++ ++     L            Y++
Sbjct: 64  LQAFKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHH 109
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           +H        + L     Q ARGM +L ++ +
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 63/149 (42%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 3   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 54
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 55  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHA 100
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                  + L     Q ARGM +L ++ +
Sbjct: 101 SETKFEMKKLIDIARQTARGMDYLHAKSI 129

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 18/142 (12%)
Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQEL 73
           +  + +++ + LG+G FG V + E     G+     VAVK LK +   +     D ++E+
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             M +LD H N++RL G      P  ++ E  P G L   LR  +               
Sbjct: 73  NAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT-------- 122
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
               L+ +  QVA GM +L S+
Sbjct: 123 ----LSRYAVQVAEGMGYLESK 140

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++G RL +P+ C +++YN+M  CW  +P +RP F 
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 18/142 (12%)
Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQEL 73
           +  + +++ + LG+G FG V + E     G+     VAVK LK +   +     D ++E+
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             M +LD H N++RL G      P  ++ E  P G L   LR  +               
Sbjct: 73  NAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT-------- 122
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
               L+ +  QVA GM +L S+
Sbjct: 123 ----LSRYAVQVAEGMGYLESK 140

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++G RL +P+ C +++YN+M  CW  +P +RP F 
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 18/142 (12%)
Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQEL 73
           +  + +++ + LG+G FG V + E     G+     VAVK LK +   +     D ++E+
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREV 66
Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             M +LD H N++RL G      P  ++ E  P G L   LR  +               
Sbjct: 67  NAMHSLD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT-------- 116
Query: 134 TSRDLTSFCYQVARGMQFLSSR 155
               L+ +  QVA GM +L S+
Sbjct: 117 ----LSRYAVQVAEGMGYLESK 134

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++G RL +P+ C +++YN+M  CW  +P +RP F 
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 18/137 (13%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQELTVMKT 78
           +++ + LG+G FG V + E     G+     VAVK LK +   +     D ++E+  M +
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           LD H N++RL G      P  ++ E  P G L   LR  +                   L
Sbjct: 68  LD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------------L 113
Query: 139 TSFCYQVARGMQFLSSR 155
           + +  QVA GM +L S+
Sbjct: 114 SRYAVQVAEGMGYLESK 130

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++G RL +P+ C +++YN+M  CW  +P +RP F 
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 18/137 (13%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQELTVMKT 78
           +++ + LG+G FG V + E     G+     VAVK LK +   +     D ++E+  M +
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           LD H N++RL G      P  ++ E  P G L   LR  +                   L
Sbjct: 68  LD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------------L 113
Query: 139 TSFCYQVARGMQFLSSR 155
           + +  QVA GM +L S+
Sbjct: 114 SRYAVQVAEGMGYLESK 130

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++G RL +P+ C +++YN+M  CW  +P +RP F 
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 18/137 (13%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQELTVMKT 78
           +++ + LG+G FG V + E     G+     VAVK LK +   +     D ++E+  M +
Sbjct: 14  LRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           LD H N++RL G      P  ++ E  P G L   LR  +                   L
Sbjct: 72  LD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------------L 117
Query: 139 TSFCYQVARGMQFLSSR 155
           + +  QVA GM +L S+
Sbjct: 118 SRYAVQVAEGMGYLESK 134

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++G RL +P+ C +++YN+M  CW  +P +RP F 
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 62/138 (44%), Gaps = 20/138 (14%)
Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCI-VAVKTLKENAGERERL--DLLQELTVMK 77
           +++ + LG+G FG V + E    D   G  + VAVK LK +   +     D ++E+  M 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEW---DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           +LD H N++RL G      P  ++ E  P G L   LR  +                   
Sbjct: 67  SLD-HRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------------ 112
Query: 138 LTSFCYQVARGMQFLSSR 155
           L+ +  QVA GM +L S+
Sbjct: 113 LSRYAVQVAEGMGYLESK 130

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFT 192
           ++G RL +P+ C +++YN+M  CW  +P +RP F 
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 74/154 (48%), Gaps = 24/154 (15%)
Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDIL---GEGCFGQVWKCEALGIDGREGPCIVAVKTLK 58
           N P    K  D+  + +Q  +VFD+L   GEG +G V+K        +E   IVA+K + 
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKA-----IHKETGQIVAIKQV- 62
Query: 59  ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
               E +  ++++E+++M+  D  P+VV+  G   +    +++MEY   G +   +R   
Sbjct: 63  --PVESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL-- 117
Query: 119 AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 152
                     ++ +LT  ++ +      +G+++L
Sbjct: 118 ----------RNKTLTEDEIATILQSTLKGLEYL 141

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 23/152 (15%)
Query: 7   NQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER 66
           ++ + D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++
Sbjct: 12  SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQ 63
Query: 67  LDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           L   + E+ V++    H N++  +G  T  +   ++ ++     L            Y++
Sbjct: 64  LQAFKNEVGVLRKTR-HVNILLFMGYSTAPQ-LAIVTQWCEGSSL------------YHH 109
Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           +H        + L     Q ARGM +L ++ +
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 12/104 (11%)
Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  + +K+   +G+G FG V   +  G         VAVK +K +A  +     L E 
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA---FLAEA 65
Query: 74  TVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSFLRS 116
           +VM  L  H N+V+LLG   E K   +++ EY+  G L  +LRS
Sbjct: 66  SVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 108

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 12/104 (11%)
Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  + +K+   +G+G FG V   +  G         VAVK +K +A  +     L E 
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA---FLAEA 237
Query: 74  TVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSFLRS 116
           +VM  L  H N+V+LLG   E K   +++ EY+  G L  +LRS
Sbjct: 238 SVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 12/104 (11%)
Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  + +K+   +G+G FG V   +  G         VAVK +K +A  +     L E 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA---FLAEA 50
Query: 74  TVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSFLRS 116
           +VM  L  H N+V+LLG   E K   +++ EY+  G L  +LRS
Sbjct: 51  SVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 93

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 12/104 (11%)
Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  + +K+   +G+G FG V   +  G         VAVK +K +A  +     L E 
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA---FLAEA 56
Query: 74  TVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSFLRS 116
           +VM  L  H N+V+LLG   E K   +++ EY+  G L  +LRS
Sbjct: 57  SVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 99

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER-ERLDLLQELTVMK 77
           Q  ++   LG G FG+V       I  R      A+K LK+    R ++++   +  +M 
Sbjct: 6   QDFQILRTLGTGSFGRVHL-----IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           ++  HP ++R+ G   + +  F+IM+Y+  G+L S LR S  QR+ N +           
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPV----------- 107
Query: 138 LTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
              +  +V   +++L S+ +   YR  KP++ 
Sbjct: 108 AKFYAAEVCLALEYLHSKDII--YRDLKPENI 137

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 76
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 123
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 124 NGVYYLHS 131

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 76
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 123
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 124 NGVYYLHS 131

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPN 84
           +LG+G FG+V KC+      R      AVK + K +A  ++   +L+E+ ++K LD HPN
Sbjct: 29  MLGKGSFGEVLKCK-----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPN 82
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKL 110
           +++L     +   F+++ E    G+L
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGEL 108

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I+E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 59/138 (42%), Gaps = 14/138 (10%)
Query: 20  HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
           H ++ + LG G F  V KC   G         +  + L  +     R ++ +E+ +++ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
             HPN++ L      K    +I+E V  G+L  FL              +  SLT  + T
Sbjct: 66  -RHPNIITLHDIFENKTDVVLILELVSGGELFDFL-------------AEKESLTEDEAT 111
Query: 140 SFCYQVARGMQFLSSRGV 157
            F  Q+  G+ +L S+ +
Sbjct: 112 QFLKQILDGVHYLHSKRI 129

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 51/85 (60%), Gaps = 4/85 (4%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G FG+V  C+   I G+E  C V V + ++   + ++  LL+E+ ++K LD HPN+
Sbjct: 33  VLGKGSFGEVILCKD-KITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNI 88
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKL 110
           ++L     +K  F+++ E    G+L
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGEL 113

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 59/138 (42%), Gaps = 14/138 (10%)
Query: 20  HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
           H ++ + LG G F  V KC   G         +  + L  +     R ++ +E+ +++ +
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
             HPN++ L      K    +I+E V  G+L  FL              +  SLT  + T
Sbjct: 73  -RHPNIITLHDIFENKTDVVLILELVSGGELFDFL-------------AEKESLTEDEAT 118
Query: 140 SFCYQVARGMQFLSSRGV 157
            F  Q+  G+ +L S+ +
Sbjct: 119 QFLKQILDGVHYLHSKRI 136

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 51/85 (60%), Gaps = 4/85 (4%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G FG+V  C+   I G+E  C V V + ++   + ++  LL+E+ ++K LD HPN+
Sbjct: 56  VLGKGSFGEVILCKD-KITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNI 111
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKL 110
           ++L     +K  F+++ E    G+L
Sbjct: 112 MKLYEFFEDKGYFYLVGEVYTGGEL 136

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 51/85 (60%), Gaps = 4/85 (4%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G FG+V  C+   I G+E  C V V + ++   + ++  LL+E+ ++K LD HPN+
Sbjct: 57  VLGKGSFGEVILCKD-KITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNI 112
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKL 110
           ++L     +K  F+++ E    G+L
Sbjct: 113 MKLYEFFEDKGYFYLVGEVYTGGEL 137

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 59/138 (42%), Gaps = 14/138 (10%)
Query: 20  HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
           H ++ + LG G F  V KC   G         +  + L  +     R ++ +E+ +++ +
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
             HPN++ L      K    +I+E V  G+L  FL              +  SLT  + T
Sbjct: 87  -RHPNIITLHDIFENKTDVVLILELVSGGELFDFL-------------AEKESLTEDEAT 132
Query: 140 SFCYQVARGMQFLSSRGV 157
            F  Q+  G+ +L S+ +
Sbjct: 133 QFLKQILDGVHYLHSKRI 150

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 51/85 (60%), Gaps = 4/85 (4%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G FG+V  C+   I G+E  C V V + ++   + ++  LL+E+ ++K LD HPN+
Sbjct: 39  VLGKGSFGEVILCKD-KITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNI 94
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKL 110
           ++L     +K  F+++ E    G+L
Sbjct: 95  MKLYEFFEDKGYFYLVGEVYTGGEL 119

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/145 (22%), Positives = 65/145 (44%), Gaps = 23/145 (15%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE--RERLDLLQE 72
           E+    + + +I+G G FG+V++   +G +       VAVK  + +  E   + ++ +++
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQ 55
Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
              +  +  HPN++ L G C ++    ++ME+   G L   L   R              
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-------------- 101
Query: 133 LTSRDLTSFCYQVARGMQFLSSRGV 157
           +    L ++  Q+ARGM +L    +
Sbjct: 102 IPPDILVNWAVQIARGMNYLHDEAI 126

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 50/85 (58%), Gaps = 4/85 (4%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G FG+V  C+   I G+E  C V V + ++   + ++  LL+E+ ++K LD HPN+
Sbjct: 33  VLGKGSFGEVILCKD-KITGQE--CAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNI 88
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKL 110
            +L     +K  F+++ E    G+L
Sbjct: 89  XKLYEFFEDKGYFYLVGEVYTGGEL 113

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++   LG+G FG+V+K +      +E   + A K + +   E E  D + E+ ++
Sbjct: 35  PEDFWEIIGELGDGAFGKVYKAQ-----NKETSVLAAAKVI-DTKSEEELEDYMVEIDIL 88
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            + D HPN+V+LL     +   ++++E+   G + + +
Sbjct: 89  ASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 125

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 28/160 (17%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           D+LG G F +V   E      +    +VA+K + + A E +   +  E+ V+  +  HPN
Sbjct: 24  DVLGTGAFSEVILAE-----DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KHPN 77
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V L          ++IM+ V  G+L  F R      Y           T RD +   +Q
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL--FDRIVEKGFY-----------TERDASRLIFQ 124
Query: 145 VARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKE 184
           V   +++L   G+   +R  KP+       N++YY  D++
Sbjct: 125 VLDAVKYLHDLGIV--HRDLKPE-------NLLYYSLDED 155

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 28/160 (17%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           D+LG G F +V   E      +    +VA+K + + A E +   +  E+ V+  +  HPN
Sbjct: 24  DVLGTGAFSEVILAE-----DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KHPN 77
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V L          ++IM+ V  G+L  F R      Y           T RD +   +Q
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL--FDRIVEKGFY-----------TERDASRLIFQ 124
Query: 145 VARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKE 184
           V   +++L   G+   +R  KP+       N++YY  D++
Sbjct: 125 VLDAVKYLHDLGIV--HRDLKPE-------NLLYYSLDED 155

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 28/160 (17%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           D+LG G F +V   E      +    +VA+K + + A E +   +  E+ V+  +  HPN
Sbjct: 24  DVLGTGAFSEVILAE-----DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KHPN 77
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V L          ++IM+ V  G+L  F R      Y           T RD +   +Q
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL--FDRIVEKGFY-----------TERDASRLIFQ 124
Query: 145 VARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKE 184
           V   +++L   G+   +R  KP+       N++YY  D++
Sbjct: 125 VLDAVKYLHDLGIV--HRDLKPE-------NLLYYSLDED 155

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 28/160 (17%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           D+LG G F +V   E      +    +VA+K + + A E +   +  E+ V+  +  HPN
Sbjct: 24  DVLGTGAFSEVILAE-----DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPN 77
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V L          ++IM+ V  G+L  F R      Y           T RD +   +Q
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL--FDRIVEKGFY-----------TERDASRLIFQ 124
Query: 145 VARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKE 184
           V   +++L   G+   +R  KP+       N++YY  D++
Sbjct: 125 VLDAVKYLHDLGIV--HRDLKPE-------NLLYYSLDED 155

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++   LG+G FG+V+K +      +E   + A K + +   E E  D + E+ ++
Sbjct: 35  PEDFWEIIGELGDGAFGKVYKAQ-----NKETSVLAAAKVI-DTKSEEELEDYMVEIDIL 88
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            + D HPN+V+LL     +   ++++E+   G + + +
Sbjct: 89  ASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 125

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++   LG+G FG+V+K +      +E   + A K + +   E E  D + E+ ++
Sbjct: 35  PEDFWEIIGELGDGAFGKVYKAQ-----NKETSVLAAAKVI-DTKSEEELEDYMVEIDIL 88
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            + D HPN+V+LL     +   ++++E+   G + + +
Sbjct: 89  ASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 125

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/70 (38%), Positives = 40/70 (57%), Gaps = 7/70 (10%)
Query: 27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER-LDLLQELTVMKTLDP--HP 83
          +GEG +G+V+K   L   GR     VA+K ++   GE    L  ++E+ V++ L+   HP
Sbjct: 19 IGEGAYGKVFKARDLKNGGR----FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 84 NVVRLLGCCT 93
          NVVRL   CT
Sbjct: 75 NVVRLFDVCT 84

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/70 (38%), Positives = 40/70 (57%), Gaps = 7/70 (10%)
Query: 27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER-LDLLQELTVMKTLDP--HP 83
          +GEG +G+V+K   L   GR     VA+K ++   GE    L  ++E+ V++ L+   HP
Sbjct: 19 IGEGAYGKVFKARDLKNGGR----FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 84 NVVRLLGCCT 93
          NVVRL   CT
Sbjct: 75 NVVRLFDVCT 84

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 17/130 (13%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNV 85
           +G G FG V+KC    +DG    CI A+K  K+  AG  +  + L+E+     L  H +V
Sbjct: 15  IGSGEFGSVFKC-VKRLDG----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 69
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           VR      E +   +  EY   G L   +  + R   Y+             +L     Q
Sbjct: 70  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA----------ELKDLLLQ 119
Query: 145 VARGMQFLSS 154
           V RG++++ S
Sbjct: 120 VGRGLRYIHS 129

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 17/130 (13%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNV 85
           +G G FG V+KC    +DG    CI A+K  K+  AG  +  + L+E+     L  H +V
Sbjct: 17  IGSGEFGSVFKC-VKRLDG----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 71
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           VR      E +   +  EY   G L   +  + R   Y+             +L     Q
Sbjct: 72  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA----------ELKDLLLQ 121
Query: 145 VARGMQFLSS 154
           V RG++++ S
Sbjct: 122 VGRGLRYIHS 131

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 17/130 (13%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNV 85
           +G G FG V+KC    +DG    CI A+K  K+  AG  +  + L+E+     L  H +V
Sbjct: 17  IGSGEFGSVFKC-VKRLDG----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 71
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           VR      E +   +  EY   G L   +  + R   Y+             +L     Q
Sbjct: 72  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA----------ELKDLLLQ 121
Query: 145 VARGMQFLSS 154
           V RG++++ S
Sbjct: 122 VGRGLRYIHS 131

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/70 (38%), Positives = 40/70 (57%), Gaps = 7/70 (10%)
Query: 27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER-LDLLQELTVMKTLDP--HP 83
          +GEG +G+V+K   L   GR     VA+K ++   GE    L  ++E+ V++ L+   HP
Sbjct: 19 IGEGAYGKVFKARDLKNGGR----FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 84 NVVRLLGCCT 93
          NVVRL   CT
Sbjct: 75 NVVRLFDVCT 84

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 17/130 (13%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNV 85
           +G G FG V+KC    +DG    CI A+K  K+  AG  +  + L+E+     L  H +V
Sbjct: 19  IGSGEFGSVFKC-VKRLDG----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS-RAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           VR      E +   +  EY   G L   +  + R   Y+             +L     Q
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA----------ELKDLLLQ 123
Query: 145 VARGMQFLSS 154
           V RG++++ S
Sbjct: 124 VGRGLRYIHS 133

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPN 84
           +LG+G FG+V KC+      R      AVK + K +A  ++   +L+E+ ++K LD HPN
Sbjct: 29  MLGKGSFGEVLKCK-----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPN 82
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKL 110
           +++L     +   F+++ E    G+L
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGEL 108

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPN 84
           +LG+G FG+V KC+      R      AVK + K +A  ++   +L+E+ ++K LD HPN
Sbjct: 29  MLGKGSFGEVLKCK-----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPN 82
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKL 110
           +++L     +   F+++ E    G+L
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGEL 108

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 24/132 (18%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNV 85
           L E   G++WK    G D       + VK LK  +   R+  D  +E   ++    HPNV
Sbjct: 18  LNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNV 69
Query: 86  VRLLGCC-TEKEPF-FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFC 142
           + +LG C +   P   +I  ++PYG L            YN +H  +N +  +     F 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSL------------YNVLHEGTNFVVDQSQAVKFA 117
Query: 143 YQVARGMQFLSS 154
             +ARGM FL +
Sbjct: 118 LDMARGMAFLHT 129

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/147 (21%), Positives = 64/147 (43%), Gaps = 24/147 (16%)
Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++ +++G G +GQV+K    G   + G  + A+K +     E E  ++ QE+ ++
Sbjct: 22  PAGIFELVELVGNGTYGQVYK----GRHVKTGQ-LAAIKVMDVTGDEEE--EIKQEINML 74
Query: 77  KTLDPHPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           K    H N+    G   +K P       +++ME+   G +   ++++           K 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-----------KG 123
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV 157
           N+L    +   C ++ RG+  L    V
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQHKV 150

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 53/128 (41%), Gaps = 14/128 (10%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G F  V KC       +     +  +  K +     R D+ +E++++K +  HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVI 77
Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L      K    +I E V  G+L  FL              +  SLT  + T F  Q+ 
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFL-------------AEKESLTEEEATEFLKQIL 124
Query: 147 RGMQFLSS 154
            G+ +L S
Sbjct: 125 NGVYYLHS 132

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 78
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 79  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHI 124
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                    L     Q A+GM +L ++ +
Sbjct: 125 IETKFEMIKLIDIARQTAQGMDYLHAKSI 153

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/96 (25%), Positives = 51/96 (53%), Gaps = 18/96 (18%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL------------DLLQELT 74
           LG G +G+V  C+      + G    A+K +K++  ++ R             ++  E++
Sbjct: 44  LGSGAYGEVLLCKE-----KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 110
           ++K+LD HPN+++L     +K+ F+++ E+   G+L
Sbjct: 99  LLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGEL 133

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 26  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 77
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 78  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHI 123
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                    L     Q A+GM +L ++ +
Sbjct: 124 IETKFEMIKLIDIARQTAQGMDYLHAKSI 152

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 27  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 78
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 79  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHI 124
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                    L     Q A+GM +L ++ +
Sbjct: 125 IETKFEMIKLIDIARQTAQGMDYLHAKSI 153

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 70
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 71  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHI 116
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                    L     Q A+GM +L ++ +
Sbjct: 117 IETKFEMIKLIDIARQTAQGMDYLHAKSI 145

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 55
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 56  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHI 101
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                    L     Q A+GM +L ++ +
Sbjct: 102 IETKFEMIKLIDIARQTAQGMDYLHAKSI 130

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 55
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 56  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHI 101
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                    L     Q A+GM +L ++ +
Sbjct: 102 IETKFEMIKLIDIARQTAQGMDYLHAKSI 130

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L  
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQA 52
Query: 70  LQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + E+ V++    H N++  +G  T K    ++ ++     L            Y+++H 
Sbjct: 53  FKNEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHI 98
Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                    L     Q A+GM +L ++ +
Sbjct: 99  IETKFEMIKLIDIARQTAQGMDYLHAKSI 127

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/133 (23%), Positives = 65/133 (48%), Gaps = 20/133 (15%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL-LQELTVMKTLDPHPN 84
           ++GEG +G V KC       ++   IVA+K   E+  ++    + ++E+ ++K L  H N
Sbjct: 32  LVGEGSYGMVMKCR-----NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HEN 85
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V LL  C +K+ ++++ E+V +  L             +++    N L  + +  + +Q
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTIL-------------DDLELFPNGLDYQVVQKYLFQ 132
Query: 145 VARGMQFLSSRGV 157
           +  G+ F  S  +
Sbjct: 133 IINGIGFCHSHNI 145

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--LLQELTVMKTLDPHPN 84
           LG+G FG V+         ++   IVA+K L ++  E+E ++  L +E+ +   L  HPN
Sbjct: 31  LGKGKFGNVYLARE-----KKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH-HPN 84
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSS 117
           ++RL     ++   ++I+EY P G+L   L+ S
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQKS 117

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 60/138 (43%), Gaps = 20/138 (14%)
Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +     D +G+G FG+V+K    GID      +VA+K +     E E  D+ QE+TV+
Sbjct: 17  PEELFTKLDRIGKGSFGEVYK----GIDNHTKE-VVAIKIIDLEEAEDEIEDIQQEITVL 71
Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
              D  P + R  G   +    ++IMEY+  G     L+    +  Y             
Sbjct: 72  SQCD-SPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETY------------- 117
Query: 137 DLTSFCYQVARGMQFLSS 154
            + +   ++ +G+ +L S
Sbjct: 118 -IATILREILKGLDYLHS 134

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 61/132 (46%), Gaps = 17/132 (12%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           ++G G FG+V+K    G+        +  +T + + G  E    ++ L+  +    HP++
Sbjct: 46  LIGHGVFGKVYK----GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR----HPHL 97
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           V L+G C E+    +I +Y+  G L+  L       Y +++   S S   R     C   
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHL-------YGSDLPTMSMSWEQR--LEICIGA 148
Query: 146 ARGMQFLSSRGV 157
           ARG+ +L +R +
Sbjct: 149 ARGLHYLHTRAI 160

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 74/150 (49%), Gaps = 26/150 (17%)
Query: 15  EVPRQHIKV--FDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD- 68
           E+P++   +  FDI   LG+G FG V+         ++   I+A+K L ++  E+E ++ 
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLARE-----KQNKFIMALKVLFKSQLEKEGVEH 60
Query: 69  -LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
            L +E+ +   L  HPN++R+     +++  ++++E+ P G+L   L+           H
Sbjct: 61  QLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----------H 109
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           G+ +   S    +F  ++A  + +   R V
Sbjct: 110 GRFDEQRS---ATFMEELADALHYCHERKV 136

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 61/132 (46%), Gaps = 17/132 (12%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           ++G G FG+V+K    G+        +  +T + + G  E    ++ L+  +    HP++
Sbjct: 46  LIGHGVFGKVYK----GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR----HPHL 97
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           V L+G C E+    +I +Y+  G L+  L       Y +++   S S   R     C   
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHL-------YGSDLPTMSMSWEQR--LEICIGA 148
Query: 146 ARGMQFLSSRGV 157
           ARG+ +L +R +
Sbjct: 149 ARGLHYLHTRAI 160

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 74/150 (49%), Gaps = 26/150 (17%)
Query: 15  EVPRQHIKV--FDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD- 68
           E+P++   +  FDI   LG+G FG V+         ++   I+A+K L ++  E+E ++ 
Sbjct: 5   EMPKRKFTIDDFDIVRPLGKGKFGNVYLARE-----KQNKFIMALKVLFKSQLEKEGVEH 59
Query: 69  -LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
            L +E+ +   L  HPN++R+     +++  ++++E+ P G+L   L+           H
Sbjct: 60  QLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----------H 108
Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
           G+ +   S    +F  ++A  + +   R V
Sbjct: 109 GRFDEQRS---ATFMEELADALHYCHERKV 135

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 29/147 (19%)
Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+    ++V  +L EG F  V++ + +G  GRE     A+K L  N  E+ R  ++QE+ 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVG-SGRE----YALKRLLSNEEEKNR-AIIQEVC 77
Query: 75  VMKTLDPHPNVVRLLGCCT-------EKEPFFVIMEYVPYGKLQSFLRSSRAQ------- 120
            MK L  HPN+V+     +         +  F+++  +  G+L  FL+   ++       
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 121 ---------RYYNNMHGKSNSLTSRDL 138
                    R   +MH +   +  RDL
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDL 164

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLD 80
           ++   +G+G F +V     + + G+E    VAVK + +       L  L +E+ +MK L+
Sbjct: 17  RLLKTIGKGNFAKVKLARHI-LTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            HPN+V+L      ++  +++MEY   G++  +L
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLD 80
           ++   +G+G F +V     + + G+E    VAVK + +       L  L +E+ +MK L+
Sbjct: 17  RLLKTIGKGNFAKVKLARHI-LTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            HPN+V+L      ++  +++MEY   G++  +L
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 24  FDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--LLQELTVMKT 78
           FDI   LG+G FG V+         R+   I+A+K L +   E+  ++  L +E+ +   
Sbjct: 14  FDIGRPLGKGKFGNVYLARE-----RQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 110
           L  HPN++RL G   +    ++I+EY P G +
Sbjct: 69  LR-HPNILRLYGYFHDATRVYLILEYAPLGTV 99

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLD 80
           ++   +G+G F +V     + + G+E    VAVK + +       L  L +E+ +MK L+
Sbjct: 17  RLLKTIGKGNFAKVKLARHI-LTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            HPN+V+L      ++  +++MEY   G++  +L
Sbjct: 72  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 104

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 23/147 (15%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L   +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFK 52
Query: 72  -ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+ V++    H N++  +G  T K    ++ ++     L            Y+++H   
Sbjct: 53  NEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHIIE 98
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV 157
                  L     Q A+GM +L ++ +
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSI 125

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 24  FDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--LLQELTVMKT 78
           FDI   LG+G FG V+         R+   I+A+K L +   E+  ++  L +E+ +   
Sbjct: 14  FDIGRPLGKGKFGNVYLARE-----RQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 110
           L  HPN++RL G   +    ++I+EY P G +
Sbjct: 69  LR-HPNILRLYGYFHDATRVYLILEYAPLGTV 99

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 23/147 (15%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L   +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFK 52
Query: 72  -ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+ V++    H N++  +G  T K    ++ ++     L            Y+++H   
Sbjct: 53  NEVGVLRKTR-HVNILLFMGYST-KPQLAIVTQWCEGSSL------------YHHLHIIE 98
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV 157
                  L     Q A+GM +L ++ +
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSI 125

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLD 80
           ++   +G+G F +V     + + GRE    VA+K + +       L  L +E+ +MK L+
Sbjct: 15  RLLKTIGKGNFAKVKLARHI-LTGRE----VAIKIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            HPN+V+L      ++  ++IMEY   G++  +L
Sbjct: 70  -HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL 102

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           +ILG G FG+V+K      DG     +VAVK LKE   +   L    E+  M ++  H N
Sbjct: 44  NILGRGGFGKVYKGRL--ADG----TLVAVKRLKEERXQGGELQFQTEVE-MISMAVHRN 96
Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLR 115
           ++RL G C       ++  Y+  G + S LR
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR 127

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLD 80
           ++   +G+G F +V K     + G+E    VAVK + +       L  L +E+ +MK L+
Sbjct: 10  RLLKTIGKGNFAKV-KLARHILTGKE----VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            HPN+V+L      ++  +++MEY   G++  +L
Sbjct: 65  -HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 97

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLD 80
           ++   +G+G F +V     + + GRE    VA+K + +       L  L +E+ +MK L+
Sbjct: 18  RLLKTIGKGNFAKVKLARHI-LTGRE----VAIKIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
            HPN+V+L      ++  ++IMEY   G++  +L
Sbjct: 73  -HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL 105

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G +G V+    L    R     +A+K + E    R    L +E+ + K L  H N+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVR-----IAIKEIPER-DSRYSQPLHEEIALHKHLK-HKNI 81
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS 116
           V+ LG  +E     + ME VP G L + LRS
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG+G +G V+    L    R     +A+K + E    R    L +E+ + K L  H N+
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVR-----IAIKEIPER-DSRYSQPLHEEIALHKHLK-HKNI 67
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS 116
           V+ LG  +E     + ME VP G L + LRS
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRS 98

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 55/132 (41%), Gaps = 24/132 (18%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHPNV 85
           L E   G++WK    G D       + VK LK  +   R+  D  +E   ++    HPNV
Sbjct: 18  LNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNV 69
Query: 86  VRLLGCC-TEKEPF-FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD-LTSFC 142
           + +LG C +   P   +I  + PYG L            YN +H  +N +  +     F 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSL------------YNVLHEGTNFVVDQSQAVKFA 117
Query: 143 YQVARGMQFLSS 154
              ARG  FL +
Sbjct: 118 LDXARGXAFLHT 129

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQELTVMKTLDPHPNV 85
           +G+G F +V K     + GRE    VAVK + +       L  L +E+ +MK L+ HPN+
Sbjct: 23  IGKGNFAKV-KLARHVLTGRE----VAVKIIDKTQLNPTSLQKLFREVRIMKILN-HPNI 76
Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
           V+L      ++  +++MEY   G++  +L
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYL 105

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 61/147 (41%), Gaps = 23/147 (15%)
Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+P   I V   +G G FG V+K +  G         VAVK L   A   ++L   +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFK 52
Query: 72  -ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+ V++    H N++  +G  T  +   ++ ++     L            Y+++H   
Sbjct: 53  NEVGVLRKTR-HVNILLFMGYSTAPQ-LAIVTQWCEGSSL------------YHHLHIIE 98
Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV 157
                  L     Q A+GM +L ++ +
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSI 125

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	230
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-71
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-70
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-70
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-69
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-69
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-67
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-67
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-66
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-65
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-65
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-62
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-61
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-61
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-60
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-60
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-60
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-55
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-54
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-51
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-51
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-51
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-50
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-50
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-50
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-49
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-16
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-49
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-16
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-49
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-49
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-48
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-48
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-47
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-47
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-47
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-47
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-46
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-46
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-46
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-46
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-45
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-45
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-44
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-44
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-44
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-44
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-42
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-15
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-15
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-09
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-13
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-09
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-28
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-10
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-10
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-28
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-10
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-27
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-11
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-27
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-10
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-25
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-20
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-18
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-04
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-05
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-18
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-18
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-06
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-17
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-17
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-06
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-16
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-16
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-05
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-16
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-16
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-05
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-16
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-16
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-16
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-14
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-14
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-13
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-13
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-12
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-12
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-12
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-12
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-12
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-12
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-12
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-12
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-12
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-12
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-11
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-11
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-11
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-11
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-11
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-11
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-11
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-10
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-10
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-10
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-10
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-10
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-10
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-10
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-10
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-10
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-09
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-09
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-08
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-08
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-07
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-06
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-06
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-06
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-05
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-05
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-05
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-05
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-05
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-05
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-04
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-04
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-04
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-04

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  218 bits (557), Expect = 6e-71
 Identities = 65/156 (41%), Positives = 80/156 (51%), Gaps = 7/156 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN-----N 125
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R     +      
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           M     +L   DL SF YQVA+GM FL+S+    RD
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 88.8 bits (221), Expect = 3e-21
 Identities = 20/53 (37%), Positives = 36/53 (67%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYI 209
           +++G+R+  P+H   E+Y+IM  CWD +P +RP F ++  L+EK +   T++I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 313

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  217 bits (556), Expect = 2e-70
 Identities = 65/161 (40%), Positives = 86/161 (53%), Gaps = 12/161 (7%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR++++   +LG G FG+V    A GI        VAVK LKE A   ER  L+
Sbjct: 37  DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 96

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            EL +M  L  H N+V LLG CT   P ++I EY  YG L ++LRS R +   + +  ++
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 131 ----------NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                     N LT  DL  F YQVA+GM+FL  +    RD
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 88.1 bits (219), Expect = 9e-21
 Identities = 14/56 (25%), Positives = 30/56 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE 212
           +++G+++++P +   E+Y IM  CW  +  +RP+F  L   L   L +  + +   
Sbjct: 288 IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQN 343

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  215 bits (550), Expect = 6e-70
 Identities = 66/162 (40%), Positives = 94/162 (58%), Gaps = 14/162 (8%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR+++ +   LGEG FG+V K  A  + GR G   VAVK LKENA   E  DLL
Sbjct: 15  DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-----------A 119
            E  V+K ++ HP+V++L G C++  P  +I+EY  YG L+ FLR SR           +
Sbjct: 75  SEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +   +  H    +LT  DL SF +Q+++GMQ+L+   +  RD
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.8 bits (208), Expect = 2e-19
 Identities = 19/49 (38%), Positives = 35/49 (71%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           ++ G+R+E+PD+C  E+Y +M  CW +EP++RP F ++   LEK+++  
Sbjct: 265 LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  214 bits (548), Expect = 1e-69
 Identities = 62/154 (40%), Positives = 82/154 (53%), Gaps = 6/154 (3%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
            KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ 
Sbjct: 20  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKLQSFLRSSR---AQRYYNNMH 127
           EL ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R            
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              + LT   L  + +QVA+GM+FL+SR    RD
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 19/51 (37%), Positives = 29/51 (56%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD 207
           +++G R+  PD+   E+Y  M  CW  EP++RP F+EL + L  LL     
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  214 bits (548), Expect = 2e-69
 Identities = 59/152 (38%), Positives = 81/152 (53%), Gaps = 3/152 (1%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           ++KWE PR +++    LG G FG+V +  A G+   +    VAVK LK  A   E+  L+
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR-AQRYYNNMHGK 129
            EL +M  L  H N+V LLG CT   P  VI EY  YG L +FLR               
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +++ ++RDL  F  QVA+GM FL+S+    RD
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 17/54 (31%), Positives = 30/54 (55%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE 210
           V+DGY++ +P    + +Y+IM  CW  EP  RP F ++C  L++    +    +
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD 333

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  210 bits (537), Expect = 1e-67
 Identities = 64/156 (41%), Positives = 93/156 (59%), Gaps = 7/156 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREG--PCIVAVKTLKENAGERERLD 68
           D KWE PR  + +   LGEG FGQV   EA+GID  +      VAVK LK++A E++  D
Sbjct: 27  DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 86

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR---AQRYYNN 125
           L+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R    +  Y+ 
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                  +T +DL S  YQ+ARGM++L+S+    RD
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.4 bits (212), Expect = 7e-20
 Identities = 21/63 (33%), Positives = 41/63 (65%), Gaps = 2/63 (3%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET--DYIELERF 214
           +++G+R++KP +C  ELY +M  CW   P++RP F +L + L+++L   T  +Y++L + 
Sbjct: 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQP 331

Query: 215 PDH 217
            + 
Sbjct: 332 LEQ 334

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  211 bits (539), Expect = 1e-67
 Identities = 65/157 (41%), Positives = 94/157 (59%), Gaps = 7/157 (4%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREG--PCIVAVKTLKENAGERERL 67
            D KWE PR  + +   LGEGCFGQV   EA+GID  +      VAVK LK++A E++  
Sbjct: 72  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 131

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR---AQRYYN 124
           DL+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +LR+ R    +  Y+
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                   +T +DL S  YQ+ARGM++L+S+    RD
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 81.6 bits (202), Expect = 2e-18
 Identities = 19/51 (37%), Positives = 35/51 (68%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD 207
           +++G+R++KP +C  ELY +M  CW   P++RP F +L + L+++L   T+
Sbjct: 318 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  207 bits (530), Expect = 5e-66
 Identities = 65/156 (41%), Positives = 96/156 (61%), Gaps = 7/156 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCI--VAVKTLKENAGERERLD 68
           D +WE+PR  + +   LGEG FGQV   EA+G+D  +   +  VAVK LK +A E++  D
Sbjct: 61  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD 120

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNN 125
           L+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN 
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            H     L+S+DL S  YQVARGM++L+S+    RD
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 216

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 88.6 bits (220), Expect = 7e-21
 Identities = 22/74 (29%), Positives = 44/74 (59%), Gaps = 1/74 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           +++G+R++KP +C  ELY +M  CW   P++RP F +L + L++ ++  T   E+  +  
Sbjct: 306 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR-IVALTSNQEMGYYHH 364

Query: 217 HSYYNMVSLSGEKL 230
           H +++    + E L
Sbjct: 365 HHHHDYDIPTTENL 378

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  205 bits (523), Expect = 2e-65
 Identities = 56/169 (33%), Positives = 79/169 (46%), Gaps = 14/169 (8%)

Query: 4   PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE 63
           P+L        E PR +I+    +GEG FG+V++  A G+   E   +VAVK LKE A  
Sbjct: 32  PLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA 91

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
             + D  +E  +M   D +PN+V+LLG C   +P  ++ EY+ YG L  FLRS       
Sbjct: 92  DMQADFQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 150

Query: 124 NNMHG-----------KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +  H                L+  +      QVA GM +LS R    RD
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 85.4 bits (212), Expect = 7e-20
 Identities = 20/55 (36%), Positives = 32/55 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIEL 211
           VRDG  L  P++C  ELYN+M  CW K P +RP+F  +  +L+++       + +
Sbjct: 289 VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  203 bits (518), Expect = 7e-65
 Identities = 53/163 (32%), Positives = 78/163 (47%), Gaps = 8/163 (4%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           +    N        +    IK  D++GEG FGQV K     I         A+K +KE A
Sbjct: 8   HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKAR---IKKDGLRMDAAIKRMKEYA 64

Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA-- 119
            + +  D   EL V+  L  HPN++ LLG C  +   ++ +EY P+G L  FLR SR   
Sbjct: 65  SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 120 -QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               +   +  +++L+S+ L  F   VARGM +LS +    RD
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  102 bits (256), Expect = 4e-26
 Identities = 23/72 (31%), Positives = 40/72 (55%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           +  GYRLEKP +C  E+Y++M  CW ++P ERP+F ++   L ++L     Y+    +  
Sbjct: 254 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 313

Query: 217 HSYYNMVSLSGE 228
            +Y  +   + E
Sbjct: 314 FTYAGIDCSAEE 325

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  195 bits (499), Expect = 4e-62
 Identities = 54/151 (35%), Positives = 82/151 (54%), Gaps = 6/151 (3%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L
Sbjct: 17  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL 76

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E +VMK  +   +VVRLLG  ++ +P  VIME +  G L+S+LRS R     N +    
Sbjct: 77  NEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA-- 133

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              +   +     ++A GM +L++     RD
Sbjct: 134 -PPSLSKMIQMAGEIADGMAYLNANKFVHRD 163

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.3 bits (191), Expect = 5e-17
 Identities = 16/55 (29%), Positives = 28/55 (50%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIEL 211
           V +G  L+KPD+C   L+ +M  CW   P  RP+F E+   +++ +      +  
Sbjct: 253 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  194 bits (494), Expect = 2e-61
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 9/151 (5%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
            D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++ LD L
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  ++   + H N+VR +G   +  P F++ME +  G L+SFLR +R +        + 
Sbjct: 82  MEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR------PSQP 134

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +SL   DL      +A G Q+L       RD
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENHFIHRD 165

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 18/55 (32%), Positives = 28/55 (50%), Gaps = 1/55 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIEL 211
           V  G R++ P +C   +Y IM  CW  +P +RPNF  + + +E    +  D I  
Sbjct: 258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP-DVINT 311

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  194 bits (496), Expect = 4e-61
 Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 9/156 (5%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
                 D  EVPR++I +   LG G FG+V++ +  G+     P  VAVKTL E   E++
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117

Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
            LD L E  ++   + H N+VR +G   +  P F+++E +  G L+SFLR +R +     
Sbjct: 118 ELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR----- 171

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              + +SL   DL      +A G Q+L       RD
Sbjct: 172 -PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD 206

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 79.0 bits (195), Expect = 2e-17
 Identities = 18/55 (32%), Positives = 28/55 (50%), Gaps = 1/55 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIEL 211
           V  G R++ P +C   +Y IM  CW  +P +RPNF  + + +E    +  D I  
Sbjct: 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP-DVINT 352

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  191 bits (487), Expect = 1e-60
 Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 7/159 (4%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
                     + R+ I +   LGEG FG+V+  E   +   +   +VAVK LK+      
Sbjct: 2   AMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAA 60

Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR---AQRY 122
           R D  +E  ++  L  H ++V+  G C + +P  ++ EY+ +G L  FLR+         
Sbjct: 61  RKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119

Query: 123 YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                     L    +     Q+A GM +L+S+    RD
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 158

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.5 bits (189), Expect = 7e-17
 Identities = 17/46 (36%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +  G  LE+P  C +E+Y++M  CW +EP +R N  E+  +L  L 
Sbjct: 248 ITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  190 bits (485), Expect = 2e-60
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 6/151 (3%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
            E+    ++  + LGE  FG+V+K    G    E    VA+KTLK+ A    R +   E 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKS 130
            +   L  HPNVV LLG  T+ +P  +I  Y  +G L  FL            ++     
Sbjct: 64  MLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           ++L   D      Q+A GM++LSS  V  +D
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKD 153

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.2 bits (183), Expect = 4e-16
 Identities = 14/44 (31%), Positives = 23/44 (52%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK 200
           +R+   L  PD C   +Y +M  CW++ P+ RP F ++   L  
Sbjct: 243 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  191 bits (488), Expect = 2e-60
 Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 6/155 (3%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
                  + R+ I +   LGEG FG+V+  E   +   +   +VAVK LKE A E  R D
Sbjct: 31  SDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQD 89

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR--AQRYYNNM 126
             +E  ++  L  H ++VR  G CTE  P  ++ EY+ +G L  FLRS    A+      
Sbjct: 90  FQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148

Query: 127 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                 L    L +   QVA GM +L+      RD
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.0 bits (211), Expect = 8e-20
 Identities = 17/55 (30%), Positives = 29/55 (52%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIEL 211
           +  G  LE+P  C  E+Y IM  CW +EP +R +  ++   L+ L      Y+++
Sbjct: 273 ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDV 327

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  179 bits (455), Expect = 1e-55
 Identities = 53/160 (33%), Positives = 75/160 (46%), Gaps = 18/160 (11%)

Query: 8   QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERER 66
           Q   +   + R  + +  ILGEG FG V +      DG      VAVKT+K +N+ +RE 
Sbjct: 23  QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLK--VAVKTMKLDNSSQREI 80

Query: 67  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-----FFVIMEYVPYGKLQSFLRSSRAQR 121
            + L E   MK    HPNV+RLLG C E          VI+ ++ YG L ++L  SR   
Sbjct: 81  EEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL-- 137

Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                      +  + L  F   +A GM++LS+R    RD
Sbjct: 138 -----ETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD 172

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 79.2 bits (196), Expect = 8e-18
 Identities = 24/51 (47%), Positives = 33/51 (64%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD 207
           +  G+RL++P+ C  ELY IMY CW  +P +RP F+ L   LEKLL +  D
Sbjct: 262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  176 bits (448), Expect = 2e-54
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 19/161 (11%)

Query: 8   QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERER 66
           ++  +   +P Q   +  +LG+G FG V + +    DG      VAVK LK +     + 
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK--VAVKMLKADIIASSDI 69

Query: 67  LDLLQELTVMKTLDPHPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQ 120
            + L+E   MK  D HP+V +L+G               VI+ ++ +G L +FL +SR  
Sbjct: 70  EEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI- 127

Query: 121 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                      +L  + L  F   +A GM++LSSR    RD
Sbjct: 128 ------GENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRD 162

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.2 bits (232), Expect = 1e-22
 Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 8/72 (11%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN--------ETDY 208
           +  G RL++P  C  E+Y++MY CW  +P +RP+FT L   LE +L +        +  Y
Sbjct: 252 LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311

Query: 209 IELERFPDHSYY 220
           I +ER   H ++
Sbjct: 312 INIERAHHHHHH 323

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  168 bits (428), Expect = 2e-51
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 20/159 (12%)

Query: 5   VLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER 64
           VL Q   D     ++++K    LGEG FG+V        +   G  +VAVK LK +AG +
Sbjct: 17  VLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTG-EMVAVKALKADAGPQ 75

Query: 65  ERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRY 122
            R    QE+ +++TL  H ++++  GCC +       ++MEYVP G L+ +L        
Sbjct: 76  HRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---- 130

Query: 123 YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                     +    L  F  Q+  GM +L ++    RD
Sbjct: 131 ----------IGLAQLLLFAQQICEGMAYLHAQHYIHRD 159

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 17/46 (36%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +  G RL +PD C  E+Y++M  CW+ E + RP F  L  +L+ + 
Sbjct: 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  168 bits (427), Expect = 2e-51
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 18/152 (11%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D     ++ +K    LGEG FG+V  C     +G      VAVK+LK  +G     DL +
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCRYDP-EGDNTGEQVAVKSLKPESGGNHIADLKK 72

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ +++ L  H N+V+  G CTE       +IME++P G L+ +L  ++ +         
Sbjct: 73  EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--------- 122

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              +  +    +  Q+ +GM +L SR    RD
Sbjct: 123 ---INLKQQLKYAVQICKGMDYLGSRQYVHRD 151

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 17/46 (36%), Positives = 28/46 (60%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++G RL  P +C  E+Y +M  CW+ +P+ R +F  L +  E LL
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  165 bits (421), Expect = 9e-51
 Identities = 51/152 (33%), Positives = 78/152 (51%), Gaps = 21/152 (13%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + DKWE+ R  I +   LG G +G+V++              VAVKTLKE+  E E  + 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT-----VAVKTLKEDTMEVE--EF 56

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q         
Sbjct: 57  LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--------- 106

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              +++  L     Q++  M++L  +    RD
Sbjct: 107 --EVSAVVLLYMATQISSAMEYLEKKNFIHRD 136

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 84.6 bits (210), Expect = 8e-20
 Identities = 17/57 (29%), Positives = 32/57 (56%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELER 213
           +   YR+E+P+ C  ++Y +M  CW   P++RP+F E+    E +    +   E+E+
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 281

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  164 bits (418), Expect = 3e-50
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 1   MNDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN 60
           +N  ++              +   +++G G FG V+    L  DG++     AVK+L   
Sbjct: 7   LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRI 64

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKLQSFLRSSRA 119
               E    L E  +MK    HPNV+ LLG C   E    V++ Y+ +G L++F+R+   
Sbjct: 65  TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET- 122

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                      ++ T +DL  F  QVA+GM++L+S+    RD
Sbjct: 123 -----------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 76.9 bits (190), Expect = 5e-17
 Identities = 15/48 (31%), Positives = 25/48 (52%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN 204
           +  G RL +P++C   LY +M  CW  +   RP+F+EL   +  +   
Sbjct: 245 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  166 bits (422), Expect = 4e-50
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 1   MNDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN 60
           +N  ++              +   +++G G FG V+    L  DG++     AVK+L   
Sbjct: 71  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRI 128

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKLQSFLRSSRA 119
               E    L E  +MK    HPNV+ LLG C   E    V++ Y+ +G L++F+R+   
Sbjct: 129 TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET- 186

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                      ++ T +DL  F  QVA+GM+FL+S+    RD
Sbjct: 187 -----------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRD 217

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 83.3 bits (206), Expect = 7e-19
 Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 6/68 (8%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN--ETDYIELERF 214
           +  G RL +P++C   LY +M  CW  +   RP+F+EL   +  +        Y+ +   
Sbjct: 309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV--- 365

Query: 215 PDHSYYNM 222
            + +Y N+
Sbjct: 366 -NATYVNV 372

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  163 bits (416), Expect = 5e-50
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 21/162 (12%)

Query: 3   DPVLNQKSDDKWEVPRQH--IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN 60
           D  L  +  D   +P +        ++G+G FG V+  E +           A+K+L   
Sbjct: 4   DSALLAEVKD-VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQ--CAIKSLSRI 60

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVPYGKLQSFLRSSRA 119
              ++    L+E  +M+ L+ HPNV+ L+G     E    V++ Y+ +G L  F+RS + 
Sbjct: 61  TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ- 118

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                       + T +DL SF  QVARGM++L+ +    RD
Sbjct: 119 -----------RNPTVKDLISFGLQVARGMEYLAEQKFVHRD 149

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 79.6 bits (197), Expect = 5e-18
 Identities = 19/57 (33%), Positives = 32/57 (56%), Gaps = 2/57 (3%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL--LNETDYIEL 211
           +  G RL +P++C   LY +M  CW+ +P  RP F  L   +E+++  L    Y++L
Sbjct: 241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  164 bits (416), Expect = 1e-49
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 19/155 (12%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
           +  D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E    D
Sbjct: 31  EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHST-EEHLRD 88

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 126
             +E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +      
Sbjct: 89  FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER------ 141

Query: 127 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                 +    L  +  Q+ +GM++L ++    RD
Sbjct: 142 ------IDHIKLLQYTSQICKGMEYLGTKRYIHRD 170

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 75.1 bits (185), Expect = 4e-16
 Identities = 16/46 (34%), Positives = 29/46 (63%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++  RL +PD C  E+Y IM  CW+   N+RP+F +L   ++++ 
Sbjct: 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  162 bits (413), Expect = 2e-49
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 19/152 (12%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D  +   +H+K    LG+G FG V  C    +    G  +VAVK L+ +  E    D  +
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHSTEE-HLRDFER 60

Query: 72  ELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           E+ ++K+L  H N+V+  G C    +    +IMEY+PYG L+ +L+  + +         
Sbjct: 61  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------- 110

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              +    L  +  Q+ +GM++L ++    RD
Sbjct: 111 ---IDHIKLLQYTSQICKGMEYLGTKRYIHRD 139

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 75.0 bits (185), Expect = 2e-16
 Identities = 17/48 (35%), Positives = 30/48 (62%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN 204
           +++  RL +PD C  E+Y IM  CW+   N+RP+F +L   ++++  N
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  162 bits (412), Expect = 4e-49
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 19/156 (12%)

Query: 8   QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL 67
               D      +H+K    LG+G FG V  C    +    G  +VAVK L+ +  +++R 
Sbjct: 12  YACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTG-ALVAVKQLQHSGPDQQR- 69

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           D  +E+ ++K L     +V+  G      ++   ++MEY+P G L+ FL+  RA+     
Sbjct: 70  DFQREIQILKALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----- 123

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                  L +  L  +  Q+ +GM++L SR    RD
Sbjct: 124 -------LDASRLLLYSSQICKGMEYLGSRRCVHRD 152

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 80.1 bits (198), Expect = 6e-18
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 1/61 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           + +G RL  P  C  E++ +M  CW   P +RP+F+ L   L+  L + +   E   F  
Sbjct: 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM-LWSGSRGCETHAFTA 315

Query: 217 H 217
           H
Sbjct: 316 H 316

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  162 bits (412), Expect = 4e-49
 Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 17/152 (11%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
                      ++   +LG G FG V K   +  +G      V +K +++ +G +    +
Sbjct: 4   KVLARIFKETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAV 62

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
              +  + +LD H ++VRLLG C       ++ +Y+P G L   +R  R           
Sbjct: 63  TDHMLAIGSLD-HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA--------- 111

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              L  + L ++  Q+A+GM +L   G+  R+
Sbjct: 112 ---LGPQLLLNWGVQIAKGMYYLEEHGMVHRN 140

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.8 bits (205), Expect = 6e-19
 Identities = 17/60 (28%), Positives = 30/60 (50%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           +  G RL +P  C  ++Y +M  CW  + N RP F EL +   ++  +   Y+ ++R   
Sbjct: 230 LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESG 289

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  160 bits (407), Expect = 2e-48
 Identities = 47/152 (30%), Positives = 65/152 (42%), Gaps = 17/152 (11%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
                E+    I +  I+G G  G+V          R+ P  VA+K LK    ER+R D 
Sbjct: 40  RSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP--VAIKALKAGYTERQRRDF 97

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L E ++M   D HPN++RL G  T      ++ EY+  G L +FLR+   Q         
Sbjct: 98  LSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------- 147

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               T   L      V  GM++LS  G   RD
Sbjct: 148 ---FTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 76.2 bits (188), Expect = 1e-16
 Identities = 17/49 (34%), Positives = 29/49 (59%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           V +GYRL  P  C   L+ +M  CW K+  +RP F+++  +L+ L+ + 
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  159 bits (404), Expect = 2e-48
 Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 25/153 (16%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
               W +  + +K+   +G+G FG V   +  G         VAVK +K +A  +     
Sbjct: 12  YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQ---AF 61

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           L E +VM  L  H N+V+LLG   E++   +++ EY+  G L  +LRS            
Sbjct: 62  LAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------- 112

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               L    L  F   V   M++L       RD
Sbjct: 113 ---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 79.9 bits (198), Expect = 4e-18
 Identities = 17/49 (34%), Positives = 28/49 (57%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           V  GY+++ PD C   +Y +M  CW  +   RP+F +L + LE +  +E
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  155 bits (395), Expect = 5e-47
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 18/152 (11%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   +E+ R+ I++   +GEG FG V +   +  +       VA+KT K    +  R   
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALA--VAIKTCKNCTSDSVREKF 63

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           LQE   M+  D HP++V+L+G  T + P ++IME    G+L+SFL+  +           
Sbjct: 64  LQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS--------- 112

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              L    L  + YQ++  + +L S+    RD
Sbjct: 113 ---LDLASLILYAYQLSTALAYLESKRFVHRD 141

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 73.4 bits (181), Expect = 7e-16
 Identities = 20/49 (40%), Positives = 28/49 (57%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           + +G RL  P +C   LY++M  CW  +P+ RP FTEL   L  +L  E
Sbjct: 230 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  161 bits (408), Expect = 5e-47
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 21/160 (13%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
                   + DKWE+ R  I +   LG G +G+V++              VAVKTLKE+ 
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLT-----VAVKTLKEDT 257

Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
            E E  + L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +LR    Q 
Sbjct: 258 MEVE--EFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ- 313

Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                      +++  L     Q++  M++L  +    R+
Sbjct: 314 ----------EVSAVVLLYMATQISSAMEYLEKKNFIHRN 343

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 81.0 bits (200), Expect = 6e-18
 Identities = 17/57 (29%), Positives = 32/57 (56%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELER 213
           +   YR+E+P+ C  ++Y +M  CW   P++RP+F E+    E +    +   E+E+
Sbjct: 432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 488

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  157 bits (399), Expect = 6e-47
 Identities = 60/204 (29%), Positives = 80/204 (39%), Gaps = 56/204 (27%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
            KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ 
Sbjct: 15  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 74

Query: 72  ELTVMKTLDPHPNVVRLLGCCT-EKEPFFVIMEYVPYGKLQSFL---------------- 114
           EL ++  +  H NVV LLG CT    P  VI+E+  +G L ++L                
Sbjct: 75  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134

Query: 115 -------------------------------------RSSRAQRYYNNMHGKSNSLTSRD 137
                                                  S  +          + LT   
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194

Query: 138 LTSFCYQVARGMQFLSSRGV--RD 159
           L  + +QVA+GM+FL+SR    RD
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRD 218

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.7 bits (199), Expect = 4e-18
 Identities = 19/46 (41%), Positives = 29/46 (63%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++G R+  PD+   E+Y  M  CW  EP++RP F+EL + L  LL
Sbjct: 309 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  155 bits (394), Expect = 7e-47
 Identities = 51/151 (33%), Positives = 72/151 (47%), Gaps = 23/151 (15%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW           G   VAVK+LK+ +   +    L
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYY------NGHTKVAVKSLKQGSMSPD--AFL 56

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T +EP ++I EY+  G L  FL++              
Sbjct: 57  AEANLMKQLQ-HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI---------- 104

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             LT   L     Q+A GM F+  R    RD
Sbjct: 105 -KLTINKLLDMAAQIAEGMAFIEERNYIHRD 134

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 78.8 bits (195), Expect = 9e-18
 Identities = 21/55 (38%), Positives = 29/55 (52%), Gaps = 1/55 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN-ETDYIE 210
           +  GYR+ +PD+C  ELY +M  CW + P +RP F  L  +LE      E  Y  
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  157 bits (399), Expect = 1e-46
 Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 17/151 (11%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +   E+   +I +  ++G G FG+V          +E    VA+KTLK    E++R D L
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTLKVGYTEKQRRDFL 94

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E ++M   D HPN++RL G  T+ +P  ++ EY+  G L SFLR   AQ          
Sbjct: 95  GEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---------- 143

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              T   L      +A GM++LS  G   RD
Sbjct: 144 --FTVIQLVGMLRGIASGMKYLSDMGYVHRD 172

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 76.2 bits (188), Expect = 2e-16
 Identities = 21/52 (40%), Positives = 29/52 (55%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY 208
           V +GYRL  P  C   LY +M  CW K+ N RP F ++  +L+KL+ N    
Sbjct: 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL 314

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (395), Expect = 2e-46
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 17/146 (11%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
           +     K   +LG G FG V+K      +G +    VA+K L+E    +   ++L E  V
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGL-WIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M ++D +P+V RLLG C       +I + +P+G L  ++R  +              + S
Sbjct: 71  MASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN------------IGS 116

Query: 136 RDLTSFCYQVARGMQFLSSRGV--RD 159
           + L ++C Q+A+GM +L  R +  RD
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRD 142

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 84.2 bits (209), Expect = 2e-19
 Identities = 17/56 (30%), Positives = 28/56 (50%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE 212
           +  G RL +P  C  ++Y IM  CW  + + RP F EL     K+  +   Y+ ++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  153 bits (389), Expect = 4e-46
 Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 23/161 (14%)

Query: 1   MNDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN 60
            N P         WE+  + +     LG G FG V   +        G   VA+K +KE 
Sbjct: 6   KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKW------RGQYDVAIKMIKEG 59

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 120
           +   +  + ++E  VM  L  H  +V+L G CT++ P F+I EY+  G L ++LR  R +
Sbjct: 60  SMSED--EFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 116

Query: 121 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                         ++ L   C  V   M++L S+    RD
Sbjct: 117 ------------FQTQQLLEMCKDVCEAMEYLESKQFLHRD 145

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 76.1 bits (188), Expect = 9e-17
 Identities = 16/49 (32%), Positives = 26/49 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           +  G RL +P     ++Y IMY CW ++ +ERP F  L   +  ++  E
Sbjct: 234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  154 bits (390), Expect = 9e-46
 Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 16/151 (10%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
               E+    +    ++G G FG+V+K       G+     VA+KTLK    E++R+D L
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-KEVPVAIKTLKAGYTEKQRVDFL 94

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +M     H N++RL G  ++ +P  +I EY+  G L  FLR    +          
Sbjct: 95  GEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---------- 143

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              +   L      +A GM++L++     RD
Sbjct: 144 --FSVLQLVGMLRGIAAGMKYLANMNYVHRD 172

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 79.3 bits (196), Expect = 1e-17
 Identities = 22/71 (30%), Positives = 33/71 (46%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           + DG+RL  P  C   +Y +M  CW +E   RP F ++  +L+KL+        L  F  
Sbjct: 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDP 322

Query: 217 HSYYNMVSLSG 227
                + S SG
Sbjct: 323 RVSIRLPSTSG 333

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  156 bits (397), Expect = 1e-45
 Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 25/159 (15%)

Query: 4   PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE 63
              ++     W +  + +K+   +G+G FG V   +  G         VAVK +K +A  
Sbjct: 178 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATA 230

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-FFVIMEYVPYGKLQSFLRSSRAQRY 122
           +     L E +VM  L  H N+V+LLG   E++   +++ EY+  G L  +LRS      
Sbjct: 231 Q---AFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-- 284

Query: 123 YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                     L    L  F   V   M++L       RD
Sbjct: 285 ---------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 77.8 bits (192), Expect = 7e-17
 Identities = 17/49 (34%), Positives = 28/49 (57%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           V  GY+++ PD C   +Y++M  CW  +   RP F +L + LE +  +E
Sbjct: 399 VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  150 bits (380), Expect = 8e-45
 Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 18/150 (12%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
            ++ + R+ + +  ILGEG FG+V++       G +    VAVKT K++     +   + 
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN--VAVKTCKKDCTLDNKEKFMS 62

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  +MK LD HP++V+L+G    +EP ++IME  PYG+L  +L  ++            N
Sbjct: 63  EAVIMKNLD-HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNK------------N 108

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           SL    L  +  Q+ + M +L S     RD
Sbjct: 109 SLKVLTLVLYSLQICKAMAYLESINCVHRD 138

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.4 bits (181), Expect = 8e-16
 Identities = 23/54 (42%), Positives = 29/54 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE 210
           +  G RL KPD C   LY +M  CWD +P++RP FTEL   L  +   E D   
Sbjct: 227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  156 bits (396), Expect = 2e-44
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 18/160 (11%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
            +      S   +E+ R+ I++   +GEG FG V +   +  +       VA+KT K   
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMA--VAIKTCKNCT 430

Query: 62  GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
            +  R   LQE   M+  D HP++V+L+G  T + P ++IME    G+L+SFL+  +   
Sbjct: 431 SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFS- 487

Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                      L    L  + YQ++  + +L S+    RD
Sbjct: 488 -----------LDLASLILYAYQLSTALAYLESKRFVHRD 516

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 73.0 bits (179), Expect = 4e-15
 Identities = 20/49 (40%), Positives = 28/49 (57%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           + +G RL  P +C   LY++M  CW  +P+ RP FTEL   L  +L  E
Sbjct: 605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  148 bits (375), Expect = 4e-44
 Identities = 43/149 (28%), Positives = 63/149 (42%), Gaps = 23/149 (15%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           KW +    +     +G G FG V     L          VA+KT++E A   E  D ++E
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGAMSEE--DFIEE 53

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
             VM  L  HP +V+L G C E+ P  ++ E++ +G L  +LR+ R              
Sbjct: 54  AEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL------------ 100

Query: 133 LTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             +  L   C  V  GM +L    V  RD
Sbjct: 101 FAAETLLGMCLDVCEGMAYLEEACVIHRD 129

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.2 bits (183), Expect = 3e-16
 Identities = 16/46 (34%), Positives = 25/46 (54%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +  G+RL KP      +Y IM +CW + P +RP F+ L   L ++ 
Sbjct: 218 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  147 bits (374), Expect = 5e-44
 Identities = 45/149 (30%), Positives = 65/149 (43%), Gaps = 23/149 (15%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
             E+ R+ I +   LG G FG V   +       +G   VAVK +KE +   +  +  QE
Sbjct: 2   HMELKREEITLLKELGSGQFGVVKLGKW------KGQYDVAVKMIKEGSMSED--EFFQE 53

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
              M  L  HP +V+  G C+++ P +++ EY+  G L ++LRS                
Sbjct: 54  AQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG------------ 100

Query: 133 LTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           L    L   CY V  GM FL S     RD
Sbjct: 101 LEPSQLLEMCYDVCEGMAFLESHQFIHRD 129

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 75.3 bits (186), Expect = 1e-16
 Identities = 18/49 (36%), Positives = 26/49 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           V  G+RL +P      +Y IMY CW + P +RP F +L   +E L   +
Sbjct: 218 VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (377), Expect = 6e-44
 Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 17/146 (11%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
           +     K   +LG G FG V+K      +G +    VA+K L+E    +   ++L E  V
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGL-WIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M ++D +P+V RLLG C       +I + +P+G L  ++R  +              + S
Sbjct: 71  MASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN------------IGS 116

Query: 136 RDLTSFCYQVARGMQFLSSRGV--RD 159
           + L ++C Q+A+GM +L  R +  RD
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRD 142

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 17/56 (30%), Positives = 28/56 (50%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE 212
           +  G RL +P  C  ++Y IM  CW  + + RP F EL     K+  +   Y+ ++
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (375), Expect = 4e-43
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 20/158 (12%)

Query: 4   PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE 63
            +      DKW +  + + + + +G G FG+V+       +       VAVK+ +E    
Sbjct: 99  VLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL-----VAVKSCRETLPP 153

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
             +   LQE  ++K    HPN+VRL+G CT+K+P +++ME V  G   +FLR+       
Sbjct: 154 DLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG----- 207

Query: 124 NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                    L  + L       A GM++L S+    RD
Sbjct: 208 -------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 71.9 bits (177), Expect = 5e-15
 Identities = 15/49 (30%), Positives = 25/49 (51%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           V  G RL  P+ C   ++ +M  CW  EP +RP+F+ +   L+ +    
Sbjct: 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  147 bits (373), Expect = 3e-42
 Identities = 51/152 (33%), Positives = 67/152 (44%), Gaps = 23/152 (15%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
             D WE+PR+ +K+   LG G FG+VW               VAVKT+K  +   E    
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATY------NKHTKVAVKTMKPGSMSVE--AF 230

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L E  VMKTL  H  +V+L    T KEP ++I E++  G L  FL+S             
Sbjct: 231 LAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS--------- 279

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                   L  F  Q+A GM F+  R    RD
Sbjct: 280 --KQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 80.5 bits (199), Expect = 8e-18
 Identities = 22/56 (39%), Positives = 32/56 (57%), Gaps = 1/56 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN-ETDYIEL 211
           +  GYR+ +P++C  ELYNIM  CW   P ERP F  +  +L+      E+ Y E+
Sbjct: 398 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  143 bits (362), Expect = 5e-42
 Identities = 27/150 (18%), Positives = 59/150 (39%), Gaps = 18/150 (12%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWK--CEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
            ++  + +   + LG+G F +++K     +G  G+     V +K L +           +
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFE 61

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
             ++M  L  H ++V   G C   +   ++ E+V +G L ++L+ ++            N
Sbjct: 62  AASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK------------N 108

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            +          Q+A  M FL    +   +
Sbjct: 109 CINILWKLEVAKQLAAAMHFLEENTLIHGN 138

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 71.2 bits (175), Expect = 6e-15
 Identities = 17/65 (26%), Positives = 29/65 (44%), Gaps = 6/65 (9%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
             D ++L  P     EL N++  C D EP+ RP+F  +   L  L   +     + R   
Sbjct: 231 YEDRHQLPAPKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL----VPRGSH 284

Query: 217 HSYYN 221
           H +++
Sbjct: 285 HHHHH 289

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  147 bits (372), Expect = 1e-41
 Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 23/158 (14%)

Query: 4   PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE 63
           P     + D WE+PR+ +++   LG+GCFG+VW           G   VA+KTLK     
Sbjct: 252 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW------NGTTRVAIKTLKPGTMS 305

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
            E    LQE  VMK L  H  +V+L    +E EP +++ EY+  G L  FL+    +   
Sbjct: 306 PE--AFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK--- 358

Query: 124 NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                    L    L     Q+A GM ++       RD
Sbjct: 359 --------YLRLPQLVDMAAQIASGMAYVERMNYVHRD 388

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.3 bits (198), Expect = 1e-17
 Identities = 23/59 (38%), Positives = 28/59 (47%), Gaps = 1/59 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN-ETDYIELERF 214
           V  GYR+  P  C   L+++M  CW KEP ERP F  L   LE    + E  Y   E  
Sbjct: 477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  144 bits (366), Expect = 3e-41
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 23/158 (14%)

Query: 4   PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE 63
           P     + D WE+PR+ +++   LG+GCFG+VW           G   VA+KTLK     
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW------NGTTRVAIKTLKPGTMS 222

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
            E    LQE  VMK L  H  +V+L    + +EP +++ EY+  G L  FL+    +   
Sbjct: 223 PE--AFLQEAQVMKKLR-HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK--- 275

Query: 124 NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                    L    L     Q+A GM ++       RD
Sbjct: 276 --------YLRLPQLVDMAAQIASGMAYVERMNYVHRD 305

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 79.4 bits (196), Expect = 2e-17
 Identities = 23/59 (38%), Positives = 28/59 (47%), Gaps = 1/59 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN-ETDYIELERF 214
           V  GYR+  P  C   L+++M  CW KEP ERP F  L   LE    + E  Y   E  
Sbjct: 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  139 bits (352), Expect = 1e-40
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 22/153 (14%)

Query: 11  DDKWEVPRQHIKVFDI-LGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERLD 68
           D K  + R ++ + DI LG G FG V +    G+   R+    VA+K LK+   + +  +
Sbjct: 1   DKKLFLKRDNLLIADIELGCGNFGSVRQ----GVYRMRKKQIDVAIKVLKQGTEKADTEE 56

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           +++E  +M  LD +P +VRL+G C   E   ++ME    G L  FL   R +        
Sbjct: 57  MMREAQIMHQLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-------- 106

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               +   ++    +QV+ GM++L  +    RD
Sbjct: 107 ----IPVSNVAELLHQVSMGMKYLEEKNFVHRD 135

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 75.0 bits (185), Expect = 3e-16
 Identities = 16/61 (26%), Positives = 26/61 (42%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           +  G R+E P  C  ELY +M  CW  +  +RP+F  +   +     +    +E      
Sbjct: 226 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 285

Query: 217 H 217
           H
Sbjct: 286 H 286

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  137 bits (347), Expect = 1e-39
 Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 20/154 (12%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERL 67
                 +  + +++ + LG+G FG V + E     G+     VAVK LK +         
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMD 66

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
           D ++E+  M +LD H N++RL G      P  ++ E  P G L   LR  +         
Sbjct: 67  DFIREVNAMHSLD-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGH------- 117

Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                     L+ +  QVA GM +L S+    RD
Sbjct: 118 -----FLLGTLSRYAVQVAEGMGYLESKRFIHRD 146

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.1 bits (175), Expect = 7e-15
 Identities = 17/44 (38%), Positives = 28/44 (63%)

Query: 158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           ++G RL +P+ C +++YN+M  CW  +P +RP F  L D L + 
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  132 bits (335), Expect = 6e-38
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 24/155 (15%)

Query: 10  SDDKWEVPRQHIKVFD-ILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGERERL 67
              +  + R+ + + D  LG G FG V K    G    ++    VAVK LK  A +    
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKK----GYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 68  -DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 126
            +LL E  VM+ LD +P +VR++G C   E + ++ME    G L  +L+ +R        
Sbjct: 63  DELLAEANVMQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR-------- 112

Query: 127 HGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                 +  +++    +QV+ GM++L       RD
Sbjct: 113 -----HVKDKNIIELVHQVSMGMKYLEESNFVHRD 142

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 71.1 bits (175), Expect = 5e-15
 Identities = 14/54 (25%), Positives = 23/54 (42%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE 210
           +  G R+  P  C RE+Y++M  CW  +   RP F  +   L     +  +   
Sbjct: 233 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 7e-34
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 22/157 (14%)

Query: 7   NQKSDDKWEVPRQHIKVFDI-LGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENAGER 64
            +  D K  + R ++ + DI LG G FG V +    G+   R+    VA+K LK+   + 
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQ----GVYRMRKKQIDVAIKVLKQGTEKA 378

Query: 65  ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 124
           +  ++++E  +M  LD +P +VRL+G C   E   ++ME    G L  FL   R +    
Sbjct: 379 DTEEMMREAQIMHQLD-NPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE---- 432

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                   +   ++    +QV+ GM++L  +    R+
Sbjct: 433 --------IPVSNVAELLHQVSMGMKYLEEKNFVHRN 461

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 71.9 bits (176), Expect = 8e-15
 Identities = 15/54 (27%), Positives = 25/54 (46%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE 210
           +  G R+E P  C  ELY +M  CW  +  +RP+F  +   +     +    +E
Sbjct: 552 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (296), Expect = 5e-32
 Identities = 38/152 (25%), Positives = 63/152 (41%), Gaps = 21/152 (13%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S          +   ++LG+GCFGQ  K          G  ++ +K L     E  +   
Sbjct: 1   SMPHRIFRPSDLIHGEVLGKGCFGQAIK----VTHRETGE-VMVMKELI-RFDEETQRTF 54

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E+ VM+ L+ HPNV++ +G   + +    I EY+  G L+  ++S             
Sbjct: 55  LKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS------------M 101

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            +        SF   +A GM +L S  +  RD
Sbjct: 102 DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 16/63 (25%), Positives = 27/63 (42%)

Query: 156 GVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFP 215
            VR       P +C    + I   C D +P +RP+F +L   LE L ++   ++ L    
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294

Query: 216 DHS 218
           +  
Sbjct: 295 EQL 297

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  111 bits (280), Expect = 6e-30
 Identities = 37/157 (23%), Positives = 60/157 (38%), Gaps = 27/157 (17%)

Query: 7   NQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLKE-NAGER 64
           ++ + D WE+P   I V   +G G FG V+K    G   G      VAVK L       +
Sbjct: 12  SRDAADDWEIPDGQITVGQRIGSGSFGTVYK----GKWHGD-----VAVKMLNVTAPTPQ 62

Query: 65  ERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 124
           +      E+ V++    H N++  +G  T      ++ ++     L   L          
Sbjct: 63  QLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAIVTQWCEGSSLYHHL---------- 110

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             H        + L     Q ARGM +L ++ +  RD
Sbjct: 111 --HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 12/48 (25%), Positives = 23/48 (47%)

Query: 155 RGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           RG       +   +C + +  +M  C  K+ +ERP+F  +   +E+L 
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  107 bits (270), Expect = 2e-28
 Identities = 36/160 (22%), Positives = 63/160 (39%), Gaps = 30/160 (18%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK------ENAGE 63
                 +    I+    +G+G FG V K   L  D       VA+K+L       E    
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGR-LVKDKSV----VAIKSLILGDSEGETEMI 64

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
            +  +  +E+ +M  L+ HPN+V+L G      P  ++ME+VP G L   L         
Sbjct: 65  EKFQEFQREVFIMSNLN-HPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRL--------- 112

Query: 124 NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV----RD 159
                K++ +           +A G++++ ++      RD
Sbjct: 113 ---LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRD 149

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 57.3 bits (139), Expect = 4e-10
 Identities = 14/45 (31%), Positives = 24/45 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
             +G R   P+ C   L N++  CW  +P +RP+F+ +   L +L
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (271), Expect = 2e-28
 Identities = 30/162 (18%), Positives = 60/162 (37%), Gaps = 26/162 (16%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLK-E 59
                      +W++P + +++ +++G+G FGQV+     G   G      VA++ +  E
Sbjct: 16  RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYH----GRWHGE-----VAIRLIDIE 66

Query: 60  NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA 119
              E +     +E+   +    H NVV  +G C       +I        L S +     
Sbjct: 67  RDNEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVV----- 120

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                        L          ++ +GM +L ++G+  +D
Sbjct: 121 -------RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 57.0 bits (138), Expect = 6e-10
 Identities = 17/48 (35%), Positives = 26/48 (54%), Gaps = 1/48 (2%)

Query: 156 GVRDGYRLEKPD-HCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
            +  G +         +E+ +I+ +CW  E  ERP FT+L D+LEKL 
Sbjct: 254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  106 bits (267), Expect = 8e-28
 Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 23/163 (14%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA 61
           N         D  ++P   + + + +G G FG V + E  G D       VAVK L E  
Sbjct: 20  NLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD-------VAVKILMEQD 72

Query: 62  GERERL-DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 120
              ER+ + L+E+ +MK L  HPN+V  +G  T+     ++ EY+  G L   L  S A+
Sbjct: 73  FHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR 131

Query: 121 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV----RD 159
                       L  R   S  Y VA+GM +L +R      R+
Sbjct: 132 E----------QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 56.9 bits (138), Expect = 6e-10
 Identities = 16/46 (34%), Positives = 24/46 (52%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
                RLE P +   ++  I+  CW  EP +RP+F  + DLL  L+
Sbjct: 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  105 bits (264), Expect = 1e-27
 Identities = 34/146 (23%), Positives = 62/146 (42%), Gaps = 25/146 (17%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE---RERLDLL 70
            E+    + + +I+G G FG+V++   +G +       VAVK  + +  E   +   ++ 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVR 54

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           QE  +   L  HPN++ L G C ++    ++ME+   G L   L                
Sbjct: 55  QEAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--------------G 99

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRG 156
             +    L ++  Q+ARGM +L    
Sbjct: 100 KRIPPDILVNWAVQIARGMNYLHDEA 125

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 59.6 bits (145), Expect = 6e-11
 Identities = 16/59 (27%), Positives = 25/59 (42%), Gaps = 7/59 (11%)

Query: 143 YQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
             VA G+         +   L  P  C      +M  CW+ +P+ RP+FT + D L  +
Sbjct: 220 LAVAYGV-------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  103 bits (260), Expect = 3e-27
 Identities = 35/150 (23%), Positives = 58/150 (38%), Gaps = 24/150 (16%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGI-DGREGPCIVAVKTLK-ENAGERERLD 68
           +    +  + +     L E   G++WK    G   G +    + VK LK  +   R+  D
Sbjct: 2   NKHSGIDFKQLNFLTKLNENHSGELWK----GRWQGND----IVVKVLKVRDWSTRKSRD 53

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 126
             +E   ++    HPNV+ +LG C         +I  ++PYG L + L            
Sbjct: 54  FNEECPRLRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE---------- 102

Query: 127 HGKSNSLTSRDLTSFCYQVARGMQFLSSRG 156
            G +  +       F   +ARGM FL +  
Sbjct: 103 -GTNFVVDQSQAVKFALDMARGMAFLHTLE 131

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 56.1 bits (136), Expect = 9e-10
 Identities = 12/45 (26%), Positives = 22/45 (48%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
             +G R   P      +  +M  C +++P +RP F  +  +LEK+
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  100 bits (251), Expect = 2e-25
 Identities = 37/139 (26%), Positives = 63/139 (45%), Gaps = 23/139 (16%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
             +  + I+V +++G G FG V K +    D       VA+K ++    E ER   + EL
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIES---ESERKAFIVEL 52

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             +  ++ HPN+V+L G C    P  ++MEY   G L + L  +                
Sbjct: 53  RQLSRVN-HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE----------PLPYY 99

Query: 134 TSRDLTSFCYQVARGMQFL 152
           T+    S+C Q ++G+ +L
Sbjct: 100 TAAHAMSWCLQCSQGVAYL 118

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 58.1 bits (141), Expect = 2e-10
 Identities = 14/63 (22%), Positives = 30/63 (47%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           V +G R     +  + + ++M  CW K+P++RP+  E+  ++  L+       E  ++P 
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276

Query: 217 HSY 219
              
Sbjct: 277 QHS 279

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 86.6 bits (215), Expect = 1e-20
 Identities = 34/138 (24%), Positives = 56/138 (40%), Gaps = 17/138 (12%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLDPHP 83
           + +G G FG V+KC    +   +G CI A+K  K   AG  +  + L+E+     L  H 
Sbjct: 17  EKIGSGEFGSVFKC----VKRLDG-CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 143
           +VVR      E +   +  EY   G L   +  +             +     +L     
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENY---------RIMSYFKEAELKDLLL 122

Query: 144 QVARGMQFLSSRGV--RD 159
           QV RG++++ S  +   D
Sbjct: 123 QVGRGLRYIHSMSLVHMD 140

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 80.9 bits (200), Expect = 3e-18
 Identities = 28/148 (18%), Positives = 53/148 (35%), Gaps = 34/148 (22%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG---ERERLD 68
           +        +++ ++   G FG VWK + L          VAVK          + E   
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVKIFPIQDKQSWQNE--- 66

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 124
              E+  +  +  H N+++ +G            ++I  +   G L  FL          
Sbjct: 67  --YEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---------- 113

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFL 152
               K+N ++  +L      +ARG+ +L
Sbjct: 114 ----KANVVSWNELCHIAETMARGLAYL 137

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 8/50 (16%), Positives = 18/50 (36%), Gaps = 5/50 (10%)

Query: 157 VRDGYRLEKPDHCR-----RELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           V    R    D+ +       L   +  CWD +   R +   + + + ++
Sbjct: 267 VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 80.3 bits (198), Expect = 5e-18
 Identities = 28/152 (18%), Positives = 59/152 (38%), Gaps = 33/152 (21%)

Query: 8   QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL 67
           + +  +  +   ++K+ +++G G +G V+K     +D R     VAVK          R 
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGS---LDERP----VAVKVFS----FANRQ 50

Query: 68  DLLQELTVMKT--LDPHPNVVRLLGCCTE-----KEPFFVIMEYVPYGKLQSFLRSSRAQ 120
           + + E  + +   ++ H N+ R +          +  + ++MEY P G L  +L      
Sbjct: 51  NFINEKNIYRVPLME-HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----- 104

Query: 121 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL 152
                     ++          + V RG+ +L
Sbjct: 105 ---------LHTSDWVSSCRLAHSVTRGLAYL 127

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 42.5 bits (100), Expect = 5e-05
 Identities = 11/70 (15%), Positives = 26/70 (37%), Gaps = 7/70 (10%)

Query: 157 VRDGYRLEKPDHCR------RELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE 210
            R+  R + P+  +      R L   +  CWD++   R       + + + L+   +  +
Sbjct: 266 SREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE-LMMIWERNK 324

Query: 211 LERFPDHSYY 220
                 H ++
Sbjct: 325 SVSPTAHHHH 334

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 79.7 bits (197), Expect = 6e-18
 Identities = 32/161 (19%), Positives = 68/161 (42%), Gaps = 26/161 (16%)

Query: 3   DPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKT--LKEN 60
            P +   +   + + ++       +G G F +V++   L  DG      VA+K   + + 
Sbjct: 23  RPDMGYNTLANFRIEKK-------IGRGQFSEVYRAACLL-DGV----PVALKKVQIFDL 70

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 120
              + R D ++E+ ++K L+ HPNV++      E     +++E    G L   ++  + Q
Sbjct: 71  MDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129

Query: 121 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +           +  R +  +  Q+   ++ + SR V  RD
Sbjct: 130 KRL---------IPERTVWKYFVQLCSALEHMHSRRVMHRD 161

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 79.8 bits (197), Expect = 9e-18
 Identities = 27/154 (17%), Positives = 54/154 (35%), Gaps = 30/154 (19%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
                + I++   +G+G +G+VW  +  G         VAVK         E     +E 
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEK-------VAVKVFF----TTEEASWFRET 80

Query: 74  TVMKTLDP-HPNVVRLLGCCTEKEP----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
            + +T+   H N++  +    +        ++I +Y   G L  +L              
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-------------- 126

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYR 162
           KS +L ++ +    Y    G+  L +       +
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 45.1 bits (107), Expect = 6e-06
 Identities = 12/51 (23%), Positives = 17/51 (33%), Gaps = 5/51 (9%)

Query: 157 VRDGYRLEKP-----DHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
                R   P     D C R++  +M  CW   P  R     +   L K+ 
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 77.5 bits (191), Expect = 5e-17
 Identities = 29/154 (18%), Positives = 51/154 (33%), Gaps = 27/154 (17%)

Query: 8   QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL 67
           +  D ++      +     +G G FG+V +      D + G    AVK ++         
Sbjct: 47  KPVDYEYREEVHWMTHQPRVGRGSFGEVHR----MKDKQTGF-QCAVKKVRLEVFRV--- 98

Query: 68  DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
              +EL     L   P +V L G   E     + ME +  G L   ++            
Sbjct: 99  ---EELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC-------- 146

Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                L       +  Q   G+++L +R +   D
Sbjct: 147 -----LPEDRALYYLGQALEGLEYLHTRRILHGD 175

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 76.2 bits (188), Expect = 9e-17
 Identities = 25/139 (17%), Positives = 49/139 (35%), Gaps = 30/139 (21%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT 78
           + I + + +G+G +G+VW+    G +       VAVK        R+     +E  +  T
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGEN-------VAVKIFSS----RDEKSWFRETELYNT 56

Query: 79  LDP-HPNVVRLLGCCT----EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           +   H N++  +             ++I  Y   G L  +L              +  +L
Sbjct: 57  VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--------------QLTTL 102

Query: 134 TSRDLTSFCYQVARGMQFL 152
            +         +A G+  L
Sbjct: 103 DTVSCLRIVLSIASGLAHL 121

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 45.0 bits (107), Expect = 6e-06
 Identities = 11/50 (22%), Positives = 17/50 (34%), Gaps = 5/50 (10%)

Query: 157 VRDGYRLEKPDH-----CRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
             D  R   P+          L  +M  CW + P+ R     +   L K+
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 76.3 bits (188), Expect = 1e-16
 Identities = 37/159 (23%), Positives = 59/159 (37%), Gaps = 31/159 (19%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           DILG+G    V++        ++   + A+K     +  R     ++E  V+K L+ H N
Sbjct: 15  DILGQGATANVFRGRH-----KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKN 68

Query: 85  VVRLLGC--CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           +V+L      T      +IME+ P G L + L               +  L   +     
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE----------PSNAYGLPESEFLIVL 118

Query: 143 YQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYY 179
             V  GM  L   G+  R+   + KP        NIM  
Sbjct: 119 RDVVGGMNHLRENGIVHRN---I-KPG-------NIMRV 146

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 76.4 bits (188), Expect = 1e-16
 Identities = 27/146 (18%), Positives = 55/146 (37%), Gaps = 31/146 (21%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
            +  + R  I + + +G+G FG+VW+ +  G +       VAVK        RE     +
Sbjct: 36  VQRTIART-IVLQESIGKGRFGEVWRGKWRGEE-------VAVKIFS----SREERSWFR 83

Query: 72  ELTVMKTLD-PHPNVVRLLGCCTEKE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNM 126
           E  + +T+   H N++  +    +        +++ +Y  +G L  +L            
Sbjct: 84  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------------ 131

Query: 127 HGKSNSLTSRDLTSFCYQVARGMQFL 152
                ++T   +       A G+  L
Sbjct: 132 --NRYTVTVEGMIKLALSTASGLAHL 155

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 44.4 bits (105), Expect = 1e-05
 Identities = 10/51 (19%), Positives = 14/51 (27%), Gaps = 5/51 (9%)

Query: 157 VRDGYRLEKPDH-----CRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
                R   P+        R +  IM  CW      R     +   L +L 
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 75.5 bits (186), Expect = 2e-16
 Identities = 35/141 (24%), Positives = 61/141 (43%), Gaps = 24/141 (17%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTL 79
           +K    +G G F  V+K    G+D       VA   L+     + ER    +E  ++K L
Sbjct: 28  LKFDIEIGRGSFKTVYK----GLDTETT-VEVAWCELQDRKLTKSERQRFKEEAEMLKGL 82

Query: 80  DPHPNVVRLLGC----CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
             HPN+VR           K+   ++ E +  G L+++L+             +   +  
Sbjct: 83  Q-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-------------RFKVMKI 128

Query: 136 RDLTSFCYQVARGMQFLSSRG 156
           + L S+C Q+ +G+QFL +R 
Sbjct: 129 KVLRSWCRQILKGLQFLHTRT 149

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 75.3 bits (185), Expect = 5e-16
 Identities = 37/159 (23%), Positives = 59/159 (37%), Gaps = 31/159 (19%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           DILG+G    V++        ++   + A+K     +  R     ++E  V+K L+ H N
Sbjct: 15  DILGQGATANVFRGRH-----KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKN 68

Query: 85  VVRLLGC--CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           +V+L      T      +IME+ P G L + L               +  L   +     
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE----------PSNAYGLPESEFLIVL 118

Query: 143 YQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYY 179
             V  GM  L   G+  R+   + KP        NIM  
Sbjct: 119 RDVVGGMNHLRENGIVHRN---I-KPG-------NIMRV 146

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 74.3 bits (183), Expect = 5e-16
 Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 19/137 (13%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
            +LG+G +G V+     G D       +A+K + E      +  L +E+ + K L  H N
Sbjct: 28  VVLGKGTYGIVYA----GRDLSNQV-RIAIKEIPERDSRYSQ-PLHEEIALHKHLK-HKN 80

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V+ LG  +E     + ME VP G L + LR         +  G       + +  +  Q
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLR---------SKWGPLK-DNEQTIGFYTKQ 130

Query: 145 VARGMQFLSSRGV--RD 159
           +  G+++L    +  RD
Sbjct: 131 ILEGLKYLHDNQIVHRD 147

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 73.9 bits (182), Expect = 7e-16
 Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 21/138 (15%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHP 83
             LG G +G+V+K  +   DG     + AVK       G ++R   L E+   + +  HP
Sbjct: 63  SRLGHGSYGEVFKVRSK-EDG----RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCY 143
             VRL     E    ++  E      LQ    +  A            SL    +  +  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGA------------SLPEAQVWGYLR 164

Query: 144 QVARGMQFLSSRGV--RD 159
                +  L S+G+   D
Sbjct: 165 DTLLALAHLHSQGLVHLD 182

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 26/141 (18%), Positives = 54/141 (38%), Gaps = 20/141 (14%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLD 80
                +GEG FG+    ++   DGR       +K +       +ER +  +E+ V+  + 
Sbjct: 27  VRLQKIGEGSFGKAILVKST-EDGR----QYVIKEINISRMSSKEREESRREVAVLANMK 81

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HPN+V+      E    +++M+Y   G L   + + +                   +  
Sbjct: 82  -HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-----------FQEDQILD 129

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           +  Q+   ++ +  R +  RD
Sbjct: 130 WFVQICLALKHVHDRKILHRD 150

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 72.0 bits (177), Expect = 3e-15
 Identities = 29/152 (19%), Positives = 58/152 (38%), Gaps = 13/152 (8%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           S   W + R   ++ +++G G    V           +    VA+K +     +    +L
Sbjct: 6   SALPWSINRDDYELQEVIGSGATAVVQA----AYCAPKK-EKVAIKRINLEKCQTSMDEL 60

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E+  M     HPN+V        K+  +++M+ +  G +   ++             K
Sbjct: 61  LKEIQAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHI-----VAKGEHK 114

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           S  L    + +   +V  G+++L   G   RD
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRD 146

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 72.9 bits (179), Expect = 4e-15
 Identities = 30/156 (19%), Positives = 55/156 (35%), Gaps = 27/156 (17%)

Query: 7   NQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERER 66
             +      V +      D+LG G  G +        D R+    VAVK +       E 
Sbjct: 12  GDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMF--DNRD----VAVKRIL-----PEC 60

Query: 67  LDLL-QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
                +E+ +++  D HPNV+R      +++  ++ +E      LQ ++           
Sbjct: 61  FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ--------- 110

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              K  +    +  +   Q   G+  L S  +  RD
Sbjct: 111 ---KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 70.9 bits (174), Expect = 9e-15
 Identities = 34/145 (23%), Positives = 56/145 (38%), Gaps = 23/145 (15%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           PR  +  +  +GEG  G V        +   G   VAVK +     +R    L  E+ +M
Sbjct: 43  PRLLLDSYVKIGEGSTGIVCL----AREKHSG-RQVAVKMMDLRKQQRRE-LLFNEVVIM 96

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           +    H NVV +       E  +V+ME++  G L   +                  L   
Sbjct: 97  RDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--------------SQVRLNEE 141

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            + + C  V + + +L ++GV  RD
Sbjct: 142 QIATVCEAVLQALAYLHAQGVIHRD 166

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 30/145 (20%), Positives = 60/145 (41%), Gaps = 23/145 (15%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P++    F+ +G+G  G V+      +D   G   VA++ +      ++   ++ E+ VM
Sbjct: 18  PKKKYTRFEKIGQGASGTVYT----AMDVATG-QEVAIRQMNLQQQPKKE-LIINEILVM 71

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           +    +PN+V  L      +  +V+MEY+  G L   +                  +   
Sbjct: 72  RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--------------TETCMDEG 116

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            + + C +  + ++FL S  V  RD
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRD 141

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 70.1 bits (171), Expect = 4e-14
 Identities = 36/170 (21%), Positives = 61/170 (35%), Gaps = 35/170 (20%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           + LG G FG V +       G +    VA+K  ++    + R     E+ +MK L+ HPN
Sbjct: 20  ERLGTGGFGYVLRWIHQ-DTGEQ----VAIKQCRQELSPKNRERWCLEIQIMKKLN-HPN 73

Query: 85  VVRLLGCCTEKEPF------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           VV         +         + MEY   G L+ +L          N       L    +
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----------NQFENCCGLKEGPI 123

Query: 139 TSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
            +    ++  +++L    +  RD   L KP+       NI+     +   
Sbjct: 124 RTLLSDISSALRYLHENRIIHRD---L-KPE-------NIVLQPGPQRLI 162

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 68.4 bits (168), Expect = 7e-14
 Identities = 35/163 (21%), Positives = 57/163 (34%), Gaps = 32/163 (19%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPHPNV 85
           LG G F  V +C +     +      A K L K   G+  R ++L E+ V++     P V
Sbjct: 37  LGRGKFAVVRQCIS-----KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 86  VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQV 145
           + L           +I+EY   G++ S      A+             +  D+     Q+
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV-----------SENDVIRLIKQI 140

Query: 146 ARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
             G+ +L    +   D   L KP        NI+       P 
Sbjct: 141 LEGVYYLHQNNIVHLD---L-KPQ-------NILLS--SIYPL 170

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 67.7 bits (166), Expect = 9e-14
 Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 18/142 (12%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLD 80
           +V   +G G +G+  K      DG+    I+  K L   +  E E+  L+ E+ +++ L 
Sbjct: 9   EVLYTIGTGSYGRCQKIRRK-SDGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63

Query: 81  PHPNVVRLLGCCTEKEP--FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
            HPN+VR      ++     +++MEY   G L S +     +R Y         L    +
Sbjct: 64  -HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY---------LDEEFV 113

Query: 139 TSFCYQVARGMQFLSSRGVRDG 160
                Q+   ++    R     
Sbjct: 114 LRVMTQLTLALKECHRRSDGGH 135

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 37/145 (25%), Positives = 62/145 (42%), Gaps = 22/145 (15%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +     + +G+G FG+V+K    GID R    +VA+K +     E E  D+ QE+TV+
Sbjct: 20  PEELFTKLEKIGKGSFGEVFK----GIDNRTQK-VVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
              D  P V +  G   +    ++IMEY+  G     L              +   L   
Sbjct: 75  SQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--------------EPGPLDET 119

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            + +   ++ +G+ +L S     RD
Sbjct: 120 QIATILREILKGLDYLHSEKKIHRD 144

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 68.0 bits (167), Expect = 1e-13
 Identities = 29/111 (26%), Positives = 45/111 (40%), Gaps = 19/111 (17%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALG-IDGREGPCIVAVKTLKENA------GERERLDL 69
            R      + +GEG FG V+K    G ++       VAVK L           +++    
Sbjct: 29  ERPISVGGNKMGEGGFGVVYK----GYVNNTT----VAVKKLAAMVDITTEELKQQ---F 77

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 120
            QE+ VM     H N+V LLG  ++ +   ++  Y+P G L   L      
Sbjct: 78  DQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 34/145 (23%), Positives = 64/145 (44%), Gaps = 21/145 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +  ++   LG+G FG+V+K      +   G  + A K ++  + E    D + E+ ++
Sbjct: 17  PNEVWEIVGELGDGAFGKVYK----AKNKETGA-LAAAKVIETKSEEELE-DYIVEIEIL 70

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
            T D HP +V+LLG        ++++E+ P G + + +                  LT  
Sbjct: 71  ATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD------------RGLTEP 117

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            +   C Q+   + FL S+ +  RD
Sbjct: 118 QIQVVCRQMLEALNFLHSKRIIHRD 142

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 67.4 bits (165), Expect = 2e-13
 Identities = 32/153 (20%), Positives = 64/153 (41%), Gaps = 22/153 (14%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
              +  +H      LGEG F  V   E L  DG       A+K +  +  +++R +  +E
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLH-DGH----FYALKRILCH-EQQDREEAQRE 76

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEP----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
             + +  + HPN++RL+  C  +       ++++ +   G L + +           +  
Sbjct: 77  ADMHRLFN-HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---------ERLKD 126

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           K N LT   +      + RG++ + ++G   RD
Sbjct: 127 KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD 159

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 66.9 bits (164), Expect = 2e-13
 Identities = 35/145 (24%), Positives = 66/145 (45%), Gaps = 22/145 (15%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVM 76
            +   +  +LG+G FG+V KC+      R      AVK + K +A  ++   +L+E+ ++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKD-----RITQQEYAVKVINKASAKNKDTSTILREVELL 75

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           K LD HPN+++L     +   F+++ E    G+L  F    + +R+           +  
Sbjct: 76  KKLD-HPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRF-----------SEH 121

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
           D      QV  G+ ++    +  RD
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRD 146

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 30/152 (19%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           +    LG G FG V++ +   +D     C  A+K ++    E  R  +++E+  +  L+ 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNK-VDD----CNYAIKRIRLPNRELAREKVMREVKALAKLE- 61

Query: 82  HPNVVRLLGCCTEKEPF------------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           HP +VR      EK               ++ M+      L+ ++               
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE------- 114

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                         Q+A  ++FL S+G+  RD
Sbjct: 115 ---RERSVCLHIFLQIAEAVEFLHSKGLMHRD 143

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 67.4 bits (165), Expect = 3e-13
 Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 35/172 (20%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVM 76
            +  +    LG G +G+V  C       +      A+K + K +        LL+E+ V+
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRD-----KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           K LD HPN+++L     +K  ++++ME    G+L  F       ++              
Sbjct: 91  KLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGEL--FDEIIHRMKF-----------NEV 136

Query: 137 DLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
           D      QV  G+ +L    +  RD   L KP+       N++     KE +
Sbjct: 137 DAAVIIKQVLSGVTYLHKHNIVHRD---L-KPE-------NLLLE--SKEKD 175

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 65.7 bits (161), Expect = 4e-13
 Identities = 29/144 (20%), Positives = 59/144 (40%), Gaps = 17/144 (11%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMK 77
                    LG G FG V   E      R       +KT+ ++  +     +  E+ V+K
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEE-----RSSGLERVIKTINKDRSQVPMEQIEAEIEVLK 75

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           +LD HPN++++     +    +++ME    G+L   + S++A         +  +L+   
Sbjct: 76  SLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA---------RGKALSEGY 125

Query: 138 LTSFCYQVARGMQFLSSRGV--RD 159
           +     Q+   + +  S+ V  +D
Sbjct: 126 VAELMKQMMNALAYFHSQHVVHKD 149

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 66.6 bits (163), Expect = 5e-13
 Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 35/172 (20%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVM 76
            +   +  +LG+G FG+V KC+      R      AVK + K +A  ++   +L+E+ ++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCK-----DRITQQEYAVKVINKASAKNKDTSTILREVELL 75

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           K LD HPN+++L     +   F+++ E    G+L  F    + +R+           +  
Sbjct: 76  KKLD-HPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRF-----------SEH 121

Query: 137 DLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
           D      QV  G+ ++    +  RD   L KP+       NI+     KE +
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRD---L-KPE-------NILLE--SKEKD 160

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 65.9 bits (161), Expect = 5e-13
 Identities = 36/167 (21%), Positives = 71/167 (42%), Gaps = 31/167 (18%)

Query: 1   MNDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN 60
           +++  L+   D     P    ++ +++G G +GQV+K    G   + G  + A+K +   
Sbjct: 11  LDEIDLSALRD-----PAGIFELVELVGNGTYGQVYK----GRHVKTG-QLAAIKVMDVT 60

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF------VIMEYVPYGKLQSFL 114
             E E  ++ QE+ ++K    H N+    G   +K P        ++ME+   G +   +
Sbjct: 61  GDEEE--EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118

Query: 115 RSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +++           K N+L    +   C ++ RG+  L    V  RD
Sbjct: 119 KNT-----------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 154

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 65.6 bits (160), Expect = 9e-13
 Identities = 41/184 (22%), Positives = 64/184 (34%), Gaps = 32/184 (17%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL-QELTVM 76
           +  +    ILG G  G V    +    GR     VAVK +       +  D+   E+ ++
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQGSF--QGRP----VAVKRML-----IDFCDIALMEIKLL 62

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
              D HPNV+R     T     ++ +E      LQ  + S       N            
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVES------KNVSDENLKLQKEY 115

Query: 137 DLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
           +  S   Q+A G+  L S  +  RD   L KP        NI+     +   ++    E 
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRD---L-KPQ-------NILVSTSSRFTADQQTGAEN 164

Query: 195 CDLL 198
             +L
Sbjct: 165 LRIL 168

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 22/145 (15%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVM 76
             +  V + LG+G F  V +C      G E     A K +  +    R+   L +E  + 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKT-TGLE----FAAKIINTKKLSARDFQKLEREARIC 82

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           + L  HPN+VRL     E+   +++ + V  G+L  F      + Y           +  
Sbjct: 83  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFY-----------SEA 128

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
           D +    Q+   + +  S G+  R+
Sbjct: 129 DASHCIQQILESIAYCHSNGIVHRN 153

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 64.9 bits (159), Expect = 1e-12
 Identities = 41/171 (23%), Positives = 72/171 (42%), Gaps = 35/171 (20%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMK 77
           R+     ++LG G F +V+  +     G+      A+K +K++   R+   L  E+ V+K
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRL-TGKL----FALKCIKKSPAFRDS-SLENEIAVLK 61

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
            +  H N+V L         ++++M+ V  G+L  F R      Y           T +D
Sbjct: 62  KIK-HENIVTLEDIYESTTHYYLVMQLVSGGEL--FDRILERGVY-----------TEKD 107

Query: 138 LTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
            +    QV   +++L   G+  RD   L KP+       N++Y     E N
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRD---L-KPE-------NLLYL--TPEEN 145

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 27/151 (17%), Positives = 52/151 (34%), Gaps = 27/151 (17%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKT-------LKENAGERERLDLL 70
            Q     D++G G    V +C      G E     AVK        L     E  R    
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRA-TGHE----FAVKIMEVTAERLSPEQLEEVREATR 147

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           +E  +++ +  HP+++ L+         F++ + +  G+L  F   +             
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL--FDYLTEKVAL-------- 197

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              + ++  S    +   + FL +  +  RD
Sbjct: 198 ---SEKETRSIMRSLLEAVSFLHANNIVHRD 225

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 23/162 (14%), Positives = 55/162 (33%), Gaps = 24/162 (14%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KEN 60
           +D   +  +++   V  +   +   +G G   +V++   L    +    I A+K +  E 
Sbjct: 39  DDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ--VLNEKKQ----IYAIKYVNLEE 92

Query: 61  AGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA 119
           A  +       E+  +  L      ++RL       +  +++ME      L S+L+    
Sbjct: 93  ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK--- 148

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                        +   +  S+   +   +  +   G+   D
Sbjct: 149 -------KKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSD 180

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 64.1 bits (157), Expect = 2e-12
 Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 22/145 (15%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVM 76
             +  V + LG+G F  V +C      G E     A K +  +    R+   L +E  + 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKT-TGLE----FAAKIINTKKLSARDFQKLEREARIC 59

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           + L  HPN+VRL     E+   +++ + V  G+L  F      + Y           +  
Sbjct: 60  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFY-----------SEA 105

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
           D +    Q+   + +  S G+  R+
Sbjct: 106 DASHCIQQILESIAYCHSNGIVHRN 130

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 32/172 (18%), Positives = 67/172 (38%), Gaps = 35/172 (20%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMK 77
            +   + + LG G FG V +C       +        K +K    ++    + +E++++ 
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETS-SKKT----YMAKFVKVKGTDQV--LVKKEISILN 56

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
               H N++ L       E   +I E++    +  F R          ++  +  L  R+
Sbjct: 57  IAR-HRNILHLHESFESMEELVMIFEFISGLDI--FER----------INTSAFELNERE 103

Query: 138 LTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPNE 187
           + S+ +QV   +QFL S  +   D   + +P+       NI+Y    +  + 
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFD---I-RPE-------NIIYQ--TRRSST 142

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 25/152 (16%), Positives = 54/152 (35%), Gaps = 28/152 (18%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK--------ENAGERERLDL 69
            ++ +  +ILG G    V +C       +E     AVK +             +  R   
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKP-TCKE----YAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E+ +++ +  HPN+++L         FF++ + +  G+L  F   +            
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTEKVTL------- 121

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               + ++       +   +  L    +  RD
Sbjct: 122 ----SEKETRKIMRALLEVICALHKLNIVHRD 149

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 29/165 (17%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPC-IVAVKTLKENAGERERLDLLQELTVM 76
                + + LG G F  V KC      G E     +  +  + +     R ++ +E++++
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           + +  HPN++ L      +    +I+E V  G+L  FL              +  SL+  
Sbjct: 70  RQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLA-------------QKESLSEE 115

Query: 137 DLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYY 179
           + TSF  Q+  G+ +L ++ +   D   L KP+       NIM  
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFD---L-KPE-------NIMLL 149

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 21/142 (14%), Positives = 47/142 (33%), Gaps = 24/142 (16%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLD 80
            +   +G G   +V++   L    +    I A+K +  E A  +       E+  +  L 
Sbjct: 31  SILKQIGSGGSSKVFQ--VLNEKKQ----IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84

Query: 81  -PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
                ++RL       +  +++ME      L S+L+                 +   +  
Sbjct: 85  QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----------KKS---IDPWERK 130

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
           S+   +   +  +   G+   D
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSD 152

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 21/142 (14%), Positives = 47/142 (33%), Gaps = 24/142 (16%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLD 80
            +   +G G   +V++   L    +    I A+K +  E A  +       E+  +  L 
Sbjct: 12  SILKQIGSGGSSKVFQ--VLNEKKQ----IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 81  -PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
                ++RL       +  +++ME      L S+L+                 +   +  
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----------KKS---IDPWERK 111

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
           S+   +   +  +   G+   D
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSD 133

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 34/169 (20%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD 80
           +   +ILG G FGQV KCE            +A K +K   G +++ ++  E++VM  LD
Sbjct: 91  VSKTEILGGGRFGQVHKCEE-----TATGLKLAAKIIKT-RGMKDKEEVKNEISVMNQLD 144

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            H N+++L      K    ++MEYV  G+L  F R          +  +S +LT  D   
Sbjct: 145 -HANLIQLYDAFESKNDIVLVMEYVDGGEL--FDR----------IIDESYNLTELDTIL 191

Query: 141 FCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPNE 187
           F  Q+  G++ +    +   D   L KP+       NI+    +++  +
Sbjct: 192 FMKQICEGIRHMHQMYILHLD---L-KPE-------NILCV--NRDAKQ 227

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 63.8 bits (156), Expect = 2e-12
 Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 24/145 (16%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVM 76
            Q+  + + +G G +G+V          +      A K + K    + +     QE+ +M
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAV-----QKGTRIRRAAKKIPKYFVEDVD--RFKQEIEIM 60

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           K+LD HPN++RL     +    +++ME    G+L  F R    + +              
Sbjct: 61  KSLD-HPNIIRLYETFEDNTDIYLVMELCTGGEL--FERVVHKRVF-----------RES 106

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
           D       V   + +     V  RD
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRD 131

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 31/145 (21%), Positives = 60/145 (41%), Gaps = 18/145 (12%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPC-IVAVKTLKENAGERERLDLLQELTVM 76
                + + LG G F  V KC      G E     +  +  + +     R ++ +E++++
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           + +  H NV+ L      +    +I+E V  G+L  FL              +  SL+  
Sbjct: 70  RQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLA-------------QKESLSEE 115

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
           + TSF  Q+  G+ +L ++ +   D
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFD 140

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 28/147 (19%), Positives = 55/147 (37%), Gaps = 23/147 (15%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKT--LKENAGERERLDLLQELT 74
           P +       +G G FG V+       D R    +VA+K           +  D+++E+ 
Sbjct: 52  PEKLFSDLREIGHGSFGAVYF----ARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVR 106

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
            ++ L  HPN ++  GC   +   +++MEY                     +      L 
Sbjct: 107 FLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDL-------------LEVHKKPLQ 152

Query: 135 SRDLTSFCYQVARGMQFLSSRGV--RD 159
             ++ +  +   +G+ +L S  +  RD
Sbjct: 153 EVEIAAVTHGALQGLAYLHSHNMIHRD 179

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 64.2 bits (156), Expect = 3e-12
 Identities = 22/151 (14%), Positives = 45/151 (29%), Gaps = 22/151 (14%)

Query: 14  WEVPRQHIKVFDILGEGC--FGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLL 70
           +       ++  ++G+G      V            G   V V+ +  E         L 
Sbjct: 20  FLPEGGCYELLTVIGKGFEDLMTVNL----ARYKPTG-EYVTVRRINLEACSNEMVTFLQ 74

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            EL V K  + HPN+V            +V+  ++ YG  +  +                
Sbjct: 75  GELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC-----------THFM 122

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           + +    +      V + + ++   G   R 
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMGYVHRS 153

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 64.2 bits (157), Expect = 3e-12
 Identities = 30/145 (20%), Positives = 55/145 (37%), Gaps = 22/145 (15%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVM 76
            +  ++F+ LG+G F  V +C              A   +  +    R+   L +E  + 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVK-----VLAGQEYAAMIINTKKLSARDHQKLEREARIC 64

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           + L  HPN+VRL    +E+   ++I + V  G+L  F      + Y           +  
Sbjct: 65  RLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGEL--FEDIVAREYY-----------SEA 110

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
           D +    Q+   +      GV  R+
Sbjct: 111 DASHCIQQILEAVLHCHQMGVVHRN 135

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 24/99 (24%), Positives = 43/99 (43%), Gaps = 5/99 (5%)

Query: 6   LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE 65
           L    +  W+   + +K    +G G +G V K     +    G  I+AVK ++    E+E
Sbjct: 9   LKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKM----VHKPSG-QIMAVKRIRSTVDEKE 63

Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 104
           +  LL +L V+      P +V+  G    +   ++ ME 
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 62.6 bits (153), Expect = 5e-12
 Identities = 29/150 (19%), Positives = 62/150 (41%), Gaps = 25/150 (16%)

Query: 17  PRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--LLQ 71
             + I+ F +   LG+G F  V+           G   VA+K + + A  +  +   +  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVY----RAESIHTGL-EVAIKMIDKKAMYKAGMVQRVQN 60

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E+ +   L  HP+++ L     +    ++++E    G++  +L++            +  
Sbjct: 61  EVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN------------RVK 107

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             +  +   F +Q+  GM +L S G+  RD
Sbjct: 108 PFSENEARHFMHQIITGMLYLHSHGILHRD 137

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 63.7 bits (155), Expect = 6e-12
 Identities = 34/164 (20%), Positives = 60/164 (36%), Gaps = 34/164 (20%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           + LG G FG V +        R      A K +       ++  + +E+  M  L  HP 
Sbjct: 163 EELGTGAFGVVHRVTE-----RATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLR-HPT 215

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V L     +     +I E++  G+L  F +          +  + N ++  +   +  Q
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL--FEK----------VADEHNKMSEDEAVEYMRQ 263

Query: 145 VARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
           V +G+  +        D   L KP+       NIM+    K  N
Sbjct: 264 VCKGLCHMHENNYVHLD---L-KPE-------NIMFT--TKRSN 294

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 62.9 bits (153), Expect = 6e-12
 Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 29/159 (18%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
             E+    ++V  +L EG F  V++ + +   GRE     A+K L  N  E+ R  ++QE
Sbjct: 22  TVELGELRLRVRRVLAEGGFAFVYEAQDV-GSGRE----YALKRLLSNEEEKNR-AIIQE 75

Query: 73  LTVMKTLDPHPNVVRLLGCC--------TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN 124
           +  MK L  HPN+V+             T +  F ++ E    G+L  FL+   ++    
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGP-- 132

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV----RD 159
                   L+   +    YQ  R +Q +  +      RD
Sbjct: 133 --------LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 63.2 bits (154), Expect = 7e-12
 Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 27/162 (16%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN- 60
               +   +           K   +LG+G FG+V  C+     G+E     AVK + +  
Sbjct: 13  PGMFVQHSTAIF----SDRYKGQRVLGKGSFGEVILCKDKI-TGQE----CAVKVISKRQ 63

Query: 61  -AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA 119
              + ++  LL+E+ ++K LD HPN+++L     +K  F+++ E    G+L  F      
Sbjct: 64  VKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISR 120

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +R+           +  D      QV  G+ ++    +  RD
Sbjct: 121 KRF-----------SEVDAARIIRQVLSGITYMHKNKIVHRD 151

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 62.7 bits (152), Expect = 8e-12
 Identities = 25/163 (15%), Positives = 55/163 (33%), Gaps = 16/163 (9%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD 68
           K   ++++  + + V  +LGEG F QV++     ++  +      +K  K  A   E   
Sbjct: 55  KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYI 113

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
             Q +  +K        ++       +    ++ E   YG L + +   +          
Sbjct: 114 GTQLMERLKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NTPEKV 168

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHC 169
               L       F  ++   ++ +    +   D     KPD+ 
Sbjct: 169 MPQGLVIS----FAMRMLYMIEQVHDCEIIHGD----IKPDNF 203

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 61.8 bits (151), Expect = 1e-11
 Identities = 35/150 (23%), Positives = 69/150 (46%), Gaps = 26/150 (17%)

Query: 17  PRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--LLQ 71
            +  ++ F+I   LG+G FG V+    L  + +    I+A+K L +   E+  ++  L +
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVY----LAREKQSK-FILALKVLFKAQLEKAGVEHQLRR 58

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E+ +   L  HPN++RL G   +    ++I+EY P G +   L+             K +
Sbjct: 59  EVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-------------KLS 104

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               +   ++  ++A  + +  S+ V  RD
Sbjct: 105 KFDEQRTATYITELANALSYCHSKRVIHRD 134

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 35/151 (23%), Positives = 57/151 (37%), Gaps = 37/151 (24%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
            +LG+G FGQV K     +D R      A+K ++    +     +L E+ ++ +L+ H  
Sbjct: 12  AVLGQGAFGQVVKARNA-LDSR----YYAIKKIRHTEEKLST--ILSEVMLLASLN-HQY 63

Query: 85  VVRLLGCCTEKEPF-------------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           VVR      E+  F             F+ MEY   G L   +                N
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-------------SEN 110

Query: 132 SLTSRDLT-SFCYQVARGMQFLSSRGV--RD 159
               RD       Q+   + ++ S+G+  RD
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQGIIHRD 141

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 61.5 bits (150), Expect = 2e-11
 Identities = 31/137 (22%), Positives = 60/137 (43%), Gaps = 21/137 (15%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           D+LGEG   +V  C  L I  +E     AVK +++  G   R  + +E+ ++     H N
Sbjct: 19  DVLGEGAHARVQTCINL-ITSQE----YAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRN 72

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           V+ L+    E++ F+++ E +  G +       + + +              + +     
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHKRRHF-----------NELEASVVVQD 119

Query: 145 VARGMQFLSSRGV--RD 159
           VA  + FL ++G+  RD
Sbjct: 120 VASALDFLHNKGIAHRD 136

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 61.4 bits (149), Expect = 2e-11
 Identities = 27/142 (19%), Positives = 50/142 (35%), Gaps = 19/142 (13%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+     +    LG G  G V+K          G  ++A K +        R  +++EL 
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKV----SHKPSG-LVMARKLIHLEIKPAIRNQIIRELQ 83

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           V+   +  P +V   G         + ME++  G L   L+             K+  + 
Sbjct: 84  VLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-------------KAGRIP 129

Query: 135 SRDLTSFCYQVARGMQFLSSRG 156
            + L      V +G+ +L  + 
Sbjct: 130 EQILGKVSIAVIKGLTYLREKH 151

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 61.1 bits (149), Expect = 2e-11
 Identities = 32/144 (22%), Positives = 60/144 (41%), Gaps = 30/144 (20%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-------RERLDLLQELTVMK 77
           + LG G +  V+K    G++   G   VA+K +K ++ E       RE + L++EL    
Sbjct: 11  EKLGNGTYATVYK----GLNKTTGV-YVALKEVKLDSEEGTPSTAIRE-ISLMKELK--- 61

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
               H N+VRL      +    ++ E++    L+ ++ S         +      L    
Sbjct: 62  ----HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDS-------RTVGNTPRGLELNL 109

Query: 138 LTSFCYQVARGMQFLSSRGV--RD 159
           +  F +Q+ +G+ F     +  RD
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRD 133

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 61.0 bits (149), Expect = 2e-11
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 27/140 (19%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDL--LQELTVMKTLDP 81
           + +GEG +G V+K  A    GR    IVA+K ++ +   E E +    ++E++++K L  
Sbjct: 27  EKVGEGTYGVVYK--AKDSQGR----IVALKRIRLDA--EDEGIPSTAIREISLLKELH- 77

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           HPN+V L+     +    ++ E++    L+  L  ++              L    +  +
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENK------------TGLQDSQIKIY 124

Query: 142 CYQVARGMQFLSSRGV--RD 159
            YQ+ RG+       +  RD
Sbjct: 125 LYQLLRGVAHCHQHRILHRD 144

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 32/145 (22%), Positives = 65/145 (44%), Gaps = 23/145 (15%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P +   V + LGEG +G V+K          G  IVA+K +     E +  ++++E+++M
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKAI----HKETG-QIVAIKQVPV---ESDLQEIIKEISIM 78

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           +  D  P+VV+  G   +    +++MEY   G +               +  ++ +LT  
Sbjct: 79  QQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI------------IRLRNKTLTED 125

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
           ++ +      +G+++L       RD
Sbjct: 126 EIATILQSTLKGLEYLHFMRKIHRD 150

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 60.7 bits (148), Expect = 3e-11
 Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 29/165 (17%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPC-IVAVKTLKENAGERERLDLLQELTVM 76
             H ++ + LG G F  V KC   G  G+E     +  + L  +     R ++ +E+ ++
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
           + +  HPN++ L      K    +I+E V  G+L  FL              +  SLT  
Sbjct: 63  REIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLA-------------EKESLTED 108

Query: 137 DLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYY 179
           + T F  Q+  G+ +L S+ +   D   L KP+       NIM  
Sbjct: 109 EATQFLKQILDGVHYLHSKRIAHFD---L-KPE-------NIMLL 142

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 61.1 bits (149), Expect = 3e-11
 Identities = 31/98 (31%), Positives = 44/98 (44%), Gaps = 11/98 (11%)

Query: 26  ILGEGCFGQVWKCEALGI--DGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP 83
           ILG G FG+V+K    G   DG      VAVK LKE   +   L    E+ ++     H 
Sbjct: 37  ILGRGGFGKVYK----GRLADGTL----VAVKRLKEERTQGGELQFQTEVEMISMAV-HR 87

Query: 84  NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
           N++RL G C       ++  Y+  G + S LR     +
Sbjct: 88  NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 61.3 bits (149), Expect = 3e-11
 Identities = 36/183 (19%), Positives = 73/183 (39%), Gaps = 46/183 (25%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK------------ENAGERE 65
            +       LG G +G+V  C+      + G    A+K +K                E+ 
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCK-----EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89

Query: 66  RLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
             ++  E++++K+LD HPN+++L     +K+ F+++ E+   G+L  F +     ++   
Sbjct: 90  HEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQIINRHKF--- 143

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDK 183
                      D  +   Q+  G+ +L    +  RD   + KP+       NI+    +K
Sbjct: 144 --------DECDAANIMKQILSGICYLHKHNIVHRD---I-KPE-------NILLE--NK 182

Query: 184 EPN 186
              
Sbjct: 183 NSL 185

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 60.6 bits (148), Expect = 4e-11
 Identities = 33/139 (23%), Positives = 69/139 (49%), Gaps = 23/139 (16%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--LQELTVMKTLDPH 82
           + +GEG +G V+K      +   G  +VA+K ++ +  E E +    ++E++++K L+ H
Sbjct: 9   EKIGEGTYGVVYK----ARNKLTGE-VVALKKIRLDT-ETEGVPSTAIREISLLKELN-H 61

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           PN+V+LL     +   +++ E++    L+ F+ +S               +    + S+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS-----------ALTGIPLPLIKSYL 109

Query: 143 YQVARGMQFLSSRGV--RD 159
           +Q+ +G+ F  S  V  RD
Sbjct: 110 FQLLQGLAFCHSHRVLHRD 128

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 27/151 (17%), Positives = 58/151 (38%), Gaps = 29/151 (19%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-------KENAGERERLDLL 70
           R    +   LG G  G+V          R+    VA++ +                L++ 
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFE-----RKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+ ++K L+ HP ++++     + E +++++E +  G+L   +               +
Sbjct: 189 TEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV-------------GN 233

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             L       + YQ+   +Q+L   G+  RD
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENGIIHRD 264

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 60.5 bits (147), Expect = 5e-11
 Identities = 28/163 (17%), Positives = 64/163 (39%), Gaps = 34/163 (20%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           LG G FG V +C       +    +   K +       ++  +  E+++M  L  HP ++
Sbjct: 59  LGSGAFGVVHRCVE-----KATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLH-HPKLI 111

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA 146
            L     +K    +I+E++  G+L            ++ +  +   ++  ++ ++  Q  
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGEL------------FDRIAAEDYKMSEAEVINYMRQAC 159

Query: 147 RGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPNE 187
            G++ +    +   D   + KP+       NIM     K+ + 
Sbjct: 160 EGLKHMHEHSIVHLD---I-KPE-------NIMCE--TKKASS 189

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 60.0 bits (146), Expect = 6e-11
 Identities = 36/141 (25%), Positives = 58/141 (41%), Gaps = 18/141 (12%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPC-IVAVKTLKENAGERERLDLLQELTVMKTLD 80
              + LG G F  V KC      G +     +  +  K +     R D+ +E++++K + 
Sbjct: 14  DTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HPNV+ L      K    +I+E V  G+L  FL              +  SLT  + T 
Sbjct: 73  -HPNVITLHEVYENKTDVILILELVAGGELFDFLA-------------EKESLTEEEATE 118

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           F  Q+  G+ +L S  +   D
Sbjct: 119 FLKQILNGVYYLHSLQIAHFD 139

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 59.8 bits (146), Expect = 6e-11
 Identities = 34/139 (24%), Positives = 62/139 (44%), Gaps = 24/139 (17%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--LQELTVMKTLDPH 82
           + +GEG +G V+K      +      IVA+K ++ +  + E +    L+E+ ++K L  H
Sbjct: 8   EKIGEGTYGTVFK----AKNRETHE-IVALKRVRLDD-DDEGVPSSALREICLLKELK-H 60

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
            N+VRL       +   ++ E+     L+ +  S             +  L    + SF 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS------------CNGDLDPEIVKSFL 107

Query: 143 YQVARGMQFLSSRGV--RD 159
           +Q+ +G+ F  SR V  RD
Sbjct: 108 FQLLKGLGFCHSRNVLHRD 126

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 59.6 bits (145), Expect = 7e-11
 Identities = 33/156 (21%), Positives = 60/156 (38%), Gaps = 40/156 (25%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           K  +++G G FGQV+K +   IDG+       +K +K            +E+  +  LD 
Sbjct: 14  KEIELIGSGGFGQVFKAKHR-IDGK----TYVIKRVK-----YNNEKAEREVKALAKLD- 62

Query: 82  HPNVVRLLGCCTEKEPF----------------FVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           H N+V   GC    +                  F+ ME+   G L+ ++   R ++    
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---- 118

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                  L          Q+ +G+ ++ S+ +  RD
Sbjct: 119 -------LDKVLALELFEQITKGVDYIHSKKLINRD 147

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 59.6 bits (145), Expect = 9e-11
 Identities = 28/166 (16%), Positives = 65/166 (39%), Gaps = 29/166 (17%)

Query: 3   DPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK---- 58
             +L+   DD   +     ++ +++G+G F  V +C      G++     AVK +     
Sbjct: 10  GGILDMADDDV--LFEDVYELCEVIGKGPFSVVRRCINRE-TGQQ----FAVKIVDVAKF 62

Query: 59  ENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF---LR 115
            ++      DL +E ++   L  HP++V LL   +     +++ E++    L      ++
Sbjct: 63  TSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADL--CFEIVK 119

Query: 116 SSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            + A   Y          +    + +  Q+   +++     +  RD
Sbjct: 120 RADAGFVY----------SEAVASHYMRQILEALRYCHDNNIIHRD 155

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 59.1 bits (144), Expect = 9e-11
 Identities = 36/154 (23%), Positives = 74/154 (48%), Gaps = 28/154 (18%)

Query: 15  EVPRQHIKV--FDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD- 68
           E+P++   +  FDI   LG+G FG V+       +      I+A+K L ++  E+E ++ 
Sbjct: 5   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQ-NKF----IMALKVLFKSQLEKEGVEH 59

Query: 69  -LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
            L +E+ +   L  HPN++R+     +++  ++++E+ P G+L   L+  +  R+     
Sbjct: 60  QLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRF----- 111

Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                 ++     F  ++A  + +   R V  RD
Sbjct: 112 --DEQRSAT----FMEELADALHYCHERKVIHRD 139

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 33/174 (18%), Positives = 71/174 (40%), Gaps = 38/174 (21%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMK 77
               +V + +G G +    +C        E     AVK +     ++ + D  +E+ ++ 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKA-TNME----FAVKII-----DKSKRDPTEEIEILL 70

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
               HPN++ L     + +  +V+ E +  G+L    +  R + +           + R+
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL--LDKILRQKFF-----------SERE 117

Query: 138 LTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPNERP 189
            ++  + + + +++L ++GV  RD   L KP        NI+Y   D+  N   
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRD---L-KPS-------NILYV--DESGNPES 158

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 37/145 (25%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGE-------RERLDLLQELTVM 76
             LGEG +G+V+K     ID       VA+K ++ E+  E       RE + LL+EL   
Sbjct: 40  TKLGEGTYGEVYK----AIDTVTNE-TVAIKRIRLEHEEEGVPGTAIRE-VSLLKELQ-- 91

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
                H N++ L           +I EY     L+ ++  +               ++ R
Sbjct: 92  -----HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP-------------DVSMR 132

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            + SF YQ+  G+ F  SR    RD
Sbjct: 133 VIKSFLYQLINGVNFCHSRRCLHRD 157

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 30/137 (21%), Positives = 56/137 (40%), Gaps = 24/137 (17%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
             LGEG F    KC       +      AVK + +    R   +  +E+T +K  + HPN
Sbjct: 17  KPLGEGSFSICRKCVHKK-SNQA----FAVKIISK----RMEANTQKEITALKLCEGHPN 67

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +V+L     ++   F++ME +  G+L  F R  + + +           +  + +    +
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHF-----------SETEASYIMRK 114

Query: 145 VARGMQFLSSRGV--RD 159
           +   +  +   GV  RD
Sbjct: 115 LVSAVSHMHDVGVVHRD 131

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 26/151 (17%), Positives = 53/151 (35%), Gaps = 26/151 (17%)

Query: 16  VPRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--LL 70
           V  +  + +     LG+G F + +       D      + A K + ++   +      + 
Sbjct: 35  VDPRSRRRYVRGRFLGKGGFAKCF----EISDADTK-EVFAGKIVPKSLLLKPHQREKMS 89

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+++ ++L  H +VV   G   + +  FV++E      L    +               
Sbjct: 90  MEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----------RKAL 138

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               +R    +  Q+  G Q+L    V  RD
Sbjct: 139 TEPEAR---YYLRQIVLGCQYLHRNRVIHRD 166

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 37/167 (22%), Positives = 65/167 (38%), Gaps = 37/167 (22%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           +V   LG G    V++C+      +      A+K LK+   ++    +  E+ V+  L  
Sbjct: 56  EVESELGRGATSIVYRCKQ-----KGTQKPYALKVLKKTVDKK---IVRTEIGVLLRLS- 106

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           HPN+++L           +++E V  G+L  F R      Y           + RD    
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGEL--FDRIVEKGYY-----------SERDAADA 153

Query: 142 CYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
             Q+   + +L   G+  RD   L KP+       N++Y      P+
Sbjct: 154 VKQILEAVAYLHENGIVHRD---L-KPE-------NLLYA--TPAPD 187

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 58.3 bits (142), Expect = 2e-10
 Identities = 32/141 (22%), Positives = 58/141 (41%), Gaps = 29/141 (20%)

Query: 25  DILGEGCFGQVWKCEALGID--GREGPCIVAVKTLKENAGERERLDL--LQELTVMKTLD 80
           + +GEG +G V+K      +  G       A+K ++    E E +    ++E++++K L 
Sbjct: 8   EKIGEGTYGVVYK----AQNNYGE----TFALKKIRLEK-EDEGIPSTTIREISILKELK 58

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            H N+V+L      K+   ++ E++    L+  L                  L S    S
Sbjct: 59  -HSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCE------------GGLESVTAKS 104

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           F  Q+  G+ +   R V  RD
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRD 125

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 27/151 (17%), Positives = 54/151 (35%), Gaps = 26/151 (17%)

Query: 16  VPRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--LL 70
           V  +  + +     LG+G F + +       D      + A K + ++   +      + 
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCF----EISDADTK-EVFAGKIVPKSLLLKPHQREKMS 63

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+++ ++L  H +VV   G   + +  FV++E      L    +               
Sbjct: 64  MEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----------RKA- 111

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             LT  +   +  Q+  G Q+L    V  RD
Sbjct: 112 --LTEPEARYYLRQIVLGCQYLHRNRVIHRD 140

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 36/150 (24%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGE-------RERLDLLQELTVM 76
             +GEG +G+V+K      D + G   VA+K ++ +   E       RE + +L+ L   
Sbjct: 17  AEIGEGAYGKVFK----ARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLET- 70

Query: 77  KTLDPHPNVVRLLGCCTEKEP-----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
                HPNVVRL   CT           ++ E+V    L ++L                 
Sbjct: 71  ---FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV-----------PEP 115

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            + +  +    +Q+ RG+ FL S  V  RD
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 58.0 bits (141), Expect = 2e-10
 Identities = 27/138 (19%), Positives = 49/138 (35%), Gaps = 15/138 (10%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           EV    ++    LG G +G V K          G  I+AVK ++     +E+  LL +L 
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKM----RHVPSG-QIMAVKRIRATVNSQEQKRLLMDLD 57

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +       P  V   G    +   ++ ME +    L  F +          +  K  ++ 
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYK---------QVIDKGQTIP 107

Query: 135 SRDLTSFCYQVARGMQFL 152
              L      + + ++ L
Sbjct: 108 EDILGKIAVSIVKALEHL 125

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 35/150 (23%), Positives = 62/150 (41%), Gaps = 25/150 (16%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN----AGERERLDLLQEL 73
               +   + G G +G V+K  A   DG++     A+K ++      +  RE + LL+EL
Sbjct: 21  LFEYEGCKV-GRGTYGHVYK--AKRKDGKDD-KDYALKQIEGTGISMSACRE-IALLREL 75

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEP--FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
                   HPNV+ L            +++ +Y  +  L   ++  RA    +  + K  
Sbjct: 76  K-------HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRA----SKANKKPV 123

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            L    + S  YQ+  G+ +L +  V  RD
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRD 153

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 58.0 bits (141), Expect = 3e-10
 Identities = 30/141 (21%), Positives = 59/141 (41%), Gaps = 25/141 (17%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL----LQELTVMKTLD 80
           D LGEG F  V+K        +    IVA+K +K       +  +    L+E+ +++ L 
Sbjct: 16  DFLGEGQFATVYKARDK-NTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HPN++ LL     K    ++ +++    L+  ++              S  LT   + +
Sbjct: 71  -HPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKD------------NSLVLTPSHIKA 116

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           +     +G+++L    +  RD
Sbjct: 117 YMLMTLQGLEYLHQHWILHRD 137

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 58.0 bits (141), Expect = 3e-10
 Identities = 32/144 (22%), Positives = 60/144 (41%), Gaps = 35/144 (24%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-------RERLDLLQELTVMK 77
           D LGEG +  V+K ++  +       +VA+K ++    E       RE + LL++L    
Sbjct: 8   DKLGEGTYATVYKGKS-KLTDN----LVALKEIRLEHEEGAPCTAIRE-VSLLKDLK--- 58

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
               H N+V L      ++   ++ EY+    L+ +L                N +   +
Sbjct: 59  ----HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD------------CGNIINMHN 101

Query: 138 LTSFCYQVARGMQFLSSRGV--RD 159
           +  F +Q+ RG+ +   + V  RD
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRD 125

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 35/163 (21%), Positives = 66/163 (40%), Gaps = 31/163 (19%)

Query: 5   VLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGER 64
           VL        +    +     ++G G FG V   +A  ++  E    VA+K + ++   +
Sbjct: 27  VLASDGKTGEQREIAYTNC-KVIGNGSFGVV--FQAKLVESDE----VAIKKVLQDKRFK 79

Query: 65  ERLDLLQELTVMKTLDPHPNVVRLLGC---CTEKEPF---FVIMEYVPYGKLQSFLRSSR 118
            R     EL +M+ +  HPNVV L        +K+      +++EYVP   +    R   
Sbjct: 80  NR-----ELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA 132

Query: 119 AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             +          ++    +  + YQ+ R + ++ S G+  RD
Sbjct: 133 KLK---------QTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 57.6 bits (140), Expect = 4e-10
 Identities = 34/139 (24%), Positives = 65/139 (46%), Gaps = 24/139 (17%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--LQELTVMKTLDPH 82
            ++GEG +G V KC     +   G  IVA+K   E+  + + +    ++E+ ++K L  H
Sbjct: 31  GLVGEGSYGMVMKC----RNKDTGR-IVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-H 83

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
            N+V LL  C +K+ ++++ E+V +  +   L                N L  + +  + 
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP------------NGLDYQVVQKYL 130

Query: 143 YQVARGMQFLSSRGV--RD 159
           +Q+  G+ F  S  +  RD
Sbjct: 131 FQIINGIGFCHSHNIIHRD 149

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 57.5 bits (139), Expect = 5e-10
 Identities = 25/175 (14%), Positives = 57/175 (32%), Gaps = 39/175 (22%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK----ENAGERERLDLLQEL 73
           ++   +   +G+G +G V           +   I A+K +          ++   +  E+
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAI-----ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL----------------------- 110
            +MK L  HPN+ RL     +++   ++ME    G L                       
Sbjct: 80  RLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 111 ----QSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                     +     +            + +++   Q+   + +L ++G+  RD
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD 193

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 29/151 (19%), Positives = 59/151 (39%), Gaps = 29/151 (19%)

Query: 18  RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-------KENAGERERLDLL 70
           R    +   LG G  G+V          R+    VA+K +                L++ 
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFE-----RKTCKKVAIKIISKRKFAIGSAREADPALNVE 63

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+ ++K L+ HP ++++     + E +++++E +  G+L  F +    +R         
Sbjct: 64  TEIEILKKLN-HPCIIKIKNFF-DAEDYYIVLELMEGGEL--FDKVVGNKRL-------- 111

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                     + YQ+   +Q+L   G+  RD
Sbjct: 112 ---KEATCKLYFYQMLLAVQYLHENGIIHRD 139

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 57.0 bits (138), Expect = 6e-10
 Identities = 21/95 (22%), Positives = 40/95 (42%), Gaps = 5/95 (5%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
              +++     ++    +G G  GQVWK        + G  ++AVK ++ +  + E   +
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKM----RFRKTG-HVIAVKQMRRSGNKEENKRI 70

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY 104
           L +L V+      P +V+  G        F+ ME 
Sbjct: 71  LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 56.4 bits (137), Expect = 9e-10
 Identities = 32/139 (23%), Positives = 55/139 (39%), Gaps = 24/139 (17%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--LQELTVMKTLDPH 82
             +GEG +G V+KC     +   G  IVA+K   E+  +   +    L+E+ ++K L  H
Sbjct: 9   GKIGEGSYGVVFKC----RNRDTGQ-IVAIKKFLESE-DDPVIKKIALREIRMLKQLK-H 61

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           PN+V LL     K    ++ EY  +  +   L   +              +    + S  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ------------RGVPEHLVKSIT 108

Query: 143 YQVARGMQFLSSRGV--RD 159
           +Q  + + F        RD
Sbjct: 109 WQTLQAVNFCHKHNCIHRD 127

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 56.5 bits (137), Expect = 9e-10
 Identities = 37/156 (23%), Positives = 58/156 (37%), Gaps = 32/156 (20%)

Query: 18  RQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQ-- 71
                 + +   LG+G FG V+    L  D  +    VA+K + +        L      
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQ----VAIKVIPRNRVLGWSPLSDSVTC 81

Query: 72  --ELTVMKTLDP---HPNVVRLLGCCTEKEPFFVIMEY-VPYGKLQSFLRSSRAQRYYNN 125
             E+ ++  +     HP V+RLL     +E F +++E  +P   L  ++           
Sbjct: 82  PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--------- 132

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             G      SR    F  QV   +Q   SRGV  RD
Sbjct: 133 -KGPLGEGPSR---CFFGQVVAAIQHCHSRGVVHRD 164

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 34/142 (23%), Positives = 54/142 (38%), Gaps = 27/142 (19%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQ----ELTVMKTLD- 80
           LG G FG V+    +  D       VA+K + K+   +   L        E+ ++K +  
Sbjct: 51  LGSGGFGSVYSGIRV-SDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYV-PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
               V+RLL      + F +I+E   P   L  F+             G      +R   
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----------RGALQEELAR--- 152

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
           SF +QV   ++   + GV  RD
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRD 174

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 29/143 (20%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
            ++G G FG V   +A   D  E   +VA+K + ++   + R     EL +M+ LD H N
Sbjct: 60  KVIGNGSFGVV--YQAKLCDSGE---LVAIKKVLQDKRFKNR-----ELQIMRKLD-HCN 108

Query: 85  VVRLLGCCTEKEPFF------VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
           +VRL                 ++++YVP   +    R     +          +L    +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK---------QTLPVIYV 158

Query: 139 TSFCYQVARGMQFLSSRGV--RD 159
             + YQ+ R + ++ S G+  RD
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRD 181

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 16/93 (17%)

Query: 26  ILGEGCFGQVWKCEALGI--DGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDP 81
           ++G G FG+V+K    G+  DG +    VA+K     +  G  E      E+  +     
Sbjct: 46  LIGHGVFGKVYK----GVLRDGAK----VALKRRTPESSQGIEE---FETEIETLSFCR- 93

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFL 114
           HP++V L+G C E+    +I +Y+  G L+  L
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.6 bits (132), Expect = 4e-09
 Identities = 33/168 (19%), Positives = 65/168 (38%), Gaps = 43/168 (25%)

Query: 26  ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNV 85
           +LG G  G+V +        +      A+K L++           +E+ +       P++
Sbjct: 25  VLGLGINGKVLQIFN-----KRTQEKFALKMLQD------CPKARREVELHWRASQCPHI 73

Query: 86  VRLLGCC----TEKEPFFVIMEYVPYGKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLTS 140
           VR++         ++   ++ME +  G+L  F R   R  + +          T R+ + 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGEL--FSRIQDRGDQAF----------TEREASE 121

Query: 141 FCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
               +   +Q+L S  +  RD   + KP+       N++Y    K PN
Sbjct: 122 IMKSIGEAIQYLHSINIAHRD---V-KPE-------NLLYT--SKRPN 156

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 53.7 bits (130), Expect = 8e-09
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 40/153 (26%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK---ENAGE--------RERLDLLQEL 73
             +G G +G V+K      D   G   VA+K+++      G         RE + LL+ L
Sbjct: 15  AEIGVGAYGTVYK----ARDPHSGH-FVALKSVRVPNGGGGGGGLPISTVRE-VALLRRL 68

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEP-----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
                   HPNVVRL+  C            ++ E+V    L+++L  +           
Sbjct: 69  EA----FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA----------- 112

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
               L +  +     Q  RG+ FL +  +  RD
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRD 145

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 54.0 bits (130), Expect = 9e-09
 Identities = 26/142 (18%), Positives = 54/142 (38%), Gaps = 30/142 (21%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
            +LG G  G+V +         +     A+K L      ++     +E+ +       P+
Sbjct: 68  QVLGLGINGKVLQIFNKR-TQEK----FALKML------QDCPKARREVELHWRASQCPH 116

Query: 85  VVRLLG----CCTEKEPFFVIMEYVPYGKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLT 139
           +VR++         ++   ++ME +  G+L  F R   R  + +          T R+ +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGEL--FSRIQDRGDQAF----------TEREAS 164

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
                +   +Q+L S  +  RD
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRD 186

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 53.5 bits (129), Expect = 9e-09
 Identities = 32/142 (22%), Positives = 52/142 (36%), Gaps = 30/142 (21%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
            +LG G  G+V +C      G++     A+K L +           QE+         P+
Sbjct: 35  QVLGLGVNGKVLECFHRR-TGQK----CALKLLYD------SPKARQEVDHHWQASGGPH 83

Query: 85  VVRLLGCC----TEKEPFFVIMEYVPYGKLQSFLR-SSRAQRYYNNMHGKSNSLTSRDLT 139
           +V +L         K    +IME +  G+L  F R   R  + +          T R+  
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGEL--FSRIQERGDQAF----------TEREAA 131

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
                +   +QFL S  +  RD
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRD 153

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 26/180 (14%), Positives = 60/180 (33%), Gaps = 39/180 (21%)

Query: 2   NDPVLNQKSDDKWEVPRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLK 58
           N   LN+   +K     ++I  + I   L +G F ++  C        +     A+K  +
Sbjct: 15  NLIYLNKYVKEK----DKYINDYRIIRTLNQGKFNKIILC-------EKDNKFYALKKYE 63

Query: 59  ENAGERERL----------------DLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM 102
           ++  E++R                 D   EL ++  +  +   +   G  T  +  ++I 
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIY 122

Query: 103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL-SSRGV--RD 159
           EY+    +  F                +  +  + +      V     ++ + + +  RD
Sbjct: 123 EYMENDSILKFDEYFFVLDK-----NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 52.6 bits (127), Expect = 2e-08
 Identities = 31/169 (18%), Positives = 63/169 (37%), Gaps = 34/169 (20%)

Query: 5   VLNQKSDDKWEVPRQHIKVFDIL---GEGCFGQVWKCEALGIDGREGPCIVAVKTLK-EN 60
           +  Q    +       +  ++ L   G+G FG+V+K        + G   VA+K +  EN
Sbjct: 1   MAKQYDSVECPFCD-EVSKYEKLAKIGQGTFGEVFK----ARHRKTGQ-KVALKKVLMEN 54

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP--------FFVIMEYVPYGKLQS 112
             E   +  L+E+ +++ L  H NVV L+  C  K           +++ ++  +  L  
Sbjct: 55  EKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAG 112

Query: 113 FLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            L +                 T  ++      +  G+ ++    +  RD
Sbjct: 113 LLSN------------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 52.3 bits (126), Expect = 2e-08
 Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 28/139 (20%)

Query: 27  LGEGCFGQVWKCEALGID---GREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLDPH 82
           +G+G F +V     L      GRE    VA+K + K          L +E+ +MK L+ H
Sbjct: 23  IGKGNFAKVK----LARHILTGRE----VAIKIIDKTQLNPTSLQKLFREVRIMKILN-H 73

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           PN+V+L      ++  ++IMEY   G++  +L +          HG+     +R   S  
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKEAR---SKF 120

Query: 143 YQVARGMQFLSSRGV--RD 159
            Q+   +Q+   + +  RD
Sbjct: 121 RQIVSAVQYCHQKRIVHRD 139

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 31/164 (18%), Positives = 62/164 (37%), Gaps = 40/164 (24%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           +V   +  G  G ++      ++GR     V +K L  +     +   + E   +  +  
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRP----VVLKGLVHSGDAEAQAMAMAERQFLAEVV- 137

Query: 82  HPNVVRLL------GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           HP++V++           +   + V MEYV  G+    L+ S+ Q+           L  
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIV-MEYVG-GQS---LKRSKGQK-----------LPV 181

Query: 136 RDLTSFCYQVARGMQFLSSRGV--RDGYRLEKPDHCRRELYNIM 177
            +  ++  ++   + +L S G+   D     KP+       NIM
Sbjct: 182 AEAIAYLLEILPALSYLHSIGLVYND----LKPE-------NIM 214

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 51.1 bits (123), Expect = 7e-08
 Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 41/150 (27%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ---ELTVMKTLDP 81
           D+LGEG +G+V K     +D     C  AVK LK+    R          E+ +++ L  
Sbjct: 11  DLLGEGSYGKV-K---EVLDSETL-CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64

Query: 82  HPNVVRL---LGCCTEKEPFFVIMEYVPYGKLQSF-------LRSSRAQRYYNNMHGKSN 131
           H NV++L   L    +++ + V MEY   G  +             +A  Y         
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMV-MEYCVCGMQEMLDSVPEKRFPVCQAHGY--------- 114

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                    FC Q+  G+++L S+G+  +D
Sbjct: 115 ---------FC-QLIDGLEYLHSQGIVHKD 134

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 48.8 bits (117), Expect = 3e-07
 Identities = 37/171 (21%), Positives = 67/171 (39%), Gaps = 41/171 (23%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           +W     +  V  + G G + +V   EA+ I   E    V VK LK    ++    + +E
Sbjct: 31  EWGNQDDYQLVRKL-GRGKYSEV--FEAINITNNE---KVVVKILKPVKKKK----IKRE 80

Query: 73  LTVMKTLDPHPNVVRLLGC---CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           + +++ L   PN++ L         + P  V  E+V     +   +              
Sbjct: 81  IKILENLRGGPNIITLADIVKDPVSRTPALVF-EHVNNTDFKQLYQ-------------- 125

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV--RDGYRLEKP-----DHCRREL 173
             +LT  D+  + Y++ + + +  S G+  RD     KP     DH  R+L
Sbjct: 126 --TLTDYDIRFYMYEILKALDYCHSMGIMHRD----VKPHNVMIDHEHRKL 170

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 48.9 bits (117), Expect = 3e-07
 Identities = 28/154 (18%), Positives = 60/154 (38%), Gaps = 32/154 (20%)

Query: 19  QHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD------ 68
           ++ + +     LG G FG VW         +E    V VK + KE   E   ++      
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDK-EKNKE----VVVKFIKKEKVLEDCWIEDPKLGK 75

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME-YVPYGKLQSFLRSSRAQRYYNNMH 127
           +  E+ ++  ++ H N++++L     +  F ++ME +     L +F+            H
Sbjct: 76  VTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR----------H 124

Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
            + +   +        Q+   + +L  + +  RD
Sbjct: 125 PRLDEPLAS---YIFRQLVSAVGYLRLKDIIHRD 155

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 48.2 bits (115), Expect = 6e-07
 Identities = 19/98 (19%), Positives = 32/98 (32%), Gaps = 16/98 (16%)

Query: 25  DILGEGCFGQVWKC--EALGIDGREGPCIVAVKTLK----ENAGERERLDLLQELTVMKT 78
              G     Q W+    AL    R+    VA+  +           +    L     +  
Sbjct: 37  IFHGGVPPLQFWQALDTALD---RQ----VALTFVDPQGVLPDDVLQET--LSRTLRLSR 87

Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRS 116
           +D  P V R+L     +    V+ E++  G LQ    +
Sbjct: 88  ID-KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT 124

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 47.7 bits (114), Expect = 8e-07
 Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 8/84 (9%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV 86
           +G G FG       L  D      +VAVK ++  A   E +   +E+   ++L  HPN+V
Sbjct: 28  IGSGNFGVAR----LMRDKLTK-ELVAVKYIERGAAIDENVQ--REIINHRSLR-HPNIV 79

Query: 87  RLLGCCTEKEPFFVIMEYVPYGKL 110
           R            +IMEY   G+L
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGEL 103

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 47.6 bits (114), Expect = 9e-07
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 16/89 (17%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL-DLLQ----ELTVMKTLDP 81
           LGEG +G+V     L ++       VAVK +     + +R  D  +    E+ + K L+ 
Sbjct: 15  LGEGAYGEV----QLAVNRVTE-EAVAVKIV-----DMKRAVDCPENIKKEICINKMLN- 63

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKL 110
           H NVV+  G   E    ++ +EY   G+L
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL 92

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 46.9 bits (112), Expect = 1e-06
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 16/89 (17%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL-DLLQ----ELTVMKTLDP 81
           LGEG +G+V     L ++       VAVK +     + +R  D  +    E+ + K L+ 
Sbjct: 15  LGEGAYGEV----QLAVNRVTE-EAVAVKIV-----DMKRAVDCPENIKKEICINKMLN- 63

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKL 110
           H NVV+  G   E    ++ +EY   G+L
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGEL 92

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 47.3 bits (113), Expect = 1e-06
 Identities = 35/148 (23%), Positives = 57/148 (38%), Gaps = 33/148 (22%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPH 82
            + G+G FG V                VA+K + ++     RE    LQ +  +  L  H
Sbjct: 29  RMAGQGTFGTV--QLGKEKSTGM---SVAIKKVIQDPRFRNRE----LQIMQDLAVLH-H 78

Query: 83  PNVVRLL------GCCTEKEPFF-VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           PN+V+L       G    ++ +  V+MEYVP   L    R+   ++          +   
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQ---------VAPPP 128

Query: 136 RDLTSFCYQVARGMQFL--SSRGV--RD 159
             +  F +Q+ R +  L   S  V  RD
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRD 156

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 33/157 (21%), Positives = 72/157 (45%), Gaps = 33/157 (21%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK---ENAGERERLDL 69
            W++P ++ ++  ++G G +G V +      D  E   +VA+K +    E+  + +R  +
Sbjct: 48  DWQIPDRY-EIRHLIGTGSYGHVCEA----YDKLEK-RVVAIKKILRVFEDLIDCKR--I 99

Query: 70  LQELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYN 124
           L+E+ ++  L+ H +VV++L      + E F   +V++E       +   R+        
Sbjct: 100 LREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRT-------- 149

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                   LT   + +  Y +  G++++ S G+  RD
Sbjct: 150 -----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRD 181

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 27/106 (25%), Positives = 50/106 (47%), Gaps = 11/106 (10%)

Query: 10  SDDKWEVPRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERE 65
           ++ +    R  I  + +   LG G FG+V     +G     G   VAVK L ++     +
Sbjct: 4   AEKQKHDGRVKIGHYILGDTLGVGTFGKVK----VGKHELTG-HKVAVKILNRQKIRSLD 58

Query: 66  RLDLLQ-ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKL 110
            +  ++ E+  +K    HP++++L    +     F++MEYV  G+L
Sbjct: 59  VVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVSGGEL 103

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 32/155 (20%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--L 70
              V R++ ++   LG+G +G VWK     ID R G  +VAVK +  +A +         
Sbjct: 4   DRHVLRKY-ELVKKLGKGAYGIVWKS----IDRRTG-EVVAVKKI-FDAFQNSTDAQRTF 56

Query: 71  QELTVMKTLDPHPNVVRLLGCCT--EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG 128
           +E+ ++  L  H N+V LL           +++ +Y+                   ++H 
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-----------------DLHA 99

Query: 129 --KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
             ++N L         YQ+ + +++L S G+  RD
Sbjct: 100 VIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRD 134

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 45.7 bits (109), Expect = 3e-06
 Identities = 33/137 (24%), Positives = 59/137 (43%), Gaps = 23/137 (16%)

Query: 27  LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQ-ELTVMKTLDPHPN 84
           LG G FG+V     +G     G   VAVK L ++     + +  ++ E+  +K    HP+
Sbjct: 19  LGVGTFGKV----KIGEHQLTG-HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPH 72

Query: 85  VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ 144
           +++L    +    FF++MEYV  G+L  ++            HG+   + +R       Q
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEMEAR---RLFQQ 119

Query: 145 VARGMQFLSSRGV--RD 159
           +   + +     V  RD
Sbjct: 120 ILSAVDYCHRHMVVHRD 136

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 3e-06
 Identities = 33/278 (11%), Positives = 67/278 (24%), Gaps = 105/278 (37%)

Query: 5   VLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEAL------GIDGREGPCIVAVKTLK 58
           VL     +      +    F++           C+ L       +            +L 
Sbjct: 249 VL----LNVQN--AKAWNAFNL----------SCKILLTTRFKQVTDFLSAATTTHISLD 292

Query: 59  ENAG---ERERLDLLQELTVMKTLD-P------HPNVVRLLGCCTEKEP----FFVIMEY 104
            ++      E   LL +    +  D P      +P  + ++             +   ++
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW---KH 349

Query: 105 VPYGKLQSFLRSSRA-------QRYY---------------------------------N 124
           V   KL + + SS         ++ +                                 N
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVN 409

Query: 125 NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRR--ELYNIM--YYC 180
            +H    SL  +        +   +       + + Y L    H R   + YNI   +  
Sbjct: 410 KLHKY--SLVEKQPKESTISI-PSIYLELKVKLENEYAL----H-RSIVDHYNIPKTFDS 461

Query: 181 WDKEPNERPNF--------------TELCDLLEKLLLN 204
            D  P     +               E   L   + L+
Sbjct: 462 DDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.0 bits (107), Expect = 7e-06
 Identities = 30/144 (20%), Positives = 51/144 (35%), Gaps = 29/144 (20%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-----ENAGERERLDLLQELTVM 76
           ++   LGEG FG+V +C    +D   G   VA+K ++       A   E +++L+++   
Sbjct: 22  EIVGNLGEGTFGKVVEC----LDHARGKSQVALKIIRNVGKYREAARLE-INVLKKI--- 73

Query: 77  KTLDPHP--NVVRLLGCCTEKEPFFVIMEYVPYGK-LQSFLRSSRAQRYYNNMHGKSNSL 133
           K  D       V +           +  E    GK    FL+        NN        
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKE-------NNFQPYPLPH 124

Query: 134 TSRDLTSFCYQVARGMQFLSSRGV 157
                    YQ+   ++FL    +
Sbjct: 125 VRH----MAYQLCHALRFLHENQL 144

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 28/156 (17%), Positives = 55/156 (35%), Gaps = 31/156 (19%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--L 70
              VP  +  +  ++G G +G V+       D       VA+K +     E        L
Sbjct: 21  NVHVPDNY-IIKHLIGRGSYGYVYLA----YDKNTE-KNVAIKKV-NRMFEDLIDCKRIL 73

Query: 71  QELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           +E+T++  L     ++RL       +   F   ++++E      L+   ++         
Sbjct: 74  REITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKT--------- 122

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                  LT   + +  Y +  G  F+   G+  RD
Sbjct: 123 ----PIFLTEEHIKTILYNLLLGENFIHESGIIHRD 154

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 21/172 (12%), Positives = 40/172 (23%), Gaps = 41/172 (23%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTV 75
             + +K+ + L  G    V+       D        A+K         R  L+ L E T 
Sbjct: 60  GERKLKLVEPLRVGDRSVVFLV----RDVERL-EDFALKVFTMGAENSRSELERLHEATF 114

Query: 76  MKTLDPHPNVVRLLGCCTEKEP--------------------------FFVIMEYVPYGK 109
                   +            P                          + ++M       
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVD 173

Query: 110 LQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           L+    +       + ++          L     Q+ R    L S+G+    
Sbjct: 174 LELLFST------LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 43.8 bits (104), Expect = 2e-05
 Identities = 28/166 (16%), Positives = 59/166 (35%), Gaps = 45/166 (27%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQ 71
            +++  ++      LG G  G V+      +D       VA+K +   +    +    L+
Sbjct: 6   GFDLGSRY-MDLKPLGCGGNGLVFSA----VDNDCD-KRVAIKKIVLTDPQSVKHA--LR 57

Query: 72  ELTVMKTLDPHPNVVRLL-----------GCCTEKEPF---FVIMEYVPYGKLQSFLRSS 117
           E+ +++ LD H N+V++                        +++ EY+            
Sbjct: 58  EIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---------- 106

Query: 118 RAQRYYNNMHG--KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                  ++    +   L       F YQ+ RG++++ S  V  RD
Sbjct: 107 -------DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRD 145

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 25/159 (15%), Positives = 52/159 (32%), Gaps = 24/159 (15%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           +    +G G FG V++ +   +D     C  A+K ++    E  R  +++E+  +  L+ 
Sbjct: 9   EPIQCMGRGGFGVVFEAKNK-VDD----CNYAIKRIRLPNRELAREKVMREVKALAKLE- 62

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           HP +VR      E  P                      +          ++       S 
Sbjct: 63  HPGIVRYFNAWLETPPE------------------KWQEEMDEIWLKDESTDWPLSSPSP 104

Query: 142 CYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYC 180
               +  ++ +     ++     +P   +  LY  M  C
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 43.4 bits (103), Expect = 2e-05
 Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 11/96 (11%)

Query: 15  EVPRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD--L 69
            + ++HI  + I   LGEG FG+V     L    +     VA+K +     ++  +   +
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVK----LATHYKTQ-QKVALKFISRQLLKKSDMHMRV 56

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV 105
            +E++ +K L  HP++++L    T      +++EY 
Sbjct: 57  EREISYLKLLR-HPHIIKLYDVITTPTDIVMVIEYA 91

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 43.0 bits (102), Expect = 3e-05
 Identities = 32/158 (20%), Positives = 58/158 (36%), Gaps = 37/158 (23%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--L 70
            + +     ++  +LGEG +G V            G  IVA+K  K    ++    L  L
Sbjct: 6   VYNISSDF-QLKSLLGEGAYGVVCSA----THKPTG-EIVAIK--KIEPFDKPLFALRTL 57

Query: 71  QELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYNN 125
           +E+ ++K    H N++ +         E F   ++I E +                   +
Sbjct: 58  REIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQT-----------------D 99

Query: 126 MHG--KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +H    +  L+   +  F YQ  R ++ L    V  RD
Sbjct: 100 LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 3e-05
 Identities = 35/144 (24%), Positives = 56/144 (38%), Gaps = 29/144 (20%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-----ENAGERERLDLLQELTVM 76
           ++ D LGEG FG+V +C    ID + G   VAVK +K       A   E + +L+ L   
Sbjct: 17  EIVDTLGEGAFGKVVEC----IDHKAGGRHVAVKIVKNVDRYCEAARSE-IQVLEHL--- 68

Query: 77  KTLDPHP--NVVRLLGCCTEKEPFFVIMEYVPYGK-LQSFLRSSRAQRYYNNMHGKSNSL 133
            T DP+     V++L          ++ E    G     F++        N         
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKE-------NGFLP----F 115

Query: 134 TSRDLTSFCYQVARGMQFLSSRGV 157
               +    YQ+ + + FL S  +
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKL 139

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 31/119 (26%), Positives = 57/119 (47%), Gaps = 14/119 (11%)

Query: 8   QKSDDKWEVPRQH---IKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KEN 60
           +    KWE P Q+   +  FD    LG G FG+V   +      +E     A+K L K+ 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH-----KESGNHYAMKILDKQK 78

Query: 61  AGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
             + ++++  L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR   
Sbjct: 79  VVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 42.6 bits (101), Expect = 4e-05
 Identities = 32/125 (25%), Positives = 48/125 (38%), Gaps = 15/125 (12%)

Query: 3   DPVLNQKSDDKWEVPRQHIKV----FDI---LGEGCFGQVWKCEALGIDGREGPCIVAVK 55
           +P     S    + P Q  K     F     LGEG F  V     L    R      A+K
Sbjct: 7   EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELA-TSR----EYAIK 61

Query: 56  TL-KENAGERERLD-LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSF 113
            L K +  +  ++  + +E  VM  LD HP  V+L     + E  +  + Y   G+L  +
Sbjct: 62  ILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120

Query: 114 LRSSR 118
           +R   
Sbjct: 121 IRKIG 125

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 28/143 (19%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-----ENAGERERLDLLQELTVM 76
           +V  ++G+G FGQV K      D +     VA+K ++           E + +L+ L   
Sbjct: 100 EVLKVIGKGSFGQVVKA----YDHKVH-QHVALKMVRNEKRFHRQAAEE-IRILEHL--- 150

Query: 77  KTLDPHP--NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           +  D     NV+ +L   T +    +  E +    L   ++        N   G S  L 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIK-------KNKFQGFSLPLV 202

Query: 135 SRDLTSFCYQVARGMQFLSSRGV 157
            +    F + + + +  L    +
Sbjct: 203 RK----FAHSILQCLDALHKNRI 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 42.3 bits (100), Expect = 6e-05
 Identities = 28/157 (17%), Positives = 62/157 (39%), Gaps = 37/157 (23%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK--ENAGERERLDLLQ 71
           ++V  ++      +GEG +G V        D       VA+K +   E+    +R   L+
Sbjct: 23  FDVGPRY-TNLSYIGEGAYGMVCSA----YDNLNK-VRVAIKKISPFEHQTYCQRT--LR 74

Query: 72  ELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSRAQRYYNNM 126
           E+ ++     H N++ +         E     +++ + +                   ++
Sbjct: 75  EIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMET-----------------DL 116

Query: 127 HG--KSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +   K+  L++  +  F YQ+ RG++++ S  V  RD
Sbjct: 117 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 42.0 bits (99), Expect = 7e-05
 Identities = 18/77 (23%), Positives = 29/77 (37%), Gaps = 15/77 (19%)

Query: 22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-----AGERERLDLLQELTVM 76
           +   LG G F  VW       D       VA+K ++ +     A E E + LLQ +   
Sbjct: 22 ILVRKLGWGHFSTVWLA----KDMVNN-THVAMKIVRGDKVYTEAAEDE-IKLLQRVNDA 75

Query: 77 KTLDPHP----NVVRLL 89
                     ++++LL
Sbjct: 76 DNTKEDSMGANHILKLL 92

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 41.9 bits (99), Expect = 7e-05
 Identities = 26/163 (15%), Positives = 55/163 (33%), Gaps = 38/163 (23%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ-- 71
             +   +  V   +  G +G V     +  +G      VA+K +     +   +++L   
Sbjct: 18  HAMQSPY-TVQRFISSGSYGAVCA--GVDSEGIP----VAIKRVFNTVSDGRTVNILSDS 70

Query: 72  --------ELTVMKTLDPHPNVVRLLGCCT--EKEPF---FVIMEYVPYGKLQSFLRSSR 118
                   E+ ++     HPN++ L       E+      +++ E +    L   +   R
Sbjct: 71  FLCKRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR 128

Query: 119 AQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                         ++ + +  F Y +  G+  L   GV  RD
Sbjct: 129 ------------IVISPQHIQYFMYHILLGLHVLHEAGVVHRD 159

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 38/162 (23%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKT 78
           I+V   LG+G FG+V          +E   + AVK L K+   + + ++  + E  ++  
Sbjct: 28  IRV---LGKGSFGKVMLARV-----KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 79  LDPHPNVVRLLGCC-TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
              HP + +L  C  T    FFV ME+V  G L       +++R+               
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFV-MEFVNGGDL--MFHIQKSRRF------------DEA 124

Query: 138 LTSFCY--QVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIM 177
              F Y  ++   + FL  +G+   YR  K D       N++
Sbjct: 125 RARF-YAAEIISALMFLHDKGII--YRDLKLD-------NVL 156

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 11/107 (10%)

Query: 17  PRQHIKVFDI---LGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD-LLQ 71
           P+  ++ F I   LG G FG+V    +     R      A+K L KE     ++++    
Sbjct: 1   PKYSLQDFQILRTLGTGSFGRVHLIRS-----RHNGRYYAMKVLKKEIVVRLKQVEHTND 55

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR 118
           E  ++  +  HP ++R+ G   + +  F+IM+Y+  G+L S LR S+
Sbjct: 56  ERLMLSIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ 101

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.2 bits (97), Expect = 1e-04
 Identities = 26/141 (18%), Positives = 51/141 (36%), Gaps = 25/141 (17%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL-- 79
            V   +G+G FG+V  C        +     AVK ++    ++       E  ++K +  
Sbjct: 38  LVIRKMGDGTFGRVLLC----QH-IDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQN 90

Query: 80  -DPH-PNVVRLLGCCTEKEPFFVIMEYVPYGK-LQSFLRSSRAQRYYNNMHGKSNSLTSR 136
            D +  N+V+  G     +   +I E  P G  L   +         NN +G        
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITR-------NNYNGFHIEDIK- 140

Query: 137 DLTSFCYQVARGMQFLSSRGV 157
               +C ++ + + +L    +
Sbjct: 141 ---LYCIEILKALNYLRKMSL 158

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 20/160 (12%), Positives = 43/160 (26%), Gaps = 32/160 (20%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTL--KENAGERERLDLLQELTVMKTLDP- 81
            +LG+       +       G        V      E         + +E+  ++ L   
Sbjct: 84  TVLGQEDPYAYLEATDQ-ETGES----FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 82  --------------------HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQR 121
                                P   +++    ++   +V+  +  Y ++QS L++     
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT--FGE 196

Query: 122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              +      SL          QV R +  L   G+    
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 34/160 (21%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKT 78
           + V   LG+G FG+V   E      +    + AVK L K+   + + ++  + E  V+  
Sbjct: 346 LMV---LGKGSFGKVMLSER-----KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 79  LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
               P + +L  C    +  + +MEYV  G L       +  R+                
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRF------------KEPH 443

Query: 139 TSF-CYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIM 177
             F   ++A G+ FL S+G+   YR  K D       N+M
Sbjct: 444 AVFYAAEIAIGLFFLQSKGII--YRDLKLD-------NVM 474

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 40.7 bits (96), Expect = 2e-04
 Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 38/162 (23%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKT 78
            K+   LG+G FG+V+  E      ++     A+K L K+     + ++  + E  V+  
Sbjct: 22  HKM---LGKGSFGKVFLAEF-----KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73

Query: 79  LDPHPNVVRLLGC-CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
              HP +  +     T++  FFV MEY+  G L          ++               
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFV-MEYLNGGDL--MYHIQSCHKF------------DLS 118

Query: 138 LTSFCY--QVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIM 177
             +F Y  ++  G+QFL S+G+   YR  K D       NI+
Sbjct: 119 RATF-YAAEIILGLQFLHSKGIV--YRDLKLD-------NIL 150

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 40.3 bits (95), Expect = 2e-04
 Identities = 31/144 (21%), Positives = 56/144 (38%), Gaps = 27/144 (18%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE----RERLDLLQELTVMK 77
           K+ D LG G    V+       D       VA+K +     E     +R +  +E+    
Sbjct: 14  KIVDKLGGGGMSTVYL----AEDTILN-IKVAIKAIFIPPREKEETLKRFE--REVHNSS 66

Query: 78  TLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
            L  H N+V ++    E + ++++MEY+    L  ++ S          HG    L+   
Sbjct: 67  QLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----------HGP---LSVDT 112

Query: 138 LTSFCYQVARGMQFLSSRGV--RD 159
             +F  Q+  G++      +  RD
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRD 136

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 39.2 bits (92), Expect = 5e-04
 Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 21/94 (22%)

Query: 71  QELTVMKTLDPHPNVVRL---LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMH 127
           QE+ ++K LD HPNVV+L   L    E   + V  E V  G +                 
Sbjct: 85  QEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMV-FELVNQGPVMEVPT-----------L 131

Query: 128 GKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
              +   +R    +   + +G+++L  + +  RD
Sbjct: 132 KPLSEDQAR---FYFQDLIKGIEYLHYQKIIHRD 162

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 39.3 bits (92), Expect = 6e-04
 Identities = 33/175 (18%), Positives = 60/175 (34%), Gaps = 41/175 (23%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E   +   +   LG G FG V  CE   I+  +     A+K + ++   + R     EL 
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIV--CEVFDIESGK---RFALKKVLQDPRYKNR-----ELD 52

Query: 75  VMKTLDPHPNVVRLLGC---CTEKEPFFVIMEYVPYGKLQSFLRSSRA------------ 119
           +MK LD H N+++L+       ++EP                   +              
Sbjct: 53  IMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 120 -------------QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                         +   +      S+    ++ + YQ+ R + F+ S G+  RD
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRD 166

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 39.1 bits (92), Expect = 7e-04
 Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 38/162 (23%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKT 78
           ++V   +G G + +V          ++   I A+K + KE   + E +D +  E  V + 
Sbjct: 14  LRV---IGRGSYAKVLLVRL-----KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 79  LDPHPNVVRLLGCC-TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
              HP +V L  C  TE   FFV +EYV  G L       R ++               +
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFV-IEYVNGGDL--MFHMQRQRKL------------PEE 110

Query: 138 LTSFCY--QVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIM 177
              F Y  +++  + +L  RG+   YR  K D       N++
Sbjct: 111 HARF-YSAEISLALNYLHERGII--YRDLKLD-------NVL 142

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 38.7 bits (89), Expect = 8e-04
 Identities = 24/182 (13%), Positives = 57/182 (31%), Gaps = 40/182 (21%)

Query: 7   NQKSDDKWE--VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVK-------TL 57
           +QK    +   +P + ++  + +GEG FG+V++  A           VA+K        L
Sbjct: 6   SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP-------VAIKIIAIEGPDL 58

Query: 58  KENAGERERLDLLQELTVMKTLDP--------HPNVVRLLG--CCTEKEPFFVIMEYVPY 107
              + ++   ++L E+ + K L              + L    C     P  ++  +  Y
Sbjct: 59  VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118

Query: 108 GKLQSFLRSSRAQRYYNNM--------------HGKSNSLTSRDLTSFCYQVARGMQFLS 153
              +            + +                ++   +     S  +Q+   +    
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178

Query: 154 SR 155
           + 
Sbjct: 179 AS 180

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 38.9 bits (91), Expect = 8e-04
 Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 38/162 (23%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD-LLQELTVMKT 78
           ++V   +G G + +V          ++   I A++ + KE   + E +D +  E  V + 
Sbjct: 57  LRV---IGRGSYAKVLLVRL-----KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108

Query: 79  LDPHPNVVRLLGCC-TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
              HP +V L  C  TE   FFV +EYV  G L       R ++               +
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFV-IEYVNGGDL--MFHMQRQRKL------------PEE 153

Query: 138 LTSFCY--QVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIM 177
              F Y  +++  + +L  RG+   YR  K D       N++
Sbjct: 154 HARF-YSAEISLALNYLHERGII--YRDLKLD-------NVL 185

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	230
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.94
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.94
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.93
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.93
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.93
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.93
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.93
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.93
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.93
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.93
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.93
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.93
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.93
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.93
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.93
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.93
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.92
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.92
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.92
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.92
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.92
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.92
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.92
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.92
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.92
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.92
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.92
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.92
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.92
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.92
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.92
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.92
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.92
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.92
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.91
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.91
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.91
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.91
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.91
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.91
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.91
3niz_A	311	Rhodanese family protein; structural genomics, str	99.91
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.91
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.91
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.91
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.91
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.91
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.91
3bhy_A	283	Death-associated protein kinase 3; death associate	99.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.91
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.91
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.91
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.91
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.91
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.91
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.91
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.91
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.91
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.91
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.91
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.91
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.91
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.9
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.9
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.9
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.9
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.9
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.9
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.9
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.9
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.9
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.9
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.9
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.9
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.9
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.9
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.9
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.9
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.9
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.9
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.9
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.89
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.89
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.89
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.89
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.89
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.89
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.89
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.89
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.89
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.89
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.89
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.89
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.89
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.89
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.89
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.89
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.88
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.88
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.88
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.88
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.88
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.88
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.88
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.88
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.88
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.88
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.88
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.88
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.87
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.87
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.87
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.87
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.87
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.87
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.87
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.87
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.86
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.86
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.85
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.84
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.84
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.84
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.84
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.84
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.84
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.81
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.76
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.68
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.65
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.57
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.57
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.46
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.27
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.47
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.94
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.48
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.4
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.29
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.98
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.39
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.13
3ats_A	357	Putative uncharacterized protein; hypothetical pro	95.85
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	95.38
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.01
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	93.11
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	89.39
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	89.03
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.63
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	87.8
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	85.99
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.7
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	85.16
3mes_A	424	Choline kinase; malaria, structural genomics, stru	81.93

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-37  Score=248.76  Aligned_cols=195  Identities=30%  Similarity=0.603  Sum_probs=161.5

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ..|++++|.+.+.||+|+||.||+|.+.+.....++..||||+++.. .....+.|.+|+.++..++ |||||+++|++.
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQ-HEHIVKFYGVCV   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEe
Confidence            57899999999999999999999999876544566778999999753 4566788999999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+.+++|||||++|+|.++++.................+++..++.|+.||+.||.|||+++                 
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999875322111111123346899999999999999999999998                 


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence                                                                                         445


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccccc
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE  210 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~  210 (230)
                      +.+++.|..||+++.+|+.+||+.||++||||.+|.+.|+.+....+.+.+
T Consensus       246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ld  296 (299)
T 4asz_A          246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLD  296 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSC
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCcccc
Confidence            566788899999999999999999999999999999999999988777654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=243.71  Aligned_cols=197  Identities=32%  Similarity=0.552  Sum_probs=160.6

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...+.|..++|.+.++||+|+||.||+|.+.+.....++..||||+++.. .....+.|.+|+.++..++ |||||+++|
T Consensus        33 ~~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~-HpnIV~l~g  110 (329)
T 4aoj_A           33 ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQ-HQHIVRFFG  110 (329)
T ss_dssp             CCSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred             hhhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEE
Confidence            34467889999999999999999999999876544566788999999753 4566788999999999999 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhh--ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY--YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      ++...+.+++|||||++|+|.+++........  ..........+++..++.|+.||+.||.|||+++            
T Consensus       111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL  190 (329)
T 4aoj_A          111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL  190 (329)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence            99999999999999999999999986431100  0000112345899999999999999999999998            


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence                                                                                            


Q ss_pred             --CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccc
Q psy15820        157 --VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYI  209 (230)
Q Consensus       157 --i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~  209 (230)
                        +..+.+++.|..|++++.+|+.+||+.||++||||.+|++.|+.+.+..+.|.
T Consensus       271 ~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~l  325 (329)
T 4aoj_A          271 DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYL  325 (329)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC---
T ss_pred             HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcccc
Confidence              44556778899999999999999999999999999999999999987655544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-36  Score=243.63  Aligned_cols=197  Identities=31%  Similarity=0.533  Sum_probs=152.4

Q ss_pred             CCcCCCCCCC-cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCC
Q psy15820          3 DPVLNQKSDD-KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP   81 (230)
Q Consensus         3 ~~~~~~~~~~-~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~   81 (230)
                      .|..++.... -.+|+.+++++.+.||+|+||.||+|.+.+.....++..||||+++........+.|.+|+.++..++ 
T Consensus         9 ~p~~~~~~~~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-   87 (308)
T 4gt4_A            9 MPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-   87 (308)
T ss_dssp             ----------CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-
T ss_pred             ccccCccccCCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-
Confidence            3444443333 35789999999999999999999999987654455677899999976555555678999999999999 


Q ss_pred             CCceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhcc---ccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--
Q psy15820         82 HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYN---NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--  156 (230)
Q Consensus        82 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--  156 (230)
                      |||||+++|++...+.+++|||||++|+|.+++..........   ........+++..++.|+.|||.||.|||+++  
T Consensus        88 HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii  167 (308)
T 4gt4_A           88 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV  167 (308)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999999997643211000   00112345899999999999999999999998  


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       168 HRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P  247 (308)
T 4gt4_A          168 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP  247 (308)
T ss_dssp             CSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence                                                                                            


Q ss_pred             ------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        157 ------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       157 ------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                                  +..+.+++.|..||+++.+|+.+||+.||++||||.+|++.|+.
T Consensus       248 f~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          248 YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             TTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                        55667788899999999999999999999999999999998864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.9e-36  Score=242.50  Aligned_cols=195  Identities=41%  Similarity=0.708  Sum_probs=164.1

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.|+|++++|++++.||+|+||.||+|.+.+.....+.+.||+|.++..........+.+|+.++..+.+|||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            35899999999999999999999999999887766777889999998766677778899999999999846999999999


Q ss_pred             EecC-CCeEEEEecCCCCCHHHHHHHhhhhhhccc---cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         92 CTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        92 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +... +.+++|||||++|+|.++++..+.......   .......+++..++.++.|||.||.|||+++           
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            8764 568999999999999999987542110000   0011245899999999999999999999999           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence                                                                                            


Q ss_pred             ----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 ----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 ----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                          +..+.+++.|..|++++.+++.+||+.||++||||.+|++.|+.+++.+.
T Consensus       297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence                44556778889999999999999999999999999999999999987643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=229.13  Aligned_cols=176  Identities=24%  Similarity=0.415  Sum_probs=147.0

Q ss_pred             CCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC-cCCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820          8 QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus         8 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      ..+...|+|+.+++++++.||+|+||.||+|.+.+        .||||+++. .......+.|.+|+.++..++ |||||
T Consensus        25 ~~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV   95 (307)
T 3omv_A           25 RDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNIL   95 (307)
T ss_dssp             ----CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBC
T ss_pred             CCCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEe
Confidence            34556799999999999999999999999998732        289999973 345667788999999999999 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------  156 (230)
                      ++++++.. +.+++|||||++|+|.+++...            ...+++..++.|+.|||.||.|||+++          
T Consensus        96 ~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~N  162 (307)
T 3omv_A           96 LFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQ------------ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN  162 (307)
T ss_dssp             CEEEEECS-SSCEEEEECCSSCBHHHHHHTS------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSS
T ss_pred             eEEEEEEC-CeEEEEEEcCCCCCHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHH
Confidence            99998754 5689999999999999999763            235899999999999999999999999          


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       163 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~  242 (307)
T 3omv_A          163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN  242 (307)
T ss_dssp             EEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence                                                                                            


Q ss_pred             -------CCCCccC----CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 -------VRDGYRL----EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 -------i~~~~~~----~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                             +..+...    ..+.+|++++.+|+.+||+.||++||||.+|++.|+.+-.+.
T Consensus       243 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          243 RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                   1222222    345689999999999999999999999999999998775443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-32  Score=223.04  Aligned_cols=164  Identities=17%  Similarity=0.358  Sum_probs=138.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC-cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      -..++|++++.||+|+||.||+|.+     ..+++.||+|+++. .........+.+|+.++..+. |||||++++++.+
T Consensus        21 ~sme~Y~~~~~lG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~   94 (350)
T 4b9d_A           21 QSMEKYVRLQKIGEGSFGKAILVKS-----TEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEE   94 (350)
T ss_dssp             SCCCCEEEEEEC------CEEEEEE-----TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             CcccceEEeEEEecCCCeEEEEEEE-----CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEE
Confidence            3568999999999999999999998     55677899999963 345667788999999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+.+|+|||||+||+|.+++...+           ...+++..++.|+.||+.||.|||+++                  
T Consensus        95 ~~~~yiVmEy~~gg~L~~~i~~~~-----------~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~  163 (350)
T 4b9d_A           95 NGSLYIVMDYCEGGDLFKRINAQK-----------GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT  163 (350)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC
Confidence            999999999999999999998642           234788999999999999999999999                  


Q ss_pred             -------------------------------------------------------------------------CCCCccC
Q psy15820        157 -------------------------------------------------------------------------VRDGYRL  163 (230)
Q Consensus       157 -------------------------------------------------------------------------i~~~~~~  163 (230)
                                                                                               +..+..+
T Consensus       164 vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~  243 (350)
T 4b9d_A          164 VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP  243 (350)
T ss_dssp             EEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred             EEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence                                                                                     3344455


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      +.+..+++++.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            677889999999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=8.2e-31  Score=211.54  Aligned_cols=168  Identities=21%  Similarity=0.283  Sum_probs=142.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +....++|++.++||+|+||.||+|.+     +.++..||+|+++....      ..+|+.++..+. |||||++++++.
T Consensus        53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~-----~~~g~~vAiK~i~~~~~------~~~E~~il~~l~-HpnIV~l~~~~~  120 (336)
T 4g3f_A           53 YREEVHWMTHQPRVGRGSFGEVHRMKD-----KQTGFQCAVKKVRLEVF------RVEELVACAGLS-SPRIVPLYGAVR  120 (336)
T ss_dssp             CCBTTTEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEETTTC------CTHHHHTTTTCC-CTTBCCEEEEEE
T ss_pred             hhcchhheEeCcEeccCCCeEEEEEEE-----CCCCCEEEEEEECHHHh------HHHHHHHHHhCC-CCCCCcEEEEEE
Confidence            445667899999999999999999998     56677899999964321      246999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      +.+.+|+|||||+||+|.+++....             .+++..++.|+.||+.||.|||+++                 
T Consensus       121 ~~~~~~ivmEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g  187 (336)
T 4g3f_A          121 EGPWVNIFMELLEGGSLGQLIKQMG-------------CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG  187 (336)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS
T ss_pred             ECCEEEEEEeccCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC
Confidence            9999999999999999999998742             4899999999999999999999999                 


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       188 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  267 (336)
T 4g3f_A          188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK  267 (336)
T ss_dssp             CCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH
T ss_pred             CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCcc--CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 VRDGYR--LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 i~~~~~--~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      +..+..  ...|+.+++++.++|.+||+.||++|||+.||++.+...+....
T Consensus       268 i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          268 IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             HHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            111111  13567899999999999999999999999999999888776543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=5.8e-31  Score=207.23  Aligned_cols=157  Identities=16%  Similarity=0.312  Sum_probs=131.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .+|++++.||+|+||.||+|.+     ..++..||+|+++...  .......+.+|+.++..+. |||||++++++.+.+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYH-----TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEEC-----TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEE-----CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECC
Confidence            5899999999999999999998     5566789999996432  2333567899999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      .+|+||||| +|+|.+++...             ..+++..+..++.||+.||.|||+++                    
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~-------------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vk  152 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR-------------DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK  152 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS-------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEE
T ss_pred             EEEEEEeCC-CCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEE
Confidence            999999999 67999998763             35899999999999999999999999                    


Q ss_pred             -----------------------------------------------------------------------CCCCccCCC
Q psy15820        157 -----------------------------------------------------------------------VRDGYRLEK  165 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~~~~~~  165 (230)
                                                                                             +.. .....
T Consensus       153 l~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~-~~~~~  231 (275)
T 3hyh_A          153 IADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-GVYTL  231 (275)
T ss_dssp             ECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCC
T ss_pred             EeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence                                                                                   111 12446


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      |..+++++.+|+.+||+.||++|||+.|+++
T Consensus       232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            6789999999999999999999999999987

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.97  E-value=6.5e-31  Score=212.75  Aligned_cols=158  Identities=24%  Similarity=0.431  Sum_probs=134.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+.|++.+.||+|+||.||+|.+     +.++..||+|+++.... ...+.+.+|+.++..+. |||||++++++.+.+.
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~-----~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  145 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATV-----RSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE  145 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEE-----CCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence            45799999999999999999999     56677899999963321 22356889999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      +|+|||||+||+|.+++...              .+++..+..|+.||+.||.|||+++                     
T Consensus       146 ~~ivmEy~~gg~L~~~l~~~--------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl  211 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTHT--------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL  211 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEE
Confidence            99999999999999998752              3899999999999999999999999                     


Q ss_pred             ----------------------------------------------------------------------CCCCc--cCC
Q psy15820        157 ----------------------------------------------------------------------VRDGY--RLE  164 (230)
Q Consensus       157 ----------------------------------------------------------------------i~~~~--~~~  164 (230)
                                                                                            +..+.  ...
T Consensus       212 ~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~  291 (346)
T 4fih_A          212 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK  291 (346)
T ss_dssp             CCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS
T ss_pred             ecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC
Confidence                                                                                  11111  122


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .+..+++++.+||.+||+.||++|||+.|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            34578999999999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.97  E-value=2.7e-31  Score=212.04  Aligned_cols=163  Identities=20%  Similarity=0.290  Sum_probs=139.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .....++|++++.||+|+||.||+|.+     ..+++.||+|+++...  .......+.+|+.++..+. |||||+++++
T Consensus        27 ~~~~~~dy~i~~~lG~G~fg~V~~a~~-----~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~  100 (311)
T 4aw0_A           27 RKKRPEDFKFGKILGEGSFSTVVLARE-----LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFT  100 (311)
T ss_dssp             CCCCGGGEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred             CCCCccccEEEEEEecccCeEEEEEEE-----CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence            345567899999999999999999999     5667789999996321  1223467899999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +.+.+.+|+|||||+||+|.+++....             .+++..+..++.||+.||.|||+++               
T Consensus       101 ~~~~~~~yivmEy~~gG~L~~~i~~~~-------------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~  167 (311)
T 4aw0_A          101 FQDDEKLYFGLSYAKNGELLKYIRKIG-------------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE  167 (311)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC
Confidence            999999999999999999999998742             4899999999999999999999999               


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       168 ~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~  247 (311)
T 4aw0_A          168 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII  247 (311)
T ss_dssp             TSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                                                                                          11


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      . .....|+.+++++.+||.+||+.||++|||+.|++.
T Consensus       248 ~-~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          248 K-LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             H-TCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             c-CCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            1 124567889999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=3.6e-30  Score=204.30  Aligned_cols=157  Identities=27%  Similarity=0.438  Sum_probs=132.2

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC-cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec----C
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----K   95 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~----~   95 (230)
                      |++.+.||+|+||.||+|.+     ..++..||+|.+.. .........+.+|+.++..+. |||||++++++..    .
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLD-----TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTE
T ss_pred             EEeeeEEecCcCcEEEEEEE-----CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCC
Confidence            57888999999999999998     45666799999853 345666788999999999999 9999999999864    3


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +.+|+|||||+||+|.+++....             .+++..+..|+.||+.||.|||+++                   
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~  168 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFK-------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT  168 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTT
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCC
Confidence            45899999999999999998742             4899999999999999999999986                   


Q ss_pred             -------------------------------------------------------------------------CCCCccC
Q psy15820        157 -------------------------------------------------------------------------VRDGYRL  163 (230)
Q Consensus       157 -------------------------------------------------------------------------i~~~~~~  163 (230)
                                                                                               +..+..+
T Consensus       169 g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~  248 (290)
T 3fpq_A          169 GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             SCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             CCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC
Confidence                                                                                     2222222


Q ss_pred             -CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        164 -EKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       164 -~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                       ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             234567889999999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=2.5e-30  Score=214.20  Aligned_cols=158  Identities=24%  Similarity=0.437  Sum_probs=135.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+.|++.+.||+|+||.||+|.+     +.++..||+|+++... ....+.+.+|+.++..+. |||||++++++...+.
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~-----~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATV-----RSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE  222 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEE-----CCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCE
Confidence            46799999999999999999999     5667789999996432 222356889999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      +|+|||||+||+|.+++...              .+++..+..|+.||+.||.|||+++                     
T Consensus       223 ~~iVmEy~~gG~L~~~i~~~--------------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl  288 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTHT--------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL  288 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEE
T ss_pred             EEEEEeCCCCCcHHHHHhcc--------------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEE
Confidence            99999999999999998753              3899999999999999999999999                     


Q ss_pred             ----------------------------------------------------------------------CCCCc--cCC
Q psy15820        157 ----------------------------------------------------------------------VRDGY--RLE  164 (230)
Q Consensus       157 ----------------------------------------------------------------------i~~~~--~~~  164 (230)
                                                                                            +..+.  ...
T Consensus       289 ~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~  368 (423)
T 4fie_A          289 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK  368 (423)
T ss_dssp             CCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred             ecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCc
Confidence                                                                                  11111  223


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .+..+++++.+||.+||..||++|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            44578999999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=2e-29  Score=207.86  Aligned_cols=177  Identities=33%  Similarity=0.662  Sum_probs=156.1

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+.|.++.++|++++.||+|+||.||+|.+     ..++..||+|.++..........+.+|+.++..+. ||||++++
T Consensus       105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~  178 (377)
T 3cbl_A          105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRL-----RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLI  178 (377)
T ss_dssp             CCCTTBCCGGGEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC-CTTBCCEE
T ss_pred             cccccEEchHHeEEeeEeccCCCCeEEEEEE-----ecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC-CCCEEEEE
Confidence            3457899999999999999999999999999     44556799999976656666678999999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++...+..++||||+++|+|.+++....            ..+++..++.++.|++.||.|||+++             
T Consensus       179 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~  246 (377)
T 3cbl_A          179 GVCTQKQPIYIVMELVQGGDFLTFLRTEG------------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV  246 (377)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             EEEecCCCcEEEEEcCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE
Confidence            99999899999999999999999998642            23889999999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       247 ~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~  326 (377)
T 3cbl_A          247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE  326 (377)
T ss_dssp             CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred             cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence                                                                                            


Q ss_pred             -CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 -VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 -i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                       +..+.+.+.|..|++++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence             233445667888999999999999999999999999999999988754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=1.4e-30  Score=207.76  Aligned_cols=128  Identities=21%  Similarity=0.393  Sum_probs=103.6

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..+++.++|++++.||+|+||.||+|.....  ..+++.||+|+++.. ........+.+|+.++..+. |||||+++++
T Consensus        18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~   94 (304)
T 3ubd_A           18 HEKADPSQFELLKVLGQGSFGKVFLVKKISG--SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYA   94 (304)
T ss_dssp             CCCCCGGGEEEEEEEECGGGCEEEEEEECSS--TTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEE
T ss_pred             cccCCccccEEEEEEecCCCeEEEEEEEccC--CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEE
Confidence            3456778999999999999999999987432  345667999999633 12222346788999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.+.+.+|+|||||+||+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        95 ~~~~~~~~ivmEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~ylH~~~  146 (304)
T 3ubd_A           95 FQTEGKLYLILDFLRGGDLFTRLSKEV-------------MFTEEDVKFYLAELALALDHLHSLG  146 (304)
T ss_dssp             EEETTEEEEEECCCTTCEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEECCEEEEEEEcCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999998742             4899999999999999999999999

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=4.1e-30  Score=205.31  Aligned_cols=122  Identities=22%  Similarity=0.435  Sum_probs=101.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      ++|++++.||+|+||.||+|.+     +.++..||+|+++........+.+.+|+.++..+. |||||++++++...+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKN-----KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEE-----TTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEE-----CCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcc
Confidence            4689999999999999999998     55667799999975556667788999999999999 999999999987544  


Q ss_pred             ----------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ----------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                                .+|++||||++|+|.+++.....          ....++..++.++.||+.||.|||+++
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~al~ylH~~~  138 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT----------IEERERSVCLHIFLQIAEAVEFLHSKG  138 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCS----------GGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCC----------CChhHHHHHHHHHHHHHHHHHHHHHCc
Confidence                      26999999999999999986321          112455668899999999999999999

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=1.7e-29  Score=202.33  Aligned_cols=113  Identities=20%  Similarity=0.363  Sum_probs=92.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      ++|.+.+.||+|+||.||+|.+.       +..||||+++...  .....+..|+..+..++ |||||++++++...+  
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-------g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSRE--ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-------TEEEEEEEECGGG--HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccc--hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCC
Confidence            46889999999999999999873       3459999996432  22222334566667788 999999999997643  


Q ss_pred             --CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         97 --PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        97 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                        .+++|||||++|+|.++++..              .+++..+..++.|++.||.|||++
T Consensus        73 ~~~~~lV~Ey~~~gsL~~~l~~~--------------~l~~~~~~~i~~~ia~gl~ylH~~  119 (303)
T 3hmm_A           73 WTQLWLVSDYHEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHME  119 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred             ceEEEEEecCCCCCcHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHh
Confidence              479999999999999999763              388999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.1e-28  Score=197.60  Aligned_cols=201  Identities=30%  Similarity=0.573  Sum_probs=161.2

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      ..++..++|++.+.||+|+||.||+|.+.... ...+..||+|.++..........+.+|+.++..+. |+||+++++++
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~  115 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVI  115 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            35788999999999999999999999886443 23345699999986656667778999999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..++||||+++++|.+++...            ...+++..++.++.|++.||.|||+++                
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~  183 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREK------------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN  183 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC
Confidence            9999999999999999999999763            235899999999999999999999998                


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     +
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  263 (333)
T 1mqb_A          184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI  263 (333)
T ss_dssp             CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence                                                                                           2


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCCCcceeeeccccc
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMVSLSG  227 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (230)
                      ..+.+.+.+..+++++.+++.+||+.||++|||+.++++.|+.++...........+.........+++|
T Consensus       264 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~~~~~p~~~~~~p~~sg  333 (333)
T 1mqb_A          264 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG  333 (333)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSBCCC-------------
T ss_pred             HCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhhcCCCccchhhCCCCCC
Confidence            2233455667899999999999999999999999999999999998887777777766665555555443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=2.9e-28  Score=195.71  Aligned_cols=195  Identities=43%  Similarity=0.806  Sum_probs=160.3

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .....|.+..++|.+.+.||+|+||.||+|.+.......++..||+|+++..........+.+|+.++..+. ||||+++
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~   91 (314)
T 2ivs_A           13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKL   91 (314)
T ss_dssp             -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCE
T ss_pred             cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeE
Confidence            456778999999999999999999999999987655456677899999986666777788999999999998 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhc-----------cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY-----------NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-  156 (230)
                      ++++...+..+++|||+++++|.+++......+..           .........+++..++.++.|++.||.|||+++ 
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  171 (314)
T 2ivs_A           92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL  171 (314)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            99999999999999999999999999875321000           000001234788999999999999999999998 


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence                                                                                            


Q ss_pred             -------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 -------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 -------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                                   +..+.....|..+++++.+++.+||+.||++|||+.++++.|+.++..
T Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence                         122233455678899999999999999999999999999999998865

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=6.7e-28  Score=198.34  Aligned_cols=195  Identities=41%  Similarity=0.778  Sum_probs=158.2

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccC--CCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGID--GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..|.+..++|++++.||+|+||.||+|.+.+..  ....+..||+|+++..........+.+|+.++..+..||||++++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            446788899999999999999999999986433  224566799999986656667788999999999993399999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhc---cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------  156 (230)
                      +++...+..++||||+++|+|.+++......+..   .........+++..++.++.||+.||.|||+++          
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            9999999999999999999999999875311000   000001234788999999999999999999998          


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence                                                                                            


Q ss_pred             ----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 ----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 ----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                          +..+.+...|..+++++.+++.+||+.||++|||+.++++.|+.++....
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                22334556778899999999999999999999999999999999886543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.7e-27  Score=196.71  Aligned_cols=201  Identities=40%  Similarity=0.773  Sum_probs=163.4

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      .....|++..++|.+++.||+|+||.||+|.+.+...  ...+..||+|+++..........+.+|+.++..+..||||+
T Consensus        59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv  138 (382)
T 3tt0_A           59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII  138 (382)
T ss_dssp             CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhh
Confidence            3556689999999999999999999999999865432  23456799999987666777788999999999994499999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------  156 (230)
                      ++++++...+..++||||+++|+|.+++......+.   ..........+++..++.++.|++.||.|||+++       
T Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  218 (382)
T 3tt0_A          139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  218 (382)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            999999999999999999999999999987532100   0000111245899999999999999999999998       


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence                                                                                            


Q ss_pred             -------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccc
Q psy15820        157 -------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYI  209 (230)
Q Consensus       157 -------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~  209 (230)
                             +..+.+...|..+++++.+++.+||+.||++|||+.++++.|+.+........
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          299 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred             HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence                   22333455667899999999999999999999999999999999987655443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=5e-28  Score=197.90  Aligned_cols=196  Identities=40%  Similarity=0.692  Sum_probs=158.2

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      +...|.+..++|++++.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+.+||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            34558899999999999999999999999987655567788899999986666667788999999999995599999999


Q ss_pred             eEEecCC-CeEEEEecCCCCCHHHHHHHhhhhhh----------------------------------------------
Q psy15820         90 GCCTEKE-PFFVIMEYVPYGKLQSFLRSSRAQRY----------------------------------------------  122 (230)
Q Consensus        90 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~----------------------------------------------  122 (230)
                      +++...+ ..+++|||+++|+|.+++........                                              
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9988755 48999999999999999987431000                                              


Q ss_pred             -------ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------------------------
Q psy15820        123 -------YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------------------------  156 (230)
Q Consensus       123 -------~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------------------------  156 (230)
                             ..........+++..++.++.|++.||.|||+++                                       
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                   0000001223889999999999999999999999                                       


Q ss_pred             -----------------------------------CCC-C--------------------ccCCCCCcCcHHHHHHHHHh
Q psy15820        157 -----------------------------------VRD-G--------------------YRLEKPDHCRRELYNIMYYC  180 (230)
Q Consensus       157 -----------------------------------i~~-~--------------------~~~~~p~~~~~~~~~li~~c  180 (230)
                                                         +.. |                    .....|..+++++.+++.+|
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC  332 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence                                               111 2                    13345567889999999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        181 WDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       181 l~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                      |+.||.+|||+.++++.|+.++...
T Consensus       333 l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHHHHHHHHHh
Confidence            9999999999999999999988754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=1e-27  Score=192.34  Aligned_cols=199  Identities=41%  Similarity=0.698  Sum_probs=160.2

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .....|.+..++|++++.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+..||||+++
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence            35566899999999999999999999999998654445667789999998666666778899999999999339999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhh-----ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY-----YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------  156 (230)
                      ++++...+..+++|||+++|+|.+++........     ..........+++..++.++.|++.||.|||+++       
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  172 (313)
T 1t46_A           93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (313)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            9999999999999999999999999987431100     0000011234899999999999999999999998       


Q ss_pred             -------------------------------------------------------------------CCC----------
Q psy15820        157 -------------------------------------------------------------------VRD----------  159 (230)
Q Consensus       157 -------------------------------------------------------------------i~~----------  159 (230)
                                                                                         +..          
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence                                                                               111          


Q ss_pred             -----------CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        160 -----------GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       160 -----------~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                                 +.+...+..+++++.+++.+||+.||.+|||+.++++.|+.++.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence                       112334567889999999999999999999999999999998876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=6.4e-28  Score=195.10  Aligned_cols=180  Identities=33%  Similarity=0.587  Sum_probs=154.6

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      ...+...+|++.+.||+|+||.||+|.+....  ..+..||+|.++..........+.+|+.++..+. ||||+++++++
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~  119 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPG--QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVV  119 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTT--SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCC--CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            35678899999999999999999999985322  2345699999986666777788999999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..++||||+++++|.+++...            ...+++..++.++.|++.||.|||+++                
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~  187 (325)
T 3kul_A          120 TRGRLAMIVTEYMENGSLDTFLRTH------------DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN  187 (325)
T ss_dssp             CGGGCCEEEEECCTTCBHHHHHHTT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred             EeCCccEEEeeCCCCCcHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC
Confidence            9988999999999999999999763            235899999999999999999999998                


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     +
T Consensus       188 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  267 (325)
T 3kul_A          188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV  267 (325)
T ss_dssp             CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred             CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence                                                                                           2


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                      ..+.+.+.|..+++++.+++.+||+.||++|||+.++++.|+.+......
T Consensus       268 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            22334556778999999999999999999999999999999999876544

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=9.6e-28  Score=190.06  Aligned_cols=181  Identities=35%  Similarity=0.643  Sum_probs=152.3

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      +...|.+..++|++.+.||+|+||.||+|.+....  ..+..+|+|.++..........+.+|+.++..+. ||||++++
T Consensus         6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~   82 (281)
T 1mp8_A            6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLI   82 (281)
T ss_dssp             ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred             cccceEEehHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCccceEE
Confidence            45678999999999999999999999999885422  3355699999876656677788999999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++. .+..+++|||+++++|.+++...            ...+++..++.++.|++.||.|||+++             
T Consensus        83 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  149 (281)
T 1mp8_A           83 GVIT-ENPVWIIMELCTLGELRSFLQVR------------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV  149 (281)
T ss_dssp             EEEC-SSSCEEEEECCTTEEHHHHHHHT------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EEEc-cCccEEEEecCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE
Confidence            9984 46789999999999999999763            234889999999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~  229 (281)
T 1mp8_A          150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR  229 (281)
T ss_dssp             EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             CCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      +..+.+.+.+..+++++.+++.+||+.||++|||+.++++.|+.+++.++
T Consensus       230 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          230 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            12223445677899999999999999999999999999999999987754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=9.7e-28  Score=197.17  Aligned_cols=185  Identities=35%  Similarity=0.647  Sum_probs=154.0

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ..+..++|++++.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+. |+||+++++++.
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  144 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSL  144 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            4678899999999999999999999986554456677899999976666777778999999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      .....++||||+++|+|.+++......      ......+++..++.++.||+.||.|||+++                 
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCC------SSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccc------cCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC
Confidence            999999999999999999999875311      112245889999999999999999999998                 


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~  298 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  298 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                      +..+.+...+..+++++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       299 i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            2222345566789999999999999999999999999999998876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=9.3e-28  Score=191.34  Aligned_cols=179  Identities=31%  Similarity=0.643  Sum_probs=149.2

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ++..+..++|++.+.||+|+||.||+|.+.... ..++..||+|++... .......+.+|+.++..+. ||||++++++
T Consensus         3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   79 (295)
T 3ugc_A            3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQ-HDNIVKYKGV   79 (295)
T ss_dssp             ---CCCGGGEEEEEEEEECSSEEEEEEEECTTC-SSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred             CcCcCCHHHhhhhheeeccCCEEEEEEEEeccc-CCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence            445678899999999999999999999864333 456778999998743 4556678999999999999 9999999999


Q ss_pred             Eec--CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         92 CTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        92 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +..  ...+++||||+++++|.+++....            ..+++..++.++.|++.||.|||+++             
T Consensus        80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~  147 (295)
T 3ugc_A           80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK------------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV  147 (295)
T ss_dssp             ECHHHHTSCEEEEECCTTCBHHHHHHHCG------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EecCCCCceEEEEEeCCCCCHHHHHHhcc------------cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE
Confidence            854  356899999999999999998742            24889999999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~  227 (295)
T 3ugc_A          148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM  227 (295)
T ss_dssp             EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred             cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence                                                                                            


Q ss_pred             -----------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 -----------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 -----------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                                       +..+.+.+.|..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence                             1122344567789999999999999999999999999999999987654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=1.7e-27  Score=193.56  Aligned_cols=192  Identities=37%  Similarity=0.661  Sum_probs=155.4

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+.+..++|++.+.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+. ||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE
Confidence            35778899999999999999999999997544345567899999986666667788999999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhc-----------cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY-----------NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----  156 (230)
                      ...+..+++|||+++++|.+++.........           .........+++..++.++.||+.||.|||+++     
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999874211000           000001245899999999999999999999998     


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence                                                                                            


Q ss_pred             ---------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 ---------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 ---------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                               +..+.....|..+++++.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence                     1223334567789999999999999999999999999999998876544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=1.4e-27  Score=189.20  Aligned_cols=181  Identities=31%  Similarity=0.619  Sum_probs=146.7

Q ss_pred             CcCCCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCC
Q psy15820          4 PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP   83 (230)
Q Consensus         4 ~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~   83 (230)
                      |+........|.+..++|++.+.||+|+||.||++.+.      ++..||+|+++.....  ...+.+|+.++..+. |+
T Consensus         9 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~   79 (283)
T 3gen_A            9 PSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLS-HE   79 (283)
T ss_dssp             -------CCTTBCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCC-CT
T ss_pred             ccccCCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCC-CC
Confidence            44445567789999999999999999999999999873      3445999999744222  256889999999999 99


Q ss_pred             ceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------
Q psy15820         84 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------  156 (230)
Q Consensus        84 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------  156 (230)
                      ||+++++++...+..+++|||+++++|.+++....            ..+++..++.++.|++.||.|||+++       
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik  147 (283)
T 3gen_A           80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA  147 (283)
T ss_dssp             TBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG------------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS
T ss_pred             CEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCc
Confidence            99999999999999999999999999999997632            24899999999999999999999998       


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       148 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~  227 (283)
T 3gen_A          148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN  227 (283)
T ss_dssp             GGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence                                                                                            


Q ss_pred             ------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 ------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 ------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                            +..+.+...|..+++.+.+++.+||+.||.+|||+.++++.|..++..+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          228 SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence                  1222234456678999999999999999999999999999999988654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=2.8e-27  Score=189.06  Aligned_cols=179  Identities=33%  Similarity=0.615  Sum_probs=147.7

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..++..+..+.|++.+.||+|+||.||+|.+.... ..++..||+|+++..........+.+|+.++..+. |+||++++
T Consensus        12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~   89 (302)
T 4e5w_A           12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYK   89 (302)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred             ecChhhhhhhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeee
Confidence            44556677888999999999999999999864433 45677899999975544445577899999999999 99999999


Q ss_pred             eEEecC--CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         90 GCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        90 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +++...  ..++++|||+++++|.+++....            ..+++..++.++.|++.||.|||+++           
T Consensus        90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni  157 (302)
T 4e5w_A           90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNK------------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNV  157 (302)
T ss_dssp             EEEEC---CCEEEEEECCTTCBHHHHHHHHT------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             eEEecCCCceEEEEEEeCCCCcHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheE
Confidence            999876  66899999999999999997642            34899999999999999999999998           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       158 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  237 (302)
T 4e5w_A          158 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL  237 (302)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred             EEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh
Confidence                                                                                            


Q ss_pred             ------------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        157 ------------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       157 ------------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                                        +..+.+.+.|..+++++.+++.+||+.||.+|||+.++++.|+.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          238 KMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence                              1122344556788999999999999999999999999999999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=1.2e-27  Score=201.66  Aligned_cols=171  Identities=32%  Similarity=0.629  Sum_probs=148.5

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..|.+..++|++.+.||+|+||.||+|.+.       +..||+|+++...   ....+.+|+.++..+. ||||++++++
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~  254 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLLGV  254 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT---TSHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch---HHHHHHHHHHHHHhcc-CCCEEEEEEE
Confidence            568899999999999999999999999884       3359999997543   3457899999999998 9999999999


Q ss_pred             EecCC-CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         92 CTEKE-PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      +.... ..++||||+++|+|.+++....           ...+++..++.++.|++.||.|||+++              
T Consensus       255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~  323 (450)
T 1k9a_A          255 IVEEKGGLYIVTEYMAKGSLVDYLRSRG-----------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS  323 (450)
T ss_dssp             EECTTSCEEEEEECCTTCBHHHHHHHHC-----------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             EEcCCCceEEEEEecCCCcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC
Confidence            87654 7999999999999999998742           223688999999999999999999998              


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       324 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~  403 (450)
T 1k9a_A          324 EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY  403 (450)
T ss_dssp             TTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC
T ss_pred             CCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence                                                                                       33445


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      +.+.|..|++++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            6677889999999999999999999999999999999988754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=1.6e-27  Score=191.53  Aligned_cols=181  Identities=32%  Similarity=0.556  Sum_probs=148.1

Q ss_pred             CCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820          8 QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus         8 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      ..+.+.+.+...+|++.+.||+|+||.||+|.+.       +..||+|++... ........+.+|+.++..+. ||||+
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv   97 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIV   97 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEEC-------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEe
Confidence            4567778999999999999999999999999773       334999998643 34556678999999999999 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--C-------
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--V-------  157 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--i-------  157 (230)
                      ++++++...+..++||||+++|+|.+++.....          ...+++..++.++.|++.||.|||+++  +       
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp  167 (309)
T 3p86_A           98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA----------REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS  167 (309)
T ss_dssp             CEEEEECSTTCCEEEEECCTTCBHHHHHHSTTH----------HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCG
T ss_pred             eEEEEEEECCceEEEEecCCCCcHHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCCh
Confidence            999999999999999999999999999976321          113889999999999999999999986  1       


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        158 --------------------------------------------------------------------------------  157 (230)
Q Consensus       158 --------------------------------------------------------------------------------  157 (230)
                                                                                                      
T Consensus       168 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~  247 (309)
T 3p86_A          168 PNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV  247 (309)
T ss_dssp             GGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred             hhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                                                                                            


Q ss_pred             -----CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        158 -----RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       158 -----~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                           ....+...|..+++++.+++.+||+.||.+|||+.++++.|..++....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                 1223345667889999999999999999999999999999999887643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.3e-27  Score=194.47  Aligned_cols=196  Identities=39%  Similarity=0.679  Sum_probs=150.6

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...|++..++|++++.||+|+||.||+|.+.+......+..||+|+++..........+.+|+.++..+..||||+++++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            34688999999999999999999999999865544556778999999755445556789999999999933999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhc----------cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY----------NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----  156 (230)
                      ++...+..+++|||+++|+|.+++......-..          .........+++..++.++.|++.||.|||+++    
T Consensus       117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            999999999999999999999999864310000          000001134789999999999999999999998    


Q ss_pred             ----------------------------------------------------------------------CC--------
Q psy15820        157 ----------------------------------------------------------------------VR--------  158 (230)
Q Consensus       157 ----------------------------------------------------------------------i~--------  158 (230)
                                                                                            +.        
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence                                                                                  11        


Q ss_pred             -------------CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        159 -------------DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       159 -------------~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                                   .+.....|..+++++.+++.+||+.||.+|||+.++++.|..++....
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence                         122334566789999999999999999999999999999998776543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=2.8e-27  Score=186.19  Aligned_cols=173  Identities=31%  Similarity=0.626  Sum_probs=146.4

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      +..|.+..++|++.+.||+|+||.||+|.+.      .+..||+|++......  ...+.+|+.++..+. ||||+++++
T Consensus         2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~~i~~~~~   72 (269)
T 4hcu_A            2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLS-HPKLVQLYG   72 (269)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCC-CTTBCCEEE
T ss_pred             CccEEeChhhceeeheecCCCccEEEEEEec------CCCeEEEEEecccccC--HHHHHHHHHHHHhCC-CCCEeeEEE
Confidence            3568999999999999999999999999883      2345999999744222  256889999999999 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++...+..+++|||+++++|.+++...            ...+++..++.++.|++.||.|||+++              
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~  140 (269)
T 4hcu_A           73 VCLEQAPICLVFEFMEHGCLSDYLRTQ------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG  140 (269)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHTT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             EEecCCceEEEEEeCCCCcHHHHHHhc------------CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc
Confidence            999999999999999999999999763            234899999999999999999999998              


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     +
T Consensus       141 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~  220 (269)
T 4hcu_A          141 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI  220 (269)
T ss_dssp             GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence                                                                                           1


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      ..+.+...|..+++.+.+++.+||+.||++|||+.++++.|..+.++
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          221 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            22224445667899999999999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=3.4e-27  Score=191.13  Aligned_cols=196  Identities=37%  Similarity=0.694  Sum_probs=157.3

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ....|++..++|++.+.||+|+||.||+|.+.+.........||+|.++..........+.+|+.++..+..||||++++
T Consensus        37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34568999999999999999999999999986655444556799999986666677788999999999993399999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhcccc-CCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNM-HGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      +++...+..+++|||+++|+|.+++............ ......+++..++.++.|++.||.|||+++            
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9999999999999999999999999875321000000 001234789999999999999999999998            


Q ss_pred             --------------------------------------------------------------CCC-C-------------
Q psy15820        157 --------------------------------------------------------------VRD-G-------------  160 (230)
Q Consensus       157 --------------------------------------------------------------i~~-~-------------  160 (230)
                                                                                    +.. |             
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence                                                                          111 1             


Q ss_pred             -------ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        161 -------YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       161 -------~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                             .....|..+++.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence                   122345668899999999999999999999999999999887654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=8.2e-28  Score=204.81  Aligned_cols=174  Identities=36%  Similarity=0.731  Sum_probs=150.6

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      .+.|++..++|++.+.||+|+||.||+|.+.     .++..||+|.++....  ....+.+|+.++..+. ||||+++++
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~  283 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-HPNLVQLLG  283 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEG-----GGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEc-----CCCeEEEEEEecCccc--chHHHHHHHHHHHhcC-CCCEeeEEE
Confidence            4679999999999999999999999999994     4456799999975422  3467999999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++...+..++||||+++|+|.+++....           ...+++..++.++.||+.||.|||+++              
T Consensus       284 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~  352 (495)
T 1opk_A          284 VCTREPPFYIITEFMTYGNLLDYLRECN-----------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG  352 (495)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHSC-----------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             EEecCCcEEEEEEccCCCCHHHHHHhcC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC
Confidence            9999899999999999999999998632           234889999999999999999999998              


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     +
T Consensus       353 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~  432 (495)
T 1opk_A          353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL  432 (495)
T ss_dssp             GGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence                                                                                           2


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                      ..+.+...|..+++++.+||.+||+.||++|||+.+|++.|+.++.
T Consensus       433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            2334456678899999999999999999999999999999987653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=2.7e-27  Score=194.91  Aligned_cols=178  Identities=37%  Similarity=0.659  Sum_probs=151.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .++..++|++.+.||+|+||.||+|.+...  ...+..||+|.++..........+.+|+.++..+. ||||+++++++.
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  116 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLP--SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVT  116 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCT--TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecC--CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            467778999999999999999999987522  13455699999986656677788999999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..++||||+++|+|.+++...            ...+++..++.++.|++.||.|||+++                 
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  184 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRKH------------DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL  184 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             eCCceEEEEeCCCCCcHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC
Confidence            989999999999999999999763            234899999999999999999999998                 


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~  264 (373)
T 2qol_A          185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD  264 (373)
T ss_dssp             CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred             CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence                                                                                          22


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      .+.+.+.+..++.++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence            233455667899999999999999999999999999999999987543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=2.4e-27  Score=186.32  Aligned_cols=171  Identities=26%  Similarity=0.469  Sum_probs=146.7

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .+.+..++|++.+.||+|+||.||+|.+.       +..+|+|+++.. ........+.+|+.++..+. ||||++++++
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   75 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGA   75 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEE
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEE
Confidence            46788899999999999999999999883       345999999743 35566678999999999998 9999999999


Q ss_pred             EecC--CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         92 CTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        92 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +...  +..+++|||+++|+|.+++....           ...+++..++.++.|++.||.|||+++             
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Ni  144 (271)
T 3kmu_A           76 CQSPPAPHPTLITHWMPYGSLYNVLHEGT-----------NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSV  144 (271)
T ss_dssp             ECTTTSSSCEEEEECCTTCBHHHHHHSCS-----------SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGE
T ss_pred             EccCCCCCeEeeecccCCCcHHHHHhhcc-----------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceE
Confidence            9876  77899999999999999997632           224899999999999999999999976             


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     .
T Consensus       145 l~~~~~~~~l~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  224 (271)
T 3kmu_A          145 MIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA  224 (271)
T ss_dssp             EECTTSCEEEEGGGSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH
T ss_pred             EEcCCcceeEEeccceeeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH
Confidence                                                                                           1


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                      ..+.++..|..+++++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            233345567789999999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=6.9e-27  Score=185.65  Aligned_cols=185  Identities=28%  Similarity=0.515  Sum_probs=156.2

Q ss_pred             CcccccCCCeeEee-eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFD-ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..+.+..++|.+.+ .||+|+||.||+|.+..   ...+..||+|+++..........+.+|+.++..+. ||||+++++
T Consensus         2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~   77 (287)
T 1u59_A            2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIG   77 (287)
T ss_dssp             CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             CcccccHHHhhhhhccccccCceeEEEeEecc---CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC-CCCEeEEEE
Confidence            46788899999987 99999999999998743   23456799999986656677788999999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++ ..+..+++|||+++++|.+++...            ...+++..+..++.|++.||.|||+++              
T Consensus        78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~  144 (287)
T 1u59_A           78 VC-QAEALMLVMEMAGGGPLHKFLVGK------------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV  144 (287)
T ss_dssp             EE-ESSSEEEEEECCTTEEHHHHHTTC------------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred             Ee-cCCCcEEEEEeCCCCCHHHHHHhC------------CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc
Confidence            99 456799999999999999998652            234899999999999999999999998              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       145 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  224 (287)
T 1u59_A          145 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA  224 (287)
T ss_dssp             ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH
T ss_pred             CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence                                                                                            


Q ss_pred             -CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccC
Q psy15820        157 -VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELER  213 (230)
Q Consensus       157 -i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~  213 (230)
                       +..+.++..|..+++++.+++.+||+.||++|||+.++++.|..++.+.........
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~  282 (287)
T 1u59_A          225 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH  282 (287)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred             HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence             122334556778999999999999999999999999999999999988776665543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.95  E-value=4.2e-27  Score=189.70  Aligned_cols=181  Identities=31%  Similarity=0.577  Sum_probs=151.2

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      +..+..+.|++++.||+|+||.||++.+.... ..++..||+|+++..........+.+|+.++..+. ||||+++++++
T Consensus        25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~  102 (318)
T 3lxp_A           25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN-DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCC  102 (318)
T ss_dssp             CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             CceecHHHHhhhheecCCCCeEEEEEEEccCC-CCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEE
Confidence            34456666799999999999999998775443 45677899999987666777788999999999999 99999999999


Q ss_pred             ecC--CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         93 TEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        93 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ...  ..++++|||+++++|.+++...              .+++..++.++.|++.||.|||+++              
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~  168 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRH--------------SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD  168 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc
Confidence            874  5689999999999999998652              3889999999999999999999998              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       169 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~  248 (318)
T 3lxp_A          169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI  248 (318)
T ss_dssp             TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred             CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh
Confidence                                                                                            


Q ss_pred             ---------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccc
Q psy15820        157 ---------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYI  209 (230)
Q Consensus       157 ---------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~  209 (230)
                                     +..+...+.+..+++++.+|+.+||+.||++|||+.++++.|+.+.+......
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          249 GIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             CSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             cccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence                           11223445677899999999999999999999999999999999988766543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=2.4e-27  Score=199.79  Aligned_cols=174  Identities=37%  Similarity=0.710  Sum_probs=149.0

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+.|++..++|++.+.||+|+||.||+|.+.+      +..||+|+++....  ..+.+.+|+.++..+. ||||++++
T Consensus       175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hp~iv~~~  245 (452)
T 1fmk_A          175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLR-HEKLVQLY  245 (452)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSS--CHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred             CccccccChhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCCC--CHHHHHHHHHHHHhCC-CCCEeeEE
Confidence            467799999999999999999999999998842      23599999975422  2357899999999999 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++.. +..++||||+++|+|.+++....           ...+++..++.++.|++.||.|||+++             
T Consensus       246 ~~~~~-~~~~iv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill  313 (452)
T 1fmk_A          246 AVVSE-EPIYIVTEYMSKGSLLDFLKGET-----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV  313 (452)
T ss_dssp             EEECS-SSCEEEECCCTTCBHHHHHSHHH-----------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EEEcC-CceEEEehhhcCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE
Confidence            99876 67899999999999999997532           124789999999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       314 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~  393 (452)
T 1fmk_A          314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ  393 (452)
T ss_dssp             CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred             CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      +..+.+.+.|..+++.+.+++.+||+.||++|||+.+|++.|+.++..
T Consensus       394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            233445667789999999999999999999999999999999887654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=6e-27  Score=189.95  Aligned_cols=198  Identities=40%  Similarity=0.760  Sum_probs=157.1

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      +...|.+..++|++++.||+|+||.||+|.+.+...  ..++..||+|+++..........+.+|+.++..+..||||++
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  105 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN  105 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence            556689999999999999999999999999864321  244567999999866666777889999999999944999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhc---cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY---NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------  156 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------  156 (230)
                      +++++...+..++||||+++|+|.+++......+..   .........+++..++.++.|++.||.|||+++        
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            999999999999999999999999999874311000   000001234789999999999999999999998        


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence                                                                                            


Q ss_pred             ------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 ------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 ------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                            +..+.+...+..+++++.+++.+||+.||.+|||+.++++.|+.++.....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          266 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence                  112223456678899999999999999999999999999999999876543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=5.1e-27  Score=189.18  Aligned_cols=192  Identities=35%  Similarity=0.600  Sum_probs=158.0

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ...+.|.+..++|++.+.||+|+||.||+|.+.+.....++..||+|.+...........+.+|+.++..+. |+||+++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~   93 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRL   93 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeee
Confidence            345678999999999999999999999999986533334566799999986666667778999999999998 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      ++++...+..+++|||+++|+|.+++.........   ......+++..++.++.|++.||.|||+++            
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN---NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHH---CTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhcc---CCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence            99999999999999999999999999875321100   001234688999999999999999999998            


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence                                                                                            


Q ss_pred             --CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 --VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 --i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                        +..+.....+..+++.+.+++.+||+.||.+|||+.++++.|..++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence              122233456678899999999999999999999999999998776553

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.95  E-value=5.9e-27  Score=189.42  Aligned_cols=209  Identities=34%  Similarity=0.650  Sum_probs=164.0

Q ss_pred             CCCcc-cccCCCeeEeeeecceeceeEEEeEEeccCCCCCce--EEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820         10 SDDKW-EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPC--IVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus        10 ~~~~~-~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      +...+ .+..++|++.+.||+|+||.||+|.+..     ++.  .+++|.++..........+.+|+.++..+..||||+
T Consensus        15 ~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv   89 (327)
T 1fvr_A           15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII   89 (327)
T ss_dssp             -CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBC
T ss_pred             CCcccccccHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchh
Confidence            33444 4678999999999999999999999843     333  358998875444555677899999999993499999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------  156 (230)
                      ++++++...+..+++|||+++++|.+++........   ..........+++..++.++.|++.||.|||+++       
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  169 (327)
T 1fvr_A           90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA  169 (327)
T ss_dssp             CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCc
Confidence            999999999999999999999999999986421000   0000012345899999999999999999999998       


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       170 p~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~  249 (327)
T 1fvr_A          170 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  249 (327)
T ss_dssp             GGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             cceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence                                                                                            


Q ss_pred             ----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCCCcceeeec
Q psy15820        157 ----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMV  223 (230)
Q Consensus       157 ----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  223 (230)
                          +..+.+...|..+++++.+++.+||+.||.+|||+.++++.|..++.....+.+...+....|..+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~  320 (327)
T 1fvr_A          250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID  320 (327)
T ss_dssp             HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCCCCCCC
T ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccchhccCCcCCCC
Confidence                1222234556788999999999999999999999999999999999999999998888888877664

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=4.4e-27  Score=186.68  Aligned_cols=178  Identities=35%  Similarity=0.732  Sum_probs=153.0

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      +.+.|++..++|++.+.||+|+||.||+|.+     ..++..+|+|.+...  ......+.+|+.++..+. |+||++++
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~   75 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVW-----KKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQLL   75 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEE-----GGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEe-----cCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCC-CCCEeeEE
Confidence            4568999999999999999999999999999     445667999998754  334567899999999999 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++...+..+++|||+++++|.+++....           ...+++..++.++.|++.||.|||+++             
T Consensus        76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~  144 (288)
T 3kfa_A           76 GVCTREPPFYIITEFMTYGNLLDYLRECN-----------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV  144 (288)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHCC-----------TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE
T ss_pred             EEEccCCCEEEEEEcCCCCcHHHHHHhcc-----------cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE
Confidence            99999999999999999999999998632           234889999999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       145 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~  224 (288)
T 3kfa_A          145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL  224 (288)
T ss_dssp             CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      +....+...|..+++.+.+++.+||+.||.+|||+.++++.|..++....
T Consensus       225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            11122344567889999999999999999999999999999999887643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.95  E-value=1.3e-26  Score=183.49  Aligned_cols=182  Identities=37%  Similarity=0.663  Sum_probs=153.4

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ....|.+..++|++.+.||+|+||.||+|.+....  ..+..||+|.++..........+.+|+.++..+. ||||++++
T Consensus         3 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~   79 (281)
T 3cc6_A            3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLI   79 (281)
T ss_dssp             -CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEE
T ss_pred             CCccceecccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEE
Confidence            34568899999999999999999999999885432  3455699999976656667788999999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++.. +..+++|||+++++|.+++....            ..+++..+..++.|++.||.|||+++             
T Consensus        80 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~  146 (281)
T 3cc6_A           80 GIIEE-EPTWIIMELYPYGELGHYLERNK------------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV  146 (281)
T ss_dssp             EEECS-SSCEEEEECCTTCBHHHHHHHHT------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             EEEcC-CCCEEEEecCCCCCHHHHHHhcc------------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence            99865 45789999999999999997642            34889999999999999999999998             


Q ss_pred             ------------------------------------------------------------CCC-C---------------
Q psy15820        157 ------------------------------------------------------------VRD-G---------------  160 (230)
Q Consensus       157 ------------------------------------------------------------i~~-~---------------  160 (230)
                                                                                  +.. |               
T Consensus       147 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~  226 (281)
T 3cc6_A          147 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV  226 (281)
T ss_dssp             EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred             CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence                                                                        111 1               


Q ss_pred             ----ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        161 ----YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       161 ----~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                          .+.+.|..+++.+.+++.+||+.||++|||+.++++.|+.+...+.+
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence                23445677899999999999999999999999999999999877654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=2.1e-27  Score=200.26  Aligned_cols=174  Identities=39%  Similarity=0.735  Sum_probs=148.0

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+.|++..++|++.+.||+|+||.||+|.+.      .+..||+|.++...  .....+.+|+.++..+. ||||++++
T Consensus       179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~  249 (454)
T 1qcf_A          179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQ-HDKLVKLH  249 (454)
T ss_dssp             CTTCSBCCGGGEEEEEEEECCSSEEEEEEEET------TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCC-CTTBCCEE
T ss_pred             cccceeechHHeEEEEEcccCCceEEEEEEEC------CccEEEEEEecCCC--ccHHHHHHHHHHHhhCC-CCCEeeEE
Confidence            35679999999999999999999999999883      23459999997532  23567999999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++. .+..++||||+++|+|.+++.....           ..+++..++.++.||+.||.|||+++             
T Consensus       250 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill  317 (454)
T 1qcf_A          250 AVVT-KEPIYIITEFMAKGSLLDFLKSDEG-----------SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV  317 (454)
T ss_dssp             EEEC-SSSCEEEECCCTTCBHHHHHHSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE
T ss_pred             EEEe-CCccEEEEeecCCCcHHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence            9986 5678999999999999999986421           13788899999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       318 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~  397 (454)
T 1qcf_A          318 SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA  397 (454)
T ss_dssp             CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      +..+.+.+.|..|++++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       398 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          398 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            223345667789999999999999999999999999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.95  E-value=4.3e-27  Score=188.83  Aligned_cols=176  Identities=28%  Similarity=0.493  Sum_probs=147.8

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+.+..++|.+++.||+|+||.||+|.+     ..++..+|+|.+.. ........+.+|+.++..+. ||||+++++++
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~   76 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTH-----RETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVL   76 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEE-----TTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEE-----CCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEE
Confidence            3456789999999999999999999998     45566799998854 34666788999999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCC------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDG------------  160 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~------------  160 (230)
                      ...+..++||||+++++|.+++...            ...+++..+..++.|++.||.|||++++.++            
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~  144 (310)
T 3s95_A           77 YKDKRLNFITEYIKGGTLRGIIKSM------------DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN  144 (310)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHC------------CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT
T ss_pred             ecCCeeEEEEEecCCCcHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC
Confidence            9999999999999999999999873            2358999999999999999999999981100            


Q ss_pred             --------------------------------------------------------------------------c-----
Q psy15820        161 --------------------------------------------------------------------------Y-----  161 (230)
Q Consensus       161 --------------------------------------------------------------------------~-----  161 (230)
                                                                                                .     
T Consensus       145 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence                                                                                      0     


Q ss_pred             ----------------cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        162 ----------------RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       162 ----------------~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                                      ....|..+++++.+++.+||+.||++|||+.++++.|+.+......
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          225 YLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             TSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             hhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                            0012456778899999999999999999999999999988765443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=6.9e-27  Score=187.82  Aligned_cols=195  Identities=41%  Similarity=0.697  Sum_probs=156.0

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..|.+..++|++.+.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+.+||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            35788899999999999999999999998765556677889999998666666777899999999999559999999999


Q ss_pred             EecCC-CeEEEEecCCCCCHHHHHHHhhhhhhcc---ccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         92 CTEKE-PFFVIMEYVPYGKLQSFLRSSRAQRYYN---NMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +...+ ..++++||+++++|.+++..........   ........+++..++.++.|++.||.|||+++           
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni  179 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  179 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            87654 5899999999999999998743110000   00001123788999999999999999999998           


Q ss_pred             ---------------------------------------------------------------CC---------------
Q psy15820        157 ---------------------------------------------------------------VR---------------  158 (230)
Q Consensus       157 ---------------------------------------------------------------i~---------------  158 (230)
                                                                                     +.               
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence                                                                           11               


Q ss_pred             ------CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        159 ------DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       159 ------~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                            .+.+...|..+++++.+++.+||+.||.+|||+.++++.|..++....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence                  111234456788999999999999999999999999999999987654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=3.4e-27  Score=203.79  Aligned_cols=120  Identities=22%  Similarity=0.394  Sum_probs=106.4

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++++.||+|+||.||+|.+     +.++..||+|++... .......+.+|+.+|..++ |||||++++++.+.+.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~-----~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTE-----RATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSE
T ss_pred             ccccEEEEEEeeccCeEEEEEEE-----CCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            36899999999999999999999     566778999998643 3445677899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +|++||||+||+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~------------~~~l~e~~~~~~~~qi~~al~ylH~~~  275 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADE------------HNKMSEDEAVEYMRQVCKGLCHMHENN  275 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCT------------TSCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEeecCCCcHHHHHHHh------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999988652            235899999999999999999999999

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=1.6e-26  Score=181.39  Aligned_cols=171  Identities=32%  Similarity=0.628  Sum_probs=146.3

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|.++.++|++.+.||+|+||.||+|.+.      ++..+|+|+++....  ....+.+|+.++..+. ||||+++++++
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~   72 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLS-HPKLVQLYGVC   72 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccCC--CHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            58899999999999999999999999883      244699999975422  2256889999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..+++|||+++++|.+++...            ...+++..+..++.|++.||.|||+++                
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~  140 (267)
T 3t9t_A           73 LEQAPICLVTEFMEHGCLSDYLRTQ------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN  140 (267)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG
T ss_pred             ccCCCeEEEEeCCCCCcHHHHHhhC------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC
Confidence            9999999999999999999999764            234789999999999999999999998                


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       141 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~  220 (267)
T 3t9t_A          141 QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST  220 (267)
T ss_dssp             GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             CCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence                                                                                         122


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      +.+...|..+++.+.+++.+||+.||++|||+.++++.|..+.++
T Consensus       221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            223445667899999999999999999999999999999998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.95  E-value=3.6e-27  Score=195.07  Aligned_cols=118  Identities=22%  Similarity=0.430  Sum_probs=102.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec---
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE---   94 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~---   94 (230)
                      ++|++++.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+.+|..+. |||||++++++..   
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~-----~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARR-----RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVP  127 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSC
T ss_pred             CCeEEEEEEecccCeEEEEEEE-----CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccc
Confidence            5799999999999999999999     566778999999643 34556678899999999999 9999999998754   


Q ss_pred             ---CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 ---KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         .+.+|+|||||+ |+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~-------------~~l~~~~~~~~~~qil~al~ylH~~~  178 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSS-------------QPLTLEHVRYFLYQLLRGLKYMHSAQ  178 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSS-------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence               356899999996 6799988653             35899999999999999999999999

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=9.2e-27  Score=183.06  Aligned_cols=171  Identities=36%  Similarity=0.665  Sum_probs=144.5

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+.+..++|++.+.||+|+||.||+|.+.      ++..+|+|+++....  ....+.+|+.++..+. ||||+++++++
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~   72 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWK------GQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLS-HPKLVKFYGVC   72 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECBTTB--CHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEec------CceeEEEEEeccCCC--cHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            46789999999999999999999999773      344599999974422  2256889999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..+++|||+++++|.+++....            ..+++..++.++.|++.||.|||+++                
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~  140 (268)
T 3sxs_A           73 SKEYPIYIVTEYISNGCLLNYLRSHG------------KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD  140 (268)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT
T ss_pred             ccCCceEEEEEccCCCcHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC
Confidence            99999999999999999999998742            23899999999999999999999998                


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       141 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  220 (268)
T 3sxs_A          141 LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ  220 (268)
T ss_dssp             CCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             CCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc
Confidence                                                                                         112


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      +.....|..+++++.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       221 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            223445667899999999999999999999999999999776443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.95  E-value=1.3e-26  Score=187.32  Aligned_cols=185  Identities=35%  Similarity=0.650  Sum_probs=148.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ..+..++|++.+.||+|+||.||+|.+.+.....++..||+|.+...........+.+|+.++..+. ||||+++++++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc
Confidence            4678899999999999999999999975543345667899999976556667778999999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..+++|||+++++|.+++......      ......+++..++.++.|++.||.|||+++                 
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~  177 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPR------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG  177 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCC------SSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhccc------ccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC
Confidence            988999999999999999999874311      111234888999999999999999999998                 


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  257 (327)
T 2yfx_A          178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF  257 (327)
T ss_dssp             TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                      +..+.+...+..+++.+.+++.+||+.||.+|||+.++++.|..+....
T Consensus       258 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          258 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            1222334456688999999999999999999999999999998876543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=6.3e-27  Score=201.09  Aligned_cols=175  Identities=37%  Similarity=0.702  Sum_probs=148.9

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ...+.|+|..++|++.+.||+|+||.||+|.+.+      ...||+|+++....  ..+.+.+|+.++..+. |+||+++
T Consensus       257 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~  327 (535)
T 2h8h_A          257 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLR-HEKLVQL  327 (535)
T ss_dssp             SSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTSS--CHHHHHHHHHHHHHCC-CTTBCCE
T ss_pred             cCccceecchhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCCC--CHHHHHHHHHHHHhCC-CCCEeeE
Confidence            3467799999999999999999999999998842      23599999975422  2357899999999999 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      ++++.. +..++||||+++|+|.+++....           ...+++..++.++.||+.||.|||+++            
T Consensus       328 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl  395 (535)
T 2h8h_A          328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGET-----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL  395 (535)
T ss_dssp             EEEECS-SSCEEEECCCTTEEHHHHHSHHH-----------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEee-ccceEeeehhcCCcHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEE
Confidence            999876 67899999999999999997632           124789999999999999999999998            


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       396 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~  475 (535)
T 2h8h_A          396 VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD  475 (535)
T ss_dssp             ECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH
T ss_pred             EcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence                                                                                            


Q ss_pred             -CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 -VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 -i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                       +..+.+.+.|..|++++.+||.+||+.||++|||+.+|++.|+.++..
T Consensus       476 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          476 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence             233445566788999999999999999999999999999999887654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.9e-26  Score=198.91  Aligned_cols=179  Identities=28%  Similarity=0.514  Sum_probs=151.6

Q ss_pred             CcccccCCCeeEee-eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFD-ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..+.+..+++.+.+ .||+|+||.||+|.+...   ..+..||+|+++..........+.+|+.++..+. |+||+++++
T Consensus       328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~  403 (613)
T 2ozo_A          328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIG  403 (613)
T ss_dssp             CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECS---SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred             cceeccccceeEcCcEEecCCCcEEEEEEEecC---CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence            34667778888777 899999999999988542   3456799999976544455678999999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++.. +..++||||+++|+|.+++...            ...+++..++.++.||+.||.|||+++              
T Consensus       404 ~~~~-~~~~lv~E~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~  470 (613)
T 2ozo_A          404 VCQA-EALMLVMEMAGGGPLHKFLVGK------------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV  470 (613)
T ss_dssp             EEES-SSEEEEEECCTTCBHHHHHTTC------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             Eecc-CCeEEEEEeCCCCcHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc
Confidence            9876 5699999999999999998653            234899999999999999999999998              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       471 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~  550 (613)
T 2ozo_A          471 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA  550 (613)
T ss_dssp             ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH
T ss_pred             CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence                                                                                            


Q ss_pred             -CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 -VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 -i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                       +..+.+...|..|++++.+||..||+.||++|||+.+|++.|+.++.....
T Consensus       551 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          551 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence             344556677889999999999999999999999999999999998876443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.95  E-value=3.5e-26  Score=181.92  Aligned_cols=179  Identities=30%  Similarity=0.546  Sum_probs=147.3

Q ss_pred             CCCcccccCCCeeEee-eecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820         10 SDDKWEVPRQHIKVFD-ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      ....+.++.++|++.+ .||+|+||.||+|.+..   ...+..+|+|+++... .......+.+|+.++..+. ||||++
T Consensus         7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~   82 (291)
T 1xbb_A            7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVR   82 (291)
T ss_dssp             ----CBCCGGGEEEEEEEEEECSSEEEEEEEEEC---SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCC
T ss_pred             CcceeeecchhhhhccCccccccCeeeEeeeecC---CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEE
Confidence            3456778899999998 99999999999997643   3456679999997442 3344678999999999998 999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +++++ ..+..++++||+++++|.+++...             ..+++..++.++.|++.||.|||+++           
T Consensus        83 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni  148 (291)
T 1xbb_A           83 MIGIC-EAESWMLVMEMAELGPLNKYLQQN-------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  148 (291)
T ss_dssp             EEEEE-ESSSEEEEEECCTTEEHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceE
Confidence            99998 557789999999999999999863             24889999999999999999999998           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  228 (291)
T 1xbb_A          149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE  228 (291)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred             EEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence                                                                                            


Q ss_pred             ----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 ----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 ----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                          +..+.++..|..+++++.+++.+||+.||.+|||+.++++.|+.++....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                12233445567889999999999999999999999999999999887654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.95  E-value=7.4e-26  Score=181.78  Aligned_cols=189  Identities=38%  Similarity=0.628  Sum_probs=150.6

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      .....+.+..++|.+++.||+|+||.||+|.....  ..++..||+|.++.. ........+.+|+.++..+. ||||++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~  100 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIR  100 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECT--TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCC
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEecc--CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeee
Confidence            34456788999999999999999999999987543  234567999999643 34566678999999999999 999999


Q ss_pred             EeeEEecCC-----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------
Q psy15820         88 LLGCCTEKE-----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------  156 (230)
Q Consensus        88 l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------  156 (230)
                      +++++...+     ..++++||+++++|.+++......       .....+++..++.++.|++.||.|||+++      
T Consensus       101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di  173 (313)
T 3brb_A          101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE-------TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL  173 (313)
T ss_dssp             CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBT-------TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCC
T ss_pred             eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh-------cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            999987654     359999999999999998754211       12345899999999999999999999998      


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       174 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             SGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence                                                                                            


Q ss_pred             --------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 --------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 --------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                              +..+.+...|..+++++.+++.+||+.||.+|||+.++++.|+.++...++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~  312 (313)
T 3brb_A          254 QNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD  312 (313)
T ss_dssp             CGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             CHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                    122234456678899999999999999999999999999999999876553

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=5.9e-26  Score=183.55  Aligned_cols=180  Identities=30%  Similarity=0.584  Sum_probs=146.0

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec-
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~-   94 (230)
                      ++.++|++.+.||+|+||.||+|.+.... ..++..||+|++... .......+.+|+.++..+. |+||+++++++.. 
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLG-DNTGALVAVKQLQHS-GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGP   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTS-SSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCC-CCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecC
Confidence            67899999999999999999999865433 456778999998754 4556678999999999998 9999999998863 


Q ss_pred             -CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         95 -KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                       ....+++|||+++++|.+++....            ..+++..++.++.|++.||.|||+++                 
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~  164 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHR------------ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA  164 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHG------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcc------------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC
Confidence             456899999999999999998743            23899999999999999999999998                 


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  244 (327)
T 3lxl_A          165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE  244 (327)
T ss_dssp             EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred             CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence                                                                                            


Q ss_pred             ------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccccc
Q psy15820        157 ------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE  210 (230)
Q Consensus       157 ------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~  210 (230)
                                  +..+.+.+.+..+++++.+++.+||+.||.+|||+.++++.|+.++........
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence                        112233456678899999999999999999999999999999998877665544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.94  E-value=9.6e-26  Score=182.27  Aligned_cols=180  Identities=31%  Similarity=0.625  Sum_probs=147.0

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      +.++..+..++|++++.||+|+||.||+|.+.... ..++..||+|++... .......+.+|+.++..+. |+||++++
T Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~  108 (326)
T 2w1i_A           32 DRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQ-HDNIVKYK  108 (326)
T ss_dssp             -----CCCGGGEEEEEEEECCSSEEEEEEEECTTS-SSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred             ccCccccCHHHceeeeeeccCCCeEEEEEEecccc-CCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCC-CCCeeeEE
Confidence            44456678889999999999999999999864332 456778999999754 3455678999999999998 99999999


Q ss_pred             eEEecCC--CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         90 GCCTEKE--PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        90 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +++...+  ..++++||+++++|.+++...            ...+++..++.++.|++.||.|||+++           
T Consensus       109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NI  176 (326)
T 2w1i_A          109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------------KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNI  176 (326)
T ss_dssp             EEECC----CCEEEECCCTTCBHHHHHHHS------------TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEEEecCCCceEEEEECCCCCCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence            9987643  789999999999999999874            234889999999999999999999998           


Q ss_pred             ----------------------------------------------------------------C---------------
Q psy15820        157 ----------------------------------------------------------------V---------------  157 (230)
Q Consensus       157 ----------------------------------------------------------------i---------------  157 (230)
                                                                                      +               
T Consensus       177 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  256 (326)
T 2w1i_A          177 LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM  256 (326)
T ss_dssp             EEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH
T ss_pred             EEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH
Confidence                                                                            0               


Q ss_pred             --------------------CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        158 --------------------RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       158 --------------------~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                                          ..+.+.+.|..+++++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          257 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                                11223456678999999999999999999999999999999988764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=9.2e-26  Score=197.87  Aligned_cols=179  Identities=35%  Similarity=0.643  Sum_probs=152.8

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...+.+..++|++++.||+|+||.||+|.+....  ..+..+|+|.++..........+.+|+.++..+. ||||+++++
T Consensus       382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~  458 (656)
T 2j0j_A          382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIG  458 (656)
T ss_dssp             GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSS--SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             ccccccccccEEEeeEEeeCCCEEEEEEEEecCC--CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEE
Confidence            3457788899999999999999999999885432  2355799999876666777788999999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++. .+..++||||+++|+|.+++...            ...+++..++.++.|++.||.|||+++              
T Consensus       459 ~~~-~~~~~lv~E~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~  525 (656)
T 2j0j_A          459 VIT-ENPVWIIMELCTLGELRSFLQVR------------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS  525 (656)
T ss_dssp             EEC-SSSCEEEEECCTTCBHHHHHHHT------------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             EEe-cCceEEEEEcCCCCcHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe
Confidence            985 46689999999999999999863            234889999999999999999999998              


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     +
T Consensus       526 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i  605 (656)
T 2j0j_A          526 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI  605 (656)
T ss_dssp             ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence                                                                                           1


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                      ..+.+.+.|..+++.+.+++.+||+.||++|||+.++++.|..++..+
T Consensus       606 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            222345567889999999999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=8.9e-26  Score=180.04  Aligned_cols=175  Identities=32%  Similarity=0.595  Sum_probs=144.5

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe-cC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT-EK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~-~~   95 (230)
                      ...+|++.+.||+|+||.||+|.+....  .....+|+|.++..........+.+|+.++..+. ||||+++++++. ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSE   99 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCC
Confidence            4456888999999999999999875322  2334589999876666777788999999999999 999999999864 45


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..+++|||+++++|.+++...            ...+++..++.++.|++.||.|||+++                   
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~  167 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNE------------THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV  167 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCT------------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred             CceEEEEeCCCCCCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCE
Confidence            6789999999999999999753            234789999999999999999999998                   


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T 3f66_A          168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ  247 (298)
T ss_dssp             EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred             EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence                                                                                         122


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      +.+...|..+++++.+++.+||+.||.+|||+.++++.|+.++....
T Consensus       248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            23344567789999999999999999999999999999999887543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=5.6e-26  Score=179.58  Aligned_cols=176  Identities=39%  Similarity=0.745  Sum_probs=146.4

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      -++.|.+..++|++.+.||+|+||.||+|...      ++..+|+|.++....  ....+.+|+.++..+. |+||++++
T Consensus         4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~   74 (279)
T 1qpc_A            4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQ-HQRLVRLY   74 (279)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred             chhhcccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCC-CcCcceEE
Confidence            35679999999999999999999999999873      234599999864322  2457889999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++.. +..+++|||+++++|.+++.....           ..+++..+..++.|++.||.|||+++             
T Consensus        75 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~  142 (279)
T 1qpc_A           75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSG-----------IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV  142 (279)
T ss_dssp             EEECS-SSCEEEEECCTTCBHHHHTTSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             EEEcC-CCcEEEEecCCCCCHHHHHhcCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE
Confidence            99864 568999999999999999875321           13889999999999999999999998             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       143 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  222 (279)
T 1qpc_A          143 SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN  222 (279)
T ss_dssp             CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred             cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      +..+.+...+..+++++.+++.+||+.||++|||+.++++.|+.++....
T Consensus       223 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            11222344567889999999999999999999999999999999886643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.94  E-value=7.2e-26  Score=183.17  Aligned_cols=177  Identities=31%  Similarity=0.600  Sum_probs=142.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+..++|++.+.||+|+||.||+|.+.... ......+|+|.++..........+.+|+.++..+. ||||+++++++..
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   88 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT   88 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEES
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCC-ceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec
Confidence            367889999999999999999999985433 22233478898865444455678999999999999 9999999999987


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      . ..++++||+++|+|.+++...            ...+++..++.++.|++.||.|||+++                  
T Consensus        89 ~-~~~~v~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~  155 (327)
T 3poz_A           89 S-TVQLITQLMPFGCLLDYVREH------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             S-SEEEEEECCTTCBHHHHHHHS------------TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE
T ss_pred             C-CeEEEEEecCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC
Confidence            4 488999999999999999873            235899999999999999999999998                  


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  235 (327)
T 3poz_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG  235 (327)
T ss_dssp             EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence                                                                                        1223


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      .+.+.|..++.++.+++.+||+.||++|||+.++++.|..+.....
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~  281 (327)
T 3poz_A          236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence            3455667899999999999999999999999999999999876543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=1e-25  Score=181.69  Aligned_cols=186  Identities=34%  Similarity=0.586  Sum_probs=140.7

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ....+.+..++|++++.||+|+||.||+|.+....  .....||+|+++.. ........+.+|+.++..+. ||||+++
T Consensus        14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~   90 (323)
T 3qup_A           14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQED--GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKL   90 (323)
T ss_dssp             --CTTBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCC
T ss_pred             HhhhcccChhHeEEeceecccCCeEEEEEEEcccC--CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehh
Confidence            44567789999999999999999999999885332  11235999999643 23445678999999999998 9999999


Q ss_pred             eeEEecCCCe------EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------
Q psy15820         89 LGCCTEKEPF------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------  156 (230)
Q Consensus        89 ~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------  156 (230)
                      ++++......      ++++||+++|+|.+++.......       ....+++..++.++.|++.||.|||+++      
T Consensus        91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Di  163 (323)
T 3qup_A           91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE-------NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDL  163 (323)
T ss_dssp             CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC----------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccc-------cccccCHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence            9999876554      99999999999999998653210       1224889999999999999999999998      


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       164 kp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  243 (323)
T 3qup_A          164 AARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI  243 (323)
T ss_dssp             SGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence                                                                                            


Q ss_pred             --------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 --------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 --------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                              +..+.....+..+++++.+++.+||+.||++|||+.++++.|+.++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          244 ENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                    1112234556788999999999999999999999999999999988653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.7e-25  Score=178.31  Aligned_cols=179  Identities=31%  Similarity=0.570  Sum_probs=147.7

Q ss_pred             ccccCC--CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQ--HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~--~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.++..  .|.+.+.||+|+||.||+|.+....  .....+|+|.++..........+.+|+.++..+. ||||++++++
T Consensus        14 ~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   90 (298)
T 3pls_A           14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGI   90 (298)
T ss_dssp             GBCCGGGEEEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEE
T ss_pred             eEccccceEEccCceeccCCCceEEEEEEecCC--CceeeeeeeeccccccHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Confidence            444444  3456799999999999999875432  3345699999976666677788999999999998 9999999999


Q ss_pred             EecCCCe-EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         92 CTEKEPF-FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        92 ~~~~~~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      +...+.. ++++||+.+++|.+++...            ...+++..++.++.|++.||.|||+++              
T Consensus        91 ~~~~~~~~~~v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~  158 (298)
T 3pls_A           91 MLPPEGLPHVLLPYMCHGDLLQFIRSP------------QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD  158 (298)
T ss_dssp             ECCSSSCCEEEECCCTTCBHHHHHHCT------------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             EecCCCCcEEEEecccCCCHHHHHhcc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence            9866654 9999999999999999763            234788999999999999999999998              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~  238 (298)
T 3pls_A          159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT  238 (298)
T ss_dssp             TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH
T ss_pred             CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH
Confidence                                                                                            


Q ss_pred             --CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 --VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 --i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                        +..+...+.+..+++.+.+++.+||+.||.+|||+.++++.|+.++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence              122234455677899999999999999999999999999999999877543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=6.3e-26  Score=186.73  Aligned_cols=179  Identities=32%  Similarity=0.581  Sum_probs=147.4

Q ss_pred             ccccCC--CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQ--HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~--~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.+..+  .|++.+.||+|+||.||+|.+....  .....+|+|.++..........+.+|+.++..+. ||||++++++
T Consensus        82 ~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~  158 (373)
T 3c1x_A           82 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGI  158 (373)
T ss_dssp             TBCCSTTEEEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEE
T ss_pred             cccChhhceeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEE
Confidence            334444  3677899999999999999885432  2344689999976555667788999999999998 9999999998


Q ss_pred             Eec-CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         92 CTE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        92 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      +.. .+..+++|||+++|+|.+++...            ...+++..++.++.||+.||.|||+++              
T Consensus       159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  226 (373)
T 3c1x_A          159 CLRSEGSPLVVLPYMKHGDLRNFIRNE------------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD  226 (373)
T ss_dssp             ECCCSSCCEEEEECCTTCBHHHHHHCT------------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             EEcCCCCeEEEEECCCCCCHHHHHhhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC
Confidence            754 56789999999999999999753            234788899999999999999999998              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       227 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~  306 (373)
T 3c1x_A          227 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT  306 (373)
T ss_dssp             TTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH
T ss_pred             CCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH
Confidence                                                                                            


Q ss_pred             --CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        157 --VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       157 --i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                        +..+.+...|..+++++.+++.+||+.||++|||+.++++.|+.++.....
T Consensus       307 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence              223334556778999999999999999999999999999999999876543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=1.3e-25  Score=181.87  Aligned_cols=163  Identities=19%  Similarity=0.323  Sum_probs=139.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ....+|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. ||||+++++++..
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~   85 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARH-----ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIET   85 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE
Confidence            4567899999999999999999998     456667999998543 45566778999999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC-----------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV-----------------  157 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i-----------------  157 (230)
                      .+..++||||+++|+|.+++....             .+++..+..++.|++.||.|||++++                 
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~  152 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYLVAHG-------------RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN  152 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred             CCEEEEEEECCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC
Confidence            999999999999999999997642             48999999999999999999999980                 


Q ss_pred             -------------------------------------------------------CCC------------------ccCC
Q psy15820        158 -------------------------------------------------------RDG------------------YRLE  164 (230)
Q Consensus       158 -------------------------------------------------------~~~------------------~~~~  164 (230)
                                                                             ..|                  ....
T Consensus       153 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  232 (328)
T 3fe3_A          153 IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR  232 (328)
T ss_dssp             EEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             EEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence                                                                   000                  1123


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .|..+++++.+|+.+||+.||.+|||+.++++.
T Consensus       233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            456788999999999999999999999999863

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.94  E-value=1.5e-25  Score=177.02  Aligned_cols=174  Identities=32%  Similarity=0.611  Sum_probs=143.3

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ....|.+..++|++.+.||+|+||.||++.+.       +..+|+|+++...   ....+.+|+.++..+. |+||++++
T Consensus        12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~~iv~~~   80 (278)
T 1byg_A           12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLL   80 (278)
T ss_dssp             ---CCBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-----HHHHHTHHHHTTCC-CTTBCCEE
T ss_pred             hhccccCChhhceEEeEEecCCCceEEEEEEc-------CCEEEEEEecchh---HHHHHHHHHHHHHhCC-CCCEeeEE
Confidence            44558899999999999999999999999873       3459999997432   3467889999999998 99999999


Q ss_pred             eEEecC-CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         90 GCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        90 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      +++... +..++++||+++++|.+++.....           ..+++..+..++.|++.||.|||+++            
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil  149 (278)
T 1byg_A           81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL  149 (278)
T ss_dssp             EEECCC--CCEEEECCCTTEEHHHHHHHHHH-----------HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEcCCCceEEEEecCCCCCHHHHHHhccc-----------ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEE
Confidence            987654 478999999999999999986431           12788899999999999999999998            


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       150 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~  229 (278)
T 1byg_A          150 VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK  229 (278)
T ss_dssp             ECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred             EeCCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence                                                                                         122


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                      +.+...+..+++++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          230 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            2344556788999999999999999999999999999999886543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=3.9e-25  Score=175.73  Aligned_cols=167  Identities=14%  Similarity=0.117  Sum_probs=137.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..+|++.+.||+|+||.||+|.+     ..++..||+|++...  ........+.+|+..+..+. |+||+++++++...
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~  103 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALD-----TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTR  103 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEE-----TTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred             cCcEEEEEEEcccCCeEEEEEEe-----cCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEEC
Confidence            37899999999999999999998     456677999999744  23556678999999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC-----------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR-----------------  158 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~-----------------  158 (230)
                      +..|+||||++|++|.+++..               ......+..++.|++.||.|||++++.                 
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~---------------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~  168 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADT---------------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDV  168 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTT---------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCE
T ss_pred             CcEEEEEEecCCCCHHHHHhc---------------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCE
Confidence            999999999999999999843               135567889999999999999999910                 


Q ss_pred             ----------------------------CC--------------------cc-C----CCCCcCcHHHHHHHHHhcCCCC
Q psy15820        159 ----------------------------DG--------------------YR-L----EKPDHCRRELYNIMYYCWDKEP  185 (230)
Q Consensus       159 ----------------------------~~--------------------~~-~----~~p~~~~~~~~~li~~cl~~dp  185 (230)
                                                  .|                    .. .    ..+..+++++.+++.+||+.||
T Consensus       169 kl~~~~~~~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP  248 (286)
T 3uqc_A          169 VLAYPATMPDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDG  248 (286)
T ss_dssp             EECSCCCCTTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTS
T ss_pred             EEEeccccCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCC
Confidence                                        00                    00 0    0124688999999999999999


Q ss_pred             CCCCCHHHHHHHHHHHHhhcc
Q psy15820        186 NERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       186 ~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      .+| |+.++++.|..+.....
T Consensus       249 ~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          249 GIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             SCC-CHHHHHHHHHHHHC---
T ss_pred             ccC-CHHHHHHHHHHHhccCC
Confidence            999 99999999998776543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=2.3e-25  Score=180.29  Aligned_cols=179  Identities=31%  Similarity=0.606  Sum_probs=148.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+..++|++.+.||+|+||.||+|.+.... ......+++|.+...........+.+|+.++..+. ||||+++++++..
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   88 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT   88 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTT-CSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEES
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCC-ceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEec
Confidence            467899999999999999999999985433 22233468888865444455677899999999999 9999999999987


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      . ..++++||+++|+|.+++...            ...+++..++.++.|++.||.|||+++                  
T Consensus        89 ~-~~~~v~~~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           89 S-TVQLITQLMPFGCLLDYVREH------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             S-SEEEEECCCSSCBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE
T ss_pred             C-CceEEEEecCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC
Confidence            5 488999999999999999874            234889999999999999999999998                  


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  235 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG  235 (327)
T ss_dssp             EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        1223


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      .+.+.|..++.++.+++.+||+.||.+|||+.++++.|..+......+
T Consensus       236 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  283 (327)
T 3lzb_A          236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY  283 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCce
Confidence            345566789999999999999999999999999999999988665443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=9.5e-26  Score=177.45  Aligned_cols=165  Identities=27%  Similarity=0.550  Sum_probs=134.2

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC---HHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG---ERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ++..++|++.+.||+|+||.||+|.+.       +..+|+|+++....   ......+.+|+.++..+. ||||++++++
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~   74 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI-------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGV   74 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET-------TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc-------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEE
Confidence            578899999999999999999999873       34599999864322   223467889999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +...+..+++|||+++++|.+++..              ..+++..+..++.|++.||.|||+++               
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil  140 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLSG--------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL  140 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHTS--------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred             EecCCceEEEEEcCCCCCHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence            9999999999999999999988853              24899999999999999999999965               


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  220 (271)
T 3dtc_A          141 ILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL  220 (271)
T ss_dssp             ESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred             EecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                                                                                            


Q ss_pred             ------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHH
Q psy15820        157 ------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL  201 (230)
Q Consensus       157 ------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~  201 (230)
                            .......+.+..+++++.+++.+||+.||.+|||+.++++.|+.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          221 AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                  111223345667889999999999999999999999999988653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=7.1e-25  Score=175.80  Aligned_cols=175  Identities=19%  Similarity=0.406  Sum_probs=143.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ...+|++.+.||+|+||.||+|..     ..++..+|+|+++..  ........+.+|+.++..+. |+||+++++++..
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~  103 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAAC-----LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE  103 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEE-----TTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEE-----cCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc
Confidence            456899999999999999999998     445667999998642  34566778999999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+..+++|||+++++|.+++.....         ....+++..++.++.|++.||.|||+++                  
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~  174 (310)
T 2wqm_A          104 DNELNIVLELADAGDLSRMIKHFKK---------QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV  174 (310)
T ss_dssp             TTEEEEEEECCCSCBHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred             CCcEEEEEecCCCCCHHHHHHHhcc---------cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC
Confidence            9999999999999999999986432         1345889999999999999999999998                  


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       175 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  254 (310)
T 2wqm_A          175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD  254 (310)
T ss_dssp             EEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC
T ss_pred             EEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc
Confidence                                                                                       00111


Q ss_pred             cCC-CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        162 RLE-KPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       162 ~~~-~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      .+. .+..+++++.+++.+||+.||.+|||+.++++.|..+.....
T Consensus       255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            111 235688999999999999999999999999999998876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.94  E-value=2.2e-25  Score=182.73  Aligned_cols=126  Identities=21%  Similarity=0.289  Sum_probs=108.9

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ...+.....++|++.+.||+|+||.||++..     ..++..||+|++.....  ....+.+|+.++..+. ||||++++
T Consensus        11 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~   82 (361)
T 3uc3_A           11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRD-----KLTKELVAVKYIERGAA--IDENVQREIINHRSLR-HPNIVRFK   82 (361)
T ss_dssp             CCCCCCCCTTTEEEEEEESSSTTSSEEEEEE-----TTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred             CCccCCCCCCcEEEEEEeccCCCEEEEEEEE-----CCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCC-CCCCCcEE
Confidence            3445566789999999999999999999998     45566799999964322  2245779999999999 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++...+..++||||+++|+|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~ql~~~L~~LH~~~  136 (361)
T 3uc3_A           83 EVILTPTHLAIIMEYASGGELYERICNAG-------------RFSEDEARFFFQQLLSGVSYCHSMQ  136 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeeCCEEEEEEEeCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999987642             4899999999999999999999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.94  E-value=3.9e-26  Score=184.55  Aligned_cols=179  Identities=27%  Similarity=0.567  Sum_probs=144.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+..++|++.+.||+|+||.||+|.+.... ......+++|.+...........+.+|+.++..+. |+||+++++++. 
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-   85 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEG-ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-   85 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTT-CSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCC-ceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-
Confidence            467889999999999999999999985433 22233478888754333333345778999999998 999999999886 


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+..++++||+++|+|.+++....            ..+++..++.++.|++.||.|||+++                  
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~  153 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR------------GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ  153 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG------------GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe
Confidence            467899999999999999987632            24888999999999999999999998                  


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  233 (325)
T 3kex_A          154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG  233 (325)
T ss_dssp             EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred             EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence                                                                                        1222


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      .+...|..++.++.+++.+||+.||.+|||+.++++.|..+....+.+
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~  281 (325)
T 3kex_A          234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRY  281 (325)
T ss_dssp             CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHH
T ss_pred             CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence            345556678889999999999999999999999999999987665443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=6e-25  Score=192.05  Aligned_cols=174  Identities=29%  Similarity=0.546  Sum_probs=145.4

Q ss_pred             cccccCCCeeEe-eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVF-DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      .+.++.+.+.+. +.||+|+||.||+|.+..   ...+..||+|+++.. ........+.+|+.++..+. |+||+++++
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  437 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIG  437 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEEC---SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcC---CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence            355566666654 489999999999997643   345567999999743 33445678999999999999 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++.. +..++||||+++|+|.+++...             ..+++..++.++.||+.||.|||+++              
T Consensus       438 ~~~~-~~~~lv~E~~~~g~L~~~l~~~-------------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~  503 (635)
T 4fl3_A          438 ICEA-ESWMLVMEMAELGPLNKYLQQN-------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV  503 (635)
T ss_dssp             EEES-SSEEEEEECCTTEEHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             EEec-CCEEEEEEccCCCCHHHHHhhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe
Confidence            9864 5689999999999999999763             24889999999999999999999998              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       504 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~  583 (635)
T 4fl3_A          504 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA  583 (635)
T ss_dssp             ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred             CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence                                                                                            


Q ss_pred             -CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 -VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 -i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                       +..+.+...|..+++++.+||..||+.||++|||+.+|++.|..++..
T Consensus       584 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          584 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             333445667788999999999999999999999999999999988764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.93  E-value=5.9e-26  Score=180.24  Aligned_cols=177  Identities=23%  Similarity=0.406  Sum_probs=142.8

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      ++..++|++.+.||+|+||.||+|.+.....  ......+|+|.+... .......+.+|+.++..+. ||||+++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   81 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLS-HKHLVLNYGVC   81 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence            5778899999999999999999998864321  111246999998643 2344567999999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC---------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV---------------  157 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i---------------  157 (230)
                      ...+..+++|||+++++|.+++....            ..+++..+..++.|++.||.|||++++               
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNK------------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTG------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC
Confidence            99999999999999999999998742            238899999999999999999999981               


Q ss_pred             --------------------------------------------------------------CCC---------------
Q psy15820        158 --------------------------------------------------------------RDG---------------  160 (230)
Q Consensus       158 --------------------------------------------------------------~~~---------------  160 (230)
                                                                                    ..|               
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~  229 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ  229 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred             CcccccccceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence                                                                          111               


Q ss_pred             ---ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        161 ---YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       161 ---~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                         .....|..+++++.+++.+||+.||.+|||+.++++.|+.++.+.
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          230 FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence               112234456777889999999999999999999999998877643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.93  E-value=2.1e-25  Score=182.51  Aligned_cols=117  Identities=19%  Similarity=0.306  Sum_probs=101.3

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||+|.++..  ..++..||+|.+.....   ...+.+|+.++..+.+||||+++++++...+.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            5799999999999999999987532  23466799999864432   245788999999886599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+|||||++|+|.+++..                +++..+..++.||+.||.|||++|
T Consensus        96 ~lvmE~~~g~~L~~~~~~----------------l~~~~~~~~~~qll~al~ylH~~g  137 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNS----------------LSFQEVREYMLNLFKALKRIHQFG  137 (361)
T ss_dssp             EEEEECCCCCCHHHHHTT----------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEeCCCcccHHHHHcC----------------CCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999998743                889999999999999999999999

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.93  E-value=1.4e-25  Score=179.13  Aligned_cols=119  Identities=21%  Similarity=0.453  Sum_probs=103.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ...+|++.+.||+|+||.||+|.+     ..++..||+|++...... ....+.+|+.++..+. ||||+++++++...+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMD-----VATGQEVAIRQMNLQQQP-KKELIINEILVMRENK-NPNIVNYLDSYLVGD   90 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEB-----TTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             hhhceeeeeeeccCCCeEEEEEEE-----CCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence            456899999999999999999988     455667999998533222 2356889999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++||||+++|+|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~~  136 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQ  136 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEECCCCCCHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999998763              3889999999999999999999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.93  E-value=2.8e-25  Score=176.56  Aligned_cols=174  Identities=26%  Similarity=0.475  Sum_probs=139.7

Q ss_pred             CCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820          8 QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus         8 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      ....++++|...+|++.+.||+|+||.||+|.+.+        .+|+|+++.. ........+.+|+.++..+. |+||+
T Consensus        13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv   83 (289)
T 3og7_A           13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNIL   83 (289)
T ss_dssp             -----CCBCCTTSCEEEEEEEECSSEEEEEEESSS--------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBC
T ss_pred             CCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC--------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEE
Confidence            34667789999999999999999999999997632        2899998643 35566788999999999999 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------  156 (230)
                      +++++. ..+..+++|||+++++|.+++...            ...+++..++.++.|++.||.|||+++          
T Consensus        84 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~N  150 (289)
T 3og7_A           84 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS------------ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN  150 (289)
T ss_dssp             CEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             EEEeec-cCCccEEEEEecCCCcHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            999965 456789999999999999998653            234889999999999999999999998          


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       151 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  230 (289)
T 3og7_A          151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  230 (289)
T ss_dssp             EEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             EEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence                                                                                            


Q ss_pred             -------CCCCcc----CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        157 -------VRDGYR----LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       157 -------i~~~~~----~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                             +..+..    ...+..+++++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                   000000    11224688999999999999999999999999999987653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.93  E-value=7.8e-26  Score=195.89  Aligned_cols=123  Identities=21%  Similarity=0.367  Sum_probs=101.6

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-----CCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-----AGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      .+..++|++++.||+|+||.||+|..     +.++..||+|+++..     ...........++.++..+. |||||+++
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~-----~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~  258 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMS  258 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEE
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEE-----CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEE
Confidence            35567899999999999999999999     566778999998532     11122222233455666667 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++.+.+.+|+|||||+||+|.+++...             ..+++..+..|+.||+.||.|||+++
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~-------------~~l~E~~a~~y~~qIl~aL~yLH~~g  312 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-------------GVFSEADMRFYAAEIILGLEHMHNRF  312 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999999874             24899999999999999999999999

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.93  E-value=2.2e-25  Score=179.30  Aligned_cols=176  Identities=21%  Similarity=0.375  Sum_probs=142.9

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+.+..++|++.+.||+|+||.||++..     ..++..||+|++... .......+.+|+.++..+. ||||+++++++
T Consensus        23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   95 (317)
T 2buj_A           23 MVIIDNKHYLFIQKLGEGGFSYVDLVEG-----LHDGHFYALKRILCH-EQQDREEAQREADMHRLFN-HPNILRLVAYC   95 (317)
T ss_dssp             EEEETTEEEEEEEEEEC--CEEEEEEEE-----TTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEE
T ss_pred             EEEECCeEEEEEEEecCCCCeEEEEEEe-----cCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEE
Confidence            3667889999999999999999999998     455667999988543 4556678999999999998 99999999998


Q ss_pred             e----cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------
Q psy15820         93 T----EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------  156 (230)
Q Consensus        93 ~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------  156 (230)
                      .    .....++++||+++++|.+++.....         ....+++..++.++.|++.||.|||+++            
T Consensus        96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl  166 (317)
T 2buj_A           96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKD---------KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL  166 (317)
T ss_dssp             EEEETTEEEEEEEEECCTTCBHHHHHHHHHT---------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             EeccCCCceeEEEEEeCCCCcHHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence            6    33468999999999999999987432         1345899999999999999999999998            


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       167 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  246 (317)
T 2buj_A          167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY  246 (317)
T ss_dssp             ECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCCh
Confidence                                                                                            


Q ss_pred             -------------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 -------------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 -------------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                                   +......+.+..++.++.+++.+||+.||.+|||+.++++.|..+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          247 DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence                         011112233456788999999999999999999999999999876533

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.93  E-value=1.4e-25  Score=179.90  Aligned_cols=176  Identities=28%  Similarity=0.531  Sum_probs=144.2

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .++.++|++.+.||+|+||.||++.+.       +..||+|.+...   .....+.+|+.++..+. ||||+++++++. 
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~-   71 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE---SERKAFIVELRQLSRVN-HPNIVKLYGACL-   71 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST---THHHHHHHHHHHHHHCC-CTTBCCEEEBCT-
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh---hHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-
Confidence            467889999999999999999999873       245999998642   34567899999999998 999999999876 


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh---cC---------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS---RG---------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~---------------  156 (230)
                       +..+++|||+++++|.+++....          ....++...++.++.|++.||.|||+   ++               
T Consensus        72 -~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~  140 (307)
T 2eva_A           72 -NPVCLVMEYAEGGSLYNVLHGAE----------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA  140 (307)
T ss_dssp             -TTTEEEEECCTTCBHHHHHHCSS----------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET
T ss_pred             -CCcEEEEEcCCCCCHHHHHhccC----------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC
Confidence             44899999999999999997632          11236788999999999999999999   55               


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       141 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  220 (307)
T 2eva_A          141 GGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG  220 (307)
T ss_dssp             TTTEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT
T ss_pred             CCCEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC
Confidence                                                                                        1122


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccC
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELER  213 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~  213 (230)
                      .++..+..+++.+.+++.+||+.||++|||+.++++.|..+....+....+..
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~  273 (307)
T 2eva_A          221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ  273 (307)
T ss_dssp             CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred             CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence            33445567899999999999999999999999999999998877665554443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.93  E-value=1.8e-25  Score=180.50  Aligned_cols=122  Identities=20%  Similarity=0.435  Sum_probs=104.1

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ....+.+..++|++.+.||+|+||.||+|.+.       +..||+|+++..  .........|+.++..+. ||||++++
T Consensus        15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~   84 (322)
T 3soc_A           15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMK-HENILQFI   84 (322)
T ss_dssp             CCCCEEETTEEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGG--GHHHHHHHHHHHTSTTCC-CTTBCCEE
T ss_pred             CccccccchhhchhhheecccCceEEEEEEEC-------CCEEEEEEeecC--chHHHHHHHHHHHHhcCC-CCCchhhc
Confidence            45557799999999999999999999999873       346999998643  333445667899999998 99999999


Q ss_pred             eEEecCCC----eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         90 GCCTEKEP----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        90 ~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      +++.....    +++||||+++|+|.+++...              .+++..+..++.|++.||.|||+.
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~qi~~al~~LH~~  140 (322)
T 3soc_A           85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--------------VVSWNELCHIAETMARGLAYLHED  140 (322)
T ss_dssp             EEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHTCC
T ss_pred             ceeccCCCCCceEEEEEecCCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHhh
Confidence            99987543    69999999999999999763              389999999999999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.93  E-value=4.1e-25  Score=175.29  Aligned_cols=167  Identities=25%  Similarity=0.507  Sum_probs=138.0

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC---HHHH---HHHHHHHHHHhhcCCCCceee
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG---ERER---LDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~---~~~~~e~~~l~~~~~h~niv~   87 (230)
                      -.+..++|++.+.||+|+||.||+|.+     ..++..||+|++.....   ....   ..+.+|+.++..+. |+||++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~   87 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRL-----VKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVK   87 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEE-----TTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCC
T ss_pred             hhhhhccceehhccccCCceeEEEEEE-----cCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchh
Confidence            357789999999999999999999998     45566799999853321   1111   57899999999998 999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--C--------
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--V--------  157 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--i--------  157 (230)
                      +++++....  +++|||+++++|.+++...            ...+++..++.++.|++.||.|||+++  +        
T Consensus        88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~  153 (287)
T 4f0f_A           88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDK------------AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSP  153 (287)
T ss_dssp             EEEEETTTT--EEEEECCTTCBHHHHHHCT------------TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGG
T ss_pred             hheeecCCC--eEEEEecCCCCHHHHHhcc------------cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcc
Confidence            999986554  7999999999999988763            235899999999999999999999986  1        


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        158 --------------------------------------------------------------------------------  157 (230)
Q Consensus       158 --------------------------------------------------------------------------------  157 (230)
                                                                                                      
T Consensus       154 Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          154 NIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             GEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             eEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence                                                                                            


Q ss_pred             ----------CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        158 ----------RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       158 ----------~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                                ..+..+..+..+++++.+++.+||+.||++|||+.++++.|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          234 GKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             cHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                      1122334566788999999999999999999999999998864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.93  E-value=6.2e-25  Score=173.85  Aligned_cols=125  Identities=26%  Similarity=0.472  Sum_probs=106.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+..+..+..||||+++++++...+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVK-----RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cchhhhhhhhcCCCceEEEEEEE-----cCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            36799999999999999999998     445667999998643 334456778899999999934999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+++.....         ....+++..+..++.|++.||.|||+++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~~  135 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYR---------IMSYFKEAELKDLLLQVGRGLRYIHSMS  135 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEEecCCCcHHHHHHhhcc---------cccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999987432         1235899999999999999999999987

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=7e-25  Score=174.83  Aligned_cols=172  Identities=20%  Similarity=0.306  Sum_probs=143.0

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCC--cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE--NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +-.++|++.+.||+|+||.||+|.+     ..++..+|+|.+..  .........+.+|+.++..+. ||||+++++++.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~   81 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAED-----TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDE   81 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEE-----TTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEE-----CCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeee
Confidence            4567899999999999999999988     45566799999843  234566778999999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV----------------  157 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i----------------  157 (230)
                      ..+..+++|||+++++|.+++....             .+++..++.++.|++.||.|||++++                
T Consensus        82 ~~~~~~lv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~  148 (294)
T 4eqm_A           82 EDDCYYLVMEYIEGPTLSEYIESHG-------------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK  148 (294)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred             eCCeEEEEEeCCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence            9999999999999999999998642             48999999999999999999999980                


Q ss_pred             ---------------------------------------------------------CCCcc------------------
Q psy15820        158 ---------------------------------------------------------RDGYR------------------  162 (230)
Q Consensus       158 ---------------------------------------------------------~~~~~------------------  162 (230)
                                                                               ..|..                  
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~  228 (294)
T 4eqm_A          149 TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS  228 (294)
T ss_dssp             CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC
T ss_pred             CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc
Confidence                                                                     00000                  


Q ss_pred             -----CCCCCcCcHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHhhcc
Q psy15820        163 -----LEKPDHCRRELYNIMYYCWDKEPNERP-NFTELCDLLEKLLLNET  206 (230)
Q Consensus       163 -----~~~p~~~~~~~~~li~~cl~~dp~~Rp-t~~~i~~~l~~~~~~~~  206 (230)
                           ...+..+++.+.+++.+||+.||.+|| ++.++.+.|..++....
T Consensus       229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence                 012345788999999999999999998 89999988887665443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.93  E-value=1.5e-25  Score=181.05  Aligned_cols=120  Identities=25%  Similarity=0.377  Sum_probs=101.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++...........+.+|+.++..+. |+||+++++++...+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVN-----RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEE-----CCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCe
Confidence            47899999999999999999988     45566799999864433444567889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~g  125 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPD-------------IGMPEPDAQRFFHQLMAGVVYLHGIG  125 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTT-------------TBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEcCCCCcHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999998887542             34899999999999999999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.93  E-value=1.1e-24  Score=180.10  Aligned_cols=130  Identities=15%  Similarity=0.266  Sum_probs=112.9

Q ss_pred             CCCcccccCCCeeEeeeecce--eceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820         10 SDDKWEVPRQHIKVFDILGEG--CFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      +...+.....+|++.+.||+|  +||.||+|.+     ..++..||+|+++.. ........+.+|+.++..+. ||||+
T Consensus        16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv   89 (389)
T 3gni_B           16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARY-----KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIV   89 (389)
T ss_dssp             --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEE-----TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred             hhhcccCCCCcEEEEecccCCcCCceEEEEEEE-----cCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCC
Confidence            445577789999999999999  9999999999     455667999999643 34556678889999999999 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++++...+..++||||+++|+|.+++....           ...+++..+..++.||+.||.|||+++
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~~  148 (389)
T 3gni_B           90 PYRATFIADNELWVVTSFMAYGSAKDLICTHF-----------MDGMNELAIAYILQGVLKALDYIHHMG  148 (389)
T ss_dssp             CEEEEEEETTEEEEEEECCTTCBHHHHHHHTC-----------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cEeEEEEECCEEEEEEEccCCCCHHHHHhhhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999998742           234899999999999999999999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.93  E-value=3.6e-25  Score=176.67  Aligned_cols=137  Identities=20%  Similarity=0.374  Sum_probs=93.4

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .+..+|.+..++|++.+.||+|+||.||+|.+     ..++..||+|++...........+.+|+.++..+. ||||+++
T Consensus         5 s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~   78 (303)
T 2vwi_A            5 SSALPWSINRDDYELQEVIGSGATAVVQAAYC-----APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSY   78 (303)
T ss_dssp             --------CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC----------------CCCCCC-CTTBCCE
T ss_pred             ccccccccchhhhhhhheeccccceEEEEEEE-----CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC-CCCEeeE
Confidence            34667999999999999999999999999988     34455699999875444445667889999999998 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++...+..+++|||+++++|.+++.......     ......+++..+..++.|++.||.|||+++
T Consensus        79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  141 (303)
T 2vwi_A           79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG-----EHKSGVLDESTIATILREVLEGLEYLHKNG  141 (303)
T ss_dssp             EEEEESSSCEEEEEECCTTCBHHHHHHHHHHTT-----TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEeecCCcEEEehhccCCchHHHHHHHhhcc-----ccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999998632210     001335899999999999999999999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.1e-24  Score=175.83  Aligned_cols=119  Identities=22%  Similarity=0.374  Sum_probs=105.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++++.||+|+||.||+|.+     ..++..+|+|.++..  ......+.+|+.++..+. ||||+++++++...+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVE-----TSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR-HRNILHLHESFESMEE   75 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTE
T ss_pred             hhceEeeeEEecCCCeEEEEEEE-----CCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCE
Confidence            47899999999999999999998     556778999998743  344567889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++++|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~g  122 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTS------------AFELNEREIVSYVHQVCEALQFLHSHN  122 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS------------SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999988652            235899999999999999999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.93  E-value=1.4e-25  Score=181.16  Aligned_cols=131  Identities=27%  Similarity=0.413  Sum_probs=107.5

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .+...+.+..++|++.+.||+|+||.||+|...      ++..||+|++...........+.+|+.++..+. |+||+++
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~   92 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRL   92 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCC
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccce
Confidence            344556778899999999999999999999752      345699999975433333346889999999999 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      ++++...+..+++|||+++|+|.+++.....         ....+++..+..++.|++.||.|||++
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~  150 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPE---------SQPPLDWPKRQRIALGSARGLAYLHDH  150 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCST---------TCCCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccc---------cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999986421         233489999999999999999999999

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.93  E-value=9.2e-25  Score=173.32  Aligned_cols=124  Identities=22%  Similarity=0.393  Sum_probs=106.8

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|.+.+.||+|+||.||++..     ..++..+|+|.+...........+.+|+.++..+. ||||+++++++.....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEE-----RSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             hhheeecceeccCCCeEEEEEEE-----ccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCe
Confidence            36799999999999999999998     45566799999865443444567889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++||||+++++|.+++......         ...+++..+..++.|++.||.|||+++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~  144 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQAR---------GKALSEGYVAELMKQMMNALAYFHSQH  144 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhc---------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999998764321         245899999999999999999999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=1.2e-24  Score=171.89  Aligned_cols=166  Identities=22%  Similarity=0.347  Sum_probs=138.6

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe--c
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT--E   94 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~--~   94 (230)
                      .++|++.+.||+|+||.||++..     ..++..+|+|.+... ........+.+|+.++..+. ||||+++++++.  .
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRR-----KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEE-----CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCC
Confidence            46899999999999999999998     455667999999643 35566778999999999998 999999999874  3


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      ....+++|||+++++|.+++.....         ....+++..++.++.|++.||.|||+++                  
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~  149 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTK---------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL  149 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcc---------cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE
Confidence            5678999999999999999987532         1334899999999999999999999864                  


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  229 (279)
T 2w5a_A          150 DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  229 (279)
T ss_dssp             CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh
Confidence                                                                                          22


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      .+.....|..+++++.+++.+||+.||++|||+.++++.+
T Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          230 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             hcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            2333456678899999999999999999999999998743

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.93  E-value=2.9e-25  Score=179.31  Aligned_cols=122  Identities=21%  Similarity=0.445  Sum_probs=101.6

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC-
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP-   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~-   97 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. ||||+++++++...+. 
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   79 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKN-----KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPE   79 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEE-----TTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSC
T ss_pred             hcCceeeEecCCCCeEEEEEEE-----cCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccc
Confidence            5789999999999999999998     45566799999975545556678999999999998 9999999999865432 


Q ss_pred             --------------------------------------------------------eEEEEecCCCCCHHHHHHHhhhhh
Q psy15820         98 --------------------------------------------------------FFVIMEYVPYGKLQSFLRSSRAQR  121 (230)
Q Consensus        98 --------------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~  121 (230)
                                                                              .+++||||++++|.+++.....  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--  157 (332)
T 3qd2_B           80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--  157 (332)
T ss_dssp             HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--
T ss_pred             hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--
Confidence                                                                    7999999999999999986421  


Q ss_pred             hccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        122 YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                              ....++..++.++.|++.||.|||+++
T Consensus       158 --------~~~~~~~~~~~i~~qi~~aL~~LH~~~  184 (332)
T 3qd2_B          158 --------LEDREHGVCLHIFIQIAEAVEFLHSKG  184 (332)
T ss_dssp             --------GGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             --------ccchhhHHHHHHHHHHHHHHHHHHhCC
Confidence                    123466678999999999999999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.93  E-value=5e-25  Score=177.64  Aligned_cols=126  Identities=25%  Similarity=0.450  Sum_probs=105.3

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .....++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+.++..+. ||||+++++++.
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  105 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPES-SQGIEEFETEIETLSFCR-HPHLVSLIGFCD  105 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCC-CTTBCCEEEECC
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccC-hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc
Confidence            3445688999999999999999999862      34569999886442 344567899999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..+++|||+++|+|.+++.....         ....+++..++.++.|++.||.|||+++
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~~l~~lH~~~  159 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDL---------PTMSMSWEQRLEICIGAARGLHYLHTRA  159 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCC---------CSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCC---------CccccCHHHHHHHHHHHHHHHHHhcCCC
Confidence            99999999999999999888754211         1234889999999999999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.92  E-value=8e-25  Score=179.33  Aligned_cols=121  Identities=26%  Similarity=0.437  Sum_probs=104.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----HHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      -.+.|++++.||+|+||.||+|.+     ..++..+|+|+++.....     .....+.+|+.++..+. ||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCRE-----KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEE-----CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEE
Confidence            346799999999999999999998     456677999998643221     13467889999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..++||||+++|+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~g  135 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQK-------------ESLSEEEATSFIKQILDGVNYLHTKK  135 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTC-------------SCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999998652             34899999999999999999999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.92  E-value=4.2e-24  Score=169.64  Aligned_cols=175  Identities=31%  Similarity=0.588  Sum_probs=137.0

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...+..++|++.+.||+|+||.||+|.+....  .....||+|+++...  .......+.+|+.++..+. |+||+++++
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~   88 (291)
T 1u46_A           12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYG   88 (291)
T ss_dssp             CEECCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             ccccchhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEE
Confidence            35678899999999999999999999875322  223458999986432  3345678999999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++.... .++++||+++++|.+++....            ..+++..+..++.|++.||.|||+++              
T Consensus        89 ~~~~~~-~~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~  155 (291)
T 1u46_A           89 VVLTPP-MKMVTELAPLGSLLDRLRKHQ------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA  155 (291)
T ss_dssp             EECSSS-CEEEEECCTTCBHHHHHHHHG------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE
T ss_pred             EEccCC-ceeeEecccCCCHHHHHHhcc------------CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc
Confidence            997754 899999999999999998742            23889999999999999999999998              


Q ss_pred             -------------------------------------------------------------C------------------
Q psy15820        157 -------------------------------------------------------------V------------------  157 (230)
Q Consensus       157 -------------------------------------------------------------i------------------  157 (230)
                                                                                   +                  
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  235 (291)
T 1u46_A          156 TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH  235 (291)
T ss_dssp             ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH
Confidence                                                                         1                  


Q ss_pred             ---CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        158 ---RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       158 ---~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                         ..+...+.+..++.++.+++.+||+.||++|||+.++++.|..+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          236 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence               1122334556889999999999999999999999999999887653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.92  E-value=6.1e-24  Score=168.19  Aligned_cols=120  Identities=23%  Similarity=0.372  Sum_probs=106.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..+|+|++... ........+.+|+.++..+. |+||+++++++...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   78 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVH-----KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES   78 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEE-----cCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCC
Confidence            57899999999999999999998     455667999998643 45566678899999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+.+....             .+++..+..++.|++.||.|||+++
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~~  125 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVARE-------------FYSEADASHCIQQILESIAYCHSNG  125 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999887642             4899999999999999999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.92  E-value=8.6e-25  Score=177.60  Aligned_cols=122  Identities=22%  Similarity=0.360  Sum_probs=105.8

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +..++|++.+.||+|+||.||+|..     ..++..||+|+++...  .......+.+|+.++..+. ||||+++++++.
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~   75 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVRE-----KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ   75 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEE-----CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEE
Confidence            5678999999999999999999998     4566779999986321  1223456889999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..++||||+++|+|..++....             .+++..+..++.||+.||.|||+++
T Consensus        76 ~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~  125 (337)
T 1o6l_A           76 THDRLCFVMEYANGGELFFHLSRER-------------VFTEERARFYGAEIVSALEYLHSRD  125 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999987642             4899999999999999999999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.92  E-value=6.5e-25  Score=175.49  Aligned_cols=162  Identities=25%  Similarity=0.444  Sum_probs=137.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..+.|++.+.||+|+||.||+|.+     ..++..||+|++...........+.+|+.++..+. |+||+++++++...+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   93 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGID-----NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDT   93 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEE-----CCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            456799999999999999999988     45566799999965444445678999999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..+++|||+++++|.+++..              ..+++..+..++.|++.||.|||+++                    
T Consensus        94 ~~~lv~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  159 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLEP--------------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK  159 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred             eEEEEEEeCCCCcHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEE
Confidence            99999999999999998854              24889999999999999999999998                    


Q ss_pred             -----------------------------------------------------------------------CCCCccCCC
Q psy15820        157 -----------------------------------------------------------------------VRDGYRLEK  165 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~~~~~~  165 (230)
                                                                                             +..+..+..
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  239 (303)
T 3a7i_A          160 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL  239 (303)
T ss_dssp             ECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             EeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC
Confidence                                                                                   111122334


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCDLL  198 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l  198 (230)
                      +..++.++.+++.+||+.||++|||+.++++..
T Consensus       240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            557889999999999999999999999998743

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=3.4e-24  Score=180.04  Aligned_cols=121  Identities=21%  Similarity=0.344  Sum_probs=105.0

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..++|++.+.||+|+||.||+|.+     ..++..+|+|++.... .......+.+|+.++..+. ||||+++++++...
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~-----~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~   82 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVK-----VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSISEE   82 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEE-----TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEE-----CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEEC
Confidence            356799999999999999999998     5667789999986443 3445677899999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++|||||++|+|.+.+...             ..+++..+..++.||+.||.|||+++
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~-------------~~~~e~~~~~i~~qil~aL~~lH~~g  130 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR-------------EYYSEADASHCIQQILEAVLHCHQMG  130 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC-------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999998863             24899999999999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.92  E-value=7.9e-25  Score=173.02  Aligned_cols=164  Identities=21%  Similarity=0.398  Sum_probs=136.9

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+..++|++.+.||+|+||.||+|.+     ..++..+|+|++.....  ......+.+|+.++..+. ||||+++++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~   78 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLARE-----KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYF   78 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEE-----ccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheE
Confidence            45668899999999999999999998     45566799999853211  122456889999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..+++|||+++++|.+++....             .+++..+..++.|++.||.|||+++                
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~  145 (279)
T 3fdn_A           79 HDATRVYLILEYAPLGTVYRELQKLS-------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA  145 (279)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC
Confidence            99999999999999999999987642             4889999999999999999999998                


Q ss_pred             ------------------------------------------------------CCCC------------------ccCC
Q psy15820        157 ------------------------------------------------------VRDG------------------YRLE  164 (230)
Q Consensus       157 ------------------------------------------------------i~~~------------------~~~~  164 (230)
                                                                            +..|                  ....
T Consensus       146 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  225 (279)
T 3fdn_A          146 GELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT  225 (279)
T ss_dssp             SCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             CCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC
Confidence                                                                  0000                  1123


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .|..+++.+.+|+.+||+.||.+|||+.++++.
T Consensus       226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            456688999999999999999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.92  E-value=3.2e-24  Score=175.52  Aligned_cols=123  Identities=20%  Similarity=0.338  Sum_probs=110.1

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+..++|++.+.||+|+||.||+|.+     ..++..+|+|++...........+.+|+.++..+. |+||+++++++..
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  102 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSH-----KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS  102 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEE-----CCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEE
Confidence            46678999999999999999999998     45566799999976656777788999999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      .+..++||||+++++|.+++....             .+++..+..++.|++.||.|||++ +
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~~i~~~l~~lh~~~~  152 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKAG-------------RIPEQILGKVSIAVIKGLTYLREKHK  152 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999998742             488999999999999999999986 6

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.92  E-value=3.8e-24  Score=171.69  Aligned_cols=170  Identities=18%  Similarity=0.219  Sum_probs=140.9

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ....+|++.+.||+|+||.||+|.+     ..++..||+|++...  ........+.+|+.++..+. ||||+++++++.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~  104 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAED-----TVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGE  104 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEE-----TTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEE-----cCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEe
Confidence            4568899999999999999999998     455677999998643  23445678999999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..++++||+++++|.+++....             .+++..++.++.|++.||.|||+++                 
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~  171 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLRRQG-------------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD  171 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred             eCCeEEEEEEecCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC
Confidence            9999999999999999999998642             4889999999999999999999998                 


Q ss_pred             --------------------------------------------------------CCCCc-------------------
Q psy15820        157 --------------------------------------------------------VRDGY-------------------  161 (230)
Q Consensus       157 --------------------------------------------------------i~~~~-------------------  161 (230)
                                                                              +..|.                   
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (309)
T 2h34_A          172 FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI  251 (309)
T ss_dssp             CEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC
T ss_pred             CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC
Confidence                                                                    00000                   


Q ss_pred             --cCCCCCcCcHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHHhh
Q psy15820        162 --RLEKPDHCRRELYNIMYYCWDKEPNERP-NFTELCDLLEKLLLN  204 (230)
Q Consensus       162 --~~~~p~~~~~~~~~li~~cl~~dp~~Rp-t~~~i~~~l~~~~~~  204 (230)
                        ....+..+++++.+++.+||+.||++|| |+.++++.|...+..
T Consensus       252 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          252 PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence              1123456888999999999999999999 999999999876544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.92  E-value=4.4e-24  Score=171.94  Aligned_cols=125  Identities=25%  Similarity=0.379  Sum_probs=106.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +...+|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. ||||+++++++...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   79 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRH-----KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEET   79 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEE-----CCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecC
Confidence            4567899999999999999999998     44566799999975433344567889999999999 99999999998765


Q ss_pred             C--CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 E--PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +  ..++||||+++++|.+++.....          ...+++..++.++.|++.||.|||+++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~  132 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSN----------AYGLPESEFLIVLRDVVGGMNHLRENG  132 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGG----------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            5  68999999999999999987431          223899999999999999999999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.92  E-value=4e-24  Score=176.68  Aligned_cols=120  Identities=18%  Similarity=0.426  Sum_probs=104.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..+|+|++.... ......+.+|+.++..+. |+||+++++++.....
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVE-----KATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEecCCCEEEEEEEE-----CCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCE
Confidence            46799999999999999999998     4556679999986432 444567899999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++||||+++|+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~g  169 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAE------------DYKMSEAEVINYMRQACEGLKHMHEHS  169 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCT------------TCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEcCCCCcHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999988652            235899999999999999999999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.92  E-value=9e-25  Score=177.37  Aligned_cols=161  Identities=18%  Similarity=0.277  Sum_probs=133.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ...+|.+.+.||+|+||.||+|.+     ..++..||+|++.....  ......+.+|+.++..+. ||||+++++++..
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~   80 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATH-----YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITT   80 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEE-----CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe
Confidence            346899999999999999999998     45566799999863211  112346889999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+..++||||+ +|+|.+++....             .+++..+..++.|++.||.|||+++                  
T Consensus        81 ~~~~~lv~E~~-~g~l~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~  146 (336)
T 3h4j_B           81 PTDIVMVIEYA-GGELFDYIVEKK-------------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN  146 (336)
T ss_dssp             SSEEEEEECCC-CEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC
T ss_pred             CCEEEEEEECC-CCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC
Confidence            99999999999 679999887642             4899999999999999999999998                  


Q ss_pred             ------------------------------------------------------------------------CCCCccCC
Q psy15820        157 ------------------------------------------------------------------------VRDGYRLE  164 (230)
Q Consensus       157 ------------------------------------------------------------------------i~~~~~~~  164 (230)
                                                                                              ........
T Consensus       147 ~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~  226 (336)
T 3h4j_B          147 VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV  226 (336)
T ss_dssp             EEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC
T ss_pred             EEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC
Confidence                                                                                    00011223


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .|..+++++.+|+.+||+.||.+|||+.++++.
T Consensus       227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            466789999999999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.92  E-value=6.2e-24  Score=168.57  Aligned_cols=127  Identities=24%  Similarity=0.382  Sum_probs=102.3

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHH-HHhhcCCCCceeeEeeEE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT-VMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~~~~h~niv~l~~~~   92 (230)
                      +++..++|++.+.||+|+||.||+|.+     ..++..||+|+++.............+.. .+..+. ||||+++++++
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~   75 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRH-----VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGAL   75 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEe-----cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC-CCeEEEEeeee
Confidence            568889999999999999999999998     45677899999975544444444444444 466677 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      ...+..+++|||+++ +|.+++.....         ....+++..+..++.|++.||.|||++ +
T Consensus        76 ~~~~~~~lv~e~~~~-~l~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~  130 (290)
T 3fme_A           76 FREGDVWICMELMDT-SLDKFYKQVID---------KGQTIPEDILGKIAVSIVKALEHLHSKLS  130 (290)
T ss_dssp             ECSSSEEEEEECCSE-EHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             eccCCEEEEEehhcc-chHHHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence            999999999999984 89888876322         134589999999999999999999998 7

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.92  E-value=1.4e-24  Score=171.16  Aligned_cols=165  Identities=21%  Similarity=0.303  Sum_probs=136.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      -.+...+|++++.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.++..+. |+||++++++
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~   79 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEH-----QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQV   79 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEE-----CCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEE
Confidence            456778999999999999999999998     4456679999986321  1123457889999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +...+..++++||+++++|.+++....             .+++..+..++.|++.||.|||+++               
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~  146 (276)
T 2h6d_A           80 ISTPTDFFMVMEYVSGGELFDYICKHG-------------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA  146 (276)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT
T ss_pred             EecCCeEEEEEeccCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC
Confidence            999999999999999999999997642             4889999999999999999999998               


Q ss_pred             ---------------------------------------------------------CCCC------------------c
Q psy15820        157 ---------------------------------------------------------VRDG------------------Y  161 (230)
Q Consensus       157 ---------------------------------------------------------i~~~------------------~  161 (230)
                                                                               +..|                  .
T Consensus       147 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  226 (276)
T 2h6d_A          147 HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG  226 (276)
T ss_dssp             TSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence                                                                     0000                  1


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      ....|..++.++.+++.+||+.||.+|||+.++++.
T Consensus       227 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            123456678899999999999999999999999873

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.92  E-value=1.9e-24  Score=174.80  Aligned_cols=120  Identities=30%  Similarity=0.444  Sum_probs=103.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----HHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+.|++.+.||+|+||.||+|.+     ..++..+|+|+++.....     .....+.+|+.++..+. ||||+++++++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~   83 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCRE-----KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY   83 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEE-----TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEE-----CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            35699999999999999999998     455667999998643211     13567889999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..++||||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~  134 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAEK-------------ESLTEEEATEFLKQILNGVYYLHSLQ  134 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTS-------------SCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHhc-------------CCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999998652             34899999999999999999999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.92  E-value=2.3e-24  Score=176.01  Aligned_cols=125  Identities=18%  Similarity=0.297  Sum_probs=104.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc----CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      ..+.|++.+.||+|+||.||+|.+     ..++..||+|++...    ........+.+|+.++..+. ||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCIN-----RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            346799999999999999999998     455667999998532    11113467889999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..++|||||++++|.+++.....         ....+++..+..++.||+.||.|||+++
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~~i~~qi~~al~~lH~~~  150 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRAD---------AGFVYSEAVASHYMRQILEALRYCHDNN  150 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcc---------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999988876432         1234789999999999999999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.92  E-value=4.3e-24  Score=175.11  Aligned_cols=120  Identities=23%  Similarity=0.374  Sum_probs=105.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..+|+|++... ........+.+|+.++..+. ||||+++++++...+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVH-----KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES  101 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             ccCeEEeeEEecCCCeEEEEEEE-----CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            35799999999999999999998     455667999999643 34556678999999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++||||+++|+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~  148 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAR-------------EFYSEADASHCIQQILESIAYCHSNG  148 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC-------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEecCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999988652             24899999999999999999999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.92  E-value=2.5e-24  Score=175.94  Aligned_cols=125  Identities=22%  Similarity=0.426  Sum_probs=104.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      -.+..++|++.+.||+|+||.||+|.+     +.++..||+|+++...  .......+..|..++..+..||||++++++
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~   92 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARV-----KETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC   92 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEE-----cCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence            357789999999999999999999998     4556679999986421  222345678899999988559999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..++||||+++|+|..++....             .+++..+..++.||+.||.|||+++
T Consensus        93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~g  144 (353)
T 3txo_A           93 FQTPDRLFFVMEFVNGGDLMFHIQKSR-------------RFDEARARFYAAEIISALMFLHDKG  144 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999998742             4899999999999999999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.92  E-value=1.2e-23  Score=168.56  Aligned_cols=120  Identities=26%  Similarity=0.445  Sum_probs=104.0

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. |+||+++++++...+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRN-----RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEe-----CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheeecCC
Confidence            36899999999999999999998     455667999988644 34445677889999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~  122 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQ-------------RGVPEHLVKSITWQTLQAVNFCHKHN  122 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTS-------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEEeCCCchHHHHHhhh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999998887652             34899999999999999999999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=1.1e-25  Score=181.16  Aligned_cols=186  Identities=25%  Similarity=0.473  Sum_probs=141.5

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      .....|.+..++|++.+.||+|+||.||+|.+.+        .+++|.++.. ........+.+|+.++..+. |+||++
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~   93 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVL   93 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCC
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeE
Confidence            3456789999999999999999999999998842        2899998643 22223345778999999998 999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCC--------
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRD--------  159 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~--------  159 (230)
                      +++++...+..++++||+++++|.+++...            ...+++..+..++.|++.||.|||++++.+        
T Consensus        94 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NI  161 (319)
T 2y4i_B           94 FMGACMSPPHLAIITSLCKGRTLYSVVRDA------------KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV  161 (319)
T ss_dssp             CCEEEECSSCEEEECBCCCSEEHHHHTTSS------------CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTE
T ss_pred             EEEEEecCCceEEEeecccCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhE
Confidence            999999999999999999999999998652            234889999999999999999999998110        


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        160 --------------------------------------------------------------------------------  159 (230)
Q Consensus       160 --------------------------------------------------------------------------------  159 (230)
                                                                                                      
T Consensus       162 l~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~  241 (319)
T 2y4i_B          162 FYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW  241 (319)
T ss_dssp             EEC--CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EEeCCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence                                                                                            


Q ss_pred             ----------------CccCC-CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCC
Q psy15820        160 ----------------GYRLE-KPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFP  215 (230)
Q Consensus       160 ----------------~~~~~-~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~  215 (230)
                                      +..+. .+..++.++.+++.+||..||++|||+.++++.|+.+.........+..++
T Consensus       242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          242 PFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             SSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             CCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence                            00111 112467789999999999999999999999999998887766655554443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=1.2e-24  Score=173.52  Aligned_cols=122  Identities=21%  Similarity=0.379  Sum_probs=98.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-------------------------HHHHHHH
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-------------------------ERERLDL   69 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~   69 (230)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||+|++.....                         ......+
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYN-----ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV   83 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEE-----TTTTEEEEEEEEECC-------------------------------CHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEE-----CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH
Confidence            45678999999999999999999988     55677899999854321                         1123568


Q ss_pred             HHHHHHHhhcCCCCceeeEeeEEec--CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHh
Q psy15820         70 LQELTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVAR  147 (230)
Q Consensus        70 ~~e~~~l~~~~~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  147 (230)
                      .+|+.++..+. ||||+++++++..  .+..+++|||+++++|.+++.              ...+++..+..++.|++.
T Consensus        84 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~~~~qi~~  148 (298)
T 2zv2_A           84 YQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--------------LKPLSEDQARFYFQDLIK  148 (298)
T ss_dssp             HHHHHHHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--------------SSCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--------------cCCCCHHHHHHHHHHHHH
Confidence            89999999998 9999999999986  457899999999999876432              235899999999999999


Q ss_pred             hhhhhhhcC
Q psy15820        148 GMQFLSSRG  156 (230)
Q Consensus       148 gl~~LH~~~  156 (230)
                      ||.|||+++
T Consensus       149 ~l~~lH~~~  157 (298)
T 2zv2_A          149 GIEYLHYQK  157 (298)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHHHCC
Confidence            999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.92  E-value=3.8e-24  Score=177.12  Aligned_cols=125  Identities=20%  Similarity=0.394  Sum_probs=105.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..+..++|++.+.||+|+||.||+|..     +.++..+|+|+++..  ........+..|..++..+..||||++++++
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~-----~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRL-----KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            457788999999999999999999998     556778999999643  2233345678899999887449999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+.+++||||+++|+|..++....             .+++..+..++.||+.||.|||+++
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~g  173 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERG  173 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999988642             4899999999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=1e-23  Score=170.61  Aligned_cols=132  Identities=24%  Similarity=0.415  Sum_probs=109.0

Q ss_pred             CCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceee
Q psy15820          8 QKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus         8 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      +.....+.+...+|++.+.||+|+||.||+|.+     ..++..||+|++... .......+.+|+.++..+..|+||++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~   90 (337)
T 3ll6_A           17 DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQD-----VGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQ   90 (337)
T ss_dssp             SSTTCEEEETTEEEEEEEEEECCSSEEEEEEEE-----TTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred             HhhcceeeccCceEEEEEEEccCCceEEEEEEE-----CCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhh
Confidence            445566788888999999999999999999998     445667999988543 35556788999999999966999999


Q ss_pred             EeeEEe--------cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         88 LLGCCT--------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        88 l~~~~~--------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++.        ....+++++||+. |+|.+++.....          ...+++..++.++.||+.||.|||+++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~  156 (337)
T 3ll6_A           91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES----------RGPLSCDTVLKIFYQTCRAVQHMHRQK  156 (337)
T ss_dssp             EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT----------TCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999984        2334899999996 699999876431          235899999999999999999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.92  E-value=7.9e-24  Score=172.47  Aligned_cols=124  Identities=21%  Similarity=0.405  Sum_probs=108.1

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+..++|++.+.||+|+||.||+|.+     +.++..+|+|+++..  ........+.+|..++..+..||||+++++++
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   79 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRL-----KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF   79 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEE-----CCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence            35678999999999999999999998     556778999999643  34455677889999999884499999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..++||||+++|+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        80 ~~~~~~~lv~e~~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~~  130 (345)
T 3a8x_A           80 QTESRLFFVIEYVNGGDLMFHMQRQR-------------KLPEEHARFYSAEISLALNYLHERG  130 (345)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999987642             4899999999999999999999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=6.2e-24  Score=171.85  Aligned_cols=131  Identities=18%  Similarity=0.343  Sum_probs=102.7

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---CHHHHHHHHHHHHHHhhcCCCCcee
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVV   86 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~~h~niv   86 (230)
                      +..+..+..++|++.+.||+|+||.||++.....  ..++..+|+|+++...   .......+.+|+.++..+. ||||+
T Consensus         8 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv   84 (327)
T 3a62_A            8 NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIV   84 (327)
T ss_dssp             -----CCCGGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBC
T ss_pred             CCCCCCCCHHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCcc
Confidence            3445678889999999999999999999987421  2456679999997432   2234456788999999999 99999


Q ss_pred             eEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         87 RLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        87 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++++...+..++||||+++++|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~al~~lH~~~  141 (327)
T 3a62_A           85 DLIYAFQTGGKLYLILEYLSGGELFMQLEREG-------------IFMEDTACFYLAEISMALGHLHQKG  141 (327)
T ss_dssp             CEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999997642             4789999999999999999999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.92  E-value=4.8e-24  Score=169.75  Aligned_cols=162  Identities=20%  Similarity=0.333  Sum_probs=137.4

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ..++|.+++.||+|+||.||++.+     ..++..+|+|++...  ........+.+|+.++..+. |+||+++++++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~   86 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISD-----ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFED   86 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred             cccceEEEEEEeecCCEEEEEEEE-----CCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeecc
Confidence            457899999999999999999998     445567999998543  34556678999999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++                  
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~  153 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRR-------------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE  153 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC
Confidence            99999999999999999988763             24889999999999999999999998                  


Q ss_pred             ------------------------------------------------------CCCC------------------ccCC
Q psy15820        157 ------------------------------------------------------VRDG------------------YRLE  164 (230)
Q Consensus       157 ------------------------------------------------------i~~~------------------~~~~  164 (230)
                                                                            +..|                  ....
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  233 (294)
T 2rku_A          154 VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS  233 (294)
T ss_dssp             EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             EEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC
Confidence                                                                  0000                  1223


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .|..+++.+.+++.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          234 IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            456788999999999999999999999999974

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=6.3e-24  Score=170.52  Aligned_cols=122  Identities=20%  Similarity=0.307  Sum_probs=105.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .-.++|++.+.||+|+||.||+|.+     ..++..||+|+++..  ........+.+|+.++..+. ||||+++++++.
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~   82 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARD-----LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGE   82 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEE
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEE-----CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeee
Confidence            4567899999999999999999998     456778999999643  34455678999999999998 999999999987


Q ss_pred             cCCC----eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEP----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....    .++||||+++++|.+++....             .+++..++.++.|++.||.|||+++
T Consensus        83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~  136 (311)
T 3ork_A           83 AETPAGPLPYIVMEYVDGVTLRDIVHTEG-------------PMTPKRAIEVIADACQALNFSHQNG  136 (311)
T ss_dssp             EEETTEEEEEEEEECCCEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCCCcccEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            6544    399999999999999997642             4899999999999999999999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=2.9e-24  Score=169.63  Aligned_cols=161  Identities=21%  Similarity=0.400  Sum_probs=133.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      .++|++.+.||+|+||.||+|..     ..++..||+|++.....  ......+.+|+.++..+. ||||+++++++...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAES-----IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEE-----ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccC
Confidence            46799999999999999999988     44566799999853211  112467889999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..++++||+++++|.+++...            ...+++..+..++.|++.||.|||+++                   
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~  151 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR------------VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNI  151 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC------------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCE
T ss_pred             CeEEEEEecCCCCcHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCE
Confidence            9999999999999999998763            235899999999999999999999998                   


Q ss_pred             -----------------------------------------------------CCCC------------------ccCCC
Q psy15820        157 -----------------------------------------------------VRDG------------------YRLEK  165 (230)
Q Consensus       157 -----------------------------------------------------i~~~------------------~~~~~  165 (230)
                                                                           +..|                  .....
T Consensus       152 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  231 (278)
T 3cok_A          152 KIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM  231 (278)
T ss_dssp             EECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC
T ss_pred             EEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC
Confidence                                                                 0000                  01224


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      |..++.++.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            5668899999999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.92  E-value=2.3e-24  Score=182.30  Aligned_cols=163  Identities=20%  Similarity=0.321  Sum_probs=137.1

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+...+|.+++.||+|+||.||+|.+     ..++..||+|+++...  .......+.+|+.++..+. ||||+++++++
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~   85 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKH-----ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVI   85 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEE-----TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            35668899999999999999999998     4566679999986321  1123457889999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..++||||+++|+|.+++...             ..+++..+..++.||+.||.|||+++                
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~  152 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKN-------------GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH  152 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSS-------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC
Confidence            9999999999999999999988642             34899999999999999999999998                


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +.. .
T Consensus       153 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~  231 (476)
T 2y94_A          153 MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD-G  231 (476)
T ss_dssp             CCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT-T
T ss_pred             CCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-C
Confidence                                                                                       110 1


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      ....|..+++++.+|+.+||+.||.+|||+.++++.
T Consensus       232 ~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          232 IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            123456788999999999999999999999999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.92  E-value=6.8e-24  Score=168.96  Aligned_cols=121  Identities=17%  Similarity=0.188  Sum_probs=104.2

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||+|++.....   ...+.+|+.++..+.+|+|++++++++..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   77 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTN-----LLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE   77 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEE-----TTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEE-----CCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence            46678999999999999999999998     45667899999864322   23477899999999559999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....+++|||+ +++|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        78 ~~~~~lv~e~~-~~~L~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~  126 (298)
T 1csn_A           78 GLHNVLVIDLL-GPSLEDLLDLC------------GRKFSVKTVAMAAKQMLARVQSIHEKS  126 (298)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             CceeEEEEEec-CCCHHHHHHHh------------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999 89999999863            234899999999999999999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.92  E-value=8.8e-24  Score=168.13  Aligned_cols=119  Identities=29%  Similarity=0.515  Sum_probs=102.4

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+.++..+. |+||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKN-----RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEE-----CCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCE
Confidence            6899999999999999999998     455667999999633 33445577889999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++||||+++ ++.+.+...            ...+++..+..++.|++.||.|||+++
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~------------~~~l~~~~~~~~~~ql~~~l~~lH~~~  121 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSC------------NGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCC-CHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999986 666666552            235899999999999999999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.92  E-value=1.4e-24  Score=179.17  Aligned_cols=126  Identities=20%  Similarity=0.428  Sum_probs=108.9

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ....+..++|++.+.||+|+||.||++.+     ..++..+|+|++....  .......+.+|+.++..+. ||||++++
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~-----~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~   81 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQK-----NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLW   81 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEE
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEE
Confidence            34568889999999999999999999998     4556679999985321  1123457889999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++...+..++||||++||+|..++...             ..+++..+..++.||+.||.|||+++
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~g  135 (384)
T 4fr4_A           82 YSFQDEEDMFMVVDLLLGGDLRYHLQQN-------------VHFKEETVKLFICELVMALDYLQNQR  135 (384)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEeCCEEEEEEecCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999998763             34899999999999999999999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.92  E-value=2.3e-24  Score=169.87  Aligned_cols=119  Identities=25%  Similarity=0.386  Sum_probs=103.9

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|++...........+.+|+.++..+. |+||+++++++...+..
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVN-----RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             cceEEEEEeecCCCcEEEEEEE-----CCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEE
Confidence            5799999999999999999998     44566799999864444455678899999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++||+++++|.+++..             ...+++..+..++.|++.||.|||+++
T Consensus        81 ~lv~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~~~i~~~l~~lH~~~  125 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEP-------------DIGMPEPDAQRFFHQLMAGVVYLHGIG  125 (276)
T ss_dssp             EEEEECCTTEEGGGGSBT-------------TTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCCcHHHHHhh-------------ccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999887754             234889999999999999999999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=7.3e-24  Score=169.17  Aligned_cols=122  Identities=27%  Similarity=0.567  Sum_probs=103.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ...++|++.+.||+|+||.||+|.+     ..++..+|+|++... .......+.+|+.++..+. ||||+++++++...
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKN-----KETGALAAAKVIETK-SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHD   88 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEE-----TTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred             CCccceeecceeccCCCeEEEEEEE-----cCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence            3567899999999999999999998     445667999998643 2334567889999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++++||+++++|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        89 ~~~~lv~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~  137 (302)
T 2j7t_A           89 GKLWIMIEFCPGGAVDAIMLEL------------DRGLTEPQIQVVCRQMLEALNFLHSKR  137 (302)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CeEEEEEEeCCCCcHHHHHHhh------------ccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            9999999999999999988763            234899999999999999999999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.91  E-value=7e-24  Score=169.71  Aligned_cols=116  Identities=28%  Similarity=0.383  Sum_probs=98.6

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc---CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN---AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      .++.||+|+||.||+|...       +..+|+|.+...   ........+.+|+.++..+. ||||+++++++...+..+
T Consensus        35 ~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  106 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYVN-------NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLC  106 (307)
T ss_dssp             TCCEEEECSSEEEEEEESS-------SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred             cCCccccCCCeEEEEEEEC-------CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceE
Confidence            4588999999999999763       335999998643   23445678999999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|||+++++|.+++....          ....+++..++.++.|++.||.|||+++
T Consensus       107 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~~  153 (307)
T 2nru_A          107 LVYVYMPNGSLLDRLSCLD----------GTPPLSWHMRCKIAQGAANGINFLHENH  153 (307)
T ss_dssp             EEEECCTTCBHHHHHHTGG----------GCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            9999999999999987542          1235889999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.91  E-value=5e-24  Score=172.47  Aligned_cols=133  Identities=24%  Similarity=0.395  Sum_probs=102.0

Q ss_pred             CcCCCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCC
Q psy15820          4 PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPH   82 (230)
Q Consensus         4 ~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h   82 (230)
                      |.+.+.+..+-....++|++.+.||+|+||.||+|.+     ..++..||+|+++... .......+.+|+.++..+. |
T Consensus        19 p~s~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h   92 (329)
T 3gbz_A           19 PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAID-----TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-H   92 (329)
T ss_dssp             -------------CGGGEEEEEEEEECSSSEEEEEEE-----TTTTEEEEEEECCCCC--------CHHHHHHGGGCC-C
T ss_pred             CCcceeccCCcccchhhEEEEEEEEecCCeEEEEEEE-----CCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-C
Confidence            3334444445556778999999999999999999988     5567789999996442 3334567889999999998 9


Q ss_pred             CceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         83 PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        83 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +||+++++++...+..++||||+++ +|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        93 ~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-------------~~~~~~~~~~i~~ql~~~l~~LH~~~  152 (329)
T 3gbz_A           93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-------------PDVSMRVIKSFLYQLINGVNFCHSRR  152 (329)
T ss_dssp             TTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999985 999998763             24899999999999999999999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.91  E-value=6.1e-24  Score=176.20  Aligned_cols=125  Identities=25%  Similarity=0.379  Sum_probs=105.9

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. ||||+++++++...
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~   79 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRH-----KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEET   79 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEE-----CCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeeccC
Confidence            4567899999999999999999998     45566799999975433344567889999999999 99999999998865


Q ss_pred             C--CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 E--PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +  ..++||||+++|+|.+++.....          ...+++..++.++.|++.||.|||+++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH~~~  132 (396)
T 4eut_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSN----------AYGLPESEFLIVLRDVVGGMNHLRENG  132 (396)
T ss_dssp             TTCCEEEEECCCTTEEHHHHTTSGGG----------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCeeEEEEecCCCCCHHHHHHhhhc----------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4  67999999999999999876431          223899999999999999999999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.91  E-value=4.7e-24  Score=173.03  Aligned_cols=162  Identities=20%  Similarity=0.333  Sum_probs=137.1

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ..++|.+++.||+|+||.||++.+     ..++..+|+|++...  ........+.+|+.++..+. |+||+++++++..
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  112 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISD-----ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFED  112 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence            456899999999999999999998     445567999998533  34556778999999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+..+++|||+++++|.+++...             ..+++..++.++.|++.||.|||+++                  
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~  179 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRR-------------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE  179 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred             CCeEEEEEecCCCCCHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC
Confidence            99999999999999999988763             24899999999999999999999998                  


Q ss_pred             ------------------------------------------------------CCCC------------------ccCC
Q psy15820        157 ------------------------------------------------------VRDG------------------YRLE  164 (230)
Q Consensus       157 ------------------------------------------------------i~~~------------------~~~~  164 (230)
                                                                            +..|                  ....
T Consensus       180 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  259 (335)
T 2owb_A          180 VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS  259 (335)
T ss_dssp             EEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             EEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC
Confidence                                                                  0000                  1123


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .|..+++++.+++.+||+.||++|||+.++++.
T Consensus       260 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          260 IPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            456788899999999999999999999999974

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=5.4e-24  Score=168.63  Aligned_cols=164  Identities=19%  Similarity=0.354  Sum_probs=136.7

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+..++|++.+.||+|+||.||+|.+     ..++..+|+|++.....  ......+.+|+.++..+. |+||+++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~   83 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLARE-----KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYF   83 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEE-----cCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEE
Confidence            45667899999999999999999998     45566799999853211  112356889999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..+++|||+++++|.+++....             .+++..+..++.|++.||.|||+++                
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~  150 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHG-------------RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK  150 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC
Confidence            99999999999999999999998642             4889999999999999999999998                


Q ss_pred             ------------------------------------------------------CCCC------------------ccCC
Q psy15820        157 ------------------------------------------------------VRDG------------------YRLE  164 (230)
Q Consensus       157 ------------------------------------------------------i~~~------------------~~~~  164 (230)
                                                                            +..|                  ....
T Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  230 (284)
T 2vgo_A          151 GELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK  230 (284)
T ss_dssp             CCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             CCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC
Confidence                                                                  0000                  1123


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      .|..+++++.+++.+||+.||.+|||+.++++.
T Consensus       231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            456788999999999999999999999999873

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.91  E-value=1.4e-23  Score=168.62  Aligned_cols=122  Identities=24%  Similarity=0.334  Sum_probs=102.2

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|++... ...........|+..+..+..|+||+++++++...
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRS-----KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEE-----TTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhheeeeheeccCCCeEEEEEEE-----CCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            336799999999999999999998     455667999988543 34455566777777777774499999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..+++|||+ +++|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~  177 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAW------------GASLPEAQVWGYLRDTLLALAHLHSQG  177 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHH------------CSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEEEecc-CCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999 66999988764            234899999999999999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.91  E-value=5.1e-24  Score=171.73  Aligned_cols=162  Identities=21%  Similarity=0.377  Sum_probs=135.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +..++|++.+.||+|+||.||++..     ..++..+|+|+++....  ......+.+|..++..+. ||||+++++++.
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~   76 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRS-----RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ   76 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEE
Confidence            4567899999999999999999998     45667799999863211  122456788999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      +....+++|||+++|+|.+++...             ..+++..+..++.||+.||.|||+++                 
T Consensus        77 ~~~~~~lv~e~~~gg~L~~~l~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g  143 (318)
T 1fot_A           77 DAQQIFMIMDYIEGGELFSLLRKS-------------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG  143 (318)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHT-------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC
Confidence            999999999999999999999863             24899999999999999999999998                 


Q ss_pred             ----------------------------------------------------CCCC------------------ccCCCC
Q psy15820        157 ----------------------------------------------------VRDG------------------YRLEKP  166 (230)
Q Consensus       157 ----------------------------------------------------i~~~------------------~~~~~p  166 (230)
                                                                          +..|                  .....|
T Consensus       144 ~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p  223 (318)
T 1fot_A          144 HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP  223 (318)
T ss_dssp             CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC
T ss_pred             CEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                                                                0000                  123356


Q ss_pred             CcCcHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy15820        167 DHCRRELYNIMYYCWDKEPNERP-----NFTELCD  196 (230)
Q Consensus       167 ~~~~~~~~~li~~cl~~dp~~Rp-----t~~~i~~  196 (230)
                      ..+++++.+++.+||..||.+||     ++.++++
T Consensus       224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            67889999999999999999999     8888885

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.91  E-value=6.4e-24  Score=181.21  Aligned_cols=120  Identities=23%  Similarity=0.480  Sum_probs=101.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH------------HHHHHHHHHHHHHhhcCCCCce
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE------------RERLDLLQELTVMKTLDPHPNV   85 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~~~~h~ni   85 (230)
                      .++|++++.||+|+||.||+|.+     ..++..+|+|+++.....            .....+.+|+.++..+. ||||
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni  108 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKE-----KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNI  108 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEE-----TTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTB
T ss_pred             ccceEEEeEecccCCeEEEEEEE-----CCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCC
Confidence            46799999999999999999998     455667999998643211            23467889999999998 9999


Q ss_pred             eeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         86 VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        86 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++++......++|||||++|+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus       109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~  166 (504)
T 3q5i_A          109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-------------KFDECDAANIMKQILSGICYLHKHN  166 (504)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999987642             4899999999999999999999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.91  E-value=5.7e-24  Score=168.21  Aligned_cols=166  Identities=23%  Similarity=0.364  Sum_probs=134.6

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      ...+|++.+.||+|+||.||+|.+     ..++..||+|.++...     ..+.+|+.++..+. ||||+++++++..  
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKH-----RIDGKTYVIKRVKYNN-----EKAEREVKALAKLD-HVNIVHYNGCWDGFD   77 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEE-----TTTCCEEEEEEEECCS-----GGGHHHHHHHHHCC-CTTBCCEEEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEE-----cCCCeEEEEEEecccc-----HHHHHHHHHHHhCC-CCCEEEEeeeEeccc
Confidence            346799999999999999999998     4456679999986432     24668999999998 9999999998754  


Q ss_pred             --------------CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC---
Q psy15820         95 --------------KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV---  157 (230)
Q Consensus        95 --------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i---  157 (230)
                                    ....+++|||+++++|.+++....           ...+++..++.++.|++.||.|||++++   
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  146 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----------GEKLDKVLALELFEQITKGVDYIHSKKLINR  146 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-----------GSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence                          344899999999999999998642           2358899999999999999999999980   


Q ss_pred             --------------------------------------------------------------------CCC---------
Q psy15820        158 --------------------------------------------------------------------RDG---------  160 (230)
Q Consensus       158 --------------------------------------------------------------------~~~---------  160 (230)
                                                                                          ..+         
T Consensus       147 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  226 (284)
T 2a19_B          147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK  226 (284)
T ss_dssp             CCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH
T ss_pred             cCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH
Confidence                                                                                000         


Q ss_pred             -----ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        161 -----YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       161 -----~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                           .....+..++.++.+++.+||+.||.+|||+.++++.|..+...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          227 FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                 01123456788899999999999999999999999999876544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.91  E-value=1.3e-23  Score=169.57  Aligned_cols=116  Identities=24%  Similarity=0.435  Sum_probs=100.6

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeE
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~   99 (230)
                      .|...+.||+|+||.||+|..     ..++..||+|++.... ......+.+|+.++..+. |+||+++++++...+..+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~-----~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  118 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLARE-----KHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELW  118 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhccEEeccCCCeEEEEEEE-----CCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence            377788999999999999998     4456679999986432 223456889999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|||+++++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus       119 lv~e~~~~~~L~~~l~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~~  161 (321)
T 2c30_A          119 VLMEFLQGGALTDIVSQV--------------RLNEEQIATVCEAVLQALAYLHAQG  161 (321)
T ss_dssp             EEECCCCSCBHHHHHTTC--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999987542              4899999999999999999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.91  E-value=7.1e-24  Score=173.04  Aligned_cols=162  Identities=19%  Similarity=0.322  Sum_probs=136.7

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      ....++|++.+.||+|+||.||++.+     ..++..||+|+++...  .......+.+|+.++..+. ||||+++++++
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~  110 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKH-----KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSF  110 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEE-----CCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence            35678999999999999999999998     4556679999985321  1123456889999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..++||||+++|+|.+++....             .+++..+..++.||+.||.|||+++                
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  177 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRIG-------------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ  177 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC
Confidence            99999999999999999999998742             4899999999999999999999998                


Q ss_pred             ------------------------------------------------------------------------CCCCccCC
Q psy15820        157 ------------------------------------------------------------------------VRDGYRLE  164 (230)
Q Consensus       157 ------------------------------------------------------------------------i~~~~~~~  164 (230)
                                                                                              +.. ....
T Consensus       178 g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~  256 (350)
T 1rdq_E          178 GYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-GKVR  256 (350)
T ss_dssp             SCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCC
T ss_pred             CCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc-CCCC
Confidence                                                                                    111 1234


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPN-----FTELCD  196 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt-----~~~i~~  196 (230)
                      .|..+++++.++|.+||+.||.+||+     +.+|++
T Consensus       257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            56788999999999999999999998     888875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.91  E-value=4.1e-23  Score=164.85  Aligned_cols=159  Identities=21%  Similarity=0.336  Sum_probs=127.2

Q ss_pred             cCCCeeEe-eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec-
Q psy15820         17 PRQHIKVF-DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-   94 (230)
Q Consensus        17 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~-   94 (230)
                      ...+|.+. +.||+|+||.||+|.+     ..++..||+|+++..      ..+.+|+.++.....||||+++++++.. 
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFN-----KRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEE-----cCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            44567776 7899999999999998     455667999998642      3466788888555459999999999876 


Q ss_pred             ---CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC-------------
Q psy15820         95 ---KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR-------------  158 (230)
Q Consensus        95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~-------------  158 (230)
                         ....+++|||+++++|.+++....           ...+++..+..++.|++.||.|||++++.             
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  152 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRG-----------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS  152 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCT-----------TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEec
Confidence               567899999999999999998742           23589999999999999999999999810             


Q ss_pred             ----------------------------------------CCcc----------------------CCCC----CcCcHH
Q psy15820        159 ----------------------------------------DGYR----------------------LEKP----DHCRRE  172 (230)
Q Consensus       159 ----------------------------------------~~~~----------------------~~~p----~~~~~~  172 (230)
                                                              .|..                      ...|    ..++++
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (299)
T 3m2w_A          153 KRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE  232 (299)
T ss_dssp             SSTTCCEEECCCTTCEECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHH
T ss_pred             CCCCCcEEEeccccccccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHH
Confidence                                                    0000                      0111    467899


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        173 LYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       173 ~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      +.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          233 VKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcC
Confidence            9999999999999999999999873

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.91  E-value=1.2e-23  Score=169.07  Aligned_cols=124  Identities=22%  Similarity=0.427  Sum_probs=103.1

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .-.--.++|++.+.||+|+||.||+|.+.      ++..||+|+++.. ........+.+|+.++..+. ||||++++++
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~   87 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDV   87 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeE
Confidence            34456789999999999999999999872      2556999998643 22334567889999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..++||||+++ +|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        88 ~~~~~~~~lv~e~~~~-~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~  139 (311)
T 3niz_A           88 IHSERCLTLVFEFMEK-DLKKVLDEN------------KTGLQDSQIKIYLYQLLRGVAHCHQHR  139 (311)
T ss_dssp             ECCSSCEEEEEECCSE-EHHHHHHTC------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EccCCEEEEEEcCCCC-CHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999985 888887763            234899999999999999999999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.91  E-value=3.9e-24  Score=179.92  Aligned_cols=125  Identities=22%  Similarity=0.354  Sum_probs=98.3

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...+..++|++.+.||+|+||.||+|.+     ..++..||+|+++..  ........+.+|+.++..+. ||||+++++
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~  215 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKE-----KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKY  215 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEE
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEE-----cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEE
Confidence            3456778899999999999999999998     556677999998632  23344567888999999999 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      ++...+.+++||||+++|+|.+++....             .+++..+..++.||+.||.|||+ ++
T Consensus       216 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~g  269 (446)
T 4ejn_A          216 SFQTHDRLCFVMEYANGGELFFHLSRER-------------VFSEDRARFYGAEIVSALDYLHSEKN  269 (446)
T ss_dssp             EEEETTEEEEEECCCSSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred             EEeeCCEEEEEEeeCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence            9999999999999999999999987642             48999999999999999999998 76

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.91  E-value=3.1e-23  Score=168.71  Aligned_cols=123  Identities=16%  Similarity=0.263  Sum_probs=105.9

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCC--CceeeEe
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPH--PNVVRLL   89 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h--~niv~l~   89 (230)
                      ...+..++|++.+.||+|+||.||++...      ++..||+|++... ........+.+|+.++..+. |  +||++++
T Consensus         3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~iv~~~   75 (343)
T 3dbq_A            3 CISVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRLY   75 (343)
T ss_dssp             CEESSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHT-TTCTTBCCEE
T ss_pred             eeeeecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhh-hcCCceEEEe
Confidence            35678889999999999999999999772      2456999998633 45566678999999999998 5  9999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++...+..+++|| +.+++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~  128 (343)
T 3dbq_A           76 DYEITDQYIYMVME-CGNIDLNSWLKKK-------------KSIDPWERKSYWKNMLEAVHTIHQHG  128 (343)
T ss_dssp             EEEECSSEEEEEEC-CCSEEHHHHHHHS-------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEeeCCEEEEEEe-CCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999 5678999999873             24889999999999999999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.91  E-value=1.3e-23  Score=171.39  Aligned_cols=119  Identities=22%  Similarity=0.357  Sum_probs=97.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ...++|++.+.||+|+||.||+|.+     ..++..||+|+++...   ....+.+|+.++..+. |+||+++++++...
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  120 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQ-----KGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP  120 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEC-------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEE-----CCCCcEEEEEEeccch---hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence            3456799999999999999999998     4455679999987432   3356788999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~  168 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEK-------------GYYSERDAADAVKQILEAVAYLHENG  168 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTC-------------SSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CeEEEEEEeCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999988652             24889999999999999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.91  E-value=6.7e-24  Score=173.36  Aligned_cols=127  Identities=23%  Similarity=0.389  Sum_probs=104.8

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..-.+..++|++.+.||+|+||.||+|..     ..++..||+|+++...  .......+..|..++..+..||||++++
T Consensus        13 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~   87 (353)
T 2i0e_A           13 NRDRMKLTDFNFLMVLGKGSFGKVMLSER-----KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH   87 (353)
T ss_dssp             ------CTTEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred             CcCCCchHHcEEEEEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence            33467889999999999999999999998     4566789999986421  1123456788999998885599999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++...+..|+||||++||+|.+++....             .+++..++.++.||+.||.|||+++
T Consensus        88 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~g  141 (353)
T 2i0e_A           88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG-------------RFKEPHAVFYAAEIAIGLFFLQSKG  141 (353)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEcCCEEEEEEeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999998642             4899999999999999999999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=3.5e-23  Score=164.93  Aligned_cols=123  Identities=19%  Similarity=0.309  Sum_probs=106.2

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC----C----HHHHHHHHHHHHHHhhcCCCCceee
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA----G----ERERLDLLQELTVMKTLDPHPNVVR   87 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~~e~~~l~~~~~h~niv~   87 (230)
                      -..++|++.+.||+|+||.||+|.+     ..++..||+|+++...    .    ......+.+|+.++..+.+||||++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIH-----KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             chhhccceeeeecCCCceEEEEEEE-----cCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            3568999999999999999999998     5566779999986432    1    2335678899999999966999999


Q ss_pred             EeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         88 LLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        88 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++++...+..+++|||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~  144 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV-------------TLSEKETRKIMRALLEVICALHKLN  144 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999899999999999999999998642             4899999999999999999999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.91  E-value=2.8e-24  Score=175.09  Aligned_cols=126  Identities=25%  Similarity=0.417  Sum_probs=104.3

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...+..++|++.+.||+|+||.||+|.+     +.++..||+|+++...  .......+..|..++..+..||||+++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~   85 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEF-----KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC   85 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEE-----TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence            3567889999999999999999999998     5567789999986421  11224567788999988734999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+..++||||++||+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~  138 (345)
T 1xjd_A           86 TFQTKENLFFVMEYLNGGDLMYHIQSCH-------------KFDLSRATFYAAEIILGLQFLHSKG  138 (345)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999998642             4899999999999999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=2.4e-23  Score=170.28  Aligned_cols=130  Identities=18%  Similarity=0.306  Sum_probs=109.1

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC----CCCc
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----PHPN   84 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~----~h~n   84 (230)
                      .+-.+..+-.++|++.+.||+|+||.||+|.+     ..++..||+|+++.  .......+..|+.++..+.    .|+|
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQH-----IDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEE-----CCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            34445556778999999999999999999998     45566799999874  2445566778999988875    4999


Q ss_pred             eeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820         85 VVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus        85 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      |+++++++...+..++||||+ +++|.+++....           ...+++..+..++.||+.||.|||++++
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~~i  158 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-----------YNGFHIEDIKLYCIEILKALNYLRKMSL  158 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            999999999999999999999 899999998742           2348899999999999999999999983

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.91  E-value=1.4e-23  Score=169.25  Aligned_cols=130  Identities=19%  Similarity=0.447  Sum_probs=107.0

Q ss_pred             CCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820          9 KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus         9 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      .+...+.....+|++.+.||+|+||.||+|.+     ..++..||+|++.....  ....+.+|+.++..+..|+||+++
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~   86 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRH-----VKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATY   86 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEE-----CCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeee
Confidence            34445666788999999999999999999998     44566799999864322  235688999999999449999999


Q ss_pred             eeEEec------CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         89 LGCCTE------KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        89 ~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++..      .+..+++|||+++++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~~  149 (326)
T 2x7f_A           87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----------GNTLKEEWIAYICREILRGLSHLHQHK  149 (326)
T ss_dssp             EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-----------GGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999976      457899999999999999998742           124889999999999999999999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=8.9e-24  Score=170.35  Aligned_cols=120  Identities=26%  Similarity=0.432  Sum_probs=104.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----HHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .++|++++.||+|+||.||+|.+     ..++..+|+|+++.....     .....+.+|+.++..+. ||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   84 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCRE-----KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVY   84 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEE-----CCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEE
Confidence            46799999999999999999998     455667999998643211     13567899999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~  135 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQK-------------ESLSEEEATSFIKQILDGVNYLHTKK  135 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC-------------SCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999752             24789999999999999999999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.91  E-value=2.2e-23  Score=165.54  Aligned_cols=123  Identities=28%  Similarity=0.460  Sum_probs=105.0

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ......|++.+.||+|+||.||+|.+     ..++..||+|.+... ........+.+|+.++..+. ||||+++++++.
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   95 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLD-----TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWE   95 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEe-----cCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeec
Confidence            44566789999999999999999988     455667999998633 45666788999999999998 999999999886


Q ss_pred             c----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 E----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .    ...+++||||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~  149 (290)
T 1t4h_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRFK-------------VMKIKVLRSWCRQILKGLQFLHTRT  149 (290)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             cccCCCceEEEEEEecCCCCHHHHHHHcc-------------CCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            5    345899999999999999997642             4889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.91  E-value=1.6e-23  Score=166.62  Aligned_cols=167  Identities=23%  Similarity=0.372  Sum_probs=134.9

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+....+++.....||+|+||.||+|.+     ..++..||+|.+.... ......+.+|+.++..+. |+||+++++++
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~   88 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRD-----LSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLK-HKNIVQYLGSF   88 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEE-----TTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEE-----CCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCC-CCCEeeEeeEE
Confidence            3455566666667999999999999998     4556679999986442 344567889999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      ...+..++++||+++++|.+++....          ....+++..+..++.|++.||.|||+++                
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~  158 (295)
T 2clq_A           89 SENGFIKIFMEQVPGGSLSALLRSKW----------GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY  158 (295)
T ss_dssp             EETTEEEEEEECCSEEEHHHHHHHTT----------CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred             EeCCcEEEEEEeCCCCCHHHHHHhhc----------cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC
Confidence            99999999999999999999998642          1224678889999999999999999998                


Q ss_pred             -----------------------------------------------------------C--------------------
Q psy15820        157 -----------------------------------------------------------V--------------------  157 (230)
Q Consensus       157 -----------------------------------------------------------i--------------------  157 (230)
                                                                                 +                    
T Consensus       159 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  238 (295)
T 2clq_A          159 SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV  238 (295)
T ss_dssp             TCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH
T ss_pred             CCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh
Confidence                                                                       0                    


Q ss_pred             -CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        158 -RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       158 -~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                       .....+..|..+++++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             001123456678999999999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.91  E-value=1.6e-23  Score=170.82  Aligned_cols=119  Identities=21%  Similarity=0.468  Sum_probs=102.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.|++.+.||+|+||.||+|..     ..++..||+|++...  ........+.+|+.++..+. ||||+++++++...+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARD-----VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEE-----ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence            4589999999999999999998     456778999998643  23344567899999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..++||||+. |+|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~  174 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH------------KKPLQEVEIAAVTHGALQGLAYLHSHN  174 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEecCC-CCHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999998 5888888653            235899999999999999999999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.91  E-value=6e-24  Score=180.65  Aligned_cols=121  Identities=25%  Similarity=0.487  Sum_probs=105.0

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      -.++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. ||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   93 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKD-----RITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEE-----TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEE-----CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence            457899999999999999999998     455667999998532 11223467889999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++|||||++++|.+.+....             .+++..+..++.||+.||.|||+++
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~qi~~al~~lH~~~  141 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRK-------------RFSEHDAARIIKQVFSGITYMHKHN  141 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999887642             4899999999999999999999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.91  E-value=8.3e-24  Score=167.34  Aligned_cols=120  Identities=28%  Similarity=0.457  Sum_probs=103.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----HHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..+|+|+++.....     .....+.+|+.++..+. ||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~   77 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQ-----KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIF   77 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEE-----cCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhhee
Confidence            35799999999999999999998     445667999998543211     13567899999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..+++|||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~~  128 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEKE-------------SLTEDEATQFLKQILDGVHYLHSKR  128 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99899999999999999999997632             4899999999999999999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.91  E-value=1.6e-23  Score=178.29  Aligned_cols=118  Identities=25%  Similarity=0.448  Sum_probs=99.2

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +|++++.||+|+||.||+|.+     ..++..+|+|+++.. ........+.+|+.++..+. ||||+++++++...+..
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRD-----KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEE-----TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             CeEEeeEEecCCCEEEEEEEE-----CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence            699999999999999999998     455667999998643 22333567889999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|||||++|+|.+.+....             .+++..+..++.||+.||.|||+++
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~  156 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRM-------------KFNEVDAAVIIKQVLSGVTYLHKHN  156 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEecCCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999887642             4889999999999999999999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.91  E-value=1.4e-23  Score=170.06  Aligned_cols=117  Identities=22%  Similarity=0.437  Sum_probs=91.4

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHH--HhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV--MKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~~~~h~niv~l~~   90 (230)
                      ...+..++|++.+.||+|+||.||+|...       +..||+|+++...    ...+..|.++  +..+. |+||+++++
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~-h~~i~~~~~   74 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSLD-------ERPVAVKVFSFAN----RQNFINEKNIYRVPLME-HDNIARFIV   74 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEET-------TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEE
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEEC-------CeEEEEEEeeccc----hhhHHHHHHHHHHHhcc-Ccchhhhee
Confidence            35688899999999999999999999762       3469999986331    2233344444  44577 999999998


Q ss_pred             EEec-----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         91 CCTE-----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        91 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      .+..     ...+++||||+++|+|.+++...              ..++..++.++.|++.||.|||++
T Consensus        75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~  130 (336)
T 3g2f_A           75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------------TSDWVSSCRLAHSVTRGLAYLHTE  130 (336)
T ss_dssp             EEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred             cccccccCCCceEEEEEecCCCCcHHHHHhhc--------------ccchhHHHHHHHHHHHHHHHHHhh
Confidence            5532     23578999999999999999763              257889999999999999999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.91  E-value=1.4e-23  Score=165.65  Aligned_cols=119  Identities=21%  Similarity=0.324  Sum_probs=103.0

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..+|+|.+..... .....+.+|+.++..+. ||||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQ-----KGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEe-----CCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence            35699999999999999999998     44556699998864322 22467889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~~i~~~l~~lH~~~  126 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKR-------------VFRESDAARIMKDVLSAVAYCHKLN  126 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEeccCCCcHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999887642             4899999999999999999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.91  E-value=2.4e-23  Score=169.43  Aligned_cols=116  Identities=17%  Similarity=0.379  Sum_probs=100.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||+|.+     +.++..+|+|+++....     ...+|++++..+..||||+++++++.+.+.
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIH-----KATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            46799999999999999999998     55677899999964322     234678888887459999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++||||+++|+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~g  136 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ-------------KFFSEREASAVLFTITKTVEYLHAQG  136 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-------------TTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEeCCCCCcHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999998763             24899999999999999999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.91  E-value=3.3e-23  Score=167.31  Aligned_cols=132  Identities=20%  Similarity=0.414  Sum_probs=108.1

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHH-HHhhcCCCCceeeE
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT-VMKTLDPHPNVVRL   88 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~~~~h~niv~l   88 (230)
                      ....|.+..++|++.+.||+|+||.||+|.+     ..++..||+|+++..........+..|+. ++..+. ||||+++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~-h~niv~~   86 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVH-----KPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD-CPYIVQF   86 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEE-----TTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCC-CTTBCCE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEE-----cCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCC-CCcEeee
Confidence            4566899999999999999999999999998     45667899999976555555566777777 555666 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      ++++...+..+++|||+++ +|.+++......        ....+++..+..++.|++.||.|||++ +
T Consensus        87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  146 (327)
T 3aln_A           87 YGALFREGDCWICMELMST-SFDKFYKYVYSV--------LDDVIPEEILGKITLATVKALNHLKENLK  146 (327)
T ss_dssp             EEEEECSSEEEEEECCCSE-EHHHHHHHHHHT--------TCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             eeEEEeCCceEEEEeecCC-ChHHHHHHHHhh--------hcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence            9999999999999999985 888887753210        134588999999999999999999998 6

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.91  E-value=2.6e-23  Score=166.87  Aligned_cols=121  Identities=25%  Similarity=0.534  Sum_probs=98.2

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ....++|++.+.||+|+||.||+|.+     ..++..||+|.+.....   ...+.+|+.++..+. |+||+++++++..
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   95 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIH-----KETGQIVAIKQVPVESD---LQEIIKEISIMQQCD-SPHVVKYYGSYFK   95 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEE-----TTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEE-----CCCCCEEEEEecCchHH---HHHHHHHHHHHHhCC-CCCCccEEEEEEe
Confidence            45678899999999999999999988     45566799999864322   346889999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+..+++|||+++++|.+++...            ...+++..+..++.|++.||.|||+.+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~  145 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLR------------NKTLTEDEIATILQSTLKGLEYLHFMR  145 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEEEEeecCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            89999999999999999998753            235899999999999999999999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.91  E-value=4.9e-23  Score=164.71  Aligned_cols=119  Identities=24%  Similarity=0.413  Sum_probs=101.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|.+.+.||+|+||.||++.+     ..++..+|+|+++... ......+.+|+.++..+. ||||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQ-----RLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIK-HENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEECC-------HHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             hccceeeeeccCCCCceEEEEEE-----CCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCC-CCCeeehhhhcccCCE
Confidence            45789999999999999999998     4456679999997432 223356889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~  126 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERG-------------VYTEKDASLVIQQVLSAVKYLHENG  126 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEcCCCccHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999987642             4889999999999999999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=5.3e-23  Score=168.92  Aligned_cols=118  Identities=24%  Similarity=0.441  Sum_probs=96.2

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. |+||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVD-----GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEE-----TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEE-----CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence            46899999999999999999998     456667999999543 44556678999999999999 999999999997653


Q ss_pred             ------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            .++++|||+ +++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~  148 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKHE--------------KLGEDRIQFLVYQMLKGLRYIHAAG  148 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                  469999999 78999998752              3889999999999999999999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.91  E-value=3.3e-23  Score=170.53  Aligned_cols=115  Identities=31%  Similarity=0.504  Sum_probs=95.4

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEE
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIM  102 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~  102 (230)
                      ..+.||+|+||.||+|..     ..++..||+|+++.. .......+.+|+.++..+. ||||+++++++...+..++||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~-----~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEE-----TATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             EEEECC-----CEEEEEE-----TTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEecCcCEEEEEEEE-----cCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEE
Confidence            367899999999999998     455667999998753 2345678999999999998 999999999999999999999


Q ss_pred             ecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        103 EYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       103 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++++|.+++....            ..+++..++.++.||+.||.|||+++
T Consensus       166 E~~~~~~L~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~  207 (373)
T 2x4f_A          166 EYVDGGELFDRIIDES------------YNLTELDTILFMKQICEGIRHMHQMY  207 (373)
T ss_dssp             ECCTTCEEHHHHHHTG------------GGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eCCCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999887632            24889999999999999999999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.91  E-value=1.6e-23  Score=177.84  Aligned_cols=123  Identities=25%  Similarity=0.430  Sum_probs=106.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.++..+. ||||+++++++
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   95 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKD-----KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFF   95 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEE-----CCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence            34556899999999999999999998     4566679999985331  2334567899999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..++|+||+.+|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~  146 (484)
T 3nyv_A           96 EDKGYFYLVGEVYTGGELFDEIISR-------------KRFSEVDAARIIRQVLSGITYMHKNK  146 (484)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC-------------SCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999988763             34899999999999999999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.91  E-value=4.2e-23  Score=169.26  Aligned_cols=179  Identities=15%  Similarity=0.174  Sum_probs=135.8

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHH----------HHHHHHHHHHHhhcCCCCc
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE----------RLDLLQELTVMKTLDPHPN   84 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~~~~h~n   84 (230)
                      .+...+|++++.||+|+||.||+|.+........+..||+|++........          ...+..|+..+..+. |+|
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~  109 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLG  109 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCC
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCC
Confidence            356679999999999999999999886544333456799999864321110          012334555566777 999


Q ss_pred             eeeEeeEEecC----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----
Q psy15820         85 VVRLLGCCTEK----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----  156 (230)
Q Consensus        85 iv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----  156 (230)
                      |+++++++...    ...+++|||+ +++|.+++...            ...+++..++.++.||+.||.|||+++    
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHr  176 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN------------AKRFSRKTVLQLSLRILDILEYIHEHEYVHG  176 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEe
Confidence            99999998764    3489999999 99999999873            235899999999999999999999998    


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       177 Dlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  256 (364)
T 3op5_A          177 DIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT  256 (364)
T ss_dssp             CCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh
Confidence                                                                                         000


Q ss_pred             CccC-----------------------------CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccc
Q psy15820        160 GYRL-----------------------------EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD  207 (230)
Q Consensus       160 ~~~~-----------------------------~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~  207 (230)
                      |..+                             ..+..+++++.+++..||+.||++|||+.+|++.|..++.....
T Consensus       257 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          257 GHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             SCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            1100                             01145688999999999999999999999999999999876443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.91  E-value=5.3e-23  Score=163.33  Aligned_cols=118  Identities=23%  Similarity=0.399  Sum_probs=100.3

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|+||.||+|.+.      ++..+|+|++.... .......+.+|+.++..+. ||||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCe
Confidence            68999999999999999999872      24469999986432 2223456889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++|||+++ +|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVC------------EGGLESVTAKSFLLQLLNGIAYCHDRR  120 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTS------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEecCC-CHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999985 898888753            235889999999999999999999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.91  E-value=4e-23  Score=163.90  Aligned_cols=121  Identities=25%  Similarity=0.487  Sum_probs=104.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..++|++.+.||+|+||.||+|..     ..++..||+|++... ........+.+|+.++..+. ||||+++++++...
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   93 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKD-----RITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDS   93 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEE-----cCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCC
Confidence            346899999999999999999998     445667999998532 22334567889999999998 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++++||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~~  141 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRK-------------RFSEHDAARIIKQVFSGITYMHKHN  141 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CeEEEEEEccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999887642             4889999999999999999999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.90  E-value=7e-23  Score=169.50  Aligned_cols=123  Identities=16%  Similarity=0.272  Sum_probs=104.6

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCC-CCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDP-HPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~-h~niv~l~~~   91 (230)
                      ..+..++|++.+.||+|+||.||++...     . +..||+|++... ........+.+|+.++..+.. |+||++++++
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-----~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~  124 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNE-----K-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY  124 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-----T-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcC-----C-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence            3456677999999999999999999872     2 556999998643 455667889999999999973 6999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+.+++||| +.+++|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus       125 ~~~~~~~~lv~E-~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~~  175 (390)
T 2zmd_A          125 EITDQYIYMVME-CGNIDLNSWLKKK-------------KSIDPWERKSYWKNMLEAVHTIHQHG  175 (390)
T ss_dssp             EECSSEEEEEEE-CCSEEHHHHHHHC-------------SSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             EecCCEEEEEEe-cCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999 5678999999863             24788899999999999999999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.90  E-value=5.8e-23  Score=163.68  Aligned_cols=118  Identities=25%  Similarity=0.454  Sum_probs=101.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec----
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE----   94 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~----   94 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|+++.  .......+.+|+.++..+. ||||+++++++..    
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   77 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARN-----ALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNF   77 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCC
T ss_pred             ccchhhheeccCCcEEEEEEEE-----cCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcch
Confidence            5789999999999999999998     45566799999864  2455678899999999998 9999999998754    


Q ss_pred             ---------CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 ---------KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                               .+..+++|||+++++|.+++....            ..+++..++.++.|++.||.|||+++
T Consensus        78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~  136 (303)
T 1zy4_A           78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN------------LNQQRDEYWRLFRQILEALSYIHSQG  136 (303)
T ss_dssp             CC------CEEEEEEEEECCCSCBHHHHHHHSC------------GGGCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhcccccCCceEEEEecCCCCCHHHhhhccc------------cccchHHHHHHHHHHHHHHHHHHhCC
Confidence                     346899999999999999998632            23678899999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.90  E-value=5.2e-23  Score=165.28  Aligned_cols=121  Identities=22%  Similarity=0.390  Sum_probs=103.0

Q ss_pred             cCCCeeEe-eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVF-DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..+.|++. +.||+|+||.||+|.+     ..++..||+|++.... ......+.+|+.++..+.+||||+++++++...
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCIN-----LITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEEC-----SSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceeEEecCceecCCceEEEEEEEE-----cCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            34678884 7899999999999988     4556679999996432 233467889999998864499999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++||||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~  131 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRR-------------HFNELEASVVVQDVASALDFLHNKG  131 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEEEEcCCCCcHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999998742             4889999999999999999999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.90  E-value=1.1e-23  Score=169.57  Aligned_cols=125  Identities=22%  Similarity=0.419  Sum_probs=91.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. ||||+++++++...+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLN-----KTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEEC-----SSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEE-----CCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCe
Confidence            46899999999999999999988     45566799999965433334456889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++||||++ ++|.+++......       .....+++..+..++.||+.||.|||+++
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~  128 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVG-------NTPRGLELNLVKYFQWQLLQGLAFCHENK  128 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSS-------SCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEecC-CCHHHHHHhcccc-------ccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999998 5999998874311       11234889999999999999999999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.90  E-value=1.8e-23  Score=168.97  Aligned_cols=110  Identities=22%  Similarity=0.393  Sum_probs=97.1

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEec
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +.||+|+||.||+|.+     ..++..||+|++...    ....+.+|+.++..+.+||||+++++++......++||||
T Consensus        17 ~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~   87 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVH-----KKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL   87 (325)
T ss_dssp             CCSEEETTEEEEEEEE-----TTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CccccCCCeEEEEEEE-----CCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence            7899999999999998     455667999998632    2356778999999987799999999999999999999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++|+|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        88 ~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~  126 (325)
T 3kn6_A           88 LNGGELFERIKKK-------------KHFSETEASYIMRKLVSAVSHMHDVG  126 (325)
T ss_dssp             CCSCBHHHHHHHC-------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999863             24899999999999999999999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=3.8e-23  Score=167.37  Aligned_cols=113  Identities=22%  Similarity=0.464  Sum_probs=93.2

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhc--CCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL--DPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~--~~h~niv~l~~~~~~   94 (230)
                      -.++|++.+.||+|+||.||+|.+.       +..||+|++...    ....+..|.+++...  . |+||+++++++..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~  102 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-------GEKVAVKVFFTT----EEASWFRETEIYQTVLMR-HENILGFIAADIK  102 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-------CceEEEEEEecc----ccchhhhHHHHHHHHhhc-CCCeeeEEEEEcc
Confidence            3468999999999999999999873       456999998532    123344555555544  6 9999999999987


Q ss_pred             C----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         95 K----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        95 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                      .    ...+++|||+++|+|.+++...              .+++..++.++.|++.||.|||++
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~~i~~~l~~lH~~  153 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST--------------TLDAKSMLKLAYSSVSGLCHLHTE  153 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHSC
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHHh
Confidence            6    6789999999999999999753              388999999999999999999988

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.90  E-value=9.2e-24  Score=171.42  Aligned_cols=161  Identities=20%  Similarity=0.316  Sum_probs=133.0

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-------HHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-------ERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++....       ......+.+|+.++..+. ||||+++++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~   96 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVD-----KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLD   96 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEE-----TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEE
T ss_pred             ccceEEEeEEEecCCEEEEEEEE-----CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence            35799999999999999999998     55677899999864321       112345778999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCC-CHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         91 CCTEKEPFFVIMEYVPYG-KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      ++...+..+++|||+.+| +|.+++...             ..+++..+..++.|++.||.|||+++             
T Consensus        97 ~~~~~~~~~lv~e~~~~g~~l~~~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  163 (335)
T 3dls_A           97 IFENQGFFQLVMEKHGSGLDLFAFIDRH-------------PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI  163 (335)
T ss_dssp             EEECSSEEEEEEECCTTSCBHHHHHHTC-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             EEeeCCEEEEEEEeCCCCccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE
Confidence            999999999999998766 999998763             24899999999999999999999998             


Q ss_pred             -----------------------------------------------------------CC------------CCccCCC
Q psy15820        157 -----------------------------------------------------------VR------------DGYRLEK  165 (230)
Q Consensus       157 -----------------------------------------------------------i~------------~~~~~~~  165 (230)
                                                                                 +.            .......
T Consensus       164 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  243 (335)
T 3dls_A          164 AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP  243 (335)
T ss_dssp             CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCC
T ss_pred             cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCC
Confidence                                                                       00            0012234


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                      |..+++++.+|+.+||+.||++|||+.++++.
T Consensus       244 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            55688999999999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.90  E-value=2.2e-23  Score=166.27  Aligned_cols=112  Identities=21%  Similarity=0.427  Sum_probs=92.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhh--cCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT--LDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~~h~niv~l~~~~~   93 (230)
                      +..++|++.+.||+|+||.||+|.+.       +..||+|++...    ....+..|.+++..  +. ||||+++++++.
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~   72 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQ-------GENVAVKIFSSR----DEKSWFRETELYNTVMLR-HENILGFIASDM   72 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEET-------TEEEEEEEECGG----GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEEC-------CEEEEEEEeccc----cchhhHHHHHHHHHhhcc-CcCeeeEEEeec
Confidence            45678999999999999999999873       345999998643    23445667777766  66 999999999865


Q ss_pred             c----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhh
Q psy15820         94 E----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS  153 (230)
Q Consensus        94 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH  153 (230)
                      .    ....+++|||+++|+|.+++..              ..+++..++.++.|++.||.|||
T Consensus        73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--------------~~~~~~~~~~i~~~i~~~l~~lH  122 (301)
T 3q4u_A           73 TSRHSSTQLWLITHYHEMGSLYDYLQL--------------TTLDTVSCLRIVLSIASGLAHLH  122 (301)
T ss_dssp             EEETTEEEEEEEECCCTTCBHHHHHTT--------------CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCCCceeEEehhhccCCCHHHHHhh--------------cccCHHHHHHHHHHHHHHHHHHH
Confidence            4    2458999999999999999854              24899999999999999999999

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=1.5e-23  Score=170.36  Aligned_cols=134  Identities=19%  Similarity=0.302  Sum_probs=102.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc----CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN----AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      -.++|++.+.||+|+||.||+|.+     ..++..+|+|++...    ........+.+|+.++..+. ||||+++++++
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   97 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIE-----NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY   97 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhheeecceeeecCCeEEEEEEE-----CCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence            457799999999999999999988     455667999998532    13345678999999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhh---------------------------hccccCCCCCCCChHHHHHHHHHH
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQR---------------------------YYNNMHGKSNSLTSRDLTSFCYQV  145 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~i~~qi  145 (230)
                      ...+..++||||+++|+|.+++.......                           ...........+++..+..++.|+
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            99999999999999999999885211000                           000000001124567788999999


Q ss_pred             HhhhhhhhhcC
Q psy15820        146 ARGMQFLSSRG  156 (230)
Q Consensus       146 ~~gl~~LH~~~  156 (230)
                      +.||.|||+++
T Consensus       178 ~~~l~~LH~~~  188 (345)
T 3hko_A          178 FSALHYLHNQG  188 (345)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHHCC
Confidence            99999999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.90  E-value=4.7e-23  Score=166.71  Aligned_cols=120  Identities=14%  Similarity=0.157  Sum_probs=102.8

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++.+.||+|+||.||+|.+     ..++..||+|++.....   ...+.+|+.++..+..|+||+++++++...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKN-----LYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEE-----TTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEE-----CCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            4568899999999999999999998     55677899999864322   235778999999994499999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +..++||||+ +++|.+++...            ...+++..++.++.|++.||.|||+++
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~  125 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLC------------DRTFSLKTVLMIAIQLISRMEYVHSKN  125 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CccEEEEEeC-CCCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999 89999999863            235899999999999999999999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.90  E-value=6.5e-24  Score=171.46  Aligned_cols=119  Identities=23%  Similarity=0.458  Sum_probs=99.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. |+||+++++++...+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKS-----KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEE-----CCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence            6899999999999999999998     45566799999975433333334567999999998 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++||||++ |+|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        76 ~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~~  120 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDC------------GNIINMHNVKLFLFQLLRGLAYCHRQK  120 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecccc-cCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999998 5899988763            234889999999999999999999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.90  E-value=1.1e-22  Score=163.34  Aligned_cols=131  Identities=15%  Similarity=0.234  Sum_probs=108.3

Q ss_pred             CCCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCC-CC
Q psy15820          6 LNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDP-HP   83 (230)
Q Consensus         6 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~-h~   83 (230)
                      -.........+..++|++.+.||+|+||.||++.+.      ++..+|+|++... ........+.+|+.++..+.. |+
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~   88 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD   88 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCT
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCC
Confidence            344455667888899999999999999999999872      2556999998643 455667789999999999973 59


Q ss_pred             ceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         84 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        84 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ||+++++++...+..+++|| +.+++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        89 ~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~  147 (313)
T 3cek_A           89 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-------------KSIDPWERKSYWKNMLEAVHTIHQHG  147 (313)
T ss_dssp             TBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-------------SSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999 5678999999863             24789999999999999999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.90  E-value=3e-23  Score=167.94  Aligned_cols=124  Identities=25%  Similarity=0.492  Sum_probs=107.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      +.-..++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. |+||+++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   93 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRN-----KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVC   93 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEE-----TTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEE-----CCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEe
Confidence            455788999999999999999999998     455667999998533 34555677889999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..+++|||+++++|..+....             ..+++..+..++.|++.||.|||+++
T Consensus        94 ~~~~~~~lv~e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~LH~~~  144 (331)
T 4aaa_A           94 KKKKRWYLVFEFVDHTILDDLELFP-------------NGLDYQVVQKYLFQIINGIGFCHSHN  144 (331)
T ss_dssp             EETTEEEEEEECCSEEHHHHHHHST-------------TCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ecCCEEEEEEecCCcchHHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999998888776542             34899999999999999999999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.90  E-value=2.5e-23  Score=171.15  Aligned_cols=123  Identities=20%  Similarity=0.410  Sum_probs=96.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHH-HhhcCCCCceeeEeeE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTV-MKTLDPHPNVVRLLGC   91 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~-l~~~~~h~niv~l~~~   91 (230)
                      .+..++|++.+.||+|+||.||+|.+     +.++..+|+|+++..  ........+..|..+ +..+. ||||++++++
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~  107 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARH-----KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFS  107 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEE-----TTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEE-----cCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEE
Confidence            46778999999999999999999998     455667999999643  223334556777776 45666 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..|+||||++||+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus       108 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~g  159 (373)
T 2r5t_A          108 FQTADKLYFVLDYINGGELFYHLQRER-------------CFLEPRARFYAAEIASALGYLHSLN  159 (373)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999988642             4889999999999999999999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.90  E-value=2.1e-23  Score=168.66  Aligned_cols=124  Identities=22%  Similarity=0.361  Sum_probs=103.0

Q ss_pred             cCCCeeEe-eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVF-DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ....|.+. +.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+.++..+..||||+++++++..
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCIS-----KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEE-----CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            34456665 8899999999999998     455667999998643 2333456789999999999768999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+..++||||+++|+|.+++...           ....+++..++.++.|++.||.|||+++
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~i~~ql~~~L~~LH~~g  151 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPE-----------LAEMVSENDVIRLIKQILEGVYYLHQNN  151 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSC-----------C-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCcHHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999998887542           1245899999999999999999999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=4.6e-23  Score=166.54  Aligned_cols=115  Identities=19%  Similarity=0.377  Sum_probs=100.4

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|+++...    ...+.+|+.++..+.+|+||+++++++..  
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAIN-----ITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CCCceEEEEEecccCCeEEEEEEE-----CCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            457899999999999999999998     4556679999987432    35688999999999779999999999987  


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ....+++|||+++++|.+++..                +++..+..++.|++.||.|||+++
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~~----------------~~~~~~~~~~~qi~~~l~~lH~~~  150 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQT----------------LTDYDIRFYMYEILKALDYCHSMG  150 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGGG----------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCceEEEEeccCchhHHHHHHh----------------CCHHHHHHHHHHHHHHHHHHHhCC
Confidence            5678999999999999888743                788999999999999999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.90  E-value=5.4e-23  Score=164.33  Aligned_cols=162  Identities=25%  Similarity=0.444  Sum_probs=129.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe-
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLGCCT-   93 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~-   93 (230)
                      ..+|++++.||+|+||.||++.+     ..++..+|+|+++...   .......+.+|+.++..+. |+||+++++++. 
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   77 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLD-----SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYN   77 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEB-----TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             ccceeEeeEEecCCCeEEEEEEE-----CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEc
Confidence            46899999999999999999988     4556679999986431   1234567899999999998 999999999984 


Q ss_pred             -cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         94 -EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        94 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                       .....+++|||++++ |.+++....           ...+++..+..++.|++.||.|||+++                
T Consensus        78 ~~~~~~~lv~e~~~~~-l~~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~  145 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCG-MQEMLDSVP-----------EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG  145 (305)
T ss_dssp             C---CEEEEEECCSEE-HHHHHHHST-----------TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred             CCCCeEEEEehhccCC-HHHHHHhCc-----------ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC
Confidence             455789999999876 777776532           235899999999999999999999998                


Q ss_pred             ------------------------------------------------------------CCCC----------------
Q psy15820        157 ------------------------------------------------------------VRDG----------------  160 (230)
Q Consensus       157 ------------------------------------------------------------i~~~----------------  160 (230)
                                                                                  +..|                
T Consensus       146 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  225 (305)
T 2wtk_C          146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI  225 (305)
T ss_dssp             CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH
Confidence                                                                        0000                


Q ss_pred             --ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy15820        161 --YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDL  197 (230)
Q Consensus       161 --~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~  197 (230)
                        .....|..+++++.+++.+||+.||.+|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          226 GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              1123456788999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.90  E-value=4.6e-22  Score=158.17  Aligned_cols=168  Identities=15%  Similarity=0.238  Sum_probs=133.5

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee-EEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG-CCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~-~~~~~   95 (230)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|++......   ..+.+|+.++..+. |++++..+. +....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~   77 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTD-----IAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQ-GGVGIPTIRWCGAEG   77 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEE-----TTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHT-TSTTCCCEEEEEEET
T ss_pred             eccEEEEEEEEccCCCeEEEEEEE-----cCCCcEEEEEEecCCcch---hHHHHHHHHHHHhh-cCCCCCccccccCCC
Confidence            357899999999999999999998     556778999998643222   34788999999999 666554444 44567


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..+++|||+ +++|.+++...            ...+++..++.++.|++.||.|||+++                   
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~  144 (296)
T 3uzp_A           78 DYNVMVMELL-GPSLEDLFNFC------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG  144 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT
T ss_pred             CceEEEEEec-CCCHHHHHHhh------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC
Confidence            7789999999 89999999753            235899999999999999999999998                   


Q ss_pred             ---------------------------------------------------------------CCCCccC----------
Q psy15820        157 ---------------------------------------------------------------VRDGYRL----------  163 (230)
Q Consensus       157 ---------------------------------------------------------------i~~~~~~----------  163 (230)
                                                                                     +..|..+          
T Consensus       145 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  224 (296)
T 3uzp_A          145 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR  224 (296)
T ss_dssp             TCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS
T ss_pred             CeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh
Confidence                                                                           0000000          


Q ss_pred             -----------CC-----CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        164 -----------EK-----PDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       164 -----------~~-----p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                                 ..     +..+++++.+++.+||+.||.+|||+.++++.|..++....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          225 QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             SHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence                       01     14578899999999999999999999999999999887654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.90  E-value=3.2e-23  Score=173.11  Aligned_cols=120  Identities=21%  Similarity=0.393  Sum_probs=98.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-------CHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..++|.+.+.||+|+||.||+|.+     ..++..||+|++....       .......+.+|+.++..+. ||||++++
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  206 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFE-----RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK  206 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCC
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEE-----CCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEE
Confidence            357899999999999999999998     4556679999985321       1122235789999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++.. +..++||||+++|+|.+++..             ...+++..+..++.|++.||.|||+++
T Consensus       207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~  259 (419)
T 3i6u_A          207 NFFDA-EDYYIVLELMEGGELFDKVVG-------------NKRLKEATCKLYFYQMLLAVQYLHENG  259 (419)
T ss_dssp             EEEES-SEEEEEEECCTTCBGGGGTSS-------------SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEec-CceEEEEEcCCCCcHHHHHhc-------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99854 458999999999999887654             235899999999999999999999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.90  E-value=1.6e-22  Score=164.12  Aligned_cols=110  Identities=23%  Similarity=0.446  Sum_probs=94.8

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhh--cCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKT--LDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~~h~niv~l~~~~~~~   95 (230)
                      .++|++.+.||+|+||.||+|.+.       +..||+|+++..    ....+.+|.+++..  +. ||||+++++++...
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSR----EERSWFREAEIYQTVMLR-HENILGFIAADNKD  108 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECGG----GHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECC
T ss_pred             cccEEEEeeecCCCCcEEEEEEEc-------CccEEEEEeCch----hHHHHHHHHHHHHHhhcC-CCcEEEEEeeeccc
Confidence            478999999999999999999873       446999998632    23567788888887  56 99999999999876


Q ss_pred             C----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhh
Q psy15820         96 E----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS  153 (230)
Q Consensus        96 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH  153 (230)
                      .    ..+++|||+++|+|.+++...              .+++..++.++.|++.||.|||
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~i~~~i~~~l~~lH  156 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLH  156 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--------------CccHHHHHHHHHHHHHHHHHHH
Confidence            5    789999999999999999763              3889999999999999999999

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=7.4e-23  Score=164.98  Aligned_cols=119  Identities=21%  Similarity=0.407  Sum_probs=98.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-------CHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++....       .......+.+|+.++..+. ||||+++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~   82 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFE-----RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKN   82 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEE
T ss_pred             hhceeEeeEEecCCCEEEEEEEE-----cCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEee
Confidence            46799999999999999999998     4566779999986432       1122345789999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++.... .+++|||+++++|.+++...             ..+++..+..++.|++.||.|||+++
T Consensus        83 ~~~~~~-~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~  134 (322)
T 2ycf_A           83 FFDAED-YYIVLELMEGGELFDKVVGN-------------KRLKEATCKLYFYQMLLAVQYLHENG  134 (322)
T ss_dssp             EEESSS-EEEEEECCTTEETHHHHSTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEcCCc-eEEEEecCCCCcHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            987654 89999999999999988652             34899999999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.90  E-value=4.6e-23  Score=165.38  Aligned_cols=165  Identities=24%  Similarity=0.392  Sum_probs=124.4

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----HHHHHHHHHHHHHhhc----CCCC
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTL----DPHP   83 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~----~~h~   83 (230)
                      ......++|++.+.||+|+||.||+|.+     ..++..||+|++......     .....+.+|+.++..+    . |+
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-h~   98 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHR-----LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG-HP   98 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEEC-----TTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCC-CS
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEE-----ccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCC-CC
Confidence            3456678899999999999999999988     455667999999643211     1233466788888888    6 99


Q ss_pred             ceeeEeeEEecCCCeEEEEec-CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------
Q psy15820         84 NVVRLLGCCTEKEPFFVIMEY-VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------  156 (230)
Q Consensus        84 niv~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------  156 (230)
                      ||+++++++...+..++++|+ +.+++|.+++....             .+++..++.++.|++.||.|||+++      
T Consensus        99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  165 (312)
T 2iwi_A           99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-------------PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDI  165 (312)
T ss_dssp             SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHHTEECCCC
T ss_pred             CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence            999999999988899999999 78999999998742             4899999999999999999999998      


Q ss_pred             ------------------------------------------------------------------CCCC----------
Q psy15820        157 ------------------------------------------------------------------VRDG----------  160 (230)
Q Consensus       157 ------------------------------------------------------------------i~~~----------  160 (230)
                                                                                        +..|          
T Consensus       166 kp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  245 (312)
T 2iwi_A          166 KDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI  245 (312)
T ss_dssp             SGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH
T ss_pred             ChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH
Confidence                                                                              0001          


Q ss_pred             --ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        161 --YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       161 --~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                        .....+..+++++.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              112244678889999999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.89  E-value=1.8e-22  Score=170.27  Aligned_cols=119  Identities=20%  Similarity=0.455  Sum_probs=93.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC-
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~-   95 (230)
                      .++|++++.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. |+||+++++++... 
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYD-----KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEE-----CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEE-----CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence            37899999999999999999998     455667999998643 34556678999999999998 99999999998543 


Q ss_pred             ----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                          ..+|+||||+. ++|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus       126 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~  176 (458)
T 3rp9_A          126 VEKFDELYVVLEIAD-SDFKKLFRTP-------------VYLTELHIKTLLYNLLVGVKYVHSAG  176 (458)
T ss_dssp             TTTCCCEEEEECCCS-EEHHHHHHSS-------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccCceEEEEEeccc-cchhhhcccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                56899999985 6899888752             35899999999999999999999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.89  E-value=2.4e-22  Score=159.70  Aligned_cols=167  Identities=16%  Similarity=0.264  Sum_probs=129.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee-EEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG-CCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~-~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++....   ....+.+|+.++..+. |++++..+. ++...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTD-----IAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEE-----TTTTEEEEEEEEEC------CCCHHHHHHHHHHHT-TSTTCCCEEEEEEETT
T ss_pred             CCceEEeeeecCCCCeEEEEEEE-----cCCCceEEEEeecccc---cchHHHHHHHHHHHhc-CCCCCCeeeeecCCCC
Confidence            46899999999999999999998     4566779999875321   2234778999999998 666555444 556677


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR------------------  158 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~------------------  158 (230)
                      ..+++|||+ +++|.+++...            ...+++..+..++.|++.||.|||++++.                  
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~  145 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN  145 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC
Confidence            889999999 89999999853            23489999999999999999999999810                  


Q ss_pred             ----------------------------------------------------------------CCccC-----------
Q psy15820        159 ----------------------------------------------------------------DGYRL-----------  163 (230)
Q Consensus       159 ----------------------------------------------------------------~~~~~-----------  163 (230)
                                                                                      .|..+           
T Consensus       146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  225 (296)
T 4hgt_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  225 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred             eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence                                                                            00000           


Q ss_pred             ----------CCC-----CcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        164 ----------EKP-----DHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       164 ----------~~p-----~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                                ..|     ..+++++.+++.+||+.||++|||+.++++.|..++....
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          226 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence                      001     3458899999999999999999999999999999987754

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.89  E-value=1.8e-22  Score=160.87  Aligned_cols=121  Identities=23%  Similarity=0.505  Sum_probs=100.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++... .......+.+|+.++..+. |+||+++++++...+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   75 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARN-----KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTEN   75 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETT
T ss_pred             cchhhhhhhhccCCCeeEEEEEE-----cCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcC-CCCeeeEEEEEecCC
Confidence            47899999999999999999998     4456679999986432 2223457889999999998 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+++|||++ ++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        76 ~~~lv~e~~~-~~L~~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~  123 (299)
T 2r3i_A           76 KLYLVFEFLH-QDLKKFMDASA-----------LTGIPLPLIKSYLFQLLQGLAFCHSHR  123 (299)
T ss_dssp             EEEEEEECCS-EEHHHHHHHTT-----------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ceEEEEEccc-CCHHHHHHhhh-----------ccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999998 59999988742           234788999999999999999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.89  E-value=2.8e-22  Score=164.37  Aligned_cols=118  Identities=18%  Similarity=0.377  Sum_probs=103.5

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      ..+|++.+.||+|+||.||+|.+     ..++..||+|++...........+.+|+.++..+. |+||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYD-----NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEE-----CCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCc
Confidence            46899999999999999999988     55667799999976556666788999999999999 99999999998754  


Q ss_pred             ---CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ---EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ...++++||+. ++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~  148 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ--------------HLSNDHICYFLYQILRGLKYIHSAN  148 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence               36899999997 4899988753              3899999999999999999999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.89  E-value=1.4e-22  Score=168.30  Aligned_cols=117  Identities=21%  Similarity=0.327  Sum_probs=95.6

Q ss_pred             CCCeeEe-eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         18 RQHIKVF-DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        18 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      .++|.+. +.||+|+||.||+|.+     ..++..||+|+++..      ..+.+|+.++.....|+||+++++++..  
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFN-----KRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEE-----CCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            4567765 7899999999999998     456667999998632      3466788887666559999999998865  


Q ss_pred             --CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 --KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        ...+++|||||++|+|.+++....           ...+++..+..++.||+.||.|||+++
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~  181 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRG-----------DQAFTEREASEIMKSIGEAIQYLHSIN  181 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC--------------CCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence              456899999999999999997631           234899999999999999999999988

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.89  E-value=8.3e-23  Score=168.62  Aligned_cols=122  Identities=30%  Similarity=0.422  Sum_probs=96.2

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ++....+|++++.||+|+||.||+|.+     ..++..||+|++......     ..+|+.++..+. |+||+++++++.
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~-----~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~-hpnIv~l~~~~~   70 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFD-----IESGKRFALKKVLQDPRY-----KNRELDIMKVLD-HVNIIKLVDYFY   70 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEE-----TTTCCEEEEEEEECCTTS-----CCHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEE-----CCCCCEEEEEEEecCcch-----HHHHHHHHHHcC-CCCccchhheee
Confidence            456778999999999999999999998     455667999998643211     236899999998 999999999985


Q ss_pred             cC--------------------------------------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCCh
Q psy15820         94 EK--------------------------------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS  135 (230)
Q Consensus        94 ~~--------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~  135 (230)
                      ..                                      ...++||||++ ++|.+.+.....         ....+++
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~l~~  140 (383)
T 3eb0_A           71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---------SGRSIPM  140 (383)
T ss_dssp             EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHH---------TTCCCCH
T ss_pred             ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---------cCCCCCH
Confidence            43                                      23889999998 588888876422         2345899


Q ss_pred             HHHHHHHHHHHhhhhhhhhcC
Q psy15820        136 RDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus       136 ~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..++.||+.||.|||+++
T Consensus       141 ~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A          141 NLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCc
Confidence            999999999999999999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.89  E-value=1.4e-22  Score=171.23  Aligned_cols=117  Identities=23%  Similarity=0.363  Sum_probs=99.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++++.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. ||||+++++++....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYD-----AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEE-----TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEE-----CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCC
Confidence            57899999999999999999998     556777999999643 34556778999999999998 999999999997653


Q ss_pred             ------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            .+++||||+++ +|.+.+..               .+++..+..++.||+.||.|||+++
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~~---------------~l~~~~~~~~~~qil~aL~~lH~~~  184 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAG  184 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHTS---------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHhh---------------cCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                  46999999986 56665532               3889999999999999999999999

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.89  E-value=2.9e-22  Score=164.40  Aligned_cols=120  Identities=21%  Similarity=0.391  Sum_probs=103.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---C----HHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---G----ERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~----~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .+|++.+.||+|+||.||+|.+     ..++..||+|+++...   .    ......+.+|+.++..+.+||||++++++
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~-----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVH-----RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhcccceEEecCCCEEEEEEEE-----CCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            5689999999999999999998     4456679999985432   1    12355788999999999449999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..++||||+++++|.+++....             .+++..+..++.||+.||.|||+.|
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~g  220 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV-------------ALSEKETRSIMRSLLEAVSFLHANN  220 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999997632             4899999999999999999999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=2e-22  Score=164.14  Aligned_cols=121  Identities=23%  Similarity=0.453  Sum_probs=95.8

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH----HHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE----RERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|+++.....    .....+.+|+.++..+. |+||+++++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   81 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARD-----KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAF   81 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEEC-----SSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             HhcccEEEeEEeecCCEEEEEEEE-----CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence            457899999999999999999988     445667999999643211    12346789999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..+++|||+++ +|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        82 ~~~~~~~lv~e~~~~-~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~  132 (346)
T 1ua2_A           82 GHKSNISLVFDFMET-DLEVIIKDN------------SLVLTPSHIKAYMLMTLQGLEYLHQHW  132 (346)
T ss_dssp             CCTTCCEEEEECCSE-EHHHHHTTC------------CSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeCCceEEEEEcCCC-CHHHHHHhc------------CcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999986 888887652            234788999999999999999999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.89  E-value=4.6e-23  Score=177.30  Aligned_cols=124  Identities=18%  Similarity=0.337  Sum_probs=106.0

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      +..++|++.+.||+|+||.||+|..     ..++..||+|++....  .......+.+|+.++..+. ||||+++++++.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~  254 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYE  254 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEE-----CCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEe
Confidence            6778899999999999999999998     4566779999985321  1122356789999999998 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ..+..++||||++||+|.+++....           ...+++..++.++.||+.||.|||+++
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~-----------~~~l~e~~~~~i~~qIl~aL~yLH~~g  306 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMG-----------QAGFPEARAVFYAAEICCGLEDLHRER  306 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSS-----------SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999987631           234899999999999999999999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.89  E-value=3.3e-22  Score=162.25  Aligned_cols=118  Identities=24%  Similarity=0.367  Sum_probs=92.9

Q ss_pred             ccCCCeeEe-eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHH-HhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVF-DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV-MKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~~~~h~niv~l~~~~~   93 (230)
                      .-.++|++. +.||+|+||.||+|.+     ..++..||+|++...  ..    ..+|+.. +..+. |+||+++++++.
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~--~~----~~~e~~~~~~~~~-h~~i~~~~~~~~   92 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFH-----RRTGQKCALKLLYDS--PK----ARQEVDHHWQASG-GPHIVCILDVYE   92 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEESS--HH----HHHHHHHHHHHTT-STTBCCEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEE-----CCCCCEEEEEEecCc--HH----HHHHHHHHHHhcC-CCChHHHHHHHh
Confidence            455778885 4699999999999998     455667999998642  22    2233333 34445 999999999987


Q ss_pred             c----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 E----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .    ....++||||+++|+|.+++....           ...+++..++.++.|++.||.|||+++
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~ql~~~l~~LH~~~  148 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERG-----------DQAFTEREAAEIMRDIGTAIQFLHSHN  148 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC------------CCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            5    345899999999999999998642           235899999999999999999999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.89  E-value=7.1e-22  Score=165.54  Aligned_cols=119  Identities=18%  Similarity=0.396  Sum_probs=103.8

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC-
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~-   95 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+.++..+. |+||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYD-----KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEE-----TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEE-----CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence            57899999999999999999998     556778999999643 34556678999999999999 99999999999765 


Q ss_pred             ----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                          ..+|+||||+. ++|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~g  149 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTP-------------IFLTEEHIKTILYNLLLGENFIHESG  149 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSS-------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                56899999997 5999998752             34899999999999999999999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=3.5e-23  Score=169.28  Aligned_cols=128  Identities=18%  Similarity=0.343  Sum_probs=105.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---CHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..+..++|++.+.||+|+||.||++.....  ..++..||+|+++...   .......+.+|+.++..+..|+||+++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            345668999999999999999999988431  2456779999986321   11223456678999998844999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+..++||||+++++|.+++....             .+++..+..++.|++.||.|||+++
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~~  179 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQRE-------------RFTEHEVQIYVGEIVLALEHLHKLG  179 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999999999999998642             4889999999999999999999998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.89  E-value=2e-22  Score=164.51  Aligned_cols=122  Identities=15%  Similarity=0.165  Sum_probs=97.3

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCC---CCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceee-----
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGR---EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVR-----   87 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~-----   87 (230)
                      ...++|++.+.||+|+||.||+|.+......   ..+..||+|++...      ..+.+|+.++..+. |+||++     
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            3468999999999999999999998542100   02556999998643      35778999999998 999887     


Q ss_pred             ----------EeeEEec-CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         88 ----------LLGCCTE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        88 ----------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                                +++++.. .+..+++|||+ +++|.+++....           ...+++..++.++.||+.||.|||+++
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~  179 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-----------KHVLSERSVLQVACRLLDALEFLHENE  179 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-----------GGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                      5666665 67789999999 999999998742           135899999999999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.89  E-value=2.4e-23  Score=173.09  Aligned_cols=123  Identities=20%  Similarity=0.343  Sum_probs=105.0

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.+..++|++.+.||+|+||.||+|.+     ..++..+|+|+++....  ......+.+|..++..+. ||||++++++
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~-----~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~  137 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRH-----KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYA  137 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEE-----CCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence            456788999999999999999999998     45566799999853210  011224778999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.+...+++||||++||+|.+++...              .+++..+..++.||+.||.|||+++
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~~e~~~~~~~~qi~~aL~~LH~~g  188 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSNY--------------DVPEKWARFYTAEVVLALDAIHSMG  188 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999998753              3889999999999999999999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.89  E-value=4.4e-22  Score=159.87  Aligned_cols=128  Identities=21%  Similarity=0.445  Sum_probs=95.6

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHH-HHHhhcCCCCceeeE
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL-TVMKTLDPHPNVVRL   88 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~~~~h~niv~l   88 (230)
                      +...|.+..++|++.+.||+|+||.||+|.+     ..++..||+|++...........+..|. .++..+. |+||+++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~   89 (318)
T 2dyl_A           16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRF-----RKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD-CPYIVQC   89 (318)
T ss_dssp             SSSEEECCGGGEEEEEEC------CEEEEEE-----TTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT-CTTBCCE
T ss_pred             cchhhhhhhccccccceeeecCCeeEEEEEE-----ecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCceeeE
Confidence            4556788889999999999999999999998     4456679999997554444444444444 4566666 9999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      ++++...+..+++|||+ ++.+..+....            ...+++..+..++.|++.||.|||++ +
T Consensus        90 ~~~~~~~~~~~lv~e~~-~~~~~~l~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~  145 (318)
T 2dyl_A           90 FGTFITNTDVFIAMELM-GTCAEKLKKRM------------QGPIPERILGKMTVAIVKALYYLKEKHG  145 (318)
T ss_dssp             EEEEECSSEEEEEECCC-SEEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             EEEEecCCcEEEEEecc-CCcHHHHHHHh------------ccCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence            99999999999999999 45555554432            23589999999999999999999995 6

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=7.1e-23  Score=166.72  Aligned_cols=125  Identities=14%  Similarity=0.177  Sum_probs=95.0

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHH----------HHHHHHHHHHHhhcCCCCc
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE----------RLDLLQELTVMKTLDPHPN   84 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~~~~h~n   84 (230)
                      .+..++|++++.||+|+||.||+|.+...  ...+..+|+|++........          ...+.+|+..+..+. |+|
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~n  109 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNK--PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLG  109 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSS--CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCC--CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccC
Confidence            35668999999999999999999998531  12455699999864432211          123567788888888 999


Q ss_pred             eeeEeeEEec----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         85 VVRLLGCCTE----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        85 iv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+++++++..    ....+++|||+ +++|.+++....             .+++..++.++.||+.||.|||+++
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~  171 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-------------TFKKSTVLQLGIRMLDVLEYIHENE  171 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-------------BCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999887    67899999999 999999987532             4899999999999999999999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.89  E-value=4.7e-22  Score=162.06  Aligned_cols=119  Identities=21%  Similarity=0.398  Sum_probs=103.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC-
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK-   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~-   95 (230)
                      -.++|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. |+||+++++++... 
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATH-----KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDS   82 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEE-----CCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccc
Confidence            357899999999999999999998     45667899999976556666778899999999998 99999999987654 


Q ss_pred             ----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                          ...++++||+. ++|.+++...              .+++..+..++.|++.||.|||+++
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~  132 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVISTQ--------------MLSDDHIQYFIYQTLRAVKVLHGSN  132 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCccceEEEEEeccC-ccHHHHHhhc--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                67899999997 5899888752              3889999999999999999999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.89  E-value=1.3e-22  Score=178.48  Aligned_cols=126  Identities=23%  Similarity=0.387  Sum_probs=104.6

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ...+..++|++.+.||+|+||.||+|.+     ..++..||+|+++...  .......+..|..++..+..|++|+.+++
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~-----~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSER-----KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEE-----SSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEE-----CCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            3456788999999999999999999998     4556679999986321  12234567889999998866999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+.+|+||||+++|+|..++....             .+++..++.++.||+.||.|||+++
T Consensus       410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~g  462 (674)
T 3pfq_A          410 CFQTMDRLYFVMEYVNGGDLMYHIQQVG-------------RFKEPHAVFYAAEIAIGLFFLQSKG  462 (674)
T ss_dssp             ECBCSSEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred             EEEeCCEEEEEEeCcCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999998742             4899999999999999999999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.88  E-value=6.6e-22  Score=163.46  Aligned_cols=120  Identities=23%  Similarity=0.474  Sum_probs=95.5

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+.+|+||+++++++...
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~   81 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSID-----RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD   81 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEE-----TTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEE-----CCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence            357899999999999999999998     556667999998533 44566778899999999997799999999999754


Q ss_pred             C--CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 E--PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +  .+++||||++ ++|.+++...              .+++..+..++.|++.||.|||+.+
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~  129 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRAN--------------ILEPVHKQYVVYQLIKVIKYLHSGG  129 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHHT--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCEEEEEecccC-cCHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4  6899999998 5899888763              3889999999999999999999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.88  E-value=4.9e-22  Score=159.52  Aligned_cols=118  Identities=23%  Similarity=0.393  Sum_probs=95.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe---
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT---   93 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~---   93 (230)
                      -.++|++.+.||+|+||.||+|.+     ..++..||+|++... .......+.+|+.++..+. ||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVD-----NDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG   81 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEE-----TTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred             cCCceeEEEEeccCCCeEEEEEEE-----CCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence            357899999999999999999998     455677999998643 3556678999999999998 999999999874   


Q ss_pred             -----------cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 -----------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 -----------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                                 ..+..+++|||++ |+|.+++..              ..+++..+..++.|++.||.|||+++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~~  140 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--------------GPLLEEHARLFMYQLLRGLKYIHSAN  140 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc--------------CCccHHHHHHHHHHHHHHHHHHHhCC
Confidence                       3356899999998 599988854              24889999999999999999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.88  E-value=2e-22  Score=172.71  Aligned_cols=127  Identities=17%  Similarity=0.304  Sum_probs=107.1

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||+|+++....  ......+.+|+.++..+. ||||+++++++
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~-----~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~  254 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQM-----KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAF  254 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEE-----CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEE
Confidence            35678999999999999999999998     45667799999863211  122356889999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+..++||||++||+|.+++.....         ....+++..++.++.||+.||.|||+++
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~---------~~~~l~e~~~~~~~~qi~~aL~~LH~~g  309 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDE---------DNPGFQEPRAIFYTAQIVSGLEHLHQRN  309 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSST---------TSCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhc---------ccccccHHHHHHHHHHHHHHHHHHHHcC
Confidence            999999999999999999999876321         1235899999999999999999999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.88  E-value=1.1e-21  Score=166.28  Aligned_cols=168  Identities=17%  Similarity=0.246  Sum_probs=135.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ..++|++++.||+|+||.||+|.+     ..++..||+|++......   ..+..|+.++..+..++++..+..++....
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEE-----TTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEE-----CCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            457899999999999999999998     455667999987533221   247789999999985577777777777888


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..+++|||+ +++|.+++...            ...+++..++.++.||+.||.|||+++                    
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~  143 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFC------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN  143 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT
T ss_pred             EEEEEEECC-CCCHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC
Confidence            899999999 89999999863            235899999999999999999999998                    


Q ss_pred             --------------------------------------------------------------CCCCccCC----------
Q psy15820        157 --------------------------------------------------------------VRDGYRLE----------  164 (230)
Q Consensus       157 --------------------------------------------------------------i~~~~~~~----------  164 (230)
                                                                                    +..|..+-          
T Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~  223 (483)
T 3sv0_A          144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ  223 (483)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred             eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence                                                                          00011110          


Q ss_pred             ----------------CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        165 ----------------KPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       165 ----------------~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                                      .+..+++++.+++..||+.||++||++.+|++.|..++...
T Consensus       224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          224 KYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                            01456788999999999999999999999999999988754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.88  E-value=1.6e-22  Score=169.40  Aligned_cols=125  Identities=16%  Similarity=0.266  Sum_probs=106.2

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--HHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--ERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.+..++|++.+.||+|+||.||+|.+     ..++..+|+|+++....  ......+.+|..++..+. |+||++++++
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~  142 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKL-----KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYA  142 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEE-----cCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence            456778999999999999999999998     55667899999863210  111223788999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+.+++||||+++|+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~------------~~~l~e~~~~~~~~qi~~aL~~LH~~g  195 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKF------------EDRLPEEMARFYLAEMVIAIDSVHQLH  195 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTT------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHc------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999999763            235899999999999999999999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.88  E-value=6.4e-22  Score=162.66  Aligned_cols=121  Identities=24%  Similarity=0.479  Sum_probs=102.5

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .|.+. ++|.+.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. ||||++++++
T Consensus        37 ~~~l~-~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~  109 (371)
T 4exu_A           37 AWELP-KTYVSPTHVGSGAYGSVCSAID-----KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDV  109 (371)
T ss_dssp             EEEEE-TTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEE
T ss_pred             eeccc-ccEEEEeEEecCCCeEEEEEEE-----CCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhh
Confidence            34443 6899999999999999999998     556778999999643 34555678999999999999 9999999999


Q ss_pred             EecCCCe------EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPF------FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+..      +++|||+. ++|.+++..               .+++..+..++.|++.||.|||+++
T Consensus       110 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~  164 (371)
T 4exu_A          110 FTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM---------------EFSEEKIQYLVYQMLKGLKYIHSAG  164 (371)
T ss_dssp             ECSCSSSTTCCCCEEEEECCC-EEHHHHTTS---------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeccCCcccceeEEEEEcccc-ccHHHHhhc---------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9876654      99999998 578776532               3899999999999999999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.88  E-value=6.2e-22  Score=174.58  Aligned_cols=121  Identities=16%  Similarity=0.272  Sum_probs=102.4

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +-..+|++.+.||+|+||.||+|.+..    .++..||+|++...........+.+|+.++..+. ||||+++++++...
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT  151 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGG----GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcC----CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence            345899999999999999999999843    1456799999876556667778999999999999 99999999999876


Q ss_pred             CC-----eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 EP-----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.     .|+||||++|++|.+++..               .+++..++.++.||+.||.|||+++
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~~g  202 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ---------------KLPVAEAIAYLLEILPALSYLHSIG  202 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C---------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            65     7999999999999876543               4899999999999999999999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.88  E-value=1.1e-21  Score=161.23  Aligned_cols=117  Identities=23%  Similarity=0.363  Sum_probs=100.8

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. ||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYD-----AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEE-----CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence            47899999999999999999988     456677999998643 34556678899999999998 999999999997654


Q ss_pred             ------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 ------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            ..++||||+++ +|.+++..               .+++..+..++.|++.||.|||+++
T Consensus        98 ~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~~  147 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMDA-NLCQVIQM---------------ELDHERMSYLLYQMLCGIKHLHSAG  147 (371)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHHS---------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccccccceEEEEEcCCC-CHHHHHhh---------------ccCHHHHHHHHHHHHHHHHHHHHCC
Confidence                  57999999985 78887753               3789999999999999999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.88  E-value=1.7e-22  Score=168.06  Aligned_cols=125  Identities=15%  Similarity=0.258  Sum_probs=106.7

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.+..++|++.+.||+|+||.||++..     +.++..||+|+++...  .......+.+|..++..+. |+||++++++
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~-----~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~  129 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKM-----KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFA  129 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEE
Confidence            456788999999999999999999998     4566779999986321  1112335788999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.+.+..|+||||++||+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~g  182 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKF------------GERIPAEMARFYLAEIVMAIDSVHRLG  182 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH------------SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999864            224899999999999999999999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.88  E-value=4.3e-21  Score=160.64  Aligned_cols=122  Identities=18%  Similarity=0.289  Sum_probs=102.7

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC-----CCCceeeEee
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-----PHPNVVRLLG   90 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~niv~l~~   90 (230)
                      ....+|++.+.||+|+||.||+|.+     ..++..||+|+++..  ......+.+|+.++..+.     .|+||+++++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~-----~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYD-----HKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEE-----TTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEE-----CCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            4456799999999999999999988     556678999999743  444566778888887763     3779999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+..+++|||+. ++|.+++....           ...+++..+..++.||+.||.|||+++
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~~  220 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNK-----------FQGFSLPLVRKFAHSILQCLDALHKNR  220 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9999999999999996 59999988743           234899999999999999999999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.88  E-value=3.7e-22  Score=164.40  Aligned_cols=130  Identities=12%  Similarity=0.087  Sum_probs=96.9

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHH---HhhcCCCCceeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTV---MKTLDPHPNVVRL   88 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~---l~~~~~h~niv~l   88 (230)
                      |....++|++.+.||+|+||.||+|.+     ..++..||+|+++..  ........+.+|+.+   +..+. ||||+++
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~-hpniv~~  141 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATD-----QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK-NQKQAKV  141 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCC-SHHHHHH
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEE-----CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccC-CHHHHHH
Confidence            334467899999999999999999998     445667999998632  234456788999954   44556 9999999


Q ss_pred             e-------eEEecCC-----------------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHH
Q psy15820         89 L-------GCCTEKE-----------------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQ  144 (230)
Q Consensus        89 ~-------~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  144 (230)
                      +       +++...+                 ..+++|||+ +|+|.+++......      ......+++..++.++.|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~------~~~~~~l~~~~~~~i~~q  214 (377)
T 3byv_A          142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH------SSTHKSLVHHARLQLTLQ  214 (377)
T ss_dssp             HHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT------TTTTHHHHHHHHHHHHHH
T ss_pred             HhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc------ccccccccHHHHHHHHHH
Confidence            8       6555443                 389999999 57999999874310      000112345788889999


Q ss_pred             HHhhhhhhhhcC
Q psy15820        145 VARGMQFLSSRG  156 (230)
Q Consensus       145 i~~gl~~LH~~~  156 (230)
                      |+.||.|||+++
T Consensus       215 i~~aL~~LH~~~  226 (377)
T 3byv_A          215 VIRLLASLHHYG  226 (377)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHhCC
Confidence            999999999999

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.88  E-value=2.9e-21  Score=154.69  Aligned_cols=124  Identities=23%  Similarity=0.485  Sum_probs=94.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC----CHHHHHHHHHHHHHHhhcC--CCCceeeEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA----GERERLDLLQELTVMKTLD--PHPNVVRLL   89 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~--~h~niv~l~   89 (230)
                      +..++|++.+.||+|+||.||+|.+     ..++..||+|+++...    .......+.+|+.++..+.  .||||++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARD-----PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEEC-----TTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEE-----CCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            4567999999999999999999988     4556679999985321    1111234556666655443  399999999


Q ss_pred             eEEecCC-----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKE-----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++....     ..++++||+. ++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~~  140 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-----------PPGLPAETIKDLMRQFLRGLDFLHANC  140 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC-----------TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeeeccCCCCceeEEEEehhhh-cCHHHHHhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            9997655     3799999997 59999987642           223899999999999999999999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.88  E-value=6.7e-23  Score=166.76  Aligned_cols=129  Identities=14%  Similarity=0.230  Sum_probs=102.0

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH----------------HHHHHHHHHHHHHhh
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE----------------RERLDLLQELTVMKT   78 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~e~~~l~~   78 (230)
                      .+...+|++.+.||+|+||.||+|.+       ++..||+|++......                .....+.+|+.++..
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   99 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD   99 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence            34568999999999999999999988       2456999998532100                112678999999999


Q ss_pred             cCCCCceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         79 LDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        79 ~~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      +. ||||+++++++...+..++||||+++++|.+++.....     ........+++..+..++.|++.||.|||+ ++
T Consensus       100 l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~  172 (348)
T 2pml_X          100 IK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-----LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN  172 (348)
T ss_dssp             CC-CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEES-----SCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC
T ss_pred             CC-CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhh-----hhhccccCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            99 99999999999999999999999999999887321100     000013458999999999999999999999 76

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=2.2e-22  Score=162.16  Aligned_cols=167  Identities=22%  Similarity=0.338  Sum_probs=133.4

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----HHHHHHHHHHHHHhhcC-CCCce
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----RERLDLLQELTVMKTLD-PHPNV   85 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~-~h~ni   85 (230)
                      .......++|++.+.||+|+||.||+|.+     ..++..||+|+++.....     .....+.+|+.++..+. .|+||
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIR-----VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEE-----TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEE-----CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            34556788999999999999999999988     456678999998643111     12234667899999986 36999


Q ss_pred             eeEeeEEecCCCeEEEEecCCC-CCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------
Q psy15820         86 VRLLGCCTEKEPFFVIMEYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------  156 (230)
Q Consensus        86 v~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------  156 (230)
                      +++++++...+..++++|++.+ ++|.+++....             .+++..+..++.|++.||.|||+++        
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp  177 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-------------ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD  177 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCH
Confidence            9999999999999999999976 89999988642             4889999999999999999999998        


Q ss_pred             ----------------------------------------------------------------CCCCc-----------
Q psy15820        157 ----------------------------------------------------------------VRDGY-----------  161 (230)
Q Consensus       157 ----------------------------------------------------------------i~~~~-----------  161 (230)
                                                                                      +..|.           
T Consensus       178 ~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  257 (320)
T 3a99_A          178 ENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR  257 (320)
T ss_dssp             GGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH
T ss_pred             HHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc
Confidence                                                                            00011           


Q ss_pred             -cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        162 -RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       162 -~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                       ....+..+++++.+++.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             12234567889999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.87  E-value=6.3e-22  Score=162.53  Aligned_cols=123  Identities=24%  Similarity=0.443  Sum_probs=96.6

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..|.+. ++|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. |+||+++++
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~   95 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFD-----TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLD   95 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEE-----TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSE
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEE-----CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEE
Confidence            345444 7899999999999999999988     556778999999643 34556678899999999999 999999999


Q ss_pred             EEecC------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEK------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...      ...++++|++ +++|.+++...              .+++..+..++.||+.||.|||+++
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~~LH~~g  152 (367)
T 2fst_X           96 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--------------KLTDDHVQFLIYQILRGLKYIHSAD  152 (367)
T ss_dssp             EECSCSSGGGCCCCEEEEECC-CEECC-----C--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEecCCccccCCeEEEEeccc-CCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            98654      5689999999 67998887642              4899999999999999999999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.87  E-value=8.7e-22  Score=160.52  Aligned_cols=122  Identities=20%  Similarity=0.395  Sum_probs=101.1

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      -...+|++.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. |+||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   87 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARH-----RKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRT   87 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEE-----TTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             ccccceeEEEEEecCCCcEEEEEEE-----CCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeec
Confidence            3568999999999999999999998     455667999998533 22233456789999999999 9999999999876


Q ss_pred             C--------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 K--------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .        +..++||||+++ +|.+.+...            ...+++..+..++.|++.||.|||+++
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~  144 (351)
T 3mi9_A           88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNV------------LVKFTLSEIKRVMQMLLNGLYYIHRNK  144 (351)
T ss_dssp             C--------CEEEEEEECCSE-EHHHHHHCT------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccCCceEEEEEeccCC-CHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3        458999999985 787777653            234899999999999999999999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.87  E-value=2.2e-21  Score=158.28  Aligned_cols=120  Identities=24%  Similarity=0.469  Sum_probs=100.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      |.+ .++|.+.+.||+|+||.||+|.+     ..++..||+|++... ........+.+|+.++..+. ||||+++++++
T Consensus        20 ~~l-~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   92 (353)
T 3coi_A           20 WEL-PKTYVSPTHVGSGAYGSVCSAID-----KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVF   92 (353)
T ss_dssp             EEE-ETTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEE
T ss_pred             ccc-CceEEEeeeEecCCCeEEEEEEE-----CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheE
Confidence            443 36899999999999999999998     556778999999643 34555678899999999999 99999999999


Q ss_pred             ecCCC------eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+.      .+++|||+. ++|.+++.               ..+++..+..++.||+.||.|||+++
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------------~~~~~~~~~~i~~qi~~al~~LH~~~  146 (353)
T 3coi_A           93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG---------------LKFSEEKIQYLVYQMLKGLKYIHSAG  146 (353)
T ss_dssp             CSCSSGGGCCCCEEEEECCS-EEGGGTTT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ecccccccceeEEEEecccc-CCHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            87654      499999997 57766542               23899999999999999999999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.87  E-value=3.4e-21  Score=155.77  Aligned_cols=123  Identities=24%  Similarity=0.396  Sum_probs=102.9

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCC------ceeeE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP------NVVRL   88 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~------niv~l   88 (230)
                      .+-.++|++.+.||+|+||.||+|.+.    ..++..||+|+++..  ......+.+|+.++..+. |+      +++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~   82 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDH----KAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQM   82 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEET----TTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEec----CCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhh-hcCCCCceeeEee
Confidence            345679999999999999999999873    234567999998743  455667888999988876 54      59999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++...+..+++|||+ +++|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~  138 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENG-----------FLPFRLDHIRKMAYQICKSVNFLHSNK  138 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcC-----------CCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999 789999997742           234789999999999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.87  E-value=6.1e-22  Score=162.05  Aligned_cols=122  Identities=16%  Similarity=0.318  Sum_probs=100.4

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC----------CHHHHHHHHHHHHHHhhcCCCCc
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA----------GERERLDLLQELTVMKTLDPHPN   84 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~e~~~l~~~~~h~n   84 (230)
                      ....++|++.+.||+|+||.||+|.+.      .+..||+|++....          .......+.+|+.++..+. |||
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~   90 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPN   90 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTT
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcC
Confidence            445689999999999999999999872      25569999985321          2233578999999999999 999


Q ss_pred             eeeEeeEEec-----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         85 VVRLLGCCTE-----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        85 iv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |+++++++..     ....+++|||++ |+|.+++...            ...+++..+..++.|++.||.|||+++
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~  154 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ------------RIVISPQHIQYFMYHILLGLHVLHEAG  154 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence            9999999854     235799999998 5888888753            235899999999999999999999998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.87  E-value=2.7e-21  Score=158.87  Aligned_cols=124  Identities=17%  Similarity=0.116  Sum_probs=84.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcC-CCCceeeEe--
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLD-PHPNVVRLL--   89 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~-~h~niv~l~--   89 (230)
                      ......|++.+.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.++..+. .||||++++  
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~  132 (371)
T 3q60_A           58 SQGERKLKLVEPLRVGDRSVVFLVRD-----VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR  132 (371)
T ss_dssp             TCCEEEEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------C
T ss_pred             CCCceeeeeeeeccCCCCEEEEEEEE-----CCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhcee
Confidence            33455699999999999999999998     5567789999997543  2344556777754444332 399988755  


Q ss_pred             -----eEEecC-----------------CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHH------HHH
Q psy15820         90 -----GCCTEK-----------------EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL------TSF  141 (230)
Q Consensus        90 -----~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~------~~i  141 (230)
                           +++...                 ...++||||++ |+|.+++.....            .+++..+      ..+
T Consensus       133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------~~~~~~~~~~~vk~~i  199 (371)
T 3q60_A          133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF------------VYVFRGDEGILALHIL  199 (371)
T ss_dssp             BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH------------SCCCCHHHHHHHHHHH
T ss_pred             EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc------------ccchhhhhhhhhHHHH
Confidence                 344332                 23799999999 899999987521            2444455      677


Q ss_pred             HHHHHhhhhhhhhcC
Q psy15820        142 CYQVARGMQFLSSRG  156 (230)
Q Consensus       142 ~~qi~~gl~~LH~~~  156 (230)
                      +.||+.||.|||+++
T Consensus       200 ~~qi~~aL~~LH~~~  214 (371)
T 3q60_A          200 TAQLIRLAANLQSKG  214 (371)
T ss_dssp             HHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHCC
Confidence            799999999999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.87  E-value=5.6e-21  Score=155.47  Aligned_cols=123  Identities=20%  Similarity=0.337  Sum_probs=101.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCc------eeeE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN------VVRL   88 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~n------iv~l   88 (230)
                      .+-.++|++.+.||+|+||.||+|.+..    ..+..||+|+++..  ......+.+|+.++..+. |++      ++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~   87 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHA----RGKSQVALKIIRNV--GKYREAARLEINVLKKIK-EKDKENKFLCVLM   87 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecC----CCceEEEEEEEccc--ccchhHHHHHHHHHHHHh-hcCCCCceeEEEe
Confidence            3457899999999999999999998842    22357999999743  455667888999999887 655      8999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++...+..+++|||+ ++++.+++....           ...+++..+..++.||+.||.|||+++
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~L~~lH~~~  143 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENN-----------FQPYPLPHVRHMAYQLCHALRFLHENQ  143 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTT-----------TCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999 567878776632           235899999999999999999999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.87  E-value=2.5e-21  Score=156.06  Aligned_cols=124  Identities=30%  Similarity=0.583  Sum_probs=97.8

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-HHHHHHHHHHHHHHhhc---CCCCceeeEeeE
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-ERERLDLLQELTVMKTL---DPHPNVVRLLGC   91 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~---~~h~niv~l~~~   91 (230)
                      ...++|++.+.||+|+||.||+|.+..    .++..||+|+++.... ......+.+|+.++..+   . ||||++++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-h~~i~~~~~~   82 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE-HPNVVRLFDV   82 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTC-CTTBCCEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccC-CCCeEeeeee
Confidence            345789999999999999999998831    3456799999863321 11223456777777666   6 9999999999


Q ss_pred             Ee-----cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CT-----EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.     .....++++||++ |+|.+++....           ...+++..+..++.|++.||.|||+++
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~g  140 (326)
T 1blx_A           83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-----------EPGVPTETIKDMMFQLLRGLDFLHSHR  140 (326)
T ss_dssp             EEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-----------TTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeecccCCCceEEEEEecCC-CCHHHHHHhcc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            86     4567899999998 59999988742           234889999999999999999999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.87  E-value=5.1e-22  Score=172.83  Aligned_cols=123  Identities=22%  Similarity=0.348  Sum_probs=103.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec---
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE---   94 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~---   94 (230)
                      ..+|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. ||||+++++++..   
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~-----~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIH-----QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCC-----TTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEE-----CCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccc
Confidence            47899999999999999999988     44556699999976666777788999999999998 9999999998755   


Q ss_pred             ---CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 ---KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         .+..++||||+++|+|.+++....          ....+++..++.++.|++.||.|||+++
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~----------~~~~lse~~i~~I~~QLl~aL~yLHs~g  141 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFE----------NCCGLKEGPIRTLLSDISSALRYLHENR  141 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSS----------CTTCCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcc----------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence               667899999999999999998632          1234888999999999999999999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.86  E-value=3.2e-21  Score=159.28  Aligned_cols=122  Identities=23%  Similarity=0.322  Sum_probs=100.4

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC-------CCCceeeE
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-------PHPNVVRL   88 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-------~h~niv~l   88 (230)
                      +-..+|++.+.||+|+||.||+|.+     ..++..||+|+++..  ......+.+|+.++..+.       .|+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWD-----IQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEe-----cCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            3458899999999999999999988     556778999999743  555677889999999885       17789999


Q ss_pred             eeEEe----cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         89 LGCCT----EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        89 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      ++++.    .....++||||+ ++++.+.+....           ...+++..+..++.||+.||.|||++ +
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-----------~~~~~~~~~~~i~~qi~~aL~~lH~~~g  167 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-----------YQGLPLPCVKKIIQQVLQGLDYLHTKCR  167 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-----------TSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcc-----------cCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            99987    455789999999 567777766532           23589999999999999999999998 5

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.86  E-value=2.8e-20  Score=152.42  Aligned_cols=134  Identities=13%  Similarity=0.224  Sum_probs=104.0

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC--CCCceeeE
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD--PHPNVVRL   88 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--~h~niv~l   88 (230)
                      ...+.+..++|.+.+.||+|+||.||+|.+.......++..||+|+++... .   ..+..|+.++..+.  .|+||+.+
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~---~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-P---WEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-H---HHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-h---hHHHHHHHHHHHhhhhhhhhhhhh
Confidence            345677889999999999999999999975443335566779999997532 2   34555666665554  28999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++++...+..++||||+++|+|.+++......        ....+++..++.++.||+.||.|||+++
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~lH~~~  192 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNT--------PEKVMPQGLVISFAMRMLYMIEQVHDCE  192 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTS--------TTCSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcc--------cccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            99999999999999999999999999864311        1345899999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.85  E-value=4.7e-21  Score=157.16  Aligned_cols=123  Identities=15%  Similarity=0.277  Sum_probs=102.4

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC----------CCCc
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----------PHPN   84 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~----------~h~n   84 (230)
                      .+...+|++.+.||+|+||.||+|.+     ..++..||+|++..  .......+.+|+.++..+.          .|+|
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKD-----MVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEe-----cCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccch
Confidence            45678999999999999999999998     45667899999874  3445567888998888765          2789


Q ss_pred             eeeEeeEEecCC----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         85 VVRLLGCCTEKE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        85 iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      |+++++++...+    ..++++||+ +++|.+++....           ...+++..+..++.||+.||.|||++ +
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~aL~~lH~~~~  152 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-----------HRGIPLIYVKQISKQLLLGLDYMHRRCG  152 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-----------TSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-----------ccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            999999987643    689999999 889999998742           23488999999999999999999998 6

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.84  E-value=1.3e-20  Score=157.26  Aligned_cols=118  Identities=24%  Similarity=0.384  Sum_probs=94.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      ..+|++.+.||+|+||.||+|.+     ..++..||+|++.....     ...+|+.++..+. |+||+++++++...  
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~-hpniv~l~~~~~~~~~  121 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKL-----CDSGELVAIKKVLQDKR-----FKNRELQIMRKLD-HCNIVRLRYFFYSSGE  121 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEECCTT-----SCCHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred             cceEEeeeEEeeCCCEEEEEEEE-----CCCCcEEEEEEecccch-----hHHHHHHHHHHcC-CCCccceeeEEeccCC
Confidence            34699999999999999999999     44566799999854321     1336899999998 99999999988542  


Q ss_pred             ----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                          ..++++|||+++ ++.+++.....         ....+++..+..++.||+.||.|||+++
T Consensus       122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~aL~~LH~~~  176 (420)
T 1j1b_A          122 KKDEVYLNLVLDYVPE-TVYRVARHYSR---------AKQTLPVIYVKLYMYQLFRSLAYIHSFG  176 (420)
T ss_dssp             TTTEEEEEEEEECCCE-EHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             CCcceeEEeehhcccc-cHHHHHHHHhh---------ccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                136799999985 77777665321         2345899999999999999999999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.84  E-value=5.2e-21  Score=156.27  Aligned_cols=125  Identities=26%  Similarity=0.327  Sum_probs=87.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      .....++|++.+.||+|+||.||+|.+     ..++..||+|++....  .......+++..+..+. |+||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~-h~niv~~~~~~~   89 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKE-----KSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLH-HPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEE-----TTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHC-CTTBCCEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEE-----CCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcC-CCCcccHHHhhh
Confidence            456778999999999999999999998     4556679999885331  12234567777888888 999999999986


Q ss_pred             cCCC-------eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhh--hcC
Q psy15820         94 EKEP-------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLS--SRG  156 (230)
Q Consensus        94 ~~~~-------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH--~~~  156 (230)
                      ..+.       .+++|||+++ +|...+.....         ....+++..+..++.|++.||.|||  +++
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~  151 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR---------RQVAPPPILIKVFLFQLIRSIGCLHLPSVN  151 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHT---------TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhh---------cccCCCHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            5433       8899999986 66665554211         2345788999999999999999999  776

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.84  E-value=1.7e-20  Score=155.34  Aligned_cols=118  Identities=24%  Similarity=0.404  Sum_probs=90.6

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      ...+|++.+.||+|+||.||+|.+.     .++. +|+|.+......     ..+|+.++..+. |+||+++++++...+
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~-----~~~~-~aikk~~~~~~~-----~~~E~~il~~l~-h~niv~l~~~~~~~~  105 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLV-----ESDE-VAIKKVLQDKRF-----KNRELQIMRIVK-HPNVVDLKAFFYSNG  105 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEET-----TTEE-EEEEEEECCTTS-----CCHHHHHHHTCC-CTTBCCEEEEEEEES
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEEC-----CCCe-EEEEEEecCcch-----HHHHHHHHHhCC-CCCcceEEEEEEecC
Confidence            3457999999999999999999883     3333 788877432211     226899999998 999999999986543


Q ss_pred             C------eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 P------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .      .++||||+++ ++...+.....         ....+++..+..++.|++.||.|||+++
T Consensus       106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~~~~qi~~aL~~LH~~~  161 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPE-TVYRASRHYAK---------LKQTMPMLLIKLYMYQLLRSLAYIHSIG  161 (394)
T ss_dssp             SSSSCEEEEEEEECCSE-EHHHHHHHHHH---------TTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCceEEEEEeeccCc-cHHHHHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3      8899999986 55555443211         1345899999999999999999999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.84  E-value=1.1e-20  Score=158.23  Aligned_cols=121  Identities=20%  Similarity=0.217  Sum_probs=96.1

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .+.+...+|.+.+.||+|+||.|+....      .++..||+|++.....    ..+.+|+.++..+..||||+++++++
T Consensus        18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~------~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~   87 (432)
T 3p23_A           18 VVIVGKISFCPKDVLGHGAEGTIVYRGM------FDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTE   87 (432)
T ss_dssp             CEEETTEEEEEEEEEEECGGGCEEEEEE------SSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cEEEccEEEecCCeeecCcCEEEEEEEE------eCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEE
Confidence            3677888899999999999999654322      2345699999864321    12457999999984499999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ......+++||||. |+|.+++....            ....+..++.++.||+.||.|||+++
T Consensus        88 ~~~~~~~lv~E~~~-g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~  138 (432)
T 3p23_A           88 KDRQFQYIAIELCA-ATLQEYVEQKD------------FAHLGLEPITLLQQTTSGLAHLHSLN  138 (432)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHSSS------------CCCCSSCHHHHHHHHHHHHHHHHHTT
T ss_pred             ecCCEEEEEEECCC-CCHHHHHHhcC------------CCccchhHHHHHHHHHHHHHHHHHCc
Confidence            99999999999997 59999987632            23455567899999999999999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.84  E-value=1.6e-20  Score=155.95  Aligned_cols=125  Identities=20%  Similarity=0.362  Sum_probs=90.1

Q ss_pred             CeeE-eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--CC
Q psy15820         20 HIKV-FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--KE   96 (230)
Q Consensus        20 ~~~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--~~   96 (230)
                      .|.+ +++||+|+||.||+|.+..   ..++..||+|++......   ..+.+|+.++..+. ||||+++++++..  ..
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKD---GKDDKDYALKQIEGTGIS---MSACREIALLRELK-HPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESS---SSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCC-CTTBCCCCEEEEETTTT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEcc---CCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcC-CCCeeeEeeEEecCCCC
Confidence            3555 5689999999999999742   234556999999744222   35778999999999 9999999999954  56


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+++||||+.+ +|.+++........    ......+++..++.++.||+.||.|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~  148 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKA----NKKPVQLPRGMVKSLLYQILDGIHYLHANW  148 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-----------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccc----cccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            79999999974 88888875432110    001224899999999999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.84  E-value=4.5e-19  Score=146.16  Aligned_cols=119  Identities=21%  Similarity=0.326  Sum_probs=99.3

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCC-----ceeeEeeE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP-----NVVRLLGC   91 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~-----niv~l~~~   91 (230)
                      -.++|++.+.||+|+||.||+|.+     ..++..||+|+++..  ......+..|+.++..+..|+     +|++++++
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYD-----RVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEE-----TTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEE-----cCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            457899999999999999999998     556677999999743  444566778888888775355     49999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS  154 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~  154 (230)
                      +...+..++||||+++ +|.+++....           ...+++..+..++.|++.||.|||+
T Consensus       125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~  175 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLSY-NLYDLLRNTN-----------FRGVSLNLTRKFAQQMCTALLFLAT  175 (382)
T ss_dssp             EEETTEEEEEEECCCC-BHHHHHHHTT-----------TSCCCHHHHHHHHHHHHHHHHHHTS
T ss_pred             eccCCceEEEEecCCC-CHHHHHhhcC-----------cCCCCHHHHHHHHHHHHHHHHHhcc
Confidence            9999999999999974 9999998742           2348899999999999999999995

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.81  E-value=2.3e-19  Score=150.36  Aligned_cols=128  Identities=23%  Similarity=0.221  Sum_probs=91.5

Q ss_pred             CcccccCCCe-eEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHI-KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      .++.....++ .+.+.||+|+||.||.+..      .++..||+|++...    ....+.+|+.++..+..||||+++++
T Consensus         7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~~~------~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~   76 (434)
T 2rio_A            7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGS------FQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYC   76 (434)
T ss_dssp             -CCSCSCSSCEEEEEEEEECSTTCEEEEEE------SSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cchhhhhhheeeccCeEeeCCCeEEEEEEE------ECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEE
Confidence            3444444444 4578899999999986433      24567999998642    23457789999988744999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+..+++||||. |+|.+++.......      .......+..++.++.||+.||.|||+++
T Consensus        77 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  135 (434)
T 2rio_A           77 SETTDRFLYIALELCN-LNLQDLVESKNVSD------ENLKLQKEYNPISLLRQIASGVAHLHSLK  135 (434)
T ss_dssp             EEECSSEEEEEECCCS-EEHHHHHHTC------------------CCHHHHHHHHHHHHHHHHHTT
T ss_pred             EEecCCeEEEEEecCC-CCHHHHHhccCCCc------hhhhhccchhHHHHHHHHHHHHHHHHHCC
Confidence            9999899999999996 59999998642100      00011234456789999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.76  E-value=2.4e-19  Score=145.26  Aligned_cols=131  Identities=18%  Similarity=0.260  Sum_probs=103.6

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-------CHHHHHHHHHHHHHHhhcC--------
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-------GERERLDLLQELTVMKTLD--------   80 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~~~--------   80 (230)
                      +..++|++.+.||+|+||.||+|.+.       +..||+|+++...       .......+.+|+.++..+.        
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~   89 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIAD-------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN   89 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEET-------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred             cccccchheeeecccCceEEEEEEeC-------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence            56688999999999999999999872       3569999996432       2223456788888888774        


Q ss_pred             CCCceeeEeeEEe------------------------------cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCC
Q psy15820         81 PHPNVVRLLGCCT------------------------------EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS  130 (230)
Q Consensus        81 ~h~niv~l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~  130 (230)
                      .|+||+++.+.+.                              ..+..++|||||++|++.+.+..              
T Consensus        90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------------  155 (336)
T 2vuw_A           90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------------  155 (336)
T ss_dssp             BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------------
T ss_pred             cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------------
Confidence            4777777777643                              26789999999999976555532              


Q ss_pred             CCCChHHHHHHHHHHHhhhhhhh-hcCCCCCccCCCCCcC
Q psy15820        131 NSLTSRDLTSFCYQVARGMQFLS-SRGVRDGYRLEKPDHC  169 (230)
Q Consensus       131 ~~~~~~~~~~i~~qi~~gl~~LH-~~~i~~~~~~~~p~~~  169 (230)
                      ..+++..+..++.||+.||.||| ++++.  |++.+|+|+
T Consensus       156 ~~~~~~~~~~i~~qi~~aL~~lH~~~~iv--HrDlKp~NI  193 (336)
T 2vuw_A          156 KLSSLATAKSILHQLTASLAVAEASLRFE--HRDLHWGNV  193 (336)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHHHCCB--CSCCCGGGE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhCCEe--ECCCCHHHE
Confidence            24789999999999999999999 99999  999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.68  E-value=8.6e-16  Score=127.88  Aligned_cols=128  Identities=14%  Similarity=0.076  Sum_probs=86.5

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH--HHHHHHHHHHHHHhhcCCC-Cceee-----
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE--RERLDLLQELTVMKTLDPH-PNVVR-----   87 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~~h-~niv~-----   87 (230)
                      .....|..++.||+|+||.||+|.+     ..++..||+|+++.....  ...+.+.+|+.++..+. | .|...     
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~  148 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATD-----QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHL  148 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHT
T ss_pred             CCceeEEEecccccCCCEEEEEEEe-----cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhc
Confidence            4455688999999999999999998     455667999998733222  23567889999999887 5 22111     


Q ss_pred             ----------------EeeEEec-----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHH
Q psy15820         88 ----------------LLGCCTE-----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVA  146 (230)
Q Consensus        88 ----------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  146 (230)
                                      +...+..     ....+++|+++ +++|.+++.......      .....+++..++.++.|++
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~------~~~~~l~~~~~~~i~~qi~  221 (413)
T 3dzo_A          149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS------STHKSLVHHARLQLTLQVI  221 (413)
T ss_dssp             CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT------TTSHHHHHHHHHHHHHHHH
T ss_pred             ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc------ccCCCCCHHHHHHHHHHHH
Confidence                            1111111     22467777765 579999986432100      0122367788899999999


Q ss_pred             hhhhhhhhcC
Q psy15820        147 RGMQFLSSRG  156 (230)
Q Consensus       147 ~gl~~LH~~~  156 (230)
                      .||.|||+++
T Consensus       222 ~aL~~LH~~~  231 (413)
T 3dzo_A          222 RLLASLHHYG  231 (413)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHhCC
Confidence            9999999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.65  E-value=2.6e-16  Score=135.81  Aligned_cols=120  Identities=13%  Similarity=0.079  Sum_probs=88.8

Q ss_pred             ecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---------CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         27 LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---------GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        27 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+.|+.|....+..     .+.+..+++|++....         .......|.+|+.+|.++..|+||+++++++.+.+.
T Consensus       242 ~~~~~~~~h~~~rr-----~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRR-----YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS  316 (569)
T ss_dssp             -C--------CCEE-----EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred             cccCCccccccccc-----ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence            34445544444333     2334558999985331         123456799999999999769999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      .||||||++|++|.+++...             ..++..   .|+.||+.||.|+|++||.  ||+.+|+|+
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~-------------~~l~~~---~I~~QIl~AL~ylH~~GII--HRDIKPeNI  370 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAG-------------EEIDRE---KILGSLLRSLAALEKQGFW--HDDVRPWNV  370 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTT-------------CCCCHH---HHHHHHHHHHHHHHHTTCE--ESCCCGGGE
T ss_pred             EEEEEecCCCCcHHHHHHhC-------------CCCCHH---HHHHHHHHHHHHHHHCCce--eccCchHhE
Confidence            99999999999999999863             235443   5889999999999999999  999999763

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.57  E-value=6.2e-15  Score=126.56  Aligned_cols=115  Identities=10%  Similarity=0.074  Sum_probs=85.0

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCH-----HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      .+.||+|+||.||+|...+       ..+++|.....  ...     ...+.+.+|+.++..+. |+||+++..++...+
T Consensus       341 ~~~LG~G~fg~Vy~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~  412 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYLD-------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD  412 (540)
T ss_dssp             -------CCEEEEEEECSS-------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred             CCEEeeCCCEEEEEEEECC-------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence            5689999999999995532       33788875322  111     12456899999999998 999995555555667


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC  169 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~  169 (230)
                      ..+++|||+++++|.+++..                     +..++.|++.||.|||++++.  |++.+|+|+
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~---------------------~~~i~~qi~~aL~~LH~~gIi--HrDiKp~NI  462 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED---------------------NLDIAYKIGEIVGKLHKNDVI--HNDLTTSNF  462 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT---------------------CTHHHHHHHHHHHHHHHTTEE--CTTCCTTSE
T ss_pred             ccEEEEECCCCCCHHHHHHH---------------------HHHHHHHHHHHHHHHHHCcCc--cCCCCHHHE
Confidence            78999999999999887642                     457899999999999999999  999999875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.57  E-value=1.2e-14  Score=114.87  Aligned_cols=118  Identities=14%  Similarity=0.061  Sum_probs=89.3

Q ss_pred             CeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH-----------------HHHHHHHHHHHHHhhcCCC
Q psy15820         20 HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE-----------------RERLDLLQELTVMKTLDPH   82 (230)
Q Consensus        20 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~~h   82 (230)
                      .|.+++.||+|+||.||+|.+ .     ++..+|+|+++.....                 .....+.+|+.++..+. |
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~  163 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-E-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G  163 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-T-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T
T ss_pred             EEEecCEeccCCCceEEEEEe-C-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C
Confidence            345669999999999999988 2     3456999998633111                 24567899999999998 5


Q ss_pred             CceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCcc
Q psy15820         83 PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYR  162 (230)
Q Consensus        83 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~  162 (230)
                      .   ++++++.. +..++||||++|++|.+ +                   .......++.|++.||.|||++++.  |+
T Consensus       164 ~---~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------------------~~~~~~~i~~qi~~~l~~lH~~gii--Hr  217 (282)
T 1zar_A          164 L---AVPKVYAW-EGNAVLMELIDAKELYR-V-------------------RVENPDEVLDMILEEVAKFYHRGIV--HG  217 (282)
T ss_dssp             S---SSCCEEEE-ETTEEEEECCCCEEGGG-C-------------------CCSCHHHHHHHHHHHHHHHHHTTEE--CS
T ss_pred             C---CcCeEEec-cceEEEEEecCCCcHHH-c-------------------chhhHHHHHHHHHHHHHHHHHCCCE--eC
Confidence            4   44444433 56799999999999976 2                   1123457999999999999999999  99


Q ss_pred             CCCCCcCc
Q psy15820        163 LEKPDHCR  170 (230)
Q Consensus       163 ~~~p~~~~  170 (230)
                      +.+|.|+-
T Consensus       218 Dlkp~NIL  225 (282)
T 1zar_A          218 DLSQYNVL  225 (282)
T ss_dssp             CCSTTSEE
T ss_pred             CCCHHHEE
Confidence            99998763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.46  E-value=1.6e-13  Score=107.06  Aligned_cols=122  Identities=13%  Similarity=0.088  Sum_probs=89.1

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceE--EEEEecCCcCCH-----------------------HHHHHHHHHHHH
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCI--VAVKTLKENAGE-----------------------RERLDLLQELTV   75 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~   75 (230)
                      |++.+.||+|+||.||+|.+.     .++..  ||+|+++.....                       .....+.+|+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~-----~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  123 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGV-----FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN  123 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEE-----ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEc-----CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence            678899999999999999882     34566  999987532111                       122468899999


Q ss_pred             HhhcCCCCc--eeeEeeEEecCCCeEEEEecCCC-C----CHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhh
Q psy15820         76 MKTLDPHPN--VVRLLGCCTEKEPFFVIMEYVPY-G----KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARG  148 (230)
Q Consensus        76 l~~~~~h~n--iv~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~g  148 (230)
                      +..+. |++  ++.++..    +..++||||+.+ |    +|.++...                .++..+..++.|++.|
T Consensus       124 l~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----------------~~~~~~~~i~~qi~~~  182 (258)
T 1zth_A          124 LERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----------------LKELDVEGIFNDVVEN  182 (258)
T ss_dssp             HHHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----------------GGGSCHHHHHHHHHHH
T ss_pred             HHHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----------------cChHHHHHHHHHHHHH
Confidence            99997 765  3444443    357899999942 3    56554321                2345678899999999


Q ss_pred             hhhhh-hcCCCCCccCCCCCcCc
Q psy15820        149 MQFLS-SRGVRDGYRLEKPDHCR  170 (230)
Q Consensus       149 l~~LH-~~~i~~~~~~~~p~~~~  170 (230)
                      |.||| +.++.  |++.+|.|+-
T Consensus       183 l~~lH~~~giv--HrDlkp~NIL  203 (258)
T 1zth_A          183 VKRLYQEAELV--HADLSEYNIM  203 (258)
T ss_dssp             HHHHHHTSCEE--CSSCSTTSEE
T ss_pred             HHHHHHHCCEE--eCCCCHHHEE
Confidence            99999 99999  9999998753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.27  E-value=6.7e-12  Score=102.68  Aligned_cols=116  Identities=15%  Similarity=0.077  Sum_probs=78.4

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC----------------CH-----HHHHHHHHHHHHHhhc
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA----------------GE-----RERLDLLQELTVMKTL   79 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~-----~~~~~~~~e~~~l~~~   79 (230)
                      |.++..||+|++|.||+|..      ..+..||+|+++...                ..     ..+....+|...+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d------~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD------EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC------TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEEC------CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999987      235679999875320                00     0111234566677766


Q ss_pred             CCCCce--eeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820         80 DPHPNV--VRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus        80 ~~h~ni--v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      . +.++  ...+++    ...+|||||++|++|.++                   ........+..|++.||.+||..|+
T Consensus       171 ~-~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l-------------------~~~~~~~~l~~qll~~l~~lH~~gI  226 (397)
T 4gyi_A          171 Y-EEGFPVPEPIAQ----SRHTIVMSLVDALPMRQV-------------------SSVPDPASLYADLIALILRLAKHGL  226 (397)
T ss_dssp             H-HTTCSCCCEEEE----ETTEEEEECCSCEEGGGC-------------------CCCSCHHHHHHHHHHHHHHHHHTTE
T ss_pred             H-hcCCCCCeeeec----cCceEEEEecCCccHhhh-------------------cccHHHHHHHHHHHHHHHHHHHCCC
Confidence            4 4333  222322    234799999999887432                   1223446788999999999999998


Q ss_pred             CCCccCCCCCc
Q psy15820        158 RDGYRLEKPDH  168 (230)
Q Consensus       158 ~~~~~~~~p~~  168 (230)
                      .  |++.+|.|
T Consensus       227 V--HrDLKp~N  235 (397)
T 4gyi_A          227 I--HGDFNEFN  235 (397)
T ss_dssp             E--CSCCSTTS
T ss_pred             c--CCCCCHHH
Confidence            8  77777754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.47  E-value=4e-07  Score=70.58  Aligned_cols=112  Identities=11%  Similarity=-0.041  Sum_probs=84.3

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ..|++...++.|+.+.||++...       +..+++|....... .....+.+|+.++..+..+.++++++++....+..
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~-------~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   85 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS-------SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC-------CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence            46888888888999999998642       23489998864211 11235788999999886577888999998888889


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      |++|||++|.+|.+.+                  .+......++.+++.+|..||+..
T Consensus        86 ~lv~e~i~G~~l~~~~------------------~~~~~~~~~~~~l~~~l~~LH~~~  125 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEY------------------EDEQSPEKIIELYAECIRLFHSID  125 (263)
T ss_dssp             EEEEECCSSEEHHHHC------------------CTTTCHHHHHHHHHHHHHHHHHSC
T ss_pred             EEEEEecCCeehhhcc------------------CCcccHHHHHHHHHHHHHHHhCCC
Confidence            9999999999986542                  112234477889999999999853

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.94  E-value=1.7e-05  Score=64.35  Aligned_cols=113  Identities=15%  Similarity=0.179  Sum_probs=77.7

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecC--CcCCHHHHHHHHHHHHHHhhcCC-CCceeeEeeEEecC---C
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK--ENAGERERLDLLQELTVMKTLDP-HPNVVRLLGCCTEK---E   96 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~~~~-h~niv~l~~~~~~~---~   96 (230)
                      ..+.++.|.++.+|+....+       ..+++|+..  ..........+.+|..++..+.. +.++++++.++.+.   +
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g  114 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG  114 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred             eEEEcCCcccceEEEEEECC-------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence            45778999999999976532       237888765  33222234567889999998872 35578888888765   4


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      ..+++|||++|..+.+.               ....++......++.+++.+|..||+...
T Consensus       115 ~~~~vme~v~G~~l~~~---------------~~~~l~~~~~~~~~~~l~~~La~LH~~~~  160 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWDQ---------------SLPGMSPAERTAIYDEMNRVIAAMHTVDY  160 (359)
T ss_dssp             SCEEEEECCCCBCCCCT---------------TCTTCCHHHHHHHHHHHHHHHHHHHHSCT
T ss_pred             CeEEEEEecCCeecCCC---------------ccccCCHHHHHHHHHHHHHHHHHHhCCCc
Confidence            58999999998776321               11236777888999999999999999753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.70  E-value=0.00013  Score=55.95  Aligned_cols=109  Identities=18%  Similarity=0.062  Sum_probs=74.2

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC-CceeeEeeEEecCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH-PNVVRLLGCCTEKE   96 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h-~niv~l~~~~~~~~   96 (230)
                      ...+.+....+.|..+.||++...      ++..+++|.....    ....+..|+.++..+..+ -.+++++++....+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~   88 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG   88 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             cCCCceEecccCCCCceEEEEecC------CCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence            345565444446667999998541      2334899987543    113467888888888634 22667888888777


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      ..+++|||++|.++.  . .               ..   ....++.+++..|..||+...
T Consensus        89 ~~~~v~e~i~G~~l~--~-~---------------~~---~~~~~~~~l~~~l~~lh~~~~  128 (264)
T 1nd4_A           89 RDWLLLGEVPGQDLL--S-S---------------HL---APAEKVSIMADAMRRLHTLDP  128 (264)
T ss_dssp             CEEEEEECCSSEETT--T-S---------------CC---CHHHHHHHHHHHHHHHTTSCG
T ss_pred             CCEEEEEecCCcccC--c-C---------------cC---CHhHHHHHHHHHHHHHhCCCC
Confidence            899999999998773  1 1               01   123677889999999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.48  E-value=0.0016  Score=50.18  Aligned_cols=105  Identities=12%  Similarity=0.061  Sum_probs=75.3

Q ss_pred             ecceece-eEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEecC
Q psy15820         27 LGEGCFG-QVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYV  105 (230)
Q Consensus        27 lg~G~~g-~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e~~  105 (230)
                      +..|..| .||+...     ..++..+++|+-..    .....+.+|...+..+..+-.+.++++++...+..+++||++
T Consensus        32 ~~~G~S~~~v~rl~~-----~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           32 DNVGQSGATIYRLYG-----KPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EECSSSSCEEEEEEC-----CTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccCCCcCCeEEEEEe-----cCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            3445444 5787554     23334488887642    234567889999988876667888999988888899999999


Q ss_pred             CCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820        106 PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus       106 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      +|.++.+....                 .......+..+++..|.-||....
T Consensus       103 ~G~~~~~~~~~-----------------~~~~~~~~~~~l~~~L~~Lh~~~~  137 (272)
T 4gkh_A          103 PGKTAFQVLEE-----------------YPDSGENIVDALAVFLRRLHSIPV  137 (272)
T ss_dssp             CSEEHHHHHHH-----------------CGGGHHHHHHHHHHHHHHHHTSCG
T ss_pred             CCccccccccC-----------------CHHHHHHHHHHHHHHHHHhcCCCc
Confidence            99988776543                 123345677889999999998653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.11  E-value=0.01  Score=46.83  Aligned_cols=106  Identities=19%  Similarity=0.051  Sum_probs=77.0

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCC--ceeeEeeEEe-cCCCeEE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP--NVVRLLGCCT-EKEPFFV  100 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~--niv~l~~~~~-~~~~~~l  100 (230)
                      .+.++.|....||..   +.       .+++|+..   .......+.+|..++..+..+.  .+.+.+.+.. ..+..++
T Consensus        24 v~~l~~G~~n~v~~v---g~-------~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NG-------DWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE---TT-------TEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred             eeecCCCcceeEEEE---CC-------EEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence            345788888889886   21       17888753   2344567889999999987332  3566666663 4456789


Q ss_pred             EEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820        101 IMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus       101 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      +|||++|.++....-.               .++......++.+++..|..||+...
T Consensus        91 v~e~i~G~~l~~~~~~---------------~l~~~~~~~~~~~lg~~La~LH~~~~  132 (306)
T 3tdw_A           91 GYRKVQGQILGEDGMA---------------VLPDDAKDRLALQLAEFMNELSAFPV  132 (306)
T ss_dssp             EEECCCSEECHHHHHT---------------TSCHHHHHHHHHHHHHHHHHHHHSCH
T ss_pred             EEeccCCeECchhhhh---------------hCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence            9999999988764221               25777888999999999999999764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.98  E-value=0.0041  Score=48.91  Aligned_cols=106  Identities=18%  Similarity=0.170  Sum_probs=75.7

Q ss_pred             eeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCc--eeeEeeEEecCC---CeE
Q psy15820         25 DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN--VVRLLGCCTEKE---PFF   99 (230)
Q Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~n--iv~l~~~~~~~~---~~~   99 (230)
                      +.++.|....||....          .+++|+...   ......+.+|.+++..+..+..  ++.++......+   ..|
T Consensus        26 ~~~~~G~~n~v~~v~~----------~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~   92 (304)
T 3sg8_A           26 EISGEGNDCIAYEINR----------DFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF   92 (304)
T ss_dssp             CEEEECSSEEEEESTT----------SEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred             EecCCCCcceEEEECC----------EEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence            4588999999998641          288887653   3445678899999988742433  445555443332   358


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      +||++++|.++......               .++..+...++.+++..+..||+....
T Consensus        93 ~vm~~i~G~~l~~~~~~---------------~l~~~~~~~~~~~l~~~la~LH~~~~~  136 (304)
T 3sg8_A           93 AGFTKIKGVPLTPLLLN---------------NLPKQSQNQAAKDLARFLSELHSINIS  136 (304)
T ss_dssp             EEEECCCCEECCHHHHH---------------TSCHHHHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEEcccCCeECCccccc---------------cCCHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            89999999888654322               267888899999999999999987554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.39  E-value=0.015  Score=46.15  Aligned_cols=98  Identities=19%  Similarity=0.121  Sum_probs=70.7

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCC--CCceeeEeeEEecCCCeE
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFF   99 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~--h~niv~l~~~~~~~~~~~   99 (230)
                      .-.+.|+.|....+|+....       +..+++|+....    ....+..|.+.+..+..  ...+++++.+....+..+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~-------~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~  107 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE-------VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSF  107 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS-------SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEE
T ss_pred             eeeEEeCCccceeeeEEEEC-------CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceE
Confidence            34567899999999987641       224788876532    24567888888887752  366888888887777899


Q ss_pred             EEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820        100 VIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus       100 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      ++|||+++..+.                       .    ....++..+|+-||....
T Consensus       108 lvme~l~G~~~~-----------------------~----~~~~~lG~~LA~LH~~~~  138 (312)
T 3jr1_A          108 LLLEALNKSKNK-----------------------Q----SSFTIFAEKIAQLHQIQG  138 (312)
T ss_dssp             EEEECCCCCCCC-----------------------T----THHHHHHHHHHHHHHCCC
T ss_pred             EEEEeccCCCCC-----------------------c----hhHHHHHHHHHHHHcCCC
Confidence            999999986531                       1    234578889999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=95.85  E-value=0.024  Score=45.50  Aligned_cols=129  Identities=13%  Similarity=0.022  Sum_probs=75.7

Q ss_pred             eeEeeee-cceeceeEEEeEEecc-CCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCC--CceeeEeeEEec
Q psy15820         21 IKVFDIL-GEGCFGQVWKCEALGI-DGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPH--PNVVRLLGCCTE   94 (230)
Q Consensus        21 ~~~~~~l-g~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h--~niv~l~~~~~~   94 (230)
                      ....+.| +.|....+|+...... .....+..+++|......  .......+.+|..++..+..+  -.+.+++.+...
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3345677 8898999998765300 000013347888765321  000013456778877777533  357778887765


Q ss_pred             C---CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 K---EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .   +..+++|||++|.++.+.+...-     .  ......++......++.+++..|.-||+..
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~~~~~~~~-----~--~~~~~~~~~~~~~~~~~~l~~~La~LH~~~  159 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPPDVMPYTF-----G--DNWFADAPAERQRQLQDATVAALATLHSIP  159 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCCBTTBGGG-----S--CSTTTTSCHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             CCccCCceEEEEecCCCChhhcCcccc-----c--ccccCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence            4   35689999999877643210000     0  000012455566778899999999999865

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=95.38  E-value=0.017  Score=47.18  Aligned_cols=80  Identities=19%  Similarity=0.126  Sum_probs=49.2

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC---H---HHHHHHHHHHHHHhhcCCC--CceeeEeeEEecC
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG---E---RERLDLLQELTVMKTLDPH--PNVVRLLGCCTEK   95 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~---~~~~~~~~e~~~l~~~~~h--~niv~l~~~~~~~   95 (230)
                      .+.||.|..+.||++...     .++..+++|.......   .   .....+..|.+++..+...  ..+++++.+  +.
T Consensus        35 ~~~lg~G~~n~vyrv~~~-----~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQ-----EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred             EEECCCCceEEEEEEEEC-----CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC
Confidence            567899999999998652     2233588997643211   0   1123466788888876422  334566654  34


Q ss_pred             CCeEEEEecCCCCCH
Q psy15820         96 EPFFVIMEYVPYGKL  110 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L  110 (230)
                      +..+++||++++...
T Consensus       108 ~~~~lvmE~l~g~~~  122 (397)
T 2olc_A          108 EMAVTVMEDLSHLKI  122 (397)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CccEEEEEeCCCcch
Confidence            456899999987443

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.01  E-value=0.18  Score=39.02  Aligned_cols=82  Identities=16%  Similarity=0.088  Sum_probs=54.7

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC--CceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH--PNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h--~niv~l~~~~~~   94 (230)
                      ....+.-.+.+|.|..+.||+...      .+++.+++|+..... ......+..|.+.|..+...  -.+++++++.  
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l------~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--   83 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVEL------ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--   83 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEE------TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEE------CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence            345666778899999999999876      344568999865332 11123467888888877522  3355666542  


Q ss_pred             CCCeEEEEecCCCCC
Q psy15820         95 KEPFFVIMEYVPYGK  109 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~  109 (230)
                        .-+++|||++++.
T Consensus        84 --~~~lv~e~l~~~~   96 (288)
T 3f7w_A           84 --DRTLAMEWVDERP   96 (288)
T ss_dssp             --TTEEEEECCCCCC
T ss_pred             --CceEEEEeecccC
Confidence              3478999997653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=93.11  E-value=0.59  Score=37.97  Aligned_cols=113  Identities=16%  Similarity=0.173  Sum_probs=63.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccC--CCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGID--GREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      .+.+++ +.+..|-...+|++......  ....+..+++++....  ........+|.+++..+..+.-..++++.+.. 
T Consensus        50 ~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-  125 (379)
T 3feg_A           50 PEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-  125 (379)
T ss_dssp             GGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred             cCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence            344443 45777888889998763210  0112345788875321  11234456888888877634334677776643 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                         .+|+||++|.+|..    .              .+..   ..+..+++..|+-||+..+.
T Consensus       126 ---g~v~e~i~G~~l~~----~--------------~l~~---p~~~~~ia~~La~LH~~~~~  164 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKT----Q--------------ELRE---PVLSAAIATKMAQFHGMEMP  164 (379)
T ss_dssp             ---EEEEECCSEEECCG----G--------------GGGC---HHHHHHHHHHHHHHHTCCCS
T ss_pred             ---ccEEEEecCccCCh----h--------------HhCC---HHHHHHHHHHHHHHhCCCCC
Confidence               39999999866521    0              0111   24567899999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=89.39  E-value=3  Score=32.59  Aligned_cols=98  Identities=16%  Similarity=0.240  Sum_probs=52.1

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCC-CCceeeEee------EEecCC
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP-HPNVVRLLG------CCTEKE   96 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~-h~niv~l~~------~~~~~~   96 (230)
                      .+.|+.|..+.+|+....      ++ .+++|+....  ..   .+..|..++..+.. .-.+++++.      +....+
T Consensus        37 ~~~l~gG~~n~~~~v~~~------~~-~~vlk~~~~~--~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~  104 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD------SG-AVCLKRIHRP--EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGS  104 (346)
T ss_dssp             EEECC----CEEEEEEET------TE-EEEEEEECSC--HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETT
T ss_pred             eeeccccccCcEEEEEeC------CC-CEEEEecCCC--HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECC
Confidence            345666778899987652      12 2788888642  22   22234444443320 112334333      112355


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      ..+++++|++|.++..                    .+.    ..+.+++..|.-||....
T Consensus       105 ~~~~l~~~i~G~~~~~--------------------~~~----~~~~~~g~~La~lH~~~~  141 (346)
T 2q83_A          105 FLFVVYDWIEGRPFEL--------------------TVK----QDLEFIMKGLADFHTASV  141 (346)
T ss_dssp             EEEEEEECCCCBCCCT--------------------TSH----HHHHHHHHHHHHHHHHHT
T ss_pred             EEEEEEEeecCccCCC--------------------CCH----HHHHHHHHHHHHHHHhCC
Confidence            6789999999865520                    111    224678888999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=89.03  E-value=6.5  Score=30.27  Aligned_cols=140  Identities=6%  Similarity=-0.064  Sum_probs=72.1

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEe
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME  103 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e  103 (230)
                      .+.|+.|....+|+.    .  .     +++|+.......  ......|..++..+..+.-..++++..  ...-++++|
T Consensus        23 i~~l~gG~tN~~~~~----~--~-----~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----G--D-----LCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE----T--T-----EEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred             eeEcCCcccccccee----e--e-----EEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence            567888999999997    1  2     788877532111  112245777666664222224566543  333578999


Q ss_pred             cC-CCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccCCCCCcCcHHHHHHHHHhcC
Q psy15820        104 YV-PYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWD  182 (230)
Q Consensus       104 ~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~~~p~~~~~~~~~li~~cl~  182 (230)
                      |+ +|.++......                    ....++.+++..|.-||+.....+    .+...-..+......+-.
T Consensus        88 ~i~~g~~l~~~~~~--------------------~~~~~~~~~~~~La~lH~~~~~~~----~~~~~~~~~~~~~~~~~~  143 (301)
T 3dxq_A           88 YIAGAQTMSPEKFK--------------------TRPGSPARAGEAFRKLHGSGAVFP----FRFELFAMIDDYLKVLST  143 (301)
T ss_dssp             CCTTCEECCHHHHH--------------------HSTTHHHHHHHHHHHHHTSCCCCS----SBCCHHHHHHHHHHHHC-
T ss_pred             ecCCCccCCHhhHh--------------------hhHHHHHHHHHHHHHHhCCCCCCC----CCCCHHHHHHHHHHHHhh
Confidence            99 66554221000                    001356788999999999753311    111223344444444433


Q ss_pred             CCCCCCCCHHHHHHHHHHHH
Q psy15820        183 KEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       183 ~dp~~Rpt~~~i~~~l~~~~  202 (230)
                      .....-+....+.+.+..+.
T Consensus       144 ~~~~~~~~~~~l~~~~~~l~  163 (301)
T 3dxq_A          144 KNVTLPAGYHDVVREAGGVR  163 (301)
T ss_dssp             -CCCCCTTHHHHHHHHHHHH
T ss_pred             cCCCchhhHHHHHHHHHHHH
Confidence            32222233455555444443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.63  E-value=1.8  Score=35.67  Aligned_cols=107  Identities=16%  Similarity=0.230  Sum_probs=64.9

Q ss_pred             eeeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      .+.|+.|....+|++.......  ...+..+++|+......   ...+..|..++..+..+.-.+++++.+..    .++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            4567888889999987632100  01134578887743212   12345788888877634334677776542    389


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      +||++|.++..                  ..+   .-..++.+++..|.-||...+.
T Consensus       151 ~e~l~G~~l~~------------------~~l---~~~~~~~~ia~~La~LH~~~~~  186 (429)
T 1nw1_A          151 EEYIPSRPLSC------------------HEI---SLAHMSTKIAKRVAKVHQLEVP  186 (429)
T ss_dssp             ECCCCEEECCT------------------TGG---GSHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEeCCcccCh------------------hhc---CCHHHHHHHHHHHHHHhCCccc
Confidence            99998755521                  001   1124577899999999987543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=87.80  E-value=1.9  Score=35.26  Aligned_cols=107  Identities=15%  Similarity=0.061  Sum_probs=58.5

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc---CCH-----HHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN---AGE-----RERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~-----~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      -.+.||.|..+.||++..       ++..+++|.....   ...     .....+..|+..+........+++++.+.  
T Consensus        38 ~i~~l~~G~~n~vyrv~~-------~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--  108 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-------SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--  108 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-------SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--
T ss_pred             EEEEccCCCcEEEEEEEc-------CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--
Confidence            346789999999999843       1234888943210   000     02222333333222211145567777765  


Q ss_pred             CCCeEEEEecC-CCC-CHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYV-PYG-KLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~-~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .+..++||||+ ++. .+...+....              ...    ..+.+++..|.-+|...
T Consensus       109 ~~~~~lv~e~l~~g~~~l~~~l~~~~--------------~~~----~~~~~lg~~La~lH~~~  154 (420)
T 2pyw_A          109 RTMALIGMRYLEPPHIILRKGLIAGI--------------EYP----FLADHMSDYMAKTLFFT  154 (420)
T ss_dssp             TTTTEEEECCCCTTCEEHHHHHHHTC--------------CCT----THHHHHHHHHHHHHHTT
T ss_pred             CCccEEEEeecCCcchhHHHHHhcCC--------------CCH----HHHHHHHHHHHHHHHhc
Confidence            46679999999 873 3433333210              111    24567778888888654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=85.99  E-value=1.8  Score=36.04  Aligned_cols=103  Identities=13%  Similarity=0.157  Sum_probs=61.5

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEEEe
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIME  103 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv~e  103 (230)
                      .+.|+.|-...+|++...+     .+..+++|+..... ... -...+|..++..+..+.-.+++++.+.  +  .+++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~-~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e  181 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKT-DEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEE  181 (458)
T ss_dssp             EEEECC--CEEEEEEEETT-----TTEEEEEEEECC-C-CSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred             EEEcCCCeEeEEEEEEECC-----CCceEEEEECCCCh-hhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence            4568888889999987632     22447788764221 110 012468888888873443467777763  2  35999


Q ss_pred             cCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820        104 YVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus       104 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      |++|.+|..                  ..+..   ..++.+++..|+-||.....
T Consensus       182 ~I~G~~l~~------------------~~l~~---~~~~~~ia~~La~LH~~~~~  215 (458)
T 2qg7_A          182 FMDGYALSR------------------EDIKN---PKFQKLIAKNLKLLHDIKLN  215 (458)
T ss_dssp             CCCSEECCT------------------TTTTS---HHHHHHHHHHHHHHHTCCCC
T ss_pred             eeCCccCCh------------------hhcCC---HHHHHHHHHHHHHHhcCCcc
Confidence            999865521                  01111   24577899999999987543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.70  E-value=0.057  Score=45.23  Aligned_cols=64  Identities=11%  Similarity=0.169  Sum_probs=17.2

Q ss_pred             eEeeeecceeceeEEEeEEeccCCCCCceEEEE------EecCC-cCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         22 KVFDILGEGCFGQVWKCEALGIDGREGPCIVAV------KTLKE-NAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vav------K~~~~-~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .+.+.||   ||.||.|.+.+.     ...||+      |..+. ....+....+.+|..+..... |+|+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~-----~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKK-----HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQ-IPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC--------------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhccccccc-----CCchhhhhccCcccccccccccccccccccccccccccc-ccccCCCcceEEe
Confidence            3445666   999999998542     123777      65543 223344457888888888888 9999998887653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=85.16  E-value=5.7  Score=29.62  Aligned_cols=34  Identities=18%  Similarity=0.306  Sum_probs=29.2

Q ss_pred             CCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhh
Q psy15820        107 YGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFL  152 (230)
Q Consensus       107 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L  152 (230)
                      .-+|.+.+...            +.++++.+++.++.|.+.+|.-+
T Consensus        32 ~vSL~eIL~~~------------~~PlsEEqaWALc~Qc~~~L~~~   65 (229)
T 2yle_A           32 ALSLEEILRLY------------NQPINEEQAWAVCYQCCGSLRAA   65 (229)
T ss_dssp             EEEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccHHHHHHHc------------CCCcCHHHHHHHHHHHHHHHHhh
Confidence            45899999885            56799999999999999998876

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=81.93  E-value=2.1  Score=35.26  Aligned_cols=107  Identities=17%  Similarity=0.131  Sum_probs=61.6

Q ss_pred             eeeecceeceeEEEeEEeccCCC--CCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCeEEE
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGR--EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVI  101 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~~lv  101 (230)
                      .+.+..|-...+|+.........  ..+..+++++..... .. .....+|..++..+..+.-.+++++.+.    -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            45677788888999876421100  013447888764321 11 1122467777776653333456665432    2789


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCC
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV  157 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i  157 (230)
                      +||++|.+|..                  ..+.   ...++.+++..|+-||+..+
T Consensus       149 ~efI~G~~l~~------------------~~l~---~~~~~~~ia~~La~LH~~~~  183 (424)
T 3mes_A          149 EEFIDGEPLTT------------------KQLQ---LTHICVEVAKNMGSLHIINS  183 (424)
T ss_dssp             EECCCSEECCT------------------GGGG---SHHHHHHHHHHHHHHHTHHH
T ss_pred             EEEeCCccCCh------------------hhcC---CHHHHHHHHHHHHHHhcCch
Confidence            99999865421                  0011   12467789999999999865

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	230
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-09
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-08
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-09
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-09
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-08
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-27
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-09
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-27
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-09
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-25
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-07
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-25
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-09
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-25
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-09
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-24
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-09
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-08
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-24
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-12
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-23
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-09
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-23
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-22
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	0.001
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-21
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-21
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-04
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-21
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-09
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-21
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-21
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-07
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-21
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-09
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-20
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-20
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-08
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-20
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-08
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-19
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	0.001
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-19
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-19
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-09
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-19
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-10
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-19
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-19
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-04
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-18
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-08
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-18
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-18
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-17
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-17
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	0.003
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-17
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-17
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-17
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-16
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-15
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-15
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-14
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-14
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-14
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-14
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-14
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-14
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-05
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-14
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-06
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-13
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-13
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-13
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-13
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-12
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-12
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-12
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-12
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-12
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-07
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-10
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-04

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-37
 Identities = 65/156 (41%), Positives = 80/156 (51%), Gaps = 7/156 (4%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR  +     LG G FG+V +  A G+   +    VAVK LK +A   ER  L+
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN----- 125
            EL V+  L  H N+V LLG CT   P  VI EY  YG L +FLR  R     +      
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           M     +L   DL SF YQVA+GM FL+S+    RD
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.7 bits (128), Expect = 3e-09
 Identities = 19/51 (37%), Positives = 34/51 (66%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETD 207
           +++G+R+  P+H   E+Y+IM  CWD +P +RP F ++  L+EK +   T+
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 9e-36
 Identities = 65/161 (40%), Positives = 83/161 (51%), Gaps = 12/161 (7%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           D KWE PR++++   +LG G FG+V    A GI        VAVK LKE A   ER  L+
Sbjct: 29  DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 88

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ---------- 120
            EL +M  L  H N+V LLG CT   P ++I EY  YG L ++LRS R +          
Sbjct: 89  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 121 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +         N LT  DL  F YQVA+GM+FL  +    RD
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (120), Expect = 3e-08
 Identities = 14/46 (30%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++G+++++P +   E+Y IM  CW  +  +RP+F  L   L   L
Sbjct: 280 IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 8e-33
 Identities = 63/152 (41%), Positives = 92/152 (60%), Gaps = 5/152 (3%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGID--GREGPCIVAVKTLKENAGERERLD 68
           D +WE+PR  + +   LGEG FGQV   EA+G+D         VAVK LK +A E++  D
Sbjct: 5   DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD 64

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSR---AQRYYNN 125
           L+ E+ +MK +  H N++ LLG CT+  P +VI+EY   G L+ +L++ R    +  YN 
Sbjct: 65  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
            H     L+S+DL S  YQVARGM++L+S+  
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.1 bits (129), Expect = 2e-09
 Identities = 17/46 (36%), Positives = 33/46 (71%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++G+R++KP +C  ELY +M  CW   P++RP F +L + L++++
Sbjct: 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 2e-29
 Identities = 61/162 (37%), Positives = 86/162 (53%), Gaps = 6/162 (3%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
            KWE PR  +K+   LG G FGQV + +A GID       VAVK LKE A   E   L+ 
Sbjct: 6   SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           EL ++  +  H NVV LLG CT+   P  VI+E+  +G L ++LRS R +     +  + 
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 131 ---NSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
              + LT   L  + +QVA+GM+FL+SR     +R     + 
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCI--HRDLAARNI 165

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.7 bits (128), Expect = 3e-09
 Identities = 19/46 (41%), Positives = 29/46 (63%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +++G R+  PD+   E+Y  M  CW  EP++RP F+EL + L  LL
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-28
 Identities = 51/146 (34%), Positives = 79/146 (54%), Gaps = 4/146 (2%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D+WEV R+ I +   LG+G FG V++  A G+   E    VA+KT+ E A  RER++ L 
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E +VMK  +   +VVRLLG  ++ +P  VIME +  G L+S+LRS    R     +    
Sbjct: 73  EASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS---LRPAMANNPVLA 128

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
             +   +     ++A GM +L++   
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKF 154

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.5 bits (117), Expect = 8e-08
 Identities = 16/46 (34%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           V +G  L+KPD+C   L+ +M  CW   P  RP+F E+   +++ +
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 1e-27
 Identities = 49/147 (33%), Positives = 71/147 (48%), Gaps = 21/147 (14%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLL 70
           +D+WEVPR+ +K+ + LG G FG+VW           G   VAVK+LK+ +   +    L
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGY------YNGHTKVAVKSLKQGSMSPDA--FL 56

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E  +MK L  H  +VRL    T+ EP ++I EY+  G L  FL++    +         
Sbjct: 57  AEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK--------- 105

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV 157
             LT   L     Q+A GM F+  R  
Sbjct: 106 --LTINKLLDMAAQIAEGMAFIEERNY 130

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (124), Expect = 9e-09
 Identities = 19/46 (41%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +  GYR+ +PD+C  ELY +M  CW + P +RP F  L  +LE   
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (256), Expect = 7e-27
 Identities = 52/157 (33%), Positives = 76/157 (48%), Gaps = 12/157 (7%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
              E PR +I+    +GEG FG+V++  A G+   E   +VAVK LKE A    + D  +
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  +M   D +PN+V+LLG C   +P  ++ EY+ YG L  FLRS       +  H   +
Sbjct: 66  EAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 132 S-----------LTSRDLTSFCYQVARGMQFLSSRGV 157
           +           L+  +      QVA GM +LS R  
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 161

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.5 bits (130), Expect = 2e-09
 Identities = 20/46 (43%), Positives = 30/46 (65%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           VRDG  L  P++C  ELYN+M  CW K P +RP+F  +  +L+++ 
Sbjct: 255 VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.9 bits (246), Expect = 1e-25
 Identities = 36/151 (23%), Positives = 56/151 (37%), Gaps = 25/151 (16%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLL 70
           D WE+P   I V   +G G FG V+K +  G         VAVK L       ++     
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFK 52

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
            E+ V++    H N++  +G  T  +   V  ++     L   L            H   
Sbjct: 53  NEVGVLRKTR-HVNILLFMGYSTAPQLAIV-TQWCEGSSLYHHL------------HIIE 98

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                  L     Q A+GM +L ++ +  RD
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (113), Expect = 3e-07
 Identities = 13/54 (24%), Positives = 25/54 (46%)

Query: 149 MQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           + F+  RG       +   +C + +  +M  C  K+ +ERP F ++   +E L 
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.5 bits (242), Expect = 6e-25
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 19/148 (12%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL 69
           + DKWE+ R  I +   LG G +G+V++        ++    VAVKTLKE+  E E    
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVW-----KKYSLTVAVKTLKEDTMEVEEF-- 60

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
           L+E  VMK +  HPN+V+LLG CT + PF++I E++ YG L  +L               
Sbjct: 61  LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-----------RECN 108

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV 157
              +++  L     Q++  M++L  +  
Sbjct: 109 RQEVSAVVLLYMATQISSAMEYLEKKNF 136

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.4 bits (125), Expect = 7e-09
 Identities = 18/58 (31%), Positives = 33/58 (56%), Gaps = 2/58 (3%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL--LNETDYIELE 212
           +   YR+E+P+ C  ++Y +M  CW   P++RP+F E+    E +    + +D +E E
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (240), Expect = 6e-25
 Identities = 40/145 (27%), Positives = 60/145 (41%), Gaps = 23/145 (15%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           W +  + +K+   +G+G FG V   +  G         VAVK +K +A  +     L E 
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGN-------KVAVKCIKNDATAQA---FLAEA 51

Query: 74  TVMKTLDPHPNVVRLLGCCTE-KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
           +VM  L  H N+V+LLG   E K   +++ EY+  G L  +LRS                
Sbjct: 52  SVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----------- 99

Query: 133 LTSRDLTSFCYQVARGMQFLSSRGV 157
           L    L  F   V   M++L     
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEGNNF 124

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.9 bits (129), Expect = 2e-09
 Identities = 17/49 (34%), Positives = 28/49 (57%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           V  GY+++ PD C   +Y +M  CW  +   RP+F +L + LE +  +E
Sbjct: 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 2e-24
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 18/146 (12%)

Query: 13  KWEVPRQHIKVFDI-LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           K  + R ++ + DI LG G FG V +        +     VA+K LK+   + +  ++++
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQI---DVAIKVLKQGTEKADTEEMMR 58

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  +M  LD +P +VRL+G C  +    V ME    G L  FL             GK  
Sbjct: 59  EAQIMHQLD-NPYIVRLIGVCQAEALMLV-MEMAGGGPLHKFL------------VGKRE 104

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
            +   ++    +QV+ GM++L  +  
Sbjct: 105 EIPVSNVAELLHQVSMGMKYLEEKNF 130

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (126), Expect = 5e-09
 Identities = 15/54 (27%), Positives = 25/54 (46%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE 210
           +  G R+E P  C  ELY +M  CW  +  +RP+F  +   +     +    +E
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 2e-24
 Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 16/144 (11%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
           +E+ R+ I++   +GEG FG V +   +  +       VA+KT K    +  R   LQE 
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPA--LAVAIKTCKNCTSDSVREKFLQEA 59

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             M+  D HP++V+L+G  TE   + + ME    G+L+SF            +  +  SL
Sbjct: 60  LTMRQFD-HPHIVKLIGVITENPVWII-MELCTLGELRSF------------LQVRKYSL 105

Query: 134 TSRDLTSFCYQVARGMQFLSSRGV 157
               L  + YQ++  + +L S+  
Sbjct: 106 DLASLILYAYQLSTALAYLESKRF 129

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (122), Expect = 2e-08
 Identities = 19/46 (41%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           + +G RL  P +C   LY++M  CW  +P+ RP FTEL   L  +L
Sbjct: 222 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 8e-24
 Identities = 51/146 (34%), Positives = 75/146 (51%), Gaps = 6/146 (4%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
            +    IK  D++GEG FGQV K      DG       A+K +KE A + +  D   EL 
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKK-DGLR--MDAAIKRMKEYASKDDHRDFAGELE 62

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRA---QRYYNNMHGKSN 131
           V+  L  HPN++ LLG C  +   ++ +EY P+G L  FLR SR       +   +  ++
Sbjct: 63  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
           +L+S+ L  F   VARGM +LS +  
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQF 148

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.4 bits (148), Expect = 6e-12
 Identities = 24/72 (33%), Positives = 40/72 (55%), Gaps = 1/72 (1%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPD 216
           +  GYRLEKP +C  E+Y++M  CW ++P ERP+F ++   L ++L     Y+    +  
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 298

Query: 217 HSYYNMVSLSGE 228
            +Y   +  S E
Sbjct: 299 FTYAG-IDCSAE 309

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 91.7 bits (227), Expect = 8e-23
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 17/156 (10%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
            E+    +K+  ++G G FG+V          RE    VA+KTLK    E++R D L E 
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE--IFVAIKTLKSGYTEKQRRDFLSEA 78

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
           ++M   D HPNV+ L G  T+  P  +I E++  G L SF            +       
Sbjct: 79  SIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSF------------LRQNDGQF 125

Query: 134 TSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
           T   L      +A GM++L+       +R     + 
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNYV--HRDLAARNI 159

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.8 bits (126), Expect = 6e-09
 Identities = 17/49 (34%), Positives = 27/49 (55%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
           +   YRL  P  C   L+ +M  CW K+ N RP F ++ + L+K++ N 
Sbjct: 246 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 92.0 bits (228), Expect = 8e-23
 Identities = 38/174 (21%), Positives = 69/174 (39%), Gaps = 28/174 (16%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           + E  R      D+LG G F +V   E      +    +VA+K + + A E +   +  E
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKR-TQK----LVAIKCIAKKALEGKEGSMENE 57

Query: 73  LTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
           + V+  +  HPN+V L          ++IM+ V  G+L   +              +   
Sbjct: 58  IAVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------------EKGF 103

Query: 133 LTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWDKEPN 186
            T RD +   +QV   +++L   G+          H   +  N++YY  D++  
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIV---------HRDLKPENLLYYSLDEDSK 148

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.0 bits (223), Expect = 3e-22
 Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 21/145 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVM 76
           P    ++   LG+G FG+V+K +      +E   + A K +   + E E  D + E+ ++
Sbjct: 10  PEDFWEIIGELGDGAFGKVYKAQ-----NKETSVLAAAKVIDTKS-EEELEDYMVEIDIL 63

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
            + D HPN+V+LL     +   ++++E+   G + +             M      LT  
Sbjct: 64  ASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAV------------MLELERPLTES 110

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
            +   C Q    + +L    +  RD
Sbjct: 111 QIQVVCKQTLDALNYLHDNKIIHRD 135

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.001
 Identities = 6/36 (16%), Positives = 14/36 (38%)

Query: 159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
           +   L +P        + +  C +K  + R   ++L
Sbjct: 231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 2e-21
 Identities = 27/141 (19%), Positives = 50/141 (35%), Gaps = 19/141 (13%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELT 74
           E+     +    LG G  G V+K       G     ++A K +        R  +++EL 
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKP-SGL----VMARKLIHLEIKPAIRNQIIRELQ 56

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
           V+   +  P +V   G         + ME++  G L   L+             K+  + 
Sbjct: 57  VLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-------------KAGRIP 102

Query: 135 SRDLTSFCYQVARGMQFLSSR 155
            + L      V +G+ +L  +
Sbjct: 103 EQILGKVSIAVIKGLTYLREK 123

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 87.7 bits (217), Expect = 3e-21
 Identities = 24/143 (16%), Positives = 55/143 (38%), Gaps = 21/143 (14%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELT 74
           P +       +G G FG V+    +  +      +VA+K +  +      +  D+++E+ 
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVR-NSE----VVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 75  VMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLT 134
            ++ L  HPN ++  GC   +   +++MEY             +              L 
Sbjct: 68  FLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-------------PLQ 113

Query: 135 SRDLTSFCYQVARGMQFLSSRGV 157
             ++ +  +   +G+ +L S  +
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNM 136

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.4 bits (89), Expect = 4e-04
 Identities = 8/38 (21%), Positives = 13/38 (34%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
            ++     +  H      N +  C  K P +RP    L
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.3 bits (213), Expect = 6e-21
 Identities = 40/169 (23%), Positives = 64/169 (37%), Gaps = 27/169 (15%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERL--DLLQEL 73
           +  + +++ + LG+G FG V + E     G+     VAVK LK +   +     D ++E+
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
             M +LD H N++RL G         V  E  P G L               +       
Sbjct: 63  NAMHSLD-HRNLIRLYGVVLTPPMKMV-TELAPLGSLLDR------------LRKHQGHF 108

Query: 134 TSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCWD 182
               L+ +  QVA GM +L S+            H      N++    D
Sbjct: 109 LLGTLSRYAVQVAEGMGYLESKRF---------IHRDLAARNLLLATRD 148

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.1 bits (124), Expect = 9e-09
 Identities = 17/45 (37%), Positives = 28/45 (62%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
            ++G RL +P+ C +++YN+M  CW  +P +RP F  L D L + 
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 87.4 bits (216), Expect = 6e-21
 Identities = 32/178 (17%), Positives = 61/178 (34%), Gaps = 32/178 (17%)

Query: 5   VLNQKSDDKWEVPRQHI----KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN 60
           +  Q      E+   H+     + + LG G FG V +       G       A K +   
Sbjct: 8   IWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA-TGN----NFAAKFVM-T 61

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQ 120
             E ++  + +E+  M  L  HP +V L     +     +I E++  G+L   +      
Sbjct: 62  PHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV------ 114

Query: 121 RYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMY 178
                   + N ++  +   +  QV +G+  +               H   +  NIM+
Sbjct: 115 ------ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV---------HLDLKPENIMF 157

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 8e-21
 Identities = 36/142 (25%), Positives = 60/142 (42%), Gaps = 21/142 (14%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
           +  + +     LG G FG V   +        G   VA+K +KE +   +    ++E  V
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGK------WRGQYDVAIKMIKEGSMSEDEF--IEEAKV 52

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M  L  H  +V+L G CT++ P F+I EY+  G L ++L                +   +
Sbjct: 53  MMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL------------REMRHRFQT 99

Query: 136 RDLTSFCYQVARGMQFLSSRGV 157
           + L   C  V   M++L S+  
Sbjct: 100 QQLLEMCKDVCEAMEYLESKQF 121

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (111), Expect = 5e-07
 Identities = 15/45 (33%), Positives = 24/45 (53%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKL 201
           +  G RL +P     ++Y IMY CW ++ +ERP F  L   +  +
Sbjct: 214 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.0 bits (212), Expect = 9e-21
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 16/156 (10%)

Query: 14  WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQEL 73
            E+    +    ++G G FG+V+K       G++    VA+KTLK    E++R+D L E 
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE-VPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            +M     H N++RL G  ++ +P  +I EY+  G L  F            +  K    
Sbjct: 61  GIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKF------------LREKDGEF 107

Query: 134 TSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
           +   L      +A GM++L++      +R     + 
Sbjct: 108 SVLQLVGMLRGIAAGMKYLANMNYV--HRDLAARNI 141

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.9 bits (126), Expect = 5e-09
 Identities = 17/46 (36%), Positives = 27/46 (58%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           + DG+RL  P  C   +Y +M  CW +E   RP F ++  +L+KL+
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 86.3 bits (213), Expect = 1e-20
 Identities = 23/136 (16%), Positives = 55/136 (40%), Gaps = 19/136 (13%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
            + + LG G FG V +C      GR    +   K +       ++  +  E+++M  L  
Sbjct: 32  DILEELGSGAFGVVHRCVEKA-TGR----VFVAKFIN-TPYPLDKYTVKNEISIMNQLH- 84

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           HP ++ L     +K    +I+E++  G+L   + +            +   ++  ++ ++
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA------------EDYKMSEAEVINY 132

Query: 142 CYQVARGMQFLSSRGV 157
             Q   G++ +    +
Sbjct: 133 MRQACEGLKHMHEHSI 148

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (210), Expect = 2e-20
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 12  DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQ 71
           D WE+PR+ +++   LG+GCFG+VW           G   VA+KTLK      E    LQ
Sbjct: 10  DAWEIPRESLRLEVKLGQGCFGEVWMGT------WNGTTRVAIKTLKPGTMSPE--AFLQ 61

Query: 72  ELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSN 131
           E  VMK L  H  +V+L    + +EP +++ EY+  G L  FL+    +           
Sbjct: 62  EAQVMKKLR-HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRL------- 112

Query: 132 SLTSRDLTSFCYQVARGMQFLSSRGV 157
                 L     Q+A GM ++     
Sbjct: 113 ----PQLVDMAAQIASGMAYVERMNY 134

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (117), Expect = 8e-08
 Identities = 20/48 (41%), Positives = 25/48 (52%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN 204
           V  GYR+  P  C   L+++M  CW KEP ERP F  L   LE    +
Sbjct: 227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.2 bits (205), Expect = 7e-20
 Identities = 36/142 (25%), Positives = 59/142 (41%), Gaps = 21/142 (14%)

Query: 16  VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTV 75
           +    +     +G G FG V     L  +  +    VA+KT++E A   E  D ++E  V
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL--NKDK----VAIKTIREGAMSEE--DFIEEAEV 53

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M  L  HP +V+L G C E+ P  ++ E++ +G L  +            +  +     +
Sbjct: 54  MMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY------------LRTQRGLFAA 100

Query: 136 RDLTSFCYQVARGMQFLSSRGV 157
             L   C  V  GM +L    V
Sbjct: 101 ETLLGMCLDVCEGMAYLEEACV 122

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (120), Expect = 3e-08
 Identities = 16/46 (34%), Positives = 25/46 (54%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           +  G+RL KP      +Y IM +CW + P +RP F+ L   L ++ 
Sbjct: 215 ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.1 bits (205), Expect = 1e-19
 Identities = 32/154 (20%), Positives = 66/154 (42%), Gaps = 25/154 (16%)

Query: 17  PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTV 75
           P++    F+ +G+G  G V+    +   G+E    VA++ +  +   ++E +  + E+ V
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVA-TGQE----VAIRQMNLQQQPKKELI--INEILV 70

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           M+    +PN+V  L      +  +V+MEY+  G L   +  +                  
Sbjct: 71  MRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------------DE 115

Query: 136 RDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
             + + C +  + ++FL S  V   +R  K D+ 
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVI--HRDIKSDNI 147

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.001
 Identities = 7/34 (20%), Positives = 14/34 (41%)

Query: 161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
             L+ P+       + +  C D +  +R +  EL
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.2 bits (200), Expect = 5e-19
 Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 21/148 (14%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
            +   LGEG +G+V                VAVK +          ++ +E+ + K L+ 
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRV-TEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN- 61

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           H NVV+  G   E    ++ +EY   G+L   +                  +   D   F
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-------------GMPEPDAQRF 108

Query: 142 CYQVARGMQFLSSRGVRDGYRLEKPDHC 169
            +Q+  G+ +L   G+   +R  KP++ 
Sbjct: 109 FHQLMAGVVYLHGIGI--THRDIKPENL 134

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 5e-19
 Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 15/136 (11%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           K   +LG G FG V+K   +  +G +    VA+K L+E    +   ++L E  VM ++D 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           +P+V RLLG C        I + +P+G L             + +    +++ S+ L ++
Sbjct: 70  NPHVCRLLGICLTSTVQL-ITQLMPFGCL------------LDYVREHKDNIGSQYLLNW 116

Query: 142 CYQVARGMQFLSSRGV 157
           C Q+A+GM +L  R +
Sbjct: 117 CVQIAKGMNYLEDRRL 132

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (130), Expect = 2e-09
 Identities = 17/56 (30%), Positives = 28/56 (50%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELE 212
           +  G RL +P  C  ++Y IM  CW  + + RP F EL     K+  +   Y+ ++
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (200), Expect = 6e-19
 Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 19/158 (12%)

Query: 3   DPVLNQKSDDKWEVPRQHIKVF--DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN 60
           +P L Q       +    + V   +++G G FG V+    L  DG++     AVK+L   
Sbjct: 10  NPELVQAVQH-VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK--IHCAVKSLNRI 66

Query: 61  AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE-PFFVIMEYVPYGKLQSFLRSSRA 119
               E    L E  +MK    HPNV+ LLG C   E    V++ Y+ +G L++F      
Sbjct: 67  TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF------ 119

Query: 120 QRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV 157
                 +  ++++ T +DL  F  QVA+GM+FL+S+  
Sbjct: 120 ------IRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (135), Expect = 4e-10
 Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 6/68 (8%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL--LNETDYIELERF 214
           +  G RL +P++C   LY +M  CW  +   RP+F+EL   +  +        Y+ +   
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV--- 303

Query: 215 PDHSYYNM 222
            + +Y N+
Sbjct: 304 -NATYVNV 310

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.6 bits (201), Expect = 6e-19
 Identities = 26/136 (19%), Positives = 52/136 (38%), Gaps = 20/136 (14%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
            + + LG G FG V +C                K +K    ++  +   +E++++     
Sbjct: 8   MIAEDLGRGEFGIVHRCVE-----TSSKKTYMAKFVKVKGTDQVLV--KKEISILNIAR- 59

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
           H N++ L       E   +I E++    +   + +S               L  R++ S+
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSA------------FELNEREIVSY 107

Query: 142 CYQVARGMQFLSSRGV 157
            +QV   +QFL S  +
Sbjct: 108 VHQVCEALQFLHSHNI 123

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.4 bits (198), Expect = 8e-19
 Identities = 31/138 (22%), Positives = 56/138 (40%), Gaps = 18/138 (13%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLD 80
           +V   +G G +G+  K      DG+    I+  K L   +  E E+  L+ E+ +++ L 
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKS-DGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61

Query: 81  PHPNVVRLLGCCTEKE--PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDL 138
            HPN+VR      ++     +++MEY   G L S +     +R Y         L    +
Sbjct: 62  -HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY---------LDEEFV 111

Query: 139 TSFCYQVARGMQFLSSRG 156
                Q+   ++    R 
Sbjct: 112 LRVMTQLTLALKECHRRS 129

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (93), Expect = 1e-04
 Identities = 9/38 (23%), Positives = 16/38 (42%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
           +R+G     P     EL  I+    + +   RP+  E+
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 1e-18
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 22/156 (14%)

Query: 16  VPRQHIKVFD-ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLD-LLQEL 73
           + R+ + + D  LG G FG V K        ++    VAVK LK  A +    D LL E 
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALKDELLAEA 59

Query: 74  TVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSL 133
            VM+ LD +P +VR++G C E E + ++ME    G L  +L+             ++  +
Sbjct: 60  NVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ-------------QNRHV 104

Query: 134 TSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
             +++    +QV+ GM++L        +R     + 
Sbjct: 105 KDKNIIELVHQVSMGMKYLEESNFV--HRDLAARNV 138

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (117), Expect = 8e-08
 Identities = 14/43 (32%), Positives = 21/43 (48%)

Query: 157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE 199
           +  G R+  P  C RE+Y++M  CW  +   RP F  +   L 
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 79.0 bits (194), Expect = 3e-18
 Identities = 31/166 (18%), Positives = 56/166 (33%), Gaps = 27/166 (16%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTL 79
           ++ +ILG G   +V     L    R+    VAVK L+ +        L   +E      L
Sbjct: 10  ELGEILGFGGMSEVHLARDLR-LHRD----VAVKVLRADLARDPSFYLRFRREAQNAAAL 64

Query: 80  DPHPNVVRLLGCCTEKEP----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           + HP +V +      + P     +++MEYV    L+  +                  +T 
Sbjct: 65  N-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-------------TEGPMTP 110

Query: 136 RDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYCW 181
           +          + + F    G+   +R  KP +      N +    
Sbjct: 111 KRAIEVIADACQALNFSHQNGI--IHRDVKPANIMISATNAVKVMD 154

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 78.2 bits (192), Expect = 5e-18
 Identities = 28/159 (17%), Positives = 62/159 (38%), Gaps = 28/159 (17%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--------ERERLDLL 70
           ++ +  +ILG G    V +C       +E     AVK +    G        +  R   L
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKP-TCKE----YAVKIIDVTGGGSFSAEEVQELREATL 57

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           +E+ +++ +  HPN+++L         FF++ + +  G+L  +L              + 
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-------------EK 104

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
            +L+ ++       +   +  L    +   +R  KP++ 
Sbjct: 105 VTLSEKETRKIMRALLEVICALHKLNIV--HRDLKPENI 141

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (190), Expect = 2e-17
 Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 20/135 (14%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPH 82
            +LG+G FG+V+  E      +      A+K LK++    + +    + E  V+     H
Sbjct: 8   KMLGKGSFGKVFLAEFKK-TNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 83  PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFC 142
           P +  +      KE  F +MEY+  G L   ++               +       T + 
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-------------SCHKFDLSRATFYA 109

Query: 143 YQVARGMQFLSSRGV 157
            ++  G+QFL S+G+
Sbjct: 110 AEIILGLQFLHSKGI 124

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.2 bits (187), Expect = 2e-17
 Identities = 33/151 (21%), Positives = 66/151 (43%), Gaps = 25/151 (16%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERE--RLDLL 70
           +W +  +  ++   LG+G FG V+         ++   I+A+K L +   E+      L 
Sbjct: 2   QWAL--EDFEIGRPLGKGKFGNVYLARE-----KQSKFILALKVLFKAQLEKAGVEHQLR 54

Query: 71  QELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           +E+ +   L  HPN++RL G   +    ++I+EY P G +   L+             K 
Sbjct: 55  REVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-------------KL 100

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
           +    +   ++  ++A  + +  S+ V  RD
Sbjct: 101 SKFDEQRTATYITELANALSYCHSKRVIHRD 131

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.3 bits (81), Expect = 0.003
 Identities = 6/33 (18%), Positives = 12/33 (36%)

Query: 162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTEL 194
               PD       +++       P++RP   E+
Sbjct: 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.2 bits (187), Expect = 4e-17
 Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 23/142 (16%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTL 79
           K   ILGEG F  V     L    RE     A+K L++     E +   + +E  VM  L
Sbjct: 11  KFGKILGEGSFSTVVLARELA-TSRE----YAIKILEKRHIIKENKVPYVTRERDVMSRL 65

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
           D HP  V+L     + E  +  + Y   G+L  ++R             K  S       
Sbjct: 66  D-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTR 111

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
            +  ++   +++L  +G+  RD
Sbjct: 112 FYTAEIVSALEYLHGKGIIHRD 133

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.0 bits (184), Expect = 7e-17
 Identities = 37/152 (24%), Positives = 62/152 (40%), Gaps = 24/152 (15%)

Query: 21  IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTL 79
           +K    +G G F  V+K         E    VA   L      + ER    +E  ++K L
Sbjct: 11  LKFDIEIGRGSFKTVYKGLD-----TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 80  DPHPNVVRLLGCC----TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
             HPN+VR           K+   ++ E +  G L+++L+             +   +  
Sbjct: 66  Q-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-------------RFKVMKI 111

Query: 136 RDLTSFCYQVARGMQFLSSRGVRDGYRLEKPD 167
           + L S+C Q+ +G+QFL +R     +R  K D
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.9 bits (186), Expect = 7e-17
 Identities = 23/137 (16%), Positives = 50/137 (36%), Gaps = 26/137 (18%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
            +LG G  G+V +               A+K L++           +E+ +       P+
Sbjct: 18  QVLGLGINGKVLQIFNKR-TQE----KFALKMLQDCP------KARREVELHWRASQCPH 66

Query: 85  VVRLLGCC----TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
           +VR++         ++   ++ME +  G+L S ++    Q             T R+ + 
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----------FTEREASE 115

Query: 141 FCYQVARGMQFLSSRGV 157
               +   +Q+L S  +
Sbjct: 116 IMKSIGEAIQYLHSINI 132

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.6 bits (180), Expect = 6e-16
 Identities = 32/153 (20%), Positives = 59/153 (38%), Gaps = 26/153 (16%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-----ENAGERERLDLLQELTVM 76
            V  I+G G FG+V+ C      G+    + A+K L         GE   L+    L+++
Sbjct: 7   SVHRIIGRGGFGEVYGCRKAD-TGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
            T D  P +V +       +    I++ +  G L   L              +    +  
Sbjct: 62  STGD-CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-------------QHGVFSEA 107

Query: 137 DLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
           D+  +  ++  G++ + +R V   YR  KP + 
Sbjct: 108 DMRFYAAEIILGLEHMHNRFVV--YRDLKPANI 138

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.5 bits (177), Expect = 1e-15
 Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 29/146 (19%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
               ++G G FG V++ + L   G     +VA+K + ++   + R     EL +M+ LD 
Sbjct: 23  TDTKVIGNGSFGVVYQAK-LCDSGE----LVAIKKVLQDKRFKNR-----ELQIMRKLD- 71

Query: 82  HPNVVRLLGCCTEKEP------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           H N+VRL                 ++++YVP    +     SRA++          +L  
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ----------TLPV 121

Query: 136 RDLTSFCYQVARGMQFLSSRGV--RD 159
             +  + YQ+ R + ++ S G+  RD
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRD 147

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 2e-15
 Identities = 36/160 (22%), Positives = 60/160 (37%), Gaps = 19/160 (11%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDL 69
              WEV R   +    +G G +G V       +DGR G   VA+K L +    E      
Sbjct: 11  KTAWEV-RAVYRDLQPVGSGAYGAVCSA----VDGRTG-AKVAIKKLYRPFQSELFAKRA 64

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
            +EL ++K +  H NV+ LL   T  E      ++                        K
Sbjct: 65  YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM---------K 114

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
              L    +    YQ+ +G++++ + G+   +R  KP + 
Sbjct: 115 HEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNL 152

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.7 bits (170), Expect = 6e-15
 Identities = 28/142 (19%), Positives = 52/142 (36%), Gaps = 23/142 (16%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-----ENAGERERLDLLQELTVM 76
           +V  +LG G FG V+    +  D       VA+K ++     +         +  E+ ++
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVS-DNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 77  KTLD-PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           K +      V+RLL      + F +I+E     +      + R             +L  
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER------------GALQE 109

Query: 136 RDLTSFCYQVARGMQFLSSRGV 157
               SF +QV   ++   + GV
Sbjct: 110 ELARSFFWQVLEAVRHCHNCGV 131

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 69.5 bits (169), Expect = 1e-14
 Identities = 26/159 (16%), Positives = 61/159 (38%), Gaps = 30/159 (18%)

Query: 13  KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQE 72
           +W   +   ++   LG G + +V++              V VK LK    ++    + +E
Sbjct: 30  EWGN-QDDYQLVRKLGRGKYSEVFEAI-----NITNNEKVVVKILKPVKKKK----IKRE 79

Query: 73  LTVMKTLDPHPNVVRLLGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKS 130
           + +++ L   PN++ L     +       ++ E+V     +   +               
Sbjct: 80  IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------------- 124

Query: 131 NSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
            +LT  D+  + Y++ + + +  S G+   +R  KP + 
Sbjct: 125 -TLTDYDIRFYMYEILKALDYCHSMGIM--HRDVKPHNV 160

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (168), Expect = 2e-14
 Identities = 28/139 (20%), Positives = 54/139 (38%), Gaps = 23/139 (16%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK----ENAGERERLDLLQELTVMKTLD 80
           D LGEG F  V+K        +    IVA+K +K      A +      L+E+ +++ L 
Sbjct: 4   DFLGEGQFATVYKARD-----KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HPN++ LL     K    ++ +++                    +   S  LT   + +
Sbjct: 59  -HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-------------IKDNSLVLTPSHIKA 104

Query: 141 FCYQVARGMQFLSSRGVRD 159
           +     +G+++L    +  
Sbjct: 105 YMLMTLQGLEYLHQHWILH 123

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.6 bits (167), Expect = 2e-14
 Identities = 36/148 (24%), Positives = 58/148 (39%), Gaps = 24/148 (16%)

Query: 15  EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-----ENAGERERLDL 69
           E    +    + LG G F  V KC      G       A K +K      +     R D+
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKS-TGL----QYAAKFIKKRRTKSSRRGVSREDI 60

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
            +E++++K +  HPNV+ L      K    +I+E V  G+L              +   +
Sbjct: 61  EREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELF-------------DFLAE 106

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGV 157
             SLT  + T F  Q+  G+ +L S  +
Sbjct: 107 KESLTEEEATEFLKQILNGVYYLHSLQI 134

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.8 bits (167), Expect = 2e-14
 Identities = 37/156 (23%), Positives = 65/156 (41%), Gaps = 23/156 (14%)

Query: 9   KSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERL 67
           ++D ++E   +       +GEG +G+V+K   L   GR     VA+K ++ +   E   L
Sbjct: 4   RADQQYECVAE-------IGEGAYGKVFKARDLKNGGR----FVALKRVRVQTGEEGMPL 52

Query: 68  DLLQELTVMKTLDP--HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNN 125
             ++E+ V++ L+   HPNVVRL   CT           + +  +               
Sbjct: 53  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-------DLTTYL 105

Query: 126 MHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                  + +  +    +Q+ RG+ FL S  V  RD
Sbjct: 106 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 141

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (166), Expect = 3e-14
 Identities = 24/142 (16%), Positives = 57/142 (40%), Gaps = 18/142 (12%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKE---NAGERERLDLLQELTV 75
           ++ ++  +LG G +G+V+      I G +   + A+K LK+       +       E  V
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRK--ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81

Query: 76  MKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTS 135
           ++ +   P +V L      +    +I++Y+  G+L + L              +    T 
Sbjct: 82  LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-------------QRERFTE 128

Query: 136 RDLTSFCYQVARGMQFLSSRGV 157
            ++  +  ++   ++ L   G+
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGI 150

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (165), Expect = 4e-14
 Identities = 24/143 (16%), Positives = 46/143 (32%), Gaps = 28/143 (19%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPN 84
           + +G+G FG+VW+ +  G         VAVK            +   E+     L  H N
Sbjct: 9   ESIGKGRFGEVWRGKWRGE-------EVAVKIFSSREERSWFRE--AEIYQTVMLR-HEN 58

Query: 85  VVRLLGCCTEKEP----FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
           ++  +    +        +++ +Y  +G L  +L                  +T   +  
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------------VTVEGMIK 104

Query: 141 FCYQVARGMQFLSSRGVRDGYRL 163
                A G+  L    V    + 
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKP 127

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 5e-05
 Identities = 11/54 (20%), Positives = 15/54 (27%), Gaps = 5/54 (9%)

Query: 157 VRDGYRLEKPDH-----CRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
                R   P+        R +  IM  CW      R     +   L +L   E
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 66.8 bits (162), Expect = 9e-14
 Identities = 21/136 (15%), Positives = 46/136 (33%), Gaps = 21/136 (15%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
           ++   +G G FG ++    +   G E    VA+K         +   L  E  + K +  
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIA-AGEE----VAIKLECVKTKHPQ---LHIESKIYKMMQG 61

Query: 82  HPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSF 141
              +  +  C  E +   ++ME +       F   SR               + + +   
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-------------KFSLKTVLLL 108

Query: 142 CYQVARGMQFLSSRGV 157
             Q+   ++++ S+  
Sbjct: 109 ADQMISRIEYIHSKNF 124

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.2 bits (106), Expect = 2e-06
 Identities = 6/42 (14%), Positives = 15/42 (35%)

Query: 164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE 205
                   E    + +C     +++P+++ L  L   L   +
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.8 bits (162), Expect = 1e-13
 Identities = 26/152 (17%), Positives = 55/152 (36%), Gaps = 26/152 (17%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
                +GEG +G V                VA+K +     +      L+E+ ++     
Sbjct: 11  TNLSYIGEGAYGMVCSAY-----DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 64

Query: 82  HPNVVRLLGCC----TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRD 137
           H N++ +         E+     ++ ++    L   L++                L++  
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--------------LSNDH 110

Query: 138 LTSFCYQVARGMQFLSSRGVRDGYRLEKPDHC 169
           +  F YQ+ RG++++ S  V   +R  KP + 
Sbjct: 111 ICYFLYQILRGLKYIHSANVL--HRDLKPSNL 140

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.3 bits (158), Expect = 3e-13
 Identities = 36/171 (21%), Positives = 58/171 (33%), Gaps = 19/171 (11%)

Query: 11  DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDL 69
              WEVP ++ +    +G G +G V         G      VAVK L +           
Sbjct: 11  KTIWEVPERY-QNLSPVGSGAYGSVCAAFDTK-TGLR----VAVKKLSRPFQSIIHAKRT 64

Query: 70  LQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGK 129
            +EL ++K +  H NV+ LL   T         +      L              N   K
Sbjct: 65  YRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMG---------ADLNNIVK 114

Query: 130 SNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYC 180
              LT   +    YQ+ RG++++ S  +   +R  KP +        +   
Sbjct: 115 CQKLTDDHVQFLIYQILRGLKYIHSADII--HRDLKPSNLAVNEDCELKIL 163

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.9 bits (157), Expect = 4e-13
 Identities = 30/141 (21%), Positives = 64/141 (45%), Gaps = 21/141 (14%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLD 80
           +  + +GEG +G V+K       G     +VA+K ++ +   E      ++E++++K L+
Sbjct: 5   QKVEKIGEGTYGVVYKARNKL-TGE----VVALKKIRLDTETEGVPSTAIREISLLKELN 59

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            HPN+V+LL     +   +++ E++     +    S+               +    + S
Sbjct: 60  -HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL------------TGIPLPLIKS 106

Query: 141 FCYQVARGMQFLSSRGV--RD 159
           + +Q+ +G+ F  S  V  RD
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRD 127

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 64.7 bits (157), Expect = 6e-13
 Identities = 32/145 (22%), Positives = 62/145 (42%), Gaps = 23/145 (15%)

Query: 19  QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVM 76
           Q  ++   LG G FG+V    +   +GR      A+K LK+      ++      E  ++
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRH-NGR----YYAMKVLKKEIVVRLKQVEHTNDERLML 58

Query: 77  KTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSR 136
             +  HP ++R+ G   + +  F+IM+Y+  G+L S             +  KS    + 
Sbjct: 59  SIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-------------LLRKSQRFPNP 104

Query: 137 DLTSFCYQVARGMQFLSSRGV--RD 159
               +  +V   +++L S+ +  RD
Sbjct: 105 VAKFYAAEVCLALEYLHSKDIIYRD 129

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 64.1 bits (155), Expect = 7e-13
 Identities = 27/137 (19%), Positives = 52/137 (37%), Gaps = 21/137 (15%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLD 80
              + +GEG +G V+K +             A+K ++ E   E      ++E++++K L 
Sbjct: 5   HGLEKIGEGTYGVVYKAQ------NNYGETFALKKIRLEKEDEGIPSTTIREISILKELK 58

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            H N+V+L      K+   ++ E++     +                     L S    S
Sbjct: 59  -HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-------------CEGGLESVTAKS 104

Query: 141 FCYQVARGMQFLSSRGV 157
           F  Q+  G+ +   R V
Sbjct: 105 FLLQLLNGIAYCHDRRV 121

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 63.3 bits (153), Expect = 2e-12
 Identities = 34/158 (21%), Positives = 62/158 (39%), Gaps = 29/158 (18%)

Query: 12  DKWEVPRQHIKVFD------ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGE 63
            KWE P Q+    D       LG G FG+V   +      +E     A+K L +      
Sbjct: 28  KKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH-----KESGNHYAMKILDKQKVVKL 82

Query: 64  RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY 123
           ++    L E  +++ ++  P +V+L     +    +++MEYV  G++ S LR        
Sbjct: 83  KQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-------- 133

Query: 124 NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGV--RD 159
                +    +      +  Q+    ++L S  +  RD
Sbjct: 134 -----RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (152), Expect = 2e-12
 Identities = 30/142 (21%), Positives = 51/142 (35%), Gaps = 23/142 (16%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTL 79
               +LG+G FG+V         GR      A+K L++     + E    + E  V++  
Sbjct: 8   DYLKLLGKGTFGKVILVREKA-TGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
             HP +  L       +    +MEY   G+L   L              +    T     
Sbjct: 63  R-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-------------RERVFTEERAR 108

Query: 140 SFCYQVARGMQFLSSRGV--RD 159
            +  ++   +++L SR V  RD
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRD 130

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.2 bits (150), Expect = 4e-12
 Identities = 25/145 (17%), Positives = 55/145 (37%), Gaps = 28/145 (19%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLDLLQELTVMKTLD 80
           +    +G+G FG+V+K       G++    VA+K +  EN  E   +  L+E+ +++ L 
Sbjct: 13  EKLAKIGQGTFGEVFKARHRK-TGQK----VALKKVLMENEKEGFPITALREIKILQLLK 67

Query: 81  PHPNVVRLLGCCTEKEP--------FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNS 132
            H NVV L+  C  K           +++ ++  +                  +      
Sbjct: 68  -HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-------------LSNVLVK 113

Query: 133 LTSRDLTSFCYQVARGMQFLSSRGV 157
            T  ++      +  G+ ++    +
Sbjct: 114 FTLSEIKRVMQMLLNGLYYIHRNKI 138

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.1 bits (147), Expect = 8e-12
 Identities = 41/227 (18%), Positives = 76/227 (33%), Gaps = 44/227 (19%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLK-ENAGERERLDLLQELTVMKTLD 80
           +  + +GEG +G V+K +      RE   IVA+K ++ ++  E      L+E+ ++K L 
Sbjct: 5   EKLEKIGEGTYGTVFKAKN-----RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK 59

Query: 81  PHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTS 140
            H N+VRL       +   ++ E+                         +  L    + S
Sbjct: 60  -HKNIVRLHDVLHSDKKLTLVFEFCDQ-------------DLKKYFDSCNGDLDPEIVKS 105

Query: 141 FCYQVARGMQFLSSRGV--RD---------------------GYRLEKPDHCRRELYNIM 177
           F +Q+ +G+ F  SR V  RD                           P  C       +
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165

Query: 178 YYCWDKEPNERPNFTELCDLLE-KLLLNETDYIELERFPDHSYYNMV 223
           +Y           ++   D+     +  E        FP +   + +
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 61.0 bits (147), Expect = 8e-12
 Identities = 19/138 (13%), Positives = 47/138 (34%), Gaps = 21/138 (15%)

Query: 20  HIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTL 79
           H KV   +GEG FG +++   L ++ ++    VA+K     +   +   L  E    K L
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNL-LNNQQ----VAIKFEPRRSDAPQ---LRDEYRTYKLL 57

Query: 80  DPHPNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
                +  +     E     ++++ +                  + +       + + + 
Sbjct: 58  AGCTGIPNVYYFGQEGLHNVLVIDLLGPS-------------LEDLLDLCGRKFSVKTVA 104

Query: 140 SFCYQVARGMQFLSSRGV 157
               Q+   +Q +  + +
Sbjct: 105 MAAKQMLARVQSIHEKSL 122

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.3 bits (109), Expect = 8e-07
 Identities = 10/39 (25%), Positives = 16/39 (41%)

Query: 164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL 202
           E       E Y  M+Y  +   +  P++  L  L  K+L
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 7e-10
 Identities = 33/178 (18%), Positives = 62/178 (34%), Gaps = 32/178 (17%)

Query: 10  SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTL-KENAGERERLD 68
            D  + V +   +    +G G  G V       +  R     VA+K L +    +     
Sbjct: 9   GDSTFTVLK-RYQNLKPIGSGAQGIVCAAYDA-VLDRN----VAIKKLSRPFQNQTHAKR 62

Query: 69  LLQELTVMKTLDPHPNVVRLLGCCT------EKEPFFVIMEYVPYGKLQSFLRSSRAQRY 122
             +EL +MK ++ H N++ LL   T      E +  +++ME +     Q           
Sbjct: 63  AYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----- 116

Query: 123 YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRLEKPDHCRRELYNIMYYC 180
                          ++   YQ+  G++ L S G+   +R  KP +   +    +   
Sbjct: 117 -----------DHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKIL 161

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 41.6 bits (96), Expect = 4e-05
 Identities = 16/137 (11%), Positives = 41/137 (29%), Gaps = 11/137 (8%)

Query: 22  KVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDP 81
            +   LG G F  VW  + +  +       VA+K ++ +    E      E+ +++ ++ 
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMV-NNTH----VAMKIVRGDKVYTEA--AEDEIKLLQRVN- 67

Query: 82  HPNVVRLLGCCTEK--EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLT 139
             +  +          +         P G     +     +     +    +        
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 140 -SFCYQVARGMQFLSSR 155
                Q+  G+ ++  R
Sbjct: 128 KQISKQLLLGLDYMHRR 144

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 36.7 bits (84), Expect = 8e-04
 Identities = 25/172 (14%), Positives = 53/172 (30%), Gaps = 23/172 (13%)

Query: 25  DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDL--------LQELTVM 76
            ++GEG    V+ C +      E      VK  K      +++             L + 
Sbjct: 6   KLMGEGKESAVFNCYSE--KFGE----CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 77  KTLDPHPNVVRLLGCCTEK----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHG---- 128
              +    + +L G    K    E   V+ME +   +L      +  +     +      
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 129 KSNSLTSRDLTSFCYQVARGMQFLSSRGV-RDGYRLEKPDHCRRELYNIMYY 179
               +   DL+ +   V+    ++       +       +   R++ NI+ Y
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	230
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.98
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.98
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.98
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.95
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.95
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.95
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.94
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.94
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.94
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.94
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.94
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.93
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.93
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.92
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.91
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.82
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.58
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.17
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	94.03
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	91.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	86.54

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-36  Score=240.32  Aligned_cols=180  Identities=36%  Similarity=0.732  Sum_probs=158.2

Q ss_pred             CCcCCCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCC
Q psy15820          3 DPVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPH   82 (230)
Q Consensus         3 ~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h   82 (230)
                      ||+++  +.+.|+|+.++|++.+.||+|+||.||+|.+     ..++..||+|+++....  ..+.+.+|+.++..++ |
T Consensus         3 ~p~~p--~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~-H   72 (287)
T d1opja_           3 DPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVW-----KKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIK-H   72 (287)
T ss_dssp             CTTST--TCCTTBCCGGGEEEEEETTTTTTSSEEEEEE-----GGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCC-C
T ss_pred             CCCCC--CCcccEecHHHeEEeeEEeeCCCeEEEEEEE-----CCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCC-C
Confidence            67777  4478999999999999999999999999999     44566799999975432  3457999999999999 9


Q ss_pred             CceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------
Q psy15820         83 PNVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------  156 (230)
Q Consensus        83 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------  156 (230)
                      ||||++++++...+..+++||||++|+|.+++....           ...+++..++.++.||+.||.|||+++      
T Consensus        73 pnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl  141 (287)
T d1opja_          73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL  141 (287)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC-----------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             CCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc-----------ccchHHHHHHHHHHHHHHHHHHHHHCCcccCcc
Confidence            999999999999999999999999999999987642           235899999999999999999999999      


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       142 Kp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~  221 (287)
T d1opja_         142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  221 (287)
T ss_dssp             SGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence                                                                                            


Q ss_pred             -------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        157 -------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       157 -------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                             +..+.+++.|..+++++.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       222 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   45556778889999999999999999999999999999998887654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=230.46  Aligned_cols=194  Identities=41%  Similarity=0.725  Sum_probs=163.7

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..|+|+.++|++++.||+|+||.||+|.+.+.....++..||+|+++..........+.+|+.++..+.+|||||+++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            35999999999999999999999999999776556778889999998666677778899999999999559999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhc-----cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY-----NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------  156 (230)
                      +......+++||||++|+|.+++.........     .........+++..+..++.||+.||.|||+++          
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            99999999999999999999999875421100     011123345899999999999999999999999          


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence                                                                                            


Q ss_pred             -----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 -----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 -----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                           +..+.++..|..+++++.+||.+||+.||++||||.+|++.|++++.+.
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence                 4455667788899999999999999999999999999999999877653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=230.39  Aligned_cols=207  Identities=34%  Similarity=0.642  Sum_probs=168.3

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      .|+.++|++.+.||+|+||.||+|.+....   ....||||.++........+.+.+|+.++..+.+||||+++++++..
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCC---eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            478899999999999999999999985421   12247888886554555667899999999998449999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhh---hccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQR---YYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      .+..++||||+++|+|.+++.......   ...........+++..+..++.||+.||.|||+++               
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence            999999999999999999997632100   00001123456899999999999999999999999               


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence                                                                                        6677


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhccccccccCCCCcceeeecc
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIELERFPDHSYYNMVS  224 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (230)
                      .+++.|.++++++.+||.+||+.||++||||.+|++.|+.+++..+.+++....+...|.++..
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~~~~~e~~~~~~~~~  306 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDC  306 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCCCCCCCG
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCCCchhhcccccCCCC
Confidence            7888899999999999999999999999999999999999999998888887777777766643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-34  Score=226.12  Aligned_cols=178  Identities=35%  Similarity=0.650  Sum_probs=156.2

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      +|+|++++|++++.||+|+||.||+|.+....  ..+..||+|.++..........+.+|+.++..++ ||||+++++++
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~   77 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVI   77 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            58999999999999999999999999885432  2345689999976666777788999999999998 99999999998


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      . .+.+++||||+++|+|.+++...            ...+++..++.++.||+.||.|||+++                
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~------------~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~  144 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVR------------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN  144 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHT------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET
T ss_pred             e-cCeEEEEEEeccCCcHHhhhhcc------------CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC
Confidence            5 46789999999999999988764            235899999999999999999999999                


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy15820        157 -----------------------------------------------------------------------------VRD  159 (230)
Q Consensus       157 -----------------------------------------------------------------------------i~~  159 (230)
                                                                                                   +..
T Consensus       145 ~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~  224 (273)
T d1mp8a_         145 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN  224 (273)
T ss_dssp             TEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence                                                                                         456


Q ss_pred             CccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        160 GYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       160 ~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      +.+++.|.++|+++.+||.+||+.||++|||+.+|++.|+.+++..+
T Consensus       225 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            66778899999999999999999999999999999999999887654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-34  Score=224.05  Aligned_cols=183  Identities=30%  Similarity=0.598  Sum_probs=158.4

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      -+|..+.|++.+.||+|+||.||+|.+.... ......||||+++..........|.+|+.++..++ |||||+++|++.
T Consensus         2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~   79 (283)
T d1mqba_           2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS   79 (283)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCC-CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEe
Confidence            3688899999999999999999999986543 22345699999976666777778999999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------------
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------------  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------------  156 (230)
                      ..+..+++||||.++++.+++...            ...+++..++.++.||+.||.|||+++                 
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~  147 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREK------------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL  147 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             cCCceEEEEEecccCcchhhhhcc------------cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC
Confidence            999999999999999999988763            235899999999999999999999998                 


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       148 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~  227 (283)
T d1mqba_         148 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN  227 (283)
T ss_dssp             CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh
Confidence                                                                                          56


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccccc
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDYIE  210 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~~~  210 (230)
                      .+.+++.|.++++++.+|+.+||+.||++||||.+|++.|+.+.+...+...
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~~  279 (283)
T d1mqba_         228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT  279 (283)
T ss_dssp             TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred             ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccccc
Confidence            6677888999999999999999999999999999999999998876433333

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-34  Score=225.76  Aligned_cols=179  Identities=28%  Similarity=0.522  Sum_probs=153.6

Q ss_pred             cccccCCCeeEeee-ecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         13 KWEVPRQHIKVFDI-LGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        13 ~~~i~~~~~~~~~~-lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      .|.++.++|.+.+. ||+|+||.||+|.+...   ..+..||||+++........+.|.+|+.++..++ |||||+++++
T Consensus         2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~   77 (285)
T d1u59a_           2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGV   77 (285)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred             ceeecccCeEECCcEEecccCeEEEEEEEecC---CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-CCCEeeEeee
Confidence            36678889999885 99999999999988532   3345699999986666777889999999999998 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +.. +.+++|||||++|+|.+++...            ...+++..++.++.||+.||.|||+++               
T Consensus        78 ~~~-~~~~lvmE~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~  144 (285)
T d1u59a_          78 CQA-EALMLVMEMAGGGPLHKFLVGK------------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN  144 (285)
T ss_dssp             EES-SSEEEEEECCTTEEHHHHHTTC------------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE
T ss_pred             ecc-CeEEEEEEeCCCCcHHHHhhcc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc
Confidence            865 5689999999999999987653            235899999999999999999999999               


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       145 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~  224 (285)
T d1u59a_         145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF  224 (285)
T ss_dssp             TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH
T ss_pred             CCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcccc
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNETDY  208 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~~~  208 (230)
                      +..+.+++.|+++|+++.+|+.+||+.||++||||.+|++.|+..+.+....
T Consensus       225 i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence            5566778889999999999999999999999999999999998877654443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-34  Score=226.51  Aligned_cols=175  Identities=34%  Similarity=0.628  Sum_probs=153.4

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      +++.++|++.+.||+|+||.||+|.+....  .....||+|.+.........+.|.+|+.++..++ |||||+++|++..
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~   98 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPG--KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTK   98 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEee
Confidence            577889999999999999999999985332  1233589999876667777788999999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+.+++|||||++|+|.+++...            ...+++..++.++.||+.||.|||+++                  
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~------------~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~  166 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQN------------DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV  166 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTT------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred             CCEEEEEEEecCCCcceeeeccc------------cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc
Confidence            99999999999999999988763            234899999999999999999999999                  


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     +
T Consensus       167 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i  246 (299)
T d1jpaa_         167 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI  246 (299)
T ss_dssp             EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence                                                                                           4


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      ..+.+++.|..+++++.+|+.+||+.||++|||+.+|++.|+.+++.
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         247 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            45567788889999999999999999999999999999999998864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-34  Score=222.69  Aligned_cols=168  Identities=31%  Similarity=0.614  Sum_probs=148.0

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |+.++|++++.||+|+||.||+|.+.      ++..||+|+++....  ..+.+.+|+.++..++ ||||++++|++...
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~   72 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQ   72 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET------TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC------CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcC-CCCcccccceeccC
Confidence            67889999999999999999999883      234699999975422  2356999999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..++|||||++|+|.+++...            ...+++..++.++.||+.||.|||+++                   
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~  140 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRTQ------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI  140 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCE
T ss_pred             CceEEEEEecCCCcHHHHhhcc------------ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCe
Confidence            9999999999999999998763            235789999999999999999999999                   


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                +..+.+
T Consensus       141 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~  220 (263)
T d1sm2a_         141 KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR  220 (263)
T ss_dssp             EECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC
T ss_pred             EecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC
Confidence                                                                                      455567


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      +..|..+++++.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            778899999999999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-34  Score=224.48  Aligned_cols=174  Identities=39%  Similarity=0.757  Sum_probs=150.4

Q ss_pred             CCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         10 SDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        10 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      ..+.|+|+.++|++++.||+|+||.||+|.+.      ++..||||+++...  ...+.+.+|+.++..++ |||||+++
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~~~   74 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQ-HQRLVRLY   74 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCC-CTTBCCEE
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCC-CCCEeEEE
Confidence            46789999999999999999999999999873      34569999997432  22357999999999998 99999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------  156 (230)
                      +++.. +..++|||||++|+|.+++.....           ..+++..++.++.||+.||.|||+++             
T Consensus        75 g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~-----------~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll  142 (272)
T d1qpca_          75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSG-----------IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV  142 (272)
T ss_dssp             EEECS-SSCEEEEECCTTCBHHHHTTSHHH-----------HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             eeecc-CCeEEEEEeCCCCcHHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee
Confidence            98754 568999999999999997765321           24899999999999999999999999             


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       143 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~  222 (272)
T d1qpca_         143 SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN  222 (272)
T ss_dssp             CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred             ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      +..+.++..|.++++++.+|+.+||+.||++|||+.+|++.|+.++.+
T Consensus       223 i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            456677888899999999999999999999999999999999887754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-34  Score=226.69  Aligned_cols=188  Identities=36%  Similarity=0.621  Sum_probs=161.7

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.|+|+.++|++++.||+|+||.||+|.+.+.....++..||||+++..........+.+|+.++..+. ||||++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeeeeE
Confidence            469999999999999999999999999997655445567799999986666777778999999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +...+..++||||+++|+|.+++...+.....   ......+++..+..++.|++.||.|||+++               
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN---NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHH---CTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhccccccc---ccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC
Confidence            99999999999999999999999875432111   112234688899999999999999999998               


Q ss_pred             -------------------------------------------------------------------------------C
Q psy15820        157 -------------------------------------------------------------------------------V  157 (230)
Q Consensus       157 -------------------------------------------------------------------------------i  157 (230)
                                                                                                     +
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i  248 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  248 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence                                                                                           5


Q ss_pred             CCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        158 RDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       158 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                      ..+.+++.|..+++.+.+||.+||+.||++|||+.+|++.|++.++
T Consensus       249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            5667788889999999999999999999999999999998876544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-33  Score=227.08  Aligned_cols=190  Identities=40%  Similarity=0.703  Sum_probs=152.1

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      +..|+|++++|++++.||+|+||.||+|.+.+.........||+|.+...........+.+|+.++..+..|||||++++
T Consensus        29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            34588999999999999999999999999987665555667999998755555566789999999999844999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhc----------cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY----------NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----  156 (230)
                      ++...+.+++|||||++|+|.+++...+.....          .........+++..++.++.||+.||.|||+++    
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR  188 (325)
T d1rjba_         109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  188 (325)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            999999999999999999999999864321000          000011235889999999999999999999999    


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence                                                                                            


Q ss_pred             -----------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        157 -----------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       157 -----------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                                 +..+.+++.|..+++++.+||.+||+.||++|||+.+|++.|..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence                       34455677888999999999999999999999999999998853

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=220.24  Aligned_cols=168  Identities=33%  Similarity=0.649  Sum_probs=146.8

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |+|+.++|++++.||+|+||.||+|.+.+       ..||+|+++...   ..+.+.+|+.++.+++ ||||++++|++.
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~i~~~~---~~~~~~~E~~~l~~l~-HpnIv~~~g~~~   70 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLLGVIV   70 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC-----HHHHHTHHHHTTCC-CTTBCCEEEEEC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEECC-------eEEEEEEECcHH---HHHHHHHHHHHHHhCC-CCCEeeEEEEEE
Confidence            89999999999999999999999998843       349999997542   3356899999999998 999999999886


Q ss_pred             c-CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         94 E-KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        94 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      . .+.+++||||+++|+|.+++.....           ..+++..++.++.||+.||.|||+++                
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~-----------~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~  139 (262)
T d1byga_          71 EEKGGLYIVTEYMAKGSLVDYLRSRGR-----------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED  139 (262)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHHH-----------HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred             ecCCcEEEEEeccCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC
Confidence            5 4568999999999999999976431           13789999999999999999999999                


Q ss_pred             -------------------------------------------------------------------------CCCCccC
Q psy15820        157 -------------------------------------------------------------------------VRDGYRL  163 (230)
Q Consensus       157 -------------------------------------------------------------------------i~~~~~~  163 (230)
                                                                                               +..+.++
T Consensus       140 ~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~  219 (262)
T d1byga_         140 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM  219 (262)
T ss_dssp             SCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred             CCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence                                                                                     5667888


Q ss_pred             CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        164 EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       164 ~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                      +.|..+++++.+|+.+||+.||++||||.+|++.|+.+..
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999999999999988754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-33  Score=222.06  Aligned_cols=193  Identities=41%  Similarity=0.814  Sum_probs=155.3

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCC--CCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeE
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGR--EGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRL   88 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l   88 (230)
                      ++.|.|+.++|++++.||+|+||.||+|...+....  ..+..||+|+++..........+.+|...+..+.+|||||++
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            455999999999999999999999999998765422  334579999998776777778899999999988559999999


Q ss_pred             eeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhh---ccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------
Q psy15820         89 LGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRY---YNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------  156 (230)
Q Consensus        89 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------  156 (230)
                      ++++...+.+++|||||++|+|.+++......+.   ..........+++..++.++.||+.||.|||+++         
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~  164 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  164 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence            9999999999999999999999999986432110   0011112345899999999999999999999999         


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence                                                                                            


Q ss_pred             -----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        157 -----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       157 -----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                           +..+.+++.|.++++++.+|+.+||+.||.+|||+.+|++.|+.++.
T Consensus       245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                 45667788899999999999999999999999999999999998864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=221.23  Aligned_cols=173  Identities=26%  Similarity=0.453  Sum_probs=146.7

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ++|+|+.++|++++.||+|+||.||+|++.+        .||||+++.. ........|.+|+.++..++ ||||+++++
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~   71 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG   71 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS--------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC--------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeE
Confidence            5799999999999999999999999997632        3999999643 34556778999999999998 999999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      ++.. +.+++|||||++|+|.+++...            ...+++..++.++.||+.||.|||+++              
T Consensus        72 ~~~~-~~~~lv~Ey~~~g~L~~~l~~~------------~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~  138 (276)
T d1uwha_          72 YSTA-PQLAIVTQWCEGSSLYHHLHII------------ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH  138 (276)
T ss_dssp             EECS-SSCEEEEECCCEEEHHHHHHTS------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EEec-cEEEEEEecCCCCCHHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc
Confidence            8754 5689999999999999999763            335899999999999999999999999              


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       139 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~  218 (276)
T d1uwha_         139 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI  218 (276)
T ss_dssp             TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred             CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence                                                                                            


Q ss_pred             ---CCCCcc----CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        157 ---VRDGYR----LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       157 ---i~~~~~----~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                         +..+..    ...+.+|++++.+|+.+||+.||++||||.+|++.|+.+.++.|
T Consensus       219 ~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence               111111    12456799999999999999999999999999999998876543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-33  Score=222.07  Aligned_cols=189  Identities=38%  Similarity=0.676  Sum_probs=160.5

Q ss_pred             cccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         13 KWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        13 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      .|+++.++|++++.||+|+||.||+|++.+.....++..||||+++..........+.+|+.++..++ ||||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-CCCcccceeee
Confidence            37888999999999999999999999998766667778899999987666777788999999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhc-----------cccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYY-----------NNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----  156 (230)
                      ...+..++++||+++|+|.+++.........           .........+++..++.++.|++.||+|||+++     
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD  165 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  165 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence            9999999999999999999999764311000           001112334889999999999999999999998     


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence                                                                                            


Q ss_pred             ---------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHH
Q psy15820        157 ---------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLL  202 (230)
Q Consensus       157 ---------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~  202 (230)
                               +..+.+++.|..+++++.+|+.+||+.||++||||.+|++.|++++
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                     5666677788999999999999999999999999999999998875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=221.30  Aligned_cols=180  Identities=36%  Similarity=0.678  Sum_probs=154.7

Q ss_pred             CcCCCCCCCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCC
Q psy15820          4 PVLNQKSDDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHP   83 (230)
Q Consensus         4 ~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~   83 (230)
                      |..+...-+.|+|+.++|++++.||+|+||.||+|.+.     . +..||+|+++....  ..+.|.+|+.++..++ |+
T Consensus         2 ~~~~~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~-----~-~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~-h~   72 (285)
T d1fmka3           2 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-----G-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLR-HE   72 (285)
T ss_dssp             CCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEET-----T-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCC-CT
T ss_pred             CCCCCCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEEC-----C-CCEEEEEEECcccC--CHHHHHHHHHHHHhcc-cC
Confidence            55666778889999999999999999999999999883     2 23599999974432  2357999999999999 99


Q ss_pred             ceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------
Q psy15820         84 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------  156 (230)
Q Consensus        84 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------  156 (230)
                      |||++++++.. +..++|||||++|+|..++....           ...+++..++.++.||+.||+|||+++       
T Consensus        73 nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~-----------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlK  140 (285)
T d1fmka3          73 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-----------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR  140 (285)
T ss_dssp             TBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-----------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc-----------cccchHHHHHHHHHHHHHHHHHHhhhheeccccc
Confidence            99999999854 56899999999999998887643           234899999999999999999999999       


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       141 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~  220 (285)
T d1fmka3         141 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN  220 (285)
T ss_dssp             GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             ceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH
Confidence                                                                                            


Q ss_pred             ------CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        157 ------VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       157 ------i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                            +..+.+.+.|..|++++.++|.+||+.||++|||+.+|++.|+..+.+
T Consensus       221 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         221 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                  455667788999999999999999999999999999999988775543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-33  Score=219.52  Aligned_cols=194  Identities=41%  Similarity=0.710  Sum_probs=158.0

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      +.|+|+.++|++++.||+|+||.||+|.+.+.....+++.||+|+++..........+.+|...+..+.+|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            45899999999999999999999999999877767778889999998666666777889999999888669999999998


Q ss_pred             EecC-CCeEEEEecCCCCCHHHHHHHhhhhhhccc---cCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-----------
Q psy15820         92 CTEK-EPFFVIMEYVPYGKLQSFLRSSRAQRYYNN---MHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-----------  156 (230)
Q Consensus        92 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-----------  156 (230)
                      +... ..++++||||++|+|.+++...+.......   .......+++..++.++.||+.||.|||+++           
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI  165 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  165 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence            8654 468999999999999999987542110000   0011235889999999999999999999999           


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence                                                                                            


Q ss_pred             ----CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        157 ----VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       157 ----i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                          +..+.++..|..+++++.+++.+||+.||++|||+.+|++.|+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence                3445567778899999999999999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=219.63  Aligned_cols=163  Identities=33%  Similarity=0.640  Sum_probs=143.4

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      |+.++|++++.||+|+||.||+|.+.      ++..||+|.++....  ..+.+.+|+.++..+. ||||++++|++...
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCC-CTTBCCEEEEECCS
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcC-CCceeeEEEEEeeC
Confidence            46789999999999999999999983      345699999974322  2357999999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +.+++||||+++|+|.+++....            ..+++..+..++.|+++||.|||+++                   
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~------------~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~  139 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMR------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV  139 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGG------------GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCE
T ss_pred             CceEEEEEccCCCcHHHhhhccc------------cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcE
Confidence            99999999999999999877642            24789999999999999999999999                   


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                +..+.+
T Consensus       140 kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~  219 (258)
T d1k2pa_         140 KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR  219 (258)
T ss_dssp             EECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC
Confidence                                                                                      556667


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLE  199 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~  199 (230)
                      +..|..+++++.+||.+||+.||++||||.+|++.|.
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            8889999999999999999999999999999998774

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-32  Score=214.55  Aligned_cols=168  Identities=30%  Similarity=0.567  Sum_probs=141.1

Q ss_pred             CCCeeEe-eeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVF-DILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      .+.+.+. +.||+|+||.||+|.+..   ..++..||+|+++.. ......+.+.+|+.++..++ |||||++++++.. 
T Consensus         5 ~~~~~le~k~iG~G~fG~Vy~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-   79 (277)
T d1xbba_           5 RKLLTLEDKELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-   79 (277)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEEC---SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-
T ss_pred             hhhCeecCCCcccCCCeEEEEEEEcc---CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-
Confidence            3444443 469999999999998754   334567999999643 33445678999999999998 9999999999865 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..++|||||++|+|.+++...             ..+++..++.++.||+.||.|||+++                   
T Consensus        80 ~~~~lvmE~~~~g~L~~~l~~~-------------~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~  146 (277)
T d1xbba_          80 ESWMLVMEMAELGPLNKYLQQN-------------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA  146 (277)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC-------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             CCEEEEEEcCCCCcHHHHHhhc-------------cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcc
Confidence            5689999999999999998863             24899999999999999999999999                   


Q ss_pred             ----------------------------------------------------------------------------CCCC
Q psy15820        157 ----------------------------------------------------------------------------VRDG  160 (230)
Q Consensus       157 ----------------------------------------------------------------------------i~~~  160 (230)
                                                                                                  +..+
T Consensus       147 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~  226 (277)
T d1xbba_         147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG  226 (277)
T ss_dssp             EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             cccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence                                                                                        5566


Q ss_pred             ccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHh
Q psy15820        161 YRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLL  203 (230)
Q Consensus       161 ~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~  203 (230)
                      .+++.|..||+++.+|+.+||+.||++|||+.+|++.|...+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            7888899999999999999999999999999999988877654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2e-31  Score=213.09  Aligned_cols=176  Identities=31%  Similarity=0.608  Sum_probs=146.4

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      +..++|++++.||+|+||.||+|.+.... +.....||+|.++........+.+.+|+.++..++ |||||+++|++.. 
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~-   82 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT-   82 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES-
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCC-CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-
Confidence            45678999999999999999999985433 22234689999875545555678999999999998 9999999999976 


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +..++++|++.+|+|.+++...            ...+++..++.++.||+.||.|||+++                   
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~  150 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREH------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV  150 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHT------------SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred             CCeeEEEEeccCCccccccccc------------ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCe
Confidence            4678889999999999988774            335899999999999999999999999                   


Q ss_pred             ---------------------------------------------------------------------------CCCCc
Q psy15820        157 ---------------------------------------------------------------------------VRDGY  161 (230)
Q Consensus       157 ---------------------------------------------------------------------------i~~~~  161 (230)
                                                                                                 +..+.
T Consensus       151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~  230 (317)
T d1xkka_         151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  230 (317)
T ss_dssp             EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred             EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence                                                                                       44566


Q ss_pred             cCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        162 RLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       162 ~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                      +++.|+.+++++.+|+.+||+.||++|||+.+|++.|..+.....
T Consensus       231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~  275 (317)
T d1xkka_         231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  275 (317)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred             CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence            788889999999999999999999999999999999988876543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.6e-32  Score=210.92  Aligned_cols=164  Identities=22%  Similarity=0.367  Sum_probs=139.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      .++|++.+.||+|+||.||+|.+     +.++..||+|.++.. ......+.+.+|+.++..+. ||||+++++++.+  
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~   76 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRR-----KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC--
T ss_pred             chhCEEeEEEecCCCeEEEEEEE-----CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCC
Confidence            46899999999999999999998     556677999999643 45666778999999999999 9999999999864  


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      .+.+|+|||||++|+|.+++.....         ....+++..++.++.|++.||.|||+++                  
T Consensus        77 ~~~~~ivmEy~~~g~L~~~i~~~~~---------~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll  147 (269)
T d2java1          77 NTTLYIVMEYCEGGDLASVITKGTK---------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL  147 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHH---------HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccc---------cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc
Confidence            4568999999999999999976432         1345899999999999999999999864                  


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       148 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~  227 (269)
T d2java1         148 DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  227 (269)
T ss_dssp             CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence                                                                                          33


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .+.....|..+++++.+|+.+||+.||++|||+.||++
T Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            44455677889999999999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.2e-31  Score=208.41  Aligned_cols=170  Identities=32%  Similarity=0.626  Sum_probs=138.1

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      -|+.++|++.+.||+|+||.||+|.+....  .....||+|+++..  ........|.+|+.++..++ ||||++++|++
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~   80 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVV   80 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE
Confidence            477899999999999999999999886543  23346899998643  23345578999999999998 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      .+ +..++|||||++|++.+.+....            ..+++..++.++.||+.||.|||+++                
T Consensus        81 ~~-~~~~lv~e~~~~~~l~~~~~~~~------------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~  147 (273)
T d1u46a_          81 LT-PPMKMVTELAPLGSLLDRLRKHQ------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR  147 (273)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHHG------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET
T ss_pred             ee-cchheeeeeecCcchhhhhhccc------------CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc
Confidence            66 56789999999999999887643            24899999999999999999999999                


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       148 ~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i  227 (273)
T d1u46a_         148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI  227 (273)
T ss_dssp             TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q psy15820        157 VRDGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEK  200 (230)
Q Consensus       157 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~  200 (230)
                      ...+.+++.|.++|+++.+|+.+||+.||++||||.+|++.|.+
T Consensus       228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            34555677888999999999999999999999999999988765

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5e-31  Score=209.99  Aligned_cols=167  Identities=34%  Similarity=0.636  Sum_probs=144.0

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec-CCCeEEE
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE-KEPFFVI  101 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~-~~~~~lv  101 (230)
                      +.++||+|+||+||+|.+....  .....||||+++..........|.+|+.++.+++ ||||++++|++.. .+..++|
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEE
Confidence            3678999999999999985432  2234689999976667777889999999999999 9999999999865 4578999


Q ss_pred             EecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------------
Q psy15820        102 MEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------------  156 (230)
Q Consensus       102 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------------  156 (230)
                      ||||++|+|.+++...            ...+++..++.++.|++.||.|||+.+                         
T Consensus       108 ~E~~~~g~l~~~~~~~------------~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNE------------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EECCTTCBHHHHHHCT------------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEeecCchhhhhccc------------cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEeccc
Confidence            9999999999998763            234678889999999999999999998                         


Q ss_pred             -----------------------------------------------------------------------CCCCccCCC
Q psy15820        157 -----------------------------------------------------------------------VRDGYRLEK  165 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~~~~~~  165 (230)
                                                                                             +..+.++..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~  255 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  255 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                                                                                   456678888


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhh
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLN  204 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~  204 (230)
                      |..+++++.+|+.+||+.||++|||+.||++.|+++..+
T Consensus       256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            999999999999999999999999999999999999865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.1e-32  Score=211.63  Aligned_cols=120  Identities=25%  Similarity=0.377  Sum_probs=102.8

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++++.||+|+||.||+|.+     +.++..||+|+++........+.+.+|+.++..+. ||||+++++++.+.+.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVN-----RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEE-----CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCce
Confidence            46799999999999999999999     55667799999965444445567899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +|+|||||++|+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~-------------~~l~e~~~~~i~~qi~~al~ylH~~~  123 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPD-------------IGMPEPDAQRFFHQLMAGVVYLHGIG  123 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTT-------------TBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEeccCCCcHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            99999999999999888542             35899999999999999999999999

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-31  Score=207.63  Aligned_cols=159  Identities=21%  Similarity=0.423  Sum_probs=137.2

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      .++|++++.||+|+||.||+|.+     +.++..||+|++....  .......+.+|+.++..+. ||||+++++++.+.
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~   78 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLARE-----KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDA   78 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEE-----CCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEEC
Confidence            46899999999999999999998     4566779999985321  1223456889999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +.+++|||||++|+|.+++....             .+++..+..++.||+.||.|||+++                   
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~-------------~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~  145 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLS-------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGEL  145 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEeecCCCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCE
Confidence            99999999999999999998642             4899999999999999999999999                   


Q ss_pred             ----------------------------------------------------------------------CCCCccCCCC
Q psy15820        157 ----------------------------------------------------------------------VRDGYRLEKP  166 (230)
Q Consensus       157 ----------------------------------------------------------------------i~~~~~~~~p  166 (230)
                                                                                            +. ......|
T Consensus       146 kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-~~~~~~p  224 (263)
T d2j4za1         146 KIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVEFTFP  224 (263)
T ss_dssp             EECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-TTCCCCC
T ss_pred             eecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence                                                                                  11 1234567


Q ss_pred             CcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        167 DHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       167 ~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ..+++++.+|+.+||+.||++|||+.|+++
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            789999999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=7.3e-31  Score=208.61  Aligned_cols=120  Identities=27%  Similarity=0.431  Sum_probs=100.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+.|++++.||+|+||.||+|.+     +.++..||+|++...........+.+|+.++..+. ||||+++++++.+.+.
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAED-----KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYESGGH   81 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEE-----TTTCCEEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEeeccCeEEEEEEE-----CCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence            35699999999999999999998     45567799999965443444567889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +|+|||||+||+|.+++...             ..+++..+..++.||+.||.|||+++
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~-------------~~l~e~~~~~~~~qi~~al~ylH~~~  127 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEK-------------GFYTERDASRLIFQVLDAVKYLHDLG  127 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEeccCCCcHHHhhhcc-------------cCCCHHHHHHHHHHHHHHHHhhhhce
Confidence            99999999999999999763             35899999999999999999999999

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-31  Score=208.31  Aligned_cols=120  Identities=23%  Similarity=0.518  Sum_probs=105.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .+.|++++.||+|+||.||+|.+     ..++..||+|+++.. .....+.+.+|+.++..+. |||||++++++.+.+.
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~   83 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQN-----KETSVLAAAKVIDTK-SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENN   83 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEE-----CCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCe
Confidence            35689999999999999999998     455667999998643 2334567899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++|||||++|+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~------------~~~l~e~~~~~i~~qi~~gL~ylH~~~  130 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLEL------------ERPLTESQIQVVCKQTLDALNYLHDNK  130 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999988763            234899999999999999999999999

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.3e-31  Score=206.96  Aligned_cols=119  Identities=30%  Similarity=0.441  Sum_probs=105.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-----CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-----GERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ++|++++.||+|+||.||+|.+     +.++..||+|+++...     .....+.+.+|+.++..+. |||||++++++.
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~-----~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~   83 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCRE-----KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE   83 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEE-----CCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence            5799999999999999999998     5566779999985321     1223567999999999999 999999999999


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +.+.+|+|||||++|+|.+++....             .+++..++.++.|++.||.|||+++
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~-------------~l~~~~~~~~~~qi~~al~yLH~~~  133 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKE-------------SLTEEEATEFLKQILNGVYYLHSLQ  133 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ECCEEEEEEEcCCCccccchhcccc-------------ccchhHHHHHHHHHHHHHHhhhhcc
Confidence            9999999999999999999998742             4899999999999999999999999

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.7e-31  Score=206.44  Aligned_cols=158  Identities=20%  Similarity=0.424  Sum_probs=134.4

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++.... ...+.+.+|+.++..+. ||||+++++++...+.
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~-----~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~   91 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMD-----VATGQEVAIRQMNLQQQ-PKKELIINEILVMRENK-NPNIVNYLDSYLVGDE   91 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEB-----TTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             ccccEEEEEEecCcCcEEEEEEE-----CCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence            45799999999999999999998     55667799999864322 22467899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------------
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------------  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------------  156 (230)
                      +|+|||||+||+|.+++...              .+++..+..++.||+.||.|||++|                     
T Consensus        92 ~~ivmEy~~gg~L~~~~~~~--------------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl  157 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTET--------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL  157 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEecCCCcHHHHhhcc--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEee
Confidence            99999999999999987652              4899999999999999999999999                     


Q ss_pred             -----------------------------------------------------------------------CCCC-ccCC
Q psy15820        157 -----------------------------------------------------------------------VRDG-YRLE  164 (230)
Q Consensus       157 -----------------------------------------------------------------------i~~~-~~~~  164 (230)
                                                                                             +..+ ....
T Consensus       158 ~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~  237 (293)
T d1yhwa1         158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ  237 (293)
T ss_dssp             CCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS
T ss_pred             ccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence                                                                                   0000 1223


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      .|..+++++.+||.+||+.||++|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            45678999999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-30  Score=207.72  Aligned_cols=123  Identities=20%  Similarity=0.338  Sum_probs=110.5

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      +|..++|++.+.||+|+||.||+|.+     ..++..||+|+++..........+.+|+.++..+. |||||++++++.+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~   75 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSH-----KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS   75 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEE-----TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEEC
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEE-----CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence            56788999999999999999999998     56677899999976555566678999999999999 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc-C
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR-G  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~-~  156 (230)
                      .+.+++|||||+||+|.+++....             .+++..+..++.|++.||.|||++ +
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~~-------------~l~~~~~~~~~~qil~aL~yLH~~~~  125 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKAG-------------RIPEQILGKVSIAVIKGLTYLREKHK  125 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999998642             489999999999999999999975 7

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=8e-30  Score=199.76  Aligned_cols=121  Identities=20%  Similarity=0.351  Sum_probs=106.3

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC--------HHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG--------ERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      .++|++.+.||+|+||+||+|.+     ..++..+|+|+++....        ......+.+|+.++..+..||||++++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~-----~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~   76 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIH-----KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             cccCEEceEEecCcCeEEEEEEE-----CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            57899999999999999999988     55677899999854311        123456889999999997799999999


Q ss_pred             eEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++.+++.+|+|||||++|+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-------------~l~e~~~~~~~~qi~~al~~lH~~~  130 (277)
T d1phka_          77 DTYETNTFFFLVFDLMKKGELFDYLTEKV-------------TLSEKETRKIMRALLEVICALHKLN  130 (277)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eecccCcceEEEEEcCCCchHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            99999999999999999999999998642             4899999999999999999999999

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=2.8e-30  Score=205.35  Aligned_cols=159  Identities=19%  Similarity=0.386  Sum_probs=134.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      +.|+..+.||+|+||.||+|.+     ..++..||+|+++...  .......+.+|+.++..+. |||||++++++.+.+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARD-----VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEE-----TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEE-----CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECC
Confidence            3499999999999999999998     5667789999986432  3445567999999999999 999999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      .+|+|||||++|+|..++...             ..+++..++.++.||+.||.|||+++                    
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~-------------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~K  155 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHK-------------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK  155 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHT-------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEE
T ss_pred             EEEEEEEecCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEE
Confidence            999999999999887666542             35899999999999999999999999                    


Q ss_pred             ----------------------------------------------------------------------CCCC-ccCCC
Q psy15820        157 ----------------------------------------------------------------------VRDG-YRLEK  165 (230)
Q Consensus       157 ----------------------------------------------------------------------i~~~-~~~~~  165 (230)
                                                                                            +..+ .....
T Consensus       156 l~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~  235 (309)
T d1u5ra_         156 LGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ  235 (309)
T ss_dssp             ECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred             EeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence                                                                                  1111 12234


Q ss_pred             CCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        166 PDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       166 p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      +..+++++.+||.+||+.||++|||+.++++
T Consensus       236 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            5578999999999999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.2e-30  Score=204.90  Aligned_cols=119  Identities=22%  Similarity=0.374  Sum_probs=105.8

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++++.||+|+||.||+|.+     +.++..||+|+++..  ......+.+|+.++..++ ||||+++++++.+.+.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~-----~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVE-----TSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR-HRNILHLHESFESMEE   75 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTE
T ss_pred             ccceEEEEEEecCCCeEEEEEEE-----CCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            46899999999999999999998     566778999999754  233456889999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +|+|||||+||+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~------------~~~l~e~~~~~i~~qi~~al~yLH~~~  122 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTS------------AFELNEREIVSYVHQVCEALQFLHSHN  122 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS------------SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            99999999999999998753            235899999999999999999999999

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=8.7e-30  Score=205.69  Aligned_cols=119  Identities=22%  Similarity=0.404  Sum_probs=106.5

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++++.||+|+||.||+|.+     ..++..||+|++... .....+.+.+|+.++..++ |||||++++++.+.+.+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~-----~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTE-----RATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-----TTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEE-----CCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            5899999999999999999998     566778999999644 3445678899999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|||||+||+|.+++...            ...+++..+..++.||+.||.|||+++
T Consensus        99 ~ivmE~~~gg~L~~~l~~~------------~~~l~e~~~~~i~~qi~~aL~ylH~~~  144 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADE------------HNKMSEDEAVEYMRQVCKGLCHMHENN  144 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCT------------TSCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEcCCCCCHHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            9999999999999998642            235899999999999999999999999

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-29  Score=198.44  Aligned_cols=119  Identities=29%  Similarity=0.486  Sum_probs=102.1

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec---
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE---   94 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~---   94 (230)
                      +.|++.+.||+|+||.||+|.+     ..++..||+|.+... ......+.+.+|++++..++ |||||++++++..   
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~-----~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~   82 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLD-----TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK   82 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred             CEEEeeeEEecCcCcEEEEEEE-----CCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccc
Confidence            3457888999999999999998     455667999998643 45666778999999999999 9999999999864   


Q ss_pred             -CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 -KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                       ...+++|||||++|+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        83 ~~~~~~ivmE~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~qi~~gl~yLH~~~  132 (270)
T d1t4ha_          83 GKKCIVLVTELMTSGTLKTYLKRFK-------------VMKIKVLRSWCRQILKGLQFLHTRT  132 (270)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             cCCEEEEEEeCCCCCcHHHHHhccc-------------cccHHHHHHHHHHHHHHHHHHHHCC
Confidence             345899999999999999998742             4899999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-30  Score=204.90  Aligned_cols=163  Identities=20%  Similarity=0.290  Sum_probs=139.2

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      -++..++|++++.||+|+||.||+|.+     +.++..||+|+++...  .......+.+|+.++..+. ||||++++++
T Consensus         3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~   76 (288)
T d1uu3a_           3 RKKRPEDFKFGKILGEGSFSTVVLARE-----LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFT   76 (288)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEE
T ss_pred             CCCCCCCCEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEE
Confidence            345567899999999999999999999     4556679999986321  1223457899999999999 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +.+.+.+|+|||||+||+|.+++....             .+++..+..++.|++.||.|||+++               
T Consensus        77 ~~~~~~~~ivmEy~~gg~L~~~~~~~~-------------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~  143 (288)
T d1uu3a_          77 FQDDEKLYFGLSYAKNGELLKYIRKIG-------------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE  143 (288)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             EEECCEEEEEEEccCCCCHHHhhhccC-------------CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC
Confidence            999999999999999999999988742             4899999999999999999999999               


Q ss_pred             ------------------------------------------------------------------------------CC
Q psy15820        157 ------------------------------------------------------------------------------VR  158 (230)
Q Consensus       157 ------------------------------------------------------------------------------i~  158 (230)
                                                                                                    +.
T Consensus       144 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~  223 (288)
T d1uu3a_         144 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII  223 (288)
T ss_dssp             TSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH
Confidence                                                                                          11


Q ss_pred             CCccCCCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        159 DGYRLEKPDHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       159 ~~~~~~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      . .....|..+++++.+||.+||+.||.+|||+.|+++
T Consensus       224 ~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         224 K-LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             T-TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             c-CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            1 234567889999999999999999999999999865

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=2.2e-29  Score=203.46  Aligned_cols=120  Identities=18%  Similarity=0.426  Sum_probs=105.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      .++|++++.||+|+||.||+|.+     ..++..||+|+++... ......+.+|+.++..+. ||||+++++++...+.
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVE-----KATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE  100 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred             ccceEEEEEEecCCCeEEEEEEE-----CCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence            46799999999999999999998     5566779999986542 445567889999999998 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +|+|||||+||+|.+++...            ...+++..++.++.||+.||.|||++|
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~------------~~~l~e~~~~~i~~qi~~aL~ylH~~~  147 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAE------------DYKMSEAEVINYMRQACEGLKHMHEHS  147 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCT------------TCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEcCCCChHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999998877542            335899999999999999999999999

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=6.9e-29  Score=194.65  Aligned_cols=166  Identities=19%  Similarity=0.263  Sum_probs=138.9

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|+++..  ........+.+|+.++..+. ||||+++++++...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~   79 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARD-----LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeec
Confidence            36799999999999999999998     556778999999643  34556678999999999999 99999999998764


Q ss_pred             C----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC---------------
Q psy15820         96 E----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG---------------  156 (230)
Q Consensus        96 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---------------  156 (230)
                      +    ..|+|||||+|++|.+++....             .+++..++.++.||+.||.|||+++               
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~-------------~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~  146 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTEG-------------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA  146 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred             cCCCceEEEEEECCCCCEehhhhcccC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc
Confidence            3    3799999999999999887642             4899999999999999999999999               


Q ss_pred             --------------------------------------------------------------------------------
Q psy15820        157 --------------------------------------------------------------------------------  156 (230)
Q Consensus       157 --------------------------------------------------------------------------------  156 (230)
                                                                                                      
T Consensus       147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~  226 (277)
T d1o6ya_         147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH  226 (277)
T ss_dssp             TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence                                                                                            


Q ss_pred             CCCCcc--CCCCCcCcHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHHHH
Q psy15820        157 VRDGYR--LEKPDHCRRELYNIMYYCWDKEPNERP-NFTELCDLLEKLL  202 (230)
Q Consensus       157 i~~~~~--~~~p~~~~~~~~~li~~cl~~dp~~Rp-t~~~i~~~l~~~~  202 (230)
                      +..+..  ...+..+|+++.++|.+||+.||.+|| |+.+++..|..+.
T Consensus       227 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            111111  122357899999999999999999999 8999998887764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.9e-29  Score=200.76  Aligned_cols=163  Identities=20%  Similarity=0.307  Sum_probs=138.6

Q ss_pred             cccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEE
Q psy15820         15 EVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCC   92 (230)
Q Consensus        15 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~   92 (230)
                      +|..++|++++.||+|+||.||+|.+     +.++..||+|+++...  .......+.+|+.++..+. ||||+++++++
T Consensus         1 ~i~l~dy~~~~~lG~G~fg~V~~~~~-----~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~   74 (337)
T d1o6la_           1 KVTMNDFDYLKLLGKGTFGKVILVRE-----KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAF   74 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEE
T ss_pred             CCchHhcEEEEEEecCcCeEEEEEEE-----CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeee
Confidence            36678999999999999999999998     5667789999996331  1223467889999999999 99999999999


Q ss_pred             ecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------
Q psy15820         93 TEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------  156 (230)
Q Consensus        93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------  156 (230)
                      .+.+.+|+|||||+||+|.+++....             .+++..+..++.||+.||.|||+++                
T Consensus        75 ~~~~~~~iv~ey~~gg~L~~~~~~~~-------------~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~  141 (337)
T d1o6la_          75 QTHDRLCFVMEYANGGELFFHLSRER-------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD  141 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred             ccccccccceeccCCCchhhhhhccc-------------CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC
Confidence            99999999999999999999988743             4899999999999999999999999                


Q ss_pred             --------------------------------------------------------------------------CCCCcc
Q psy15820        157 --------------------------------------------------------------------------VRDGYR  162 (230)
Q Consensus       157 --------------------------------------------------------------------------i~~~~~  162 (230)
                                                                                                ......
T Consensus       142 g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~  221 (337)
T d1o6la_         142 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE  221 (337)
T ss_dssp             SCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             CCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC
Confidence                                                                                      000113


Q ss_pred             CCCCCcCcHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy15820        163 LEKPDHCRRELYNIMYYCWDKEPNERPN-----FTELCD  196 (230)
Q Consensus       163 ~~~p~~~~~~~~~li~~cl~~dp~~Rpt-----~~~i~~  196 (230)
                      ...|..+++++.+||.+||+.||.+|++     +.++++
T Consensus       222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            4567889999999999999999999995     777776

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.9e-29  Score=198.22  Aligned_cols=158  Identities=23%  Similarity=0.416  Sum_probs=132.9

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHh-hcCCCCceeeEeeEEecC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMK-TLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~~~~h~niv~l~~~~~~~   95 (230)
                      ++|++++.||+|+||.||+|.+     +.++..||+|+++...  .......+..|..++. .+. ||||+++++++.+.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~-----~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEF-----KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-----TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEE-----CCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC-CCcEEEEEEEEccC
Confidence            6899999999999999999998     5667789999996321  1223455677777766 466 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +.+|+|||||++|+|.+++....             .+++..+..++.||+.||.|||+++                   
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~-------------~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~  142 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH-------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI  142 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE
T ss_pred             CceeEEEeecCCCcHHHHhhccC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCce
Confidence            99999999999999999998743             4889999999999999999999999                   


Q ss_pred             ------------------------------------------------------------------------CCCCccCC
Q psy15820        157 ------------------------------------------------------------------------VRDGYRLE  164 (230)
Q Consensus       157 ------------------------------------------------------------------------i~~~~~~~  164 (230)
                                                                                              +. ...+.
T Consensus       143 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-~~~~~  221 (320)
T d1xjda_         143 KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-MDNPF  221 (320)
T ss_dssp             EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCC
T ss_pred             eccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCC
Confidence                                                                                    11 12345


Q ss_pred             CCCcCcHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q psy15820        165 KPDHCRRELYNIMYYCWDKEPNERPNFT-ELCD  196 (230)
Q Consensus       165 ~p~~~~~~~~~li~~cl~~dp~~Rpt~~-~i~~  196 (230)
                      .|..+++++.+|+.+||..||++|||+. ++++
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            6778999999999999999999999995 6764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=1.1e-27  Score=194.42  Aligned_cols=121  Identities=21%  Similarity=0.362  Sum_probs=99.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-----CHHHHHHHHHHHHHHhhcCCCCceeeEeeE
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-----GERERLDLLQELTVMKTLDPHPNVVRLLGC   91 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~niv~l~~~   91 (230)
                      ..++|++++.||+|+||.||+|.+     ..++..||+|++....     ..........++.++..+. ||||++++++
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~-----~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~   75 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYA   75 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEE-----CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEE
Confidence            467899999999999999999998     5567779999985321     1111222233466666777 9999999999


Q ss_pred             EecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         92 CTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +...+.+|+|||||+||+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        76 ~~~~~~~~ivmE~~~gg~L~~~l~~~~-------------~~~e~~~~~~~~qi~~aL~ylH~~~  127 (364)
T d1omwa3          76 FHTPDKLSFILDLMNGGDLHYHLSQHG-------------VFSEADMRFYAAEIILGLEHMHNRF  127 (364)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHC-------------SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEECCEEEEEEEecCCCcHHHHHHhcc-------------cccHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999998742             4789999999999999999999999

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.6e-28  Score=190.90  Aligned_cols=120  Identities=23%  Similarity=0.513  Sum_probs=99.8

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++++.||+|+||.||+|.+     ..++..||+|+++... .......+.+|+.++..+. ||||+++++++.+.+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARN-----KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEE-----CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccc
Confidence            6899999999999999999999     4556679999996432 2233567899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++||||+.+ ++.+++...           ....+++..+..++.|++.||.|||+++
T Consensus        76 ~~iv~e~~~~-~~~~~~~~~-----------~~~~l~e~~~~~~~~qil~~L~yLH~~~  122 (298)
T d1gz8a_          76 LYLVFEFLHQ-DLKKFMDAS-----------ALTGIPLPLIKSYLFQLLQGLAFCHSHR  122 (298)
T ss_dssp             EEEEEECCSE-EHHHHHHHT-----------TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEeecCC-chhhhhhhh-----------cccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence            9999999975 555555443           1345899999999999999999999999

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.5e-27  Score=191.52  Aligned_cols=117  Identities=21%  Similarity=0.326  Sum_probs=97.5

Q ss_pred             CCCeeEee-eecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         18 RQHIKVFD-ILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        18 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      .++|++.. .||+|+||.||+|.+     ..++..||+|+++..      ..+.+|+.++.++.+||||+++++++.+  
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFN-----KRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEE-----CCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            46798864 699999999999998     456667999998642      3466899887766449999999999865  


Q ss_pred             --CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 --KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                        ...+|+|||||+||+|.+++....           ...+++..+..++.||+.||.|||+++
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~-----------~~~l~e~~~~~i~~qi~~al~ylH~~~  131 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRG-----------DQAFTEREASEIMKSIGEAIQYLHSIN  131 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCS-----------CCCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcC-----------CCCcCHHHHHHHHHHHHHHHHHHHHcC
Confidence              356899999999999999997631           235899999999999999999999999

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=8.6e-28  Score=191.48  Aligned_cols=159  Identities=21%  Similarity=0.385  Sum_probs=135.7

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK   95 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~   95 (230)
                      .++|++++.||+|+||.||+|.+     +.++..||+|+++...  .....+.+.+|+.++..+. ||||+++++++.+.
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~   76 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRS-----RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDA   76 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEE-----CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeC
Confidence            46899999999999999999998     5566779999986321  1223467889999999999 99999999999999


Q ss_pred             CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC-------------------
Q psy15820         96 EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG-------------------  156 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~-------------------  156 (230)
                      +.+|+|||||+||+|..++...             ..+++..+..++.||+.||.|||+++                   
T Consensus        77 ~~~~ivmE~~~gg~l~~~~~~~-------------~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~v  143 (316)
T d1fota_          77 QQIFMIMDYIEGGELFSLLRKS-------------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHI  143 (316)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT-------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCE
T ss_pred             CeeeeEeeecCCcccccccccc-------------ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCE
Confidence            9999999999999999988874             34788899999999999999999999                   


Q ss_pred             ---------------------------------------------------------------------CCCCccCCCCC
Q psy15820        157 ---------------------------------------------------------------------VRDGYRLEKPD  167 (230)
Q Consensus       157 ---------------------------------------------------------------------i~~~~~~~~p~  167 (230)
                                                                                           +.. .....|+
T Consensus       144 kL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-~~~~~p~  222 (316)
T d1fota_         144 KITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-AELRFPP  222 (316)
T ss_dssp             EECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-CCCCCCT
T ss_pred             EEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc-CCCCCCC
Confidence                                                                                 111 1245677


Q ss_pred             cCcHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy15820        168 HCRRELYNIMYYCWDKEPNERP-----NFTELCD  196 (230)
Q Consensus       168 ~~~~~~~~li~~cl~~dp~~Rp-----t~~~i~~  196 (230)
                      .+++++.+++.+||..||.+|+     |+.+|++
T Consensus       223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            8999999999999999999995     8999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.8e-27  Score=188.38  Aligned_cols=123  Identities=25%  Similarity=0.480  Sum_probs=98.5

Q ss_pred             CcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         12 DKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        12 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      ..|++ .++|++++.||+|+||.||+|.+     ..++..||+|+++.. ......+.+.+|+.++..+. |||||++++
T Consensus        12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~   84 (346)
T d1cm8a_          12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVD-----GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLD   84 (346)
T ss_dssp             SEECC-BSSEEEEEEC------CEEEEEE-----TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSE
T ss_pred             ceeec-CCcEEEEEEEecCCCeEEEEEEE-----CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEE
Confidence            33665 67899999999999999999998     456677999999743 45566778999999999998 999999999


Q ss_pred             EEecCC------CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKE------PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++...+      .++++|||| +.+|..++...              .+++..+..++.||+.||.|||+++
T Consensus        85 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~~  141 (346)
T d1cm8a_          85 VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--------------KLGEDRIQFLVYQMLKGLRYIHAAG  141 (346)
T ss_dssp             EECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EeccCccccccceEEEEEecc-cccHHHHHHhc--------------cccHHHHHHHHHHHHHHHHHHHhCC
Confidence            997654      479999999 56777776542              4899999999999999999999999

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.94  E-value=5.8e-27  Score=184.38  Aligned_cols=118  Identities=21%  Similarity=0.345  Sum_probs=100.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++.+.||+|+||.||+|.+.      ++..||+|+++... .......+.+|+.++..++ ||||+++++++...+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCc
Confidence            68999999999999999999872      34579999996442 2333567899999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++|++.++.+..+...             ...+++..+..++.||+.||.|||+++
T Consensus        75 ~~i~~e~~~~~~~~~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~  120 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVC-------------EGGLESVTAKSFLLQLLNGIAYCHDRR  120 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTS-------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEeehhhhHHHHHhh-------------cCCcchhhhHHHHHHHHHHHHHhccCc
Confidence            9999999987655555432             345899999999999999999999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=5.6e-27  Score=189.20  Aligned_cols=160  Identities=19%  Similarity=0.332  Sum_probs=136.4

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC--CHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA--GERERLDLLQELTVMKTLDPHPNVVRLLGCCTE   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~   94 (230)
                      ..++|++++.||+|+||.||+|.+     +.++..||+|+++...  .......+.+|+.++..+. ||||+++++++..
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~-----~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~  112 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKH-----KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKD  112 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-----TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             CccCeEEEEEeecCcCcEEEEEEE-----CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccc
Confidence            347899999999999999999998     5567789999985321  1223457889999999998 9999999999999


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC------------------
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG------------------  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~------------------  156 (230)
                      ....+++|||+.+|+|.+++....             .+++..+..++.||+.||.|||+++                  
T Consensus       113 ~~~~~~v~e~~~~g~l~~~l~~~~-------------~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~  179 (350)
T d1rdqe_         113 NSNLYMVMEYVAGGEMFSHLRRIG-------------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY  179 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC
T ss_pred             ccccccccccccccchhhhHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC
Confidence            999999999999999999987642             4899999999999999999999999                  


Q ss_pred             ----------------------------------------------------------------------CCCCccCCCC
Q psy15820        157 ----------------------------------------------------------------------VRDGYRLEKP  166 (230)
Q Consensus       157 ----------------------------------------------------------------------i~~~~~~~~p  166 (230)
                                                                                            +.. .....|
T Consensus       180 ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-~~~~~p  258 (350)
T d1rdqe_         180 IQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-GKVRFP  258 (350)
T ss_dssp             EEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCC
T ss_pred             EEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc-CCCCCC
Confidence                                                                                  111 124566


Q ss_pred             CcCcHHHHHHHHHhcCCCCCCC-----CCHHHHHH
Q psy15820        167 DHCRRELYNIMYYCWDKEPNER-----PNFTELCD  196 (230)
Q Consensus       167 ~~~~~~~~~li~~cl~~dp~~R-----pt~~~i~~  196 (230)
                      ..+++++.+||.+||+.||.+|     ||+.+|++
T Consensus       259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            7899999999999999999998     48999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.4e-26  Score=182.55  Aligned_cols=119  Identities=28%  Similarity=0.468  Sum_probs=104.9

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCC
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEP   97 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~   97 (230)
                      ++|++++.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+.++..++ |+||+++++++.....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKN-----RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEE-----CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccc
Confidence            6899999999999999999998     556677999999643 33456678999999999999 9999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         98 FFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        98 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      .++++|++.++++..++...             ..+++..+..++.|++.||.|||+++
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~q~~~aL~~lH~~~  121 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN-------------GDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT-------------TCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEeeeccccccccccccc-------------cccchhHHHHHHHHHHHHHHHhhcCC
Confidence            99999999998887777653             35789999999999999999999999

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.4e-27  Score=185.36  Aligned_cols=161  Identities=22%  Similarity=0.371  Sum_probs=131.4

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CH----HHHHHHHHHHHHHhhcC-CCCceeeEeeE
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GE----RERLDLLQELTVMKTLD-PHPNVVRLLGC   91 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~----~~~~~~~~e~~~l~~~~-~h~niv~l~~~   91 (230)
                      .++|++++.||+|+||.||+|.+     ..++..||+|+++... ..    .....+.+|+.++..+. .||||++++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~   77 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIR-----VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW   77 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence            35799999999999999999998     5566779999985321 10    11234668999999885 48999999999


Q ss_pred             EecCCCeEEEEecCCC-CCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------
Q psy15820         92 CTEKEPFFVIMEYVPY-GKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------  156 (230)
Q Consensus        92 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------  156 (230)
                      +.+.+..++||||+.+ +++.+++...             ..+++..+..++.||+.||.|||+++              
T Consensus        78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~-------------~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~  144 (273)
T d1xwsa_          78 FERPDSFVLILERPEPVQDLFDFITER-------------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID  144 (273)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH-------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred             EeeCCeEEEEEEeccCcchHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe
Confidence            9999999999999976 6777887763             24899999999999999999999999              


Q ss_pred             ----------------------------------------------------------CCCC------------ccCCCC
Q psy15820        157 ----------------------------------------------------------VRDG------------YRLEKP  166 (230)
Q Consensus       157 ----------------------------------------------------------i~~~------------~~~~~p  166 (230)
                                                                                +..|            .....+
T Consensus       145 ~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~  224 (273)
T d1xwsa_         145 LNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR  224 (273)
T ss_dssp             TTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCS
T ss_pred             cCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCC
Confidence                                                                      1111            123456


Q ss_pred             CcCcHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy15820        167 DHCRRELYNIMYYCWDKEPNERPNFTELCD  196 (230)
Q Consensus       167 ~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~  196 (230)
                      ..+|+++.+|+.+||+.||++|||+.|+++
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         225 QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            789999999999999999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2e-26  Score=182.63  Aligned_cols=113  Identities=20%  Similarity=0.363  Sum_probs=90.2

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE--   96 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~--   96 (230)
                      ++|.+.+.||+|+||.||+|++.       +..||+|+++...  ........|+..+..++ ||||+++++++...+  
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-------g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSRE--ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-------TEEEEEEEECGGG--HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccc--hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence            56888999999999999999873       3459999986432  21122233444555677 999999999997643  


Q ss_pred             --CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhc
Q psy15820         97 --PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSR  155 (230)
Q Consensus        97 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~  155 (230)
                        .+++|||||++|+|.++++..              .+++..++.++.|++.||.|||+.
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~--------------~l~~~~~~~~~~~ia~gl~~lH~~  119 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY--------------TVTVEGMIKLALSTASGLAHLHME  119 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC--------------CBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred             ceEEEEEEecccCCCHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHh
Confidence              479999999999999999763              388999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.8e-26  Score=186.18  Aligned_cols=122  Identities=18%  Similarity=0.331  Sum_probs=99.7

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      |+|.. +|++++.||+|+||.||+|.+     ..++..||||+++..........+++|+.++..+. ||||+++++++.
T Consensus         4 ~~i~~-rY~~~~~LG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~   76 (345)
T d1pmea_           4 FDVGP-RYTNLSYIGEGAYGMVCSAYD-----NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIR   76 (345)
T ss_dssp             CCCCT-TEEEEEECC---CCCEEEEEE-----TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEEC
T ss_pred             cCcCC-CeEEEEEEeeccCeEEEEEEE-----CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEe
Confidence            44544 599999999999999999998     55677899999976556667788999999999999 999999999986


Q ss_pred             cCC----CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         94 EKE----PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        94 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...    ..+++++++.+|+|.+++...              .+++..++.++.|++.||.|||+++
T Consensus        77 ~~~~~~~~~~~l~~~~~~g~L~~~l~~~--------------~l~~~~i~~i~~qil~al~yLH~~~  129 (345)
T d1pmea_          77 APTIEQMKDVYLVTHLMGADLYKLLKTQ--------------HLSNDHICYFLYQILRGLKYIHSAN  129 (345)
T ss_dssp             CSSTTTCCCEEEEEECCCEEHHHHHHHC--------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eccccccceEEEEEeecCCchhhhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            543    234455667789999999753              3899999999999999999999999

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.94  E-value=1e-26  Score=186.39  Aligned_cols=115  Identities=19%  Similarity=0.375  Sum_probs=98.9

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      +.++|++++.||+|+||.||+|.+     ..++..||+|+++...    ...+.+|+.++..+..||||+++++++..  
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~-----~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~  103 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAIN-----ITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPV  103 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEE-----CCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecC
Confidence            456899999999999999999998     5667789999997432    34678999999999669999999999874  


Q ss_pred             CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ...+++|||||++++|..+.                ..+++..+..++.||+.||.|||+++
T Consensus       104 ~~~~~~v~e~~~~~~L~~~~----------------~~l~e~~i~~i~~qil~aL~~LH~~g  149 (328)
T d3bqca1         104 SRTPALVFEHVNNTDFKQLY----------------QTLTDYDIRFYMYEILKALDYCHSMG  149 (328)
T ss_dssp             TCSEEEEEECCCSCBGGGTT----------------TSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCceeEEEeecCCCcHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHhhcc
Confidence            35689999999999986542                24899999999999999999999999

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7.5e-27  Score=188.58  Aligned_cols=125  Identities=24%  Similarity=0.384  Sum_probs=105.3

Q ss_pred             CCcccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEe
Q psy15820         11 DDKWEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLL   89 (230)
Q Consensus        11 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~   89 (230)
                      .+.|+++ ++|++++.||+|+||.||+|.+     ..++..||+|+++.. ........+.+|+.++..+. |+||++++
T Consensus        11 ~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~   83 (348)
T d2gfsa1          11 KTIWEVP-ERYQNLSPVGSGAYGSVCAAFD-----TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLL   83 (348)
T ss_dssp             SSEEEEE-TTEEEEEECGGGTTSSEEEEEE-----TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred             CccccCC-CCeEEEEEEecCCCeEEEEEEE-----CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEE
Confidence            4457774 7799999999999999999998     566788999999643 44556678999999999999 99999999


Q ss_pred             eEEecC-----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         90 GCCTEK-----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        90 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      +++...     ...+++++++.+|+|.+++..              ..+++..+..++.||+.||.|||+++
T Consensus        84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--------------~~l~e~~~~~i~~qil~aL~~LH~~g  141 (348)
T d2gfsa1          84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--------------QKLTDDHVQFLIYQILRGLKYIHSAD  141 (348)
T ss_dssp             EEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeeccccccCceEEEEEeecCCchhhhccc--------------ccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            998643     234666778889999998854              24899999999999999999999999

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.3e-27  Score=185.73  Aligned_cols=115  Identities=23%  Similarity=0.410  Sum_probs=93.3

Q ss_pred             EeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCH----HHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         23 VFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGE----RERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      .++.||+|+||.||+|.+     +.++..||+|+++.....    .....+.+|+.++..+. |||||++++++...+.+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARD-----KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEEC-----SSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCC
T ss_pred             cceEeccCcCeEEEEEEE-----CCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCce
Confidence            467899999999999998     456677999999643221    12346889999999999 99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++|||||.++++..+...             ...+++..+..++.||+.||.|||+++
T Consensus        76 ~ivmE~~~~~~~~~~~~~-------------~~~l~~~~~~~~~~qil~aL~~lH~~~  120 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDN-------------SLVLTPSHIKAYMLMTLQGLEYLHQHW  120 (299)
T ss_dssp             EEEEECCSEEHHHHHTTC-------------CSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred             eehhhhhcchHHhhhhhc-------------ccCCCHHHHHHHHHHHHHHHHHhhccc
Confidence            999999998766544332             335889999999999999999999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.2e-26  Score=182.83  Aligned_cols=128  Identities=18%  Similarity=0.343  Sum_probs=107.7

Q ss_pred             ccccCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC---CHHHHHHHHHHHHHHhhcCCCCceeeEee
Q psy15820         14 WEVPRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA---GERERLDLLQELTVMKTLDPHPNVVRLLG   90 (230)
Q Consensus        14 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~~h~niv~l~~   90 (230)
                      -++..++|++++.||+|+||.||+|.....  +.++..||+|+++...   .....+.+.+|+.++.++.+||||+++++
T Consensus        19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          19 EKVGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             cccchhceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence            346778999999999999999999987432  3457789999986321   12234568899999999983589999999


Q ss_pred             EEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         91 CCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                      ++.+...+++++||+.+|+|.+++....             .+++..+..++.||+.||.|||+++
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~-------------~~~e~~~~~~~~Qi~~al~~lH~~~  149 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQRE-------------RFTEHEVQIYVGEIVLALEHLHKLG  149 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeccCCceeeeeecccccHHHHHHHhcc-------------cccHHHHHHHHHHHHHHHHHhhcCC
Confidence            9999999999999999999999998753             3788999999999999999999999

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.5e-26  Score=183.95  Aligned_cols=116  Identities=23%  Similarity=0.370  Sum_probs=96.6

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC--
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK--   95 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~--   95 (230)
                      ++|++++.||+|+||.||+|.+     ..++..||||+++.. ........+.+|+.++..+. ||||+++++++...  
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d-----~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~   90 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYD-----AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKT   90 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEE-----TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEE-----CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccc
Confidence            6799999999999999999998     566788999999643 44556678999999999998 99999999999643  


Q ss_pred             ----CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ----EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                          ..+|+|||||.++ +.+.+.               ..+++..++.++.||+.||.|||++|
T Consensus        91 ~~~~~~~~iv~Ey~~~~-l~~~~~---------------~~~~~~~i~~~~~qil~gl~~LH~~g  139 (355)
T d2b1pa1          91 LEEFQDVYLVMELMDAN-LCQVIQ---------------MELDHERMSYLLYQMLCGIKHLHSAG  139 (355)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHHT---------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccCceeEEEEeccchH-HHHhhh---------------cCCCHHHHHHHHHHHHHHHHHhhhcc
Confidence                5689999999765 444432               24899999999999999999999999

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.2e-25  Score=180.03  Aligned_cols=117  Identities=24%  Similarity=0.383  Sum_probs=92.9

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecC---
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEK---   95 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~---   95 (230)
                      .+|+.+++||+|+||.||+|.+     ..++..||+|+++....     ...+|+.++..++ |+||+++++++...   
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~   88 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKL-----CDSGELVAIKKVLQDKR-----FKNRELQIMRKLD-HCNIVRLRYFFYSSGEK   88 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEE-----TTTCCEEEEEEEECCSS-----SCCHHHHHHHHCC-CTTBCCEEEEEEEC--C
T ss_pred             CCcEeeeEEeeCcCeEEEEEEE-----CCCCCEEEEEEECccch-----HHHHHHHHHHhcC-CCCCCcEEEEEEecCcc
Confidence            3689999999999999999999     45667799999964321     1236999999998 99999999998543   


Q ss_pred             ---CCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         96 ---EPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                         ..+++|||||+++ +...+.....         ....+++..+..++.||+.||.|||+++
T Consensus        89 ~~~~~~~lv~Ey~~~~-~~~~l~~~~~---------~~~~l~~~~~~~i~~qil~aL~yLH~~~  142 (350)
T d1q5ka_          89 KDEVYLNLVLDYVPET-VYRVARHYSR---------AKQTLPVIYVKLYMYQLFRSLAYIHSFG  142 (350)
T ss_dssp             CSCCEEEEEEECCSEE-HHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             CCceEEEEEEeccCCc-cHHHHHhhhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence               2378999999865 4444433211         2345899999999999999999999999

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=3.7e-25  Score=175.05  Aligned_cols=166  Identities=15%  Similarity=0.245  Sum_probs=130.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      ++|++++.||+|+||.||+|.+     ..++..||+|+++.....   ..+..|++++..+.+|++|+.+.+++...+..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~-----~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTD-----IAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-----TTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEE-----CCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            4699999999999999999998     556678999988643222   34678999999998345566667777788889


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC----------------------
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG----------------------  156 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~----------------------  156 (230)
                      ++||||+. +++...+...            ...+++..+..++.|++.||.|||+++                      
T Consensus        79 ~ivme~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~v  145 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFC------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV  145 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCE
T ss_pred             EEEEEEcC-Cchhhhhhhc------------cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCcee
Confidence            99999995 5777766553            335899999999999999999999999                      


Q ss_pred             ------------------------------------------------------------CCCCcc--------------
Q psy15820        157 ------------------------------------------------------------VRDGYR--------------  162 (230)
Q Consensus       157 ------------------------------------------------------------i~~~~~--------------  162 (230)
                                                                                  +..|..              
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~  225 (299)
T d1ckia_         146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  225 (299)
T ss_dssp             EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred             eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence                                                                        000000              


Q ss_pred             ---------C---CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhc
Q psy15820        163 ---------L---EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNE  205 (230)
Q Consensus       163 ---------~---~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~  205 (230)
                               .   ..+.++|+++.+++..||+.||++||++.+|.+.|+.++...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         226 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                     0   112478899999999999999999999999999998887543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2e-25  Score=177.03  Aligned_cols=123  Identities=28%  Similarity=0.511  Sum_probs=93.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcC-CHHHHHHHHHHHHHHhhcC--CCCceeeEeeEEec
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENA-GERERLDLLQELTVMKTLD--PHPNVVRLLGCCTE   94 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~--~h~niv~l~~~~~~   94 (230)
                      .++|++++.||+|+||.||+|.+..    .+++.||+|+++... .......+.+|+.++..+.  .||||+++++++..
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~   81 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   81 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC----CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence            3689999999999999999998842    235579999985332 2222234567777776552  39999999999853


Q ss_pred             -----CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 -----KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                           ...+++++||+.++.+......            ....+++..+..++.|++.||.|||+++
T Consensus        82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~  136 (305)
T d1blxa_          82 SRTDRETKLTLVFEHVDQDLTTYLDKV------------PEPGVPTETIKDMMFQLLRGLDFLHSHR  136 (305)
T ss_dssp             EECSSEEEEEEEEECCSCBHHHHHHHS------------CTTCSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccCceEEEEEEeccCCchhhhhhc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                 2458999999988765443332            2345899999999999999999999999

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.3e-24  Score=173.27  Aligned_cols=120  Identities=19%  Similarity=0.363  Sum_probs=96.1

Q ss_pred             CCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc-CCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEec--
Q psy15820         18 RQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN-AGERERLDLLQELTVMKTLDPHPNVVRLLGCCTE--   94 (230)
Q Consensus        18 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~--   94 (230)
                      .++|++++.||+|+||.||+|.+     ..++..||||++... ........+.+|+.++..++ |+||+++++.+..  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~   82 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARH-----RKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKA   82 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-----TTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC--
T ss_pred             cCCEEEEEEEecCcCeEEEEEEE-----CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeeccc
Confidence            47899999999999999999998     456677999998533 22334567889999999999 9999999998855  


Q ss_pred             ------CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC
Q psy15820         95 ------KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG  156 (230)
Q Consensus        95 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  156 (230)
                            .+.++++|||++++.+......             ...+++..+..++.|++.||.|||+++
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~-------------~~~~~~~~~~~i~~qil~~l~~lH~~~  137 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSNV-------------LVKFTLSEIKRVMQMLLNGLYYIHRNK  137 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTCT-------------TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccccccCceEEEEEeccCCCccchhhhc-------------ccccccHHHHHHHHHHHHHHHHhccCC
Confidence                  3458999999987655433222             345889999999999999999999999

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.91  E-value=4.6e-24  Score=168.17  Aligned_cols=169  Identities=18%  Similarity=0.203  Sum_probs=138.1

Q ss_pred             cCCCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCC
Q psy15820         17 PRQHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKE   96 (230)
Q Consensus        17 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~   96 (230)
                      -..+|++++.||+|+||.||+|.+     ..++..||+|+++.....   ..+.+|++.+..+.+|+|++.+++++....
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~-----~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTN-----LLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEE-----TTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CCCceEEEEEEecCCCeEEEEEEE-----CCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            357899999999999999999998     556778999988543222   246678889999885699999999999999


Q ss_pred             CeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcC--------------------
Q psy15820         97 PFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRG--------------------  156 (230)
Q Consensus        97 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--------------------  156 (230)
                      ..++||||+ +++|.+++...            ...++...+..++.|++.||.|||+++                    
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~------------~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~  141 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLC------------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKN  141 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTT
T ss_pred             ccEEEEEec-CCCHHHHHHhh------------ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccccc
Confidence            999999999 67999988763            235899999999999999999999999                    


Q ss_pred             ----------------------------------------------------------------CCCCccC---------
Q psy15820        157 ----------------------------------------------------------------VRDGYRL---------  163 (230)
Q Consensus       157 ----------------------------------------------------------------i~~~~~~---------  163 (230)
                                                                                      +..|..+         
T Consensus       142 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~  221 (293)
T d1csna_         142 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN  221 (293)
T ss_dssp             TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred             CCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence                                                                            0000000         


Q ss_pred             -----------------CCCCcCcHHHHHHHHHhcCCCCCCCCCHHHHHHHHHHHHhhcc
Q psy15820        164 -----------------EKPDHCRRELYNIMYYCWDKEPNERPNFTELCDLLEKLLLNET  206 (230)
Q Consensus       164 -----------------~~p~~~~~~~~~li~~cl~~dp~~Rpt~~~i~~~l~~~~~~~~  206 (230)
                                       ..+.++|+++.+++..||..+|++||++..+.+.|..+++...
T Consensus       222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence                             0124688999999999999999999999999999998886543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.82  E-value=5.7e-20  Score=148.51  Aligned_cols=121  Identities=16%  Similarity=0.251  Sum_probs=91.0

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC----------CCCceeeE
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD----------PHPNVVRL   88 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~----------~h~niv~l   88 (230)
                      .+|++++.||+|+||.||+|.+     ..++..||||+++..  ....+.+.+|+.++..+.          .|+||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~-----~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKD-----MVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-----TTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEE-----CCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            4599999999999999999998     566778999999743  444566778888877654          26889999


Q ss_pred             eeEEec--CCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhh-cC
Q psy15820         89 LGCCTE--KEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSS-RG  156 (230)
Q Consensus        89 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~  156 (230)
                      ++++..  ....+++++++..+..........          ....+++..+..++.||+.||.|||+ .+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~i~~i~~qil~al~~lh~~~~  146 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKY----------EHRGIPLIYVKQISKQLLLGLDYMHRRCG  146 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEeeeccccceeeeeeecccccccccccccc----------cccCCcHHHHHHHHHHHHHHHHHHhhhcC
Confidence            988754  345667777765554433333221          23458899999999999999999998 66

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.58  E-value=6e-15  Score=108.27  Aligned_cols=116  Identities=15%  Similarity=0.087  Sum_probs=88.3

Q ss_pred             eeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCC-----------------HHHHHHHHHHHHHHhhcCCCC
Q psy15820         21 IKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAG-----------------ERERLDLLQELTVMKTLDPHP   83 (230)
Q Consensus        21 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~e~~~l~~~~~h~   83 (230)
                      +.+++.||+|+||.||+|..     . ++..||+|+++....                 .........|...+..+. |.
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-----~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~   74 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-----E-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GL   74 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-----T-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TS
T ss_pred             chhCCEeeeCcceEEEEEEC-----C-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CC
Confidence            35789999999999999987     2 356799998753211                 112234566888888998 99


Q ss_pred             ceeeEeeEEecCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCCCCccC
Q psy15820         84 NVVRLLGCCTEKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVRDGYRL  163 (230)
Q Consensus        84 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~~~~~~  163 (230)
                      +++..+++..    .+++|||+++..+.                    .++......++.|++.||.|||++++.  |++
T Consensus        75 ~v~~~~~~~~----~~lvme~~~~~~~~--------------------~l~~~~~~~i~~ql~~~l~~lH~~gii--HrD  128 (191)
T d1zara2          75 AVPKVYAWEG----NAVLMELIDAKELY--------------------RVRVENPDEVLDMILEEVAKFYHRGIV--HGD  128 (191)
T ss_dssp             SSCCEEEEET----TEEEEECCCCEEGG--------------------GCCCSCHHHHHHHHHHHHHHHHHTTEE--CSC
T ss_pred             CcceEEEecC----CEEEEEeecccccc--------------------chhhHHHHHHHHHHHHHHHHHhhCCEE--Ecc
Confidence            9998886642    37999999876542                    145566778999999999999999999  999


Q ss_pred             CCCCcC
Q psy15820        164 EKPDHC  169 (230)
Q Consensus       164 ~~p~~~  169 (230)
                      .+|+|+
T Consensus       129 iKP~NI  134 (191)
T d1zara2         129 LSQYNV  134 (191)
T ss_dssp             CSTTSE
T ss_pred             CChhhe
Confidence            999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.17  E-value=0.0006  Score=50.51  Aligned_cols=114  Identities=11%  Similarity=-0.016  Sum_probs=74.7

Q ss_pred             CCeeEeeeecceeceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEecCCCe
Q psy15820         19 QHIKVFDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCTEKEPF   98 (230)
Q Consensus        19 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~~~~~~   98 (230)
                      +.|+..+..+.++.+.||+....       +..+.+|+..... ......+.+|...+..+..+-.+.+++.+....+..
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~~-------~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEECS-------SCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             hceEEEEcCCCCCCCcEEEEEeC-------CCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45666665544555789986532       1226778765321 111224567888887776566678888888888889


Q ss_pred             EEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820         99 FVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus        99 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      +++|++++|.++.+...                  +......++.+++..+..||+....
T Consensus        86 ~lv~~~l~G~~~~~~~~------------------~~~~~~~~~~~l~~~l~~lH~~~~~  127 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYE------------------DEQSPEKIIELYAECIRLFHSIDIS  127 (263)
T ss_dssp             EEEEECCSSEEHHHHTT------------------TCSCHHHHHHHHHHHHHHHHTSCCT
T ss_pred             EEEEEeccccccccccc------------------ccccHHHHHHHHHHHHHHHhccCcc
Confidence            99999999988765432                  2223345677888899999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=94.03  E-value=0.076  Score=38.30  Aligned_cols=101  Identities=23%  Similarity=0.194  Sum_probs=61.8

Q ss_pred             eccee-ceeEEEeEEeccCCCCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcC-CCCceeeEeeEEecCCCeEEEEec
Q psy15820         27 LGEGC-FGQVWKCEALGIDGREGPCIVAVKTLKENAGERERLDLLQELTVMKTLD-PHPNVVRLLGCCTEKEPFFVIMEY  104 (230)
Q Consensus        27 lg~G~-~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-~h~niv~l~~~~~~~~~~~lv~e~  104 (230)
                      +..|. -+.||+....      ++..+++|.......    ..+..|...+..+. ..-.+.+++.+....+..+++|++
T Consensus        18 ~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             CSCTTSSCEEEEEECT------TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             cCCcccCCeEEEEEeC------CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            34444 3568876552      223377887653321    23456666666554 134467788888888889999999


Q ss_pred             CCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820        105 VPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus       105 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      ++|.++.+                  .....   ...+.++...|.-||+....
T Consensus        88 i~G~~~~~------------------~~~~~---~~~~~~l~~~la~LH~~~~~  120 (255)
T d1nd4a_          88 VPGQDLLS------------------SHLAP---AEKVSIMADAMRRLHTLDPA  120 (255)
T ss_dssp             CSSEETTT------------------SCCCH---HHHHHHHHHHHHHHTTSCGG
T ss_pred             eecccccc------------------ccccH---HHHHHHHHHHHHHHccCChh
Confidence            99866521                  11222   23456788888899986543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=91.13  E-value=0.34  Score=37.56  Aligned_cols=80  Identities=16%  Similarity=0.100  Sum_probs=48.3

Q ss_pred             eeeecceeceeEEEeEEeccCCCCCceEEEEEecCCc--C----CHHHHHHHHHHHHHHhhcCCC--CceeeEeeEEecC
Q psy15820         24 FDILGEGCFGQVWKCEALGIDGREGPCIVAVKTLKEN--A----GERERLDLLQELTVMKTLDPH--PNVVRLLGCCTEK   95 (230)
Q Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~----~~~~~~~~~~e~~~l~~~~~h--~niv~l~~~~~~~   95 (230)
                      .+.||.|....||+...     ..+++.+++|.....  .    -+....+...|.+.+..+..+  ..+++++.+  +.
T Consensus        31 ~~eig~G~~N~vfrV~~-----~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYD-----QEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred             EEEeCCCceEeEEEEEe-----CCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence            45689999999999876     233445888865321  0    011223345677777765423  446666655  34


Q ss_pred             CCeEEEEecCCCCCH
Q psy15820         96 EPFFVIMEYVPYGKL  110 (230)
Q Consensus        96 ~~~~lv~e~~~~g~L  110 (230)
                      ...+++||++++..+
T Consensus       104 ~~~~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CCCEEEEeccCCccc
Confidence            456799999987655

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=86.54  E-value=2  Score=32.83  Aligned_cols=114  Identities=18%  Similarity=0.271  Sum_probs=69.8

Q ss_pred             ccCCCeeEeeeecceeceeEEEeEEeccCC--CCCceEEEEEecCCcCCHHHHHHHHHHHHHHhhcCCCCceeeEeeEEe
Q psy15820         16 VPRQHIKVFDILGEGCFGQVWKCEALGIDG--REGPCIVAVKTLKENAGERERLDLLQELTVMKTLDPHPNVVRLLGCCT   93 (230)
Q Consensus        16 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~~h~niv~l~~~~~   93 (230)
                      ++.+++++ +.|+.|-.-.+|+........  +..+..+.+++.-.....   ....+|..++..+..+.-.+++++++.
T Consensus        40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE---SHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh---hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            34455665 567888889999987643211  122334666655422222   234578888887764444567888874


Q ss_pred             cCCCeEEEEecCCCCCHHHHHHHhhhhhhccccCCCCCCCChHHHHHHHHHHHhhhhhhhhcCCC
Q psy15820         94 EKEPFFVIMEYVPYGKLQSFLRSSRAQRYYNNMHGKSNSLTSRDLTSFCYQVARGMQFLSSRGVR  158 (230)
Q Consensus        94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~i~  158 (230)
                      .    ++|+||++|.++.                     ........+..+++..|.-+|...+.
T Consensus       116 ~----g~I~efi~g~~l~---------------------~~d~~~~~~~~~iA~~La~lH~~~~~  155 (395)
T d1nw1a_         116 G----GRLEEYIPSRPLS---------------------CHEISLAHMSTKIAKRVAKVHQLEVP  155 (395)
T ss_dssp             T----EEEECCCCEEECC---------------------TTGGGSHHHHHHHHHHHHHHTTCCCS
T ss_pred             C----ceEEEEeccccCC---------------------hhhccchhhhHHHHHHHHHHhhcccc
Confidence            3    5899999875542                     11122234677888889999986543